PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zimmermann, MB; Jooste, PL; Pandav, CS				Zimmermann, Michael B.; Jooste, Pieter L.; Pandav, Chandrakant S.			Iodine-deficiency disorders	LANCET			English	Review							SCHOOL-AGE-CHILDREN; IODIZED SALT; GOITER PREVALENCE; UNITED-STATES; REPRODUCTIVE FAILURE; DEVELOPING-COUNTRIES; THYROID-DEFICIENCY; ENDEMIC GOITER; DIETARY IODINE; BOSTON-AREA	2 billion individuals worldwide have insufficient iodine intake, with those in south Asia and sub-Saharan Africa particularly affected. Iodine deficiency has many adverse effects on growth and development. These effects are due to inadequate production of thyroid hormone and are termed iodine-deficiency disorders. Iodine deficiency is the most common cause of preventable mental impairment worldwide. Assessment methods include urinary iodine concentration, goitre, newborn thyroid-stimulating hormone, and blood thyroglobulin. In nearly all countries, the best strategy to control iodine deficiency is iodisation of salt, which is one of the most cost-effective ways to contribute to economic and social development. When iodisation of salt is not possible, iodine supplements can be given to susceptible groups. Introduction of iodised salt to regions of chronic iodine-deficiency disorders might transiently increase the proportion of thyroid disorders, but overall the small risks of iodine excess are far outweighed by the substantial risks of iodine deficiency. International efforts to control iodine-deficiency disorders are slowing, and reaching the third of the worldwide population that remains deficient poses major challenges.	[Zimmermann, Michael B.] Swiss Fed Inst Technol, Human Nutr Lab, CH-8092 Zurich, Switzerland; [Zimmermann, Michael B.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; [Jooste, Pieter L.] MRC, Nutr Intervent Res Unit, Cape Town, South Africa; [Pandav, Chandrakant S.] All India Inst Med Sci, Ctr Community Med, New Delhi, India	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; All India Institute of Medical Sciences (AIIMS) New Delhi	Zimmermann, MB (corresponding author), Swiss Fed Inst Technol, Human Nutr Lab, Schmelzbergstr 7,LFV E19, CH-8092 Zurich, Switzerland.	michael.zimmermann@ilw.agrl.ethz.ch	Zimmermann, Michael B/C-3062-2016					Abuye C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-316; Aguayo VM, 2003, PUBLIC HEALTH NUTR, V6, P653, DOI 10.1079/PHN2003484; Andersen S, 2008, BRIT J NUTR, V99, P813, DOI 10.1017/S0007114507842292; Andersson M, 2007, PUBLIC HEALTH NUTR, V10, P1606, DOI 10.1017/S1368980007361004; [Anonymous], WORLD POP PROSP 2004; [Anonymous], WHO GLOB DAT IOD DEF; Assey VD, 2006, FOOD NUTR BULL, V27, P292, DOI 10.1177/156482650602700402; Atego EA, 2005, IDD NEWSLETTER, V21, P1; BENMILOUD M, 1994, J CLIN ENDOCR METAB, V79, P20, DOI 10.1210/jc.79.1.20; Bleichrodt N., 1987, PREVENTION CONTROL I, P65; Brauer VFH, 2006, EUR J ENDOCRINOL, V155, P807, DOI 10.1530/eje.1.02302; Braverman LE, 2007, THYROID, V17, P819, DOI 10.1089/thy.2007.0105; Caldwell KL, 2005, ACCREDIT QUAL ASSUR, V10, P356, DOI 10.1007/s00769-005-0003-x; Caldwell KL, 2005, THYROID, V15, P692, DOI 10.1089/thy.2005.15.692; CAO XY, 1994, NEW ENGL J MED, V331, P1739, DOI 10.1056/NEJM199412293312603; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chavasit V, 2002, J FOOD COMPOS ANAL, V15, P265, DOI 10.1006/jfca.2002.1054; Chen ZP., 2007, IDD NEWSLETTER, V23, P18; CHOW CC, 1991, CLIN ENDOCRINOL, V34, P413, DOI 10.1111/j.1365-2265.1991.tb00314.x; Cobra C, 1997, J NUTR, V127, P574, DOI 10.1093/jn/127.4.574; CONNOLLY KJ, 1979, LANCET, V2, P1149; Corvilain B, 1998, THYROID, V8, P107, DOI 10.1089/thy.1998.8.107; De Benoist B, FOOD NUTR B IN PRESS; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Delange F, 2002, THYROID, V12, P915, DOI 10.1089/105072502761016557; Delange F, 1999, THYROID, V9, P545, DOI 10.1089/thy.1999.9.545; DELANGE F, THYROID ITS DIS; DeLong GR, 1997, LANCET, V350, P771, DOI 10.1016/S0140-6736(96)12365-5; Dillon JC, 2000, BRIT J OBSTET GYNAEC, V107, P631, DOI 10.1111/j.1471-0528.2000.tb13305.x; Diosady L. L., 1998, Food and Nutrition Bulletin, V19, P240; Diosady L. L., 1997, Food and Nutrition Bulletin, V18, P388; *DIS CONTR PRIOR P, IOD DEF CHILDR AG 5; Doerge DR, 2002, J CHROMATOGR B, V777, P269, DOI 10.1016/S1570-0232(02)00214-3; Dunn JT, 2000, THYROID, V10, P681, DOI 10.1089/10507250050137752; Dunn JT, 2003, J NUTR, V133, p3008S, DOI 10.1093/jn/133.9.3008S; Egbuta J, 2003, PUBLIC HEALTH NUTR, V6, P169, DOI 10.1079/PHN2002413; El-Ghawi UM, 2006, BIOL TRACE ELEM RES, V111, P31, DOI 10.1385/BTER:111:1:31; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; *EUR COMM HACPD GS, 2002, OP SCI COMM FOOD TOL; Glinoer D, 2006, THYROID, V16, P947, DOI 10.1089/thy.2006.16.947; *GOV IND MIN HLTH, 2007, 2005 06 NAT FAM HLTH; Haddow JE, 2007, J CLIN ENDOCR METAB, V92, P1019, DOI 10.1210/jc.2006-2156; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Haldimann M, 2005, J FOOD COMPOS ANAL, V18, P461, DOI 10.1016/j.jfca.2004.06.003; Horton S, 2006, J NUTR, V136, P1068, DOI 10.1093/jn/136.4.1068; IBRAHIM M, 2006, COCHRANE DB SYST REV, V2; Jooste PL, 2001, B WORLD HEALTH ORGAN, V79, P534; Knudsen N, 2000, EUR J CLIN NUTR, V54, P361, DOI 10.1038/sj.ejcn.1600935; KOPP P, 1994, J CLIN ENDOCR METAB, V79, P134, DOI 10.1210/jc.79.1.134; Laurberg P, 2004, J CLIN ENDOCR METAB, V89, P181, DOI 10.1210/jc.2003-030829; LAURBERG P, 1991, J INTERN MED, V229, P415, DOI 10.1111/j.1365-2796.1991.tb00368.x; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P219, DOI 10.1530/eje.1.02210; Li M, 2006, MED J AUSTRALIA, V184, P165, DOI 10.5694/j.1326-5377.2006.tb00177.x; Mason J. B., 2002, Food and Nutrition Bulletin, V23, P292; McGuire J., 1994, ENRICHING LIVES OVER; *NAT AC DIET I MED, 2001, REF INT VIT A VIT K; Nazaimoon WMW, 1996, CLIN ENDOCRINOL, V45, P79, DOI 10.1046/j.1365-2265.1996.00785.x; O'Donnell KJ, 2002, DEV MED CHILD NEUROL, V44, P76, DOI 10.1017/S0012162201001712; Okosieme OE, 2006, J ROY SOC MED, V99, P396, DOI 10.1258/jrsm.99.8.396; Pearce EN, 2007, J CLIN ENDOCR METAB, V92, P1673, DOI 10.1210/jc.2006-2738; Pearce EN, 2004, J CLIN ENDOCR METAB, V89, P3421, DOI 10.1210/jc.2003-032002; Pedersen IB, 2007, J CLIN ENDOCR METAB, V92, P3122, DOI 10.1210/jc.2007-0732; Pedersen IB, 2006, J CLIN ENDOCR METAB, V91, P3830, DOI 10.1210/jc.2006-0652; PHAROAH POD, 1971, LANCET, V1, P308; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; Pop VJ, 2005, LANCET, V365, P1604, DOI 10.1016/S0140-6736(05)66489-6; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Qian M, 2005, ASIA PAC J CLIN NUTR, V14, P32; ROUSSET BA, THYROID ITS DIS; Sack Joseph, 2003, Pediatr Endocrinol Rev, V1 Suppl 2, P170; Sankar R, 2005, NATL MED J INDIA, V18, P169; Sartelet H, 1996, NUTRITION, V12, P100, DOI 10.1016/0899-9007(96)90707-8; Seal JA, 2007, MED J AUSTRALIA, V186, P69, DOI 10.5694/j.1326-5377.2007.tb00803.x; Sehestedt T, 2006, CLIN ENDOCRINOL, V65, P229, DOI 10.1111/j.1365-2265.2006.02580.x; SQUATRITO S, 1986, J CLIN ENDOCR METAB, V63, P368, DOI 10.1210/jcem-63-2-368; Sullivan KM, 1997, J NUTR, V127, P55, DOI 10.1093/jn/127.1.55; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Thomson BM, 2008, BRIT J NUTR, V99, P614, DOI 10.1017/S0007114507812001; Todd CH, 1998, AM J CLIN NUTR, V67, P1279, DOI 10.1093/ajcn/67.6.1279; *UNICEF, STAT WORLDS CHILDR 2; *UNICEF, FACT SHEET IDD ACH C; *UNICEF NUTR SECT, 2007, PROT CHILDR BRAIN DE, P1; United Nations, MILL DEV GOALS MDGS; Untoro J, 2006, AM J CLIN NUTR, V84, P1208, DOI 10.1093/ajcn/84.5.1208; Utiger RD, 2006, NEW ENGL J MED, V354, P2819, DOI 10.1056/NEJMe068092; Vanderpas J, 2006, ANNU REV NUTR, V26, P293, DOI 10.1146/annurev.nutr.26.010506.103810; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; *WHO INT COUNC CON, 2001, WHONHD011 INT COUNC; Yang F, 2007, EUR J ENDOCRINOL, V156, P403, DOI 10.1530/EJE-06-0651; Zimmermann M, 2000, EUR J ENDOCRINOL, V143, P727, DOI 10.1530/eje.0.1430727; Zimmermann MB, 2006, AM J CLIN NUTR, V83, P108; Zimmermann MB, 2005, AM J CLIN NUTR, V82, P388, DOI 10.1093/ajcn/82.2.388; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P840, DOI 10.1093/ajcn/81.4.840; Zimmermann MB, 2004, J NUTR, V134, P1673, DOI 10.1093/jn/134.7.1673; Zimmermann MB, 2004, AM J CLIN NUTR, V79, P642; Zimmermann MB, 2004, AM J CLIN NUTR, V79, P231; Zimmermann MB, 2003, AM J CLIN NUTR, V77, P663, DOI 10.1093/ajcn/77.3.663; Zimmermann MB, 2007, THYROID, V17, P829, DOI 10.1089/thy.2007.0108; Zimmermann MB, 2007, AM J CLIN NUTR, V86, P1040, DOI 10.1093/ajcn/86.4.1040; Zimmermann MB, 2007, J CLIN ENDOCR METAB, V92, P3436, DOI 10.1210/jc.2007-1082; Zimmermann MB, 2007, J CLIN ENDOCR METAB, V92, P437, DOI 10.1210/jc.2006-1901; Zimmermann MB, 2006, J CLIN ENDOCR METAB, V91, P4881, DOI 10.1210/jc.2006-1370; Zimmermann MB, 2006, ANNU REV NUTR, V26, P367, DOI 10.1146/annurev.nutr.26.061505.111236	104	580	618	3	86	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1251	1262		10.1016/S0140-6736(08)61005-3	http://dx.doi.org/10.1016/S0140-6736(08)61005-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357YB	18676011				2022-12-28	WOS:000259882000031
J	Stone, JL; O'Donovan, MC; Gurling, H; Kirov, GK; Blackwood, DHR; Corvin, A; Craddock, NJ; Gill, M; Hultman, CM; Lichtenstein, P; McQuillin, A; Pato, CN; Ruderfer, DM; Owen, MJ; St Clair, D; Sullivan, PF; Sklar, P; Purcell, SM; Scolnick, EM; Holmans, PA; Georgieva, L; Nikolov, I; Norton, N; Williams, H; Williams, NM; Toncheva, D; Milanova, V; Thelander, EF; Morris, DW; O'Dushlaine, CT; Kenny, E; Waddington, JL; Choudhury, K; Datta, S; Pimm, J; Thirumalai, S; Puri, V; Krasucki, R; Lawrence, J; Quested, D; Bass, N; Curtis, D; Crombie, C; Fraser, G; Kwan, SL; Muir, WJ; McGhee, KA; Pickard, B; Malloy, P; Maclean, AW; Van Beck, M; Visscher, PM; Macgregor, S; Pato, MT; Medeiros, H; Middleton, F; Carvalho, C; Morley, C; Fanous, A; Conti, D; Knowles, JA; Ferreira, CP; Azevedo, MH; McCarroll, SA; Gates, C; Daly, MJ; Sklar, P				Stone, Jennifer L.; O'Donovan, Michael C.; Gurling, Hugh; Kirov, George K.; Blackwood, Douglas H. R.; Corvin, Aiden; Craddock, Nick J.; Gill, Michael; Hultman, Christina M.; Lichtenstein, Paul; McQuillin, Andrew; Pato, Carlos N.; Ruderfer, Douglas M.; Owen, Michael J.; St Clair, David; Sullivan, Patrick F.; Sklar, Pamela; Purcell, Shaun M.; Scolnick, E. M.; Holmans, P. A.; Georgieva, L.; Nikolov, I.; Norton, N.; Williams, H.; Williams, N. M.; Toncheva, D.; Milanova, V.; Thelander, E. F.; Morris, D. W.; O'Dushlaine, C. T.; Kenny, E.; Waddington, J. L.; Choudhury, K.; Datta, S.; Pimm, J.; Thirumalai, S.; Puri, V.; Krasucki, R.; Lawrence, J.; Quested, D.; Bass, N.; Curtis, D.; Crombie, C.; Fraser, G.; Kwan, S. L.; Muir, W. J.; McGhee, K. A.; Pickard, B.; Malloy, P.; Maclean, A. W.; Van Beck, M.; Visscher, P. M.; Macgregor, S.; Pato, M. T.; Medeiros, H.; Middleton, F.; Carvalho, C.; Morley, C.; Fanous, A.; Conti, D.; Knowles, J. A.; Ferreira, C. P.; Azevedo, M. H.; McCarroll, S. A.; Gates, C.; Daly, M. J.; Sklar, P.		Int Schizophrenia Consortium	Rare chromosomal deletions and duplications increase risk of schizophrenia	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LOW COPY REPEATS; DISORDERS; REARRANGEMENTS; ASSOCIATION; LINKAGE; NUMBER; LOCUS; MICRODELETION; ARCHITECTURE	Schizophrenia is a severe mental disorder marked by hallucinations, delusions, cognitive deficits and apathy, with a heritability estimated at 73 - 90% ( ref. 1). Inheritance patterns are complex, and the number and type of genetic variants involved are not understood. Copy number variants ( CNVs) have been identified in individual patients with schizophrenia(2-7) and also in neurodevelopmental disorders(8-11), but large- scale genome- wide surveys have not been performed. Here we report a genome- wide survey of rare CNVs in 3,391 patients with schizophrenia and 3,181 ancestrally matched controls, using high- density microarrays. For CNVs that were observed in less than 1% of the sample and were more than 100 kilobases in length, the total burden is increased 1.15- fold in patients with schizophrenia in comparison with controls. This effect was more pronounced for rarer, single- occurrence CNVs and for those that involved genes as opposed to those that did not. As expected, deletions were found within the region critical for velo- cardio- facial syndrome, which includes psychotic symptoms in 30% of patients(12). Associations with schizophrenia were also found for large deletions on chromosome 15q13.3 and 1q21.1. These associations have not previously been reported, and they remained significant after genome- wide correction. Our results provide strong support for a model of schizophrenia pathogenesis that includes the effects of multiple rare structural variants, both genome- wide and at specific loci.	[Stone, Jennifer L.; Ruderfer, Douglas M.; Sklar, Pamela; Purcell, Shaun M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Stone, Jennifer L.; Ruderfer, Douglas M.; Sklar, Pamela; Purcell, Shaun M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Stone, Jennifer L.; Ruderfer, Douglas M.; Sklar, Pamela; Purcell, Shaun M.; Scolnick, E. M.; McCarroll, S. A.; Gates, C.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Stone, Jennifer L.; Ruderfer, Douglas M.; Sklar, Pamela; Purcell, Shaun M.; McCarroll, S. A.] Massachusetts Gen Hosp, Ctr Human Genet Res, Cambridge, MA 02142 USA; [O'Donovan, Michael C.; Kirov, George K.; Craddock, Nick J.; Owen, Michael J.; Holmans, P. A.; Georgieva, L.; Nikolov, I.; Norton, N.; Williams, H.; Williams, N. M.] Cardiff Univ, Sch Med, Dept Med Psychol, Sch Med, Cardiff C14 4XN, Wales; [Gurling, Hugh; McQuillin, Andrew; Choudhury, K.; Datta, S.; Pimm, J.; Puri, V.; Krasucki, R.; Lawrence, J.; Bass, N.] UCL, Sch Med, Mol Psychiat Lab, Dept Mental Hlth Sci,Windeyer Inst Med Sci, London W1T 4JF, England; [Blackwood, Douglas H. R.; Muir, W. J.; McGhee, K. A.; Pickard, B.; Malloy, P.; Maclean, A. W.; Van Beck, M.] Univ Edinburgh, Div Psychiat, Sch Mol & Clin Med, Edinburgh EH10 5HF, Midlothian, Scotland; [Corvin, Aiden; Gill, Michael; Morris, D. W.; O'Dushlaine, C. T.; Kenny, E.] Univ Dublin Trinity Coll, Neuropsychiat Genet Res Grp, Dept Psychiat, Dublin 2, Ireland; [Corvin, Aiden; Gill, Michael; Morris, D. W.; O'Dushlaine, C. T.; Kenny, E.] Univ Dublin Trinity Coll, Neuropsychiat Genet Res Grp, Inst Mol Med, Dublin 2, Ireland; [Hultman, Christina M.; Lichtenstein, Paul; Thelander, E. F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Hultman, Christina M.] Uppsala Univ, Dept Neurosci Psychiat, SE-75017 Uppsala, Sweden; [Pato, Carlos N.; Pato, M. T.; Medeiros, H.; Carvalho, C.; Fanous, A.; Conti, D.; Knowles, J. A.] Univ So Calif, Ctr Genom Psychiat, Los Angeles, CA 90033 USA; [St Clair, David; Kwan, S. L.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Visscher, P. M.; Macgregor, S.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Toncheva, D.] Univ Hosp Maichin Dom, Dept Med Genet, Sofia 1431, Bulgaria; [Milanova, V.] Alexander Univ Hosp, Dept Psychiat, Psychiat Clin 1, Sofia 1431, Bulgaria; [Waddington, J. L.] Royal Coll Surgeons Ireland, Molec & Cellular Therapeut & RCSI res Inst, Dublin 2, Ireland; [Thirumalai, S.] W Berkshire NHS Trust, Reading RG3 5LR, Berks, England; [Quested, D.] W London Mental Hlth Trust, Hammersmith & Fulham Mental Hlth Unit, London W6 8RF, England; St Bernards Hosp, London, England; [Curtis, D.] Royal London Hosp, Univ London & E London & City Mental Hlth Trust, Quenn Mary Coll, London E1 1BB, England; [Crombie, C.; Fraser, G.] Univ Aberdeen, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland; Ravenscraig Hosp, Greenock PA16 9HA, Scotland; [Middleton, F.; Morley, C.] SUNY, Upstate Med Ctr, Syracuse, NY 13210 USA; [Fanous, A.] Washington VA Med Ctr, Washington, DC 20422 USA; [Fanous, A.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC 20057 USA; [Fanous, A.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA; [Ferreira, C. P.; Azevedo, M. H.] Dept Psychiat, P-9500310 Sao Miguel, Portugal; Univ Coimbra, Dept Psychiat, P-3004504 Coimbra, Portugal	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Cardiff University; University of London; University College London; UCL Medical School; University of Edinburgh; Trinity College Dublin; Trinity College Dublin; Karolinska Institutet; Uppsala University; University of Southern California; University of Aberdeen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; QIMR Berghofer Medical Research Institute; Medical University Sofia; Medical University Sofia; Royal College of Surgeons - Ireland; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Aberdeen; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; SUNY Maritime College; Georgetown University; Virginia Commonwealth University; Universidade de Coimbra	Sklar, P (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, 185 Cambridge St, Boston, MA 02114 USA.	sklar@chgr.mgh.harvard.edu	McQuillin, Andrew/C-1623-2008; Macgregor, Stuart/C-6442-2009; macedo, antónio/AFQ-1570-2022; St Clair, David/AAN-2412-2021; Curtis, David/HGB-3921-2022; Pickard, Benjamin S/K-3923-2014; Ruderfer, Douglas M/M-5795-2016; Visscher, Peter/ABB-6151-2020; Morley, Christopher P./W-5037-2019; Fanous, Ayman H/O-1263-2017; Morris, Derek/AAW-8343-2021; Williams, Hywel/AAL-2440-2021; Morley, Christopher P./K-1907-2014; Holmans, Peter/F-4518-2015; macedo, antónio/AFQ-1571-2022; Daly, Mark J/B-2453-2017; O'Donovan, Michael C/P-7005-2018; blackwood, douglas/AIB-8874-2022; Barreto Carvalho, Célia/AAY-8962-2021; macedo santos, antónio/M-5737-2013; Gurling, Hugh M/A-5029-2010	McQuillin, Andrew/0000-0003-1567-2240; Macgregor, Stuart/0000-0001-6731-8142; macedo, antónio/0000-0003-2180-2718; Curtis, David/0000-0002-4089-9183; Pickard, Benjamin S/0000-0002-2374-6329; Ruderfer, Douglas M/0000-0002-2365-386X; Visscher, Peter/0000-0002-2143-8760; Morley, Christopher P./0000-0003-0185-7148; Morris, Derek/0000-0002-3413-570X; Williams, Hywel/0000-0001-7758-0312; Morley, Christopher P./0000-0003-0185-7148; Holmans, Peter/0000-0003-0870-9412; macedo, antónio/0000-0003-2180-2718; Daly, Mark J/0000-0002-0949-8752; O'Donovan, Michael C/0000-0001-7073-2379; macedo santos, antónio/0000-0003-2180-2718; Walters, James/0000-0002-6980-4053; Toncheva, Draga/0000-0002-7451-6363; de Oliveira Barreto Coimbra Carvalho, Celia Maria/0000-0003-4453-8139; Kirov, George/0000-0002-3427-3950; Middleton, Frank/0000-0002-3107-7188; Corvin, Aiden/0000-0001-6717-4089; Quested, Digby/0000-0001-6155-3336; Gill, Michael/0000-0003-0206-5337; lichtenstein, paul/0000-0003-3037-5287	Medical Research Council (UK) Programme; National Institutes of Mental Health (USA) [CONTE: 2 P50 MH066392-05A1]; Swedish Council for Working Life and Social Research [FO 184/2000; 2001-2368]; Stanley Medical Research Institute [MH071681]; Narsad Young Investigator Award; Australian National Health and Medical Research Council; Science Foundation Ireland; Health Research Board (Ireland); Stanley Medical Research Institute; Wellcome Trust; GlaxoSmithKline; Generation Scotland; Genetics Health Initiative; Neuroscience Research Charitable Trust; Camden and Islington Mental Health and Social Care Trust; East London and City Mental Heath Trust; West Berkshire NHS Trust,; West London Mental Health Trust; Oxfordshire and Buckinghamshire Mental Health Partnership NHS Trust; South Essex Partnership NHS Foundation Trust; Gloucestershire Partnership NHS Foundation Trust; Mersey Care NHS Trust; Hampshire Partnership NHS Trust; North East London Mental Health Trust; Chief Scientist Office of the Scottish Executive; Sylvan C. Herman Foundation; National Institutes of Mental Health and the Department of Veterans Affairs;  [MH074027];  [MH077139];  [MH080403]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071681, R01MH080403, R01MH074027, R01MH077139, P50MH066392] Funding Source: NIH RePORTER	Medical Research Council (UK) Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Mental Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stanley Medical Research Institute; Narsad Young Investigator Award(NARSAD); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board (Ireland); Stanley Medical Research Institute; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Generation Scotland; Genetics Health Initiative; Neuroscience Research Charitable Trust; Camden and Islington Mental Health and Social Care Trust; East London and City Mental Heath Trust; West Berkshire NHS Trust,; West London Mental Health Trust; Oxfordshire and Buckinghamshire Mental Health Partnership NHS Trust; South Essex Partnership NHS Foundation Trust; Gloucestershire Partnership NHS Foundation Trust; Mersey Care NHS Trust; Hampshire Partnership NHS Trust; North East London Mental Health Trust; Chief Scientist Office of the Scottish Executive; Sylvan C. Herman Foundation; National Institutes of Mental Health and the Department of Veterans Affairs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)US Department of Veterans Affairs); ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the patients and families who contributed their time and DNA to these studies, and also D. Altshuler and members of the Medical and Population Genetics group at the Broad Institute of Harvard and Massachusetts Institute of Technology for valuable discussion. The group at the Stanley Center for Psychiatric Research at the Broad Institute was supported by the Stanley Medical Research Institute (E.M.S.), the Sylvan C. Herman Foundation (E.M.S.), and MH071681 (P.S.). The Cardiff University group was supported by a Medical Research Council (UK) Programme grant and the National Institutes of Mental Health (USA) (CONTE: 2 P50 MH066392-05A1). The group at Karolinska Institutet was supported by the Swedish Council for Working Life and Social Research (FO 184/2000; 2001-2368). The Massachusetts General Hospital group was supported by the Stanley Medical Research Institute (P.S.), MH071681 (P.S.) and a Narsad Young Investigator Award (S.P.). The group at the Queensland Institute of Medical Research was supported by the Australian National Health and Medical Research Council. The Trinity College Dublin group was supported by Science Foundation Ireland, the Health Research Board (Ireland), the Stanley Medical Research Institute and the Wellcome Trust; Irish controls were supplied by J. McPartlin from the Trinity College Biobank. The work at the University of Aberdeen was partly funded by GlaxoSmithKline and Generation Scotland, Genetics Health Initiative. The University College London clinical and control samples were collected with support from the Neuroscience Research Charitable Trust, the Camden and Islington Mental Health and Social Care Trust, East London and City Mental Heath Trust, the West Berkshire NHS Trust, the West London Mental Health Trust, Oxfordshire and Buckinghamshire Mental Health Partnership NHS Trust, South Essex Partnership NHS Foundation Trust, Gloucestershire Partnership NHS Foundation Trust, Mersey Care NHS Trust, Hampshire Partnership NHS Trust and the North East London Mental Health Trust. The collection of the University of Edinburgh cohort was supported by grants from the Wellcome Trust, London, and the Chief Scientist Office of the Scottish Executive. The group at the University of North Carolina, Chapel Hill, was supported by MH074027, MH077139 and MH080403, the Sylvan C. Herman Foundation (P.F.S.) and the Stanley Medical Research Institute (P.F.S.) The group at the University of Southern California thanks the patients and their families for their collaboration, and acknowledges the support of the National Institutes of Mental Health and the Department of Veterans Affairs.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Butler MG, 2008, AM J MED GENET A, V146A, P854, DOI 10.1002/ajmg.a.32249; Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; *ICD 10, 2007, INT STAT CLASS DIS R; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; KORN J, IN PRESS NATURE GENE; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; MCCAROLL S, IN PRESS NATURE GENE; Moon HJ, 2006, BIOCHEM BIOPH RES CO, V344, P531, DOI 10.1016/j.bbrc.2006.03.156; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ross CA, 1996, TRENDS NEUROSCI, V19, P171, DOI 10.1016/S0166-2236(96)10022-9; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2007, GENOME RES, V17, P482, DOI 10.1101/gr.5986507; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams NM, 2006, INT REV NEUROBIOL, V73, P1, DOI 10.1016/S0074-7742(06)73001-X; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Xu JZ, 2001, AM J MED GENET, V105, P669, DOI 10.1002/ajmg.1549	31	1146	1184	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					237	241		10.1038/nature07239	http://dx.doi.org/10.1038/nature07239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18668038	Green Submitted, Green Accepted			2022-12-28	WOS:000259090800050
J	Voog, J; D'Alterio, C; Jones, DL				Voog, Justin; D'Alterio, Cecilia; Jones, D. Leanne			Multipotent somatic stem cells contribute to the stem cell niche in the Drosophila testis	NATURE			English	Article							SELF-RENEWAL; SUPPORT CELLS; GERMLINE; SPERMATOGENESIS; PROLIFERATION; OVARY; MORPHOGENESIS; MELANOGASTER; PROTEIN; MARKER	Adult stem cells reside in specialized microenvironments, or niches, that have an important role in regulating stem cell behaviour(1). Therefore, tight control of niche number, size and function is necessary to ensure the proper balance between stem cells and progenitor cells available for tissue homeostasis and wound repair. The stem cell niche in the Drosophila male gonad is located at the tip of the testis where germline and somatic stem cells surround the apical hub, a cluster of approximately 10 - 15 somatic cells that is required for stem cell self- renewal and maintenance(2-4). Here we show that somatic stem cells in the Drosophila testis contribute to both the apical hub and the somatic cyst cell lineage. The Drosophila orthologue of epithelial cadherin ( DE- cadherin) is required for somatic stem cell maintenance and, consequently, the apical hub. Furthermore, our data indicate that the transcriptional repressor escargot regulates the ability of somatic cells to assume and/ or maintain hub cell identity. These data highlight the dynamic relationship between stem cells and the niche and provide insight into genetic programmes that regulate niche size and function to support normal tissue homeostasis and organ regeneration throughout life.	[Voog, Justin; D'Alterio, Cecilia; Jones, D. Leanne] Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Voog, Justin] Univ Calif San Diego, Dept Biomed Sci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Jones, DL (corresponding author), Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.	ljones@salk.edu			California Institute for Regenerative Medicine to the University of California-San Diego; Ellison Medical Foundation; American Federation for Aging Research; G. Harold and Leila Y. Mathers Charitable Foundation; ACS; NIH; NATIONAL INSTITUTE ON AGING [R01AG028092] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine to the University of California-San Diego(California Institute for Regenerative Medicine); Ellison Medical Foundation(Lawrence Ellison Foundation); American Federation for Aging Research; G. Harold and Leila Y. Mathers Charitable Foundation; ACS(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Bach, D. Godt, S. Hayahsi, N. Perrimon and R. Read for reagents and fly stocks, and Jones laboratory members, G. Adams, M. Buszczak, C. Schulz, S. DiNardo and M. Fuller for discussions and comments on the manuscript. This work was supported by a training grant from the California Institute for Regenerative Medicine to the University of California-San Diego (L. Goldstein). D. L. J. is funded by the Ellison Medical Foundation, the American Federation for Aging Research, the G. Harold and Leila Y. Mathers Charitable Foundation, the ACS and the NIH.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; BOYLE M, 1995, DEVELOPMENT, V121, P1815; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gonczy P, 1996, DEVELOPMENT, V122, P2437; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schulz C, 2002, DEVELOPMENT, V129, P4523; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Streit A, 2002, INT J DEV BIOL, V46, P159; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	27	109	109	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1132	U63		10.1038/nature07173	http://dx.doi.org/10.1038/nature07173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18641633	Green Accepted			2022-12-28	WOS:000258719600041
J	Lipp, JS; Morono, Y; Inagaki, F; Hinrichs, KU				Lipp, Julius S.; Morono, Yuki; Inagaki, Fumio; Hinrichs, Kai-Uwe			Significant contribution of Archaea to extant biomass in marine subsurface sediments	NATURE			English	Article							SUBSEAFLOOR SEDIMENTS; MICROBIAL COMMUNITIES; PACIFIC-OCEAN; PROKARYOTES; SEA; BIOMARKERS; BIOSPHERE; BACTERIA; ECOLOGY; LIPIDS	Deep drilling into the marine sea floor has uncovered a vast sedimentary ecosystem of microbial cells(1,2). Extrapolation of direct counts of stained microbial cells to the total volume of habitable marine subsurface sediments suggests that between 56 Pg ( ref. 1) and 303 Pg ( ref. 3) of cellular carbon could be stored in this largely unexplored habitat. From recent studies using various cultureindependent techniques, no clear picture has yet emerged as to whether Archaea or Bacteria are more abundant in this extensive ecosystem(4-7). Here we show that in subsurface sediments buried deeper than 1 m in a wide range of oceanographic settings at least 87% of intact polar membrane lipids, biomarkers for the presence of live cells(7,8), are attributable to archaeal membranes, suggesting that Archaea constitute a major fraction of the biomass. Results obtained from modified quantitative polymerase chain reaction and slot- blot hybridization protocols support the lipid- based evidence and indicate that these techniques have previously underestimated archaeal biomass. The lipid concentrations are proportional to those of total organic carbon. On the basis of this relationship, we derived an independent estimate of amounts of cellular carbon in the global marine subsurface biosphere. Our estimate of 90 Pg of cellular carbon is consistent, within an order of magnitude, with previous estimates, and underscores the importance of marine subsurface habitats for global biomass budgets.	[Lipp, Julius S.; Hinrichs, Kai-Uwe] Univ Bremen, Organ Geochem Grp, Dept Geosci, D-28334 Bremen, Germany; [Lipp, Julius S.; Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Morono, Yuki; Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol, Geomicrobiol Grp, Kochi Inst Core Sample Res, Nanko Ku, Kochi 7838502, Japan	University of Bremen; University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Hinrichs, KU (corresponding author), Univ Bremen, Organ Geochem Grp, Dept Geosci, POB 330 440, D-28334 Bremen, Germany.	khinrichs@uni-bremen.de	Inagaki, Fumio/AAI-1156-2019; Hinrichs, Kai-Uwe/C-7675-2009	Inagaki, Fumio/0000-0003-2887-6525; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Morono, Yuki/0000-0001-8928-4254	Integrated Ocean Drilling Program [301, 311]; Ocean Drilling Program [201, 204, 207]; US National Science Foundation; Deutsche Forschungsgemeinschaft; IODP/ODP [Hi616-4]; JAMSTEC Multidisciplinary Research Promotion Award	Integrated Ocean Drilling Program; Ocean Drilling Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); US National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IODP/ODP; JAMSTEC Multidisciplinary Research Promotion Award	Samples for this research were provided by the Integrated Ocean Drilling Program (IODP, expeditions 301 and 311), the Ocean Drilling Program (ODP, legs 201, 204 and 207; sponsored by the US National Science Foundation and participating countries under the Joint Oceanographic Institutions, Inc.), and cruises Sonne SO147, Kaiyo KY04-11, Professor Logatchev TTR15 and Chikyu Shakedown Expedition CK06-06. We thank the participating crews and scientists for sample recovery and data; U. Proske and N. Buchs for assistance with lipid extraction and sample preparation; J. M. Hayes and A. Teske for comments on an earlier version of this manuscript; H. F. Fredricks and F. Schubotz for discussion of data; V. Heuer, A. Schippers and T. Toki for sample donation; B. Kockisch for TOC analysis; and T. Terada and N. Masui for DNA extraction and analyses. This work was supported by Deutsche Forschungsgemeinschaft ( through MARUM Center for Marine Environmental Sciences and grant Hi616-4 from the priority program IODP/ODP) and JAMSTEC Multidisciplinary Research Promotion Award 2007 ( to Y. M. and F. I.). This is MARUM publication number 0585.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Arnosti C, 2006, GEOMICROBIOL J, V23, P551, DOI 10.1080/01490450600897336; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; CARDACE D, 2006, P ODP SCI RES, V205; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; FREDRICKS HF, 2007, P ODP SCI RES, V207; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Mauclaire L, 2004, GEOBIOLOGY, V2, P217, DOI 10.1111/j.1472-4677.2004.00035.x; MIDDELBURG JJ, 1993, GLOBAL PLANET CHANGE, V8, P47, DOI 10.1016/0921-8181(93)90062-S; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Rutters H, 2002, J MICROBIOL METH, V48, P149, DOI 10.1016/S0167-7012(01)00319-0; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Seiter K, 2004, DEEP-SEA RES PT I, V51, P2001, DOI 10.1016/j.dsr.2004.06.014; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; SUMMIT M, 2000, P ODP SCI RES, V169; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Teske AP, 2006, GEOMICROBIOL J, V23, P357, DOI 10.1080/01490450600875613; Thiel V, 2007, GEOBIOLOGY, V5, P413, DOI 10.1111/j.1472-4669.2007.00119.x; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; White D., 1979, ASTM STP, V673, P87; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zink KG, 2003, ORG GEOCHEM, V34, P755, DOI 10.1016/S0146-6380(03)00041-X	30	433	462	2	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2008	454	7207					991	994		10.1038/nature07174	http://dx.doi.org/10.1038/nature07174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18641632				2022-12-28	WOS:000258591000038
J	Jit, M; Choi, YH; Edmunds, WJ				Jit, Mark; Choi, Yoon Hong; Edmunds, W. John			Economic evaluation of human papillomavirus vaccination in the United Kingdom	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS; CERVICAL-CANCER; PARTICLE VACCINE; GENITAL WARTS; HEALTH; EFFICACY; MANAGEMENT; INFECTION; SURVIVAL; TYPE-18	Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. Design Economic evaluation. Setting UK. Population Schoolgirls aged 12 or older. Main outcome measures Costs, quality adjusted life years (QALYs), and incremental cost effectiveness ratios for a range of vaccination options. Results Vaccinating 12 year old schoolgirls with a quadrivalent vaccine at 80% coverage is likely to be cost effective at a willingness to pay threshold of 30 pound 000 ((sic)37 700; $59 163) per QALY gained, if the average duration of protection from the vaccine is more than 10 years. Implementing a catch-up campaign of girls up to age 18 is likely to be cost effective. Vaccination of boys is unlikely to be cost effective. A bivalent vaccine with the same efficacy against human papillomavirus types 16 and 18 costing 13- pound 21 pound less per dose (depending on the duration of vaccine protection) may be as cost effective as the quadrivalent vaccine although less effective in terms of health benefits. Conclusions Routine vaccination of 12 year old schoolgirls combined with an initial catch-up campaign up to age 18 is likely to be cost effective in the UK. The results are robust to uncertainty in many parameters and processes. A key influential variable is the duration of vaccine protection.	[Jit, Mark; Choi, Yoon Hong; Edmunds, W. John] Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 6BT, England	Health Protection Agency	Jit, M (corresponding author), Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 6BT, England.	mark.jit@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Jit, Mark/0000-0001-6658-8255	Department of Health [DOH 039/0030, DOH 039/031]	Department of Health	This work was funded by grants from the Department of Health Policy Research programme [reference Nos DOH 039/0030 and DOH 039/031]. The authors' work was independent of the funders, who had no role in the study design, analysis of data, writing of the manuscript, or decision to submit for publication.	Bielska-Lasota M, 2007, GYNECOL ONCOL, V105, P609, DOI 10.1016/j.ygyno.2007.01.048; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; *BRIT MED ASS, 2007, BRIT NAT FORM 54; BROWN D, 2007, 47 ANN INT C ANT AG; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; Carter JJ, 2001, CANCER RES, V61, P1934; Chen SC, 2004, J INVEST DERM SYMP P, V9, P160, DOI 10.1046/j.1087-0024.2003.09112.x; Chesson HW, 2008, EMERG INFECT DIS, V14, P244, DOI 10.3201/eid1402.070499; Choi YH, 2007, 24 INT PAP C CLIN WO; Curtis L, 2007, UNIT COSTS HLTH SOCI; DASBACH E, 2008, BR J OBSTET GYN 0522; de Rijke JM, 2002, EUR J CANCER, V38, P2041, DOI 10.1016/S0959-8049(02)00315-5; *DEP HLTH, 2008, HPV VACC REC NHS IMM; *DEP HLTH, NHS REF COSTS 2005; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; *HLTH PROT AG, 2006, CDR WEEKLY, P16; *INF CTR, 2006, DEP HLTH STAT B; Insinga RP, 2007, MED DECIS MAKING, V27, P414, DOI 10.1177/0272989X07302128; Institute of Medicine, 2004, FIN VACC 21 CENT ASS; Jit M, 2007, BRIT J CANCER, V97, P989, DOI 10.1038/sj.bjc.6603955; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kahn JA, 2007, LANCET, V369, P2135, DOI 10.1016/S0140-6736(07)60947-7; KAMON J, 2004, HEALTH TECHNOL ASSES, V8, P78; KAMON J, 2004, HEALTH TECHNOL ASSES, V8, P1; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; KIM JJ, 2007, 24 INT PAP C CLIN WO; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kohli M, 2007, BRIT J CANCER, V96, P143, DOI 10.1038/sj.bjc.6603501; Kulasingam Shalini L, 2008, Cost Eff Resour Alloc, V6, P4, DOI 10.1186/1478-7547-6-4; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; Langley PC, 2004, INT J STD AIDS, V15, P501, DOI 10.1258/0956462041558168; Martin-Hirsch P, 2007, BJOG-INT J OBSTET GY, V114, P408, DOI 10.1111/j.1471-0528.2007.01261.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers ER, 2004, 21 INT PAP C CLIN WO; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; National Institute for Health and Clinical Excellence, 2004, GUID METH TECHN APPR; *NHS CANC SCREEN P, 2008, NHSCSP PUBL, V20; *OFF NAT STAT, 2008, CANC STAT 2004 REG; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Postma MJ, 2008, SEX TRANSM INFECT, V84, P152, DOI 10.1136/sti.2007.028043; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; von Krogh G, 2001, INT J STD AIDS, V12, P40, DOI 10.1258/0956462011924100; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; Woodhall S, 2008, SEX TRANSM INFECT, V84, P161, DOI 10.1136/sti.2007.029512; WOODHALL S, 2008, BASHH ASTDA 3 JOINT	53	219	222	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a769	10.1136/bmj.a769	http://dx.doi.org/10.1136/bmj.a769			35	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EO	18640957	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000258561100031
J	Jaffe, HW				Jaffe, Harold W.			Universal access to HIV/AIDS treatment - Promise and problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV-INFECTION; AFRICA; ADULTS		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Jaffe, HW (corresponding author), Univ Oxford, Dept Publ Hlth, Old Road Campus, Oxford OX3 7LF, England.	harold.jaffe@dphpc.ox.ac.uk						AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; *JOINT UN PROGR HI, 2007 AIDS EP UPD; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; Seyler C, 2007, AIDS, V21, P1157, DOI 10.1097/QAD.0b013e3281c615da; *U OXF GLOB EC PRO, SETT DEV COUNTR AG G; Underhill K, 2007, BMJ-BRIT MED J, V335, P248, DOI 10.1136/bmj.39245.446586.BE; WHO, TASK SHIFT GLOB REC; *WHO, UN ACC SCAL PRIOR HI; World Health Organization, WORLD HLTH STAT 2008; 2006, TREAT GUIDE MED LETT, V4, P67	12	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					573	575		10.1001/jama.300.5.573	http://dx.doi.org/10.1001/jama.300.5.573			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677030				2022-12-28	WOS:000258188900019
J	Eliopoulos, AG				Eliopoulos, Aristides G.			Cell signaling - "Make and brake" in signaling	SCIENCE			English	Editorial Material							UBIQUITIN-CONJUGATING ENZYME; TRAF6; ACTIVATION; COMPLEX		Univ Crete, Sch Med, Iraklion, Greece; Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Eliopoulos, AG (corresponding author), Univ Crete, Sch Med, Iraklion, Greece.	eliopag@med.uoc.gr	ELIOPOULOS, ARISTIDES/R-9449-2018; ELIOPOULOS, ARISTIDES/ABI-6632-2020	ELIOPOULOS, ARISTIDES/0000-0002-6403-6761; ELIOPOULOS, ARISTIDES/0000-0002-6403-6761				Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Davies CC, 2005, MOL CELL BIOL, V25, P9806, DOI 10.1128/MCB.25.22.9806-9819.2005; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084	10	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					648	649		10.1126/science.1162212	http://dx.doi.org/10.1126/science.1162212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669850				2022-12-28	WOS:000258077700029
J	Winer, JB				Winer, John B.			Guillain-Barre syndrome	BRITISH MEDICAL JOURNAL			English	Review							ACUTE IDIOPATHIC NEUROPATHY; MOTOR AXONAL NEUROPATHY; MILLER-FISHER-SYNDROME; MECHANICAL VENTILATION; CAMPYLOBACTER-JEJUNI; MOLECULAR MIMICRY; IGG ANTIBODY; FEATURES		Queen Elizabeth Hosp, Univ Hosp Birmingham, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Winer, JB (corresponding author), Queen Elizabeth Hosp, Univ Hosp Birmingham, Birmingham B15 2TH, W Midlands, England.	j.b.winer@bham.ac.uk						Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Bogliun G, 2002, NEUROL SCI, V23, P113, DOI 10.1007/s100720200036; Caporale CM, 2006, J NEUROIMMUNOL, V177, P112, DOI 10.1016/j.jneuroim.2006.05.018; CHEVROLET JC, 1991, AM REV RESPIR DIS, V144, P814, DOI 10.1164/ajrccm/144.4.814; CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911; FISHER CM, 1956, NEW ENGL J MED, V225, P57; Geleijns K, 2004, NEUROLOGY, V63, P1747, DOI 10.1212/01.WNL.0000143055.09646.31; Goddard EA, 1997, ARCH DIS CHILD, V76, P526, DOI 10.1136/adc.76.6.526; Griffin JW, 1996, J NEUROCYTOL, V25, P33, DOI 10.1007/BF02284784; Guillain G., 1916, B MEM SOC MED HOP P, V40, P1462; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Hauck LJ, 2008, J NEUROL NEUROSUR PS, V79, P318, DOI 10.1136/jnnp.2007.118810; HUGHES RA, 2001, COCHRANE DB SYST REV; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194; HUGHES RAC, 1994, ACTA NEUROL BELG, V94, P128; HUGHES RAC, 1990, GUILLAINBARRE SYNDRO; Jiang GX, 1997, J NEUROL NEUROSUR PS, V62, P447, DOI 10.1136/jnnp.62.5.447; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Kuwabara S, 1999, J NEUROL NEUROSUR PS, V67, P180, DOI 10.1136/jnnp.67.2.180; Lawn ND, 2001, ARCH NEUROL-CHICAGO, V58, P893, DOI 10.1001/archneur.58.6.893; Markoula S, 2007, ACTA NEUROL SCAND, V115, P167, DOI 10.1111/j.1600-0404.2006.00731.x; MURRAY NMF, 1980, MUSCLE NERVE, V3, P444; Paradiso G, 1999, ANN NEUROL, V46, P701, DOI 10.1002/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7; RAPHAEL JC, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001798; Rees JH, 1998, J NEUROL NEUROSUR PS, V64, P74, DOI 10.1136/jnnp.64.1.74; ROBERTS M, 1994, LANCET, V343, P454, DOI 10.1016/S0140-6736(94)92694-8; SAUNDERS M, 1965, LANCET, V2, P1106; Visser LH, 1999, NEUROLOGY, V53, P598, DOI 10.1212/WNL.53.3.598; Winer J, 2002, J NEUROL, V249, P616, DOI 10.1007/s004150200072; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P619, DOI 10.1136/jnnp.51.5.619; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P613, DOI 10.1136/jnnp.51.5.613; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P605, DOI 10.1136/jnnp.51.5.605; WINER JB, 1988, Q J MED, V68, P735; YUKI N, 1995, J NEUROIMMUNOL, V60, P161, DOI 10.1016/0165-5728(95)00052-4; Yuki N, 1997, J INFECT DIS, V176, pS150, DOI 10.1086/513800	36	22	24	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a671	10.1136/bmj.a671	http://dx.doi.org/10.1136/bmj.a671			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18640954				2022-12-28	WOS:000258273000042
J	Thibault, P; Dierolf, M; Menzel, A; Bunk, O; David, C; Pfeiffer, F				Thibault, Pierre; Dierolf, Martin; Menzel, Andreas; Bunk, Oliver; David, Christian; Pfeiffer, Franz			High-resolution scanning x-ray diffraction microscopy	SCIENCE			English	Article							PHASE-RETRIEVAL	Coherent diffractive imaging (CDI) and scanning transmission x-ray microscopy (STXM) are two popular microscopy techniques that have evolved quite independently. CDI promises to reach resolutions below 10 nanometers, but the reconstruction procedures put stringent requirements on data quality and sample preparation. In contrast, STXM features straightforward data analysis, but its resolution is limited by the spot size on the specimen. We demonstrate a ptychographic imaging method that bridges the gap between CDI and STXM by measuring complete diffraction patterns at each point of a STXM scan. The high penetration power of x-rays in combination with the high spatial resolution will allow investigation of a wide range of complex mesoscopic life and material science specimens, such as embedded semiconductor devices or cellular networks.	[Thibault, Pierre; Dierolf, Martin; Menzel, Andreas; Bunk, Oliver; David, Christian; Pfeiffer, Franz] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Pfeiffer, Franz] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Thibault, P (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	pierre.thibault@psi.ch	Dierolf, Martin J/B-9816-2008; Bunk, Oliver/B-7602-2013; Thibault, Pierre/B-2656-2010; Menzel, Andreas/C-4388-2012	Dierolf, Martin J/0000-0001-5150-2949; Bunk, Oliver/0000-0001-6563-4053; Thibault, Pierre/0000-0003-1278-8846; Menzel, Andreas/0000-0002-0489-609X				Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Chapman HN, 1996, ULTRAMICROSCOPY, V66, P153, DOI 10.1016/S0304-3991(96)00084-8; Eisebitt S, 2004, NATURE, V432, P885, DOI 10.1038/nature03139; Elser V, 2007, P NATL ACAD SCI USA, V104, P418, DOI 10.1073/pnas.0606359104; Elser V, 2003, J OPT SOC AM A, V20, P40, DOI 10.1364/JOSAA.20.000040; Faulkner HML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023903; HEGERL R, 1970, BERICH BUNSEN GESELL, V74, P1148, DOI 10.1002/bbpc.19700741112; Hornberger B, 2007, ULTRAMICROSCOPY, V107, P644, DOI 10.1016/j.ultramic.2006.12.006; Jefimovs K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.264801; MCNULTY I, 1992, SCIENCE, V256, P1009, DOI 10.1126/science.256.5059.1009; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Mimura H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2436469; MORRISON G, 2005, IPAP C SERIES, V7, P377; NELLIST PD, 1995, NATURE, V374, P630, DOI 10.1038/374630a0; Quiney HM, 2006, NAT PHYS, V2, P101, DOI 10.1038/nphys218; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Rodenburg JM, 2007, ULTRAMICROSCOPY, V107, P227, DOI 10.1016/j.ultramic.2006.07.007; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; RODENBURG JM, 1992, PHILOS T R SOC A, V339, P521, DOI 10.1098/rsta.1992.0050; Sayre D, 2008, ACTA CRYSTALLOGR A, V64, P33, DOI 10.1107/S010876730705550X; Schroer CG, 2003, APPL PHYS LETT, V82, P1485, DOI 10.1063/1.1556960; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Williams GJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.175501	26	929	979	14	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					379	382		10.1126/science.1158573	http://dx.doi.org/10.1126/science.1158573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635796				2022-12-28	WOS:000257713900042
J	Lew, W; Pai, M; Oxlade, O; Martin, D; Menzies, D				Lew, Woojin; Pai, Madhukar; Oxlade, Olivia; Martin, Daniel; Menzies, Dick			Initial drug resistance and tuberculosis treatment outcomes: Systematic review and meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							6-MONTH COOPERATIVE TUBERCULOSIS; POSITIVE PULMONARY TUBERCULOSIS; SHORT-COURSE CHEMOTHERAPY; RELAPSE; REGIMENS; COMPLETION; DIAGNOSIS; RIFAMPIN; THERAPY; FAILURE	Background: Despite the increasing prevalence of drug-resistant tuberculosis, most low- and middle-income countries use standardized regimens, without assessment of drug susceptibility. Purpose: To perform a systematic review and meta-analysis of the effect of initial drug resistance and treatment regimen on tuberculosis treatment outcomes. Data Sources: PubMed, the Cochrane Central Database of Clinical Trials, and EMBASE were searched for studies published in English from 1965 to June 2007. Additional studies were identified from cited references. Study Selection: Randomized, controlled trials and cohort studies of standardized treatment of previously untreated patients with culture-confirmed pulmonary tuberculosis. Drug-susceptibility testing was done on pretreatment isolates from all patients and from patients with treatment failure or relapse. Data Extraction: Two authors reviewed the studies for methods, initial drug resistance, treatment regimens, and outcomes. Data Synthesis: Pooled cumulative incidences were computed with random-effects meta-ana(yses. Association between risk factors and outcomes were determined by using stratified analyses. The cumulative incidence of acquired drug resistance with initially pan-sensitive strains was 0.8% (95% CI, 0.5% to 1.0%) compared with 6% (CI, 4% to 8%) with initially single drug-resistant strains and 14% (CI, 9% to 20%) with initially polyd rug- resistant strains. Failure and relapse were most strongly associated with initial drug resistance. Failure was also associated with shorter duration of rifampin therapy and nonuse of streptomycin, whereas the rate of relapse was higher with shorter duration of rifampin therapy and nonuse of pyrazinamide. Limitations: Few studies included HIV-infected persons, and treatment outcomes were pooled despite considerable heterogeneity. Conclusion: Treatment outcomes were substantially worse in the presence of initial drug resistance, which has important implications in resource-limited settings in which drug resistance is prevalent.	[Lew, Woojin; Pai, Madhukar; Oxlade, Olivia; Martin, Daniel; Menzies, Dick] McGill Univ, Montreal Chest Inst, Montreal, PQ H2X 2P4, Canada	McGill University	Menzies, D (corresponding author), McGill Univ, Montreal Chest Inst, Room K1-24,3650 St Urbain, Montreal, PQ H2X 2P4, Canada.	dick.menzies@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536				ALLAN WGL, 1982, TUBERCLE, V63, P89; [Anonymous], 1979, Am Rev Respir Dis, V119, P579; [Anonymous], 1972, LANCET, V1, P1079; [Anonymous], 1978, Am Rev Respir Dis, V118, P39; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 1986, Tubercle, V67, P5; [Anonymous], 1983, TUBERCLE, V64, P73; [Anonymous], 1974, Lancet, V2, P1100; [Anonymous], 1978, Am Rev Respir Dis, V118, P219; [Anonymous], 1979, Tubercle, V60, P201; [Anonymous], 1980, Tubercle, V61, P59; [Anonymous], 1981, Lancet, V1, P171; [Anonymous], 1974, Lancet, V2, P237; [Anonymous], 1976, Am Rev Respir Dis, V114, P471; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; BALASUBRAMANIAN R, 1990, TUBERCLE, V71, P253, DOI 10.1016/0041-3879(90)90037-9; BOULAHBAL F, 2006, REICHMAN HERSLIFIELD, P29; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P433; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; DARBYSHIRE JH, 1989, AM REV RESPIR DIS, V140, P990; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; EAST AFRICAN /BRITISH MEDICAL RESEARCH COUNCILS, 1973, Lancet, P1331; Enarson DA, 2000, TUBERCULOSIS GUIDE L; ESPINAL M, 2004, TOMANS TUBERCULOSIS, P207; FOX W, 1986, AM REV RESPIR DIS, V133, P779; FOX W, 1985, AM REV RESPIR DIS, V132, P374; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Girling D. J., 1991, American Review of Respiratory Disease, V143, P700; GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262; GIRLING DJ, 1989, AM REV RESPIR DIS, V139, P871; GIRLING DJ, 1988, AM REV RESPIR DIS, V137, P1147; *GLOB DRUG FAC, 2003, 1 LIN TUB DRUGS FORM; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P561, DOI 10.1164/rccm.200401-095OC; KEYES AB, 1985, AM REV RESPIR DIS, V131, P727; Li JH, 2005, CLIN INFECT DIS, V41, P83, DOI 10.1086/430377; Mitnick CD, 2007, PLOS MED, V4, P1730, DOI 10.1371/journal.pmed.0040292; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Nettles RE, 2004, CLIN INFECT DIS, V38, P731, DOI 10.1086/381675; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Palomino JC, 2005, EUR RESPIR J, V26, P339, DOI 10.1183/09031936.05.00050305; PLATT SD, 1989, BRIT MED J, V298, P1673, DOI 10.1136/bmj.298.6689.1673; PRABHAKAR R, 1986, AM REV RESPIR DIS, V134, P27; PYLE MM, 1947, P STAFF M MAYO CLIN, V22, P465; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Santha T, 2004, TROP MED INT HEALTH, V9, P551, DOI 10.1111/j.1365-3156.2004.01229.x; SANTHA T, 1989, TUBERCLE, V70, P229, DOI 10.1016/0041-3879(89)90016-0; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; SNIDER DE, 1984, AM REV RESPIR DIS, V130, P1091; Sonnenberg P, 2000, T ROY SOC TROP MED H, V94, P603, DOI 10.1016/S0035-9203(00)90205-0; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Toman K, 2004, TOMANS TUBERCULOSIS, P193; Tripathy S P, 1983, Bull Int Union Tuberc, V58, P97; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; *WHO, 2003, TREATM TUB GUID NAT, P1; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Yoshiyama T, 2004, INT J TUBERC LUNG D, V8, P31; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang LX, 1996, CURR THER RES CLIN E, V57, P849, DOI 10.1016/S0011-393X(96)80018-X; ZIERSKI M, 1981, AM REV RESPIR DIS, V124, P249; ZIERSKI M, 1980, AM REV RESPIR DIS, V122, P879; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; 1991, AM REV RESP DIS, V143, P707; 1977, AM REV RESP DIS, V116, P3; 1983, TUBERCLE, V153, P66; 1981, TUBERCLE, V62, P95; 1987, AM REV RESP DIS, V136, P1339	72	142	144	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					123	134		10.7326/0003-4819-149-2-200807150-00008	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626051				2022-12-28	WOS:000257853700006
J	Pletcher, MJ; Bibbins-Domingo, K; Lewis, CE; Wei, GS; Sidney, S; Carr, JJ; Vittinghoff, E; McCulloch, CE; Hulley, SB				Pletcher, Mark J.; Bibbins-Domingo, Kirsten; Lewis, Cora E.; Wei, Gina S.; Sidney, Steve; Carr, J. Jeffrey; Vittinghoff, Eric; McCulloch, Charles E.; Hulley, Stephen B.			Prehypertension during young adulthood and coronary calcium later in life	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; CHILDHOOD BLOOD-PRESSURE; JOINT NATIONAL COMMITTEE; INTIMA-MEDIA THICKNESS; ARTERY CALCIUM; ATHEROSCLEROTIC LESIONS; HEART-DISEASE; US ADULTS; HYPERTENSION; ASSOCIATION	Background: High blood pressure in middle age is a well-established risk factor for cardiovascular disease, but the consequences of low-level elevations during young adulthood are unknown. Objective: To measure the association between prehypertension exposure before age 35 years and coronary calcium later in life. Design: Prospective cohort study. Setting: Four communities in the United States. Participants: Black and white men and women age 18 to 30 years recruited for the CARDIA (Coronary Artery Risk Development in Young Adults) Study in 1985 through 1986 who were without hypertension before age 35 years. Measurements: Blood pressure trajectories for each participant were estimated by using measurements from 7 examinations over the course of 20 years. Cumulative exposure to blood pressure in the prehypertension range (systolic blood pressure of 120 to 139 mm Hg, or diastolic blood pressure of 80 to 89 mm Hg) from age 20 to 35 years was calculated in units of mm Hg-years (similar to pack-years of tobacco exposure) and related to the presence of coronary calcium measured at each participant's last examination (mean age, 44 years [SD, 4]). Results: Among 3560 participants, the 635 (18%) who developed prehypertension before age 35 years were more often black, male, overweight, and of lower socioeconomic status. Exposure to prehypertension before age 35 years, especially systolic prehypertension, showed a graded association with coronary calcium later in life (coronary calcium prevalence of 15%, 24%, and 38% for 0, 1 to 30, and > 30 mm Hg-years of exposure, respectively; P < 0.001). This association remained strong after adjustment for blood pressure elevation after age 35 years and other coronary risk factors and participant characteristics. Limitation: Coronary calcium, although a strong predictor of future coronary heart disease, is not a clinical outcome. Conclusion: Prehypertension during young adulthood is common and is associated with coronary atherosclerosis 20 years later. Keeping systolic pressure below 120 mrn Hg before age 35 years may provide important health benefits later in life.	Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Alabama Birmingham, Birmingham, AL USA; NHLBI, NIH, Bethesda, MD 20892 USA; Kaiser Permanente, Oakland, CA USA; Wake Forest Univ, Winston Salem, NC 27109 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kaiser Permanente; Wake Forest University	Pletcher, MJ (corresponding author), 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.du	Carr, John/AAN-7531-2021; Carr, John Jeffrey/A-1938-2012	Carr, John/0000-0002-4398-8237; Carr, John Jeffrey/0000-0002-4398-8237	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048050, N01HC048049, N01HC095095, N01HC048047] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R43CA094612, R01CA094107, R44CA094612] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048048, R01HL048050, R01HL048049, R29HL048048] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conen D, 2007, BMJ-BRIT MED J, V335, P432, DOI 10.1136/bmj.39269.672188.AE; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Drukteinis JS, 2007, CIRCULATION, V115, P221, DOI 10.1161/CIRCULATIONAHA.106.668921; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hoq S, 2002, AM J HYPERTENS, V15, P1036, DOI 10.1016/S0895-7061(02)03066-2; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Iribarren C, 1997, ARCH INTERN MED, V157, P873, DOI 10.1001/archinte.157.8.873; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Juonala M, 2005, CIRCULATION, V112, P1486, DOI 10.1161/CIRCULATIONAHA.104.502161; Juonala M, 2006, HYPERTENSION, V48, P424, DOI 10.1161/01.HYP.0000237666.78217.47; Kshirsagar AV, 2006, AM J MED, V119, P133, DOI 10.1016/j.amjmed.2005.08.023; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Liszka HA, 2005, ANN FAM MED, V3, P294, DOI 10.1370/afm.312; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Mainous AG, 2004, AM J CARDIOL, V94, P1496, DOI 10.1016/j.amjcard.2004.08.026; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McMahan CA, 2005, ARCH INTERN MED, V165, P883, DOI 10.1001/archinte.165.8.883; Neal B, 2000, LANCET, V356, P1955; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Psaty BM, 2006, AM J HYPERTENS, V19, P1110, DOI 10.1016/j.amjhyper.2006.04.002; Qureshi AI, 2005, STROKE, V36, P1859, DOI 10.1161/01.STR.0000177495.45580.f1; Qureshi AI, 2002, STROKE, V33, P2781, DOI 10.1161/01.STR.0000039402.05613.0F; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Reynolds K, 2007, J AM SOC NEPHROL, V18, P1928, DOI 10.1681/ASN.2006111199; Seshadri S, 2001, ARCH INTERN MED, V161, P2343, DOI 10.1001/archinte.161.19.2343; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Urbina EM, 2004, ATHEROSCLEROSIS, V176, P157, DOI 10.1016/j.atherosclerosis.2004.04.023; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WIFFIAMS B, 2004, BMJ-BRIT MED J, V328, P634; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; Youssef AA, 2000, AM J HYPERTENS, V13, P770, DOI 10.1016/S0895-7061(00)00233-8; Zhang Y, 2006, HYPERTENSION, V47, P410, DOI 10.1161/01.HYP.0000205119.19804.08	51	120	128	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					91	99		10.7326/0003-4819-149-2-200807150-00005	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626048	Green Accepted			2022-12-28	WOS:000257853700003
J	Schuster, MG; Edwards, JE; Sobel, JD; Darouiche, RO; Karchmer, AW; Hadley, S; Slotman, G; Panzer, H; Biswas, P; Rex, JH				Schuster, Mindy G.; Edwards, John E., Jr.; Sobel, Jack D.; Darouiche, Rabih O.; Karchmer, Adolf W.; Hadley, Susan; Slotman, Gus; Panzer, Helene; Biswas, Pinaki; Rex, John H.			Empirical fluconazole versus placebo for intensive care unit patients - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; SURGICAL-PATIENTS; DOUBLE-BLIND; PROSPECTIVE MULTICENTER; NEUTROPENIC PATIENTS; CANDIDAL INFECTIONS; AMPHOTERICIN-B; RISK-FACTORS; EPIDEMIOLOGY; PROPHYLAXIS	Background: Invasive infection with Candida species is an important cause of morbidity and mortality in intensive care unit (ICU) patients. Optimal preventive strategies have not been clearly defined. Objective: To see whether empirical fluconazole improves clinical outcomes more than placebo in adult ICU patients at high risk for invasive candidiasis. Design: Double-blind, placebo-controlled, randomized trial conducted from 1995 to 2000. Setting: 26 ICUs in the United States. Patients: 270 adult ICU patients with fever despite administration of broad-spectrum antibiotics. All had central venous catheters and an Acute Physiology and Chronic Health Evaluation II score greater than 16. Intervention: Patients were randomly assigned to either intravenous fluconazole, 800 mg daily, or placebo for 2 weeks and were followed for 4 weeks thereafter. Two hundred forty-nine participants were available for outcome assessment. Measurements: A composite primary outcome that defined success as all 4 of the following: resolution of fever; absence of invasive fungal infection; no discontinuation because of toxicity; and no need for a nonstudy, systemic antifungal medication (as assessed by a blinded oversight committee). Results: Only 44 of 122 (36%) fluconazole recipients and 48 of 127 (38%) placebo recipients had a successful outcome (relative risk, 0.95 [95% CI, 0.69 to 1.32; P = 0.781). The main reason for failure was lack of resolution of fever (51 % for fluconazole and 57% for placebo). Documented invasive candidiasis occurred in 5% of fluconazole recipients and 9% of placebo recipients (relative risk, 0.57 [CI, 0.22 to 1.491). Seven (5%) fluconazole recipients and 10 (7%) placebo recipients had adverse events resulting in discontinuation of the study drug. Discontinuation because of abnormal liver test results occurred in 3 (2%) fluconazole recipients and 5 (4%) placebo recipients. Limitations: Twenty-one randomly assigned patients were not included in the analysis because they either did not meet entry criteria or did not have postbaseline assessments. Fewer fungal infections than anticipated occurred in the control group. Confidence bounds were wide and did not exclude potentially important differences in outcomes between groups. Conclusion: In critically ill adults with risk factors for invasive candidiasis, empirical fluconazole did not clearly improve a composite outcome more than placebo.	[Schuster, Mindy G.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Calif Los Angeles, Harbor Med Ctr, Torrance, CA 90509 USA; Wayne State Univ, Sch Med, Detroit Med Ctr, Detroit, MI USA; Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA; Univ Texas Houston, Sch Med, Houston, TX USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Tufts Univ New England Med Ctr, Boston, MA USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Pfizer, New York, NY USA	University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Detroit Medical Center; Wayne State University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Beth Israel Deaconess Medical Center; Tufts Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Pfizer	Schuster, MG (corresponding author), Univ Penn, Sch Med, 3 Silverstein,Suite E,3400 Spruce St, Philadelphia, PA 19104 USA.	schustem@mail.med.upenn.edu		Rex, John/0000-0003-3265-5872				AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Ables AZ, 2000, INFECT DIS CLIN PRAC, V9, P169, DOI 10.1097/00019048-200009040-00006; BERENGUER J, 1993, DIAGN MICR INFEC DIS, V17, P103, DOI 10.1016/0732-8893(93)90020-8; Blumberg HM, 2001, CLIN INFECT DIS, V33, P177, DOI 10.1086/321811; BROSS J, 1989, AM J MED, V87, P614, DOI 10.1016/S0002-9343(89)80392-4; Cruciani M, 2005, INTENS CARE MED, V31, P1479, DOI 10.1007/s00134-005-2794-y; Eggimann P, 1999, CRIT CARE MED, V27, P1066, DOI 10.1097/00003246-199906000-00019; Garbino J, 2002, INTENS CARE MED, V28, P1708, DOI 10.1007/s00134-002-1540-y; GARBINO J, 1998, CLIN INTENSIVE CARE, V9, P25; Golan Y, 2005, ANN INTERN MED, V143, P857, DOI 10.7326/0003-4819-143-12-200512200-00004; Hughes WT, 1997, CLIN INFECT DIS, V25, P551, DOI 10.1086/513764; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; NollaSalas J, 1997, INTENS CARE MED, V23, P23, DOI 10.1007/s001340050286; Pelz RK, 2001, ANN SURG, V233, P542, DOI 10.1097/00000658-200104000-00010; Petri MG, 1997, INTENS CARE MED, V23, P317, DOI 10.1007/s001340050334; PITTET D, 1994, ANN SURG, V220, P751, DOI 10.1097/00000658-199412000-00008; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; REX JH, 1995, ANTIMICROB AGENTS CH, V39, P1, DOI 10.1128/AAC.39.1.1; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; White MH, 1997, CLIN INFECT DIS, V24, P1129, DOI 10.1086/513661; WINGARD JR, 1993, ANTIMICROB AGENTS CH, V37, P1847, DOI 10.1128/AAC.37.9.1847; WRIGARD JR, 1991, NEW ENGL J MED, V325, P1274; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	27	152	164	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					83	90		10.7326/0003-4819-149-2-200807150-00004	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626047				2022-12-28	WOS:000257853700002
J	Garnett, GP; Gazzard, B				Garnett, Geoffrey P.; Gazzard, Brian			Risk of HIV transmission in discordant couples	LANCET			English	Editorial Material							VIRAL LOAD		[Garnett, Geoffrey P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, London W2 1PG, England; [Gazzard, Brian] Chelsea & Westminster Hosp, London, England	Imperial College London; Imperial College London	Garnett, GP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, St Marys Campus, London W2 1PG, England.	g.garnett@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008					Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; DONALDSON L, 2007, IMPROVING DETECTION; Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0	10	20	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					270	271		10.1016/S0140-6736(08)61089-2	http://dx.doi.org/10.1016/S0140-6736(08)61089-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657692				2022-12-28	WOS:000258042800008
J	Shelton, JD				Shelton, James D.			Counselling and testing for HIV prevention	LANCET			English	Editorial Material							SEXUAL RISK BEHAVIOR; INFECTION; REDUCTION; IMPACT; RAKAI		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Bunnell R, 2008, LANCET, V371, P2148, DOI 10.1016/S0140-6736(08)60929-0; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Kipp W, 2001, AIDS EDUC PREV, V13, P279, DOI 10.1521/aeap.13.3.279.19743; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; MULLER O, 1995, AIDS CARE, V7, P567, DOI 10.1080/09540129550126227; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; *WHO UNIAIDS UNICE, 2008, UN ACC SCAL PRIOR HI; Xu FJ, 2002, J ACQ IMMUN DEF SYND, V29, P284, DOI 10.1097/00042560-200203010-00009	14	11	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					273	275		10.1016/S0140-6736(08)61091-0	http://dx.doi.org/10.1016/S0140-6736(08)61091-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657694				2022-12-28	WOS:000258042800010
J	Lightbody, S				Lightbody, Sarah			A patient's journey - Epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												radgies@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a799	10.1136/bmj.a799	http://dx.doi.org/10.1136/bmj.a799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EO	18676442				2022-12-28	WOS:000258561100036
J	Vermeij, GJ; Roopnarine, PD				Vermeij, Geerat J.; Roopnarine, Peter D.			The coming Arctic invasion	SCIENCE			English	Editorial Material									[Vermeij, Geerat J.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Roopnarine, Peter D.] Calif Acad Sci, Dept Invertebrate Zool & Geol, San Francisco, CA 94118 USA	University of California System; University of California Davis; California Academy of Sciences	Vermeij, GJ (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	vermeij@geology.ucdavis.edu; proopnarine@calacademy.org		Roopnarine, Peter/0000-0002-9811-1176				Andersen O.G.N., 1989, P147; CARTER LD, 1986, GEOLOGY, V14, P675, DOI 10.1130/0091-7613(1986)14<675:LCAOSI>2.0.CO;2; Dayton P.K., 1990, P631; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Krylov AA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001497; STOCKLI R, 2006, EOS T AM GEOPHYS UN, V87, P49, DOI DOI 10.1029/2006EO050002; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617	8	75	79	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					780	781		10.1126/science.1160852	http://dx.doi.org/10.1126/science.1160852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687946				2022-12-28	WOS:000258261000026
J	Fukase, K; Kato, M; Kikuchi, S; Inoue, K; Uemura, N; Okamoto, S; Terao, S; Amagai, K; Hayashi, S; Asaka, M				Fukase, Kazutoshi; Kato, Mototsugu; Kikuchi, Shogo; Inoue, Kazuhiko; Uemura, Naomi; Okamoto, Shiro; Terao, Shuichi; Amagai, Kenji; Hayashi, Shunji; Asaka, Masahiro		Japan Gast Study Grp	Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial	LANCET			English	Article							GLANDULAR STOMACH CARCINOGENESIS; INFECTION; RISK; ASSOCIATION; PREVENTION	Background The relatioin between Helicobacter pylori infection and gastric cancer has been proven in epidemiological studies and animal experiments. Our aim was to investigate the prophylactic effect of H pylori eradication on the development of metachronous gastric carcinoma after endoscopic resection for early gastric cancer. Methods In this multi-centre, open-label, randomised controlled trial, 544 patients with early gastric cancer, either newly diagnosed and planning to have endoscopic treatment or in post-resection follow-up after endoscopic treatment, were randomly assigned to receive an H pylori eradication regimen (n=272) or control (n=272). Randomisation was done by a computer-generated randomisation list and was stratified by wheather the patient was newly diagnosed or post-resection. Patients in the eradication group received lansoprazole 30 mg twice daily, amoxicillin 750 mg twice daily, and clarithromycin 200 mg twice daily for a week; those in the control group received standard care, but no treatment for H pylori. Patients were examined endoscopically at 6, 12, 24, and 36 months after allocation. The primary endpoint was diagnosis of new carcinoma at nother site in the stomach. Analyses were by intention to treat. This trial is registered with the UMIN Clinical Trials Registry, number UMIN000001169. Findings At 3-year follow-up, metachronous gastric carcinoma had developed in nine patients in the eradication group and 24 in the control group. In the full intention-to-treat population, including all patients irrespective of length of follow-up (272 patients in each group), the odds ratio for metachronous gastric carcinoma was 0.353 (95% CI 0.161-0.775; p=0.009); in the modified intention-to-treat population, including patients with at least one post-randomisation assessment of tumour status and adjusting for loss to follow-up (255 patients in the eradication group, 250 in the control group), the hazard ratio for metachronous gastric carcinoma was 0 . 339 (95% Cl 0 . 157-0.729; p=0.003). In the eradication group, 19 (7%) patients had diarrhoea and 32 (12%) had soft stools. Interpretation Prophylactic eradication of H pylori after endoscopic resection of early gastric cancer should be used to prevent the development of metachronous gastric carcinoma. Funding Hiroshima Cancer Seminar Foundation.	[Asaka, Masahiro] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Kita Ku, Sapporo, Hokkaido, Japan; [Fukase, Kazutoshi] Yamagata Prefectural Cent Hosp, Dept Gastroenterol, Yamagata, Japan; [Kato, Mototsugu] Hokkaido Univ Hosp, Div Endoscopy, Sapporo, Hokkaido 060, Japan; [Kikuchi, Shogo] Aichi Med Univ, Sch Med, Dept Publ Hlth, Aichi, Japan; [Inoue, Kazuhiko] Matsue Red Cross Hosp, Dept Gastroenterol, Matsue, Shimane, Japan; [Uemura, Naomi] Int Med Ctr Japan, Dept Endoscopy, Tokyo, Japan; [Okamoto, Shiro] Kure Kyosai Hosp, Dept Gastroenterol, Kure, Japan; [Terao, Shuichi] Kyoto Min I Ren Chuoh Hosp, Dept Gastroenterol, Kyoto, Japan; [Amagai, Kenji] Ibaraki Cent Hosp, Dept Gastroenterol, Ibaraki, Japan; [Hayashi, Shunji] Jichi Med Univ, Dept Infect & Immun, Shimotsuke, Japan	Hokkaido University; Yamagata Prefectural Central Hospital; Hokkaido University; Aichi Medical University; National Center for Global Health & Medicine - Japan; Jichi Medical University	Asaka, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Kita Ku, N 14,W 7, Sapporo, Hokkaido, Japan.	maasaka@med.hokudai.ac.jp	Asaka, Masahiro/A-5948-2012; Kato, Mototsugu/A-6736-2012					Arima N, 1999, J CLIN GASTROENTEROL, V29, P44, DOI 10.1097/00004836-199907000-00011; ASAKA M, 1994, CANCER, V73, P2691, DOI 10.1002/1097-0142(19940601)73:11<2691::AID-CNCR2820731107>3.0.CO;2-2; Danesh J, 1999, ALIMENT PHARM THERAP, V13, P851; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Forman D, 1998, HELICOBACTER PYLORI, P354; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; Fuccio L, 2007, ALIMENT PHARM THER, V25, P133, DOI 10.1111/j.1365-2036.2006.03183.x; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; Honda S, 1998, CANCER RES, V58, P4255; HONMYO U, 1989, EUR J SURG ONCOL, V15, P316; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; *INT AG RES CANC, 1994, SCHIST LIV FLUK HEL; Kato M, 2006, ALIMENT PHARM THERAP, V24, P203, DOI 10.1111/j.1365-2036.2006.00046.x; Kikuchi S, 2006, HELICOBACTER, V11, P147, DOI 10.1111/j.1523-5378.2006.00392.x; KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO;2-4; Kodama M, 1996, J SURG ONCOL, V62, P57, DOI 10.1002/(SICI)1096-9098(199605)62:1<57::AID-JSO12>3.0.CO;2-Q; KOSAKA T, 1990, CANCER, V65, P2602, DOI 10.1002/1097-0142(19900601)65:11<2602::AID-CNCR2820651134>3.0.CO;2-8; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Maruta F, 2005, J GASTROENTEROL, V40, P104, DOI 10.1007/s00535-004-1501-z; Miehlke S, 2001, WORLD J GASTROENTERO, V7, P243; Nakagawa S, 2006, ALIMENT PHARM THER, V24, P214, DOI 10.1111/j.1365-2036.2006.00048.x; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Nasu J, 2005, ENDOSCOPY, V37, P990, DOI 10.1055/s-2005-870198; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Nozaki K, 2003, CANCER SCI, V94, P235, DOI 10.1111/j.1349-7006.2003.tb01426.x; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Shimizu N, 1999, CARCINOGENESIS, V20, P669, DOI 10.1093/carcin/20.4.669; Shimizu N, 2000, CANCER RES, V60, P1512; Sugiyama A, 1998, CANCER RES, V58, P2067; Take S, 2005, AM J GASTROENTEROL, V100, P1037, DOI 10.1111/j.1572-0241.2005.41384.x; TYTGAT GNJ, 1991, J GASTROEN HEPATOL, V6, P223, DOI 10.1111/j.1440-1746.1991.tb01469.x; Uchiyama K, 2004, SCAND J GASTROENTERO, V39, P1054, DOI 10.1080/00365520410009645; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; YAGI K, 2002, DIGEST ENDOSC, V4, pS76; Zhou Li Ya, 2005, Chin J Dig Dis, V6, P114, DOI 10.1111/j.1443-9573.2005.00204.x	40	842	897	2	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					392	397		10.1016/S0140-6736(08)61159-9	http://dx.doi.org/10.1016/S0140-6736(08)61159-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18675689	Green Submitted			2022-12-28	WOS:000258196000030
J	Jackson, ML; Nelson, JC; Weiss, NS; Neuzil, KM; Barlow, W; Jackson, LA				Jackson, Michael L.; Nelson, Jennifer C.; Weiss, Noel S.; Neuzil, Kathleen M.; Barlow, William; Jackson, Lisa A.			Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study	LANCET			English	Article							PREVENTING HOSPITALIZATION; COST-EFFECTIVENESS; MORTALITY; EFFICACY; REDUCTION; BENEFITS; IMPACT; OLDER	Background Pneumonia is a common complication of influenza infection in elderly individuals and could therefore potentially be prevented by influenza vaccination. In studies with data from administrative sources, vaccinated elderly people had a reduced risk of admission for pneumonia compared with unvaccinated seniors; however, these findings could have been biased by underlying differences in health between the groups. Furthermore, since most individuals with pneumonia are not treated in hospital, such studies should include both outpatient and inpatient events. We therefore assessed whether influenza vaccination is associated with a reduced risk of community-acquired pneumonia in immunocompetent elderly people after controlling for health status indicators. Methods We did a population-based, nested case-control study in immunocompetent elderly people aged 65-94 years (cases and controls) enrolled in Group Health (a health maintenance organisation) during the 2000, 2001, and 2002 preinfluenza periods and influenza seasons. Cases were individuals with an episode of outpatient or inpatient community-acquired pneumonia (validated by review of medical records or chest radiograph reports). We randomly selected two age-matched and sex-matched controls for each case. The exposure of interest was influenza vaccination. We reviewed medical records to define potential confounders, including smoking history, presence and severity of lung and heart disease, and frailty indicators. Findings 1173 cases and 2346 controls were included in the study. After we adjusted for the presence and severity of comorbidities, as defined by chart review, influenza vaccination was not associated with a reduced risk of community-acquired pneumonia (odds ratio 0 . 92, 95% CI 0 . 77-1. 10) during the influenza season. Interpretation The effect of influenza vaccination on the risk of pneumonia in elderly people during influenza seasons might be less than previously estimated. Funding Group Health Center for Health Studies internal funds and Group Health Community Foundation fellowship grant.	[Jackson, Michael L.; Nelson, Jennifer C.; Barlow, William; Jackson, Lisa A.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Nelson, Jennifer C.; Barlow, William] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Weiss, Noel S.; Jackson, Lisa A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Neuzil, Kathleen M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Weiss, Noel S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Neuzil, Kathleen M.] PATH, Seattle, WA USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Jackson, ML (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave Suite 1600, Seattle, WA 98101 USA.	mlj3@cornell.edu						[Anonymous], 2001, Morbidity and Mortality Weekly Report, V50, P532; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P516; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P466; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P1019; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P503; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P1045; Crocetti E, 2001, EUR J EPIDEMIOL, V17, P163, DOI 10.1023/A:1017978420601; Davidson A.C., 1997, BOOTSTRAP METHODS TH; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohmit SE, 1995, INT J EPIDEMIOL, V24, P1240, DOI 10.1093/ije/24.6.1240; PuigBarbera J, 1997, J EPIDEMIOL COMMUN H, V51, P526, DOI 10.1136/jech.51.5.526; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Wang ST, 2005, VACCINE, V23, P1973, DOI 10.1016/j.vaccine.2004.10.011	30	140	143	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					398	405		10.1016/S0140-6736(08)61160-5	http://dx.doi.org/10.1016/S0140-6736(08)61160-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18675690				2022-12-28	WOS:000258196000031
J	Takashima, S; Mkrtchyan, M; Younossi-Hartenstein, A; Merriam, JR; Hartenstein, V				Takashima, Shigeo; Mkrtchyan, Marianna; Younossi-Hartenstein, Amelia; Merriam, John R.; Hartenstein, Volker			The behaviour of Drosophila adult hindgut stem cells is controlled by Wnt and Hh signalling	NATURE			English	Article							SMALL-INTESTINE; EXPRESSION; HEDGEHOG; DIFFERENTIATION; EPITHELIUM; PATTERN; MIDGUT; FATES	The intestinal tract maintains proper function by replacing aged cells with freshly produced cells that arise from a population of self-renewing intestinal stem cells ( ISCs). In the mammalian intestine, ISC self renewal, amplification and differentiation take place along the crypt - villus axis, and are controlled by the Wnt and hedgehog ( Hh) signalling pathways(1). However, little is known about the mechanisms that specify ISCs within the developing intestinal epithelium, or about the signalling centres that help maintain them in their self- renewing stem cell state. Here we show that in adult Drosophila melanogaster, ISCs of the posterior intestine ( hindgut) are confined to an anterior narrow segment, which we name the hindgut proliferation zone ( HPZ). Within the HPZ, self renewal of ISCs, as well as subsequent proliferation and differentiation of ISC descendants, are controlled by locally emanating Wingless ( Wg, a Drosophila Wnt homologue) and Hh signals. The anteriorly restricted expression of Wg in the HPZ acts as a niche signal that maintains cells in a slow- cycling, self- renewing mode. As cells divide and move posteriorly away from the Wg source, they enter a phase of rapid proliferation. During this phase, Hh signal is required for exiting the cell cycle and the onset of differentiation. The HPZ, with its characteristic proliferation dynamics and signalling properties, is set up during the embryonic phase and becomes active in the larva, where it generates all adult hindgut cells including ISCs. The mechanism and genetic control of cell renewal in the Drosophila HPZ exhibits a large degree of similarity with what is seen in the mammalian intestine. Our analysis of the Drosophila HPZ provides an insight into the specification and control of stem cells, highlighting the way in which the spatial pattern of signals that promote self renewal, growth and differentiation is set up within a genetically tractable model system.	[Takashima, Shigeo; Mkrtchyan, Marianna; Younossi-Hartenstein, Amelia; Merriam, John R.; Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Hartenstein, V (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	volkerh@mcdb.ucla.edu						Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Murakami R, 1999, CELL MOL BIOL, V45, P661; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; SMITH AV, 1991, DEVELOPMENT, V112, P997; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	20	145	154	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					651	U58		10.1038/nature07156	http://dx.doi.org/10.1038/nature07156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18633350				2022-12-28	WOS:000258026500050
J	Butler, CC; Francis, N				Butler, Christopher C.; Francis, Nicholas			Commentary: NICE guidance on antibiotic prescribing for self limiting respiratory tract infections in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL-PRACTICE; DATABASE; TRIAL		[Butler, Christopher C.; Francis, Nicholas] Cardiff Univ, Cardiff CF14 4XN, Wales	Cardiff University	Butler, CC (corresponding author), Cardiff Univ, Cardiff CF14 4XN, Wales.	butlercc@Cardiff.ac.uk	Butler, Christopher C/B-5048-2009; Francis, Nick/B-7413-2009	Francis, Nick/0000-0001-8939-7312; Butler, Christopher/0000-0002-0102-3453				Ashworth M, 2004, J PUBLIC HEALTH-UK, V26, P268, DOI 10.1093/pubmed/fdh160; Cals JWL, 2007, PATIENT EDUC COUNS, V68, P270, DOI 10.1016/j.pec.2007.06.014; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Francis NA, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-23; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Little P, 2005, BMJ-BRIT MED J, V331, P301, DOI 10.1136/bmj.331.7512.301; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; National Institute for Health and Clinical Excellence, 2008, PRESCR ANT SELF LIM; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3; Wood F, 2007, FAM PRACT, V24, P427, DOI 10.1093/fampra/cmm040	10	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2008	337	7663							a656	10.1136/bmj.a656	http://dx.doi.org/10.1136/bmj.a656			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18650240				2022-12-28	WOS:000258273000044
J	Behnia, K				Behnia, Kamran			Physics - Elemental complexity	SCIENCE			English	Editorial Material							BISMUTH; GAS		[Behnia, Kamran] Ecole Super Phys & Chim Ind Ville Paris, CNRS, LPEM, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Behnia, K (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, LPEM, 10 Rue Vauquelin, F-75005 Paris, France.	kamran.behnia@espci.fr	Behnia, Kamran/AHC-5765-2022	Behnia, Kamran/0000-0001-8997-5645				Behnia K, 2007, SCIENCE, V317, P1729, DOI 10.1126/science.1146509; HALPERIN BI, 1987, JPN J APPL PHYS 1, V26, P1913, DOI 10.7567/JJAPS.26S3.1913; Li L, 2008, SCIENCE, V321, P547, DOI 10.1126/science.1158908; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233	5	4	4	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					497	498		10.1126/science.1161381	http://dx.doi.org/10.1126/science.1161381			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653869				2022-12-28	WOS:000257888900026
J	Fauci, AS; Johnston, MI; Dieffenbach, CW; Burton, DR; Hammer, SM; Hoxie, JA; Martin, M; Overbaugh, J; Watkins, DI; Mahmoud, A; Greene, WC				Fauci, Anthony S.; Johnston, Margaret I.; Dieffenbach, Carl W.; Burton, Dennis R.; Hammer, Scott M.; Hoxie, James A.; Martin, Malcolm; Overbaugh, Julie; Watkins, David I.; Mahmoud, Adel; Greene, Warner C.			Perspective - HIV vaccine research: The way forward	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY VIRUS SIVMAC239; MEMORY T-CELLS; AIDS VACCINE; CHALLENGE; INFECTION; PREVENTION; IMMUNITY; FAILURE; MONKEYS; TRIAL		[Fauci, Anthony S.; Johnston, Margaret I.; Dieffenbach, Carl W.; Martin, Malcolm; Mahmoud, Adel] NIAID, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Hammer, Scott M.] Columbia Univ, Med Ctr, Div Infect Dis, New York, NY 10032 USA; [Hoxie, James A.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA; [Mahmoud, Adel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Greene, Warner C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; Columbia University; University of Pennsylvania; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; Princeton University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Fauci, AS (corresponding author), NIAID, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov	Mahmoud, Azza Ahmed/S-1502-2016; Franzeck, Fabian C/B-5055-2011		Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000998, Z01AI000190, ZIAAI000190, Z01AI000998] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Robertson M., 2008, 15 C RETR OPP INF BO, P3; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	19	197	206	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					530	532		10.1126/science.1161000	http://dx.doi.org/10.1126/science.1161000			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	329RS	18653883				2022-12-28	WOS:000257888900037
J	Heremans, JP; Jovovic, V; Toberer, ES; Saramat, A; Kurosaki, K; Charoenphakdee, A; Yamanaka, S; Snyder, GJ				Heremans, Joseph P.; Jovovic, Vladimir; Toberer, Eric S.; Saramat, Ali; Kurosaki, Ken; Charoenphakdee, Anek; Yamanaka, Shinsuke; Snyder, G. Jeffrey			Enhancement of thermoelectric efficiency in PbTe by distortion of the electronic density of states	SCIENCE			English	Article							THERMAL-CONDUCTIVITY; FIGURE; PERFORMANCE; MERIT	The efficiency of thermoelectric energy converters is limited by the material thermoelectric figure of merit (zT). The recent advances in zT based on nanostructures limiting the phonon heat conduction is nearing a fundamental limit: The thermal conductivity cannot be reduced below the amorphous limit. We explored enhancing the Seebeck coefficient through a distortion of the electronic density of states and report a successful implementation through the use of the thallium impurity levels in lead telluride ( PbTe). Such band structure engineering results in a doubling of zT in p- type PbTe to above 1.5 at 773 kelvin. Use of this new physical principle in conjunction with nanostructuring to lower the thermal conductivity could further enhance zT and enable more widespread use of thermoelectric systems.	[Heremans, Joseph P.; Jovovic, Vladimir] Ohio State Univ, Dept Mech Engn, Columbus, OH 43210 USA; [Heremans, Joseph P.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Toberer, Eric S.; Saramat, Ali; Snyder, G. Jeffrey] CALTECH, Pasadena, CA 91125 USA; [Kurosaki, Ken; Charoenphakdee, Anek; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; California Institute of Technology; Osaka University	Heremans, JP (corresponding author), Ohio State Univ, Dept Mech Engn, 201 W 19th Ave, Columbus, OH 43210 USA.	heremans.1@osu.edu; jsnyder@caltech.edu	Snyder, G J/I-2263-2015; Kurosaki, Ken/E-8081-2012; Heremans, Joseph P/D-3298-2015; Snyder, G. Jeffrey/E-4453-2011	Kurosaki, Ken/0000-0002-3015-3206; Heremans, Joseph P/0000-0003-3996-2744; Snyder, G. Jeffrey/0000-0003-1414-8682				Ahmad S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.056403; ALLGAIER RS, 1958, PHYS REV, V111, P1029, DOI 10.1103/PhysRev.111.1029; Androulakis J, 2006, ADV MATER, V18, P1170, DOI 10.1002/adma.200502770; [Anonymous], 1979, SOLID STATE PHYS, DOI 10.1016/S0081-1947(08)60359-8; Costescu RM, 2004, SCIENCE, V303, P989, DOI 10.1126/science.1093711; CUTLER M, 1969, PHYS REV, V181, P1336, DOI 10.1103/PhysRev.181.1336; Fritts R.W., 1960, THERMOELECTRIC MAT D, P143; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; Heremans JP, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115334; Heremans JP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.216801; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; HICKS LD, 1993, PHYS REV B, V47, P16631, DOI 10.1103/PhysRevB.47.16631; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Ioffe A., 1957, SEMICONDUCTOR THERMO; Jovovic V, 2008, J APPL PHYS, V103, DOI 10.1063/1.2890150; Jovovic V, 2008, MATER RES SOC SYMP P, V1044, P141; Mahan GD, 1996, P NATL ACAD SCI USA, V93, P7436, DOI 10.1073/pnas.93.15.7436; Matsushita Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134512; Nakayama K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.227004; Nemov S. A., 1998, Physics-Uspekhi, V41, P735, DOI 10.1070/PU1998v041n08ABEH000427; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Poudeu PFR, 2006, ANGEW CHEM INT EDIT, V45, P3835, DOI 10.1002/anie.200600865; PREIER H, 1979, APPL PHYS, V20, P189, DOI 10.1007/BF00886018; Ravich Y. I., 1995, CRC HDB THERMOELECTR, P67; Ravich Y.I., 1970, SEMICONDUCTING LEAD; RAVICH YI, 1971, PHYS STATUS SOLIDI B, V43, P453, DOI 10.1002/pssb.2220430202; SALES B, 1998, SCIENCE, V5266, P1325; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Volkov BA, 2002, PHYS-USP+, V45, P819, DOI 10.1070/PU2002v045n08ABEH001146	31	3001	3059	57	1784	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					554	557		10.1126/science.1159725	http://dx.doi.org/10.1126/science.1159725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653890				2022-12-28	WOS:000257888900045
J	Bensinger, SJ; Tontonoz, P				Bensinger, Steven J.; Tontonoz, Peter			Integration of metabolism and inflammation by lipid-activated nuclear receptors	NATURE			English	Review							LIVER-X-RECEPTOR; BETA-OXIDATION PATHWAY; PPAR-GAMMA; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; DEFICIENT MICE; LXR-ALPHA; INTERLEUKIN-12 PRODUCTION; ALTERNATIVE ACTIVATION; SIGNALING PATHWAYS	The nuclear receptors known as PPARs and LXRs are lipid-activated transcription factors that have emerged as key regulators of lipid metabolism and inflammation. PPARs and LXRs are activated by non-esterified fatty acids and cholesterol metabolites, respectively, and both exert positive and negative control over the expression of a range of metabolic and inflammatory genes. The ability of these nuclear receptors to integrate metabolic and inflammatory signalling makes them attractive targets for intervention in human metabolic diseases, such as atherosclerosis and type 2 diabetes, as well as for the modulation of inflammation and immune responses.	[Bensinger, Steven J.; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90049 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, David Geffen Sch Med, 675 Charles E Young Dr, Los Angeles, CA 90049 USA.	ptontonoz@mednet.ucla.edu			Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR021975] Funding Source: Medline; NHLBI NIH HHS [HL66088, HL30568] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR021975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL030568] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Babaev VR, 2007, CIRCULATION, V116, P1404, DOI 10.1161/CIRCULATIONAHA.106.684704; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Birrell MA, 2007, J BIOL CHEM, V282, P31882, DOI 10.1074/jbc.M703278200; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Faveeuw C, 2000, FEBS LETT, V486, P261, DOI 10.1016/S0014-5793(00)02319-X; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Geyeregger R, 2007, BLOOD, V109, P4288, DOI 10.1182/blood-2006-08-043422; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Glass CK, 2000, GENE DEV, V14, P121; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Klotz L, 2007, J IMMUNOL, V178, P2122, DOI 10.4049/jimmunol.178.4.2122; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG657, DOI 10.1152/ajpgi.00381.2006; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; STAELS B, 1992, ARTERIOSCLER THROMB, V12, P286, DOI 10.1161/01.ATV.12.3.286; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Sun Y, 2003, J BIOL CHEM, V278, P27688, DOI 10.1074/jbc.M300760200; Syrovets T, 2002, THROMB HAEMOSTASIS, V88, P274; Szatmari I, 2004, IMMUNITY, V21, P95, DOI 10.1016/j.immuni.2004.06.003; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhang-Gandhi CX, 2007, J NEUROIMMUNOL, V183, P50, DOI 10.1016/j.jneuroim.2006.11.007; Zingarelli B, 2003, J IMMUNOL, V171, P6827, DOI 10.4049/jimmunol.171.12.6827	88	628	658	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					470	477		10.1038/nature07202	http://dx.doi.org/10.1038/nature07202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650918				2022-12-28	WOS:000257860300042
J	Medzhitov, R				Medzhitov, Ruslan			Origin and physiological roles of inflammation	NATURE			English	Review							TOLL-LIKE RECEPTORS; CELL-DEATH; NALP3 INFLAMMASOME; INNATE IMMUNITY; TISSUE; MACROPHAGES; ACTIVATION; MECHANISMS; SYSTEM; HOMEOSTASIS	Inflammation underlies a wide variety of physiological and pathological processes. Although the pathological aspects of many types of inflammation are well appreciated, their physiological functions are mostly unknown. The classic instigators of inflammation - infection and tissue injury - are at one end of a large range of adverse conditions that induce inflammation, and they trigger the recruitment of leukocytes and plasma proteins to the affected tissue site. Tissue stress or malfunction similarly induces an adaptive response, which is referred to here as para-inflammation. This response relies mainly on tissue-resident macrophages and is intermediate between the basal homeostatic state and a classic inflammatory response. Para-inflammation is probably responsible for the chronic inflammatory conditions that are associated with modern human diseases.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, TAC S-669,300 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; HIGGS GA, 1984, ANN CLIN RES, V16, P287; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kumar V., 2018, ROBBINS BASIC PATHOL, V10th; MAJNO G, 1995, AM J PATHOL, V146, P3; Majno G, 2004, CELLS TISSUES DIS, VSecond; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stearns SC, 2008, EVOLUTION HLTH DIS; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yan Shi Fang, 2007, Curr Diab Rep, V7, P146, DOI 10.1007/s11892-007-0024-4; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	57	3567	3711	37	657	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					428	435		10.1038/nature07201	http://dx.doi.org/10.1038/nature07201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650913				2022-12-28	WOS:000257860300037
J	Ishikawa, HO; Takeuchi, H; Haltiwanger, RS; Irvine, KD				Ishikawa, Hiroyuki O.; Takeuchi, Hideyuki; Haltiwanger, Robert S.; Irvine, Kenneth D.			Four-jointed is a Golgi kinase that phosphorylates a subset of cadherin domains	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; PLANAR POLARITY; FAT; DROSOPHILA; GROWTH; ENCODES; PATHWAY; YORKIE; MEMBER; SITES	The atypical cadherin Fat acts as a receptor for a signaling pathway that regulates growth, gene expression, and planar cell polarity. Genetic studies in Drosophila identified the four-jointed gene as a regulator of Fat signaling. We show that four-jointed encodes a protein kinase that phosphorylates serine or threonine residues within extracellular cadherin domains of Fat and its transmembrane ligand, Dachsous. Four-jointed functions in the Golgi and is the first molecularly defined kinase that phosphorylates protein domains destined to be extracellular. An acidic sequence motif (Asp-Asn-Glu) within Four-jointed was essential for its kinase activity in vitro and for its biological activity in vivo. Our results indicate that Four-jointed regulates Fat signaling by phosphorylating cadherin domains of Fat and Dachsous as they transit through the Golgi.	[Ishikawa, Hiroyuki O.; Irvine, Kenneth D.] Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; [Ishikawa, Hiroyuki O.; Irvine, Kenneth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Takeuchi, Hideyuki/AAZ-9210-2020		Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA123071, CA123071, R01 CA123071-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM078620-02, GM078620, R01 GM078620, R01 GM061126-08, R01 GM061126, GM061126] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078620, R01GM061126] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Rock R, 2005, DEV DYNAM, V234, P602, DOI 10.1002/dvdy.20553; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Yamaguchi K, 2006, DEV DYNAM, V235, P3085, DOI 10.1002/dvdy.20946; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	28	174	182	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					401	404		10.1126/science.1158159	http://dx.doi.org/10.1126/science.1158159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635802	Green Accepted			2022-12-28	WOS:000257713900049
J	Setty, SRG; Tenza, D; Sviderskaya, EV; Bennett, DC; Raposo, G; Marks, MS				Setty, Subba Rao Gangi; Tenza, Daniele; Sviderskaya, Elena V.; Bennett, Dorothy C.; Raposo, Graca; Marks, Michael S.			Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes	NATURE			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; PROTEIN; LOCALIZATION; DISEASE; TRAFFICKING; BLOC-1; GENE; PREMELANOSOMES; MELANOGENESIS	Copper is a cofactor for many cellular enzymes and transporters(1). It can be loaded onto secreted and endomembrane cuproproteins by translocation from the cytosol into membrane- bound organelles by ATP7A or ATP7B transporters, the genes for which are mutated in the copper imbalance syndromes Menkes disease and Wilson disease, respectively(2). Endomembrane cuproproteins are thought to incorporate copper stably on transit through the trans-Golgi network, in which ATP7A accumulates(3) by dynamic cycling through early endocytic compartments(4). Here we show that the pigment- cell- specific cuproenzyme tyrosinase acquires copper only transiently and inefficiently within the trans- Golgi network of mouse melanocytes. To catalyse melanin synthesis, tyrosinase is subsequently reloaded with copper within specialized organelles called melanosomes. Copper is supplied to melanosomes by ATP7A, a cohort of which localizes to melanosomes in a biogenesis of lysosome- related organelles complex-1 ( BLOC-1)- dependent manner. These results indicate that cell- type- specific localization of a metal transporter is required to sustain metallation of an endomembrane cuproenzyme, providing a mechanism for exquisite spatial control of metalloenzyme activity. Moreover, because BLOC- 1 subunits are mutated in subtypes of the genetic disease Hermansky - Pudlak syndrome, these results also show that defects in copper transporter localization contribute to hypopigmentation, and hence perhaps other systemic defects, in Hermansky Pudlak syndrome.	[Setty, Subba Rao Gangi; Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Tenza, Daniele; Raposo, Graca] Ctr Rech, Inst Curie, F-75248 Paris, France; [Tenza, Daniele; Raposo, Graca] CNRS, UMR 144, F-75248 Paris, France; [Sviderskaya, Elena V.; Bennett, Dorothy C.] Univ London St Georges Hosp, Ctr Mol & Metab Signalling, Div Basic Med Sci, London SW17 0RE, England	University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; St Georges University London	Marks, MS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	Marks, Michael S/Q-7223-2019; Bennett, Dorothy C/C-2418-2008; Sviderskaya, Elena V/D-2419-2009	Marks, Michael S/0000-0001-7435-7262; Bennett, Dorothy C/0000-0002-3639-7527; Gangi Setty, Subba Rao/0000-0003-4035-2900; Raposo, graca/0000-0001-9590-1298	National Institute of Health [R01 EY015625, R21 GM078474]; CNRS; Institut Curie and Fondation pour la Recherche Medicale; Wellcome Trust program [064583]; American Heart Association [0625437U]; NATIONAL EYE INSTITUTE [R01EY015625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078474] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Curie and Fondation pour la Recherche Medicale; Wellcome Trust program(Wellcome Trust); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Gitlin, M. Petris, B. Eipper, S. Lutsenko and A. Peden for reagents; A. Dancis, L. King and C. Burd for comments; and D. Harper for technical assistance. This work was supported by National Institute of Health grants R01 EY015625 and R21 GM078474 ( to M. S. M.), CNRS, Institut Curie and Fondation pour la Recherche Medicale ( to G. R.), Wellcome Trust program grant 064583 ( to E. V. S. and D. C. B.), and postdoctoral fellowship 0625437U from the American Heart Association ( to S. R. G. S.).	BENNETT DC, 1989, DEVELOPMENT, V105, P379; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Boissy RE, 1998, LAB INVEST, V78, P1037; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Harris ED, 2000, ANNU REV NUTR, V20, P291, DOI 10.1146/annurev.nutr.20.1.291; Krajacic P, 2006, INVEST OPHTH VIS SCI, V47, P3129, DOI 10.1167/iovs.05-1601; LEVINSON B, 1994, NAT GENET, V6, P369, DOI 10.1038/ng0494-369; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; MARTINEZ JH, 1985, BIOCHEM INT, V11, P729; MAUL GG, 1971, J CELL BIOL, V48, P41, DOI 10.1083/jcb.48.1.41; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; NOVIKOFF AB, 1968, J HISTOCHEM CYTOCHEM, V16, P299, DOI 10.1177/16.5.299; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; SATO M, 1991, J BIOL CHEM, V266, P5128; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358	33	168	171	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1142	U75		10.1038/nature07163	http://dx.doi.org/10.1038/nature07163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18650808	Green Accepted			2022-12-28	WOS:000258719600043
J	Narkar, VA; Downes, M; Yu, RT; Embler, E; Wang, YX; Banayo, E; Mihaylova, MM; Nelson, MC; Zou, YH; Juguilon, H; Kang, H; Shaw, RJ; Evans, RM				Narkar, Vihang A.; Downes, Michael; Yu, Ruth T.; Embler, Emi; Wang, Yong-Xu; Banayo, Ester; Mihaylova, Maria M.; Nelson, Michael C.; Zou, Yuhua; Juguilon, Henry; Kang, Heonjoong; Shaw, Reuben J.; Evans, Ronald M.			AMPK and PPAR delta Agonists are exercise mimetics	CELL			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; RECEPTOR-DELTA; ENDURANCE EXERCISE; GLUCOSE-TRANSPORT; FOOD-INTAKE; MITOCHONDRIAL-FUNCTION; DIRECT PHOSPHORYLATION; SIGNALING PATHWAYS	The benefits of endurance exercise on general health make it desirable to identify orally active agents that would mimic or potentiate the effects of exercise to treat metabolic diseases. Although certain natural compounds, such as reseveratrol, have endurance-enhancing activities, their exact metabolic targets remain elusive. We therefore tested the effect of pathwayspecific drugs on endurance capacities of mice in a treadmill running test. We found that PPAR beta/ delta agonist and exercise training synergistically increase oxidative myofibers and running endurance in adult mice. Because training activates AMPK and PGC1 alpha, we then tested whether the orally active AMPK agonist AICAR might be sufficient to overcome the exercise requirement. Unexpectedly, even in sedentary mice, 4 weeks of AICAR treatment alone induced metabolic genes and enhanced running endurance by 44%. These results demonstrate that AMPK-PPAR delta pathway can be targeted by orally active drugs to enhance training adaptation or even to increase endurance without exercise.	[Narkar, Vihang A.; Downes, Michael; Yu, Ruth T.; Embler, Emi; Nelson, Michael C.; Zou, Yuhua; Juguilon, Henry; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Banayo, Ester; Evans, Ronald M.] Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Wang, Yong-Xu] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Kang, Heonjoong] Seoul Natl Univ, Sch Earth & Environm Sci, Marine Biotechnol Lab, Seoul 151747, South Korea	Salk Institute; Salk Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU)	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019; Nelson, Michael Shawn/GXF-4934-2022; Mihaylova, Maria M./ACZ-4949-2022	Evans, Ronald/0000-0002-9986-5965; Mihaylova, Maria M./0000-0002-2725-767X; Yu, Ruth/0000-0002-9527-9627	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR053803-03]; Howard Hughes Medical Institute, Hilblom Foundation [HD027183]; National Institutes of Health [DK057978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute, Hilblom Foundation(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Cho, G. D. Barish, and C. H. Zhang for valuable suggestions and discussion of the manuscript and S. Ganley and E. Ong for administrative assistance. R. M. E is an investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology. V.A.N. is supported by a Ruth L. Kirschstein National Research Service Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR053803-03). This work was supported by the Howard Hughes Medical Institute, Hilblom Foundation, and National Institutes of Health (HD027183 and DK057978).	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Durante PE, 2002, AM J PHYSIOL-ENDOC M, V283, pE178, DOI 10.1152/ajpendo.00404.2001; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lucia A, 2001, SPORTS MED, V31, P325, DOI 10.2165/00007256-200131050-00004; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mahoney Douglas J, 2005, Phys Med Rehabil Clin N Am, V16, P859; Man MQ, 2008, J INVEST DERMATOL, V128, P370, DOI 10.1038/sj.jid.5701026; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Minnaard R, 2005, MUSCLE NERVE, V31, P339, DOI 10.1002/mus.20268; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Schmitt B, 2003, PHYSIOL GENOMICS, V15, P148, DOI 10.1152/physiolgenomics.00089.2003; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Short KR, 2005, J APPL PHYSIOL, V99, P95, DOI 10.1152/japplphysiol.00129.2005; Siu PM, 2004, J APPL PHYSIOL, V97, P277, DOI 10.1152/japplphysiol.00534.2004; Sprecher DL, 2007, ARTERIOSCL THROM VAS, V27, P359, DOI 10.1161/01.ATV.0000252790.70572.0c; Terada S, 2006, AM J PHYSIOL-ENDOC M, V290, pE607, DOI 10.1152/ajpendo.00430.2005; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yoshioka M, 2003, FASEB J, V17, P1812, DOI 10.1096/fj.02-1200com; Zapala MA, 2002, GENOME BIOL, V3	51	905	949	5	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					405	415		10.1016/j.cell.2008.06.051	http://dx.doi.org/10.1016/j.cell.2008.06.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18674809	Green Accepted, Bronze			2022-12-28	WOS:000258665500014
J	Ko, HC; Stoykovich, MP; Song, JZ; Malyarchuk, V; Choi, WM; Yu, CJ; Geddes, JB; Xiao, JL; Wang, SD; Huang, YG; Rogers, JA				Ko, Heung Cho; Stoykovich, Mark P.; Song, Jizhou; Malyarchuk, Viktor; Choi, Won Mook; Yu, Chang-Jae; Geddes, Joseph B., III; Xiao, Jianliang; Wang, Shuodao; Huang, Yonggang; Rogers, John A.			A hemispherical electronic eye camera based on compressible silicon optoelectronics	NATURE			English	Article							SPHERICAL SURFACES; SOFT LITHOGRAPHY; STAMP COLLAPSE; FABRICATION; MICROSTRUCTURES; ARRAYS	The human eye is a remarkable imaging device, with many attractive design features(1,2). Prominent among these is a hemispherical detector geometry, similar to that found in many other biological systems, that enables a wide field of view and low aberrations with simple, few-component imaging optics(3-5). This type of configuration is extremely difficult to achieve using established optoelectronics technologies, owing to the intrinsically planar nature of the patterning, deposition, etching, materials growth and doping methods that exist for fabricating such systems. Here we report strategies that avoid these limitations, and implement them to yield high-performance, hemispherical electronic eye cameras based on single-crystalline silicon. The approach uses wafer-scale optoelectronics formed in unusual, two-dimensionally compressible configurations and elastomeric transfer elements capable of transforming the planar layouts in which the systems are initially fabricated into hemispherical geometries for their final implementation. In a general sense, these methods, taken together with our theoretical analyses of their associated mechanics, provide practical routes for integrating well-developed planar device technologies onto the surfaces of complex curvilinear objects, suitable for diverse applications that cannot be addressed by conventional means.	[Ko, Heung Cho; Stoykovich, Mark P.; Choi, Won Mook; Yu, Chang-Jae; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Song, Jizhou; Rogers, John A.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Malyarchuk, Viktor; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Geddes, Joseph B., III; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Xiao, Jianliang; Wang, Shuodao; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	y-huang@northwestern.edu; jrogers@uiuc.edu	huang, yonggang/O-6236-2019; Wang, Shuodao/H-6014-2011; Rogers, John/L-2798-2016; Huang, Yonggang/B-6998-2009; Song, Jizhou/B-1935-2008; Xiao, Jianliang/B-4535-2008	Wang, Shuodao/0000-0002-0481-7902; Song, Jizhou/0000-0003-2821-9429; 				Boncheva M, 2005, P NATL ACAD SCI USA, V102, P3924, DOI 10.1073/pnas.0500807102; Boncheva M, 2005, ADV MATER, V17, P553, DOI 10.1002/adma.200400940; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Childs WR, 2004, ADV MATER, V16, P1323, DOI 10.1002/adma.200400592; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Grayson TP, 2002, P SOC PHOTO-OPT INS, V4849, P269, DOI 10.1117/12.460757; Hsu PHI, 2004, IEEE T ELECTRON DEV, V51, P371, DOI 10.1109/TED.2003.822873; Hsu PI, 2004, J APPL PHYS, V95, P705, DOI 10.1063/1.1634370; Huang YGY, 2005, LANGMUIR, V21, P8058, DOI 10.1021/la0502185; JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795; Jacobs HO, 2002, SCIENCE, V296, P323, DOI 10.1126/science.1069153; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Land MF, 2002, ANIMAL EYES; Lee KJ, 2005, ADV FUNCT MATER, V15, P557, DOI 10.1002/adfm.200400189; Lima O, 2007, J VAC SCI TECHNOL B, V25, P2412, DOI 10.1116/1.2804428; Miller SM, 2002, J VAC SCI TECHNOL B, V20, P2320, DOI 10.1116/1.1520554; Paul KE, 2003, ADV FUNCT MATER, V13, P259, DOI 10.1002/adfm.200304255; Radtke D, 2007, OPT EXPRESS, V15, P1167, DOI 10.1364/OE.15.001167; Ruchhoeft P, 2000, J VAC SCI TECHNOL B, V18, P3185, DOI 10.1116/1.1319842; Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131; Swain P, 2004, P SOC PHOTO-OPT INS, V5499, P281, DOI 10.1117/12.554840; WALTHER A, 1995, RAY WAVE THEORY LENS; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Zheng W, 2004, P NATL ACAD SCI USA, V101, P12814, DOI 10.1073/pnas.0404437101; Zhou W, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149513	25	982	1096	28	560	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					748	753		10.1038/nature07113	http://dx.doi.org/10.1038/nature07113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685704				2022-12-28	WOS:000258228000041
J	Steinbrook, R				Steinbrook, Robert			Disclosure of industry payments to physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*AM ASS MED COLL, 2008, IND FUND MED ED REP; Campbell EG, 2007, JAMA-J AM MED ASSOC, V298, P1779, DOI 10.1001/jama.298.15.1779; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; HARRIS G, 2008, NY TIMES        0326, pA1; Ross JS, 2007, JAMA-J AM MED ASSOC, V297, P1216, DOI 10.1001/jama.297.11.1216	5	28	28	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					559	561		10.1056/NEJMp0805309	http://dx.doi.org/10.1056/NEJMp0805309			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334IY	18687636				2022-12-28	WOS:000258216700003
J	Hammer, SM; Eron, JJ; Reiss, P; Schooley, RT; Thompson, MA; Walmsley, S; Cahn, P; Fischl, MA; Gatell, JM; Hirsch, MS; Jacobsen, DM; Montaner, JSG; Richman, DD; Yeni, PG; Volberding, PA				Hammer, Scott M.; Eron, Joseph J., Jr.; Reiss, Peter; Schooley, Robert T.; Thompson, Melanie A.; Walmsley, Sharon; Cahn, Pedro; Fischl, Margaret A.; Gatell, Jose M.; Hirsch, Martin S.; Jacobsen, Donna M.; Montaner, Julio S. G.; Richman, Douglas D.; Yeni, Patrick G.; Volberding, Paul A.			Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; TREATMENT-NAIVE PATIENTS; EXPERIENCED HIV-1-INFECTED PATIENTS; TENOFOVIR DISOPROXIL FUMARATE; REVERSE-TRANSCRIPTASE INHIBITORS; CHRONIC KIDNEY-DISEASE; CD4 CELL COUNTS; CLINICAL-TRIALS; DOUBLE-BLIND; OPEN-LABEL	Context The availability of new antiretroviral drugs and formulations, including drugs in new classes, and recent data on treatment choices for antiretroviral- naive and - experienced patients warrant an update of the International AIDS Society - USA guidelines for the use of antiretroviral therapy in adult human immunodeficiency virus ( HIV) infection. Objectives To summarize new data in the field and to provide current recommendations for the antiretroviral management and laboratory monitoring of HIV infection. This report provides guidelines in key areas of antiretroviral management: when to initiate therapy, choice of initial regimens, patient monitoring, when to change therapy, and how best to approach treatment options, including optimal use of recently approved drugs ( maraviroc, raltegravir, and etravirine) in treatment- experienced patients. Data Sources and Study Selection A 14- member panel with expertise in HIV research and clinical care was appointed. Data published or presented at selected scientific conferences since the last panel report ( August 2006) through June 2008 were identified. Data Extraction and Synthesis Data that changed the previous guidelines were reviewed by the panel ( according to section). Guidelines were drafted by section writing committees and were then reviewed and edited by the entire panel. Recommendations were made by panel consensus. Conclusions New data and considerations support initiating therapy before CD4 cell count declines to less than 350/mu L. In patients with 350 CD4 cells/mu L or more, the decision to begin therapy should be individualized based on the presence of comorbidities, risk factors for progression to AIDS and non- AIDS diseases, and patient readiness for treatment. In addition to the prior recommendation that a high plasma viral load ( eg, > 100 000 copies/ mL) and rapidly declining CD4 cell count ( > 100/mu L per year) should prompt treatment initiation, active hepatitis B or C virus coinfection, cardiovascular disease risk, and HIV- associated nephropathy increasingly prompt earlier therapy. The initial regimen must be individualized, particularly in the presence of comorbid conditions, but usually will include efavirenz or a ritonavir- boosted protease inhibitor plus 2 nucleoside reverse transcriptase inhibitors ( tenofovir/ emtricitabine or abacavir/ lamivudine). Treatment failure should be identified and managed promptly, with the goal of therapy, even in heavily pretreated patients, being an HIV- 1 RNA level below assay detection limits.	[Hammer, Scott M.] Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA; [Eron, Joseph J., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Schooley, Robert T.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Thompson, Melanie A.] AIDS Res Consortium Atlanta, Atlanta, GA USA; [Walmsley, Sharon] Univ Toronto, Toronto, ON, Canada; [Cahn, Pedro] Univ Buenos Aires, Sch Med, Hosp Juan Fernandez, Buenos Aires, DF, Argentina; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Fischl, Margaret A.] Univ Miami, Miami, FL USA; [Gatell, Jose M.] Univ Barcelona, Barcelona, Spain; [Hirsch, Martin S.] Harvard Univ, Sch Med, Boston, MA USA; [Jacobsen, Donna M.] Int AIDS Soc USA, San Francisco, CA USA; [Volberding, Paul A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Volberding, Paul A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Montaner, Julio S. G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Richman, Douglas D.] Univ Calif San Diego, San Diego, CA 92103 USA; [Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Yeni, Patrick G.] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Yeni, Patrick G.] Xavier Bichat Med Sch, Paris, France	Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Diego; University of Toronto; University of Buenos Aires; University of Miami; University of Barcelona; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of British Columbia; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hammer, SM (corresponding author), Columbia Univ Coll Phys & Surg, Div Infect Dis, 630 W 168th St, New York, NY 10032 USA.	smh48@columbia.edu	Gatell, Jose M/ABC-3607-2020; Montaner, Julio/K-7621-2012	Walmsley, Sharon/0000-0002-3959-5692				Alvarez D, 2006, J VIRAL HEPATITIS, V13, P683, DOI 10.1111/j.1365-2893.2006.00749.x; Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Badiou S, 2006, J INFECTION, V52, P335, DOI 10.1016/j.jinf.2005.07.020; Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Barreiro P, 2007, J INFECT DIS, V195, P973, DOI 10.1086/512086; Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; *BRIST MYERS SQUIB, 2007, REYAT PACK INS; BRUYAND M, 2008, 15 C RETR OPP INF FE; Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Choi AI, 2007, J AM SOC NEPHROL, V18, P2968, DOI 10.1681/ASN.2007040402; CLELJSEN RM, 2007, J ANTIMICROB CHEMOTH, V60, P897; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; CLUMECK N, 2007, 11 EUR AIDS C OCT 24; COOPER D, 2007, 14 C RETR OPP INF FE; COOPER D, 2008, 15 C RETR OPP INF FE; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; De Lazzari E, 2008, HIV MED, V9, P221, DOI 10.1111/j.1468-1293.2008.00552.x; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; Dube MP, 2007, JAIDS-J ACQ IMM DEF, V45, P508, DOI 10.1097/QAI.0b013e3181142d26; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; ELSADR W, 2008, 15 C RETR OPP INF FE; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Joseph E, 2006, LANCET, V368, P476, DOI 10.1016/S0140-6736(06)69155-1; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; GATHE J, 2008, 15 C RETR OPP INF FE; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Gupta SK, 2004, CLIN NEPHROL, V61, P1; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HARDY D, 2008, 15 C RETR OPP INF FE; HARRIS M, 2008, 15 C RETR OPP INF FE; HAUBRICH R, 2008, 15 C RETR OPP INF FE; HAUBRICH RH, 2007, 14 C RETR OPP INF FE; Hazuda DJ, 2007, ANTIVIR THER, V12, pS10; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Hill A, 2007, AIDS, V21, P1651, DOI 10.1097/QAD.0b013e3282703593; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Holland DT, 2004, ANTIMICROB AGENTS CH, V48, P824, DOI 10.1128/AAC.48.3.824-831.2004; Jaen A, 2008, JAIDS-J ACQ IMM DEF, V47, P212, DOI 10.1097/QAI.0b013e31815ee282; JOHNSON M, 2008, 15 C RETR OPP INF FE; Kaplan JE, 2003, CLIN INFECT DIS, V37, P951, DOI 10.1086/377606; KAYITENKORE K, 2006, 16 INT AIDS C AUG 13; KEARNEY BP, 2002, 6 INT C DRUG THER HI; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Khoo SH, 2006, JAIDS-J ACQ IMM DEF, V41, P461, DOI 10.1097/01.qai.0000218345.65434.21; Kuller L., 2008, 15 C RETR OPP INF FE; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lichtenstein KA, 2008, JAIDS-J ACQ IMM DEF, V47, P27, DOI 10.1097/QAI.0b013e31815acacc; LODWICK R, 2008, 15 C RETR OPP INF FE; Lotsch J, 2007, ANTIMICROB AGENTS CH, V51, P3264, DOI 10.1128/AAC.00036-07; Long JL, 2008, AIDS, V22, P489, DOI 10.1097/QAD.0b013e3282f47082; Luber AD, 2007, HIV MED, V8, P457, DOI 10.1111/j.1468-1293.2007.00496.x; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; Lundgren JD, 2008, HIV MED, V9, P72, DOI 10.1111/j.1468-1293.2007.00534.x; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Lyons F, 2007, AIDS, V21, P1053, DOI 10.1097/QAD.0b013e3281053a1e; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; Madruga JV, 2007, LANCET, V370, P49, DOI 10.1016/S0140-6736(07)61049-6; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Martin A, 2004, AIDS, V18, P1029, DOI 10.1097/00002030-200404300-00011; Mauskopf J, 2005, JAIDS-J ACQ IMM DEF, V39, P562; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; MAYER H, 2006, 16 INT AIDS C AUG 13; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Mocroft A, 2007, ANTIVIR THER, V12, P325; MOLINA JM, 2008, 15 C RETR OPP INF FE; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Moyle G, 2006, ANTIVIR THER, V11, P73; Moyle GJ, 2003, JAIDS-J ACQ IMM DEF, V33, P22, DOI 10.1097/00126334-200305010-00004; Neal B, 2008, PLOS MED, V5, P526, DOI 10.1371/journal.pmed.0050084; Neaton JD, 2008, CURR OPIN HIV AIDS, V3, P112, DOI 10.1097/COH.0b013e3282f3808b; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Malan DR, 2008, JAIDS-J ACQ IMM DEF, V47, P161, DOI 10.1097/QAI.0b013e31815ace6a; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Park-Wyllie LY, 2007, CLIN INFECT DIS, V45, P933, DOI 10.1086/521252; Parsonage MJ, 2005, HIV MED, V6, P341, DOI 10.1111/j.1468-1293.2005.00318.x; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; *PER HIV GUID WORK, PUBL HLTH SERV TASK; PHILLIPS A, 2008, 15 C RETR OPP INF FE; Phillips AN, 2007, AIDS, V21, P1717; Phillips AN, 2007, BRIT MED J, V334, P76, DOI 10.1136/bmj.39064.406389.94; Podzamczer D, 2007, JAIDS-J ACQ IMM DEF, V44, P139, DOI 10.1097/QAI.0b013e31802bf122; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Reynes J, 2007, AIDS PATIENT CARE ST, V21, P533, DOI 10.1089/apc.2006.0174; Ribaudo HJ, 2008, J INFECT DIS, V197, P1006, DOI 10.1086/529208; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Riedel DJ, 2008, AIDS PATIENT CARE ST, V22, P113, DOI 10.1089/apc.2007.0034; Ripamonti D, 2007, AIDS, V21, P2409, DOI 10.1097/QAD.0b013e32825a69d1; Rosso R, 2006, J ANTIMICROB CHEMOTH, V57, P1168, DOI 10.1093/jac/dkl136; SAAG M, 2007, 4 INT AIDS SOC C HIV; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; SCHOLLER M, 2006, 13 C RETR OPP INF FE; SEMINARI E, 2005, 6 INT WORKSH CLIN PH; SHERMAN K, 2008, 15 C RETR OPP INF FE; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; SMITH K, 2007, 4 INT AIDS SOC C HIV; SMITH KY, 2008, 15 C RETR OPP INF FE; STEIGBIGEL R, 2008, 15 C RETR OPP INF FE; STEIGBIGEL R, 2007, 14 C RETR OPP INF FE; Stein JH, 2008, LANCET, V371, P1391, DOI 10.1016/S0140-6736(08)60491-2; Sterling TR, 2003, J INFECT DIS, V188, P1659, DOI 10.1086/379741; Szczech A, 2002, CLIN NEPHROL, V57, P336; Szczech LA, 2002, KIDNEY INT, V61, P195, DOI 10.1046/j.1523-1755.2002.00094.x; TROTTIER B, 2008, 17 ANN CAN C HIV AID; van Luin M, 2008, CURR OPIN HIV AIDS, V3, P266, DOI 10.1097/COH.0b013e3282f82c1b; Vingerhoets J, 2007, ANTIVIR THER, V12, pS34; von Hentig N, 2006, EUR J MED RES, V11, P377; WALMSLEY S, 2007, 11 C RETR OPP INF OC; Walmsley SL, 2008, JAIDS-J ACQ IMM DEF, V47, P429, DOI 10.1097/QAI.0b013e318160a529; Walmsley SL, 2007, AIDS, V21, P2245, DOI 10.1097/QAD.0b013e3282ef6db7; Ward DJ, 2006, AIDS PATIENT CARE ST, V20, P542, DOI 10.1089/apc.2006.20.542; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; WHEELER W, 2007, 14 C RETR OPP INF FE; Winston JA, 2001, NEW ENGL J MED, V344, P1979, DOI 10.1056/NEJM200106283442604; Wood E, 2007, HIV MED, V8, P80, DOI 10.1111/j.1468-1293.2007.00430.x; ZOLOPA A, 2008, 15 C RETR OPP INF FE	137	777	826	3	132	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					555	570		10.1001/jama.300.5.555	http://dx.doi.org/10.1001/jama.300.5.555			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	333YG	18677028				2022-12-28	WOS:000258188900017
J	Manzoni, S; Jackson, RB; Trofymow, JA; Porporato, A				Manzoni, Stefano; Jackson, Robert B.; Trofymow, John A.; Porporato, Amilcare			The global stoichiometry of litter nitrogen mineralization	SCIENCE			English	Article							OLD-GROWTH FOREST; BACTERIAL-GROWTH; CARBON; SOIL; DYNAMICS; DECOMPOSITION; TRANSFORMATIONS; IMMOBILIZATION; EFFICIENCY; PATTERNS	Plant residue decomposition and the nutrient release to the soil play a major role in global carbon and nutrient cycling. Although decomposition rates vary strongly with climate, nitrogen immobilization into litter and its release in mineral forms are mainly controlled by the initial chemical composition of the residues. We used a data set of similar to 2800 observations to show that these global nitrogen- release patterns can be explained by fundamental stoichiometric relationships of decomposer activity. We show how litter quality controls the transition from nitrogen accumulation into the litter to release and alters decomposers' respiration patterns. Our results suggest that decomposers lower their carbon- use efficiency to exploit residues with low initial nitrogen concentration, a strategy used broadly by bacteria and consumers across trophic levels.	[Manzoni, Stefano; Porporato, Amilcare] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; [Jackson, Robert B.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Jackson, Robert B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Trofymow, John A.] Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC V8Z 1M5, Canada	Duke University; Duke University; Duke University; Natural Resources Canada; Canadian Forest Service	Porporato, A (corresponding author), Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA.	amilcare@duke.edu	Manzoni, Stefano/C-5330-2009	Manzoni, Stefano/0000-0002-5960-5712; Jackson, Robert/0000-0001-8846-7147				ABER JD, 1982, CAN J BOT, V60, P2263, DOI 10.1139/b82-277; Agren GI, 1996, THEORETICAL ECOSYSTE; BERG B, 1983, ECOLOGY, V64, P63, DOI 10.2307/1937329; Berg B., 2003, DECOMPOSITION PROCES; BOSATTA E, 1982, OIKOS, V39, P143, DOI 10.2307/3544478; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; HARMON ME, 2007, LONG TERM ECOLOGICAL, P23513; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Hart SC, 1999, ECOLOGY, V80, P1385, DOI 10.1890/0012-9658(1999)080[1385:NTIFTB]2.0.CO;2; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Krankina ON, 1999, CAN J FOREST RES, V29, P20, DOI 10.1139/cjfr-29-1-20; Manzoni S, 2007, SOIL BIOL BIOCHEM, V39, P1542, DOI 10.1016/j.soilbio.2007.01.006; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McGill W. B., 1981, Ecological Bulletins, P49; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; PANDIAN TJ, 1986, FRESHWATER BIOL, V16, P93, DOI 10.1111/j.1365-2427.1986.tb00950.x; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; Seneviratne G, 2000, BIOL FERT SOILS, V31, P60, DOI 10.1007/s003740050624; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Swift M. J., 1979, STUDIES ECOLOGY, V5; TROFYMOW JA, 1998, BCX378 PAC FOR CTR; Waksman SA, 1924, J AGR SCI, V14, P555, DOI 10.1017/S0021859600003981	29	449	515	29	467	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					684	686		10.1126/science.1159792	http://dx.doi.org/10.1126/science.1159792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669860				2022-12-28	WOS:000258077700042
J	Davis, S; Trapman, P; Leirs, H; Begon, M; Heesterbeek, JAP				Davis, S.; Trapman, P.; Leirs, H.; Begon, M.; Heesterbeek, J. A. P.			The abundance threshold for plague as a critical percolation phenomenon	NATURE			English	Article							WILDLIFE DISEASE; EPIDEMIC; NETWORKS; MODELS; POPULATIONS; PARAMETERS; INFECTION; SERENGETI; KAZAKSTAN; INVASION	Percolation theory is most commonly associated with the slow flow of liquid through a porous medium, with applications to the physical sciences(1). Epidemiological applications have been anticipated for disease systems where the host is a plant or volume of soil(2,3), and hence is fixed in space. However, no natural examples have been reported. The central question of interest in percolation theory(4), the possibility of an infinite connected cluster, corresponds in infectious disease to a positive probability of an epidemic. Archived records of plague ( infection with Yersinia pestis) in populations of great gerbils ( Rhombomys opimus) in Kazakhstan have been used to show that epizootics only occur when more than about 0.33 of the burrow systems built by the host are occupied by family groups(5). The underlying mechanism for this abundance threshold is unknown. Here we present evidence that it is a percolation threshold, which arises from the difference in scale between the movements that transport infectious fleas between family groups and the vast size of contiguous landscapes colonized by gerbils. Conventional theory predicts that abundance thresholds for the spread of infectious disease arise when transmission between hosts is density dependent such that the basic reproduction number ( R(0)) increases with abundance, attaining 1 at the threshold. Percolation thresholds, however, are separate, spatially explicit thresholds that indicate long- range connectivity in a system and do not coincide with R(0) = 1. Abundance thresholds are the theoretical basis for attempts to manage infectious disease by reducing the abundance of susceptibles, including vaccination and the culling of wildlife(6-8). This first natural example of a percolation threshold in a disease system invites a re- appraisal of other invasion thresholds, such as those for epidemic viral infections in African lions ( Panthera leo), and of other disease systems such as bovine tuberculosis ( caused by Mycobacterium bovis) in badgers ( Meles meles).	[Davis, S.; Heesterbeek, J. A. P.] Univ Utrecht, Fac Vet Med, NL-3584 CL Utrecht, Netherlands; [Trapman, P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Leirs, H.] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Leirs, H.] Univ Aarhus, Danish Pest Infestat Lab, Fac Agr Sci, Dept Integrated Pest Management, DK-2800 Lyngby, Denmark; [Begon, M.] Univ Liverpool, Host Parasite Biol Res Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	Utrecht University; Utrecht University; Utrecht University Medical Center; University of Antwerp; Aarhus University; University of Liverpool	Davis, S (corresponding author), Univ Utrecht, Fac Vet Med, Yalelaan 7, NL-3584 CL Utrecht, Netherlands.	S.A.Davis@uu.nl	Leirs, Herwig/B-8197-2008	Leirs, Herwig/0000-0002-7612-5024; Heesterbeek, Hans/0000-0001-8537-6418; Begon, Mike/0000-0003-1715-5327	Natural Environment Research Council [NE/E007899/1] Funding Source: researchfish; NERC [NE/E007899/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Artois M, 2001, VET J, V162, P141, DOI 10.1053/tvjl.2001.0601; Bailey DJ, 2000, NEW PHYTOL, V146, P535, DOI 10.1046/j.1469-8137.2000.00660.x; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; Begon M, 2006, EMERG INFECT DIS, V12, P268; Caley P, 1999, NEW ZEAL VET J, V47, P133, DOI 10.1080/00480169.1999.36130; Davis S, 2007, EPIDEMIOL INFECT, V135, P740, DOI 10.1017/S095026880600759X; Davis S, 2007, J R SOC INTERFACE, V4, P649, DOI 10.1098/rsif.2006.0208; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grimmett G. R., 1999, PERCOLATION; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; KESTEN H, 1980, COMMUN MATH PHYS, V74, P41, DOI 10.1007/BF01197577; Korneyev G.A., 1968, QUANTITATIVE CHARACT; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Otten W, 2004, NEW PHYTOL, V163, P125, DOI 10.1111/j.1469-8137.2004.01086.x; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; RUDENCHIK Yu. V., 1967, ZOOL ZH, V46, P117; SAHIMI M, 1994, APPL PERCOLATION THE; TRAPMAN P, 2006, THESIS VRIJE U AMSTE; Trapman P, 2007, THEOR POPUL BIOL, V71, P160, DOI 10.1016/j.tpb.2006.11.002	27	133	133	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					634	637		10.1038/nature07053	http://dx.doi.org/10.1038/nature07053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668107	Green Published			2022-12-28	WOS:000258026500046
J	Wen, PY; Kesari, S				Wen, Patrick Y.; Kesari, Santosh			Malignant gliomas in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PHASE-II TRIAL; CANCER STEM-CELLS; HIGH-GRADE GLIOMA; RADIATION-THERAPY; BRAIN-TUMORS; GLIOBLASTOMA-MULTIFORME; ANAPLASTIC OLIGODENDROGLIOMA; VENOUS THROMBOEMBOLISM; GENETIC PREDICTORS; PROGNOSTIC-FACTORS		Brigham & Womens Hosp, Div Neurooncol, Dept Neurol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Wen, PY (corresponding author), Dana Farber Brigham & Womens Canc Ctr, Ctr Neurooncol, SW430D,44 Binney St, Boston, MA 02115 USA.	pwen@partners.org	Wen, Patrick/AAE-3776-2022; Kesari, Santosh/E-8461-2013		NATIONAL CANCER INSTITUTE [U01CA062407] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA1240804, U01 CA062407] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afra D, 2002, LANCET, V359, P1011; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Asthagiri AR, 2007, NEUROL CLIN, V25, P975, DOI 10.1016/j.ncl.2007.07.006; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6; Brem Steven S, 2008, J Natl Compr Canc Netw, V6, P456; Butowski NA, 2006, J CLIN ONCOL, V24, P1273, DOI 10.1200/JCO.2005.04.7522; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; *CENTR BRAIN TUM R, 2000, CBTRUS 2008 STAT REP; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Chi AS, 2007, EXPERT OPIN THER TAR, V11, P473, DOI 10.1517/14728222.11.4.473; CLOUGHESY TF, 2008, J CLIN ONCOL S, V26, pS91; Cloughesy TF, 2006, J CLIN ONCOL, V24, P3651, DOI 10.1200/JCO.2006.06.2323; Collins VP, 2007, NAT CLIN PRACT ONCOL, V4, P362, DOI 10.1038/ncponc0820; Combs SE, 2005, J CLIN ONCOL, V23, P8863, DOI 10.1200/JCO.2005.03.4157; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Duda DG, 2007, J CLIN ONCOL, V25, P4033, DOI 10.1200/JCO.2007.11.3985; Farrell CJ, 2007, NEUROL CLIN, V25, P925, DOI 10.1016/j.ncl.2007.07.008; Ferguson Sherise, 2007, Current Drug Delivery, V4, P169, DOI 10.2174/156720107780362302; FINE HA, 1993, CANCER, V71, P2585, DOI 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S; Fine HA, 2003, J CLIN ONCOL, V21, P2299, DOI 10.1200/JCO.2003.08.045; Fisher JL, 2007, NEUROL CLIN, V25, P867, DOI 10.1016/j.ncl.2007.07.002; Fulci G, 2007, EXPERT OPIN BIOL TH, V7, P197, DOI 10.1517/14712598.7.2.197; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Gerber DE, 2006, J CLIN ONCOL, V24, P1310, DOI 10.1200/JCO.2005.04.6656; Glantz M, 2003, CANCER, V97, P2262, DOI 10.1002/cncr.11323; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Green H, 2007, MAYO CLIN PROC, V82, P1052, DOI 10.4065/82.9.1052; Guo P, 2003, AM J PATHOL, V162, P1083, DOI 10.1016/S0002-9440(10)63905-3; Haas-Koogan DA, 2005, CELL CYCLE, V4, P1369, DOI 10.4161/cc.4.10.2105; Hardell L, 2007, OCCUP ENVIRON MED, V64, P626, DOI 10.1136/oem.2006.029751; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Ino Y, 2001, CLIN CANCER RES, V7, P839; Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Keles GE, 2004, J NEUROSURG, V100, P41, DOI 10.3171/jns.2004.100.1.0041; Kesari S, 2006, NEURON, V51, P151, DOI 10.1016/j.neuron.2006.07.001; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lahkola A, 2007, INT J CANCER, V120, P1769, DOI 10.1002/ijc.22503; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee DY, 2007, EXPERT REV ANTICANC, V7, P1581, DOI 10.1586/14737140.7.11.1581; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; LEVIN JM, 1993, NEUROLOGY, V43, P1111, DOI 10.1212/WNL.43.6.1111; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Linos E, 2007, JNCI-J NATL CANCER I, V99, P1544, DOI 10.1093/jnci/djm170; Litofsky NS, 2004, NEUROSURGERY, V54, P358, DOI 10.1227/01.NEU.0000103450.94724.A2; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis D. N, 2007, 2007 WHO CLASSIFICAT; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malmer B, 2007, CANCER EPIDEM BIOMAR, V16, P1730, DOI 10.1158/1055-9965.EPI-07-0081; Mamelak AN, 2006, J CLIN ONCOL, V24, P3644, DOI 10.1200/JCO.2005.05.4569; Mellinghoff IK, 2006, NEW ENGL J MED, V354, P884; Meyers CA, 1998, J CLIN ONCOL, V16, P2522, DOI 10.1200/JCO.1998.16.7.2522; Ngo TTB, 2007, JNCI-J NATL CANCER I, V99, P639, DOI 10.1093/jnci/djk135; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pelloski CE, 2007, J CLIN ONCOL, V25, P2288, DOI 10.1200/JCO.2006.08.0705; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reardon DA, 2006, J CLIN ONCOL, V24, P115, DOI 10.1200/JCO.2005.03.4082; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Roa W, 2004, J CLIN ONCOL, V22, P1583, DOI 10.1200/JCO.2004.06.082; RUFF RL, 1983, ANN NEUROL, V13, P334, DOI 10.1002/ana.410130320; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; SAMPSON JH, IN PRESS SEMIN IMMUN; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sathornsumetee S, 2007, NEUROL CLIN, V25, P1111, DOI 10.1016/j.ncl.2007.07.004; Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741; Selker RG, 2002, NEUROSURGERY, V51, P343, DOI 10.1097/00006123-200208000-00009; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Souhami L, 2004, INT J RADIAT ONCOL, V60, P853, DOI 10.1016/j.ijrobp.2004.04.011; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Thomas D, 2001, J CLIN ONCOL, V19, P509, DOI 10.1200/JCO.2001.19.2.509; Tsao MN, 2005, INT J RADIAT ONCOL, V63, P47, DOI 10.1016/j.ijrobp.2005.05.024; Ueki K, 1996, CANCER RES, V56, P150; van den Bent MJ, 2007, NEUROL CLIN, V25, P1089, DOI 10.1016/j.ncl.2007.07.013; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wen PY, 2006, J NEURO-ONCOL, V80, P313, DOI 10.1007/s11060-006-9193-2; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Westphal M, 2006, ACTA NEUROCHIR, V148, P269, DOI 10.1007/s00701-005-0707-z; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Wrensch M, 2006, CANCER RES, V66, P4531, DOI 10.1158/0008-5472.CAN-05-4032; Young GS, 2007, NEUROL CLIN, V25, P947, DOI 10.1016/j.ncl.2007.07.010; Yung, 1999, J CLIN ONCOL, V17, P3693; Yung WKA, 1999, J CLIN ONCOL, V17, P2762, DOI 10.1200/JCO.1999.17.9.2762; Yung WKA, 2000, BRIT J CANCER, V83, P588, DOI 10.1054/bjoc.2000.1316	112	3078	3228	16	434	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					492	507		10.1056/NEJMra0708126	http://dx.doi.org/10.1056/NEJMra0708126			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669428				2022-12-28	WOS:000258039700007
J	Tikku, AA; Direen, NG				Tikku, Anahita A.; Direen, Nicholas G.			Comment on "major Australian-Antarctic plate reorganization at Hawaiian-Emperor bend time"	SCIENCE			English	Editorial Material							MARGIN		[Tikku, Anahita A.] ExxonMobil Upstream Res Co, Houston, TX 77252 USA; [Tikku, Anahita A.] Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA; [Direen, Nicholas G.] Univ Tasmania, Sch Earth Sci, Hobart, Tas 7001, Australia; [Direen, Nicholas G.] FrOG Tech Pty Ltd, Blackmans Bay, Tas 7052, Australia	Exxon Mobil Corporation; Rensselaer Polytechnic Institute; University of Tasmania	Tikku, AA (corresponding author), ExxonMobil Upstream Res Co, POB 2189, Houston, TX 77252 USA.	anahita.a.tikku@exxonmobil.com	Direen, Nicholas/P-5949-2019; Direen, Nicholas/E-6288-2011	Direen, Nicholas/0000-0002-4466-7064; Tikku, Anahita/0000-0002-8736-8603				Colwell JB, 2006, ANTARCTICA: CONTRIBUTIONS TO GLOBAL EARTH SCIENCES, P327, DOI 10.1007/3-540-32934-X_41; DAVIES TA, 1974, DSDP INTIAL REPORTS, V26; Direen NG, 2007, GEOL SOC SPEC PUBL, V282, P239, DOI 10.1144/SP282.12; Finn C, 1999, GEOLOGY, V27, P1087, DOI 10.1130/0091-7613(1999)027<1087:ALOEPS>2.3.CO;2; Gaina C, 2007, GEOPHYS J INT, V170, P151, DOI 10.1111/j.1365-246X.2007.03450.x; Menot RP, 2005, GONDWANA RES, V8, P1, DOI 10.1016/S1342-937X(05)70258-6; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; MUNSCHY M, 1993, J GEOPHYS RES-SOL EA, V98, P6367, DOI 10.1029/92JB02694; Sandwell DT, 2005, GEOPHYS J INT, V163, P79, DOI 10.1111/j.1365-246X.2005.02724.x; Sayers J, 2001, GEOL SOC SPEC PUBL, V187, P51, DOI 10.1144/GSL.SP.2001.187.01.04; Sibuet JC, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB003856; STAGG HMJ, 2006, TERRA ANTARCTICA, V13, P13; Tikku AA, 1999, J GEOPHYS RES-SOL EA, V104, P661, DOI 10.1029/1998JB900034; Tikku AA, 2000, EARTH PLANET SC LETT, V180, P117, DOI 10.1016/S0012-821X(00)00157-6; Whittaker JM, 2007, SCIENCE, V318, P83, DOI 10.1126/science.1143769	15	27	28	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888								10.1126/science.1157163	http://dx.doi.org/10.1126/science.1157163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	329RS	18653866	Green Accepted			2022-12-28	WOS:000257888900019
J	Blumberg, RS				Blumberg, Richard S.			Crohn disease - Abstract and Commentary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; PATHOGENESIS; ANTIBODY		[Blumberg, Richard S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Blumberg, RS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, 75 Francis St,Thorn Bldg 1419, Boston, MA 02115 USA.	rblumberg@partners.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053056, R37DK044319, R01DK044319, R01DK051362] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44319, DK51362, DK53056] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BURRILL B, 1932, JAMA-J AM MED ASSOC, V99, P1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Crohn BB, 1934, AM J DIG DIS, V1, P97; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; KIRSNER JB, 1984, JAMA-J AM MED ASSOC, V251, P80, DOI 10.1001/jama.251.1.80; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	15	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					439	440		10.1001/jama.300.4.439	http://dx.doi.org/10.1001/jama.300.4.439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647989				2022-12-28	WOS:000257831200024
J	Havlir, DV; Getahun, H; Sanne, I; Nunn, P				Havlir, Diane V.; Getahun, Haileyesus; Sanne, Ian; Nunn, Paul			Opportunities and challenges for HIV care in overlapping HIV and TB epidemics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISONIAZID PREVENTIVE THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDRUG-RESISTANT TUBERCULOSIS; ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE RECONSTITUTION; SOUTH-AFRICA; RISK-FACTORS; NOSOCOMIAL TRANSMISSION	Tuberculosis (TB) and the emerging multidrug-resistant TB epidemic represent major challenges to human immunodeficiency virus (HIV) care and treatment programs in resource-limited settings. Tuberculosis is a major cause of mortality among patients with HIV and poses a risk throughout the course of HIV disease, even after successful initiation of antiretroviral therapy (ART). Progress in the implementation of activities directed at reducing TB burden in the HIV population lags far behind global targets. HIV programs designed for longitudinal care are ideally suited to implement TB control measures and have no option but to address TB vigorously to save patient lives, to safeguard the massive investment in HIV treatment, and to curb the global TB burden. We propose a framework of strategic actions for HIV care programs to optimally integrate TB into their services. The core activities of this framework include intensified TB case finding, treatment of TB, isoniazid preventive treatment, infection control, administration of ART, TB recording and reporting, and joint efforts of HIV and TB programs at the national and local levels.	[Havlir, Diane V.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Getahun, Haileyesus; Nunn, Paul] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Sanne, Ian] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa	University of California System; University of California San Francisco; World Health Organization; University of Witwatersrand	Havlir, DV (corresponding author), San Francisco Gen Hosp, 995 Potrero Ave,Bldg 80,W84, San Francisco, CA 94110 USA.	dhavlir@php.ucsf.edu	Sanne, Ian/ABH-2231-2020; Getahun, Haileyesus/ABC-5181-2020					Achmat Z, 2006, INT J TUBERC LUNG D, V10, P1312; ANDREWS J, 2008, 15 C RETR OPP INF FE; [Anonymous], 2008, 4 WHO; [Anonymous], GLOB TUB CONTR SURV; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Blanc FX, 2007, J INFECT DIS, V196, pS46, DOI 10.1086/518658; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Breen RAM, 2006, J INFECT DIS, V193, P1437, DOI 10.1086/503437; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; CAIN K, 2007, 38 WORLD LUNG HLTH C; CHAUHAN LS, 2008, 13 TB HIV COR GROUP; Chintu C, 2003, LANCET, V362, P1516, DOI 10.1016/S0140-6736(03)14779-4; Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; DEMISSIE M, 2007, 38 WORLD LUNG HLTH C; *DEP PUBL HLTH FED, REP 2007 TB HIV COLL; Dubrovina I, 2008, INT J TUBERC LUNG D, V12, P756; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; FISCHL MA, 1992, ANN INTERN MED, V117, P184, DOI 10.7326/0003-4819-117-3-184; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; FRAMPTON MW, 1992, ANN INTERN MED, V117, P312, DOI 10.7326/0003-4819-117-4-312; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; GILKS CF, 1990, AIDS, V4, P981, DOI 10.1097/00002030-199010000-00006; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Godfrey-Faussett, 1998, POLICY STATEMENT PRE; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Gray A, 2006, AIDS, V20, P302, DOI 10.1097/01.aids.0000202652.49020.94; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Gunneberg C, 2008, INT J TUBERC LUNG D, V12, pS2; Harries AD, 2005, INT J TUBERC LUNG D, V9, P128; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P526; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; HUTTON MD, 1990, J INFECT DIS, V161, P286, DOI 10.1093/infdis/161.2.286; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; KIMMERLING M, 2007, 38 WORLD LUNG HLTH C; Kirk O, 2000, AM J RESP CRIT CARE, V162, P865, DOI 10.1164/ajrccm.162.3.9908018; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; MEINTJES G, 2008, 15 C RETR OPP INF FE; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moreno S, 2006, AIDS REV, V8, P115; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Ramon-Pardo P, 2008, INT J TUBERC LUNG D, V12, pS51; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Schaaf HS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-140; Schluger NW, 2002, CHEST, V122, P597, DOI 10.1378/chest.122.2.597; SEPKOWITZ KA, 1995, CLIN MICROBIOL REV, V8, P180, DOI 10.1128/CMR.8.2.180; Serra FC, 2007, BRAZ J INFECT DIS, V11, P462, DOI 10.1590/S1413-86702007000500004; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Srikantiah P, 2007, AIDS, V21, P1972, DOI 10.1097/QAD.0b013e32823ecf6e; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2007, IMPR DIAGN TREATM SM; *WHO, 2006, GUID CONTR PROPH HIV; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2006, ANT THER HIV INF AD; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238	98	97	101	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					423	430		10.1001/jama.300.4.423	http://dx.doi.org/10.1001/jama.300.4.423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647985				2022-12-28	WOS:000257831200020
J	Burns, A; Jacoby, R				Burns, Alistair; Jacoby, Robin			Dimebon in Alzheimer's disease: old drug for new indication	LANCET			English	Editorial Material							TRIAL		[Burns, Alistair] Univ Manchester, Psychiat Res Grp, Manchester M13 9PL, Lancs, England; [Jacoby, Robin] Univ Oxford, Dept Psychiat, Oxford, England	University of Manchester; University of Oxford	Burns, A (corresponding author), Univ Manchester, Psychiat Res Grp, Manchester M13 9PL, Lancs, England.	alistair.burns@manchester.ac.uk		Burns, Alistair/0000-0002-9837-0645				Aisen PS, 2005, CNS DRUGS, V19, P989, DOI 10.2165/00023210-200519120-00002; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; *MED, 2008, CONN ALZH DIS INV TR; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1	8	23	36	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					179	180		10.1016/S0140-6736(08)61046-6	http://dx.doi.org/10.1016/S0140-6736(08)61046-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640436				2022-12-28	WOS:000257763900004
J	Roberts, L; Simpson, S				Roberts, Leslie; Simpson, Stephen			Deadly defiance - Introduction	SCIENCE			English	Editorial Material																			0	12	12	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					355	355		10.1126/science.321.5887.355	http://dx.doi.org/10.1126/science.321.5887.355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635787				2022-12-28	WOS:000257713900032
J	Jauhar, S				Jauhar, Sandeep			From all walks of life - Nontraditional medical students and the future of medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jauhar, Sandeep] Long Isl Jewish Med Ctr, Heart Failure Program, New Hyde Pk, NY 11042 USA; [Jauhar, Sandeep] Albert Einstein Coll Med, Bronx, NY 10467 USA	Northwell Health; Yeshiva University; Albert Einstein College of Medicine	Jauhar, S (corresponding author), Long Isl Jewish Med Ctr, Heart Failure Program, New Hyde Pk, NY 11042 USA.							*AAMC AMA, 2007, AAMC PHYS WORKF RES	1	12	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					224	227		10.1056/NEJMp0802264	http://dx.doi.org/10.1056/NEJMp0802264			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326KD	18635427				2022-12-28	WOS:000257656600002
J	Kadaba, NS; Kaiser, JT; Johnson, E; Lee, A; Rees, DC				Kadaba, Neena S.; Kaiser, Jens T.; Johnson, Eric; Lee, Allen; Rees, Douglas C.			The high-affinity E-coli methionine ABC transporter: Structure and allosteric regulation	SCIENCE			English	Article							BINDING-PROTEIN; ATP-BINDING; SUBUNIT INTERACTIONS; MEMBRANE-PROTEINS; ACT DOMAIN; ARCHITECTURE; SYSTEMS; SUPERFAMILY; PERMEASES; MECHANISM	The crystal structure of the high- affinity Escherichia coli MetNI methionine uptake transporter, a ember of the adenosine triphosphate ( ATP)- binding cassette ( ABC) family, has been solved to 3.7 angstrom resolution. The overall architecture of MetNI reveals two copies of the adenosine triphosphatase ( ATPase) MetN in complex with two copies of the transmembrane domain MetI, with the transporter adopting an inward- facing conformation exhibiting widely separated nucleotide binding domains. Each MetI subunit is organized around a core of five transmembrane helices that correspond to a subset of the helices observed in the larger membrane- spanning subunits of the molybdate ( ModBC) and maltose ( MalFGK) ABC transporters. In addition to the conserved nucleotide binding domain of the ABC family, MetN contains a carboxyl- terminal extension with a ferredoxin- like fold previously assigned to a conserved family of regulatory ligand- binding domains. These domains separate the nucleotide binding domains and would interfere with their association required for ATP binding and hydrolysis. Methionine binds to the dimerized carboxyl- terminal domain and is shown to inhibit ATPase activity. These observations are consistent with an allosteric regulatory mechanism operating at the level of transport activity, where increased intracellular levels of the transported ligand stabilize an inward- facing, ATPase- inactive state of MetNI to inhibit further ligand translocation into the cell.	[Kadaba, Neena S.; Kaiser, Jens T.; Johnson, Eric; Lee, Allen; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kadaba, Neena S.; Kaiser, Jens T.; Johnson, Eric; Lee, Allen; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu		Johnson, Eric/0000-0002-2909-865X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045162, R01GM045162] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM045162-18, R01 GM045162, GM45162, R37 GM045162] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DeLano W.L, PYMOL MOL GRAPHICS S; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I.B., 2003, ABC PROTEINS BACTERI, P647; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; KADNER RJ, 1977, J BACTERIOL, V129, P207, DOI 10.1128/JB.129.1.207-216.1977; KADNER RJ, 1975, J BACTERIOL, V122, P110, DOI 10.1128/JB.122.1.110-119.1975; KADNER RJ, 1974, J BACTERIOL, V117, P232, DOI 10.1128/JB.117.1.232-241.1974; KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Neijssel OM, 1996, ESCHERICHIA COLI SAL, V2, P1683; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stouthamer A. H., 1979, INT REV BIOCHEM, V21, P1; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4	41	164	170	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					250	253		10.1126/science.1157987	http://dx.doi.org/10.1126/science.1157987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621668	Green Accepted			2022-12-28	WOS:000257512900040
J	Wilson, DP; Law, MG; Grulich, AE; Cooper, DA; Kaldor, JM				Wilson, David P.; Law, Matthew G.; Grulich, Andrew E.; Cooper, David A.; Kaldor, John M.			Relation between HIV viral load and infectiousness: a model-based analysis	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; REDUCING HETEROSEXUAL TRANSMISSION; SEXUAL-BEHAVIOR; RISK-FACTORS; PREGNANT-WOMEN; COITAL ACT; MEN; PREVALENCE; COUPLES	Background A consensus statement released on behalf of the Swiss Federal Commission for HIV/AIDS suggests that people receiving effective antiretroviral therapy-ie, those with undetectable plasma HIV RNA (<40 copies per mL)-are sexually non-infectious. We analysed the implications of this statement at a population level. Methods We used a simple mathematical model to estimate the cumulative risk of HIV transmission from effectively treated HIV-infected patients (HIV RNA <10 copies per mL) over a prolonged period. We investigated the risk of unprotected sexual transmission per act and cumulatively over many exposures, within couples initially discordant for HIV status. Findings Assuming that each couple had 100 sexual encounters per year, the cumulative probability of transmission to the serodiscordant partner each year is 0.0022 (uncertainty bounds 0.0008-0.0058) for female-to-male transmission, 0.0043 (0.0016-0.0115) for male-to-female transmission, and 0.043 (0.0159-0.1097) for male-to-male transmission. In a population of 10000 serodiscordant partnerships, over 10 years the expected number of seroconversions would be 215 (80-564) for female-to-male transmission, 425 (159-1096) for male-to-female transmission, and 3524 (1477-6871) for male-to-male transmission, corresponding to an increase in incidence of four times compared with incidence under current rates of condom use. Interpretation Our analyses suggest that the risk of HIV transmission in heterosexual partnerships in the presence of effective treatment is low but non-zero and that the transmission risk in male homosexual partnerships is high over repeated exposures. If the claim of non-infectiousness in effectively treated patients was widely accepted, and condom use subsequently declined, then there is the potential for substantial increases in HIV incidence. Funding Australian Research Council.	[Wilson, David P.; Law, Matthew G.; Grulich, Andrew E.; Cooper, David A.; Kaldor, John M.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Wilson, DP (corresponding author), Level 2,376 Victoria St, Darlinghurst, NSW 2010, Australia.	Dwilson@nchecr.unsw.edu.au	Kaldor, John M/D-4545-2011; Wilson, David P/G-4614-2013	Law, Matthew/0000-0002-3540-8837				Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; BLOWER SM, 1993, J ACQ IMMUN DEF SYND, V6, P1347; Burris S, 2007, ARIZONA STATE LAW J; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; CLEARY PD, 1991, AM J PUBLIC HEALTH, V81, P1586, DOI 10.2105/AJPH.81.12.1586; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Dougan S, 2007, SEX TRANSM INFECT, V83, P120, DOI 10.1136/sti.2006.021428; Dukers NHTM, 2002, AIDS, V16, pF19, DOI 10.1097/00002030-200207050-00001; ELLIOT R, 1996, CRIMINAL LAW HIV AID; Fisher M, 2007, AIDS, V21, P2309, DOI 10.1097/QAD.0b013e3282ef9fed; Fitch JT, 2002, SEX TRANSM DIS, V29, P811, DOI 10.1097/00007435-200212000-00013; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; GRIERSON J, 2006, MONOGRAPH SERIES LAT, V60; GRULICH AE, 2007, SEX HEALTH, V5, P113; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Jin FY, 2007, JAIDS-J ACQ IMM DEF, V46, P245, DOI 10.1097/QAI.0b013e3181565db5; Kalichman SC, 2008, SEX TRANSM DIS, V35, P55, DOI 10.1097/OLQ.0b013e318141fe9b; KAPLAN EH, 1990, J ACQ IMMUN DEF SYND, V3, P55; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lazzarini Z, 2002, J LAW MED ETHICS, V30, P239, DOI 10.1111/j.1748-720X.2002.tb00390.x; LeGoff J, 2007, INT J STD AIDS, V18, P593, DOI 10.1258/095646207781568457; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MCCUSKER J, 1988, AM J PUBLIC HEALTH, V78, P462, DOI 10.2105/AJPH.78.4.462; *NAT CTR HIV SOC R, 2006, ANN REP TRENDS BEH; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Phillips AN, 2004, AIDS, V18, P1795, DOI 10.1097/00002030-200409030-00008; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rangsin R, 2004, JAIDS-J ACQ IMM DEF, V36, P622, DOI 10.1097/00126334-200405010-00011; Read TRH, 2007, SEX HEALTH, V4, P35, DOI 10.1071/SH06043; Rodriguez RJ, 1997, J ACQ IMMUN DEF SYND, V15, P49, DOI 10.1097/00042560-199705010-00008; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Smith CJ, 2005, J INFECT DIS, V192, P1387, DOI 10.1086/466534; Smith RJ, 2004, LANCET INFECT DIS, V4, P636, DOI 10.1016/S1473-3099(04)01148-X; *UK COLL GROUP HIV, 2005, MAPP ISS HIV OTH SEX; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Van de Ven P, 2005, AIDS, V19, P179, DOI 10.1097/00002030-200501280-00010; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WELLER SC, 1993, SOC SCI MED, V36, P1653; Wilson DP, 2008, P NATL ACAD SCI USA, V105, P9835, DOI 10.1073/pnas.0711813105; Wilson DP, 2006, P NATL ACAD SCI USA, V103, P14228, DOI 10.1073/pnas.0509689103; Wilson DP, 2008, MATH MODELS INVESTIG; Yahya-Malima KI, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-75; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	60	260	268	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					314	320		10.1016/S0140-6736(08)61115-0	http://dx.doi.org/10.1016/S0140-6736(08)61115-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657710				2022-12-28	WOS:000258042800032
J	Martins, CL; Garly, ML; Bale, C; Rodrigues, A; Ravn, H; Whittle, HC; Lisse, IM; Aaby, P				Martins, Cesario L.; Garly, May-Lill; Bale, Carlito; Rodrigues, Amabelia; Ravn, Henrik; Whittle, Hilton C.; Lisse, Ida M.; Aaby, Peter			Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEMALE-MALE MORTALITY; DIPHTHERIA-TETANUS-PERTUSSIS; GUINEA-BISSAU; UNVACCINATED CHILDREN; PEDIATRIC WARD; IMMUNIZATION; COMMUNITY; RATIO; RESPONSES; COVERAGE	Objective To examine the protective efficacy of measles vaccination in infants in a low income country before 9 months of age. Design Randomised clinical trial. Participants 1333 infants aged 4.5 months: 441 in treatment group and 892 in control group. Setting Urban area in Guinea-Bissau. Intervention Measles vaccination using standard titre Edmonston-Zagreb vaccine at 4.5 months of age. Main outcome measures Vaccine efficacy against measles infection, admission to hospital for measles, and measles mortality before standard vaccination at 9 months of age. Results 28% of the children tested at 4.5 months of age had protective levels of maternal antibodies against measles at enrolment. After early vaccination against measles 92% had measles antibodies at 9 months of age. A measles outbreak offered a unique situation for testing the efficacy of early measles vaccination. During the outbreak, 96 children developed measles; 19% of unvaccinated children had measles before 9 months of age. The monthly incidence of measles among the 441 children enrolled in the treatment arm was 0.7% and among the 892 enrolled in the control arm was 3.1%. Early vaccination with the Edmonston-Zagreb measles vaccine prevented infection; vaccine efficacy for children with serologically confirmed measles and definite clinical measles was 94% (95% confidence interval 77% to 99%), for admissions to hospital for measles was 100% (46% to 100%), and for measles mortality was 100% (-42% to 100%). The number needed to treat to prevent one case of measles between ages 4.5 months and 9 months during the epidemic was 7.2 (6.8 to 9.2). The treatment group tended to have lower overall mortality (mortality rate ratio 0.18, 0.02 to 1.36) although this was not significant. Conclusions In low income countries, maternal antibody levels against measles may be low and severe outbreaks of measles can occur in infants before the recommended age of vaccination at 9 months. Outbreaks of measles may be curtailed by measles vaccination using the Edmonston-Zagreb vaccine as early as 4.5 months of age. Trial registration Clinical Trials NCT00168558 [ClinicalTrials.gov].	[Martins, Cesario L.; Garly, May-Lill; Bale, Carlito; Rodrigues, Amabelia; Ravn, Henrik; Aaby, Peter] Bandim Hlth Project, Indepth Network, Bissau, Guinea Bissau; [Garly, May-Lill; Ravn, Henrik; Aaby, Peter] Statens Serum Inst, Danish Epidemiol Sci Ctr, Bandim Hlth Project, DK-2300 Copenhagen S, Denmark; [Whittle, Hilton C.] MRC Labs, Fajara, Gambia; [Lisse, Ida M.] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark	Aarhus University; Statens Serum Institut; MRC Laboratory Molecular Biology; University of Copenhagen; Herlev & Gentofte Hospital	Aaby, P (corresponding author), Bandim Hlth Project, Indepth Network, Bissau, Guinea Bissau.	p.aaby@bandim.org		Aaby, Peter/0000-0001-8331-1389	DANIDA; Fonden tit Laegevidenskabens Fremme; Danish National Research Foundation; Novo Nordisk Foundation; MRC [MC_U190088488, MC_U190074200] Funding Source: UKRI; Medical Research Council [MC_U190074200, MC_U190088488] Funding Source: researchfish	DANIDA; Fonden tit Laegevidenskabens Fremme; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research on maternal antibodies that inspired the present trial was funded by the Thrasher Foundation. The present study was mostly funded by DANIDA and Fonden tit Laegevidenskabens Fremme. The Bandim Health Project received support from DANIDA and the Danish National Research Foundation. PA holds a research professorship grant from the Novo Nordisk Foundation. The funding institutions had no role in the implementation and interpretation of the study.	AABY P, 1986, J PEDIATR-US, V109, P40, DOI 10.1016/S0022-3476(86)80569-8; Aaby P, 2006, VACCINE, V24, P2764, DOI 10.1016/j.vaccine.2006.01.004; Aaby P, 2004, VACCINE, V22, P3014, DOI 10.1016/j.vaccine.2004.02.009; AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, PEDIATR INFECT DIS J, V22, P798, DOI 10.1097/01.inf.0000083821.33187.b5; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 1998, LANCET, V352, P1229, DOI 10.1016/S0140-6736(05)60575-2; AABY P, 1984, J INFECTION, V8, P13, DOI 10.1016/S0163-4453(84)93192-X; AABY P, 1997, PROSPECTIVE COMMUNIT, P276; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Aaby P, 2006, VACCINE, V24, P4701, DOI 10.1016/j.vaccine.2006.03.038; [Anonymous], 1977, Bull World Health Organ, V55, P21; [Anonymous], 1992, WKLY EPIDEMIOL REC, V67, P357; CISSE B, 2001, THESIS LONDON SCH HY; de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; DULOU AD, 1995, AM J EPIDEMIOL, V142, P643, DOI 10.1093/oxfordjournals.aje.a117688; Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527; Garly ML, 1999, INT J EPIDEMIOL, V28, P347, DOI 10.1093/ije/28.2.347; Garly ML, 2001, VACCINE, V19, P1951, DOI 10.1016/S0264-410X(00)00431-X; Grais RF, 2006, EPIDEMIOL INFECT, V134, P845, DOI 10.1017/S0950268805005716; HALL AJ, 1990, INT J EPIDEMIOL, V19, P777, DOI 10.1093/ije/19.4.777; HOSKINS EW, 1993, THESIS U OXFORD; JENSEN TG, 1994, VACCINE, V12, P1026, DOI 10.1016/0264-410X(94)90340-9; Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020; MARKOWITZ LE, 1990, NEW ENGL J MED, V322, P580, DOI 10.1056/NEJM199003013220903; MARTINS CL, 2002, O CRUZ; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; SAMB B, 1995, PEDIATR INFECT DIS J, V14, P203, DOI 10.1097/00006454-199503000-00007; Sniadack DH, 1999, B WORLD HEALTH ORGAN, V77, P545; Veirum JE, 2005, VACCINE, V23, P1197, DOI 10.1016/j.vaccine.2004.02.053; WHITTLE H, 1988, LANCET, V2, P811; WHITTLE HC, 1990, LANCET, V336, P1046, DOI 10.1016/0140-6736(90)92501-8; 1982, WEEKLY EPIDEMIOL REC, V57, P89	37	54	54	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a661	10.1136/bmj.a661	http://dx.doi.org/10.1136/bmj.a661			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EO	18653640	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000258561100033
J	Cohen, AJ; Mori-Sanchez, P; Yang, WT				Cohen, Aron J.; Mori-Sanchez, Paula; Yang, Weitao			Insights into current limitations of density functional theory	SCIENCE			English	Editorial Material							EXACT EXCHANGE; SYSTEMS; NUMBER; ENERGY; MODEL		[Cohen, Aron J.; Mori-Sanchez, Paula; Yang, Weitao] Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University	Yang, WT (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	weitao.yang@duke.edu	Yang, Weitao/C-1109-2008	Yang, Weitao/0000-0001-5576-2828; Cohen, Aron/0000-0002-0873-2391				Baerends EJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.133004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Becke AD, 2003, J CHEM PHYS, V119, P2972, DOI 10.1063/1.1589733; Cohen AJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115123; Cohen AJ, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2741248; Ke SH, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2743004; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Mori-Sanchez P, 2003, J CHEM PHYS, V119, P11001, DOI 10.1063/1.1630011; Mori-Sanchez P, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2403848; Mori-Sanchez P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146401; Parr R. G., 1989, DENSITY FUNCTIONAL T; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PERDEW JP, 1982, PHYS REV LETT, V49, P1691, DOI 10.1103/PhysRevLett.49.1691; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Ruzsinszky A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2566637; Seminario J. M., 1996, THEORET COMPUT CHEM, P327; Toher C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146402; Zhang YK, 1998, J CHEM PHYS, V109, P2604, DOI 10.1063/1.476859; Zhao Y, 2004, J PHYS CHEM A, V108, P2715, DOI 10.1021/jp049908s	21	1808	1814	8	334	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					792	794		10.1126/science.1158722	http://dx.doi.org/10.1126/science.1158722			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687952				2022-12-28	WOS:000258261000032
J	Aubert, J; Amit, H; Hulot, G; Olson, P				Aubert, Julien; Amit, Hagay; Hulot, Gauthier; Olson, Peter			Thermochemical flows couple the Earth's inner core growth to mantle heterogeneity	NATURE			English	Article							LABORATORY MODEL; MAGNETIC-FIELD; CONVECTION; SOLIDIFICATION; ATTENUATION; GEODYNAMO; ROTATION; VELOCITY; BENEATH; TOP	Seismic waves sampling the top 100 km of the Earth's inner core reveal that the eastern hemisphere (40 degrees E-180 degrees E) is seismically faster(1,2), more isotropic(2,3) and more attenuating(4) than the western hemisphere. The origin of this hemispherical dichotomy is a challenging problem for our understanding of the Earth as a system of dynamically coupled layers. Previously, laboratory experiments have established that thermal control from the lower mantle can drastically affect fluid flow in the outer core(5), which in turn can induce textural heterogeneity on the inner core solidification front(6). The resulting texture should be consistent with other expected manifestations of thermal mantle control on the geodynamo, specifically magnetic flux concentrations(7,8) in the timeaverage palaeomagnetic field(9,10) over the past 5 Myr, and preferred eddy locations(11) in flows imaged below the core-mantle boundary by the analysis of historical geomagnetic secular variation(12). Here we show that a single model of thermochemical convection and dynamo action can account for all these effects by producing a large-scale, long-term outer core flow that couples the heterogeneity of the inner core with that of the lower mantle. The main feature of this thermochemical 'wind' is a cyclonic circulation below Asia, which concentrates magnetic field on the core-mantle boundary at the observed location and locally agrees with core flow images. This wind also causes anomalously high rates of light element release in the eastern hemisphere of the inner core boundary, suggesting that lateral seismic anomalies at the top of the inner core result from mantle-induced variations in its freezing rate.	[Aubert, Julien; Amit, Hagay; Hulot, Gauthier] Univ Paris Diderot, Inst Phys Globe, INSU, CNRS, F-75252 Paris 05, France; [Olson, Peter] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University	Aubert, J (corresponding author), Univ Paris Diderot, Inst Phys Globe, INSU, CNRS, 4 Pl Jussieu, F-75252 Paris 05, France.	aubert@ipgp.jussieu.fr	Aubert, Julien/A-5616-2011; Hulot, Gauthier/A-5627-2011	Aubert, Julien/0000-0002-2756-0724; Amit, Hagay/0000-0002-6644-534X				Amit H, 2006, PHYS EARTH PLANET IN, V155, P120, DOI 10.1016/j.pepi.2005.10.006; Aubert J, 2007, PHYS EARTH PLANET IN, V160, P143, DOI 10.1016/j.pepi.2006.11.003; Aurnou J, 2000, PHYS EARTH PLANET IN, V117, P111, DOI 10.1016/S0031-9201(99)00091-6; Bergman MI, 2005, PHYS EARTH PLANET IN, V153, P150, DOI 10.1016/j.pepi.2005.03.016; Bergman MI, 2003, J CRYST GROWTH, V255, P204, DOI 10.1016/S0022-0248(03)01247-8; BRAGINSKY SI, 1995, GEOPHYS ASTRO FLUID, V79, P1, DOI 10.1080/03091929508228992; Buffett BA, 2000, GEOPHYS RES LETT, V27, P3125, DOI 10.1029/2000GL011705; Cao A, 2004, EARTH PLANET SC LETT, V228, P243, DOI 10.1016/j.epsl.2004.09.032; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Cormier VF, 2007, EARTH PLANET SC LETT, V258, P442, DOI 10.1016/j.epsl.2007.04.003; Dumberry M, 2007, GEOPHYS J INT, V170, P886, DOI 10.1111/j.1365-246X.2007.03484.x; Gubbins D, 2007, PHYS EARTH PLANET IN, V162, P256, DOI 10.1016/j.pepi.2007.04.014; JOHNSON CL, 1995, GEOPHYS J INT, V122, P489, DOI 10.1111/j.1365-246X.1995.tb07010.x; Kelly P, 1997, GEOPHYS J INT, V128, P315, DOI 10.1111/j.1365-246X.1997.tb01557.x; Labrosse S, 2001, EARTH PLANET SC LETT, V190, P111, DOI 10.1016/S0012-821X(01)00387-9; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; LISTER JR, 1995, PHYS EARTH PLANET IN, V91, P17, DOI 10.1016/0031-9201(95)03042-U; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Mound JE, 2006, EARTH PLANET SC LETT, V243, P383, DOI 10.1016/j.epsl.2006.01.043; Niu FL, 2001, NATURE, V410, P1081, DOI 10.1038/35074073; Olson P, 2002, GEOPHYS J INT, V151, P809, DOI 10.1046/j.1365-246X.2002.01818.x; Olson P, 1999, J GEOPHYS RES-SOL EA, V104, P10383, DOI 10.1029/1999JB900013; SECCO RA, 1989, J GEOPHYS RES-SOLID, V94, P5887, DOI 10.1029/JB094iB05p05887; Souriau A., 2007, TREATISE GEOPHYS, V11, P655, DOI DOI 10.1016/B978-044452748-6.00023-7; Sumita I, 1999, SCIENCE, V286, P1547, DOI 10.1126/science.286.5444.1547; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; Torsvik TH, 2006, GEOPHYS J INT, V167, P1447, DOI 10.1111/j.1365-246X.2006.03158.x; van der Hilst RD, 2007, SCIENCE, V315, P1813, DOI 10.1126/science.1137867; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Wicht J, 2002, PHYS EARTH PLANET IN, V132, P281, DOI 10.1016/S0031-9201(02)00078-X; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700; Yu WC, 2006, EARTH PLANET SC LETT, V245, P581, DOI 10.1016/j.epsl.2006.03.043	33	193	195	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					758	U80		10.1038/nature07109	http://dx.doi.org/10.1038/nature07109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685706				2022-12-28	WOS:000258228000043
J	Diemand, J; Kuhlen, M; Madau, P; Zemp, M; Moore, B; Potter, D; Stadel, J				Diemand, J.; Kuhlen, M.; Madau, P.; Zemp, M.; Moore, B.; Potter, D.; Stadel, J.			Clumps and streams in the local dark matter distribution	NATURE			English	Article							DENSITY PROFILES; SUBSTRUCTURE; HALOES; SATELLITES; GALAXIES; SIMULATIONS; EVOLUTION; SCATTER; CLUSTER; PROBE	In cold dark matter cosmological models(1,2), structures form and grow through the merging of smaller units(3). Numerical simulations have shown that such merging is incomplete; the inner cores of haloes survive and orbit as 'subhaloes' within their hosts(4,5). Here we report a simulation that resolves such substructure even in the very inner regions of the Galactic halo. We find hundreds of very concentrated dark matter clumps surviving near the solar circle, as well as numerous cold streams. The simulation also reveals the fractal nature of dark matter clustering: isolated haloes and subhaloes contain the same relative amount of substructure and both have cusped inner density profiles. The inner mass and phase-space densities of subhaloes match those of recently discovered faint, dark-matter-dominated dwarf satellite galaxies(6-8), and the overall amount of substructure can explain the anomalous flux ratios seen in strong gravitational lenses(9,10). Subhaloes boost gamma-ray production from dark matter annihilation by factors of 4 to 15 relative to smooth galactic models. Local cosmic ray production is also enhanced, typically by a factor of 1.4 but by a factor of more than 10 in one per cent of locations lying sufficiently close to a large subhalo. (These estimates assume that the gravitational effects of baryons on dark matter substructure are small.).	[Diemand, J.; Madau, P.; Zemp, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Kuhlen, M.] Inst Adv Study, Princeton, NJ 08540 USA; [Moore, B.; Potter, D.; Stadel, J.] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland	University of California System; University of California Santa Cruz; Institute for Advanced Study - USA; University of Zurich	Diemand, J (corresponding author), Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA.	diemand@ucolick.org	Diemand, Juerg/G-9448-2011	Madau, Piero/0000-0002-6336-3293; Zemp, Marcel/0000-0002-0498-3812; Stadel, Joachim Gerhard/0000-0001-7565-8622; Potter, Douglas/0000-0002-0757-5195				Beatty JJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.241102; Belokurov V, 2007, ASTROPHYS J, V654, P897, DOI 10.1086/509718; Belokurov V, 2006, ASTROPHYS J, V642, pL137, DOI 10.1086/504797; Bertschinger E, 2001, ASTROPHYS J SUPPL S, V137, P1, DOI 10.1086/322526; BLUMENTHAL GR, 1984, NATURE, V311, P517, DOI 10.1038/311517a0; Bullock JS, 2001, MON NOT R ASTRON SOC, V321, P559, DOI 10.1046/j.1365-8711.2001.04068.x; Colafrancesco S, 2006, ASTRON ASTROPHYS, V455, P21, DOI 10.1051/0004-6361:20053887; Dalal N, 2002, ASTROPHYS J, V572, P25, DOI 10.1086/340303; Diemand J, 2005, NATURE, V433, P389, DOI 10.1038/nature03270; Diemand J, 2004, MON NOT R ASTRON SOC, V353, P624, DOI 10.1111/j.1365-2966.2004.08094.x; Diemand J, 2007, ASTROPHYS J, V667, P859, DOI 10.1086/520573; Ghigna S, 1998, MON NOT R ASTRON SOC, V300, P146, DOI 10.1046/j.1365-8711.1998.01918.x; Green AM, 2004, MON NOT R ASTRON SOC, V353, pL23, DOI 10.1111/j.1365-2966.2004.08232.x; Kazantzidis S, 2004, ASTROPHYS J, V608, P663, DOI 10.1086/420840; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Lavalle J, 2008, ASTRON ASTROPHYS, V479, P427, DOI 10.1051/0004-6361:20078723; Mao SD, 1998, MON NOT R ASTRON SOC, V295, P587, DOI 10.1046/j.1365-8711.1998.01319.x; Metcalf RB, 2004, ASTROPHYS J, V607, P43, DOI 10.1086/383243; Metcalf RB, 2001, ASTROPHYS J, V563, P9, DOI 10.1086/323695; Navarro JF, 2004, MON NOT R ASTRON SOC, V349, P1039, DOI 10.1111/j.1365-2966.2004.07586.x; PEEBLES PJE, 1982, ASTROPHYS J, V263, pL1, DOI 10.1086/183911; Reed D, 2005, MON NOT R ASTRON SOC, V359, P1537, DOI 10.1111/j.1365-2966.2005.09020.x; Sharma S, 2006, MON NOT R ASTRON SOC, V373, P1293, DOI 10.1111/j.1365-2966.2006.11043.x; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Stadel J.G., 2001, THESIS U WASHINGTON; Strigari LE, 2008, ASTROPHYS J, V678, P614, DOI 10.1086/529488; Ullio P, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.123502; Zemp M, 2007, MON NOT R ASTRON SOC, V376, P273, DOI 10.1111/j.1365-2966.2007.11427.x	30	656	660	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					735	738		10.1038/nature07153	http://dx.doi.org/10.1038/nature07153			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685701	Green Submitted, Green Accepted			2022-12-28	WOS:000258228000038
J	Lape, R; Colquhoun, D; Sivilotti, LG				Lape, Remigijus; Colquhoun, David; Sivilotti, Lucia G.			On the nature of partial agonism in the nicotinic receptor superfamily	NATURE			English	Article							GLYCINE RECEPTORS; ION CHANNELS; END-PLATE; ACETYLCHOLINE; BINDING; ACTIVATION; MECHANISM; CURRENTS	Partial agonists are ligands that bind to receptors but produce only a small maximum response even at concentrations where all receptors are occupied. In the case of ligand-activated ion channels, it has been supposed since 1957 that partial agonists evoke a small response because they are inefficient at eliciting the change of conformation between shut and open states of the channel. We have investigated partial agonists for two members of the nicotinic superfamily - the muscle nicotinic acetylcholine receptor and the glycine receptor - and find that the open-shut reaction is similar for both full and partial agonists, but the response to partial agonists is limited by an earlier conformation change ('flipping') that takes place while the channel is still shut. This has implications for the interpretation of structural studies, and in the future, for the design of partial agonists for therapeutic use.	[Lape, Remigijus; Colquhoun, David; Sivilotti, Lucia G.] UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, Dept Pharmacol, Med Sci Bldg,Gower St, London WC1E 6BT, England.	d.colquhoun@ucl.ac.uk	Colquhoun, David/C-1664-2008; Sivilotti, Lucia/D-8919-2011; Lape, Remigijus/C-6175-2008	Colquhoun, David/0000-0002-4263-017X; Sivilotti, Lucia/0000-0003-2510-8424; Lape, Remigijus/0000-0002-6604-0828	MRC [G0400869] Funding Source: UKRI; Medical Research Council [G0400869(72542), G0400869] Funding Source: Medline; Wellcome Trust [074491] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ADAMS PR, 1977, J PHYSIOL-LONDON, V268, P291, DOI 10.1113/jphysiol.1977.sp011858; Andersen OS, 1999, J GEN PHYSIOL, V114, P589; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Colquhoun D, 2003, J PHYSIOL-LONDON, V547, P699, DOI 10.1113/jphysiol.2002.034165; COLQUHOUN D, 2003, DRUG DISCOVERY DRUG, P357; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; GARDNER P, 1984, NATURE, V309, P160, DOI 10.1038/309160a0; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Han NLR, 2004, J BIOL CHEM, V279, P19559, DOI 10.1074/jbc.M400548200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hatton CJ, 2003, J PHYSIOL-LONDON, V547, P729, DOI 10.1113/jphysiol.2002.034173; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; WYMAN J, 1951, J POLYM SCI, V7, P499, DOI 10.1002/pol.1951.120070506; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	26	272	274	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					722	U56		10.1038/nature07139	http://dx.doi.org/10.1038/nature07139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18633353	Green Accepted			2022-12-28	WOS:000258228000036
J	Guang, S; Bochner, AF; Pavelec, DM; Burkhart, KB; Harding, S; Lachowiec, J; Kennedy, S				Guang, Shouhong; Bochner, Aaron F.; Pavelec, Derek M.; Burkhart, Kirk B.; Harding, Sandra; Lachowiec, Jennifer; Kennedy, Scott			An Argonaute transports siRNAs from the cytoplasm to the nucleus	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; RNA INTERFERENCE; PATHWAYS; REVEALS; TARGET; LIN-15; DCR-1	Ribonucleoprotein complexes consisting of Argonaute- like proteins and small regulatory RNAs function in a wide range of biological processes. Many of these small regulatory RNAs are predicted to act, at least in part, within the nucleus. We conducted a genetic screen to identify factors essential for RNA interference ( RNAi) in nuclei of Caenorhabditis elegans and identified the Argonaute protein NRDE- 3. In the absence of small interfering RNAs ( siRNAs), NRDE- 3 resides in the cytoplasm. NRDE- 3 binds siRNAs generated by RNA- dependent RNA polymerases acting on messenger RNA templates in the cytoplasm and redistributes to the nucleus. Nuclear redistribution of NRDE- 3 requires a functional nuclear localization signal, is required for nuclear RNAi, and results in NRDE- 3 association with nuclear- localized nascent transcripts. Thus, specific Argonaute proteins can transport specific classes of small regulatory RNAs to distinct cellular compartments to regulate gene expression.	[Guang, Shouhong; Bochner, Aaron F.; Pavelec, Derek M.; Burkhart, Kirk B.; Harding, Sandra; Lachowiec, Jennifer; Kennedy, Scott] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Bochner, Aaron F.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Pavelec, Derek M.] Univ Wisconsin, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Burkhart, Kirk B.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, S (corresponding author), Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA.	sgkennedy@wisc.edu	Lachowiec, Jennifer/ABF-5182-2021; guang, shouhong/F-1127-2010	Lachowiec, Jennifer/0000-0003-2962-6448; Kennedy, Scott/0000-0002-7974-8155	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133, R01GM088289, R01GM076619] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076619-02, R01 GM076619, T32 GM007133-25, R01 GM076619-03, T32 GM007133-26, T32 GM007133-24, T32 GM007133-27, R01 GM088289, T32 GM007133, R01 GM076619-01, R01 GM088289-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Bosher JM, 1999, GENETICS, V153, P1245; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; CLARK SG, 1994, GENETICS, V137, P987; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	16	239	273	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					537	541		10.1126/science.1157647	http://dx.doi.org/10.1126/science.1157647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653886	Green Accepted			2022-12-28	WOS:000257888900040
J	Lee, I; Schindelin, H				Lee, Imsang; Schindelin, Hermann			Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes	CELL			English	Article							CRYSTAL-STRUCTURE; PROTEIN-ACTIVATION; MECHANISM; COMPLEX; NEDD8; E2; E1; IDENTIFICATION; HETERODIMER; MUTAGENESIS	Ubiquitin (Ub) and ubiquitin-like proteins (Ubls) are conjugated to their targets by specific cascades involving three classes of enzymes, E1, E2, and E3. Each E1 adenylates the C terminus of its cognate Ubl, forms a E1 similar to Ubl thioester intermediate, and ultimately generates a thioester-linked E2 similar to Ubl product. We have determined the crystal structure of yeast Uba1, revealing a modular architecture with individual domains primarily mediating these specific activities. The negatively charged C-terminal ubiquitin-fold domain (UFD) is primed for binding of E2s and recognizes their positively charged first a helix via electrostatic interactions. In addition, a mobile loop from the domain harboring the E1 catalytic cysteine contributes to E2 binding. Significant, experimentally observed motions in the UFD around a hinge in the linker connecting this domain to the rest of the enzyme suggest a conformation-dependent mechanism for the transthioesterification function of Uba1; however, this mechanism clearly differs from that of other E1 enzymes.	[Lee, Imsang; Schindelin, Hermann] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Schindelin, Hermann] Univ Wurzburg, Inst Biol Struct, D-97078 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg; University of Wurzburg	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	hermann.schindelin@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019		NIDDK NIH HHS [DK54835] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	37	177	183	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					268	278		10.1016/j.cell.2008.05.046	http://dx.doi.org/10.1016/j.cell.2008.05.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662542	Bronze			2022-12-28	WOS:000257891700016
J	Powers, ET; Balch, WE				Powers, Evan T.; Balch, William E.			Costly mistakes: Translational infidelity and protein homeostasis	CELL			English	Editorial Material							MODELS	Protein misfolding is increasingly being recognized as a key process in organismal health and disease. Drummond and Wilke (2008) show that misfolding caused by mistakes during the translation of RNA into proteins (mistranslation) also results in a strong selection pressure to optimize translational fidelity, especially for proteins that are highly expressed.	[Powers, Evan T.] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Powers, ET (corresponding author), Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	epowers@scripps.edu; webalch@scripps.edu		Powers, Evan/0000-0001-8185-8487	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM033301] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; DILL KA, 1995, PROTEIN SCI, V4, P561; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105	9	20	21	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					204	206		10.1016/j.cell.2008.07.005	http://dx.doi.org/10.1016/j.cell.2008.07.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662533	Bronze			2022-12-28	WOS:000257891700007
J	de Ridder, D; Geenen, R; Kuijer, R; van Middendorp, H				de Ridder, Denise; Geenen, Rinie; Kuijer, Roeline; van Middendorp, Henriet			Psychological adjustment to chronic disease	LANCET			English	Review							QUALITY-OF-LIFE; STAGE BREAST-CANCER; STRESS MANAGEMENT INTERVENTION; WRITTEN EMOTIONAL DISCLOSURE; ACTIVE RHEUMATOID-ARTHRITIS; DIABETES SELF-MANAGEMENT; PLACEBO-CONTROLLED TRIAL; POSTTRAUMATIC GROWTH; RESPONSE SHIFT; RANDOMIZED-TRIAL	This Review discusses physiological, emotional, behavioural, and cognitive aspects of psychological adjustment to chronic illness. Reviewing the reports of the past decade, we identify four innovative and promising themes that are relevant for understanding and explaining psychological adjustment. In particular, the emphasis on the reasons why people fail to achieve a healthy adjustment has shifted to the identification of factors that help patients make that adjustment. To promote psychological adjustment, patients should remain as active as is reasonably possible, acknowledge and express their emotions in a way that allows them to take control of their lives, engage in self-management, and try to focus on potential positive outcomes of their illness. Patients who can use these strategies have the best chance of successfully adjusting to the challenges posed by a chronic illness.	[de Ridder, Denise; Geenen, Rinie; Kuijer, Roeline; van Middendorp, Henriet] Univ Utrecht, Dept Clin & Hlth Psychol, Netherlands Res Inst Psychol & Hlth, NL-3508 TC Utrecht, Netherlands	Utrecht University	de Ridder, D (corresponding author), Univ Utrecht, Dept Clin & Hlth Psychol, Netherlands Res Inst Psychol & Hlth, POB 80140, NL-3508 TC Utrecht, Netherlands.	D.T.D.deRidder@uu.nl	van Middendorp, Henriet/B-8300-2013; Geenen, Rinie/G-3408-2012	van Middendorp, Henriet/0000-0003-4575-0895; Geenen, Rinie/0000-0002-6615-6708				ADLER N, 1994, ANNU REV PSYCHOL, V45, P229, DOI 10.1146/annurev.ps.45.020194.001305; Affleck G, 1996, J PERS, V64, P899, DOI 10.1111/j.1467-6494.1996.tb00948.x; AFFLECK G, 1987, J CONSULT CLIN PSYCH, V55, P29, DOI 10.1037/0022-006X.55.1.29; Ahmed S, 2005, QUAL LIFE RES, V14, P611, DOI 10.1007/s11136-004-3708-0; Ai AL, 1998, SOC WORK HEALTH CARE, V27, P75, DOI 10.1300/J010v27n03_05; Andrykowski MA, 1996, J CLIN EPIDEMIOL, V49, P827, DOI 10.1016/0895-4356(96)00028-5; Andrykowski MAA, 2005, J CLIN ONCOL, V23, P599, DOI 10.1200/JCO.2005.03.189; Antoni MH, 2001, HEALTH PSYCHOL, V20, P20, DOI 10.1037/0278-6133.20.1.20; Aspinwall L.G., 1996, PSYCHOSOCIAL ASPECTS, P7; Austenfeld JL, 2004, J PERS, V72, P1335, DOI 10.1111/j.1467-6494.2004.00299.x; Bailey WC, 1999, ARCH INTERN MED, V159, P2422, DOI 10.1001/archinte.159.20.2422; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Baumann LC, 2003, SELF REGULATION HLTH, P242; Bernhard J, 2004, QUAL LIFE RES, V13, P1187, DOI 10.1023/B:QURE.0000037485.59681.7d; Bower JE, 2005, ANN BEHAV MED, V29, P236, DOI 10.1207/s15324796abm2903_10; Bower JE, 1998, J CONSULT CLIN PSYCH, V66, P979, DOI 10.1037/0022-006X.66.6.979; Broderick JE, 2004, ANN BEHAV MED, V27, P50, DOI 10.1207/s15324796abm2701_7; Cameron LD, 2003, SELF REGULATION HLTH, P1; Carver CS, 2004, HEALTH PSYCHOL, V23, P595, DOI 10.1037/0278-6133.23.6.595; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Collins RL, 2001, HEALTH PSYCHOL, V20, P351, DOI 10.1037//0278-6133.20.5.351; Cruess DG, 2000, PSYCHOSOM MED, V62, P304, DOI 10.1097/00006842-200005000-00002; Cruess DG, 2001, INT J BEHAV MED, V8, P194, DOI 10.1207/S15327558IJBM0803_2; Danoff-Burg S, 2005, J BEHAV MED, V28, P91, DOI 10.1007/s10865-005-2720-3; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; de Jong Z, 2003, ARTHRITIS RHEUM, V48, P2415, DOI 10.1002/art.11216; de Moor C, 2002, HEALTH PSYCHOL, V21, P615, DOI 10.1037//0278-6133.21.6.615; de Ridder D, 2001, CLIN PSYCHOL REV, V21, P205, DOI 10.1016/S0272-7358(99)00046-X; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dowson CA, 2004, J PSYCHOSOM RES, V56, P333, DOI 10.1016/S0022-3999(03)00040-0; Dropkin MJ, 2001, CANCER NURS, V24, P143, DOI 10.1097/00002820-200104000-00010; Dunbar-Jacob J, 2001, J CLIN EPIDEMIOL, V54, pS57, DOI 10.1016/S0895-4356(01)00457-7; Durez P, 2004, ANN RHEUM DIS, V63, P1069, DOI 10.1136/ard.2003.012914; Epping-Jordan J, 2001, BMJ-BRIT MED J, V323, P947, DOI 10.1136/bmj.323.7319.947; Evers AWM, 2001, J CONSULT CLIN PSYCH, V69, P1026, DOI 10.1037//0022-006X.69.6.1026; Fehr JS, 2005, INFECTION, V33, P249, DOI 10.1007/s15010-005-4141-1; Garssen B, 2007, J BEHAV MED, V30, P471, DOI 10.1007/s10865-007-9122-7; Genovese MC, 2005, J RHEUMATOL, V32, P1232; Giese-Davis J, 2002, J CONSULT CLIN PSYCH, V70, P916, DOI 10.1037//0022-006X.70.4.916; Gillibrand W, 2001, J ADV NURS, V34, P501, DOI 10.1046/j.1365-2648.2001.01779.x; Giraldi T, 1997, PSYCHOTHER PSYCHOSOM, V66, P229, DOI 10.1159/000289140; Goodwin PJ, 2004, J CLIN ONCOL, V22, P4184, DOI 10.1200/jco.2004.12.091; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Hamilton NA, 2005, ANN BEHAV MED, V29, P216, DOI 10.1207/s15324796abm2903_8; Harris AHS, 2005, PSYCHOSOM MED, V67, P130, DOI 10.1097/01.psy.0000146345.73510.d5; Heiberg MS, 2005, ARTHRITIS RHEUM-US, V52, P2506, DOI 10.1002/art.21209; Hirokawa K, 2004, J PSYCHOSOM RES, V56, P103, DOI 10.1016/S0022-3999(03)00046-1; Hockemeyer J, 2002, BEHAV MED, V27, P161, DOI 10.1080/08964280209596041; Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526; Iwamitsu Y, 2005, PSYCHOSOMATICS, V46, P19, DOI 10.1176/appi.psy.46.1.19; Jaarsma T, 2000, HEART LUNG, V29, P319, DOI 10.1067/mhl.2000.108323; Jaarsma T, 1999, EUR J HEART FAIL, V1, P151, DOI 10.1016/S1388-9842(99)00007-0; Janoff-Bulman R, 2004, PSYCHOL INQ, V15, P30; Janszky I, 2005, BRAIN BEHAV IMMUN, V19, P555, DOI 10.1016/j.bbi.2005.01.001; Katz PP, 2005, QUAL LIFE RES, V14, P1835, DOI 10.1007/s11136-005-5693-3; Katz PP, 2001, ARTHRITIS RHEUM, V44, P1194, DOI 10.1002/1529-0131(200105)44:5<1194::AID-ANR203>3.3.CO;2-Y; Kelley JE, 1997, HEALTH PSYCHOL, V16, P331, DOI 10.1037/0278-6133.16.4.331; Kosinski M, 2002, AM J MANAG CARE, V8, P231; Lechner SC, 2003, PSYCHO-ONCOL, V12, P491, DOI 10.1002/pon.671; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lev EL, 1999, CANCER PRACT, V7, P170, DOI 10.1046/j.1523-5394.1999.74004.x; Leventhal H., 2003, SELF REGULATION HLTH, P42, DOI DOI 10.4324/9780203553220; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lloyd CE, 1999, DIABETES CARE, V22, P1278, DOI 10.2337/diacare.22.8.1278; Lustman PJ, 2005, PSYCHOSOM MED, V67, P195, DOI 10.1097/01.psy.0000155670.88919.ad; Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618; LUTGENDORF SK, 2002, WRITING CURE EXPRESS, P177; Maes S., 1996, HDB COPING THEORY RE, P221; Main J, 2003, J ASTHMA, V40, P357, DOI 10.1081/JAS-120018635; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Malik UR, 2001, CANCER, V92, P1664, DOI 10.1002/1097-0142(20010915)92:6+<1664::AID-CNCR1494>3.0.CO;2-9; Manne S, 2004, PSYCHOSOM MED, V66, P442, DOI 10.1097/01.psy.0000127689.38525.7d; Mauss IB, 2004, EMOTIONAL EXPRESSION, P61; McGregor BA, 2004, J PSYCHOSOM RES, V56, P1, DOI 10.1016/S0022-3999(03)00036-9; Mock V, 2001, CANCER PRACT, V9, P119, DOI 10.1046/j.1523-5394.2001.009003119.x; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Myer Rod, 2000, LIVING DREAM STORY V, P77; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Oort FJ, 2005, QUAL LIFE RES, V14, P599, DOI 10.1007/s11136-004-0831-x; Pakenham KI, 2005, HEALTH PSYCHOL, V24, P123, DOI 10.1037/0278-6133.24.2.123; Petrie KJ, 1999, J PSYCHOSOM RES, V47, P537, DOI 10.1016/S0022-3999(99)00054-9; Petrie KJ, 2004, PSYCHOSOM MED, V66, P272, DOI 10.1097/01.psy.0000116782.49850.d3; Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585; Polonsky W, 1999, DIABETES BURNOUT; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Raison CL, 2005, CNS DRUGS, V19, P105, DOI 10.2165/00023210-200519020-00002; Reynolds P, 2000, AM J EPIDEMIOL, V152, P940, DOI 10.1093/aje/152.10.940; Riemsma RP, 2004, ARTHRIT RHEUM-ARTHR, V51, P1045, DOI 10.1002/art.20823; Roesch SC, 2005, J BEHAV MED, V28, P281, DOI 10.1007/s10865-005-4664-z; Rosenberg HJ, 2002, INT J PSYCHIAT MED, V32, P37, DOI 10.2190/AGPF-VB1G-U82E-AE8C; ROTHENBERG RB, 1990, ANNU REV PUBL HEALTH, V11, P267; Russell AS, 2003, J RHEUMATOL, V30, P941; Safford MM, 2005, J AM BOARD FAM PRACT, V18, P262, DOI 10.3122/jabfm.18.4.262; Sany J, 2005, ANN RHEUM DIS, V64, P1647, DOI 10.1136/ard.2005.037499; Schaefer M, 2002, PROG NEURO-PSYCHOPH, V26, P731, DOI 10.1016/S0278-5846(01)00324-4; Schwartz CE, 2004, PSYCHOL HEALTH, V19, P51, DOI 10.1080/0887044031000118456; Sears SR, 2003, HEALTH PSYCHOL, V22, P487, DOI 10.1037/0278-6133.22.5.487; Senecal C, 2000, HEALTH PSYCHOL, V19, P452, DOI 10.1037//0278-6133.19.5.452; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Siegel K, 2000, SOC SCI MED, V51, P1543, DOI 10.1016/S0277-9536(00)00144-1; Skinner TC, 2002, HEALTH PSYCHOL, V21, P61, DOI 10.1037//0278-6133.21.1.61; Smidt N, 2005, AUST J PHYSIOTHER, V51, P71, DOI 10.1016/S0004-9514(05)70036-2; SMITH RD, 1978, MAYO CLIN PROC, V53, P141; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; Solano L, 2002, PSYCHOL HEALTH, V17, P641, DOI 10.1080/08870440290025830; Solano L, 2001, PSYCHOL HEALTH, V16, P689, DOI 10.1080/08870440108405867; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Sprangers MAG, 1999, ACTA ONCOL, V38, P709; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stanton AL, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P387; Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521; Stanton AL, 2000, J CONSULT CLIN PSYCH, V68, P875, DOI 10.1037/0022-006X.68.5.875; STANTON AL, 2006, HDB POSTTRAUMATIC GR; Taylor LA, 2003, J CLIN PSYCHOL MED S, V10, P9, DOI 10.1023/A:1022897512137; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tijhuis MAR, 2000, CANCER CAUSE CONTROL, V11, P589, DOI 10.1023/A:1008955818369; Tomich PL, 2005, PSYCHO-ONCOL, V14, P1018, DOI 10.1002/pon.914; Tomich PL, 2004, HEALTH PSYCHOL, V23, P16, DOI 10.1037/0278-6133.23.1.16; Trask PC, 2004, PSYCHO-ONCOL, V13, P526, DOI 10.1002/pon.770; van Middendorp H, 2005, ANN RHEUM DIS, V64, P1071, DOI 10.1136/ard.2004.020487; vantSpijker A, 1997, PSYCHOSOM MED, V59, P280, DOI 10.1097/00006842-199705000-00011; Vlaeyen JWS, 2004, PAIN, V110, P512, DOI 10.1016/j.pain.2004.04.037; Walker B L, 1999, Oncol Nurs Forum, V26, P1025; Walker C, 2005, HEALTH EXPECT, V8, P315, DOI 10.1111/j.1369-7625.2005.00343.x; Walker JG, 2004, CLIN PSYCHOL REV, V24, P461, DOI 10.1016/j.cpr.2004.03.001; Warner LJ, 2006, J PEDIATR PSYCHOL, V31, P557, DOI 10.1093/jpepsy/jsj048; Watson M, 1999, LANCET, V354, P1331, DOI 10.1016/S0140-6736(98)11392-2; Weihs KL, 2000, J PSYCHOSOM RES, V49, P59, DOI 10.1016/S0022-3999(00)00143-4; Weijman I, 2005, DIABETES RES CLIN PR, V68, P56, DOI 10.1016/j.diabres.2004.08.004; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wetherell MA, 2005, J HEALTH PSYCHOL, V10, P277, DOI 10.1177/1359105305049778; Widows MR, 2005, HEALTH PSYCHOL, V24, P266, DOI 10.1037/0278-6133.24.3.266; Wiebe D.J., 2003, SELF REGULATION HLTH, P184; Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58; Zakowski SG, 2004, HEALTH PSYCHOL, V23, P555, DOI 10.1037/0278-6133.23.6.555; Zautra A, 2001, J CONSULT CLIN PSYCH, V69, P786, DOI 10.1037//0022-006X.69.5.786; [No title captured]	142	358	367	6	117	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					246	255		10.1016/S0140-6736(08)61078-8	http://dx.doi.org/10.1016/S0140-6736(08)61078-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640461				2022-12-28	WOS:000257763900034
J	Boualem, A; Fergany, M; Fernandez, R; Troadec, C; Martin, A; Morin, H; Sari, MA; Collin, F; Flowers, JM; Pitrat, M; Purugganan, MD; Dogimont, C; Bendahmane, A				Boualem, Adnane; Fergany, Mohamed; Fernandez, Ronan; Troadec, Christelle; Martin, Antoine; Morin, Halima; Sari, Marie-Agnes; Collin, Fabrice; Flowers, Jonathan M.; Pitrat, Michel; Purugganan, Michael D.; Dogimont, Catherine; Bendahmane, Abdelhafid			A conserved mutation in an ethylene biosynthesis enzyme leads to andromonoecy in melons	SCIENCE			English	Article							CUCUMBER CUCUMIS-SATIVUS; SEX DETERMINATION; MODEL; INHERITANCE; EXPRESSION; SYNTHASE; FLOWERS; CLONING	Andromonoecy is a widespread sexual system in angiosperms characterized by plants carrying both male and bisexual flowers. In melon, this sexual form is controlled by the identity of the alleles at the andromonoecious (a) locus. Cloning of the a gene reveals that andromonoecy results from a mutation in the active site of 1-aminocyclopropane-1-carboxylic acid synthase. Expression of the active enzyme inhibits the development of the male organs and is not required for carpel development. A causal single-nucleotide polymorphism associated with andromonoecy was identified, which suggests that the a allele has been under recent positive selection and may be linked to the evolution of this sexual system.	[Boualem, Adnane; Fergany, Mohamed; Fernandez, Ronan; Troadec, Christelle; Martin, Antoine; Bendahmane, Abdelhafid] CNRS, INRA, UMR1165, Unite Rech Genom Vegetale, F-91057 Evry, France; [Morin, Halima] Inst Jean Pierre Bourgin, INRA, Biol Cellulaire Lab, UR501, F-78026 Versailles, France; [Sari, Marie-Agnes; Collin, Fabrice] Univ Paris 05, Chim & Biochim Pharmacol & Toxicol Lab, CNRS, UMR 8601, F-75270 Paris 06, France; [Flowers, Jonathan M.; Purugganan, Michael D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Pitrat, Michel; Dogimont, Catherine] INRA, Unite Genet & Ameliorat Fruits & Legumes, UR 1052, BP 94, F-84143 Montfavet, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; New York University; INRAE	Bendahmane, A (corresponding author), CNRS, INRA, UMR1165, Unite Rech Genom Vegetale, 2 Rue Gaston Cremieux, F-91057 Evry, France.	bendahm@evry.inra.fr	Boualem, Adnane/ABC-5019-2021; Collin, Fabrice/A-7800-2012	Boualem, Adnane/0000-0003-4428-6496; Collin, Fabrice/0000-0003-4310-112X; TROADEC, Christelle/0000-0003-1927-7352; Bendahmane, Abdelhafid/0000-0003-3246-868X; Martin, Antoine/0000-0002-6956-2904; Catherine, DOGIMONT/0000-0001-7399-768X				Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; BYERS RE, 1972, P NATL ACAD SCI USA, V69, P717, DOI 10.1073/pnas.69.3.717; DURAND B, 1991, PLANT SCI, V80, P49, DOI 10.1016/0168-9452(91)90272-A; Huai Q, 2001, J BIOL CHEM, V276, P38210; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1987, GENETICS, V116, P153; Kater MM, 2001, PLANT CELL, V13, P481, DOI 10.1105/tpc.13.3.481; KENIGSBUCH D, 1990, GENOME, V33, P317, DOI 10.1139/g90-049; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Miller JS, 2003, AM J BOT, V90, P707, DOI 10.3732/ajb.90.5.707; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; Perin C, 2002, THEOR APPL GENET, V104, P1017, DOI 10.1007/s00122-002-0864-x; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Ralph SG, 2007, PLANT PHYSIOL, V143, P410, DOI 10.1104/pp.106.089425; Vallejo-Marin M, 2007, EVOLUTION, V61, P404, DOI 10.1111/j.1558-5646.2007.00031.x; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Yin TJ, 1995, AM J BOT, V82, P1537, DOI 10.2307/2446182	21	225	247	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					836	838		10.1126/science.1159023	http://dx.doi.org/10.1126/science.1159023			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687965				2022-12-28	WOS:000258261000046
J	Miyake, N; Chilton, J; Psatha, M; Cheng, L; Andrews, C; Chan, WM; Law, K; Crosier, M; Lindsay, S; Cheung, M; Allen, J; Gutowski, NJ; Ellard, S; Young, E; Iannaccone, A; Appukuttan, B; Stout, JT; Christiansen, S; Ciccarelli, ML; Baldi, A; Campioni, M; Zenteno, JC; Davenport, D; Mariani, LE; Sahin, M; Guthrie, S; Engle, EC				Miyake, Noriko; Chilton, John; Psatha, Maria; Cheng, Long; Andrews, Caroline; Chan, Wai-Man; Law, Krystal; Crosier, Moira; Lindsay, Susan; Cheung, Michelle; Allen, James; Gutowski, Nick J.; Ellard, Sian; Young, Elizabeth; Iannaccone, Alessandro; Appukuttan, Binoy; Stout, J. Timothy; Christiansen, Stephen; Ciccarelli, Maria Laura; Baldi, Alfonso; Campioni, Mara; Zenteno, Juan C.; Davenport, Dominic; Mariani, Laura E.; Sahin, Mustafa; Guthrie, Sarah; Engle, Elizabeth C.			Human CHN1 mutations hyperactivate alpha 2-chimaerin and cause Duane's retraction syndrome	SCIENCE			English	Article							GROWTH-CONE COLLAPSE; GTPASE-ACTIVATING PROTEIN; CHROMOSOME 2Q31; AXON GUIDANCE; LOCUS; EPHA4; GENE; ALPHA-1-CHIMAERIN; MORPHOLOGY; HINDBRAIN	Duane's retraction syndrome (DRS) is a complex congenital eye movement disorder caused by aberrant innervation of the extraocular muscles by axons of brainstem motor neurons. Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1, a gene on chromosome 2q31 that encodes alpha 2-chimaerin, a Rac guanosine triphosphatase-activating protein (RacGAP) signaling protein previously implicated in the pathfinding of corticospinal axons in mice. We found that these are gain-of-function mutations that increase alpha 2-chimaerin RacGAP activity in vitro. Several of the mutations appeared to enhance alpha 2-chimaerin translocation to the cell membrane or enhance its ability to self-associate. Expression of mutant alpha 2-chimaerin constructs in chick embryos resulted in failure of oculomotor axons to innervate their target extraocular muscles. We conclude that alpha 2-chimaerin has a critical developmental function in ocular motor axon pathfinding.	[Miyake, Noriko; Cheng, Long; Andrews, Caroline; Chan, Wai-Man; Law, Krystal; Engle, Elizabeth C.] Childrens Hosp, Dept Med Genet, Boston, MA 02115 USA; [Miyake, Noriko; Cheng, Long; Andrews, Caroline; Sahin, Mustafa; Engle, Elizabeth C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chilton, John; Allen, James] Peninsula Med Sch, Inst Biomed & Clin Sci, Plymouth PL6 8BU, Devon, England; [Psatha, Maria; Cheung, Michelle; Davenport, Dominic; Guthrie, Sarah] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [Andrews, Caroline; Mariani, Laura E.; Sahin, Mustafa; Engle, Elizabeth C.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Crosier, Moira; Lindsay, Susan; Engle, Elizabeth C.] Univ Newcastle, Int Ctr Life, MRC Wellcome Trust Human Dev Biol Resource Newcas, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Gutowski, Nick J.; Engle, Elizabeth C.] Royal Devon & Exeter Hosp, Dept Neurol, Exeter EX2 5DW, Devon, England; [Gutowski, Nick J.; Ellard, Sian; Young, Elizabeth] Peninsula Med Sch, Exeter EX2 5DW, Devon, England; [Ellard, Sian] Royal Devon & Exeter Hosp, Dept Mol Genet, Exeter EX2 5DW, Devon, England; [Iannaccone, Alessandro] Univ Tennessee, Ctr Hlth Sci, Hamilton Eye Inst, Memphis, TN 38163 USA; [Appukuttan, Binoy; Stout, J. Timothy] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA; [Christiansen, Stephen] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; [Ciccarelli, Maria Laura] Fatebenefratelli Hosp, Div Ophthalmol, I-00100 Rome, Italy; [Baldi, Alfonso; Campioni, Mara] Univ Naples 2, Dept Biochem F Cedrangolo, Sect Pathol Anat, I-80138 Naples, Italy; [Zenteno, Juan C.] Inst Ophthalmol Conde Valenciana, Dept Genet, Mexico City 06700, DF, Mexico; [Engle, Elizabeth C.] Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Mariani, Laura E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Plymouth; University of London; King's College London; Harvard University; Boston Children's Hospital; Newcastle University - UK; University of Exeter; University of Exeter; University of Exeter; University of Tennessee System; University of Tennessee Health Science Center; Oregon Health & Science University; University of Minnesota System; University of Minnesota Twin Cities; Universita della Campania Vanvitelli; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Engle, EC (corresponding author), Childrens Hosp, Dept Med Genet, 300 Longwood Ave, Boston, MA 02115 USA.	elizabeth.engle@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019; Lindsay, Susan/B-3828-2013; Guthrie, Sarah C/C-5727-2009; Tuluc, Petronel/C-2527-2011; Baldi, Alfonso/ABG-2397-2021	SAHIN, MUSTAFA/0000-0001-7044-2953; Lindsay, Susan/0000-0003-2980-4582; Christiansen, Stephen/0000-0001-5489-5354; Baldi, Alfonso/0000-0002-8693-3842; Ellard, Sian/0000-0002-7620-5526; Iannaccone, Alessandro/0000-0001-5737-8424	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G9900837, G9900989] Funding Source: Medline; NEI NIH HHS [R01 EY015298, R01 EY015298-05, R01 EY015298-01, R01 EY015298-02, R01 EY015298-04, R01 EY015298-03] Funding Source: Medline; MRC [G9900989, G9900837] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY015298] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Appukuttan B, 1999, AM J HUM GENET, V65, P1639, DOI 10.1086/302656; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chilton JK, 2004, J COMP NEUROL, V472, P308, DOI 10.1002/cne.20071; Chung M, 2000, OPHTHALMOLOGY, V107, P500, DOI 10.1016/S0161-6420(99)00090-1; Cooke JE, 2002, TRENDS NEUROSCI, V25, P260, DOI 10.1016/S0166-2236(02)02134-3; Dalva MB, 2007, NEURON, V55, P681, DOI 10.1016/j.neuron.2007.08.015; Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P194, DOI 10.1167/iovs.06-0632; DONG JM, 1995, EUR J BIOCHEM, V227, P636, DOI 10.1111/j.1432-1033.1995.tb20183.x; Engle EC, 2007, ARCH NEUROL-CHICAGO, V64, P633, DOI 10.1001/archneur.64.5.633; Engle EC, 2007, INVEST OPHTH VIS SCI, V48, P189, DOI 10.1167/iovs.06-0631; Evans JC, 2000, HUM GENET, V106, P636, DOI 10.1007/s004390050036; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; HALL C, 1993, MOL CELL BIOL, V13, P4986, DOI 10.1128/MCB.13.8.4986; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	26	111	114	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					839	843		10.1126/science.1156121	http://dx.doi.org/10.1126/science.1156121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18653847	Green Accepted			2022-12-28	WOS:000258261000047
J	Bonetta, L				Bonetta, Laura			Detailed analysis	NATURE			English	Editorial Material							CELLS											Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105	4	9	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					795	798		10.1038/454795a	http://dx.doi.org/10.1038/454795a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685708	Bronze			2022-12-28	WOS:000258228000052
J	Freedman, DO				Freedman, David O.			Malaria prevention in short-term travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GEOSENTINEL SURVEILLANCE NETWORK; PLASMODIUM-VIVAX INFECTION; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; ATOVAQUONE-PROGUANIL; NONIMMUNE TRAVELERS; COLOMBIAN SOLDIERS; INSECT REPELLENTS; VISITING FRIENDS; CHEMOPROPHYLAXIS		Univ Alabama, Div Infect Dis, William C Gorgas Ctr Geog Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Freedman, DO (corresponding author), Univ Alabama, Div Infect Dis, William C Gorgas Ctr Geog Med, Birmingham, AL 35294 USA.		Freedman, David O./AAV-2999-2020	Freedman, David O./0000-0002-5642-5257				[Anonymous], TRAVELERS MALARIA; ARGUIN PM, 2007, HLTH INFORMATION INT; Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Baird JK, 2003, CLIN INFECT DIS, V37, P1659, DOI 10.1086/379714; Baird JK, 1998, T ROY SOC TROP MED H, V92, P687, DOI 10.1016/S0035-9203(98)90814-8; Behrens R, 2008, TRAVEL MED, P291; Behrens RH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-7; Behrens RH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-114; Boggild AK, 2007, AM J TROP MED HYG, V76, P208, DOI 10.4269/ajtmh.2007.76.208; *CDCP, 2008, MAL RISK MAP APPL; Chen LH, 2005, INFECT DIS CLIN N AM, V19, P185, DOI 10.1016/j.idc.2004.10.006; Chen LH, 2007, JAMA-J AM MED ASSOC, V297, P2251, DOI 10.1001/jama.297.20.2251; Chen LH, 2006, JAMA-J AM MED ASSOC, V296, P2234, DOI 10.1001/jama.296.18.2234; Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242; Collins WE, 2007, J INFECT DIS, V195, P919, DOI 10.1086/512246; Costantini C, 2004, T ROY SOC TROP MED H, V98, P644, DOI 10.1016/j.trstmh.2003.12.015; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Hill DR, 2006, CLIN INFECT DIS, V43, P1499, DOI 10.1086/508782; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Hogh B, 2000, LANCET, V356, P1888, DOI 10.1016/S0140-6736(00)03260-8; Keystone JS, 2001, CLIN INFECT DIS, V32, P757, DOI 10.1086/319234; Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Ling J, 2002, CLIN INFECT DIS, V35, P825, DOI 10.1086/342578; LOBEL HO, 1993, LANCET, V341, P848, DOI 10.1016/0140-6736(93)93058-9; Lobel HO, 1997, JAMA-J AM MED ASSOC, V278, P1767, DOI 10.1001/jama.278.21.1767; Mali Sonja, 2008, Morbidity and Mortality Weekly Report, V57, P24; McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285; Meier CR, 2004, DRUG SAFETY, V27, P203, DOI 10.2165/00002018-200427030-00005; MIMOUNI D, 1998, NEW ENGL J MED, V338, P927; Murray CK, 2006, MIL MED, V171, P905, DOI 10.7205/MILMED.171.9.905; Nothdurft HD, 2005, DEUT MED WOCHENSCHR, V130, P1392, DOI 10.1055/s-2005-868740; Ohrt C, 1997, ANN INTERN MED, V126, P963, DOI 10.7326/0003-4819-126-12-199706150-00006; Overbosch D, 2001, CLIN INFECT DIS, V33, P1015, DOI 10.1086/322694; Phillips-Howard PA, 1998, J TRAVEL MED, V5, P121, DOI 10.1111/j.1708-8305.1998.tb00484.x; PICKERING LK, 2006, 2006 RED BOOK REPORT, P197; Schlagenhauf P, 2003, BMJ-BRIT MED J, V327, P1078, DOI 10.1136/bmj.327.7423.1078; Schlagenhauf P, 1996, TROP MED INT HEALTH, V1, P485, DOI 10.1046/j.1365-3156.1996.d01-85.x; Schlagenhauf P, 2000, J TRAVEL MED, V7, P225, DOI 10.2310/7060.2000.00069; SCHLAGENHAUF P, 1994, J TROP MED HYG, V97, P151; Schlagenhauf P, 2008, TRAVELERS MALARIA, P134; Schwartz E, 2003, NEW ENGL J MED, V349, P1510, DOI 10.1056/NEJMoa021592; SOTO J, 1995, CLIN INFECT DIS, V21, P599, DOI 10.1093/clinids/21.3.599; Soto J, 2006, AM J TROP MED HYG, V75, P430, DOI 10.4269/ajtmh.2006.75.430; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; Vanhauwere B, 1998, AM J TROP MED HYG, V58, P17, DOI 10.4269/ajtmh.1998.58.17; WILDERSMITH A, 2008, INT TRAVEL HLTH 2008	50	79	80	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					603	612		10.1056/NEJMcp0803572	http://dx.doi.org/10.1056/NEJMcp0803572			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687641				2022-12-28	WOS:000258216700008
J							US Preventive Serv Task Force	Screening for prostate cancer: US preventive services task force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIGEN; MEN	Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).	[US Preventive Serv Task Force] Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA	Agency for Healthcare Research & Quality								*AM AC FAM PHYS, 2008, SUMM REC CLIN PREV S; *AM UR ASS, 2000, ONCOLOGY, V14, P277; *AM UR ASS, 2000, ONCOLOGY HUNTINGT, V14, P280; *AUA, 2000, ONCOLOGY WILLISTON P, V14, P267; Aus G, 2007, EUR UROL, V51, P659, DOI 10.1016/j.eururo.2006.07.012; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Coley CM, 1997, ANN INTERN MED, V126, P480; Etzioni R, 2002, J NATL CANCER I, V94, P981; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Ilic D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub2; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Lim LS, 2008, AM J PREV MED, V34, P164, DOI 10.1016/j.amepre.2007.10.003; LIN K, 2008, ANN INTERN MED, V149, pR30; *NAT CANC SEER, CANC STAT FACT SHEET; Roobol MJ, 2007, JNCI-J NATL CANCER I, V99, P1296, DOI 10.1093/jnci/djm101; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; *US CANC STAT WORK, 2007, US CANC STAT 1999 20; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Wilt T, 2008, COMP EFFECTIVENESS T	21	434	439	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					185	191		10.7326/0003-4819-149-3-200808050-00008	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18678845	Green Published			2022-12-28	WOS:000258342900005
J	Abrahamsen, B; Zhao, J; Asante, CO; Cendan, CM; Marsh, S; Martinez-Barbera, JP; Nassar, MA; Dickenson, AH; Wood, JN				Abrahamsen, Bjarke; Zhao, Jing; Asante, Curtis O.; Cendan, Cruz Miguel; Marsh, Steve; Martinez-Barbera, Juan Pedro; Nassar, Mohammed A.; Dickenson, Anthony H.; Wood, John N.			The cell and molecular basis of mechanical, cold, and inflammatory pain	SCIENCE			English	Article							RESISTANT SODIUM-CHANNEL; NEUROPATHIC PAIN; NOCICEPTORS; EXPRESSION; HEAT; GENE; HYPERSENSITIVITY; NA(V)1.8; DEFICITS; TRPV2	Peripheral pain pathways are activated by a range of stimuli. We used diphtheria toxin to kill all mouse postmitotic sensory neurons expressing the sodium channel Na(v)1.8. Mice showed normal motor activity and low- threshold mechanical and acute noxious heat responses but did not respond to noxious mechanical pressure or cold. They also showed a loss of enhanced pain responses and spontaneous pain behavior upon treatment with inflammatory insults. In contrast, nerve injury led to heightened pain sensitivity to thermal and mechanical stimuli indistinguishable from that seen with normal littermates. Pain behavior correlates well with central input from sensory neurons measured electrophysiologically in vivo. These data demonstrate that Na(v)1.8- expressing neurons are essential for mechanical, cold, and inflammatory pain but not for neuropathic pain or heat sensing.	[Abrahamsen, Bjarke; Zhao, Jing; Cendan, Cruz Miguel; Nassar, Mohammed A.; Wood, John N.] UCL, Mol Nocicept Grp, London WC1E 6BT, England; [Asante, Curtis O.; Marsh, Steve; Dickenson, Anthony H.] UCL, Dept Pharmacol, London WC1E 6BT, England; [Martinez-Barbera, Juan Pedro] UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London; University of London; University College London	Wood, JN (corresponding author), UCL, Mol Nocicept Grp, Gower St, London WC1E 6BT, England.	j.wood@ucl.ac.uk	Martinez-Barbera, Juan Pedro/AAE-9284-2020; babakinejad, babak/G-2674-2012; Martínez, Cruz Miguel Cendán/ABH-1404-2020; Abrahamsen, Bjarke/ABD-5874-2020	Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Martínez, Cruz Miguel Cendán/0000-0001-5431-4513; Zhao, Jing/0000-0003-2587-1198; Abrahamsen, Bjarke/0000-0002-6128-8269	BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G9717869] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: Medline; Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Zhao J, 2006, MOL CELL NEUROSCI, V31, P539, DOI 10.1016/j.mcn.2005.11.008; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	23	341	354	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					702	705		10.1126/science.1156916	http://dx.doi.org/10.1126/science.1156916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669863				2022-12-28	WOS:000258077700047
J	Park, CM; Goo, JM				Park, Chang Min; Goo, Jin Mo			Dynamic tumor staging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ Hosp, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Park, CM (corresponding author), Seoul Natl Univ Hosp, Seoul 110744, South Korea.	cmpark@radiol.snu.ac.kr	Goo, Jin Mo/AFT-4543-2022; Goo, Jin Mo/J-2732-2012						0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					E4	E4		10.1056/NEJMicm073652	http://dx.doi.org/10.1056/NEJMicm073652			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650509				2022-12-28	WOS:000257852100009
J	Margoliash, D; Hale, ME				Margoliash, Daniel; Hale, Melina E.			Vertebrate vocalizations	SCIENCE			English	Editorial Material							FISH		[Margoliash, Daniel; Hale, Melina E.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Margoliash, D (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu						Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Farries MA, 2002, J NEUROSCI, V22, P3776; Kittelberger JM, 2006, J NEUROPHYSIOL, V96, P71, DOI 10.1152/jn.00067.2006; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Rome LC, 1996, P NATL ACAD SCI USA, V93, P8095, DOI 10.1073/pnas.93.15.8095; SELLER TJ, 1981, TRENDS NEUROSCI, V4, P301, DOI 10.1016/0166-2236(81)90094-1; Shubin NH., 2008, YOUR INNER FISH; SIMMONS AM, 2003, ACOUSTIC COMMUNICATI, V16; ZEIGLER PM, 2004, BEHAV NEUROBIOLOGY B, V1016; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078	11	2	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					347	348		10.1126/science.1161775	http://dx.doi.org/10.1126/science.1161775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635781				2022-12-28	WOS:000257713900026
J	Hayward, RA; Kent, DM				Hayward, Rodney A.; Kent, David M.			6 EZ steps to improving your performance (or how to make P4P pay 4U!)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY; CARE					rhayward@umich.edu						Hayward RA, 2008, MED CARE, V46, P229, DOI 10.1097/MLR.0b013e318167579c; Hayward RA, 2007, AM J MANAG CARE, V13, P126; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kerr EA, 2003, MED CARE, V41, P1173, DOI 10.1097/01.MLR.0000088453.57269.29; Schwartz L M, 1999, Eff Clin Pract, V2, P76	5	25	25	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					255	256		10.1001/jama.2008.69	http://dx.doi.org/10.1001/jama.2008.69			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325ZB	18632535				2022-12-28	WOS:000257626600001
J	Cahn, P; McClure, C				Cahn, Pedro; McClure, Craig			Strengthening accountability in the global response to HIV	LANCET			English	Editorial Material							HEALTH		[Cahn, Pedro; McClure, Craig] Int AIDS Soc, CH-1216 Geneva, Switzerland		Cahn, P (corresponding author), Int AIDS Soc, CH-1216 Geneva, Switzerland.	karen.bennett@iasociety.org						[Anonymous], UN ACC SCAL PRIOR HI; Collins S, 2007, BRIT MED J, V335, P646, DOI 10.1136/bmj.39349.591296.59; El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Garrett L, 2007, FOREIGN AFF, V86, P14	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					265	265		10.1016/S0140-6736(08)61085-5	http://dx.doi.org/10.1016/S0140-6736(08)61085-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657688				2022-12-28	WOS:000258042800004
J	Audrey, S; Abel, J; Blazeby, JM; Falk, S; Campbell, R				Audrey, Suzanne; Abel, Julian; Blazeby, Jane M.; Falk, Stephen; Campbell, Rona			What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							DECISION-MAKING; CANCER-PATIENTS; CARE; COMMUNICATION; INFORMATION; PARTICIPATE; FAMILIES; LIFE; TOLD	Objective To examine how much oncologists tell patients about the survival benefit of palliative chemotherapy during consultations at which decisions about treatment are made. Design Qualitative study in which consultations were observed and digitally recorded. Setting Teaching hospital and district general hospital in south west England. Participants 37 patients with advanced non-small cell lung cancer (n=12), pancreatic cancer (n=13), and colorectal cancer (n=12); and nine oncologists, including four consultants and five registrars. Main outcome measures All recordings were transcribed completely, anonymised, and electronically coded with ATLAS.ti. Constant comparison was used to identify themes and patterns. The framework method of data management, in which data were charted, was used to aid transparency of interpretation. Results During the consultations, information given to patients about survival benefit included numerical data ("about fourweeks"), an idea of timescales ("a few months extra', vague references ("buy you some time"), or no mention at all. In most consultations (26/37) discussion of survival benefit was vague or non-existent. Conclusions Most patients were not given clear information about the survival gain of palliative chemotherapy. To aid decision making and informed consent, we recommend that oncologists sensitively describe the benefits and limitations of this treatment, including survival gain.	[Audrey, Suzanne; Campbell, Rona] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Abel, Julian] Weston Area Healthcare Trust, Weston Super Mare BS23 4TQ, England; [Blazeby, Jane M.] Univ Bristol, Clin Sci S Bristol, Bristol BS8 2PR, Avon, England; [Blazeby, Jane M.] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Blazeby, Jane M.] Univ Hosp Bristol NHS Fdn Trust, Div Head & Neck Surg, Bristol BS2 8HW, Avon, England; [Falk, Stephen] Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol BS2 8ED, Avon, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; Bristol Haematology & Oncology Centre; University of Bristol	Audrey, S (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	Suzanne.Audrey@bristol.ac.uk	Blazeby, Jane/H-6703-2019	Blazeby, Jane/0000-0002-3354-3330	Cancer Research UK [C17713/A6132]	Cancer Research UK(Cancer Research UK)	Cancer Research UK. C17713/A6132.	Ajaj A, 2001, BRIT MED J, V323, P1160, DOI 10.1136/bmj.323.7322.1160; Archer V R, 1999, Oncologist, V4, P470; Baile WF, 2006, J CLIN ONCOL, V24, P3217, DOI 10.1200/JCO.2006.06.2935; Bowcock SJ, 2004, BRIT MED J, V328, P1430, DOI 10.1136/bmj.328.7453.1430; Charles C, 2000, BRIT MED J, V320, P1220, DOI 10.1136/bmj.320.7244.1220; De Amici D, 2000, CONTROL CLIN TRIALS, V21, P103, DOI 10.1016/S0197-2456(99)00054-9; de Haes H, 2003, PATIENT EDUC COUNS, V50, P43, DOI 10.1016/S0738-3991(03)00079-X; de Kort SJ, 2006, EUR J CANCER, V42, P835, DOI 10.1016/j.ejca.2005.10.026; Department of Health, 2001, CONS WHAT YOU HAV RI; Department of Health, 2000, NHS CANC PLAN PLAN I; Fallowfield L, 2001, BRIT MED J, V323, P1144, DOI 10.1136/bmj.323.7322.1144; Fallowfield LJ, 2002, PALLIATIVE MED, V16, P297, DOI 10.1191/0269216302pm575oa; Faulkner A, 1998, BRIT MED J, V316, P130; Gattellari M, 2001, SOC SCI MED, V52, P1865, DOI 10.1016/S0277-9536(00)00303-8; Glaser B. G., 1998, DOING GROUNDED THEOR; Hagerty RG, 2005, ANN ONCOL, V16, P1005, DOI 10.1093/annonc/mdi211; Jenkins V, 2001, BRIT J CANCER, V84, P48, DOI 10.1054/bjoc.2000.1573; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; Koedoot CG, 2002, J CLIN ONCOL, V20, P3658, DOI 10.1200/JCO.2002.12.012; Leighl NB, 2004, J CLIN ONCOL, V22, P1759, DOI 10.1200/JCO.2004.02.166; Lewis, 2006, QUALITATIVE RES PRAC; Maguire P, 2002, BRIT MED J, V325, P697, DOI 10.1136/bmj.325.7366.697; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; Mayo, 1933, HUMAN PROBLEMS IND C; MUHR T, 1997, ATLAS TI WINDOWS; MUNDAY D, 2001, BRIT MED J, V322, P232; *NAT I HLTH CLIN E, 2001, TECHN APPR GUID, V26; *NAT I HLTH CLIN E, 2005, IR OX RALT TREATM AD; *NAT I HLTH CLIN E, 2007, NICE TECHN APPR GUID, V118; *NAT I HLTH CLIN E, 2001, TECHN APPR NICE, V25; *NAT I HLTH CLIN E, 2005, TECHN APPR GUID, V93; *NAT I HLTH CLIN E, 2007, TECHN APPR GUID, V118; National Institute for Health and Clinical Excellence, 2001, GUID US GEMC TREATM; National Institute for Health and Clinical Excellence, 2007, UND NICE GUID INF PE; National Institute for Health and Clinical Excellence, 2005, DIAGN TREATM LUNG CA; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Sanders T, 2003, EUR J CANCER CARE, V12, P166, DOI 10.1046/j.1365-2354.2003.00370.x; Thorne S, 2006, QUAL HEALTH RES, V16, P318, DOI 10.1177/1049732305285341	38	75	76	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 30	2008	337	7668							a752	10.1136/bmj.a752	http://dx.doi.org/10.1136/bmj.a752			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350OM	18669570	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000259362100026
J	Obayashi, E; Yoshida, H; Kawai, F; Shibayama, N; Kawaguchi, A; Nagata, K; Tame, JRH; Park, SY				Obayashi, Eiji; Yoshida, Hisashi; Kawai, Fumihiro; Shibayama, Naoya; Kawaguchi, Atsushi; Nagata, Kyosuke; Tame, Jeremy R. H.; Park, Sam-Yong			The structural basis for an essential subunit interaction in influenza virus RNA polymerase	NATURE			English	Article							AMINO-ACID MUTATION; A VIRUS; PA SUBUNIT; CAP-BINDING; PROTEIN; REPLICATION; COMPLEX; DESIGN; TRANSCRIPTION; INHIBITORS	Influenza A virus is a major human and animal pathogen with the potential to cause catastrophic loss of life. The virus reproduces rapidly, mutates frequently and occasionally crosses species barriers. The recent emergence in Asia of avian influenza related to highly pathogenic forms of the human virus has highlighted the urgent need for new effective treatments(1). Here we demonstrate the importance to viral replication of a subunit interface in the viral RNA polymerase, thereby providing a new set of potential drug binding sites entirely independent of surface antigen type. No current medication targets this heterotrimeric polymerase complex. All three subunits, PB1, PB2 and PA, are required for both transcription and replication(2-4). PB1 carries the polymerase active site, PB2 includes the capped- RNA recognition domain, and PA is involved in assembly of the functional complex(5-7), but so far very little structural information has been reported for any of them(8-11). We describe the crystal structure of a large fragment of one subunit ( PA) of influenza A RNA polymerase bound to a fragment of another subunit ( PB1). The carboxy- terminal domain of PA forms a novel fold, and forms a deep, highly hydrophobic groove into which the amino- terminal residues of PB1 can fit by forming a 3(10) helix.	[Obayashi, Eiji; Yoshida, Hisashi; Kawai, Fumihiro; Tame, Jeremy R. H.; Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [Shibayama, Naoya] Jichi Med Univ, Dept Physiol, Div Biophys, Shimotsuke, Tochigi 3290498, Japan; [Kawaguchi, Atsushi; Nagata, Kyosuke] Univ Tsukuba, Dept Infect Biol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Kawaguchi, Atsushi; Nagata, Kyosuke] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan	Yokohama City University; Jichi Medical University; University of Tsukuba; University of Tsukuba	Park, SY (corresponding author), Yokohama City Univ, Prot Design Lab, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	park@tsurumi.yokohama-cu.ac.jp	Kawai, Fumihiro/O-2712-2018	Kawaguchi, Atsushi/0000-0002-5485-1578; Shibayama, Naoya/0000-0002-2208-1126; Yoshida, Hisashi/0000-0003-0374-2600; Kawai, Fumihiro/0000-0003-0909-0789; Tame, Jeremy/0000-0002-9341-7280	ISS applied research partnership program	ISS applied research partnership program	We thank the staff at the SPring-8 BL41XU and Photon Factory BL5A beamlines for assistance with data collection, and M. Yao and Y. Zhou for help with data processing. This work was supported in part by the ISS applied research partnership program (S.-Y.P.).	[Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAAM J, 1983, CELL, V34, P609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; Elton D, 2005, CURRENT TOPICS INFLU, P1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; HORISBERGER MA, 1980, VIROLOGY, V107, P302, DOI 10.1016/0042-6822(80)90296-2; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu Y, 2007, CURR MED CHEM, V14, P2872, DOI 10.2174/092986707782360024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	42	212	234	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1127	U57		10.1038/nature07225	http://dx.doi.org/10.1038/nature07225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18660801				2022-12-28	WOS:000258719600040
J	Coates, TJ; Richter, L; Caceres, C				Coates, Thomas J.; Richter, Linda; Caceres, Carlos			HIV Prevention 3 - Behavioural strategies to reduce HIV transmission: how to make them work better	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; FRANCISCO MENS HEALTH; SEXUAL-RISK BEHAVIOR; BASE-LINE DATA; MALE CIRCUMCISION; CONDOM USE; ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; MASS-MEDIA; CONTINGENCY MANAGEMENT	This paper makes five key points. First is that the aggregate effect of radical and sustained behavioural changes in a sufficient number of individuals potentially at risk is needed for successful reductions in HIV transmission. Second, combination prevention is essential since HIV prevention is neither simple nor simplistic. Reductions in HIV transmission need widespread and sustained efforts, and a mix of communication channels to disseminate messages to motivate people to engage in a range of options to reduce risk. Third, prevention programmes can do better. The effect of behavioural strategies could be increased by aiming for many goals (eg, delay in onset of first intercourse, reduction in number of sexual partners, increases in condom use, etc) that are achieved by use of multilevel approaches (eg, couples, families, social and sexual networks, institutions, and entire communities) with populations both uninfected and infected with HIV. Fourth, prevention science can do better. Interventions derived from behavioural science have a role in overall HIV-prevention efforts, but they are insufficient when used by themselves to produce substantial and lasting reductions in HIV transmission between individuals or in entire communities. Fifth, we need to get the simple things right. The fundamentals of HIV prevention need to be agreed upon, funded, implemented, measured, and achieved. That, presently, is not the case.	[Coates, Thomas J.] Univ Calif Los Angeles, Div Infect Dis, UCLA Program Global Hlth, Los Angeles, CA 90024 USA; [Richter, Linda] Human Sci Res Council, Durban, South Africa; [Caceres, Carlos] Univ Peruana Cayetano Heredia, Lima, Peru	University of California System; University of California Los Angeles; Human Sciences Research Council-South Africa; Universidad Peruana Cayetano Heredia	Coates, TJ (corresponding author), Univ Calif Los Angeles, Div Infect Dis, UCLA Program Global Hlth, 10940 Wilshire Blvd,Suite 1220, Los Angeles, CA 90024 USA.	tcoates@mednet.ucla.edu		Caceres, Carlos F./0000-0002-8101-0790	The Ford Foundation; UCLA Center-for HIV Identification, Treatment, and Prevention Services; National Institute of Mental Health [2P30MH058107, P30MH43520]; The Diana, Princess of Wales Memorial Fund; The Franklin Mint Foundation; The MAC AIDS Fund; The UCLA AIDS Institute; UCLA Center for AIDS Research; The National Institute of Allergy and Infectious Diseases [A128697]; The John M Lloyd Foundation; Columbia Center for HIV Clinical and Behavioral Studies; HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute on Drug Abuse; Office of AIDS Research, of the National Institutes of Health; US Department of Health and Human Services; Family Health International; Fred Hutchinson Cancer Research Center; Johns Hopkins University; University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068619, U01AI046702, U01AI048014, U01AI047984, P30AI028697, U01AI046749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, P30MH043520] Funding Source: NIH RePORTER	The Ford Foundation; UCLA Center-for HIV Identification, Treatment, and Prevention Services; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); The Diana, Princess of Wales Memorial Fund; The Franklin Mint Foundation; The MAC AIDS Fund; The UCLA AIDS Institute; UCLA Center for AIDS Research; The National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The John M Lloyd Foundation; Columbia Center for HIV Clinical and Behavioral Studies; HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Office of AIDS Research, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; Family Health International; Fred Hutchinson Cancer Research Center; Johns Hopkins University(Johns Hopkins University); University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work was provided primarily by The Ford Foundation; The UCLA Center-for HIV Identification, Treatment, and Prevention Services (CHIPTS Mary Jane Rotheram-Borus, Director, funded by the National Institute of Mental Health grant number 2P30MH058107): The Diana, Princess of Wales Memorial Fund; The Franklin Mint Foundation; The MAC AIDS Fund; and The UCLA AIDS Institute and the UCLA Center for AIDS Research (Jerome Zack, Principal Investigator, funded by The National Institute of Allergy and Infectious Diseases, grant number A128697). Other supporters included: The John M Lloyd Foundation, and the Columbia Center for HIV Clinical and Behavioral Studies (Anke Ehrhrardt, Director, funded by the National Institute of Mental Health grant number P30MH43520). Support was also provided by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, US Department of Health and Human Services, through cooperative agreement U01-AI-46749 with Family Health International, U01-AI-46702 with Fred Hutchinson Cancer Research Center, U01-AI-47984 with Johns Hopkins University, and U01-A1-48014 with the University of Pennsylvania. The sponsors had no role in the preparation of this paper and none of the views expressed herein represent those of the sponsors or any employees of the sponsors. We thank Judith Auerbach and Peter Aggleton for the extensive comments on earlier drafts of this paper; Purnima. Mane of UNFPA for her guidance and feedback as this paper evolved; our colleagues at UNAIDS who contributed vital data and thoughtful comments on earlier drafts of this paper including Michael Bartos, Paul De Lay, Barbara de Zalduondo, Catherine Hankins, and Matthew Warner-Smith; and Professor King Holmes for coining the term "highly active HIV prevention" in figure 1.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Anhang, 2006, WHO TECH REP SER, V938, P317; [Anonymous], 2007, LANCET, V369, P615, DOI 10.1016/S0140-6736(07)60202-5; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Auerbach JD, 2000, AM J PUBLIC HEALTH, V90, P1029, DOI 10.2105/AJPH.90.7.1029; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P140, DOI 10.1097/01.aids.0000196168.50303.31; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; BARNETT A, IN PRESS AIDS; Bateganya MH, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006493.pub2; BERTOZZI SM, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60889-2; Bertrand JT, 2006, HEALTH EDUC RES, V21, P567, DOI 10.1093/her/cyl036; Bertrand JT, 2006, WHO TECH REP SER, V938, P205; Brink B, 2007, AIDS, V21, pS79, DOI 10.1097/01.aids.0000279697.40568.fd; CATES W, 2006, HIV AIDS ANN UPDATE; *CDCP, 2007, UPD COMP EV BAS INT; *CDCP, 2001, COMP HIV PREV INT; Celentano DD, 2000, ARCH INTERN MED, V160, P535, DOI 10.1001/archinte.160.4.535; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1110; Chesney MA, 2003, AM J PUBLIC HEALTH, V93, P933, DOI 10.2105/AJPH.93.6.933; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Coates TJ, 2008, AIDS, V22, P1079, DOI 10.1097/QAD.0b013e3282f8afb0; Coates TJ, 2007, AIDS, V21, pS3, DOI 10.1097/01.aids.0000279688.23535.04; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Cohen MS, 2007, CLIN INFECT DIS, V45, pS287, DOI 10.1086/522552; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; COLLINS C, IN PRESS AIDS; Colvin M, 2007, AIDS, V21, pS13, DOI 10.1097/01.aids.0000279690.69276.c9; Compston Alastair, LANCET, V372, P1502, DOI [DOI 10.1016/S0140-6736(08)60885-5, 10.1016/S0140-6736(08)61620-7, DOI 10.1016/S0140-6736(08)61620-7]; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Fuller CM, 2007, AM J PUBLIC HEALTH, V97, P117, DOI 10.2105/AJPH.2005.069591; Gordon CM, 2006, JAIDS-J ACQ IMM DEF, V43, pS36, DOI 10.1097/01.qai.0000248347.87512.ba; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grinstead O, 2003, AIDS EDUC PREV, V15, P547, DOI 10.1521/aeap.15.7.547.24045; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Holmes K, 2007, LANCET INFECT DIS, V7, P516; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Kalichman SC, 2007, AM J DRUG ALCOHOL AB, V33, P687, DOI 10.1080/00952990701522716; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kawichai S, 2007, AIDS BEHAV, V11, P770, DOI 10.1007/s10461-007-9242-7; Kelly JA, 2006, AIDS CARE, V18, P12, DOI 10.1080/09540120500101757; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Kelly JA, 2006, BMJ-BRIT MED J, V333, P1098, DOI 10.1136/bmj.38992.478299.55; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kippax S, 2003, SOC SCI MED, V57, P1, DOI 10.1016/S0277-9536(02)00303-9; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Koblin BA, 2007, SUBST USE MISUSE, V42, P1613, DOI 10.1080/10826080701212519; Lagakos SW, 2008, METHODOLOGICAL CHALL; Mahajan AP, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000279692.54029.a1; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Moyo W, 2008, AIDS BEHAV, V12, P431, DOI 10.1007/s10461-007-9343-3; NIMH Collaborative HIV/STD Prevention Trial Group, 2007, AIDS, V21 Suppl 2, pS3; Noar SM, 2007, AIDS CARE, V19, P392, DOI 10.1080/09540120600708469; Noar SM, 2008, PREV MED, V46, P275, DOI 10.1016/j.ypmed.2007.08.001; Noar SM, 2008, AIDS BEHAV, V12, P335, DOI 10.1007/s10461-007-9313-9; Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059; Oppenheimer J, 2007, AIDS, V21, pS11, DOI 10.1097/01.aids.0000279689.31158.66; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Pantin Hilda, 2003, Prev Sci, V4, P189, DOI 10.1023/A:1024601906942; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2007, AIDS, V21, P861, DOI 10.1097/QAD.0b013e3280f00fb3; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Prado G, 2007, J CONSULT CLIN PSYCH, V75, P914, DOI 10.1037/0022-006X.75.6.914; RAOGUPTA G, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60887-9; Rawson RA, 2006, ADDICTION, V101, P267, DOI 10.1111/j.1360-0443.2006.01312.x; Remien RH, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000298104.02356.b3; Roll JM, 2006, PSYCHIAT RES, V144, P91, DOI 10.1016/j.psychres.2005.12.003; Rotheram-Borus MJ, 2001, AM J PUBLIC HEALTH, V91, P1294, DOI 10.2105/AJPH.91.8.1294; Sawires SR, 2007, LANCET, V369, P708, DOI 10.1016/S0140-6736(07)60323-7; Sayles JN, 2006, JAIDS-J ACQ IMM DEF, V43, P226, DOI 10.1097/01.qai.0000230527.17459.5c; *SECR GEN UN, 2008, IMPL DECL COMM HIV A; SEPULVEDA J, 2007, PEPFAR IMPLEMENTATIO; Shisana O, 2004, SAMJ S AFR MED J, V94, P283; SHISANA O, 2005, S AFRICAN NATL HIV P; Sikkema KJ, 2000, AM J PUBLIC HEALTH, V90, P57, DOI 10.2105/AJPH.90.1.57; Simbayi LC, 2004, AIDS CARE, V16, P605, DOI 10.1080/09540120410001716405; Slutkin G, 2006, AIDS BEHAV, V10, P351, DOI 10.1007/s10461-006-9118-2; STALL R, 1990, J ACQ IMMUN DEF SYND, V3, P1181; STEMPLE L, IN PRESS AIDS; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Strona FV, 2006, J PSYCHOACTIVE DRUGS, P377; SZEKERES G, IN PRESS AIDS; *UN DECL COMM HIV, 2002, CAN HIV AIDS POLICY, V6, P42; UNAIDS, 2001, HIV PREV NEEDS SUCC; *UNAIDS, 2007, MON DECL COMM HIV AI; UNAIDS, 2008, REP GLOB AIDS EP; UNAIDS, 2006, REP GLOB AIDS EP; *UNAIDS, 2007, 2007 AIDS EP UPD; US Government Accountability Office, 2006, GLOB HLTH SPEND REQ; Vogel UF, 2007, UNIVERSAL ACCESS PRE; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; WEST SG, IN PRESS AM J PUBLIC; WINKELSTEIN W, 1987, AM J PUBLIC HEALTH, V77, P685, DOI 10.2105/AJPH.77.6.685; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P1470, DOI 10.1001/jama.1987.03390110046011; WODAK A, IN PRESS AIDS; Youngblade LM, 2007, PEDIATRICS, V119, pS47, DOI 10.1542/peds.2006-2089H; Zhou YQR, 2007, SOC SCI MED, V65, P284, DOI 10.1016/j.socscimed.2007.03.031	111	513	521	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2008	372	9639					669	684		10.1016/S0140-6736(08)60886-7	http://dx.doi.org/10.1016/S0140-6736(08)60886-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	340BX	18687459	Green Accepted			2022-12-28	WOS:000258622200031
J	Cheng, HC; Skehan, BM; Campellone, KG; Leong, JM; Rosen, MK				Cheng, Hui-Chun; Skehan, Brian M.; Campellone, Kenneth G.; Leong, John M.; Rosen, Michael K.			Structural mechanism of WASP activation by the enterohaemorrhagic E-coli effector EspF(U)	NATURE			English	Article							N-WASP; ARP2/3 COMPLEX; WASP/SCAR PROTEINS; NMR; TIR; BINDING; TCCP; AUTOINHIBITION; SPECTROSCOPY; INTEGRATION	During infection, enterohaemorrhagic Escherichia coli ( EHEC) takes over the actin cytoskeleton of eukaryotic cells by injecting the EspFU protein into the host cytoplasm(1,2). EspFU controls actin by activating members of the Wiskott - Aldrich syndrome protein ( WASP) family(1-5). Here we show that EspFU binds to the autoinhibitory GTPase binding domain ( GBD) in WASP proteins and displaces it from the activity- bearing VCA domain ( for verprolin homology, central hydrophobic and acidic regions). This interaction potently activates WASP and neural ( N)- WASP in vitro and induces localized actin assembly in cells. In the solution structure of the GBD - EspFU complex, EspFU forms an amphipathic helix that binds the GBD, mimicking interactions of the VCA domain in autoinhibited WASP. Thus, EspFU activates WASP by competing directly for the VCA binding site on the GBD. This mechanism is distinct from that used by the eukaryotic activators Cdc42 and SH2 domains, which globally destabilize the GBD fold to release the VCA(6-8). Such diversity of mechanism in WASP proteins is distinct from other multimodular systems, and may result from the intrinsically unstructured nature of the isolated GBD and VCA elements. The structural incompatibility of the GBD complexes with EspFU and Cdc42/SH2, plus high- affinity EspFU binding, enable EHEC to hijack the eukaryotic cytoskeletal machinery effectively.	[Cheng, Hui-Chun; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Cheng, Hui-Chun; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Skehan, Brian M.; Campellone, Kenneth G.; Leong, John M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu			National Institute of Health [NIH-R01-GM56322, NIH-R01-AI46454]; Welch Foundation [I-1544]; Chilton Foundation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Chilton Foundation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Otomo for discussion and assistance on biochemical assays and NMR spectroscopy; P. Li, I. Martins, C. A. Amezcua, K. H. Gardner and Q. Wu for assistance with NMR spectroscopy and structure calculations; G. K. Amarasinghe andD. W. Leung for sharing reagents; D. Trobaugh, J. Rennie and D. Robbins for technical assistance; S. B. Padrick for help with Mathematica and X. Yao and S. B. Padrick for assistance in writing and for critical reading of the manuscript. This work was supported by grants from the National Institute of Health ( NIH- R01- GM56322 to M. K. R.; NIH- R01- AI46454 to J. M. L.), Welch Foundation ( I - 1544 to M. K. R.) and a Chilton Foundation Fellowship to H.- C. C.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Buck M, 2001, BIOCHEMISTRY-US, V40, P14115, DOI 10.1021/bi0157215; Campellone KG, 2006, CELL MICROBIOL, V8, P1488, DOI 10.1111/j.1462-5822.2006.00728.x; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Campellone KG, 2002, MOL MICROBIOL, V43, P1227, DOI 10.1046/j.1365-2958.2002.02817.x; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2002, PYMOL USERS MANUAL; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Garmendia J, 2006, CELL MICROBIOL, V8, P1444, DOI 10.1111/j.1462-5822.2006.00723.x; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leung DW, 2006, METHOD ENZYMOL, V406, P281, DOI 10.1016/S0076-6879(06)06021-6; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lommel S, 2004, CELL MICROBIOL, V6, P243, DOI 10.1111/j.1462-5822.2004.00364.x; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	43	78	81	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					1009	U54		10.1038/nature07160	http://dx.doi.org/10.1038/nature07160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18650809	Green Accepted			2022-12-28	WOS:000258591000042
J	Larson, EB; Langa, KM				Larson, Eric B.; Langa, Kenneth M.			The rising tide of dementia worldwide	LANCET			English	Editorial Material							COGNITIVE IMPAIRMENT; DISEASE; COMPRESSION; PREVALENCE		[Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Langa, Kenneth M.] Univ Michigan, Ann Arbor, MI 48109 USA	Group Health Cooperative; University of Michigan System; University of Michigan	Larson, EB (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA.	larson.e@ghc.org		Langa, Kenneth/0000-0002-2798-1836				den Dunnen WFA, 2008, NEUROBIOL AGING, V29, P1127, DOI 10.1016/j.neurobiolaging.2008.04.010; DRUCKER PF, 2001, ECONOMIST       1103, P2; ENOS WF, 1955, JAMA-J AM MED ASSOC, V158, P912, DOI 10.1001/jama.1955.02960110018005; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Lobo A, 2000, NEUROLOGY, V54, pS4; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Moceri VM, 2001, EPIDEMIOLOGY, V12, P383, DOI 10.1097/00001648-200107000-00007; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; RODRIGUEZ JJL, 2008, LANCET          0728, DOI DOI 10.1016/S0140-6736(08)61002-8; ROGERS M, IN PRESS J GERIATR P	14	29	34	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					430	432		10.1016/S0140-6736(08)61003-X	http://dx.doi.org/10.1016/S0140-6736(08)61003-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335OD	18667232	Bronze			2022-12-28	WOS:000258299000008
J	Iglehart, JK				Iglehart, John K.			Medicare showdown	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2008, REP C MED PAYM POL; *C BUDG OFF, 2007, MED ADV PROGR ENR TR; *GOV ACC OFF, 2008, GAO08359; IGLEHART JK, 1985, NEW ENGL J MED, V312, P132, DOI 10.1056/NEJM198501103120237	4	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					556	558		10.1056/NEJMp0805760	http://dx.doi.org/10.1056/NEJMp0805760			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334IY	18635424				2022-12-28	WOS:000258216700002
J	Schunck, CH; Shin, YI; Schirotzek, A; Ketterle, W				Schunck, Christian H.; Shin, Yong-il; Schirotzek, Andre; Ketterle, Wolfgang			Determination of the fermion pair size in a resonantly interacting superfluid	NATURE			English	Article							BOSE-CONDENSATION; GAS; SUPERCONDUCTIVITY; STATE; BCS	Fermionic superfluidity requires the formation of particle pairs, the size of which varies from the femtometre scale in neutron stars and nuclei to the micrometre scale in conventional superconductors. Many properties of the superfluid depend on the pair size relative to the interparticle spacing. This is expressed in 'BCS-BEC crossover' theories(,)(1-3) describing the crossover from a Bardeen Cooper-Schrieffer (BCS)-type superfluid of loosely bound, large Cooper pairs to Bose-Einstein condensates (BECs) of tightly bound molecules. Such a crossover superfluid has been realized in ultracold atomic gases where high-temperature superfluidity has been observed(4,5). The microscopic properties of the fermion pairs can be probed using radio- frequency spectroscopy. However, previous work(6-8) was difficult to interpret owing to strong final-state interactions that were not well understood. Here we realize a superfluid spin mixture in which such interactions have negligible influence and present fermion pair dissociation spectra that reveal the underlying pairing correlations. This allows us to determine that the spectroscopic pair size in the resonantly interacting gas is 20 per cent smaller than the interparticle spacing. These are the smallest pairs so far observed in fermionic superfluids, highlighting the importance of small fermion pairs for superfluidity at high critical temperatures(9). We have also identified transitions from fermion pairs to bound molecular states and to many-body bound states in the case of strong final- state interactions.	[Schunck, Christian H.; Shin, Yong-il; Schirotzek, Andre; Ketterle, Wolfgang] MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; [Schunck, Christian H.; Shin, Yong-il; Schirotzek, Andre; Ketterle, Wolfgang] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Schunck, CH (corresponding author), MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chs@mit.edu	Shin, Yong-il/B-1955-2008; Schunck, Christian H/A-3625-2010	Shin, Yong-il/0000-0003-0481-9841; Schunck, Christian H/0000-0002-7917-8180				Bartenstein M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.103201; BASU S, 2007, FINAL STATE EFFECTS; Baym G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190407; Burovski E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.160402; Carlson J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.050401; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; DIENER RB, 2004, CONDITION UNIVERSALI; EAGLES DM, 1969, PHYS REV, V186, P456, DOI 10.1103/PhysRev.186.456; Engelbrecht JR, 1997, PHYS REV B, V55, P15153, DOI 10.1103/PhysRevB.55.15153; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; He Y, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.011602; Honerkamp C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.170403; Ketterle W., 2008, ULTRACOLD FERMI GASE, P95; Kinnunen J, 2004, SCIENCE, V305, P1131, DOI 10.1126/science.1100782; Leggett A. J., 1980, Modern Trends in the Theory of Condensed Matter. Proceedings of the XVIth Karpacz Winter School of Theoretical Physics, P13; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; Ohashi Y, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063606; Ortiz G, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.043611; Perali A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.010402; PISTOLESI F, 1994, PHYS REV B, V49, P6356, DOI 10.1103/PhysRevB.49.6356; Punk M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.170404; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.230404; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Schunck CH, 2007, SCIENCE, V316, P867, DOI 10.1126/science.1140749; Shin Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.090403; Yu Z, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063601; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	30	92	92	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					739	U70		10.1038/nature07176	http://dx.doi.org/10.1038/nature07176			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685702	Green Submitted			2022-12-28	WOS:000258228000039
J	Stewart, JT; Gaebler, JP; Jin, DS				Stewart, J. T.; Gaebler, J. P.; Jin, D. S.			Using photoemission spectroscopy to probe a strongly interacting Fermi gas	NATURE			English	Article							SUPERFLUIDITY	Ultracold atomic gases provide model systems in which to study many-body quantum physics. Recent experiments using Fermi gases have demonstrated a phase transition to a superfluid state with strong interparticle interactions(1-6). This system provides a realization of the 'BCS-BEC crossover'(7) connecting the physics of Bardeen-Cooper-Schrieffer (BCS) superconductivity with that of Bose-Einstein condensates (BECs). Although many aspects of this system have been investigated, it has not yet been possible to measure the single-particle excitation spectrum (a fundamental property directly predicted by many-body theories). Here we use photoemission spectroscopy to directly probe the elementary excitations and energy dispersion in a strongly interacting Fermi gas of K-40 atoms. In the experiments, a radio-frequency photon ejects an atom from the strongly interacting system by means of a spin-flip transition to a weakly interacting state. We measure the occupied density of single-particle states at the cusp of the BCS-BEC crossover and on the BEC side of the crossover, and compare these results to that for a nearly ideal Fermi gas. We show that, near the critical temperature, the single-particle spectral function is dramatically altered in a way that is consistent with a large pairing gap. Our results probe the many-body physics in a way that could be compared to data for the high-transition-temperature superconductors. As in photoemission spectroscopy for electronic materials, our measurement technique for ultracold atomic gases directly probes low-energy excitations and thus can reveal excitation gaps and/or pseudogaps. Furthermore, this technique can provide an analogue of angle-resolved photoemission spectroscopy for probing anisotropic systems, such as atoms in optical lattice potentials.	[Stewart, J. T.; Gaebler, J. P.; Jin, D. S.] Univ Colorado, JILA, Quantum Phys Div, Natl Inst Stand & Technol, Boulder, CO 80309 USA; [Stewart, J. T.; Gaebler, J. P.; Jin, D. S.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Jin, DS (corresponding author), Univ Colorado, JILA, Quantum Phys Div, Natl Inst Stand & Technol, Boulder, CO 80309 USA.	jin@jilau1.colorado.edu		Gaebler, John/0000-0002-2616-7410				BARNEA N, 2008, SUPERFLUID INSULATOR; BASU S, 2007, FINAL STATE EFFECTS; Bruun GM, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.033623; BULGAC A, 2008, GAP PSEUDOGAP UNITAR; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; Damascelli A, 2004, PHYS SCRIPTA, VT109, P61, DOI 10.1238/Physica.Topical.109a00061; Dao TL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.240402; Gaebler JP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200403; GIORGINI S, IN PRESS REV MOD PHY; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; HE Y, 2008, TEMPERATURE FINAL ST; Janko B, 1997, PHYS REV B, V56, P11407, DOI 10.1103/PhysRevB.56.R11407; Luo L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080402; Partridge GB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.020404; Perali A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.010402; Perali A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024510; Punk M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.170404; Randeria M, 1998, P INT SCH PHYS, V136, P53; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.230404; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Schunck CH, 2007, SCIENCE, V316, P867, DOI 10.1126/science.1140749; SCHUNCK CH, 2008, DETERMINATION FERMIO; Stewart JT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220406; TARRUELL L, 2008, ULTRA COLD FERMI GAS, P845; VEILLETTE M, 2008, RADIO FREQUENCY SPEC; Yanase Y, 1999, J PHYS SOC JPN, V68, P2999, DOI 10.1143/JPSJ.68.2999; Yu Z, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063601; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	30	414	414	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					744	747		10.1038/nature07172	http://dx.doi.org/10.1038/nature07172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685703	Green Submitted			2022-12-28	WOS:000258228000040
J	Dyer, C				Dyer, Clare			Doctors in court	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer@aol.com						British Medical Association (BMA), 2007, EXP WITN GUID; *CHIEF MED OFF, 2006, BEAR GOOD WITN; Dyer G, 2004, BMJ-BRIT MED J, V328, P604, DOI DOI 10.1136/BMJ.328.7440.604-A; *GEN MED COUNC, 2008, ACT EXP WITN	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a975	10.1136/bmj.a975	http://dx.doi.org/10.1136/bmj.a975			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18653631				2022-12-28	WOS:000258561000024
J	Bromm, V				Bromm, Volker			Astronomy - The cosmic rosetta stone	SCIENCE			English	Editorial Material							1ST STARS		Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bromm, V (corresponding author), Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA.	vbromm@astro.as.utexas.edu						Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Frebel A, 2007, MON NOT R ASTRON SOC, V380, pL40, DOI 10.1111/j.1745-3933.2007.00344.x; Greif TH, 2008, MON NOT R ASTRON SOC, V387, P1021, DOI 10.1111/j.1365-2966.2008.13326.x; Mckee CF, 2008, ASTROPHYS J, V681, P771, DOI 10.1086/587434; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; Omukai K, 2003, ASTROPHYS J, V589, P677, DOI 10.1086/374810; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Wise JH, 2007, ASTROPHYS J, V665, P899, DOI 10.1086/520036; Yoshida N, 2008, SCIENCE, V321, P669, DOI 10.1126/science.1160259	13	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					647	648		10.1126/science.1161710	http://dx.doi.org/10.1126/science.1161710			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669849				2022-12-28	WOS:000258077700028
J	Lencer, WI				Lencer, Wayne I.			Patching a leaky intestine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Lencer, WI (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.			Lencer, Wayne/0000-0001-7346-2730	NIDDK NIH HHS [P30 DK034854, R01 DK084424, R37 DK048106, P30 DK040561] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R37DK048106, R01DK084424, P30DK040561] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; JOHANSEN FE, 2006, PHYSL GASTROINTESTIN, V2, P1067; MA TY, 2006, PHYSL GASTROINTESTIN, V2, P1559; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289	4	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					526	528		10.1056/NEJMcibr0803745	http://dx.doi.org/10.1056/NEJMcibr0803745			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669433	Green Accepted			2022-12-28	WOS:000258039700014
J	Sasako, M; Sano, T; Yamamoto, S; Kurokawa, Y; Nashimoto, A; Kurita, A; Hiratsuka, M; Tsujinaka, T; Kinoshita, T; Arai, K; Yamamura, Y; Okajima, K				Sasako, Mitsuru; Sano, Takeshi; Yamamoto, Seiichiro; Kurokawa, Yukinori; Nashimoto, Atsushi; Kurita, Akira; Hiratsuka, Masahiro; Tsujinaka, Toshimasa; Kinoshita, Taira; Arai, Kuniyoshi; Yamamura, Yoshitaka; Okajima, Kunio		Japan Clin Oncol Grp	D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HOSPITAL VOLUME; D-2 RESECTIONS; SURGERY; MORBIDITY; MORTALITY; D1; CHEMORADIOTHERAPY; GASTRECTOMY; SURVIVAL	Background: Gastrectomy with D2 lymphadenectomy is the standard treatment for curable gastric cancer in eastern Asia. Whether the addition of para-aortic nodal dissection (PAND) to D2 lymphadenectomy for stage T2, T3, or T4 tumors improves survival is controversial. We conducted a randomized, controlled trial at 24 hospitals in Japan to compare D2 lymphadenectomy alone with D2 lymphadenectomy plus PAND in patients undergoing gastrectomy for curable gastric cancer. Methods: Between July 1995 and April 2001, 523 patients with curable stage T2b, T3, or T4 gastric cancer were randomly assigned during surgery to D2 lymphadenectomy alone (263 patients) or to D2 lymphadenectomy plus PAND (260 patients). We did not permit any adjuvant therapy before the recurrence of cancer. The primary end point was overall survival. Results: The rates of surgery-related complications among patients assigned to D2 lymphadenectomy alone and those assigned to D2 lymphadenectomy plus PAND were 20.9% and 28.1%, respectively (P=0.07). There were no significant differences between the two groups in the frequencies of anastomotic leakage, pancreatic fistula, abdominal abscess, pneumonia, or death from any cause within 30 days after surgery (the rate of death was 0.8% in each group). The median operation time was 63 minutes longer and the median blood loss was 230 ml greater in the group assigned to D2 lymphadenectomy plus PAND. The 5-year overall survival rate was 69.2% for the group assigned to D2 lymphadenectomy alone and 70.3% for the group assigned to D2 lymphadenectomy plus PAND; the hazard ratio for death was 1.03 (95% confidence interval [CI], 0.77 to 1.37; P=0.85). There were no significant differences in recurrence-free survival between the two groups; the hazard ratio for recurrence was 1.08 (95% CI, 0.83 to 1.42; P=0.56). Conclusions: As compared with D2 lymphadenectomy alone, treatment with D2 lymphadenectomy plus PAND does not improve the survival rate in curable gastric cancer. (ClinicalTrials.gov number, NCT00149279.).	[Sasako, Mitsuru; Sano, Takeshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan; [Yamamoto, Seiichiro; Kurokawa, Yukinori] Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr, Tokyo 104, Japan; [Nashimoto, Atsushi] Niigata Canc Ctr Hosp, Dept Surg, Niigata, Japan; [Kurita, Akira] Natl Shikoku Canc Ctr, Dept Surg, Matsuyama, Ehime, Japan; [Hiratsuka, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Tsujinaka, Toshimasa] Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Kinoshita, Taira] Natl Canc Ctr Hosp E, Dept Surg, Kashiwa, Chiba, Japan; [Arai, Kuniyoshi] Tokyo Metropolitan Komagome Hosp, Dept Surg, Tokyo, Japan; [Yamamura, Yoshitaka] Aichi Canc Ctr, Dept Surg, Nagoya, Aichi 464, Japan; [Okajima, Kunio] Osaka Med Coll, Osaka, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka National Hospital; National Cancer Center - Japan; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Aichi Cancer Center; Osaka Medical College	Sasako, M (corresponding author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo, Japan.	msasako@hyo-med.ac.jp						Baba M, 2000, HEPATO-GASTROENTEROL, V47, P893; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Cuschieri A, 1996, LANCET, V347, P995, DOI 10.1016/S0140-6736(96)90144-0; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; DEARETXABALA X, 1987, BRIT J SURG, V74, P770, DOI 10.1002/bjs.1800740904; Degiuli M, 2004, EJSO-EUR J SURG ONC, V30, P303, DOI 10.1016/j.ejso.2003.11.020; Douglass HO, 2007, SURG ONCOL CLIN N AM, V16, P133, DOI 10.1016/j.soc.2006.10.005; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hundahl SA, 2002, ANN SURG ONCOL, V9, P278, DOI 10.1007/BF02573066; Isozaki H, 1999, HEPATO-GASTROENTEROL, V46, P549; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Japanese Research Society for Gastric Cancer, 1995, JAP CLASS GASTR CARC; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Maeta M, 1999, SURGERY, V125, P325, DOI 10.1016/S0039-6060(99)70244-8; MARUYAMA K, 1987, WORLD J SURG, V11, P418, DOI 10.1007/BF01655804; Nomura E, 2007, JPN J CLIN ONCOL, V37, P429, DOI 10.1093/jjco/hym067; Peeters KCMJ, 2005, WORLD J SURG, V29, P1576, DOI 10.1007/s00268-005-7907-9; Sakuramoto S, 2008, NEW ENGL J MED, V358, P1977; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sano T, 2007, BRIT J SURG, V94, P263, DOI 10.1002/bjs.5785; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Sasako M, 2006, SCAND J SURG, V95, P232, DOI 10.1177/145749690609500404; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Sierra A, 2003, ANN SURG ONCOL, V10, P219, DOI 10.1245/ASO.2003.07.009; Sobin, 2009, UICC TNM CLASSIFICAT; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Wu CW, 2004, BRIT J SURG, V91, P283, DOI 10.1002/bjs.4433; YONEMURA Y, 1994, SURG TODAY, V24, P488, DOI 10.1007/BF01884566; Yoshikawa T, 2006, BRIT J SURG, V93, P1526, DOI 10.1002/bjs.5487	36	738	838	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					453	462		10.1056/NEJMoa0707035	http://dx.doi.org/10.1056/NEJMoa0707035			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669424				2022-12-28	WOS:000258039700003
J	Li, L; Checkelsky, JG; Hor, YS; Uher, C; Hebard, AF; Cava, RJ; Ong, NP				Li, Lu; Checkelsky, J. G.; Hor, Y. S.; Uher, C.; Hebard, A. F.; Cava, R. J.; Ong, N. P.			Phase transitions of Dirac electrons in bismuth	SCIENCE			English	Article							QUANTUM; MAGNETOREFLECTION; GRAPHENE	The Dirac Hamiltonian, which successfully describes relativistic fermions, applies equally well to electrons in solids with linear energy dispersion, for example, in bismuth and graphene. A characteristic of these materials is that a magnetic field less than 10 tesla suffices to force the Dirac electrons into the lowest Landau level, with resultant strong enhancement of the Coulomb interaction energy. Moreover, the Dirac electrons usually come with multiple flavors or valley degeneracy. These ingredients favor transitions to a collective state with novel quantum properties in large field. By using torque magnetometry, we have investigated the magnetization of bismuth to fields of 31 tesla. We report the observation of sharp field- induced phase transitions into a state with striking magnetic anisotropy, consistent with the breaking of the threefold valley degeneracy.	[Li, Lu; Checkelsky, J. G.; Ong, N. P.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Hor, Y. S.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Uher, C.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Hebard, A. F.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA	Princeton University; Princeton University; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	Li, L (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	luli@princeton.edu; npo@princeton.edu	Li, Lu/AAF-9416-2019; Ong, N. Phuan/Z-1626-2019; San Hor, Yew/S-1429-2017	Li, Lu/0000-0002-8054-7406; San Hor, Yew/0000-0002-1417-4357; Ong, N. Phuan/0000-0001-7166-1058				Alicea J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075422; Behnia K, 2007, SCIENCE, V317, P1729, DOI 10.1126/science.1146509; BHARGAVA RN, 1967, PHYS REV, V156, P785, DOI 10.1103/PhysRev.156.785; Bompadre SG, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.073103; BROWN RN, 1963, PHYS REV, V129, P2055, DOI 10.1103/PhysRev.129.2055; Checkelsky JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206801; COHEN MH, 1960, PHILOS MAG, V5, P115, DOI 10.1080/14786436008243294; FUKUYAMA H, 1970, J PHYS SOC JPN, V28, P570, DOI 10.1143/JPSJ.28.570; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Maltz M, 1970, PHYS REV B-SOLID ST, V2, P2877, DOI 10.1103/PhysRevB.2.2877; MURPHY SQ, 1994, PHYS REV LETT, V72, P728, DOI 10.1103/PhysRevLett.72.728; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Shkolnikov YP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.066809; Shoenberg D., 1984, MAGNETIC OSCILLATION; WOLFF PA, 1964, J PHYS CHEM SOLIDS, V25, P1057, DOI 10.1016/0022-3697(64)90128-3; Yang FY, 2000, PHYS REV B, V61, P6631, DOI 10.1103/PhysRevB.61.6631; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	19	135	136	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					547	550		10.1126/science.1158908	http://dx.doi.org/10.1126/science.1158908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653888				2022-12-28	WOS:000257888900043
J	Sobolev, AV; Hofmann, AW; Brugmann, G; Batanova, VG; Kuzmin, DV				Sobolev, Alexander V.; Hofmann, Albrecht W.; Bruegmann, Gerhard; Batanova, Valentina G.; Kuzmin, Dmitry V.			A quantitative link between recycling and osmium isotopes	SCIENCE			English	Article							ICELAND MANTLE PLUME; OCEANIC-CRUST; TRACE-ELEMENT		[Sobolev, Alexander V.; Batanova, Valentina G.] Russian Acad Sci, VI Vernadskii Inst Geochem & Analyt Chem, Moscow 119991, Russia; [Sobolev, Alexander V.; Hofmann, Albrecht W.; Bruegmann, Gerhard; Kuzmin, Dmitry V.] Max Planck Inst Chem, D-55020 Mainz, Germany; [Bruegmann, Gerhard] Johannes Gutenberg Univ Mainz, Inst Geowissensch, D-55099 Mainz, Germany; [Kuzmin, Dmitry V.] Russian Acad Sci, VS Sobolev Inst Geol & Mineral, Siberian Branch, Novosibirsk 630090, Russia	Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Max Planck Society; Johannes Gutenberg University of Mainz; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences	Sobolev, AV (corresponding author), Russian Acad Sci, VI Vernadskii Inst Geochem & Analyt Chem, Kosygin St 19, Moscow 119991, Russia.	sobolev@geokhi.ru	Kuzmin, Dmitry/A-3809-2014; Sobolev, Alexander/AAB-4269-2021; Sobolev, Alexander/E-6367-2010; Sobolev, Alexander/AAQ-6001-2021	Sobolev, Alexander/0000-0002-1997-2032; 				ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; Brandon AD, 2007, GEOCHIM COSMOCHIM AC, V71, P4570, DOI 10.1016/j.gca.2007.07.015; HEMOND C, 1993, J GEOPHYS RES-SOL EA, V98, P15833, DOI 10.1029/93JB01093; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Kokfelt TF, 2006, J PETROL, V47, P1705, DOI 10.1093/petrology/egl025; Lassiter JC, 1998, EARTH PLANET SC LETT, V164, P483, DOI 10.1016/S0012-821X(98)00240-4; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Skovgaard AC, 2001, EARTH PLANET SC LETT, V194, P259, DOI 10.1016/S0012-821X(01)00549-0; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411	10	54	58	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					536	536		10.1126/science.1158452	http://dx.doi.org/10.1126/science.1158452			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653885				2022-12-28	WOS:000257888900039
J	Weiss, U				Weiss, Ursula			Inflammation	NATURE			English	Editorial Material																			0	102	106	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					427	427		10.1038/454427a	http://dx.doi.org/10.1038/454427a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650912	Bronze			2022-12-28	WOS:000257860300036
J	Tabin, CJ; McMahon, AP				Tabin, Clifford J.; McMahon, Andrew P.			Grasping limb patterning	SCIENCE			English	Editorial Material							SONIC-HEDGEHOG; EMBRYONIC LETHALITY; FEEDBACK LOOP; MAMMARY-GLAND; CYCLIN D1; GROWTH; DEFECTS		[Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [McMahon, Andrew P.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@receptor.med.harvard.edu			NINDS NIH HHS [R37 NS033642] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Roy S, 2002, J CELL SCI, V115, P4393, DOI 10.1242/jcs.00158; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; TABIN CJ, 1992, DEVELOPMENT, V116, P289; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	19	27	28	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					350	352		10.1126/science.1162474	http://dx.doi.org/10.1126/science.1162474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635784				2022-12-28	WOS:000257713900029
J	Coovadia, HM; Schaller, JG				Coovadia, H. M.; Schaller, Jane G.			HIV/AIDS in children: a disaster in the making	LANCET			English	Editorial Material							HIV TRANSMISSION; SURVIVAL; COUNTRIES		[Schaller, Jane G.] British Columbia Childrens Hosp, Dept Pediat, Int Pediat Assoc, Vancouver, BC V6H 3V4, Canada; [Coovadia, H. M.] Nelson Mandela Sch Med, ZA-4013 Congella, South Africa	BC Childrens Hospital; University of British Columbia; University of Kwazulu Natal	Schaller, JG (corresponding author), British Columbia Childrens Hosp, Dept Pediat, Int Pediat Assoc, Vancouver, BC V6H 3V4, Canada.	jschaller@cw.bc.ca						Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Coovadia H, 2008, CURR OPIN INFECT DIS, V21, P11, DOI 10.1097/QCO.0b013e3282f40689; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; *UNAIDS WHO, 2007, AIDS EP UPD; UNICEF, 2007, STAT WORLDS CHILDR 2; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Wilfert CM, 2007, J INFECT DIS, V195, P165, DOI 10.1086/510255	12	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					271	273		10.1016/S0140-6736(08)61090-9	http://dx.doi.org/10.1016/S0140-6736(08)61090-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657693				2022-12-28	WOS:000258042800009
J	Kuper, A; Reeves, S; Levinson, W				Kuper, Ayelet; Reeves, Scott; Levinson, Wendy			Qualitative research - An introduction to reading and appraising qualitative research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE	This article explores the difference between qualitative and quantitative research and the need for doctors to be able to interpret and appraise qualitative research	[Kuper, Ayelet; Levinson, Wendy] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Reeves, Scott] Univ Toronto, Dept Psychiat, Li Ka Shing Knowledge Inst, Ctr Fac Dev, Toronto, ON M5G 2C4, Canada; [Reeves, Scott] Univ Toronto, Wilson Ctr Res Educ, Toronto, ON M5G 2C4, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto	Kuper, A (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	ayelet94@post.harvard.edu						Benson J, 2002, BRIT MED J, V325, P873, DOI 10.1136/bmj.325.7369.873; Britten N, 2005, MED EDUC, V39, P5, DOI 10.1111/j.1365-2929.2004.02024.x; Crotty M., 1998, FDN SOCIAL RES MEANI, P5; Farber Stuart J, 2003, J Palliat Med, V6, P19, DOI 10.1089/10966210360510082; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740; Guyatt GH, 2001, USERS GUIDES MED LIT; Jack SM, 2006, PUBLIC HEALTH NURS, V23, P277, DOI 10.1111/j.1525-1446.2006.230311.x; Lawton J, 2005, BMJ-BRIT MED J, V330, P1247, DOI 10.1136/bmj.38460.642789.E0; Leys M, 2003, HEALTH POLICY, V65, P217, DOI 10.1016/S0168-8510(02)00209-9; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Morse JM, 2006, QUAL HEALTH RES, V16, P315, DOI 10.1177/1049732305285495; Noble SIR, 2006, BMJ-BRIT MED J, V332, P577, DOI 10.1136/bmj.38733.616065.802; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Reeves S, 2006, MED EDUC, V40, P291, DOI 10.1111/j.1365-2929.2006.02468.x; Sale JEM, 2005, ARTHRIT RHEUM-ARTHR, V53, P314, DOI 10.1002/art.21088; Straus SE, 2005, EVIDENCE BASED MED P	17	145	147	3	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2008	337	7666							a288	10.1136/bmj.a288	http://dx.doi.org/10.1136/bmj.a288			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	340TZ	18687727				2022-12-28	WOS:000258669200029
J	Hegarty, K; Taft, A; Feder, G				Hegarty, Kelsey; Taft, Angela; Feder, Gene			Violence between intimate partners: working with the whole family	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOMESTIC VIOLENCE; WOMEN; PREVALENCE		[Hegarty, Kelsey] Univ Melbourne, Dept Gen Practice, Primary Care Res Unit, Carlton, Vic 3053, Australia; [Taft, Angela] La Trobe Univ, Melbourne, Vic 3000, Australia; [Feder, Gene] Univ Bristol, Unit Acad Primary Hlth Care, Bristol, Avon, England	University of Melbourne; La Trobe University; University of Bristol	Hegarty, K (corresponding author), 200 Berkeley St, Carlton, Vic 3053, Australia.	k.hegarty@unimelb.edu.au		Feder, Gene/0000-0002-7890-3926				Bradley F, 2002, BRIT MED J, V324, P271, DOI 10.1136/bmj.324.7332.271; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; FEDER G, 2008, BEST PRACTICES BEHAV; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Ferris L E, 1999, Fam Med, V31, P415; Gerbert B, 1996, WOMEN HEALTH, V24, P1; Gerbert B, 2000, J FAM PRACTICE, V49, P889; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Gondolf EW, 2000, INT J OFFENDER THER, V44, P111, DOI 10.1177/0306624X00441010; Hegarty KL, 2002, AUST NZ J PUBL HEAL, V26, P437, DOI 10.1111/j.1467-842X.2002.tb00344.x; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; McFarlane JM, 2006, NURS RES, V55, P52, DOI 10.1097/00006199-200601000-00007; Merritt MHB, 2006, PEDIATRICS, V117, pE278, DOI 10.1154/peds.2005-1473; Nelson HD, 2004, ANN INTERN MED, V140, P387, DOI 10.7326/0003-4819-140-5-200403020-00015; Oriel KA, 1998, J FAM PRACTICE, V46, P493; Pinheiro P.S., 2006, WORLD REPORT VIOLENC; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; Ramsay J, 2005, INTERVENTIONS REDUCE; Richardson J, 2002, BRIT MED J, V324, P274, DOI 10.1136/bmj.324.7332.274; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Taft A, 2006, MANAGEMENT WHOLE FAM; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; TJADEN P, 2000, EXTENT NATURE CONSEQ, P1; VicHealth, 2005, HLTH COSTS VIOL MEAS; Walby S., 2004, COST DOMESTIC VIOLEN; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; WHO (World Health Organization), 2005, MULTICOUNTRY STUDY W; World Health Organization, 2002, WORLD REPORT VIOLENC; Zink T, 2004, ANN FAM MED, V2, P231, DOI 10.1370/afm.74	31	20	20	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a839	10.1136/bmj.a839	http://dx.doi.org/10.1136/bmj.a839			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EO	18678595				2022-12-28	WOS:000258561100035
J	Jaeschke, R; Guyatt, GH; Dellinger, P; Schunemann, H; Levy, MM; Kunz, R; Norris, S; Bion, J				Jaeschke, Roman; Guyatt, Gordon H.; Dellinger, Phil; Schunemann, Holger; Levy, Mitchell M.; Kunz, Regina; Norris, Susan; Bion, Julian			Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVING SEPSIS; QUALITY; STRENGTH; RECOMMENDATIONS; CAMPAIGN		[Bion, Julian] Univ Birmingham, Queen Elizabeth Hosp, GRADE Working Grp, Birmingham B15 2TH, W Midlands, England; [Jaeschke, Roman; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON L8P 3B6, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8P 3B6, Canada; [Dellinger, Phil] Cooper Univ Hosp, Div Crit Care, Camden, NJ USA; [Dellinger, Phil] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Camden, NJ 08103 USA; [Schunemann, Holger] Italian Natl Canc Inst Rome, Dept Epidemiol, I-00144 Rome, Italy; [Levy, Mitchell M.] Brown Univ, Sch Med, Div Pulm & Crit Care Med, Providence, RI 02912 USA; [Kunz, Regina] Univ Basel Hosp, Basle Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [Norris, Susan] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA	University of Birmingham; McMaster University; McMaster University; Cooper University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Brown University; University of Basel; Oregon Health & Science University	Bion, J (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, GRADE Working Grp, Birmingham B15 2TH, W Midlands, England.	J.F.Bion@bham.ac.uk	Whittington, Craig/B-1380-2008; Fervers, Béatrice/AAD-1847-2022; Djulbegovic, Benjamin/I-3661-2012	Whittington, Craig/0000-0002-1950-0334; Fervers, Béatrice/0000-0003-3498-6499; Djulbegovic, Benjamin/0000-0003-0671-1447; Bion, Julian/0000-0003-0344-5403; Flottorp, Signe/0000-0003-2961-7461; Schunemann, Holger/0000-0003-3211-8479				Barrett H, 2006, INTENS CARE MED, V32, P1371, DOI 10.1007/s00134-006-0215-5; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; Fretheim Atle, 2006, Health Res Policy Syst, V4, P15, DOI 10.1186/1478-4505-4-15; Fretheim Atle, 2006, Health Res Policy Syst, V4, P17, DOI 10.1186/1478-4505-4-17; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; MURPHY MK, 1998, HEALTH TECHNOL ASSES, P2; Raine R, 2005, BMJ-BRIT MED J, V331, P631, DOI 10.1136/bmj.331.7517.631; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Thangaratinam S, 2005, OBSTET GYNAECOL, V7, P120, DOI 10.1576/toag.7.2.120.27071; Vella K, 2000, BRIT MED J, V320, P976, DOI 10.1136/bmj.320.7240.976	15	364	396	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a744	10.1136/bmj.a744	http://dx.doi.org/10.1136/bmj.a744			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EO	18669566				2022-12-28	WOS:000258561100030
J	King-Casas, B; Sharp, C; Lomax-Bream, L; Lohrenz, T; Fonagy, P; Montague, PR				King-Casas, Brooks; Sharp, Carla; Lomax-Bream, Laura; Lohrenz, Terry; Fonagy, Peter; Montague, P. Read			The rupture and repair of cooperation in borderline personality disorder	SCIENCE			English	Article							TIT-FOR-TAT; DECISION-MAKING; PRISONERS-DILEMMA; NEURAL BASIS; SOCIAL COOPERATION; INSULA ACTIVATION; EVOLUTION; RISK; TRUST; MECHANISMS	To sustain or repair cooperation during a social exchange, adaptive creatures must understand social gestures and the consequences when shared expectations about fair exchange are violated by accident or intent. We recruited 55 individuals afflicted with borderline personality disorder (BPD) to play a multiround economic exchange game with healthy partners. Behaviorally, individuals with BPD showed a profound incapacity to maintain cooperation, and were impaired in their ability to repair broken cooperation on the basis of a quantitative measure of coaxing. Neurally, activity in the anterior insula, a region known to respond to norm violations across affective, interoceptive, economic, and social dimensions, strongly differentiated healthy participants from individuals with BPD. Healthy subjects showed a strong linear relation between anterior insula response and both magnitude of monetary offer received from their partner (input) and the amount of money repaid to their partner (output). In stark contrast, activity in the anterior insula of BPD participants was related only to the magnitude of repayment sent back to their partner (output), not to the magnitude of offers received (input). These neural and behavioral data suggest that norms used in perception of social gestures are pathologically perturbed or missing altogether among individuals with BPD. This game-theoretic approach to psychopathology may open doors to new ways of characterizing and studying a range of mental illnesses.	[King-Casas, Brooks; Lohrenz, Terry; Montague, P. Read] Baylor Coll Med, Computat Psychiat Unit, Houston, TX 77030 USA; [King-Casas, Brooks; Lohrenz, Terry; Montague, P. Read] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [King-Casas, Brooks; Sharp, Carla; Lomax-Bream, Laura; Fonagy, Peter; Montague, P. Read] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Fonagy, Peter] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Fonagy, Peter] Anna Freud Ctr, London NW3 5SD, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of London; University College London; The Anna Freud Centre	Montague, PR (corresponding author), Baylor Coll Med, Computat Psychiat Unit, 1 Baylor Plaza, Houston, TX 77030 USA.	rmontague@hnl.bcm.edu		Fonagy, Peter/0000-0003-0229-0091; Sharp, Carla/0000-0001-8349-4701	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH078485, R01MH052797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA011723, DA11723] Funding Source: Medline; NIMH NIH HHS [MH078485, MH52797, F32 MH078485, R01 MH052797] Funding Source: Medline; NINDS NIH HHS [R01 NS045790, NS045790] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BENDOR J, 1991, J CONFLICT RESOLUT, V35, P691, DOI 10.1177/0022002791035004007; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chiu PH, 2008, NEURON, V57, P463, DOI 10.1016/j.neuron.2007.12.020; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dougherty DM, 1999, PSYCHIAT RES, V85, P315, DOI 10.1016/S0165-1781(99)00011-6; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fonagy P, 2006, J CLIN PSYCHOL, V62, P411, DOI 10.1002/jclp.20241; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; FUDENBERG D, 1990, AM ECON REV, V80, P274; Gintis H., 2000, GAME THEORY EVOLVING; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Putnam KM, 2005, DEV PSYCHOPATHOL, V17, P899, DOI 10.1017/S0954579405050431; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rogers J, 2006, PSYCHOL MED, V36, P1789, DOI 10.1017/S0033291706008853; ROTTER JB, 1967, J PERS, V35, P651, DOI 10.1111/j.1467-6494.1967.tb01454.x; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Sieswerda S, 2005, J BEHAV THER EXP PSY, V36, P209, DOI 10.1016/j.jbtep.2005.05.004; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Todorov A, 2006, BRAIN RES, V1079, P76, DOI 10.1016/j.brainres.2005.12.114; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; WU JZ, 1995, J CONFLICT RESOLUT, V39, P183, DOI 10.1177/0022002795039001008	54	400	408	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					806	810		10.1126/science.1156902	http://dx.doi.org/10.1126/science.1156902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	334ZQ	18687957	Green Accepted, Green Submitted			2022-12-28	WOS:000258261000037
J	Lin, K; Lipsitz, R; Miller, T; Janakiraman, S				Lin, Kenneth; Lipsitz, Robert; Miller, Therese; Janakiraman, Supriya			Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the US preventive services task force	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DIGITAL RECTAL EXAMINATION; ACTIVE SURVEILLANCE; UNITED-STATES; FOLLOW-UP; MORTALITY; MANAGEMENT; OUTCOMES; HISTORY; BIOPSY	Background: Prostate cancer is the most common nonskin cancer in men in the United States, and prostate cancer screening has increased in recent years. In 2002, the U. S. Preventive Services Task Force concluded that evidence was insufficient to recommend for or against screening for prostate cancer with prostate-specific antigen (PSA) testing. Purpose: To examine new evidence on benefits and harms of screening asymptomatic men for prostate cancer with PSA. Data Sources: English-language articles identified in PubMed and the Cochrane Library (search dates, January 2002 to July 2007), reference lists of retrieved articles, and expert suggestions. Study Selection: Randomized, controlled trials and meta-analyses of PSA screening and cross-sectional and cohort studies of screening harms and of the natural history of screening-detected cancer were selected to answer the following questions: Does screening for prostate cancer with PSA, as a single-threshold test or as a function of multiple tests over time, decrease morbidity or mortality? What are the magnitude and nature of harms associated with prostate cancer screening, other than overtreatment? What is the natural history of PSA-detected, nonpalpable, localized prostate cancer? Data Extraction: Studies were reviewed, abstracted, and rated for quality by using predefined U. S. Preventive Services Task Force criteria. Data Synthesis: No good-quality randomized, controlled trials of screening for prostate cancer have been completed. In 1 cross-sectional and 2 prospective cohort studies of fair to good quality, false-positive PSA screening results caused psychological adverse effects for up to 1 year after the test. The natural history of PSA-detected prostate cancer is poorly understood. Limitations: Few eligible studies were identified. Long-term adverse effects of false-positive PSA screening test results are unknown. Conclusion: Prostate-specific antigen screening is associated with psychological harms, and its potential benefits remain uncertain.	[Lin, Kenneth; Lipsitz, Robert; Miller, Therese; Janakiraman, Supriya] Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, Rockville, MD 20850 USA	Agency for Healthcare Research & Quality	Lin, K (corresponding author), Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, 540 Gaither Rd, Rockville, MD 20850 USA.	kenneth.lin@ahrq.hhs.gov						Agalliu I, 2007, CANCER CAUSE CONTROL, V18, P931, DOI 10.1007/s10552-007-9031-7; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Aus G, 2005, ARCH INTERN MED, V165, P1857, DOI 10.1001/archinte.165.16.1857; Aus G, 2007, EUR UROL, V51, P659, DOI 10.1016/j.eururo.2006.07.012; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Brindle LA, 2006, BJU INT, V98, P777, DOI 10.1111/j.1464-410X.2006.06401.x; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; CATALONA WJ, 1994, J UROLOGY, V152, P2031, DOI 10.1016/S0022-5347(17)32299-1; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; Concato J, 2006, ARCH INTERN MED, V166, P38, DOI 10.1001/archinte.166.1.38; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; Fang J, 2002, UROLOGY, V59, P889, DOI 10.1016/S0090-4295(02)01646-1; Farwell WR, 2007, ARCH INTERN MED, V167, P2497, DOI 10.1001/archinte.167.22.2497; Fowler FJ, 2006, J GEN INTERN MED, V21, P715, DOI 10.1111/j.1525-1497.2006.00464.x; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Ilic D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub2; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Katz DA, 2007, UROLOGY, V69, P215, DOI 10.1016/j.urology.2006.09.059; Kopec JA, 2005, J UROLOGY, V174, P495, DOI 10.1097/01.ju.0000165153.83698.42; Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017; Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B; Marcella SW, 2008, J GEN INTERN MED, V23, P248, DOI 10.1007/s11606-007-0479-7; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; National Cancer Institute Surveillance Epidemiology and End Results Program, 2006, CANC STAT FACT SHEET; Roemeling S, 2007, EUR UROL, V51, P1244, DOI 10.1016/j.eururo.2006.11.053; Roemeling S, 2006, EUR UROL, V50, P475, DOI 10.1016/j.eururo.2006.04.019; Sandblom G, 2004, EUR UROL, V46, P717, DOI 10.1016/j.eururo.2004.08.011; Schroder FH, 1999, EUR UROL, V35, P539, DOI 10.1159/000019894; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Weinmann S, 2005, EPIDEMIOLOGY, V16, P367, DOI 10.1097/01.ede.0000158395.05136.02; Weinmann S, 2004, CANCER CAUSE CONTROL, V15, P133, DOI 10.1023/B:CACO.0000019473.83472.18; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209	37	194	200	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					192	199		10.7326/0003-4819-149-3-200808050-00009	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18678846				2022-12-28	WOS:000258342900006
J	Matsuzawa, A; Tseng, PH; Vallabhapurapu, S; Luo, JL; Zhang, WZ; Wang, HP; Vignali, DAA; Gallagher, E; Karin, M				Matsuzawa, Atsushi; Tseng, Ping-Hui; Vallabhapurapu, Sivakumar; Luo, Jun-Li; Zhang, Weizhou; Wang, Haopeng; Vignali, Dario A. A.; Gallagher, Ewen; Karin, Michael			Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; IKK ACTIVATION; APOPTOSIS; KINASE; TRAF2; UBIQUITINATION; TRANSDUCTION; DOMAIN; DEGRADATION; SPECIFICITY	Cytokine signaling is thought to require assembly of multicomponent signaling complexes at cytoplasmic segments of membrane- embedded receptors, in which receptor- proximal protein kinases are activated. Indeed, CD40, a tumor necrosis factor receptor ( TNFR) family member, forms a complex containing adaptor molecules TRAF2 and TRAF3, ubiquitin- conjugating enzyme Ubc13, cellular inhibitor of apoptosis proteins 1 and 2 ( c-IAP1/2), I kappa B kinase regulatory subunit IKK gamma ( also called NEMO), and mitogen- activated protein kinase ( MAPK) kinase kinase MEKK1 upon ligation. TRAF2, Ubc13, and IKK gamma were required for complex assembly and activation of MEKK1 and MAPK cascades. However, these kinases were not activated unless the multicomponent signaling complex translocated from CD40 to the cytosol upon c-IAP1/2-induced degradation of TRAF3. This two- stage signaling mechanism may apply to other innate immune receptors, accounting for spatial and temporal separation of MAPK and IKK signaling.	[Matsuzawa, Atsushi; Tseng, Ping-Hui; Vallabhapurapu, Sivakumar; Luo, Jun-Li; Zhang, Weizhou; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Matsuzawa, Atsushi; Tseng, Ping-Hui; Vallabhapurapu, Sivakumar; Luo, Jun-Li; Zhang, Weizhou; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA; [Wang, Haopeng; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gallagher, Ewen] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Fac Med, London W2 1PG, England	University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital; Imperial College London	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Wang, Haopeng/F-3263-2012; Matsuzawa, Atsushi/GLU-1387-2022	Wang, Haopeng/0000-0002-4995-0838; Luo, Jun-Li/0000-0002-7625-4766; Matsuzawa, Atsushi/0000-0001-8303-3905	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI052199, R56AI052199, R21AI052199] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NIAID NIH HHS [R01 AI043477, AI043477, R01 AI043477-12, AI52199] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang HK, 2000, J BIOL CHEM, V275, P26661; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia Z. P., 2005, SCI STKE, V2005, ppe7; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2	30	181	191	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					663	668		10.1126/science.1157340	http://dx.doi.org/10.1126/science.1157340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18635759	Green Accepted			2022-12-28	WOS:000258077700036
J	Vonk, FJ; Admiraal, JF; Jackson, K; Reshef, R; de Bakker, MAG; Vanderschoot, K; van den Berge, I; van Atten, M; Burgerhout, E; Beck, A; Mirtschin, PJ; Kochva, E; Witte, F; Fry, BG; Woods, AE; Richardson, MK				Vonk, Freek J.; Admiraal, Jeroen F.; Jackson, Kate; Reshef, Ram; de Bakker, Merijn A. G.; Vanderschoot, Kim; van den Berge, Iris; van Atten, Marit; Burgerhout, Erik; Beck, Andrew; Mirtschin, Peter J.; Kochva, Elazar; Witte, Frans; Fry, Bryan G.; Woods, Anthony E.; Richardson, Michael K.			Evolutionary origin and development of snake fangs	NATURE			English	Article							EMBRYONIC-DEVELOPMENT; PYTHON-SEBAE; VENOM; APPARATUS; DENTITION; GLAND	Many advanced snakes use fangs - specialized teeth associated with a venom gland(1,2) - to introduce venom into prey or attacker. Various front- and rear- fanged groups are recognized, according to whether their fangs are positioned anterior ( for example cobras and vipers) or posterior ( for example grass snakes) in the upper jaw(3-5). A fundamental controversy in snake evolution is whether or not front and rear fangs share the same evolutionary and developmental origin(3-9). Resolving this controversy could identify a major evolutionary transition underlying the massive radiation of advanced snakes, and the associated developmental events. Here we examine this issue by visualizing the tooth- forming epithelium in the upper jaw of 96 snake embryos, covering eight species. We use the sonic hedgehog gene as a marker(10-13), and three- dimensionally reconstruct the development in 41 of the embryos. We show that front fangs develop from the posterior end of the upper jaw, and are strikingly similar in morphogenesis to rear fangs. This is consistent with their being homologous. In front- fanged snakes, the anterior part of the upper jaw lacks sonic hedgehog expression, and ontogenetic allometry displaces the fang from its posterior developmental origin to its adult front position - consistent with an ancestral posterior position of the front fang. In rear- fanged snakes, the fangs develop from an independent posterior dental lamina and retain their posterior position. In light of our findings, we put forward a new model for the evolution of snake fangs: a posterior subregion of the tooth- forming epithelium became developmentally uncoupled from the remaining dentition, which allowed the posterior teeth to evolve independently and in close association with the venom gland, becoming highly modified in different lineages. This developmental event could have facilitated the massive radiation of advanced snakes in the Cenozoic era, resulting in the spectacular diversity of snakes seen today(6,14,15).	[Vonk, Freek J.; Admiraal, Jeroen F.; de Bakker, Merijn A. G.; Vanderschoot, Kim; van den Berge, Iris; van Atten, Marit; Burgerhout, Erik; Witte, Frans; Richardson, Michael K.] Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; [Jackson, Kate] Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA; [Reshef, Ram] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Beck, Andrew; Mirtschin, Peter J.; Woods, Anthony E.] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Mirtschin, Peter J.] Venom Supplies Pty Ltd, Tanunda, SA 5352, Australia; [Kochva, Elazar] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Fry, Bryan G.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Parkville, Vic 3010, Australia	Leiden University; Leiden University - Excl LUMC; Whitman College; Technion Israel Institute of Technology; University of South Australia; Tel Aviv University; University of Melbourne	Richardson, MK (corresponding author), Leiden Univ, Inst Biol, Kaiserstr 63,POB 9516, NL-2300 RA Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Richardson, Michael K/E-8269-2011; Burgerhout, Erik/AAI-4527-2020; Woods, Anthony/D-2644-2009	Richardson, Michael K/0000-0003-1222-8101; de Bakker, Merijn/0000-0002-2061-7986				ANTHONY J., 1955, ANN SCI NAT ZOOL, V17, P7; Bogert Charles Mitchill, 1943, BULL AMER MUS NAT HIST, V81, P285; Boulenger G. A., 1896, Proceedings of the Zoological Society of London, P614; Buchtova M, 2007, ZOOLOGY, V110, P231, DOI 10.1016/j.zool.2007.01.006; Cobourne MT, 2005, CURR TOP DEV BIOL, V65, P255; COPE ED, 1900, US NATL MUS REP, P153; Fraser GJ, 2006, EVOL DEV, V8, P446, DOI 10.1111/j.1525-142X.2006.00118.x; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; FRAZZETTA TH, 1966, J MORPHOL, V118, P217, DOI 10.1002/jmor.1051180206; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Gygax P, 1971, Acta Trop, V28, P226; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Jackson K, 2007, TOXICON, V49, P975, DOI 10.1016/j.toxicon.2007.01.007; Jackson Kate, 1995, Amphibia-Reptilia, V16, P273, DOI 10.1163/156853895X00073; Kardong K.V., 1983, Memorias do Instituto Butantan (Sao Paulo), V46, P105; KARDONG KV, 1980, AM ZOOL, V20, P269; KARDONG KV, 1979, EVOLUTION, V33, P433, DOI 10.1111/j.1558-5646.1979.tb04696.x; Kochva E., 1978, P43; KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4; KOCHVA E, 1963, ACTA ANAT, V52, P49; Kuch U, 2006, NATURWISSENSCHAFTEN, V93, P84, DOI 10.1007/s00114-005-0065-y; MARTIN H, 1899, CR ASSOC ANAT, V1, P56; OVADIA M, 1984, COPEIA, P516; RESHEF R, 1994, J EXP ZOOL, V270, P538, DOI 10.1002/jez.1402700607; RESHEF R, 1994, THESIS U TEL AVIV; SHAYER-WOLLBERG M, 1967, Herpetologica, V23, P249; Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Yamanaka A, 2007, EUR J ORAL SCI, V115, P433, DOI 10.1111/j.1600-0722.2007.00499.x; Young Bruce A., 1996, Amphibia-Reptilia, V17, P261, DOI 10.1163/156853896X00432	30	121	122	3	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					630	633		10.1038/nature07178	http://dx.doi.org/10.1038/nature07178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668106				2022-12-28	WOS:000258026500045
J	Iheanacho, I				Iheanacho, Ike			Not a silly story	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com						2008, BRIT MED J, V337, pA618	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a919	10.1136/bmj.a919	http://dx.doi.org/10.1136/bmj.a919			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335EG	18650231				2022-12-28	WOS:000258273000048
J	Budovskaya, YV; Wu, K; Southworth, LK; Min, J; Tedesco, P; Johnson, TE; Kim, SK				Budovskaya, Yelena V.; Wu, Kendall; Southworth, Lucinda K.; Jiang, Min; Tedesco, Patricia; Johnson, Thomas E.; Kim, Stuart K.			An elt-3/elt-5/elt-6 GATA transcription circuit guides aging in C-elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; OXIDATIVE STRESS; GENE-EXPRESSION; CALORIC RESTRICTION; MUTATIONS; LONGEVITY; LONG; DAF-16; DNA	To define the C. elegans aging process at the molecular level, we used DNA microarray experiments to identify a set of 1294 age-regulated genes and found that the GATA transcription factors ELT-3, ELT-5, and ELT-6 are responsible for age regulation of a large fraction of these genes. Expression of elt-5 and elt-6 increases during normal aging, and both of these GATA factors repress expression of elt-3, which shows a corresponding decrease in expression in old worms. elt-3 regulates a large number of downstream genes that change expression in old age, including ugt- 9, col-144, and sod-3. elt-5( RNAi) and elt-6( RNAi) worms have extended longevity, indicating that elt-3, elt-5, and elt-6 play an important functional role in the aging process. These results identify a transcriptional circuit that guides the rapid aging process in C. elegans and indicate that this circuit is driven by drift of developmental pathways rather than accumulation of damage.	[Budovskaya, Yelena V.; Wu, Kendall; Jiang, Min; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Southworth, Lucinda K.; Kim, Stuart K.] Stanford Univ, Med Ctr, Stanford Med Informat, Stanford, CA 94305 USA; [Wu, Kendall] Affymetrix Inc, Santa Clara, CA 95051 USA; [Tedesco, Patricia; Johnson, Thomas E.] Univ Colorado, Inst Behav Genet, Dept Integrat Physiol, Boulder, CO 80309 USA	Stanford University; Stanford University; Affymetrix; University of Colorado System; University of Colorado Boulder	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu	Budovskaya, Yelena/D-2254-2011	Budovskaya, Yelena/0000-0002-1047-693X; /0000-0001-7147-8237	NATIONAL INSTITUTE ON AGING [R01AG025941, R01AG016219] Funding Source: NIH RePORTER; NIA NIH HHS [R01AG025941, R01AG16219, R01 AG016219, R01 AG025941] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2004, IMAGEJ COMPUTER PROG; Anson RM, 2004, AGING CELL, V3, P29, DOI 10.1111/j.1474-9728.2003.00077.x; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Ayub K, 2004, AGING CELL, V3, P145, DOI 10.1111/j.1474-9728.2004.00100.x; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Fisher AL, 2006, AGING CELL, V5, P127, DOI 10.1111/j.1474-9726.2006.00203.x; FRIEDMAN DB, 1988, GENETICS, V118, P75; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gilleard JS, 2001, MOL CELL BIOL, V21, P2533, DOI 10.1128/MCB.21.7.2533-2544.2001; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; Ishii N, 2002, FREE RADICAL BIO MED, V33, P1021, DOI 10.1016/S0891-5849(02)00857-2; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0; Koh K, 2001, DEVELOPMENT, V128, P2867; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LAWLESS JF, 1982, MODELS METHODS LIFET; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; LIU Y, 2005, GENOME WIDE DISCOVER; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Martin I, 2006, MECH AGEING DEV, V127, P411, DOI 10.1016/j.mad.2006.01.008; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Melov S, 2000, ANN NY ACAD SCI, V908, P219; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Praitis V, 2001, GENETICS, V157, P1217; Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rodriguez-Aguilera JC, 2005, AGEING RES REV, V4, P41, DOI 10.1016/j.arr.2004.09.001; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 1998, GENETICS, V148, P703; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WONG A, 1995, GENETICS, V139, P1247	68	188	217	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					291	303		10.1016/j.cell.2008.05.044	http://dx.doi.org/10.1016/j.cell.2008.05.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662544	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000257891700018
J	Massague, J				Massague, Joan			TGF beta in cancer	CELL			English	Review							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN; CELL SELF-RENEWAL; T-CELLS; TUMOR-SUPPRESSOR; PROSTATE-CANCER; HUMAN BREAST; TRANSFORMING GROWTH-FACTOR-BETA-1; CONDITIONAL KNOCKOUT; TRANSCRIPTION FACTOR	The transforming growth factor beta (TGF beta) signaling pathway is a key player in metazoan biology, and its misregulation can result in tumor development. The regulatory cytokine TGF beta exerts tumor-suppressive effects that cancer cells must elude for malignant evolution. Yet, paradoxically, TGF beta also modulates processes such as cell invasion, immune regulation, and microenvironment modification that cancer cells may exploit to their advantage. Consequently, the output of a TGF beta response is highly contextual throughout development, across different tissues, and also in cancer. The mechanistic basis and clinical relevance of TGF beta's role in cancer is becoming increasingly clear, paving the way for a better understanding of the complexity and therapeutic potential of this pathway.	[Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	massaguj@mskcc.org		Massague, Joan/0000-0001-9324-8408	NATIONAL CANCER INSTITUTE [P30CA008748, R37CA034610] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA008748, R37 CA034610] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Becker C, 2006, CYTOKINE GROWTH F R, V17, P97, DOI 10.1016/j.cytogfr.2005.09.004; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biswas S, 2004, CANCER RES, V64, P4687, DOI 10.1158/0008-5472.CAN-03-3255; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Bleuming SA, 2007, CANCER RES, V67, P8149, DOI 10.1158/0008-5472.CAN-06-4659; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Cerutti JM, 2003, J ENDOCRINOL INVEST, V26, P516, DOI 10.1007/BF03345213; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; DALAL BI, 1993, AM J PATHOL, V143, P381; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Dowdy SC, 2005, GYNECOL ONCOL, V96, P368, DOI 10.1016/j.ygyno.2004.10.006; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Engle SJ, 2002, CANCER RES, V62, P6362; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Friese MA, 2004, CANCER RES, V64, P7596, DOI 10.1158/0008-5472.CAN-04-1627; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; JEN J, 1994, CANCER RES, V54, P6353; Jennings MT, 1998, J NEURO-ONCOL, V36, P123, DOI 10.1023/A:1005863419880; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaklamani V, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-28; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kominsky SL, 2007, J BONE MINER RES, V22, P37, DOI 10.1359/JBMR.061005; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Letterio JJ, 2005, ONCOGENE, V24, P5701, DOI 10.1038/sj.onc.1208922; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rodgarkia-Dara C, 2006, MUTAT RES-REV MUTAT, V613, P123, DOI 10.1016/j.mrrev.2006.07.002; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Sweet K, 2005, JAMA-J AM MED ASSOC, V294, P2465, DOI 10.1001/jama.294.19.2465; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Taylor IW, 2008, CELL, V133, DOI 10.1016/j.cell.2008.04.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wolfraim LA, 2004, J IMMUNOL, V173, P3093, DOI 10.4049/jimmunol.173.5.3093; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Xie W, 2002, CANCER RES, V62, P497; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yan GH, 2004, CHINESE CHEM LETT, V15, P101; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zhang FH, 2005, CLIN CANCER RES, V11, P4512, DOI 10.1158/1078-0432.CCR-04-2571; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	119	2893	2988	10	380	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					215	230		10.1016/j.cell.2008.07.001	http://dx.doi.org/10.1016/j.cell.2008.07.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662538	Green Accepted, Bronze			2022-12-28	WOS:000257891700012
J	Roberts, L; Jasny, B				Roberts, Leslie; Jasny, Barbara			HIV/AIDS: Money matters	SCIENCE			English	Editorial Material																			0	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					511	511		10.1126/science.321.5888.511	http://dx.doi.org/10.1126/science.321.5888.511			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	329RS	18653875				2022-12-28	WOS:000257888900032
J	Limaye, AP; Kirby, KA; Rubenfeld, GD; Leisenring, WM; Bulger, EM; Neff, MJ; Gibran, NS; Huang, ML; Hayes, TKS; Corey, L; Boeckh, M				Limaye, Ajit P.; Kirby, Katharine A.; Rubenfeld, Gordon D.; Leisenring, Wendy M.; Bulger, Eileen M.; Neff, Margaret J.; Gibran, Nicole S.; Huang, Meei-Li; Hayes, Tracy K. Santo; Corey, Lawrence; Boeckh, Michael			Cytomegalovirus reactivation in critically ill immunocompetent patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	103rd International Conference of the American-Thoracic-Society	MAY 18-23, 2007	San Francisco, CA	Amer Thorac Soc			ORGAN-TRANSPLANT RECIPIENTS; PULMONARY CYTOMEGALOVIRUS; RENAL-TRANSPLANTATION; SURGICAL-PATIENTS; INFECTION; DISEASE; IMPACT; GANCICLOVIR; MORTALITY; MODELS	Context Cytomegalovirus (CMV) infection is associated with adverse clinical outcomes in immunosuppressed persons, but the incidence and association of CMV reactivation with adverse outcomes in critically ill persons lacking evidence of immunosuppression have not been well defined. Objective To determine the association of CMV reactivation with intensive care unit (ICU) and hospital length of stay in critically ill immunocompetent persons. Design, Setting, and Participants We prospectively assessed CMV plasma DNA-emia by thrice-weekly real-time polymerase chain reaction (PCR) and clinical outcomes in a cohort of 120 CMV-seropositive, immunocompetent adults admitted to 1 of 6 ICUs at 2 separate hospitals at a large US tertiary care academic medical center between 2004 and 2006. Clinical measurements were assessed by personnel blinded to CMV PCR results. Risk factors for CMV reactivation and association with hospital and ICU length of stay were assessed by multivariable logistic regression and proportional odds models. Main Outcome Measures Association of CMV reactivation with prolonged hospital length of stay or death. Results The primary composite end point of continued hospitalization (n=35) or death (n=10) by 30 days occurred in 45 (35%) of the 120 patients. Cytomegalovirus viremia at any level occurred in 33% (39/120; 95% confidence interval [CI], 24%-41%) at a median of 12 days (range, 3-57 days) and CMV viremia greater than 1000 copies/ mL occurred in 20% (24/120; 95% CI, 13%-28%) at a median of 26 days (range, 9-56 days). By logistic regression, CMV infection at any level (adjusted odds ratio [OR], 4.3; 95% CI, 1.6-11.9; P=.005) and at greater than 1000 copies/mL (adjusted OR, 13.9; 95% CI, 3.2-60; P < .001) and the average CMV area under the curve (AUC) in log(10) copies per milliliter (adjusted OR, 2.1; 95% CI, 1.3-3.2; P < .001) were independently associated with hospitalization or death by 30 days. In multivariable partial proportional odds models, both CMV 7-day moving average (OR, 5.1; 95% CI, 2.9-9.1; P < .001) and CMV AUC (OR, 3.2; 95% CI, 2.1-4.7; P < .001) were independently associated with a hospital length of stay of at least 14 days. Conclusions These preliminary findings suggest that reactivation of CMV occurs frequently in critically ill immunocompetent patients and is associated with prolonged hospitalization or death. A controlled trial of CMV prophylaxis in this setting is warranted.	[Limaye, Ajit P.; Hayes, Tracy K. Santo] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; [Limaye, Ajit P.; Rubenfeld, Gordon D.; Neff, Margaret J.; Corey, Lawrence; Boeckh, Michael] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Leisenring, Wendy M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bulger, Eileen M.; Gibran, Nicole S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Huang, Meei-Li; Corey, Lawrence; Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA; [Kirby, Katharine A.; Leisenring, Wendy M.] Fred Hutchinson Canc Res Ctr, Program Clin Stat, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Limaye, AP (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	limaye@u.washington.edu	Corey, Lawrence/AAE-1796-2020; Boeckh, Michael/AAA-1607-2022	Corey, Lawrence/0000-0002-2179-2436; Kirby, Katharine/0000-0003-0876-8113	NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA018029-279016, P01 CA018029, CA-18029] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BALE JF, 1990, INFECT CONT HOSP EP, V11, P17; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; CHASTRE J, 1995, AM J RESP CRIT CARE, V152, P231, DOI 10.1164/ajrccm.152.1.7599829; Cook CH, 1998, AM J SURG, V176, P357, DOI 10.1016/S0002-9610(98)00205-0; Cook CH, 2006, CRIT CARE MED, V34, P842, DOI 10.1097/01.CCM.0000201876.11059.05; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Cook CH, 2002, J INFECT DIS, V185, P1395, DOI 10.1086/340508; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; DOMART Y, 1990, CHEST, V97, P18, DOI 10.1378/chest.97.1.18; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Kalil AC, 2005, ANN INTERN MED, V143, P870, DOI 10.7326/0003-4819-143-12-200512200-00005; Kalil RSN, 2003, AM J TRANSPLANT, V3, P79, DOI 10.1034/j.1600-6143.2003.30114.x; Kealey G P, 1987, J Burn Care Rehabil, V8, P543, DOI 10.1097/00004630-198708060-00017; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Limaye AP, 2006, TRANSPLANTATION, V81, P1645, DOI 10.1097/01.tp.0000226071.12562.1a; Lowance D, 1999, NEW ENGL J MED, V340, P1462, DOI 10.1056/NEJM199905133401903; Manez R, 1997, J INFECT DIS, V176, P1462, DOI 10.1086/514142; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Munoz-Price LS, 2004, CLIN INFECT DIS, V39, P1293, DOI 10.1086/425002; PETERSON B, 1990, APPL STAT-J ROY ST C, V39, P205; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Small LN, 2006, CLIN INFECT DIS, V43, P869, DOI 10.1086/507337; Strippoli GFM, 2006, TRANSPLANTATION, V81, P139, DOI 10.1097/01.tp.0000183970.71366.da; Valantine HA, 1999, CIRCULATION, V100, P61, DOI 10.1161/01.CIR.100.1.61; von Muller L, 2006, EMERG INFECT DIS, V12, P1517, DOI 10.3201/eid1210.060411	35	400	413	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					413	422		10.1001/jama.300.4.413	http://dx.doi.org/10.1001/jama.300.4.413			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647984	Green Accepted, Bronze			2022-12-28	WOS:000257831200019
J	Nurnberg, HG; Hensley, PL; Heiman, JR; Croft, HA; Debattista, C; Paine, S				Nurnberg, H. George; Hensley, Paula L.; Heiman, Julia R.; Croft, Harry A.; Debattista, Charles; Paine, Susan			Sildenafil treatment of women with antidepressant-associated sexual dysfunction - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AROUSAL DISORDER; DOUBLE-BLIND; ERECTILE DYSFUNCTION; CORPUS CAVERNOSUM; ORAL SILDENAFIL; CLINICAL-TRIALS; BLOOD-FLOW; CROSS-OVER; CITRATE; DEPRESSION	Context Antidepressant-associated sexual dysfunction is a common adverse effect that frequently results in premature medication treatment discontinuation and for which no treatment has demonstrated efficacy in women. Objective To evaluate the efficacy of sildenafil for sexual dysfunction associated with selective and nonselective serotonin reuptake inhibitors (SRIs) in women. Design, Setting, and Participants An 8-week prospective, parallel-group, randomized, double-blind, placebo-controlled clinical trial conducted between September 1, 2003, and January 1, 2007, at 7 US research centers that included 98 previously sexually functioning, premenopausal women (mean [SD] age 37.1 [6] years) whose major depression was remitted by SRIs but who were also experiencing sexual dysfunction. Intervention Forty-nine patients were randomly assigned to take sildenafil or placebo at a flexible dose starting at 50 mg adjustable to 100 mg before sexual activity. Main Outcome Measures The primary outcome measure was the mean difference in change from baseline to study end (ie, lower ordinal score) on the Clinical Global Impression sexual function scale. Secondary measures included the Female Sexual Function Questionnaire, the Arizona Sexual Experience scale-female version, the University of New Mexico Sexual Function Inventory-female version, a sexual activity event log, and the Hamilton Depression Rating scale. Hormone levels were also assessed. Results In an intention-to-treat analysis, women treated with sildenafil had a mean Clinical Global Impression-sexual function score of 1.9 (95% confidence interval [CI], 1.6-2.3) compared with those taking placebo (1.1; 95% CI, 0.8-1.5), with a mean end point difference of 0.8 (95% CI, 0.6-1.0; P=.001). Assigning baseline values carried forward to the 22% of patients who prematurely discontinued resulted in a mean end point in the sexual function score of 1.5 (95% CI, 1.1-1.9) among women taking sildenafil compared with 0.9 (95% CI, 0.6-1.3) among women taking placebo with a mean end point difference of 0.6 (95% CI, 0.3-0.8; P=.03). Baseline endocrine levels were within normal limits and did not differ between groups. The mean (SD) Hamilton scores for depression remained consistent with remission in both groups (4.0 [3.6]; P=.90). Headache, flushing, and dyspepsia were reported frequently during treatment, but no patients withdrew because of serious adverse effects. Conclusion In this study population, sildenafil treatment of sexual dysfunction in women taking SRIs was associated with a reduction in adverse sexual effects. Trial Registration clinicaltrials.gov Identifier: NCT00375297.	[Nurnberg, H. George; Hensley, Paula L.; Paine, Susan] Univ New Mexico, Sch Med, Dept Psychiat, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Croft, Harry A.] Croft Grp, San Antonio, TX USA; [Heiman, Julia R.] Indiana Univ, Kinsey Inst Res Sex Gender & Reprod, Bloomington, IN USA; [Debattista, Charles] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Indiana University System; Indiana University Bloomington; Stanford University	Nurnberg, HG (corresponding author), Univ New Mexico, Sch Med, Dept Psychiat, Hlth Sci Ctr, 2400 Tucker NE,MC 09 5030, Albuquerque, NM 87131 USA.	gnurnberg@salud.unm.edu						*AG HEALTHC RES QU, 2005, TRENDS ANT US AHRQ N; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angulo J, 2003, INT J IMPOT RES, V15, P137, DOI 10.1038/sj.ijir.3900985; [Anonymous], 2007, ADV PSYHIATRIC TREAT, DOI DOI 10.1192/APT.BP.106.003194; Basson R, 2003, BJOG-INT J OBSTET GY, V110, P1014, DOI 10.1016/S1470-0328(03)02938-0; Basson R, 2002, J WOMEN HEALTH GEN-B, V11, P367, DOI 10.1089/152460902317586001; Berman JR, 2003, J UROLOGY, V170, P2333, DOI 10.1097/01.ju.0000090966.74607.34; Berman JR, 2001, J SEX MARITAL THER, V27, P411, DOI 10.1080/713846815; Caruso S, 2001, BRIT J OBSTET GYNAEC, V108, P623; Caruso S, 2003, EUR J OBSTET GYN R B, V110, P201, DOI 10.1016/S0301-2115(03)00118-0; Davis SR, 2005, JAMA-J AM MED ASSOC, V294, P91, DOI 10.1001/jama.294.1.91; Ekselius L, 2001, J CLIN PSYCHOPHARM, V21, P154, DOI 10.1097/00004714-200104000-00006; Fava M, 1998, PSYCHOTHER PSYCHOSOM, V67, P328, DOI 10.1159/000012299; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Kilicarslan H, 2006, J SEX MED, V3, P830, DOI 10.1111/j.1743-6109.2006.00289.x; KJESSLER RC, 2003, JAMA-J AM MED ASSOC, V289, P3095; Laan E, 2002, J WOMEN HEALTH GEN-B, V11, P357, DOI 10.1089/152460902317585994; Labbate LA, 2001, PSYCHOTHER PSYCHOSOM, V70, P221, DOI 10.1159/000056257; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623; Min K, 2002, AM J OBSTET GYNECOL, V187, P1370, DOI 10.1067/mob.2002.126641; Montejo AL, 2001, J CLIN PSYCHIAT, V62, P10; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nurnberg HG, 1999, PSYCHIATR SERV, V50, P1076, DOI 10.1176/ps.50.8.1076; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; Nurnberg HG, 2002, UROLOGY, V60, P58, DOI 10.1016/S0090-4295(02)01691-6; NURNBERG HG, 2006, J UROLOGY, V175, P300; NURNBERG HG, 2001, SEXUAL FUNCTION INVE; Park K, 1998, BIOCHEM BIOPH RES CO, V249, P612, DOI 10.1006/bbrc.1998.9206; Piazza LA, 1997, AM J PSYCHIAT, V154, P1757, DOI 10.1176/ajp.154.12.1757; Quirk FH, 2002, J WOMEN HEALTH GEN-B, V11, P277, DOI 10.1089/152460902753668475; Rosen R, 2006, AM J PSYCHIAT, V163, P79, DOI 10.1176/appi.ajp.163.1.79; Rudkin L, 2004, COCHRANE DB SYST REV; Seidman SN, 2003, J CLIN PSYCHIAT, V64, P721, DOI 10.4088/JCP.v64n0616; Snedecor GW, 1980, STAT METHODS, V7th; Zimmerman M, 2004, AM J PSYCHIAT, V161, P1285, DOI 10.1176/appi.ajp.161.7.1285	40	151	161	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					395	404		10.1001/jama.300.4.395	http://dx.doi.org/10.1001/jama.300.4.395			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647982	Bronze			2022-12-28	WOS:000257831200017
J	Logsdon, RG				Logsdon, Rebecca G.			Dementia: psychosocial interventions for family caregivers	LANCET			English	Editorial Material							ALZHEIMER-DISEASE; HEALTH; PREVALENCE; PLACEMENT; COST		Univ Washington, Sch Nursing, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle	Logsdon, RG (corresponding author), Univ Washington, Sch Nursing, Seattle, WA 98115 USA.	logsdon@u.washington.edu			NIA NIH HHS [P50 AG005136-25, P50 AG005136] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gallagher-Thompson D, 2007, PSYCHOL AGING, V22, P37, DOI 10.1037/0882-7974.22.1.37; Gaugler JE, 2008, J AM GERIATR SOC, V56, P421, DOI 10.1111/j.1532-5415.2007.01593.x; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Nichols LO, 2008, J AM GERIATR SOC, V56, P413, DOI 10.1111/j.1532-5415.2007.01569.x; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Zhu CW, 2006, J AM GERIATR SOC, V54, P1596, DOI 10.1111/j.1532-5415.2006.00871.x	10	18	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					182	183		10.1016/S0140-6736(08)61048-X	http://dx.doi.org/10.1016/S0140-6736(08)61048-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	327YH	18640438				2022-12-28	WOS:000257763900006
J	Woodward, D; Labonte, R				Woodward, David; Labonte, Ronald			Reducing poverty sustainably, in a carbon-constrained future	LANCET			English	Editorial Material									[Woodward, David] Rijswijk ZH, NL-2282 BW Rijswijk, Netherlands; [Labonte, Ronald] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada	University of Ottawa	Woodward, D (corresponding author), Rijswijk ZH, NL-2282 BW Rijswijk, Netherlands.	david.woodward@neweconomics.org	Labonte, Ronald/G-4229-2011					Edward P, 2006, THIRD WORLD Q, V27, P377, DOI 10.1080/01436590500432739; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Ravallion M., 2001, GROWTH INEQUALITY PO; Spence M., 2008, GROWTH REP STRAT SUS; WOODWARD D, IN PRESS POOR IS POO; Woodward David, 2006, GROWTH ISNT WORKING; *WORLD BANK, 2008, NEW REP EC GROWTH OF; *WWF, 2006, LIV PLAN REP	8	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					186	188		10.1016/S0140-6736(08)61051-X	http://dx.doi.org/10.1016/S0140-6736(08)61051-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640441				2022-12-28	WOS:000257763900009
J	Hofheinz, M; Weig, EM; Ansmann, M; Bialczak, RC; Lucero, E; Neeley, M; O'Connell, AD; Wang, H; Martinis, JM; Cleland, AN				Hofheinz, Max; Weig, E. M.; Ansmann, M.; Bialczak, Radoslaw C.; Lucero, Erik; Neeley, M.; O'Connell, A. D.; Wang, H.; Martinis, John M.; Cleland, A. N.			Generation of Fock states in a superconducting quantum circuit	NATURE			English	Article							PHOTON NUMBER STATES; TRAPPED ATOM; RADIATION; CAVITY; FIELD; COLLAPSE; QUBITS	Spin systems and harmonic oscillators comprise two archetypes in quantum mechanics(1). The spin-1/2 system, with two quantum energy levels, is essentially the most nonlinear system found in nature, whereas the harmonic oscillator represents the most linear, with an infinite number of evenly spaced quantum levels. A significant difference between these systems is that a two- level spin can be prepared in an arbitrary quantum state using classical excitations, whereas classical excitations applied to an oscillator generate a coherent state, nearly indistinguishable from a classical state(2). Quantum behaviour in an oscillator is most obvious in Fock states, which are states with specific numbers of energy quanta, but such states are hard to create(3-7). Here we demonstrate the controlled generation of multi- photon Fock states in a solid- state system. We use a superconducting phase qubit(8), which is a close approximation to a two- level spin system, coupled to a microwave resonator, which acts as a harmonic oscillator, to prepare and analyse pure Fock states with up to six photons. We contrast the Fock states with coherent states generated using classical pulses applied directly to the resonator.	[Hofheinz, Max; Weig, E. M.; Ansmann, M.; Bialczak, Radoslaw C.; Lucero, Erik; Neeley, M.; O'Connell, A. D.; Wang, H.; Martinis, John M.; Cleland, A. N.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Cleland, AN (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	cleland@physics.ucsb.edu	Cleland, Andrew/AAG-7581-2019; Hofheinz, Max/F-3288-2010; Weig, Eva M/E-9973-2010; Wang, Haohua/G-8875-2011	Weig, Eva M/0000-0003-4294-8601; Wang, Haohua/0000-0001-5380-4297				Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Bertet P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.143601; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; CIRAC JI, 1993, PHYS REV LETT, V70, P762, DOI 10.1103/PhysRevLett.70.762; Cohen-Tannoudji C., 2006, QUANTUM MECH, VI; DEVORET MH, 1989, PHYS SCRIPTA, VT25, P118, DOI 10.1088/0031-8949/1989/T25/020; DEVORET MH, 1992, QUANTUM TUNNELLING C, P337; Devoret MH, 2004, QUANTUM INF PROCESS, V3, P163, DOI 10.1007/s11128-004-3101-5; EBERLY JH, 1980, PHYS REV LETT, V44, P1323, DOI 10.1103/PhysRevLett.44.1323; FAIST A, 1972, HELV PHYS ACTA, V45, P956; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; JAYNES ET, 1963, P IEEE, V51, P89, DOI 10.1109/PROC.1963.1664; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Liu YX, 2004, EUROPHYS LETT, V67, P941, DOI 10.1209/epl/i2004-10144-3; LU N, 1989, PHYS REV A, V40, P1707, DOI 10.1103/PhysRevA.40.1707; LUCERO E, 2008, IN PRESS PHYS REV LE; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; NEELEY M, 2008, NATURE PHYS     0427; Neeley M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180508; O'Connell AD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898887; Raimond J. M., 2006, EXPLORING QUANTUM AT; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Varcoe BTH, 2000, NATURE, V403, P743, DOI 10.1038/35001526; Waks E, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/1/004; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851	30	393	397	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					310	314		10.1038/nature07136	http://dx.doi.org/10.1038/nature07136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633412	Green Submitted			2022-12-28	WOS:000257665300033
J	Heierli, J; Gumbsch, P; Zaiser, M				Heierli, J.; Gumbsch, P.; Zaiser, M.			Anticrack nucleation as triggering mechanism for snow slab avalanches	SCIENCE			English	Article							FRACTURE; PROPAGATION; PRESSURE; LAYERS	Snow slab avalanches are believed to begin by the gravity- driven shear failure of weak layers in stratified snow. The critical crack length for shear crack propagation along such layers should increase without bound as the slope decreases. However, recent experiments show that the critical length of artificially introduced cracks remains constant or, if anything, slightly decreases with decreasing slope. This surprising observation can be understood in terms of volumetric collapse of the weak layer during failure, resulting in the formation and propagation of mixed- mode anticracks, which are driven simultaneously by slope- parallel and slope- normal components of gravity. Such fractures may propagate even if crack- face friction impedes downhill sliding of the snowpack, indicating a scenario in which two separate conditions have to be met for slab avalanche release.	[Heierli, J.; Zaiser, M.] Univ Edinburgh, Ctr Mat Sci & Engn, Edinburgh EH9 3JL, Midlothian, Scotland; [Heierli, J.; Gumbsch, P.] Univ Karlsruhe, Inst Zuverlassigkeit von Bauteilen & Syst, D-76131 Karlsruhe, Germany; [Gumbsch, P.] Fraunhofer Inst Werkstoffmech, D-79108 Freiburg, Germany	University of Edinburgh; Helmholtz Association; Karlsruhe Institute of Technology; Fraunhofer Gesellschaft	Heierli, J (corresponding author), Univ Edinburgh, Ctr Mat Sci & Engn, Sanderson Bldg,Kings Bldg, Edinburgh EH9 3JL, Midlothian, Scotland.	j.heierli@ed.ac.uk	Gumbsch, Peter/E-5879-2012	Gumbsch, Peter/0000-0001-7995-228X; Heierli, Joachim/0000-0001-6500-6575; Zaiser, Michael/0000-0001-7695-0350				Birkeland KW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025104; BOHREN CF, 1974, AM J PHYS, V42, P69, DOI 10.1119/1.1987605; FLETCHER RC, 1981, GEOLOGY, V9, P419, DOI 10.1130/0091-7613(1981)9<419:AMFPSS>2.0.CO;2; GAUTHIER D, 2007, THESIS U CALGARY CAL; Gauthier D, 2008, COLD REG SCI TECHNOL, V51, P87, DOI 10.1016/j.coldregions.2007.04.005; GREEN HW, 1990, NATURE, V348, P720, DOI 10.1038/348720a0; HARVEY S, 2005, ACHTUNG LAWINEN; Heierli J, 2008, COLD REG SCI TECHNOL, V52, P385, DOI 10.1016/j.coldregions.2007.02.007; HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63, DOI 10.1016/s0065-2156(08)70164-9; Jamieson JB, 2000, J GLACIOL, V46, P151, DOI 10.3189/172756500781833278; Johnson BC, 2004, COLD REG SCI TECHNOL, V40, P41, DOI 10.1016/j.coldregions.2004.05.003; Kirchner HOK, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011306; KNIGHT CA, 1972, SCIENCE, V178, P612; Louchet F, 2002, NAT HAZARD EARTH SYS, V2, P157, DOI 10.5194/nhess-2-157-2002; MCCLUNG DM, 1979, J GEOPHYS RES, V84, P3519, DOI 10.1029/JB084iB07p03519; SHAPIRO LH, 1997, 973 US ARM CORPS ENG; SIGRIST C, 2006, INT J FRACTURE, V139, P164, DOI DOI 10.1007/SI0704-006-6580-9; SIGRIST C, 2006, INT J FRAC, V139, P3; Sigrist C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028576; Sternlof KR, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003764	20	93	94	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					240	243		10.1126/science.1153948	http://dx.doi.org/10.1126/science.1153948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621667				2022-12-28	WOS:000257512900037
J	Gordon, JG				Gordon, John Guertin			A critique of the financial requirements to fight HIV/AIDS	LANCET			English	Article							HIV PREVENTION; AFRICA	Funds available for HIV/AIDS programmes in low-income and middle-income countries rose from US$300 million in 1996 to $10 billion in 2007. However, a combination of worldwide economic uncertainty a global food crisis, and publications that indicate discontent with progress in fighting the HIV/AIDS pandemic will not only threaten to restrict increases in the overall availability of both donor and national funds, but will also increase the competition for resources during the move towards universal access to treatment and prevention services. Thus, UNAIDS will be under increasing pressure in its presentation and justification of resources needed for HIV/AIDS programming. Here I discuss UNAIDS' 2007 estimates of resource requirements for fighting HIV/AIDS in terms of their usefulness to both donor and recipient governments for budget planning and for setting priorities for HIV/AIDS programmes. I identify weaknesses in the UNAIDS estimates in terms of financial transparency and priority setting, and recommend changes to improve budgeting and priority setting.	[Gordon, John Guertin] Univ Guelph, Dept Food Agr & Resource Econ, Ontario Agr Coll, Guelph, ON N1G 2W1, Canada	University of Guelph	Gordon, JG (corresponding author), Univ Guelph, Dept Food Agr & Resource Econ, Ontario Agr Coll, JD MacLachlan Bldg, Guelph, ON N1G 2W1, Canada.	jgordon@gri.ca						*AVERTING HIV AIDS, 2008, FUND FIGHT AIDS; Chin James, 2007, AIDS PANDEMIC COLLIS; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; EPSTEIN H, 2007, INVISIBLE CURE AFRIC; JACK A, 2007, FINANCIAL TIMES 0928, P11; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; *ORG EC COOP DEV, 2008, OECD EC OUTLOOK  JUN; Over M., 2008, PREVENTION FAILURE B; OVER M, 2004, MACROECONOMICS HIV A; Pisani E, 2008, WISDOM WHORES BUREAU; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; *UNAIDS, 2007, FIN RES REQ AIDS; United Nations (UN), 2008, WORLD EC SIT PROSP 2; WHO, 2006, ANT DRUGS TREAT PREG; 2008, LANCET, V371, P1389; 2007, LANCET, V370, P1190	17	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					333	336		10.1016/S0140-6736(08)61117-4	http://dx.doi.org/10.1016/S0140-6736(08)61117-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657712				2022-12-28	WOS:000258042800034
J	Bertozzi, SM; Laga, M; Bautista-Arredondo, S; Coutinho, A				Bertozzi, Stefano M.; Laga, Marie; Bautista-Arredondo, Sergio; Coutinho, Alex			HIV prevention 5 - Making HIV prevention programmes work	LANCET			English	Article							INFECTION; TRANSMISSION; PROSTITUTES	Even after 25 years of experience, HIV prevention programming remains largely deficient. We identify four areas that managers of national HIV prevention programmes should reassess and hence refocus their efforts-improvement of targeting, selection, and delivery of prevention interventions, and optimisation of funding. Although each area is not wholly independent from one another, and because each country and epidemic context will require a different balance of time and funding allocation in each area, we present the current state of each dimension in the global HIV prevention arena and propose practical ways to remedy present deficiencies. insufficient data for intervention effectiveness and country-specific epidemiology has meant that programme managers have operated, and continue to operate, in a fog of uncertainty. Although priority must be given to the improvement of prevention methods and the capacity for the generation and use of evidence to improve programme planning and implementation, uncertainty will remain. In the meantime, however, we argue that prevention programming can be made much more effective by use of information that is readily available.	[Bertozzi, Stefano M.; Bautista-Arredondo, Sergio] Inst Nacl Salud Publ, Cuernavaca 62508, Morelos, Mexico; [Bertozzi, Stefano M.] Ctr Econ Res & Testing CIDC, Mexico City, DF, Mexico; [Bertozzi, Stefano M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Laga, Marie] Inst Trop Med, B-2000 Antwerp, Belgium; [Coutinho, Alex] Infect Dis Inst, Kampala, Uganda	Instituto Nacional de Salud Publica; University of California System; University of California Berkeley; Institute of Tropical Medicine (ITM)	Bertozzi, SM (corresponding author), Inst Nacl Salud Publ, Av Univ 655,Sta Maria Ahuacatitlan, Cuernavaca 62508, Morelos, Mexico.	sbertozzi@correo.insp.mx	Bautista-Arredondo, Sergio/N-7305-2016	Bautista-Arredondo, Sergio/0000-0001-8910-3011; Bertozzi, Stefano M/0000-0002-1723-7085				[Anonymous], 1992, AIDS WORLD; *AUSTR GOV AUSAID, 2004, M CHALL AUSTR INT HI; BAUTISTAARRENDO.S, PREDICTING EFFICIENC; BIDEN JR, 2008, BIDEN LUGAR LEGISLAT; BOLLINGER L, POTENTIAL IMPACT HIV; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; *CENSIDA, 2008, INF UNGASS MEX 2008; *COMM AUSTR, AUSTR OV AID PROGR 2; Committee for the Evaluation of the President's Emergency Plan for AIDS Relief, 2007, PEPFAR IMPL PROGR PR; Compston Alastair, LANCET, V372, P1502, DOI [DOI 10.1016/S0140-6736(08)60885-5, 10.1016/S0140-6736(08)61620-7, DOI 10.1016/S0140-6736(08)61620-7]; DANDONA L, IN PRESS AIDS; Euromonitor, 2019, WINE CHINA COUNTRY R; *FUT GROUP CONST, RES NEEDS HIV AIDS M; *GLOB FUND FIGHT A, 2005, 11 BOARD M GEN 28 30; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; *GREEK CTR DIS CON, 2008, UNGASS COUNTR PROGR; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GUPTA GR, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60887-9; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; *I MED COMM EV PEP, 2007, PEPFAR IMPL PROGR PR; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kates J., 2006, INT ASSISTANCE HIV A; KUMARANAYAKE L, IN PRESS AIDS; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Marseille E, 2004, HEALTH SERV RES, V39, P1996; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; MARTINEZBRISENO D, TECHNICAL EFFICENCY; Merson MH, 2000, AIDS, V14, pS68; MERSON MH, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60884-3; *NAT AIDS PREV ALL, 2007, UNGASS COUNTR PROGR; NGUYENVANHOUTTE D, 2005, AIDS STRAT ACT PLAN; *PEPFAR, 2008, POW PARTN 4 ANN REP; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; SIRAPRAPASIRI T, 1991, AIDS, V5, P579, DOI 10.1097/00002030-199105000-00017; *SO AFR DEV COMM, 2003, DECL HIV AIDS; STOVER J, COVERAGE SELECTED SE; *TURK MIN HLTH, 2008, UNGASS IND COUNTR RE; *UNAIDS, 2008, UNAIDS REP IN PRESS; *UNAIDS, 3 1S; UNAIDS, 2005, INT HIV PREV UNAIDS; *UNAIDS, 2007, PRACT GUID INT HIV P; *UNAIDS WHO, 2007, AIDS EP UPD; *USAID UNAIDS WHO, 2004, COV SEL SERV HIV AID; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; WILLERFORD DM, 1993, J INFECT DIS, V167, P1414, DOI 10.1093/infdis/167.6.1414; *WORLD BANK, 2005, REV NAT HIV AIDS STR; World Health Organization, 2001, MACR HLTH INV HLTH E	49	79	79	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					831	844		10.1016/S0140-6736(08)60889-2	http://dx.doi.org/10.1016/S0140-6736(08)60889-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18687457				2022-12-28	WOS:000259124900026
J	Sakamoto, T; Webb, MR; Forgacs, E; White, HD; Sellers, JR				Sakamoto, Takeshi; Webb, Martin R.; Forgacs, Eva; White, Howard D.; Sellers, James R.			Direct observation of the mechanochemical coupling in myosin Va during processive movement	NATURE			English	Article							SINGLE-MOLECULE; KINETIC MECHANISM; NECK LENGTH; ADP; ATP; MOTOR	Myosin Va transports intracellular cargoes along actin filaments in cells(1). This processive, two- headed motor takes multiple 36- nm steps in which the two heads swing forward alternately towards the barbed end of actin driven by ATP hydrolysis(2). The ability of myosin Va to move processively is a function of its long lever arm, the high duty ratio of its kinetic cycle and the gating of the kinetics between the two heads such that ADP release from the lead head is greatly retarded(3-10). Mechanical studies at the multiple- and the single- molecule level suggest that there is tight coupling ( that is, one ATP is hydrolysed per power stroke), but this has not been directly demonstrated(4,5,11). We therefore investigated the coordination between the ATPase mechanism of the two heads of myosin Va and directly visualized the binding and dissociation of single fluorescently labelled nucleotide molecules, while simultaneously observing the stepping motion of the fluorescently labelled myosin Va as it moved along an actin filament. Here we show that preferential ADP dissociation from the trail head of mouse myosin Va is followed by ATP binding and a synchronous 36- nm step. Even at low ATP concentrations, the myosin Va molecule retained at least one nucleotide ( ADP in the lead head position) when moving. Thus, we directly demonstrate tight coupling between myosin Va movement and the binding and dissociation of nucleotidebysimultaneouslyimagingwithnearnanometreprecision.	[Sakamoto, Takeshi; Sellers, James R.] NHLBI, Lab Mol Physiol, Bethesda, MD 20892 USA; [Webb, Martin R.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Forgacs, Eva; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MRC National Institute for Medical Research; Eastern Virginia Medical School	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, Bldg 10, Bethesda, MD 20892 USA.	Sellersj@mail.nih.gov		Webb, Martin/0000-0002-0134-9621	Medical Research Council, UK; National Heart, Lung and Blood Intramural Program; NIH [EB00209]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung and Blood Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. Zhang, A. Smith and G. Reid for technical assistance; E. Yokoi for the TIRF illuminator to combine two optical cables; C. Fanghella for technical help in the calculation of the number of photons; and C. Weaver for help with Metamorph. We are appreciative of the critical comments on the manuscript made by P.J. Knight and E. Homsher. M.R.W. was supported by the Medical Research Council, UK. J.R.S. and T.S. were supported by the National Heart, Lung and Blood Intramural Program. H. D. W. and E. F. were supported by NIH EB00209 and a postdoctoral fellowship from the American Heart Association.	Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Ishijima A, 1996, BIOPHYS J, V70, P383, DOI 10.1016/S0006-3495(96)79582-6; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oiwa K, 2000, BIOPHYS J, V78, P3048, DOI 10.1016/S0006-3495(00)76843-3; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; SELLERS JR, 2008, MYOSINS SUPERFAMILY, V7, P289; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	27	97	98	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					128	U99		10.1038/nature07188	http://dx.doi.org/10.1038/nature07188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668042	Green Accepted			2022-12-28	WOS:000258890200051
J	Falade, OO; Antonarakis, ES; Kaul, DR; Saint, S; Murphy, PA				Falade, Oluwaseun O.; Antonarakis, Emmanuel S.; Kaul, Daniel R.; Saint, Sanjay; Murphy, Patrick A.			Beware of first impressions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK-FACTORS; MELIOIDOSIS		[Falade, Oluwaseun O.; Antonarakis, Emmanuel S.] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA; [Murphy, Patrick A.] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Div Infect Dis, Baltimore, MD 21224 USA; [Kaul, Daniel R.] Univ Michigan, Sch Med, Div Infect Dis, Ann Arbor, MI USA; [Saint, Sanjay] Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI USA; [Saint, Sanjay] Dept Vet Affairs Hlth Serv Res, Ann Arbor, MI USA; [Saint, Sanjay] Dev Ctr Excellence, Ann Arbor, MI USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Antonarakis, ES (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Med, B-1 N,4940 Eastern Ave, Baltimore, MD 21224 USA.	eantona1@jhmi.edu	Antonarakis, Emmanuel S./E-4550-2011; Saint, Sanjay/AAF-5126-2019	Antonarakis, Emmanuel S./0000-0003-0031-9655; Falade-Nwulia, Oluwaseun/0000-0003-2321-2295; Antonarakis, Emmanuel Stylianos/0000-0003-3531-3851	NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Disease Control and Prevention, BIOT AG DIS; Chaowagul W, 2005, ANTIMICROB AGENTS CH, V49, P4020, DOI 10.1128/AAC.49.10.4020-4025.2005; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2007, CLIN MICROBIOL REV, V20, P533, DOI 10.1128/CMR.00018-07; Chierakul W, 2005, AM J TROP MED HYG, V73, P1165, DOI 10.4269/ajtmh.2005.73.1165; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; IP M, 1995, CHEST, V108, P1420, DOI 10.1378/chest.108.5.1420; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Samuel M, 2002, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD001263, 10.1002/14651858.CD001263]; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Sura T, 1997, DIAGN MICR INFEC DIS, V29, P121, DOI 10.1016/S0732-8893(97)81800-7; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; WALSH AL, 1994, J CLIN PATHOL, V47, P377, DOI 10.1136/jcp.47.4.377; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; 2004, MMWR MORB MORTAL WKL, V53, P988	16	13	13	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					628	634		10.1056/NEJMcps0708803	http://dx.doi.org/10.1056/NEJMcps0708803			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687644	Green Accepted			2022-12-28	WOS:000258216700012
J	Madueno, R; Raisanen, MT; Silien, C; Buck, M				Madueno, Rafael; Raisanen, Minna T.; Silien, Christophe; Buck, Manfred			Functionalizing hydrogen-bonded surface networks with self-assembled monolayers	NATURE			English	Article							SCANNING-TUNNELING-MICROSCOPY; UNDERPOTENTIAL DEPOSITION; SYSTEMS; AU(111); GUESTS; COMPLEXATION; INTERFACES; INCLUSION; TEMPLATE; COPPER	One of the central challenges in nanotechnology is the development of flexible and efficient methods for creating ordered structures with nanometre precision over an extended length scale. Supramolecular self- assembly on surfaces offers attractive features in this regard: it is a 'bottom- up' approach and thus allows the simple and rapid creation of surface assemblies(1,2), which are readily tuned through the choice of molecular building blocks used and stabilized by hydrogen bonding(3-8), van der Waals interactions(9), pi-pi bonding(10,11) or metal coordination(12,13) between the blocks. Assemblies in the form of two- dimensional open networks(3,9,10,13-17) are of particular interest for possible applications because well- defined pores can be used for the precise localization and confinement of guest entities such as molecules or clusters, which can add functionality to the supramolecular network. Another widely used method for producing surface structures involves self- assembled monolayers (SAMs)(18), which have introduced unprecedented flexibility in our ability to tailor interfaces and generate patterned surfaces(19-22). But SAMs are part of a top-down technology that is limited in terms of the spatial resolution that can be achieved. We therefore rationalized that a particularly powerful fabrication platform might be realized by combining non- covalent self- assembly of porous networks and SAMs, with the former providing nanometre- scale precision and the latter allowing versatile functionalization. Here we show that the two strategies can indeed be combined to create integrated network SAM hybrid systems that are sufficiently robust for further processing. We show that the supramolecular network and the SAM can both be deposited from solution, which should enable the widespread and flexible use of this combined fabrication method.	[Madueno, Rafael; Raisanen, Minna T.; Silien, Christophe; Buck, Manfred] Univ St Andrews, EaStCHEM Sch Chem, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Buck, M (corresponding author), Univ St Andrews, EaStCHEM Sch Chem, St Andrews KY16 9ST, Fife, Scotland.	rafael.madueno@uco.es; mb45@st-and.ac.uk	Madueno, Rafael/M-1483-2014; Buck, Manfred/G-5508-2017	Madueno, Rafael/0000-0002-2579-4113; Buck, Manfred/0000-0003-1225-7607; Silien, Christophe/0000-0003-0426-2166	Engineering and Physical Sciences Research Council [EP/D036828/1, EP/D048761/1] Funding Source: researchfish; EPSRC [EP/D036828/1, EP/D048761/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AAKEROY CB, 1993, CHEM SOC REV, V22, P397, DOI 10.1039/cs9932200397; Baldacchini C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2187486; Barth JV, 2007, ANNU REV PHYS CHEM, V58, P375, DOI 10.1146/annurev.physchem.56.092503.141259; Bilic A, 2006, J CHEM THEORY COMPUT, V2, P1093, DOI 10.1021/ct050237r; Canas-Ventura ME, 2007, ANGEW CHEM INT EDIT, V46, P1814, DOI 10.1002/anie.200604083; Dameron AA, 2005, J AM CHEM SOC, V127, P8697, DOI 10.1021/ja042621o; De Feyter S, 2003, CHEM SOC REV, V32, P139, DOI 10.1039/b206566p; Diaz DJ, 2001, J PHYS CHEM B, V105, P8746, DOI 10.1021/jp0105645; Furukawa S, 2007, ANGEW CHEM INT EDIT, V46, P2831, DOI 10.1002/anie.200604782; Gooding JJ, 2003, ELECTROANAL, V15, P81, DOI 10.1002/elan.200390017; Kampschulte L, 2005, J PHYS CHEM B, V109, P14074, DOI 10.1021/jp050794+; Li Z, 2005, LANGMUIR, V21, P6915, DOI 10.1021/la0507737; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Lu J, 2004, J PHYS CHEM B, V108, P5161, DOI 10.1021/jp037508j; Mena-Osteritz E, 2006, ADV MATER, V18, P447, DOI 10.1002/adma.200501575; Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e; Oyamatsu D, 2001, J ELECTROANAL CHEM, V497, P97, DOI 10.1016/S0022-0728(00)00459-9; Payer D, 2007, CHEM-EUR J, V13, P3900, DOI 10.1002/chem.200601325; Perdigao LMA, 2006, J PHYS CHEM B, V110, P12539, DOI 10.1021/jp060062x; Pinheiro LS, 2007, SURF SCI, V601, P1836, DOI 10.1016/j.susc.2007.02.009; Schenning APHJ, 2005, CHEM COMMUN, P3245, DOI 10.1039/b501804h; Schreiber F, 2004, J PHYS-CONDENS MAT, V16, pR881, DOI 10.1088/0953-8984/16/28/R01; Silien C, 2008, J PHYS CHEM C, V112, P3881, DOI 10.1021/jp710947r; Spillmann H, 2006, ADV MATER, V18, P275, DOI 10.1002/adma.200501734; Stepanow S, 2004, NAT MATER, V3, P229, DOI 10.1038/nmat1088; Stepanow S, 2007, ANGEW CHEM INT EDIT, V46, P710, DOI 10.1002/anie.200603644; Stohr M, 2007, SMALL, V3, P1336, DOI 10.1002/smll.200700099; Theobald JA, 2003, NATURE, V424, P1029, DOI 10.1038/nature01915; Thom I, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1991992; Weber UK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.156101	30	314	316	8	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					618	621		10.1038/nature07096	http://dx.doi.org/10.1038/nature07096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668104				2022-12-28	WOS:000258026500042
J	Tan, T; Little, P; Stokes, T				Tan, Toni; Little, Paul; Stokes, Tim		Guideline Dev Grp	Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Little, Paul] Univ Southampton, Sch Med, Southampton SO17 1BJ, Hants, England; [Tan, Toni; Stokes, Tim] Natl Inst Hlth & Clin Excellence, Manchester M1 4BD, Lancs, England	University of Southampton; National Institute for Health & Care Excellence	Little, P (corresponding author), Univ Southampton, Sch Med, Southampton SO17 1BJ, Hants, England.	p.little@soton.ac.uk	Stokes, Tim/M-9420-2018	Stokes, Tim/0000-0002-1127-1952; Little, Paul/0000-0003-3664-1873				Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Lindbaek M, 2006, BRIT J GEN PRACT, V56, P164; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; National Institute for Health and Clinical Excellence, 2008, PRESCR ANT SELF LIM	4	73	80	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a437	10.1136/bmj.a437	http://dx.doi.org/10.1136/bmj.a437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18650239				2022-12-28	WOS:000258273000043
J	Berman, M; Lavizzo-Mourey, R				Berman, Mark; Lavizzo-Mourey, Risa			Obesity prevention in the information age - Caloric information at the point of purchase	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FAST-FOOD; HEALTH; RESTAURANTS; CONSUMPTION; HOSPITALS; ADULTS; IMPACT		[Berman, Mark; Lavizzo-Mourey, Risa] Robert Wood Johnson Fdn, Princeton, NJ 08543 USA	Robert Wood Johnson Foundation (RWJF)	Berman, M (corresponding author), Robert Wood Johnson Fdn, POB 2316, Princeton, NJ 08543 USA.	maberman@rwjf.org						Backstrand J, 1997, FAT CHANCE; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; Chandon P, 2007, J CONSUM RES, V34, P301, DOI 10.1086/519499; *KEYST CTR, 2006, KEYST FOR AW HOM FOO; Kreuter MW, 1997, AM J PREV MED, V13, P277, DOI 10.1016/S0749-3797(18)30175-2; Lesser LI, 2006, J AM BOARD FAM MED, V19, P526, DOI 10.3122/jabfm.19.5.526; Lin B.-H., 1999, NUTR CONTRIBUTION FO; Miles S, 2003, NUTR RES REV, V16, P3, DOI 10.1079/NRR200249; Sahud HB, 2006, PEDIATRICS, V118, P2290, DOI 10.1542/peds.2006-1228; Schmidt M, 2005, ARCH PEDIAT ADOL MED, V159, P626, DOI 10.1001/archpedi.159.7.626; Simon P, 2008, MENU LABELING POTENT; Sproul AD, 2003, MIL MED, V168, P556, DOI 10.1093/milmed/168.7.556; VARIYAM J, 2005, NUTR LABELING FOOD A	14	52	54	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					433	435		10.1001/jama.300.4.433	http://dx.doi.org/10.1001/jama.300.4.433			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647987				2022-12-28	WOS:000257831200022
J	Hirsch, MS; DeMaria, A; Schaefer, PW; Branda, JA; Addo, MM; Rosenberg, ES; Ning, MM; Buonanno, FS; Spitzer, TR				Hirsch, Martin S.; DeMaria, Alfred, Jr.; Schaefer, Pamela W.; Branda, John A.; Addo, Marylyn M.; Rosenberg, Eric S.; Ning, Ming-Ming; Buonanno, Ferdinando S.; Spitzer, Thomas R.			A woman with fever and confusion - Eastern equine encephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEST-NILE-VIRUS; LYME-DISEASE; MANIFESTATIONS; MASSACHUSETTS; MOSQUITOS		[Hirsch, Martin S.] Massachusetts Gen Hosp, Dept Med, Infect Dis Serv, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [DeMaria, Alfred, Jr.] Massachusetts Dept Publ Hlth, Boston, MA USA; [Hirsch, Martin S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [DeMaria, Alfred, Jr.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Schaefer, Pamela W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Department of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hirsch, MS (corresponding author), Massachusetts Gen Hosp, Dept Med, Infect Dis Serv, Boston, MA 02114 USA.		Addo, Marylyn M./GNP-2548-2022; Spitzer, Thomas/AAR-7652-2020; Branda, John/ABD-5620-2020; Schaefer, Pamela/AAA-1323-2019					Chou S, 2005, NEW ENGL J MED, V353, P287, DOI 10.1056/NEJMcpc059017; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Edman John D., 1993, Journal of the Florida Mosquito Control Association, V64, P84; GRADY GF, 1978, AM J EPIDEMIOL, V107, P170, DOI 10.1093/oxfordjournals.aje.a112519; Hachiya M, 2007, AM J TROP MED HYG, V76, P285, DOI 10.4269/ajtmh.2007.76.285; Herpin U, 2004, ENVIRON SCI POLLUT R, V11, P57, DOI 10.1065/espr2003.07.165; Hirsch MS, 2003, NEW ENGL J MED, V348, P2239, DOI 10.1056/NEJMcpc030015; LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Spielman A., 2001, MOSQUITO NATURAL HIS; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Tyler Kenneth L, 2004, Herpes, V11 Suppl 2, p57A; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; 1999, MMWR MORB MORTAL WKL, V48, P845	17	10	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					294	303		10.1056/NEJMcpc0804149	http://dx.doi.org/10.1056/NEJMcpc0804149			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KD	18635435				2022-12-28	WOS:000257656600011
J	Campillos, M; Kuhn, M; Gavin, AC; Jensen, LJ; Bork, P				Campillos, Monica; Kuhn, Michael; Gavin, Anne-Claude; Jensen, Lars Juhl; Bork, Peer			Drug target identification using side-effect similarity	SCIENCE			English	Article							SMALL-MOLECULE; IN-VITRO; DISCOVERY; PHARMACOLOGY; ANTAGONISTS	Targets for drugs have so far been predicted on the basis of molecular or cellular features, for example, by exploiting similarity in chemical structure or in activity across cell lines. We used phenotypic side- effect similarities to infer whether two drugs share a target. Applied to 746 marketed drugs, a network of 1018 side effect- driven drug- drug relations became apparent, 261 of which are formed by chemically dissimilar drugs from different therapeutic indications. We experimentally tested 20 of these unexpected drug- drug relations and validated 13 implied drug- target relations by in vitro binding assays, of which 11 reveal inhibition constants equal to less than 10 micromolar. Nine of these were tested and confirmed in cell assays, documenting the feasibility of using phenotypic information to infer molecular interactions and hinting at new uses of marketed drugs.	[Campillos, Monica; Kuhn, Michael; Gavin, Anne-Claude; Jensen, Lars Juhl; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Jensen, Lars Juhl] Univ Copenhagen, Panum Inst, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); University of Copenhagen; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de	Bork, Peer/F-1813-2013; Kuhn, Michael/D-4978-2009; Campillos, Monica/M-9849-2014; Jensen, Lars Juhl/C-6492-2008	Bork, Peer/0000-0002-2627-833X; Kuhn, Michael/0000-0002-2841-872X; Campillos, Monica/0000-0002-8591-1713; Jensen, Lars Juhl/0000-0001-7885-715X; Gavin, Anne-Claude/0000-0003-4917-2340				Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Blagg J, 2006, ANNU REP MED CHEM, V41, P353, DOI 10.1016/S0065-7743(06)41024-1; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; CHOUINARD G, 2007, Patent No. 20070082928; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Fliri AF, 2007, CHEMMEDCHEM, V2, P1774, DOI 10.1002/cmdc.200700153; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; Guba W, 2007, J MED CHEM, V50, P6295, DOI 10.1021/jm701144e; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; Kuhn M, 2008, FEBS LETT, V582, P1283, DOI 10.1016/j.febslet.2008.02.024; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lin CJ, 2003, PHARMACOTHERAPY, V23, P711, DOI 10.1592/phco.23.6.711.32177; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Martin RE, 2007, J MED CHEM, V50, P6291, DOI 10.1021/jm701143p; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Schuffenhauer A, 2003, J CHEM INF COMP SCI, V43, P391, DOI 10.1021/ci025569t; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	27	910	941	2	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					263	266		10.1126/science.1158140	http://dx.doi.org/10.1126/science.1158140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621671				2022-12-28	WOS:000257512900044
J	Aral, SO; Adimora, AA; Fenton, KA				Aral, Sevgi O.; Adimora, Adaoro A.; Fenton, Kevin A.			Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans	LANCET			English	Editorial Material							UNITED-STATES; CONCURRENT PARTNERSHIPS; RACIAL DISPARITIES; TRANSMISSION; INEQUALITIES; MORTALITY; NETWORKS		[Aral, Sevgi O.; Fenton, Kevin A.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Adimora, Adaoro A.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Fenton, KA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, 1600 Clifton Rd NE,Mailstop E07, Atlanta, GA 30333 USA.	kfenton@cdc.gov						Adimora AA, 2006, JAIDS-J ACQ IMM DEF, V41, P616, DOI 10.1097/01.qai.0000191382.62070.a5; Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Adimora AA, 2004, ANN EPIDEMIOL, V14, P155, DOI 10.1016/S1047-2797(03)00129-7; Adimora AA, 2003, JAIDS-J ACQ IMM DEF, V34, P423, DOI 10.1097/00126334-200312010-00010; Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Aral SO, 2002, SEX TRANSM INFECT, V78, P2, DOI 10.1136/sti.78.1.2; *CDC, HIV PREV STRAT PLAN; *CDCP, 2005, SEX TRANSM DIS SURV; Center for Disease Control and Prevention, 2005, HIV AIDS SURV REP 20, V16; CHANDRA A, 2003, GEOGRAPHY RACIAL HLT; Geronimus AT, 1996, NEW ENGL J MED, V335, P1552, DOI 10.1056/NEJM199611213352102; Hallfors DD, 2007, AM J PUBLIC HEALTH, V97, P125, DOI 10.2105/AJPH.2005.075747; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Massey D., 1993, AM APARTHEID SEGREGA; MASSEY DS, 2005, POVERTY INEQUALITY, P117; MAUER M, COMP INT RATES INCAR; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; MOSHER WD, 2005, ADV DATA, V365, P1; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; *PACHA, ACH HIV AIDS GEN REC; Potterat JJ, 1999, AM J EPIDEMIOL, V150, P1331, DOI 10.1093/oxfordjournals.aje.a009965; Roux AVD, 2007, ANN EPIDEMIOL, V17, P569, DOI 10.1016/j.annepidem.2007.03.001; *US BUR CENS, 2000, CENS 2000 SUMM FIL 1, V2003; Zierler S, 1997, ANNU REV PUBL HEALTH, V18, P401, DOI 10.1146/annurev.publhealth.18.1.401	29	163	165	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					337	340		10.1016/S0140-6736(08)61118-6	http://dx.doi.org/10.1016/S0140-6736(08)61118-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657713				2022-12-28	WOS:000258042800035
J	Gegear, RJ; Casselman, A; Waddell, S; Reppert, SM				Gegear, Robert J.; Casselman, Amy; Waddell, Scott; Reppert, Steven M.			Cryptochrome mediates light-dependent magnetosensitivity in Drosophila	NATURE			English	Article							MAGNETIC-FIELD DETECTION; MAGNETORECEPTION; MECHANISM; MODEL; PHOTORECEPTOR; ORIENTATION; ANIMALS; BIRDS	Although many animals use the Earth's magnetic field for orientation and navigation(1,2), the precise biophysical mechanisms underlying magnetic sensing have been elusive. One theoretical model proposes that geomagnetic fields are perceived by chemical reactions involving specialized photoreceptors(3). However, the specific photoreceptor involved in such magnetoreception has not been demonstrated conclusively in any animal. Here we show that the ultraviolet-A/blue-light photoreceptor cryptochrome ( Cry) is necessary for light- dependent magnetosensitive responses in Drosophila melanogaster. In a binary- choice behavioural assay for magnetosensitivity, wild- type flies show significant naive and trained responses to a magnetic field under full- spectrum light (similar to 300-700 nm) but do not respond to the field when wavelengths in the Cry- sensitive, ultraviolet- A/ blue- light part of the spectrum (<420 nm) are blocked. Notably, Cry- deficient cry(0) and cry(b) flies do not show either naive or trained responses to a magnetic field under full- spectrum light. Moreover, Cry- dependent magnetosensitivity does not require a functioning circadian clock. Our work provides, to our knowledge, the first genetic evidence for a Cry-based magnetosensitive system in any animal.	[Gegear, Robert J.; Casselman, Amy; Waddell, Scott; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Chan, Ryan/AAP-1584-2020	Gegear, Robert/0000-0001-9886-1324; Waddell, Scott/0000-0003-4503-6229	NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Zhu for the protein work in Fig. 4b, c; L. Foley for assistance; J. C. Hall for the cry<SUP>0</SUP> flies; P. Emery for the Per and Cry antibodies; and P. Emery, P. Perrat, B. Leung, S. DasGupta, M. Krashes and H. Zhu for discussions. This work was supported by grants from the NIH.	Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Luschi P, 2007, CURR BIOL, V17, P126, DOI 10.1016/j.cub.2006.11.062; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; PHILLIPS JB, 1993, J COMP PHYSIOL A, V172, P303, DOI 10.1007/BF00216612; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2002, NEURON, V34, P503, DOI 10.1016/S0896-6273(02)00707-9; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; WEHNER R, 1970, EXPERIENTIA, V26, P967, DOI 10.1007/BF02114135; Wiltschko R, 2006, BIOESSAYS, V28, P157, DOI 10.1002/bies.20363; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	30	287	304	1	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					1014	U61		10.1038/nature07183	http://dx.doi.org/10.1038/nature07183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18641630	Green Accepted			2022-12-28	WOS:000258591000043
J	Bhattacharya, S; Harrild, K; Mollison, J; Wordsworth, S; Tay, C; Harrold, A; McQueen, D; Lyall, H; Johnston, L; Burrage, J; Grossett, S; Walton, H; Lynch, J; Johnstone, A; Kini, S; Raja, A; Templeton, A				Bhattacharya, S.; Harrild, K.; Mollison, J.; Wordsworth, S.; Tay, C.; Harrold, A.; McQueen, D.; Lyall, H.; Johnston, L.; Burrage, J.; Grossett, S.; Walton, H.; Lynch, J.; Johnstone, A.; Kini, S.; Raja, A.; Templeton, A.			Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE-GESTATION; EFFICACY; SUBFERTILITY; PROGNOSIS		[Bhattacharya, S.; Harrild, K.; Johnston, L.; Templeton, A.] Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland; [Mollison, J.] Univ Oxford, Ctr Stat Med, Oxford, England; [Wordsworth, S.] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Tay, C.; Johnstone, A.; Kini, S.; Raja, A.] Royal Infirm Edinburgh NHS Trust, Simpson Ctr Reprod Hlth, Edinburgh EH16 4SA, Midlothian, Scotland; [Harrold, A.; Grossett, S.] Ninewells Hosp, Assisted Concept Unit, Dundee DD1 9SY, Scotland; [McQueen, D.; Burrage, J.] Falkirk & Dist Royal Infirm, Falkirk, Scotland; [Lyall, H.; Walton, H.; Lynch, J.] Royal Infirm, ACS Unit, Glasgow G31 2ER, Lanark, Scotland	University of Aberdeen; University of Oxford; University of Oxford; Royal Infirmary of Edinburgh; University of Edinburgh; University of Dundee; Royal Infirmary of Edinburgh	Bhattacharya, S (corresponding author), Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland.	s.bhattacharya@abdn.ac.uk		Mollison, Jill/0000-0002-5539-5615; Bhattacharya, Siladitya/0000-0002-4588-356X	Chief Scientist Office, Scotland	Chief Scientist Office, Scotland	Chief Scientist Office, Scotland	*AM SOC REPR MED P, 2006, FERTIL STERIL, V86, pS111; [Anonymous], 2004, FERT ASS TREATM PEOP; Biljan MM, 1999, FERTIL STERIL, V71, P633, DOI 10.1016/S0015-0282(98)00534-2; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; Collins J, 2003, HUM REPROD, V18, P907, DOI 10.1093/humrep/deg170; COLLINS JA, 1995, FERTIL STERIL, V64, P22, DOI 10.1016/s0015-0282(16)57650-x; George K, 2006, FERTIL STERIL, V86, pS100, DOI 10.1016/j.fertnstert.2006.07.268; Gleicher N, 2006, HUM REPROD, V21, P1951, DOI 10.1093/humrep/del135; Gleicher N, 2000, NEW ENGL J MED, V343, P2, DOI 10.1056/NEJM200007063430101; Goverde AJ, 2000, LANCET, V355, P13, DOI 10.1016/S0140-6736(99)04002-7; Grouin JM, 2004, STAT MED, V23, P701; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Guzick DS, 1998, FERTIL STERIL, V70, P207, DOI 10.1016/S0015-0282(98)00177-0; HUGHES E, 2000, COCHRANE DB SYST REV; Hughes EG, 1997, HUM REPROD, V12, P1865, DOI 10.1093/humrep/12.9.1865; KIRBY CA, 1991, FERTIL STERIL, V56, P102; National Institute of Clinical Excellence, 2004, FERT ASS TREATM PEOP; Newcombe R. G., 2000, STAT CONFIDENCE, V2, P45; Ombelet W, 2005, HUM REPROD UPDATE, V11, P3, DOI 10.1093/humupd/dmh048; Osuna C, 2004, FERTIL STERIL, V82, P17, DOI 10.1016/j.fertnstert.2003.12.035; Pocock SJ., 2013, CLIN TRIALS PRACTICA; *ROYAL COLL OBST G, 1998, MAN INF SEC CAR EV B; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; TANAHATOE SI, 1995, HUM REPROD, V20, P3225; Templeton A, 1995, Health Bull (Edinb), V53, P294; Verhulst SM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001838.pub3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	103	106	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2008	337	7666							a716	10.1136/bmj.a716	http://dx.doi.org/10.1136/bmj.a716			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18687718	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000258669200025
J	Petrukovich, AA				Petrukovich, A. A.			Planetary science - The elusive onset of geomagnetic substorms	SCIENCE			English	Editorial Material							MAGNETOSPHERIC PHYSICS; BRIEF-HISTORY		Moscow Space Res Inst, Moscow 117810, Russia	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences	Petrukovich, AA (corresponding author), Moscow Space Res Inst, Moscow 117810, Russia.	apetruko@iki.rssi.ru	Petrukovich, Anatoly A./G-8764-2011	Petrukovich, Anatoly A./0000-0002-5344-2967				AKASOFU SI, 1964, PLANET SPACE SCI, V12, P273, DOI 10.1016/0032-0633(64)90151-5; Angelopoulos V, 2008, SPACE SCI REV, V141, P453, DOI 10.1007/s11214-008-9378-4; Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Freeman J. W., 2001, STORMS SPACE; Lui ATY, 1996, J GEOPHYS RES-SPACE, V101, P13067, DOI 10.1029/96JA00079; Nishida A, 2007, HANDBOOK OF THE SOLAR-TERRESTRIAL ENVIRONMENT, P279, DOI 10.1007/11367758_11; Petrukovich AA, 2006, SPACE SCI REV, V122, P81, DOI 10.1007/s11214-006-7022-8; STERN DP, 1989, REV GEOPHYS, V27, P103, DOI 10.1029/RG027i001p00103; Stern DP, 1996, REV GEOPHYS, V34, P1, DOI 10.1029/95RG03508	11	2	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2008	321	5891					920	921		10.1126/science.1162426	http://dx.doi.org/10.1126/science.1162426			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18653848				2022-12-28	WOS:000258436700024
J	Bays, PM; Husain, M				Bays, Paul M.; Husain, Masud			Dynamic shifts of limited working memory resources in human vision	SCIENCE			English	Article							SHORT-TERM-MEMORY; VISUAL-ATTENTION; EYE-MOVEMENTS; POPULATION CODES; PARIETAL CORTEX; INFORMATION; CAPACITY; CONJUNCTIONS; PERCEPTION; FEATURES	Our ability to remember what we have seen is very limited. Most current views characterize this limit as a fixed number of items-only four objects-that can be held in visual working memory. We show that visual memory capacity is not fixed by the number of objects, but rather is a limited resource that is shared out dynamically between all items in the visual scene. This resource can be shifted flexibly between objects, with allocation biased by selective attention and toward targets of upcoming eye movements. The proportion of resources allocated to each item determines the precision with which it is remembered, a relation that we show is governed by a simple power law, allowing quantitative estimates of resource distribution in a scene.	[Bays, Paul M.; Husain, Masud] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Bays, Paul M.; Husain, Masud] UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Bays, PM (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.bays@ion.ucl.ac.uk	Bays, Paul/B-3999-2009; Ca, Ma/AAW-6714-2021; Husain, Masud/C-2074-2008	Husain, Masud/0000-0002-6850-9255; Bays, Paul/0000-0003-4684-4893	Wellcome Trust [061140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Bays PM, 2007, NEUROREPORT, V18, P1207, DOI 10.1097/WNR.0b013e328244e6c3; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N., 1995, ATTENTION MEMORY INT; DAVIDSON ML, 1973, PERCEPT PSYCHOPHYS, V14, P110, DOI 10.3758/BF03198624; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; ERIKSEN CW, 1973, PERCEPT PSYCHOPHYS, V14, P155, DOI 10.3758/BF03198630; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; IRWIN DE, 1992, J EXP PSYCHOL LEARN, V18, P307, DOI 10.1037/0278-7393.18.2.307; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; PALMER J, 1990, J EXP PSYCHOL HUMAN, V16, P332, DOI 10.1037/0096-1523.16.2.332; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; WICKENS TD, 2002, ELEMENTARY SIGNAL DE; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	33	734	759	12	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					851	854		10.1126/science.1158023	http://dx.doi.org/10.1126/science.1158023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687968	Green Accepted			2022-12-28	WOS:000258261000050
J	Reilly, DJ; Taylor, JM; Petta, JR; Marcus, CM; Hanson, MP; Gossard, AC				Reilly, D. J.; Taylor, J. M.; Petta, J. R.; Marcus, C. M.; Hanson, M. P.; Gossard, A. C.			Suppressing spin qubit dephasing by nuclear state preparation	SCIENCE			English	Article							SINGLE-ELECTRON SPIN; QUANTUM COMPUTATION	Coherent spin states in semiconductor quantum dots offer promise as electrically controllable quantum bits (qubits) with scalable fabrication. For few-electron quantum dots made from gallium arsenide (GaAs), fluctuating nuclear spins in the host lattice are the dominant source of spin decoherence. We report a method of preparing the nuclear spin environment that suppresses the relevant component of nuclear spin fluctuations below its equilibrium value by a factor of similar to 70, extending the inhomogeneous dephasing time for the two-electron spin state beyond 1 microsecond. The nuclear state can be readily prepared by electrical gate manipulation and persists for more than 10 seconds.	[Reilly, D. J.; Marcus, C. M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Taylor, J. M.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Petta, J. R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Hanson, M. P.; Gossard, A. C.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Harvard University; Massachusetts Institute of Technology (MIT); Princeton University; University of California System; University of California Santa Barbara	Marcus, CM (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	marcus@harvard.edu	Taylor, Jacob M/B-7826-2011; Taylor, Jacob/O-1670-2019; Marcus, Charles M./M-4526-2014; Petta, Jason R/J-6663-2013; Reilly, David/N-8448-2015	Taylor, Jacob M/0000-0003-0493-5594; Taylor, Jacob/0000-0003-0493-5594; Marcus, Charles M./0000-0003-2420-4692; Petta, Jason R/0000-0002-6416-0789; 				Amasha S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046803; Christ H, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155324; Danon J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056603; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Erlingsson SI, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195306; Giedke G, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032316; Greilich A, 2007, SCIENCE, V317, P1896, DOI 10.1126/science.1146850; Imamoglu A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017402; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Khodjasteh K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.180501; Klauser D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205302; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Levy J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.147902; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Petta JR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.067601; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Ramon G, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.161301; Reilly DJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794995; Stepanenko D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136401; Taylor JM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035315; Taylor JM, 2005, NAT PHYS, V1, P177, DOI 10.1038/nphys174; Witzel WM, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165319; Wu LA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207902; Zhang WX, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.201302	28	217	220	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					817	821		10.1126/science.1159221	http://dx.doi.org/10.1126/science.1159221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687959	Green Submitted			2022-12-28	WOS:000258261000040
J	Iglehart, JK				Iglehart, John K.			Medicare, graduate medical education, and new policy directions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; REGIONAL-VARIATIONS; SPECIALTY CHOICES; LIFE-STYLE; STUDENTS; INCOME											American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; American College of Physicians, 2006, IMP COLL PRIM CAR ME; [Anonymous], 2007, 18 REP NEW PAR PHYS; [Anonymous], 2007, REP C MED PAYM POL; [Anonymous], 2008, REP C MED PAYM POL; *ASS AM MED COLL, 2006, AAMC STAT PHYS WORKF; *ASS AM MED COLL, 1996, CONS STAT PHYS WORKF; Association of Academic Health Centers, 2008, OUT ORD OUT TIM STAT; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; *C BUDG OFF, 1995, MED GRAD MED ED CBO; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; *COUNC GRAD MED ED, 2007, 19 REP ENH FLEX GRAD; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; Dorsey ER, 2005, ACAD MED, V80, P791, DOI 10.1097/00001888-200509000-00002; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; GRUNDY P, 2007, NAT ASS STAT MED DIR; HENDERSON TM, 2006, MED DIRECT INDIRECT; Iglehart JK, 1998, NEW ENGL J MED, V338, P402, DOI 10.1056/NEJM199802053380620; Iglehart JK, 1999, NEW ENGL J MED, V341, P299, DOI 10.1056/NEJM199907223410424; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Knapp RM, 2002, ACAD MED, V77, P1076, DOI 10.1097/00001888-200211000-00003; *MED GROUP MAN ASS, 2008, PHYS COMP PROD SURV; *MED PAYM ADV COMM, 1999, REP C RETH MED PAYM; *MED PAYM ADV COMM, 2007, PUBL M WASH DC JAN; *NAT AC SOC INS, 1999, MED AM SOC CONTR FIN; Newton DA, 2005, ACAD MED, V80, P809, DOI 10.1097/00001888-200509000-00005; O'Malley A., 2007, EXODUS MALE PHYS PRI; Orszag PR, 2007, NEW ENGL J MED, V357, P1793, DOI 10.1056/NEJMp078190; *PHYS PAYM REV COM, 1994, 1994 ANN REP C; Reuben DB, 2007, AM J MED, V120, P99, DOI 10.1016/j.amjmed.2006.10.019; SACK K, 2008, NY TIMES        0518, pA1; Sepulveda MJ, 2008, HEALTH AFFAIR, V27, P151, DOI 10.1377/hlthaff.27.1.151; Singer N., 2008, NY TIMES, pA1; SNYDER A, 2008, SAFETY NET WORKFORCE; STEINWALD AB, 2008, PRIM CAR PROF REC SU; Wennberg JE, 2008, TRACKING CARE PATIEN; Whitcomb ME, 2007, ACAD MED, V82, P825, DOI 10.1097/ACM.0b013e318132f0c5; Wynn B, 2006, ALTERNATIVE WAYS FIN	42	36	39	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					643	650		10.1056/NEJMhpr0803754	http://dx.doi.org/10.1056/NEJMhpr0803754			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334IY	18687648				2022-12-28	WOS:000258216700016
J	Yang, YF; Fisk, Z; Lee, HO; Thompson, JD; Pines, D				Yang, Yi-feng; Fisk, Zachary; Lee, Han-Oh; Thompson, J. D.; Pines, David			Scaling the Kondo lattice	NATURE			English	Article							GROUND-STATE; SUPERCONDUCTIVITY; BEHAVIOR; SYSTEM; NMR	The origin of magnetic order in metals has two extremes: an instability in a liquid of local magnetic moments interacting through conduction electrons, and a spin- density wave instability in a Fermi liquid of itinerant electrons. This dichotomy between 'local- moment' magnetism and 'itinerant- electron' magnetism is reminiscent of the valence bond/ molecular orbital dichotomy present in studies of chemical bonding. The class of heavy- electron intermetallic compounds of cerium, ytterbium and various 5f elements bridges the extremes, with itinerant- electron magnetic characteristics at low temperatures that grow out of a high-temperature local- moment state(1). Describing this transition quantitatively has proved difficult, and one of the main unsolved problems is finding what determines the temperature scale for the evolution of this behaviour. Here we present a simple, semi-quantitative solution to this problem that provides a basic framework for interpreting the physics of heavy- electron materials and offers the prospect of a quantitative determination of the physical origin of their magnetic ordering and superconductivity. It also reveals the difference between the temperature scales that distinguish the conduction electrons' response to a single magnetic impurity and their response to a lattice of local moments, and provides an updated version of the well- known Doniach diagram(2).	[Yang, Yi-feng; Lee, Han-Oh; Thompson, J. D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Yang, Yi-feng; Pines, David] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Fisk, Zachary] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Davis; University of California System; University of California Irvine	Yang, YF (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	yifengyyf@gmail.com	Yang, Yi-feng/E-4602-2010	Yang, Yi-feng/0000-0002-6702-6091				ALIEV FG, 1984, J LOW TEMP PHYS, V57, P61, DOI 10.1007/BF00681517; BESNUS MJ, 1991, Z PHYS B CON MAT, V83, P207, DOI 10.1007/BF01309419; Beyer AD, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.140506; Curro NJ, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.235117; DONIACH S, 1977, PHYSICA B & C, V91, P231, DOI 10.1016/0378-4363(77)90190-5; DURKOP D, 1986, Z PHYS B CON MAT, V63, P55, DOI 10.1007/BF01312578; GHOSH K, 1993, PHYS REV B, V48, P6249, DOI 10.1103/PhysRevB.48.6249; GOREMYCHKIN EA, 1994, PHYS REV B, V50, P13863, DOI 10.1103/PhysRevB.50.13863; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; Hewson A C, 1993, KONDO PROBLEM HEAVY; JULLIEN R, 1977, PHYS REV B, V16, P4889, DOI 10.1103/PhysRevB.16.4889; KIM JS, 1990, PHYS REV B, V41, P11073, DOI 10.1103/PhysRevB.41.11073; KITAOKA Y, 1985, J PHYS SOC JPN, V54, P3236, DOI 10.1143/JPSJ.54.3236; KYOGAKU M, 1993, J PHYS SOC JPN, V62, P4016, DOI 10.1143/JPSJ.62.4016; Li S, 2006, PHILOS MAG, V86, P3021, DOI 10.1080/14786430600651962; LIN CL, 1987, PHYS REV LETT, V58, P1232, DOI 10.1103/PhysRevLett.58.1232; MARABELLI F, 1990, PHYS REV B, V42, P3307, DOI 10.1103/PhysRevB.42.3307; Matsuhira K, 1997, J PHYS SOC JPN, V66, P2851, DOI 10.1143/JPSJ.66.2851; Medina AN, 1999, PHYS REV B, V59, P8738, DOI 10.1103/PhysRevB.59.8738; Nakatsuji S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.016401; Nakatsuji S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.106402; OTT HR, 1984, PHYS REV LETT, V52, P1551, DOI 10.1103/PhysRevLett.52.1551; PALSTRA TTM, 1986, PHYS REV B, V34, P4566, DOI 10.1103/PhysRevB.34.4566; SATOH K, 1989, J PHYS SOC JPN, V58, P1012, DOI 10.1143/JPSJ.58.1012; Sonier JE, 2000, PHYS REV LETT, V85, P2821, DOI 10.1103/PhysRevLett.85.2821; Takagi S, 2001, J PHYS SOC JPN, V70, P3098, DOI 10.1143/JPSJ.70.3098; VANDERMEULEN HP, 1991, PHYS REV B, V44, P814, DOI 10.1103/PhysRevB.44.814; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Yang YF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096404; Yokoyama M, 2002, J PHYS SOC JPN, V71, P3037, DOI 10.1143/JPSJ.71.3037	30	172	177	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					611	613		10.1038/nature07157	http://dx.doi.org/10.1038/nature07157			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668102				2022-12-28	WOS:000258026500040
J	Ushioda, R; Hoseki, J; Araki, K; Jansen, G; Thomas, DY; Nagata, K				Ushioda, Ryo; Hoseki, Jun; Araki, Kazutaka; Jansen, Gregor; Thomas, David Y.; Nagata, Kazuhiro			ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; THIOREDOXIN; EDEM; CALNEXIN; GLYCOPROTEINS; ISOMERASE; DOMAINS; STRESS; DNAJ	Membrane and secretory proteins cotranslationally enter and are folded in the endoplasmic reticulum ( ER). Misfolded or unassembled proteins are discarded by a process known as ER- associated degradation ( ERAD), which involves their retrotranslocation into the cytosol. ERAD substrates frequently contain disulfide bonds that must be cleaved before their retrotranslocation. Here, we found that an ER- resident protein ERdj5 had a reductase activity, cleaved the disulfide bonds of misfolded proteins, and accelerated ERAD through its physical and functional associations with EDEM ( ER degradation- enhancing alpha-mannosidase-like protein) and an ER- resident chaperone BiP. Thus, ERdj5 is a member of a supramolecular ERAD complex that recognizes and unfolds misfolded proteins for their efficient retrotranslocation.	[Ushioda, Ryo; Hoseki, Jun; Araki, Kazutaka; Nagata, Kazuhiro] Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Kyoto 6068397, Japan; [Hoseki, Jun; Nagata, Kazuhiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Jansen, Gregor; Thomas, David Y.] McGill Univ, Dept Biochem, Fac Med, Montreal, PQ H3G 1Y6, Canada	Kyoto University; Japan Science & Technology Agency (JST); McGill University	Nagata, K (corresponding author), Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Kyoto 6068397, Japan.	nagata@frontier.kyoto-u.ac.jp	Hoseki, Jun/AAE-6704-2020; Araki, Kazutaka/L-6296-2018; Thomas, David/M-7661-2017	Araki, Kazutaka/0000-0003-2901-2454; Ushioda, Ryo/0000-0003-2775-8746; Jansen, Gregor/0000-0002-0289-0022; Thomas, David/0000-0002-8854-762X	Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Piccirella S, 2006, J BIOL CHEM, V281, P4671, DOI 10.1074/jbc.M509406200; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365	18	290	295	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					569	572		10.1126/science.1159293	http://dx.doi.org/10.1126/science.1159293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653895				2022-12-28	WOS:000257888900050
J	Intlekofer, AM; Banerjee, A; Takemoto, N; Gordon, SM; DeJong, CS; Shin, HN; Hunter, CA; Wherry, EJ; Lindsten, T; Reiner, SL				Intlekofer, Andrew M.; Banerjee, Arnob; Takemoto, Naofumi; Gordon, Scott M.; DeJong, Caitlin S.; Shin, Haina; Hunter, Christopher A.; Wherry, E. John; Lindsten, Tullia; Reiner, Steven L.			Anomalous type 17 response to viral infection by CD8(+) T cells lacking T-bet and eomesodermin	SCIENCE			English	Article							TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; EFFECTOR; DIFFERENTIATION; DISTINCT; IL-21; INFLAMMATION; DIRECTS; CD4	When intracellular pathogens invade mammalian hosts, naive CD8(+) T cells differentiate into cytotoxic killers, which lyse infected target cells and secrete cytokines that activate intracellular microbicides. We show that CD8(+) T cells deficient in the transcription factors T-bet and eomesodermin (Eomes) fail to differentiate into functional killers required for defense against lymphocytic choriomeningitis virus. Instead, virus-specific CD8(+) T cells lacking both T-bet and Eomes differentiate into an interleukin-17-secreting lineage, reminiscent of the helper T cell fate that has been implicated in autoimmunity and extracellular microbial defense. Upon viral infection, mice with T cells lacking both T-bet and Eomes develop a CD8(+) T cell-dependent, progressive inflammatory and wasting syndrome characterized by multi-organ infiltration of neutrophils. T-bet and Eomes, thus, ensure that CD8(+) T cells adopt an appropriate course of intracellular rather than extracellular destruction.	[Intlekofer, Andrew M.; Banerjee, Arnob; Takemoto, Naofumi; Gordon, Scott M.; DeJong, Caitlin S.; Lindsten, Tullia; Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Intlekofer, Andrew M.; Banerjee, Arnob; Takemoto, Naofumi; Gordon, Scott M.; DeJong, Caitlin S.; Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Lindsten, Tullia] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Shin, Haina; Wherry, E. John] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; The Wistar Institute	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Bldg 2-3,Room 414,421 Curie Blvd, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu	Hunter, Christopher/H-1970-2011; Wherry, John/ABI-1280-2020	Shin, Haina/0000-0002-1014-1451; Intlekofer, Andrew/0000-0001-9046-6549; Gordon, Scott/0000-0003-1028-1953	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076458, R01AI042334, R01AI061699, R01AI071309, T32AI007532, R01AI076458, R01AI042370] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042370, AI007532, R01 AI061699-05, R01 AI071309, R01 AI076458-02, AI071309, R01 AI076458, AI042370, R01 AI061699, R01 AI071309-01, AI042334, R01 AI042370-12, AI076458, AI061699] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	24	301	306	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					408	411		10.1126/science.1159806	http://dx.doi.org/10.1126/science.1159806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635804	Green Accepted			2022-12-28	WOS:000257713900051
J	Monk, BC; Goffeau, A				Monk, Brian C.; Goffeau, Andre			Outwitting multidrug resistance to antifungals	SCIENCE			English	Editorial Material							PLEIOTROPIC DRUG-RESISTANCE; GENOME-WIDE EXPRESSION; CANDIDA-ALBICANS; AZOLE RESISTANCE; SACCHAROMYCES-CEREVISIAE; MULTIPLE RESISTANCE; TRANSPORTER GENES; ABC TRANSPORTERS; IN-VIVO; TRANSCRIPTION		[Monk, Brian C.; Goffeau, Andre] Univ Otago, Dept Oral Sci, Fac Dent, Dunedin, New Zealand; [Monk, Brian C.; Goffeau, Andre] Catholic Univ Louvain, Inst Sci La Vie, B-1348 Louvain, Belgium	University of Otago; Universite Catholique Louvain	Goffeau, A (corresponding author), Univ Otago, Dept Oral Sci, Fac Dent, POB 647, Dunedin, New Zealand.	andre.goffeau@uclouvain.be		Monk, Brian/0000-0003-2264-3480	NIDCR NIH HHS [DE016885] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016885] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Akache B, 2004, J BIOL CHEM, V279, P27855, DOI 10.1074/jbc.M403487200; BALZI E, 1994, J BIOL CHEM, V269, P2206; Banerjee D, 2008, EUKARYOT CELL, V7, P68, DOI 10.1128/EC.00256-07; Borman AM, 2007, J ANTIMICROB CHEMOTH, V61, pI7, DOI 10.1093/jac/dkm425; Boyanton BL, 2008, ARCH PATHOL LAB MED, V132, P667, DOI 10.1043/1543-2165(2008)132[667:DPIOPC]2.0.CO;2; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Carvajal E, 1997, MOL GEN GENET, V256, P406, DOI 10.1007/s004380050584; Cernicka J, 2007, INT J ANTIMICROB AG, V29, P170, DOI 10.1016/j.ijantimicag.2006.08.037; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; Gbelska Y, 2006, FEMS YEAST RES, V6, P345, DOI 10.1111/j.1567-1364.2006.00058.x; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; Kolaczkowska A, 2008, FEBS LETT, V582, P977, DOI 10.1016/j.febslet.2008.02.045; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Larsen B, 2006, YEAST, V23, P795, DOI 10.1002/yea.1394; Le Crom S, 2002, MOL CELL BIOL, V22, P2642, DOI 10.1128/MCB.22.8.2642-2649.2002; Liu MP, 2006, EUKARYOT CELL, V5, P638, DOI 10.1128/EC.5.4.638-649.2006; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Mamnun YM, 2002, MOL MICROBIOL, V46, P1429, DOI 10.1046/j.1365-2958.2002.03262.x; Monk BC, 2005, ANTIMICROB AGENTS CH, V49, P57, DOI 10.1128/AAC.49.1.57-70.2005; Nascimento AM, 2003, ANTIMICROB AGENTS CH, V47, P1719, DOI 10.1128/AAC.47.5.1719-1726.2003; Nourani A, 1997, MOL GEN GENET, V256, P397, DOI 10.1007/s004380050583; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Sanglard Dominique, 2002, P349; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382	34	105	112	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					367	369		10.1126/science.1159746	http://dx.doi.org/10.1126/science.1159746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635793				2022-12-28	WOS:000257713900038
J	Stengel, KF; Holdermann, I; Cain, P; Robinson, C; Wild, K; Sinning, I				Stengel, Katharina F.; Holdermann, Iris; Cain, Peter; Robinson, Colin; Wild, Klemens; Sinning, Irmgard			Structural basis for specific substrate recognition by the chloroplast signal recognition particle protein cpSRP43	SCIENCE			English	Article							LIGHT-HARVESTING PROTEINS; CRYSTAL-STRUCTURE; ANKYRIN REPEAT; BINDING; SRP; PATHWAY; RNA; COMPLEXES; PHD	Secretory and membrane proteins carry amino- terminal signal sequences that, in cotranslational targeting, are recognized by the signal recognition particle protein SRP54 without sequence specificity. The most abundant membrane proteins on Earth are the light- harvesting chlorophyll a/ b binding proteins ( LHCPs). They are synthesized in the cytoplasm, imported into the chloroplast, and posttranslationally targeted to the thylakoid membrane by cpSRP, a heterodimer formed by cpSRP54 and cpSRP43. We present the 1.5 angstrom crystal structure of cpSRP43 characterized by a unique arrangement of chromodomains and ankyrin repeats. The overall shape and charge distribution of cpSRP43 resembles the SRP RNA, which is absent in chloroplasts. The complex with the internal signal sequence of LHCPs reveals that cpSRP43 specifically recognizes a DPLG peptide motif. We describe how cpSPR43 adapts the universally conserved SRP system to posttranslational targeting and insertion of the LHCP family of membrane proteins.	[Stengel, Katharina F.; Holdermann, Iris; Wild, Klemens; Sinning, Irmgard] Heidelberg Univ, Zentrum Biochem, INF328, D-69120 Heidelberg, Germany; [Cain, Peter; Robinson, Colin] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Ruprecht Karls University Heidelberg; University of Warwick	Sinning, I (corresponding author), Heidelberg Univ, Zentrum Biochem, INF328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Sinning, Irmgard/A-2982-2010; Cain, Peter/H-1515-2011					Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Blankenfeldt W, 1999, PROTEIN SCI, V8, P2406; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; FULSON DR, 1988, PLANT PHYSIOL, V88, P1146, DOI 10.1104/pp.88.4.1146; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; High S, 1997, J BIOL CHEM, V272, P11622; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Lang M, 2001, J BIOL CHEM, V276, P7985, DOI 10.1074/jbc.M006417200; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Matias PM, 1999, STRUCTURE, V7, P119, DOI 10.1016/S0969-2126(99)80019-7; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; Rosenblad MA, 2004, PLANT CELL PHYSIOL, V45, P1633, DOI 10.1093/pcp/pch185; Rusch SL, 2007, BIOCHEMISTRY-US, V46, P9665, DOI 10.1021/bi7010064; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2007, BIOL CHEM, V388, P907, DOI 10.1515/BC.2007.111; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853	34	71	74	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					253	256		10.1126/science.1158640	http://dx.doi.org/10.1126/science.1158640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621669				2022-12-28	WOS:000257512900041
J	Fuller, J; Libman				Fuller, Jon; Libman			A 39-year-old man with HIV-associated lipodystrophy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							REVERSE-TRANSCRIPTASE INHIBITORS; IMMUNODEFICIENCY-VIRUS INFECTION; ADIPOSE REDISTRIBUTION SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; VISCERAL FAT ACCUMULATION; PLACEBO-CONTROLLED TRIAL; HUMAN GROWTH-HORMONE; BODY-COMPOSITION; METABOLIC ABNORMALITIES; RISK-FACTORS							Fuller, Jon/0000-0001-9475-1902				AGHDASSI E, 2008, 15 C RETR OPP INF FE; Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Ammassari A, 2002, JAIDS-J ACQ IMM DEF, V31, pS140, DOI 10.1097/00126334-200212153-00011; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Bacchetti P, 2006, JAIDS-J ACQ IMM DEF, V42, P562; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Blanes M, 2008, AIDS, V22, P552, DOI 10.1097/QAD.0b013e3282f56b7a; Bogner JR, 2001, J ACQ IMMUN DEF SYND, V27, P237, DOI 10.1097/00126334-200107010-00004; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Carey DL, 2007, JAIDS-J ACQ IMM DEF, V46, P581, DOI 10.1097/QAI.0b013e318158bec9; Carr A, 2003, AIDS, V17, pS141, DOI 10.1097/00002030-200304001-00017; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2001, AIDS, V15, P1811, DOI 10.1097/00002030-200109280-00010; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Cavalcanti RB, 2007, J INFECT DIS, V195, P1754, DOI 10.1086/518005; Cherry CL, 2005, JAIDS-J ACQ IMM DEF, V38, P263; CHIAPPINI F, 2008, 15 C RETR OPP INF FE; Collins E, 2000, AIDS Read, V10, P546; Corcoran C, 1999, NEW ENGL J MED, V340, P1740, DOI 10.1056/NEJM199906033402207; CRANE H, 2008, 15 C RETR OPP INF FE; DELUCA A, 2006, 13 C RETR OPP INF FE; DEWEESE J, 2003, 10 C RETR OPP INF CR; Driscoll SD, 2004, AIDS, V18, P465, DOI 10.1097/00002030-200402200-00013; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Dukers NHTM, 2001, AIDS, V15, P812, DOI 10.1097/00002030-200104130-00025; DUNN CJ, 1995, DRUGS, V49, P721, DOI 10.2165/00003495-199549050-00007; Duran S, 2001, HIV Clin Trials, V2, P38; Duran S, 2001, AIDS, V15, P2441, DOI 10.1097/00002030-200112070-00012; Echevarria KL, 1999, ANN PHARMACOTHER, V33, P859, DOI 10.1345/aph.18174; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Engelson ES, 2002, J ACQ IMMUN DEF SYND, V30, P379, DOI 10.1097/01.QAI.0000020501.93209.1C; Engelson ES, 1999, AM J CLIN NUTR, V69, P1162; FALUTZ J, 2008, 15 C RETR OPP INF FE; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; Fleischman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1666, DOI 10.1152/ajpendo.00550.2006; Fliers E, 2003, LANCET, V362, P1758, DOI 10.1016/S0140-6736(03)14858-1; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Garcia-Benayas T, 2002, AIDS, V16, P1087, DOI 10.1097/00002030-200205030-00023; Gerber JG, 2005, JAIDS-J ACQ IMM DEF, V39, P307, DOI 10.1097/01.qai.0000167156.44980.33; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grinspoon S, 2007, J INFECT DIS, V195, P1731, DOI 10.1086/518008; Grunfeld C, 2007, JAIDS-J ACQ IMM DEF, V45, P286; Haas DW, 2004, AIDS, V18, P2391; Hadigan C, 2004, ANN INTERN MED, V140, P786, DOI 10.7326/0003-4819-140-10-200405180-00008; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; HAMMOND E, 2008, 15 C RETR OPP INF FE; Hashimoto M, 1998, INT J OBESITY, V22, P477, DOI 10.1038/sj.ijo.0800620; Heath KV, 2001, AIDS, V15, P231, DOI 10.1097/00002030-200101260-00013; Hendricks KM, 2003, AM J CLIN NUTR, V78, P790, DOI 10.1093/ajcn/78.4.790; Hodgson LM, 2001, AIDS, V15, P2341, DOI 10.1097/00002030-200111230-00024; Huang JS, 2001, AIDS, V15, P975, DOI 10.1097/00002030-200105250-00005; Hulgan T, 2008, J INFECT DIS, V197, P858, DOI 10.1086/528697; Joly V, 2002, AIDS, V16, P2447, DOI 10.1097/00002030-200212060-00010; Jones SP, 2001, AIDS, V15, P2049, DOI 10.1097/00002030-200110190-00021; Joy T, 2008, JAIDS-J ACQ IMM DEF, V47, P174, DOI 10.1097/QAI.0b013e31815b0792; Joy T, 2007, AIDS, V21, P1591, DOI 10.1097/QAD.0b013e32823644ff; Kannisto K, 2003, AIDS, V17, P1753, DOI 10.1097/00002030-200308150-00004; Khara M, 2005, JAIDS-J ACQ IMM DEF, V40, P119, DOI 10.1097/01.qai.0000187137.34789.dd; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Kohli R, 2007, HIV MED, V8, P420, DOI 10.1111/j.1468-1293.2007.00488.x; Kotler DP, 1999, AM J CLIN NUTR, V69, P432; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Lafaurie M, 2005, JAIDS-J ACQ IMM DEF, V38, P393, DOI 10.1097/01.qai.0000152834.02912.98; Ledru E, 2000, BLOOD, V95, P3191, DOI 10.1182/blood.V95.10.3191.010k10_3191_3198; Lichtenstein KA, 2005, JAIDS-J ACQ IMM DEF, V39, P395, DOI 10.1097/01.qai.0000167478.28051.3a; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Lichtenstein KA, 2003, JAIDS-J ACQ IMM DEF, V32, P48, DOI 10.1097/00126334-200301010-00007; Lichtenstein KA, 2008, J INFECT DIS, V197, P784, DOI 10.1086/528698; LINDEGAARD B, 2005, 12 C RETR OPP INF FE; *LIPP WILL WILK, 2006, STEDM MED DICT; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Madge S, 1999, AIDS, V13, P735, DOI 10.1097/00002030-199904160-00020; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Martinez E, 2000, CLIN INFECT DIS, V31, P1266, DOI 10.1086/317426; Martinez E, 1999, AIDS, V13, P805, DOI 10.1097/00002030-199905070-00009; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; McComsey GA, 2004, CLIN INFECT DIS, V38, P263, DOI 10.1086/380790; McComsey Grace, 2002, AIDS Reviews, V4, P140; Mertens I, 2001, HORM METAB RES, V33, P602, DOI 10.1055/s-2001-17907; MOYLE G, 2008, 15 C RETR OPP INF FE; Mulligan K, 2007, AIDS, V21, P47, DOI 10.1097/QAD.0b013e328011220e; MUN D, 2008, 15 C RETR OPP INF FE; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; MUURAHAINEN N, 1999, ANTIVIR THER S, V4, P44; National Cholesterol Education Program, 2002, DET EV TREATM HIGH B; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Palella FJ, 2004, CLIN INFECT DIS, V38, P903, DOI 10.1086/381684; Panther LA, 2002, AM J PHYSIOL-HEART C, V283, pH1, DOI 10.1152/ajpheart.00212.2002; PATON N, 2005, 12 C RETR OPP INF FE; Paton NIJ, 1997, J ACQ IMMUN DEF SYND, V14, P119, DOI 10.1097/00042560-199702010-00004; PILIERO P, 2002, 9 C RETR OPP INF FEB; Piliero PJ, 2003, CLIN INFECT DIS, V37, P1374, DOI 10.1086/379073; PODZAMCZER D, 2008, 15 C RETR OPP INF FE; Podzamczer D, 2007, JAIDS-J ACQ IMM DEF, V44, P139, DOI 10.1097/QAI.0b013e31802bf122; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Rodriguez-Novoa S, 2005, CLIN INFECT DIS, V40, P1358, DOI 10.1086/429327; Roudiere L, 2000, AIDS, V14, P2056, DOI 10.1097/00002030-200009080-00026; Saag MS, 2004, JAMA-J AM MED ASSOC, V292, P180, DOI 10.1001/jama.292.2.180; Sabin C, 2008, 15 C RETR OPP INF FE; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; Saint-Marc T, 1999, AIDS, V13, P1000, DOI 10.1097/00002030-199905280-00023; Saint-Marc T, 1999, AIDS, V13, P2188, DOI 10.1097/00002030-199910220-00035; Sattler FR, 2001, AIDS, V15, P2001, DOI 10.1097/00002030-200110190-00013; Saves M, 2002, CLIN INFECT DIS, V34, P1396, DOI 10.1086/339866; Schambelan M, 2002, JAIDS-J ACQ IMM DEF, V31, P257, DOI 10.1097/00126334-200211010-00001; Schurmann D, 2005, AIDS, V19, P2052, DOI 10.1097/01.aids.0000191924.16561.ca; Sekhar RV, 2005, AM J CLIN NUTR, V81, P1405; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Shevitz A, 2001, AIDS, V15, P1917, DOI 10.1097/00002030-200110190-00003; Smith BA, 2001, AIDS, V15, P693, DOI 10.1097/00002030-200104130-00004; Sweeney LL, 2007, AIDS, V21, P895, DOI 10.1097/QAD.0b013e3280adc91e; Tien PC, 2003, JAIDS-J ACQ IMM DEF, V34, P461, DOI 10.1097/00126334-200312150-00003; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Torriani M, 2003, J APPL PHYSIOL, V95, P1005, DOI 10.1152/japplphysiol.00366.2003; Valantin MA, 2003, AIDS, V17, P2471, DOI 10.1097/00002030-200311210-00009; van Wijk JP, 2005, ANN INTERN MED, V143, P695, DOI 10.7326/0003-4819-143-9-200511010-00025; van Wijk JPH, 2005, ANN INTERN MED, V143, P337, DOI 10.7326/0003-4819-143-5-200509060-00009; VANVONDEREN MGA, 2008, 15 C RETR OPP INF FE; Vigouroux C, 2003, AIDS, V17, P1503, DOI 10.1097/00002030-200307040-00011; Walker UA, 2002, J ACQ IMMUN DEF SYND, V29, P117, DOI 10.1097/00042560-200202010-00002; Walli R, 2001, EUR J MED RES, V6, P413; WANKE C, 2000, 7 C RETR OPP INF JAN; Worth L, 2003, CLIN INFECT DIS, V37, P315, DOI 10.1086/375850	128	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2008	300	9					1056	1066		10.1001/jama.300.5.jrr80007	http://dx.doi.org/10.1001/jama.300.5.jrr80007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342YN	18677013				2022-12-28	WOS:000258819600022
J	Knesel, KM; Cohen, BE; Vasconcelos, PM; Thiede, DS				Knesel, Kurt M.; Cohen, Benjamin E.; Vasconcelos, Paulo M.; Thiede, David S.			Rapid change in drift of the Australian plate records collision with Ontong Java plateau	NATURE			English	Article							SOLOMON-ISLANDS; OCEANIC PLATEAUS; EARTHS MANTLE; K-AR; HOTSPOTS; PACIFIC; MOTION; GEOCHRONOLOGY; SEAMOUNTS; VOLCANISM	The subduction of oceanic plateaux, which contain extraordinarily thick basaltic crust and are the marine counterparts of continental flood-basalt provinces, is an important factor in many current models of plate motion(1-4) and provides a potential mechanism for triggering plate reorganization(5). To evaluate such models, it is essential to decipher the history of the collision between the largest and thickest of the world's oceanic plateaux, the Ontong Java plateau, and the Australian plate, but this has been hindered by poor constraints for the arrival of the plateau at the Melanesian trench. Here we present (40)Ar-(39)Ar geochronological data on hotspot volcanoes in eastern Australian that reveal a strong link between collision of the Greenland-sized Ontong Java plateau with the Melanesian arc and motion of the Australian plate. The new ages define a short-lived period of reduced northward plate motion between 26 and 23 Myr ago, coincident with an eastward offset in the contemporaneous tracks of seamount chains in the Tasman Sea east of Australia. These features record a brief westward deflection of the Australian plate as the plateau entered and choked the Melanesian trench 26 Myr ago. From 23 Myr ago, Australia returned to a rapid northerly trajectory at roughly the same time that southwest-directed subduction began along the Trobriand trough(6). The timing and brevity of this collisional event correlate well with offsets in hotspot seamount tracks on the Pacific plate, including the archetypal Hawaiian chain(7), and thus provide strong evidence that immense oceanic plateaux, like the Ontong Java, can contribute to initiating rapid change in plate boundaries and motions on a global scale.	[Knesel, Kurt M.; Cohen, Benjamin E.; Vasconcelos, Paulo M.; Thiede, David S.] Univ Queensland, St Lucia, Qld 4072, Australia	University of Queensland	Knesel, KM (corresponding author), Univ Queensland, St Lucia, Qld 4072, Australia.	k.knesel@uq.edu.au; b.cohen@uq.edu.au		Cohen, Benjamin/0000-0002-1634-8998				ASHLEY PM, 1995, AUST J EARTH SCI, V42, P471, DOI 10.1080/08120099508728217; CLOOS M, 1993, GEOL SOC AM BULL, V105, P715, DOI 10.1130/0016-7606(1993)105<0715:LBACOS>2.3.CO;2; Clouard V, 2001, GEOLOGY, V29, P695, DOI 10.1130/0091-7613(2001)029<0695:HMPHAF>2.0.CO;2; COFFIN MF, 1993, GEOLOGY, V21, P515, DOI 10.1130/0091-7613(1993)021<0515:STSEDO>2.3.CO;2; Cohen BE, 2007, AUST J EARTH SCI, V54, P105, DOI 10.1080/08120090600981483; COOPER PA, 1985, NATURE, V314, P428, DOI 10.1038/314428a0; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; DePaolo DJ, 2003, SCIENCE, V300, P920, DOI 10.1126/science.1083623; Duncan R. A., 1989, INTRAPLATE VOLCANISM, P43; EWART A, 1985, AUST J EARTH SCI, V32, P359, DOI 10.1080/08120098508729339; Foulger GR, 2003, SCIENCE, V300, P921, DOI 10.1126/science.1083376; Gaina C, 2007, EARTH-SCI REV, V83, P177, DOI 10.1016/j.earscirev.2007.04.004; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Kelley S, 2002, CHEM GEOL, V188, P1, DOI 10.1016/S0009-2541(02)00064-5; Koppers AAP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000671; Kroenke LW, 2004, GEOL SOC SPEC PUBL, V229, P9, DOI 10.1144/GSL.SP.2004.229.01.02; Ludwig K.R., 2003, BERKELEY GEOCHRONOL; Mann P, 2004, TECTONOPHYSICS, V389, P137, DOI 10.1016/j.tecto.2003.10.024; MCDOUGALL I, 1988, EARTH PLANET SC LETT, V89, P207, DOI 10.1016/0012-821X(88)90173-2; McDougall I., 1999, GEOCHRONOLOGY THERMO, V2ed; MCELHINNY MW, 1974, GEOPHYS J ROY ASTR S, V36, P141, DOI 10.1111/j.1365-246X.1974.tb03629.x; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; MULLER RD, 1993, GEOLOGY, V21, P275, DOI 10.1130/0091-7613(1993)021<0275:RPMRTT>2.3.CO;2; NIER AO, 1950, PHYS REV, V77, P789, DOI 10.1103/PhysRev.77.789; O'Neill C, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000784; PETKOVIC P, 2002, AUSTR BATHYMETRY TOP; Petterson MG, 1997, TECTONOPHYSICS, V283, P1, DOI 10.1016/S0040-1951(97)00206-0; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P362; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; Tregoning P, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000406; van Ufford AQ, 2005, AAPG BULL, V89, P119, DOI 10.1306/08300403073; Vasconcelos PM, 1999, ANNU REV EARTH PL SC, V27, P183, DOI 10.1146/annurev.earth.27.1.183; Vasconcelos PN, 2002, AN ACAD BRAS CIENC, V74, P297, DOI 10.1590/S0001-37652002000200008; Wellman P., 1975, P ROY SOC QUEENSL, V86, P147; Wessel P, 2000, J GEOPHYS RES-SOL EA, V105, P28255, DOI 10.1029/2000JB900290; Wessel P, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001636; [No title captured]	40	85	89	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					754	U75		10.1038/nature07138	http://dx.doi.org/10.1038/nature07138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685705				2022-12-28	WOS:000258228000042
J	Barfield, RC; Kane, JR				Barfield, Raymond C.; Kane, Javier R.			Balancing disclosure of diagnosis and assent for research in children with HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barfield, Raymond C.; Kane, Javier R.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Kane, Javier R.] St Jude Childrens Res Hosp, Palliat & End Life Care Program, Memphis, TN 38105 USA; [Barfield, Raymond C.; Kane, Javier R.] St Jude Childrens Res Hosp, Eth Committee, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kane, JR (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	javier.kane@stjude.org		Barfield, Raymond/0000-0003-1006-1985	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765, P30 CA021765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1998, J Child Fam Nurs, V1, P57; Barfield RC, 2005, CURR OPIN PEDIATR, V17, P20, DOI 10.1097/01.mop.0000145718.77939.b1; Field Marilyn J, 2004, ETHICAL CONDUCT CLIN; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Kline MW, 2001, PEDIATRICS, V107, P188, DOI 10.1542/peds.107.1.188; KOHRMAN A, 1994, PEDIATRICS, V93, P532; Lesch A, 2007, AIDS CARE, V19, P811, DOI 10.1080/09540120601129301; Nelson RM, 2001, PEDIATRICS, V107, P205; *US DEP HHS, I REV BOARD GUIDB, pCH6; *US DEP HHS, SUBP D ADD PROT CHIL; van Dulmen AM, 1998, PEDIATRICS, V102, P563, DOI 10.1542/peds.102.3.563; Waugh S, 2003, AIDS CARE, V15, P169, DOI 10.1080/0954012031000068317; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wilfert C, 1999, PEDIATRICS, V103, P164; 2000, PEDIATRICS, V105, P1358	15	3	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					576	578		10.1001/jama.300.5.576	http://dx.doi.org/10.1001/jama.300.5.576			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677031				2022-12-28	WOS:000258188900020
J	Running, SW				Running, Steven W.			Climate change - Ecosystem disturbance, carbon, and climate	SCIENCE			English	Editorial Material							NATURAL DISTURBANCES; FEEDBACK; BEETLE		Univ Montana, Coll Forestry, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA	University of Montana System; University of Montana	Running, SW (corresponding author), Univ Montana, Coll Forestry, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA.	swr@ntsg.umt.edu						Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Chambers JQ, 2007, SCIENCE, V318, P1107, DOI 10.1126/science.1148913; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Kurz WA, 2008, P NATL ACAD SCI USA, V105, P1551, DOI 10.1073/pnas.0708133105; Mildrexler DJ, 2007, ECOL APPL, V17, P235, DOI 10.1890/1051-0761(2007)017[0235:ANSMFC]2.0.CO;2; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Stockli R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000562; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Tansey K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031567	15	204	217	13	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					652	653		10.1126/science.1159607	http://dx.doi.org/10.1126/science.1159607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669853				2022-12-28	WOS:000258077700032
J	Prins, RM; Cloughesy, TF; Liau, LM				Prins, Robert M.; Cloughesy, Timothy F.; Liau, Linda M.			Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							INFECTION		[Prins, Robert M.; Cloughesy, Timothy F.; Liau, Linda M.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Prins, RM (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	rprins@mednet.ucla.edu	Cloughesy, Timothy Francis/AGV-1013-2022; Prins, Robert/AAX-1155-2021	Prins, Robert/0000-0002-6282-6583; Liau, Linda/0000-0002-4053-0052	NATIONAL CANCER INSTITUTE [K01CA111402, R01CA123396, R01CA112358] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA111402-01A2, R01 CA123396-02, R01 CA123396, R01 CA112358-03, K01 CA111402, R01 CA112358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cobbs CS, 2002, CANCER RES, V62, P3347; Deorah Sundeep, 2006, Neurosurg Focus, V20, pE1, DOI 10.3171/foc.2006.20.4.E1; HO KL, 1991, CLIN NEUROPATHOL, V10, P127; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035	5	121	124	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					539	541		10.1056/NEJMc0804818	http://dx.doi.org/10.1056/NEJMc0804818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669440	Green Accepted, Bronze			2022-12-28	WOS:000258039700033
J	Lenzer, J; Brownlee, S				Lenzer, Jeanne; Brownlee, Shannon			Is there an (unbiased) doctor in the house?	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEWS		[Brownlee, Shannon] New Amer Fdn, Washington, DC USA			jeanne.lenzer@gmail.com						BROWNLEE S, SLATE; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; GARBER K, US NEWS WORLD REPORT; Lenzer J, 2008, BRIT MED J, V336, P1327, DOI 10.1136/bmj.39609.364688.DB; Moynihan R, 2008, BRIT MED J, V336, P1402, DOI 10.1136/bmj.39575.675787.651; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Shuchman M, 1997, ANN INTERN MED, V126, P976, DOI 10.7326/0003-4819-126-12-199706150-00008	7	10	10	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a930	10.1136/bmj.a930	http://dx.doi.org/10.1136/bmj.a930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335EG	18650241				2022-12-28	WOS:000258273000034
J	Tzoulaki, I; Brown, IJ; Chan, Q; Van Horn, L; Ueshima, H; Zhao, LC; Stamler, J; Elliott, P				Tzoulaki, Ioanna; Brown, Ian J.; Chan, Queenie; Van Horn, Linda; Ueshima, Hirotsugu; Zhao, Liancheng; Stamler, Jeremiah; Elliott, Paul		Int Collaborative Res Grp Macro Mi	Relation of iron and red meat intake to blood pressure: cross sectional epidemiological study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; DIETARY IRON; MYOCARDIAL-INFARCTION; RISK-FACTOR; HEME-IRON; HYPERTENSION; INTERMAP; WOMEN; FOOD; METAANALYSIS	Objective To investigate associations of dietary iron (total, haem, and non-haem), supplemental iron, and red meat with blood pressure. Design Cross sectional epidemiological study. Setting 17 population samples from Japan, China, the United Kingdom, and the United States participatingin the international collaborative on macro-/micronutrients and blood pressure (INTERMAP). Participants 4680 adults aged 40-59. Main outcome measure Average of eight blood pressure readings. Results In multiple linear regression analyses dietary total. iron and non-haem iron were consistently inversely associated with blood pressure. With adjustment for potential non-dietaryand dietary confounders, dietarytotal iron intake higherby 4.20 mg/4.2 MJ (2 SID) was associated with 1.39 mm Hg (P<0.01) lower systolic blood pressure. Dietary non-haem iron intake higher by 4.13 mg/4.2 MJ (2 SID) was associated with 1.45 mm Hg (P<0.001) lower systolic blood pressure. Differences were smaller for diastolic blood pressure. In most models haem iron intake from food was positively, non-significantly associated with blood pressure. Iron intake from combined diet and supplements yielded smaller associations than dietary iron alone. Red meat intake was directly associated with blood pressure; 102.6 g/24 h (2 SD) higher intake was associated with 1.25 mm Hg higher systolic blood pressure. Associations between red meat and blood pressure persisted after adjustment for multiple confounders. Conclusion Non-haem iron has a possible role in the prevention and control of adverse blood pressure levels. An unfavourable effect of red meat on blood pressure was observed. These results need confirmation including in prospective studies, clinical trials, and from experimental evidence on possible mechanisms.	[Tzoulaki, Ioanna; Brown, Ian J.; Chan, Queenie; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Van Horn, Linda; Stamler, Jeremiah] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Shiga, Japan; [Zhao, Liancheng] Chinese Acad Sci, Fu Wai Hosp, Cardiovasc Inst, Beijing, Peoples R China; [Zhao, Liancheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Imperial College London; Northwestern University; Feinberg School of Medicine; Shiga University of Medical Science; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Tzoulaki, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, St Marys Campus, London W2 1PG, England.	I.Tzoulaki@imperial.ac.uk	Chan, Queenie/C-5017-2011; Tzoulaki, Ioanna/C-1381-2008; Tzoulaki, Ioanna/ABE-6269-2020	Chan, Queenie/0000-0001-9278-230X; Tzoulaki, Ioanna/0000-0002-4275-9328; Elliott, Paul/0000-0002-7511-5684	NHLBI NIH HHS [R01 HL050490, 2-R01-HL50490] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050490] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; ASCHERIO A, 1994, CIRCULATION, V89, P969, DOI 10.1161/01.CIR.89.3.969; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; BUZZARD M, 1998, 24 HOUR DIETARY RECA; Cade JE, 2005, AM J CLIN NUTR, V82, P813, DOI 10.1093/ajcn/82.4.813; COOK JD, 1990, AM J CLIN NUTR, V51, P301, DOI 10.1093/ajcn/51.2.301; Danesh J, 1999, CIRCULATION, V99, P852, DOI 10.1161/01.CIR.99.7.852; de Champlain J, 2004, CLIN EXP HYPERTENS, V26, P593, DOI 10.1081/CEH-200031904; Dennis B, 2003, J HUM HYPERTENS, V17, P609, DOI 10.1038/sj.jhh.1001604; DYER AR, 1994, AM J EPIDEMIOL, V139, P927, DOI 10.1093/oxfordjournals.aje.a117099; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Elliott P, 2008, HYPERTENSION, V51, P669, DOI 10.1161/HYPERTENSIONAHA.107.103747; Fleming DJ, 2001, AM J CLIN NUTR, V73, P638; Grandits Greg A., 1997, American Journal of Clinical Nutrition, V65, p211S, DOI 10.1093/ajcn/65.1.211S; Hallberg L, 2000, AM J CLIN NUTR, V71, P1147; Hallberg L, 2002, EUR J CLIN NUTR, V56, pS12, DOI 10.1038/sj.ejcn.1601348; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Klipstein-Grobusch K, 1999, AM J EPIDEMIOL, V149, P421, DOI 10.1093/oxfordjournals.aje.a009829; Lawes CMM, 2006, J HYPERTENS, V24, P413, DOI 10.1097/01.hjh.0000199801.72563.6f; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LIU K, 1988, AM J EPIDEMIOL, V127, P864, DOI 10.1093/oxfordjournals.aje.a114870; Malaviarachchi D, 2002, CAN J PUBLIC HEALTH, V93, P267, DOI 10.1007/BF03405014; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; MONSEN ER, 1978, AM J CLIN NUTR, V31, P134, DOI 10.1093/ajcn/31.1.134; Qi L, 2007, DIABETES CARE, V30, P101, DOI 10.2337/dc06-1686; REUNANEN A, 1995, J INTERN MED, V238, P223, DOI 10.1111/j.1365-2796.1995.tb00926.x; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Roughead ZK, 2000, AM J CLIN NUTR, V72, P982; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; Schakel SF, 2003, J FOOD COMPOS ANAL, V16, P395, DOI 10.1016/S0889-1575(03)00043-7; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; SULLIVAN JL, 1994, CIRCULATION, V90, P3122, DOI 10.1161/circ.90.6.7864981; Tavani A, 2006, PUBLIC HEALTH NUTR, V9, P480, DOI 10.1079/PHN2005869; Tzonou A, 1998, AM J EPIDEMIOL, V147, P161; Ueshima H, 2007, HYPERTENSION, V50, P313, DOI 10.1161/HYPERTENSIONAHA.107.090720; van der A DL, 2005, EUR HEART J, V26, P257, DOI 10.1093/eurheartj/ehi027; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Zacharski LR, 2007, JAMA-J AM MED ASSOC, V297, P603, DOI 10.1001/jama.297.6.603	44	69	69	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a258	10.1136/bmj.a258	http://dx.doi.org/10.1136/bmj.a258			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18632704	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000258273000038
J	Drummond, DA; Wilke, CO				Drummond, D. Allan; Wilke, Claus O.			Mistranslation-induced protein misfolding as a dominant constraint on coding-sequence evolution	CELL			English	Article							SYNONYMOUS CODON USAGE; TRANSFER-RNA SYNTHETASE; GENE-EXPRESSION; SUBSTITUTION RATES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL ACCURACY; MUTATION-RATE; SELECTION; DROSOPHILA	Strikingly consistent correlations between rates of coding-sequence evolution and gene expression levels are apparent across taxa, but the biological causes behind the selective pressures on coding-sequence evolution remain controversial. Here, we demonstrate conserved patterns of simple covariation between sequence evolution, codon usage, and mRNA level in E. coli, yeast, worm, fly, mouse, and human that suggest that all observed trends stem largely from a unified underlying selective pressure. In metazoans, these trends are strongest in tissues composed of neurons, whose structure and lifetime confer extreme sensitivity to protein misfolding. We propose, and demonstrate using a molecular-level evolutionary simulation, that selection against toxicity of misfolded proteins generated by ribosome errors suffices to create all of the observed covariation. The mechanistic model of molecular evolution that emerges yields testable biochemical predictions, calls into question the use of nonsynonymous-to-synonymous substitution ratios (Ka/Ks) to detect functional selection, and suggests how mistranslation may contribute to neurodegenerative disease.	[Drummond, D. Allan] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Wilke, Claus O.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA	Harvard University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Drummond, DA (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	dadrummond@cgr.harvard.edu	Wilke, Claus O./B-4643-2008; Drummond, D. Allan/A-1250-2015	Drummond, D. Allan/0000-0001-7018-7059; Wilke, Claus/0000-0002-7470-9261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM068763-05, P50 GM068763] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKASHI H, 1994, GENETICS, V136, P927; Anfinsen Christian B., 1959, MOL BASIS EVOLUTION; Bacher JM, 2007, P NATL ACAD SCI USA, V104, P1907, DOI 10.1073/pnas.0610835104; Bierne N, 2003, GENETICS, V165, P1587; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Choi JK, 2007, GENETICS, V175, P199, DOI 10.1534/genetics.106.066027; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Koonin EV, 2006, CURR OPIN BIOTECH, V17, P481, DOI 10.1016/j.copbio.2006.08.003; Kourie JI, 2002, CLIN EXP PHARMACOL P, V29, P741, DOI 10.1046/j.1440-1681.2002.03737.x; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; LI WH, 1985, MOL BIOL EVOL, V2, P150; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Marais G, 2004, J MOL EVOL, V59, P771, DOI 10.1007/s00239-004-2671-2; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Parmley JL, 2007, PLOS BIOL, V5, P343, DOI 10.1371/journal.pbio.0050014; Popescu CE, 2006, GENETICS, V172, P1567, DOI 10.1534/genetics.105.047399; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2007, NEUROSCIENTIST, V13, P519, DOI 10.1177/1073858407303428; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Wilke CO, 2006, GENETICS, V173, P473, DOI 10.1534/genetics.105.051300; Wilke CO, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-25; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Wright SI, 2004, MOL BIOL EVOL, V21, P1719, DOI 10.1093/molbev/msh191; Wyckoff GJ, 2005, TRENDS GENET, V21, P381, DOI 10.1016/j.tig.2005.05.005; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974; ZUCKERKANDL E, 1976, J MOL EVOL, V7, P167, DOI 10.1007/BF01731487	68	739	758	2	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					341	352		10.1016/j.cell.2008.05.042	http://dx.doi.org/10.1016/j.cell.2008.05.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662548	Green Accepted, Bronze			2022-12-28	WOS:000257891700022
J	Li, Q; Zhou, H; Wurtele, H; Davies, B; Horazdovsky, B; Verreault, A; Zhang, ZG				Li, Qing; Zhou, Hui; Wurtele, Hugo; Davies, Brian; Horazdovsky, Bruce; Verreault, Alain; Zhang, Zhiguo			Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly	CELL			English	Article							DNA-REPLICATION; EPIGENETIC INHERITANCE; S-PHASE; CHROMATIN; H3; ASF1; H4; YEAST; COMPLEX; HETEROCHROMATIN	Chromatin assembly factor 1 (CAF-1) and Rtt106 participate in the deposition of newly synthesized histones onto replicating DNA to form nucleosomes. This process is critical for the maintenance of genome stability and inheritance of functionally specialized chromatin structures in proliferating cells. However, the molecular functions of the acetylation of newly synthesized histones in this DNA replication-coupled nucleosome assembly pathway remain enigmatic. Here we show that histone H3 acetylated at lysine 56 (H3K56Ac) is incorporated onto replicating DNA and, by increasing the binding affinity of CAF-1 and Rtt106 for histone H3, H3K56Ac enhances the ability of these histone chaperones to assemble DNA into nucleosomes. Genetic analysis indicates that H3K56Ac acts in a nonredundant manner with the acetylation of the N-terminal residues of H3 and H4 in nucleosome assembly. These results reveal a mechanism by which H3K56Ac regulates replication-coupled nucleosome assembly mediated by CAF-1 and Rtt106.	[Wurtele, Hugo; Verreault, Alain] IRIC, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; [Li, Qing; Zhou, Hui; Davies, Brian; Horazdovsky, Bruce; Zhang, Zhiguo] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Universite de Montreal; Mayo Clinic	Verreault, A (corresponding author), IRIC, Dept Pathol & Biol Cellulaire, POB 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	alain.verreault@umontreal.ca; zhang.zhiguo@mayo.edu			NIGMS NIH HHS [R01 GM081838, R01 GM081838-01A1, R01 GM072719, R01 GM072719-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838, R01GM072719] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Falbo KB, 2006, J CELL BIOCHEM, V97, P684, DOI 10.1002/jcb.20752; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shibahara K, 2000, P NATL ACAD SCI USA, V97, P7766, DOI 10.1073/pnas.97.14.7766; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	46	328	334	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					244	255		10.1016/j.cell.2008.06.018	http://dx.doi.org/10.1016/j.cell.2008.06.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662540	Green Accepted, Bronze			2022-12-28	WOS:000257891700014
J	Shima, S; Pilak, O; Vogt, S; Schick, M; Stagni, MS; Meyer-Klaucke, W; Warkentin, E; Thauer, RK; Ermler, U				Shima, Seigo; Pilak, Oliver; Vogt, Sonja; Schick, Michael; Stagni, Marco S.; Meyer-Klaucke, Wolfram; Warkentin, Eberhard; Thauer, Rudolf K.; Ermler, Ulrich			The crystal structure of [Fe]-hydrogenase reveals the geometry of the active site	SCIENCE			English	Article							CLUSTER-FREE HYDROGENASE; FE-ONLY HYDROGENASE; METAL-FREE HYDROGENASE; DESULFOVIBRIO-DESULFURICANS; CLOSTRIDIUM-PASTEURIANUM; METHANOGENIC ARCHAEA; CARBON-MONOXIDE; COORDINATION CHEMISTRY; LIGHT-INACTIVATION; NIFE HYDROGENASES	Biological formation and consumption of molecular hydrogen (H(2)) are catalyzed by hydrogenases, of which three phylogenetically unrelated types are known: [ NiFe]- hydrogenases, [ FeFe]- hydrogenases, and [ Fe]- hydrogenase. We present a crystal structure of [ Fe]- hydrogenase at 1.75 angstrom resolution, showing a mononuclear iron coordinated by the sulfur of cysteine 176, two carbon monoxide ( CO) molecules, and the sp(2)- hybridized nitrogen of a 2- pyridinol compound with back- bonding properties similar to those of cyanide. The three- dimensional arrangement of the ligands is similar to that of thiolate, CO, and cyanide ligated to the low- spin iron in binuclear [ NiFe]- and [ FeFe]- hydrogenases, although the enzymes have evolved independently and the CO and cyanide ligands are not found in any other metalloenzyme. The related iron ligation pattern of hydrogenases exemplifies convergent evolution and presumably plays an essential role in H(2) activation. This finding may stimulate the ongoing synthesis of catalysts that could substitute for platinum in applications such as fuel cells.	[Shima, Seigo; Pilak, Oliver; Vogt, Sonja; Schick, Michael; Thauer, Rudolf K.] Univ Marburg, Max Planck Inst Terr Microbiol, Fachbereich Biol, D-35043 Marburg, Germany; [Shima, Seigo; Pilak, Oliver; Vogt, Sonja; Schick, Michael; Thauer, Rudolf K.] Univ Marburg, Mikrobiol Lab, Fachbereich Biol, D-35043 Marburg, Germany; [Stagni, Marco S.; Meyer-Klaucke, Wolfram] EMBL Hamburg, D-22603 Hamburg, Germany; [Warkentin, Eberhard; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society; Philipps University Marburg; Philipps University Marburg; European Molecular Biology Laboratory (EMBL); Max Planck Society	Shima, S (corresponding author), Univ Marburg, Max Planck Inst Terr Microbiol, Fachbereich Biol, Karl von Frisch Str, D-35043 Marburg, Germany.	shima@mpi-marburg.mpg.de; ulermler@mpibp-frankfurt.mpg.de	Salomone-Stagni, Marco/F-4458-2010; Meyer-Klaucke, Wolfram/G-1148-2010					Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Buurman G, 2000, FEBS LETT, V485, P200, DOI 10.1016/S0014-5793(00)02225-0; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; HEINEKEY DM, 1993, CHEM REV, V93, P913, DOI 10.1021/cr00019a004; Hu XL, 2007, J AM CHEM SOC, V129, P8988, DOI 10.1021/ja067876b; Justice AK, 2007, INORG CHEM, V46, P1655, DOI 10.1021/ic0618706; Korbas M, 2006, J BIOL CHEM, V281, P30804, DOI 10.1074/jbc.M605306200; Kubas GJ, 2005, CATAL LETT, V104, P79, DOI 10.1007/s10562-005-7440-3; Lemon BJ, 1999, BIOCHEMISTRY-US, V38, P12969, DOI 10.1021/bi9913193; Liu TB, 2007, J AM CHEM SOC, V129, P7008, DOI 10.1021/ja071851a; Lyon EJ, 2004, EUR J BIOCHEM, V271, P195, DOI 10.1046/j.1432-1033.2003.03920.x; Lyon EJ, 2004, J AM CHEM SOC, V126, P14239, DOI 10.1021/ja046818s; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; RAWSON JM, 1995, COORDIN CHEM REV, V139, P313, DOI 10.1016/0010-8545(94)01117-T; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Shima S, 2004, ANGEW CHEM INT EDIT, V43, P2547, DOI 10.1002/anie.200353763; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Silakov A, 2007, J AM CHEM SOC, V129, P11447, DOI 10.1021/ja072592s; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vogt S, 2008, J BIOL INORG CHEM, V13, P97, DOI 10.1007/s00775-007-0302-2; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wolfe S, 2007, THEOR CHEM ACC, V118, P265, DOI 10.1007/s00214-007-0321-7	31	446	455	5	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					572	575		10.1126/science.1158978	http://dx.doi.org/10.1126/science.1158978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653896				2022-12-28	WOS:000257888900051
J	Urban, KW				Urban, Knut W.			Studying atomic structures by aberration-corrected transmission electron microscopy	SCIENCE			English	Review							SPHERICAL-ABERRATION; PHASE-RETRIEVAL; FOCUS-VARIATION; RESOLUTION; RECONSTRUCTION; OXYGEN; SCALE; CRYSTALS; TOMOGRAPHY; INTERFACES	Seventy- five years after its invention, transmission electron microscopy has taken a great step forward with the introduction of aberration- corrected electron optics. An entirely new generation of instruments enables studies in condensed- matter physics and materials science to be performed at atomic- scale resolution. These new possibilities are meeting the growing demand of nanosciences and nanotechnology for the atomic- scale characterization of materials, nanosynthesized products and devices, and the validation of expected functions. Equipped with electron- energy filters and electron- energy- loss spectrometers, the new instruments allow studies not only of structure but also of elemental composition and chemical bonding. The energy resolution is about 100 milli- electron volts, and the accuracy of spatial measurements has reached a few picometers. However, understanding the results is generally not straightforward and only possible with extensive quantum- mechanical computer calculations.	[Urban, Knut W.] Forschungszentrum Julich, Helmholtz Res Ctr, Inst Solid State Res, D-52425 Julich, Germany; [Urban, Knut W.] Forschungszentrum Julich, Helmholtz Res Ctr, Ernst Ruska Ctr Microscopy & Spect Electrons, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Urban, KW (corresponding author), Forschungszentrum Julich, Helmholtz Res Ctr, Inst Solid State Res, D-52425 Julich, Germany.	k.urban@fz-juelich.de						Allen LJ, 2003, ULTRAMICROSCOPY, V96, P47, DOI 10.1016/S0304-3991(02)00380-7; Bar Sadan M, 2008, NANO LETT, V8, P891, DOI 10.1021/nl073149i; Batson PE, 2003, ULTRAMICROSCOPY, V96, P239, DOI 10.1016/S0304-3991(03)00091-3; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Billinge SJL, 2007, SCIENCE, V316, P561, DOI 10.1126/science.1135080; Borisevich AY, 2006, J ELECTRON MICROSC, V55, P7, DOI 10.1093/jmicro/dfi075; Bosman M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.086102; COENE W, 1992, PHYS REV LETT, V69, P3743, DOI 10.1103/PhysRevLett.69.3743; Coene WMJ, 1996, ULTRAMICROSCOPY, V64, P109, DOI 10.1016/0304-3991(96)00010-1; Dellby N, 2001, J ELECTRON MICROSC, V50, P177, DOI 10.1093/jmicro/50.3.177; Falke U, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.116103; Geiger D, 2008, MICROSC MICROANAL, V14, P68, DOI 10.1017/S143192760808001X; Gontard LC, 2007, ANGEW CHEM INT EDIT, V46, P3683, DOI 10.1002/anie.200604811; Haider M, 2008, ULTRAMICROSCOPY, V108, P167, DOI 10.1016/j.ultramic.2007.07.007; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Houben L, 2006, ULTRAMICROSCOPY, V106, P200, DOI 10.1016/j.ultramic.2005.07.009; Jia CL, 2008, NAT MATER, V7, P57, DOI 10.1038/nmat2080; Jia CL, 1999, PHYS REV LETT, V82, P5052, DOI 10.1103/PhysRevLett.82.5052; Jia CL, 2004, SCIENCE, V303, P2001, DOI 10.1126/science.1093617; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Kimoto K, 2007, NATURE, V450, P702, DOI 10.1038/nature06352; Koch CT, 2006, MICROSC MICROANAL, V12, P506, DOI 10.1017/S1431927606060624; Krivanek OL, 2008, ULTRAMICROSCOPY, V108, P179, DOI 10.1016/j.ultramic.2007.07.010; Lentzen M, 2000, ACTA CRYSTALLOGR A, V56, P235, DOI 10.1107/S0108767300000040; Lentzen M, 2004, ULTRAMICROSCOPY, V99, P211, DOI 10.1016/j.ultramic.2003.12.007; LENTZEN M, 2006, MICROSC MICROANAL S2, V12, P1456; Lentzen M, 2006, MICROSC MICROANAL, V12, P191, DOI 10.1017/S1431927606060326; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Mkhoyan KA, 2006, SCIENCE, V312, P1354, DOI 10.1126/science.1124511; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Nellist PD, 1999, ULTRAMICROSCOPY, V78, P111, DOI 10.1016/S0304-3991(99)00017-0; O'Keefe MA, 2008, ULTRAMICROSCOPY, V108, P196, DOI 10.1016/j.ultramic.2007.07.009; Oxley MP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064303; Oxley MP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203906; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; ROSE H, 1990, OPTIK, V85, P19; SCHERZER O, 1949, J APPL PHYS, V20, P20, DOI 10.1063/1.1698233; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Smith DJ, 2008, MICROSC MICROANAL, V14, P2, DOI 10.1017/S1431927608080124; Smith DJ, 1997, REP PROG PHYS, V60, P1513, DOI 10.1088/0034-4885/60/12/002; Sohlberg K, 2004, CHEMPHYSCHEM, V5, P1893, DOI 10.1002/cphc.200400212; Spence JCH, 2003, SCIENCE, V299, P839; Tang CY, 2006, ULTRAMICROSCOPY, V106, P539, DOI 10.1016/j.ultramic.2006.01.008; Thomas JM, 2003, CHEMPHYSCHEM, V4, P927, DOI 10.1002/cphc.200300772; THUST A, 2006, TRUEIMAGE SOFTWARE; Tillmann K, 2004, MICROSC MICROANAL, V10, P185, DOI 10.1017/S1431927604040395; Uhlemann S, 1998, ULTRAMICROSCOPY, V72, P109, DOI 10.1016/S0304-3991(97)00102-2; van Benthem K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1991989; Varela M, 2005, ANNU REV MATER RES, V35, P539, DOI 10.1146/annurev.matsci.35.102103.090513; Varela M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095502; Williams and Carter, 2010, TRANSMISSION ELECT M; Winkelman GB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2009067	54	256	270	11	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					506	510		10.1126/science.1152800	http://dx.doi.org/10.1126/science.1152800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653874				2022-12-28	WOS:000257888900031
J	Mantovani, A; Allavena, P; Sica, A; Balkwill, F				Mantovani, Alberto; Allavena, Paola; Sica, Antonio; Balkwill, Frances			Cancer-related inflammation	NATURE			English	Review							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TUMOR-ASSOCIATED MACROPHAGES; CHEMOKINE RECEPTOR CXCR4; COLITIS-ASSOCIATED CANCER; CELL LUNG-CANCER; COLORECTAL-CANCER; OVARIAN-CANCER; SIGNALING PATHWAY; BONE-MARROW	The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.	[Mantovani, Alberto; Allavena, Paola] IRCCS, Ist Clin Humanitas, I-20089 Milan, Italy; [Mantovani, Alberto] Univ Milan, Ist Patol Gen, I-20133 Milan, Italy; [Sica, Antonio] Fdn Humanitas Ric, I-20089 Milan, Italy; [Balkwill, Frances] Ctr Canc & Inflammat, Inst Canc, London EC1M 6BQ, England; [Balkwill, Frances] Univ London St Bartholomews Hosp Med Coll, Sch Med & Dent, Canc Res UK Clin Ctr, London EC1M 6BQ, England	IRCCS Humanitas Research Hospital; University of Milan; Cancer Research UK; University of London; Queen Mary University London	Mantovani, A (corresponding author), IRCCS, Ist Clin Humanitas, Via Manzoni 56, I-20089 Milan, Italy.	alberto.mantovani@humanitas.it	Mantovani, Alberto/HCI-7449-2022; Allavena, Paola/HHM-5218-2022; Peng, Chunwei/F-6788-2010; Sica, Antonio/AAB-9546-2020	Mantovani, Alberto/0000-0001-5578-236X; Allavena, Paola/0000-0002-6697-6028; Balkwill, Frances/0000-0002-5587-9759	Cancer Research UK Funding Source: Medline; Medical Research Council [G0501974] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; MRC [G0501974] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brown ER, 2008, ANN ONCOL, V19, P1340, DOI 10.1093/annonc/mdn054; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cooley W.B., 1893, AM J MED SCI, V105, P487, DOI [10.1097/00000441-189305000-00001, DOI 10.1097/00000441-189305000-00001]; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dally H, 2002, INT J CANCER, V102, P530, DOI 10.1002/ijc.10756; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Garlanda C, 2007, CANCER RES, V67, P6017, DOI 10.1158/0008-5472.CAN-07-0560; Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gungor N, 2007, FASEB J, V21, P2359, DOI 10.1096/fj.07-8163com; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; Kaifi JT, 2005, J NATL CANCER I, V97, P1840, DOI 10.1093/jnci/dji431; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kulbe H, 2005, CANCER RES, V65, P10355, DOI 10.1158/0008-5472.CAN-05-0957; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lewis CE, 2007, CANCER RES, V67, P8429, DOI 10.1158/0008-5472.CAN-07-1684; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Madhusudan S, 2005, J CLIN ONCOL, V23, P5950, DOI 10.1200/JCO.2005.04.127; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2007, NATURE, V448, P547, DOI 10.1038/448547a; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nickoloff BJ, 2005, J INVEST DERMATOL, V124, pX, DOI 10.1111/j.0022-202X.2005.23724.x; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Sato Y, 2006, CARCINOGENESIS, V27, P1068, DOI 10.1093/carcin/bgi327; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sozzani S, 2007, TRENDS IMMUNOL, V28, P385, DOI 10.1016/j.it.2007.07.006; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087	98	7494	7846	74	1741	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					436	444		10.1038/nature07205	http://dx.doi.org/10.1038/nature07205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650914	Green Submitted			2022-12-28	WOS:000257860300038
J	Sequist, LV; Settleman, JE; Ackman, JB; Iafrate, AJ				Sequist, Lecia V.; Settleman, Jeffrey E.; Ackman, Jeanne B.; Iafrate, A. John			A man with back pain and a mass in the lung - Poorly differentiated adenocarcinoma of the lung, with an activating mutation in the EGFR gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR-RECEPTOR; PHASE-II TRIAL; ACQUIRED-RESISTANCE; T790M MUTATIONS; GEFITINIB; CANCER; RETREATMENT; KINASE; COMMON; INHIBITOR		[Sequist, Lecia V.; Settleman, Jeffrey E.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Ackman, Jeanne B.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sequist, Lecia V.; Settleman, Jeffrey E.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Ackman, Jeanne B.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Sequist, LV (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.							ALBERTI W, 1995, BRIT MED J, V311, P899; Asahina H, 2006, BRIT J CANCER, V95, P998, DOI 10.1038/sj.bjc.6603393; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bleyer A, 2006, NIH PUBLICATION, V06-5767; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Isomura M, 2004, J CLIN ONCOL, V22, p200S; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kurata T, 2004, ANN ONCOL, V15, P173, DOI 10.1093/annonc/mdh006; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; PAZARES L, 2006, 2006 AM SOC CLIN ONC; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Pham DK, 2006, J CLIN ONCOL, V24, P1700, DOI 10.1200/JCO.2005.04.3224; Sandler A, 2007, NEW ENGL J MED, V356, P318; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Shepherd FA, 2006, J CLIN ONCOL, V24, P1219, DOI 10.1200/JCO.2005.04.4420; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Surveillance E and End Results ( SEER) Program, 2007, SEER STAT DAT INC SE; Yano S, 2005, ONCOL RES, V15, P107, DOI 10.3727/096504005775082020; Yokouchi H, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-51; Yoshimoto A, 2007, AM J MED SCI, V333, P221, DOI 10.1097/MAJ.0b013e31803b8acb	35	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					405	414		10.1056/NEJMcpc0803971	http://dx.doi.org/10.1056/NEJMcpc0803971			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650517				2022-12-28	WOS:000257852100010
J	Proukakis, C; Bonakis, A; Salman, AM; Kalfakis, N; Papageorgiou, SG				Proukakis, Christos; Bonakis, Anastasios; Salman, Ali M.; Kalfakis, Nikolaos; Papageorgiou, Sokratis G.			Exit, pursued by a bear	LANCET			English	Editorial Material							MULTIPLE SYSTEM ATROPHY; STRIDOR		[Proukakis, Christos; Bonakis, Anastasios; Kalfakis, Nikolaos; Papageorgiou, Sokratis G.] Univ Athens, Dept Neurol, Egnit Hosp, Sch Med, Athens 11528, Greece; [Salman, Ali M.] Clin Otolaryngol, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens	Papageorgiou, SG (corresponding author), Univ Athens, Dept Neurol, Egnit Hosp, Sch Med, 74 Vassilissis Sofias Ave, Athens 11528, Greece.	Sokpapa@med.uoa.gr	Papageorgiou, Sokratis G./AAQ-9759-2020; Proukakis, Christos/G-4548-2013; proukakis, christos/ABE-3447-2020	proukakis, christos/0000-0001-6423-6539; Papageorgiou, Sokratis/0000-0001-8863-3635				Dray TG, 1999, LARYNGOSCOPE, V109, P995, DOI 10.1097/00005537-199906000-00028; Iranzo A, 2000, LANCET, V356, P1329, DOI 10.1016/S0140-6736(00)02824-5; PIAZZI F, 1997, NEUROLOGY, V48, P1094; Vetrugno R, 2007, MOVEMENT DISORD, V22, P673, DOI 10.1002/mds.21384; Wenning GK, 2004, LANCET NEUROL, V3, P93, DOI 10.1016/S1474-4422(03)00662-8	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					262	262		10.1016/S0140-6736(08)61079-X	http://dx.doi.org/10.1016/S0140-6736(08)61079-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640462				2022-12-28	WOS:000257763900036
J	Doran, T; Fullwood, C; Reeves, D; Gravelle, H; Roland, M				Doran, Tim; Fullwood, Catherine; Reeves, David; Gravelle, Hugh; Roland, Martin			Exclusion of patients from pay-for-performance targets by english physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES FRAMEWORK; PRIMARY-CARE; UNITED-KINGDOM; QUALITY	Background: In the English pay-for-performance program, physicians use a range of criteria to exclude individual patients from the quality calculations that determine their pay. This process, which is called exception reporting, is intended to safeguard patients against inappropriate treatment by physicians seeking to maximize their income. However, exception reporting may allow physicians to inappropriately exclude patients for whom targets have been missed (a practice known as gaming). Methods: We analyzed data extracted automatically from clinical computing systems for 8105 family practices in England (96% of all practices), data from the U.K. Census, and data on practice characteristics from the U.K. Department of Health. We determined the rate of exception reporting for 65 clinical activities and the association between this rate and the characteristics of patients and medical practices. Results: From April 2005 through March 2006, physicians excluded a median of 5.3% of patients (interquartile range, 4.0 to 6.9) from the quality calculations. Physicians were most likely to exclude patients from indicators that were related to providing treatments and achieving target levels of intermediate outcomes; they were least likely to exclude patients from indicators that were related to routine checks and measurements and to offers of treatment. The characteristics of patients and practices explained only 2.7% of the variance in exception reporting. We estimate that exception reporting accounted for approximately 1.5% of the cost of the pay-for-performance program. Conclusions: Exception reporting brings substantial benefits to pay-for-performance programs, providing that the process is used appropriately. In England, rates of exception reporting have generally been low, with little evidence of widespread gaming.	[Doran, Tim; Fullwood, Catherine; Reeves, David; Roland, Martin] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; [Gravelle, Hugh] Univ York, Natl Primary Care Res & Dev Ctr, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of Manchester; University of York - UK	Doran, T (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Williamson Bldg, Manchester M13 9PL, Lancs, England.	tim.doran@manchester.ac.uk	Reeves, David/H-6203-2014	Reeves, David/0000-0001-6377-6859; Fullwood, Catherine/0000-0003-4136-2027; Roland, Martin/0000-0002-8533-3060; Gravelle, Hugh/0000-0002-7753-4233	Department of Health Funding Source: Medline	Department of Health		Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Casalino LP, 2007, HEALTH AFFAIR, V26, P492, DOI 10.1377/hlthaff.26.2.492; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; *CTR MED MED SERV, PHYS QUAL REP IN PQR; Custers T, 2007, HEALTH POLICY, V82, P226, DOI 10.1016/j.healthpol.2006.09.005; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Epstein AM, 2007, NEW ENGL J MED, V356, P515, DOI 10.1056/NEJMe078002; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Giuffrida A, 2001, J HEALTH ECON, V20, P755, DOI 10.1016/S0167-6296(01)00094-7; GRAVELLE H, 2008, 34 CHE U YORK; GRAVELLE H, 2007, 28 CHE U YORK; Gress S, 2006, HEALTH POLICY, V78, P295, DOI 10.1016/j.healthpol.2005.11.011; Guthrie B, 2006, BRIT J GEN PRACT, V56, P836; McLean G, 2006, J EPIDEMIOL COMMUN H, V60, P917, DOI 10.1136/jech.2005.044628; McMahon LF, 2007, AM J MANAG CARE, V13, P233; Medicare Australia, PRACT INC PROGR PIP; *NHS INF CTR, QUAL OUTC FRAM DAT 2; *OFF DEP PRIM MIN, IND DEPR 2004; Perkins Rod, 2006, N Z Med J, V119, pU2149; Pink George H, 2006, Healthc Pap, V6, P8; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Sigfrid LA, 2006, J PUBLIC HEALTH-UK, V28, P221, DOI 10.1093/pubmed/fdl028; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Yip WC, 1998, J HEALTH ECON, V17, P675, DOI 10.1016/S0167-6296(98)00024-1	26	115	115	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					274	284		10.1056/NEJMsa0800310	http://dx.doi.org/10.1056/NEJMsa0800310			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KD	18635432	Bronze			2022-12-28	WOS:000257656600007
J	Wilson, JF				Wilson, Jennifer Fisher			Oregon surpasses struggles of early reform and develops a road map for future success	ANNALS OF INTERNAL MEDICINE			English	News Item							HEALTH PLAN; CARE					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Bodenheimer T, 1997, NEW ENGL J MED, V337, P651, DOI 10.1056/NEJM199708283370923; Kitzhaber John, 2003, Health Aff (Millwood), V22, P114; Oberlander J, 2001, CAN MED ASSOC J, V164, P1583; Oberlander J, 2007, HEALTH AFFAIR, V26, pW96, DOI 10.1377/hlthaff.26.1.w96; Wilson JF, 2008, ANN INTERN MED, V148, P489, DOI 10.7326/0003-4819-148-6-200803180-00029	5	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					149	152		10.7326/0003-4819-149-2-200807150-00025	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00025			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626061				2022-12-28	WOS:000257853700020
J	Tsou, MT; Tsou, MW; Wu, MP; Liu, JT				Tsou, Meng-Ting; Tsou, Meng-Wen; Wu, Ming-Ping; Liu, Jin-Tan			Academic achievement of twins and singletons in early adulthood: Taiwanese cohort study	BRITISH MEDICAL JOURNAL			English	Article							BIRTH-WEIGHT; COGNITIVE FUNCTION; ABERDEEN CHILDREN; 1950S COHORT; INTELLIGENCE; ADOLESCENCE; PERFORMANCE	Objectives To examine the long term effects of low birth weight on academic achievements in twins and singletons and to determine whether the academic achievement of twins in early adulthood is inferior to that of singletons. Design Cohort study. Setting Taiwanese nationwide register of academic outcome. Participants A cohort of 218 972 singletons and 1687 twins born in Taiwan, 1983-5. Main outcome measure College attendance and test scores in the college joint entrance examinations. Results After adjustment for birth weight, gestational age, birth order, and sex and the sociodemographic characteristics of the parents, twins were found to have significantly lower mean test scores than singletons in Chinese, mathematics, and natural science, as well as a 2.2% lower probability of attending college. Low birthweight twins had an 8.5% lower probability of college attendance than normal weight twins, while low birthweight singletons had only a 3.2% lower probability. The negative effects of low birth weight on the test scores in English and mathematics were substantially greater for twins than for singletons. The twin pair analysis showed that the association between birth weight and academic achievement scores, which existed for opposite sex twin pairs, was not discernible for same sex twin pairs, indicating that birth weight might partly reflect other underlying genetic variations. Conclusions These data support the proposition that twins perform less well academically than singletons. Low birth weight has a negative association with subsequent academic achievement in early adulthood, with the effect being stronger for twins than for singletons. The association between birth weight and academic performance might be partly attributable to genetic factors.	[Liu, Jin-Tan] Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan; [Tsou, Meng-Ting] Mackay Mem Hosp, Dept Family Med, Taipei, Taiwan; [Tsou, Meng-Ting] Mackay Med, Nursing & Management Coll, Taipei, Taiwan; [Tsou, Meng-Wen] Tamkang Univ, Dept Int Trade, Taipei, Taiwan; [Wu, Ming-Ping] Chi Mei Fdn Hosp, Dept Obstet & Gynecol, Div Urogynecol & Pelv Floor Reconstruct, Tainan, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Tamkang University; Chi Mei Hospital	Liu, JT (corresponding author), Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan.	liujt@ntu.edu.tw			National Health Research Institutes, Taiwan [NHRI-EX94-9226, NHRI-EX96-9622]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	National Health Research Institutes, Taiwan (NHRI-EX94-9226, NHRI-EX96-9622).	ALLIN AB, 1991, ACTA GENET MED GEMEL, V40, P29; Behrman JR, 2004, REV ECON STAT, V86, P586, DOI 10.1162/003465304323031139; Bergvall N, 2006, PEDIATRICS, V117, P714, DOI 10.1542/peds.2005-0735; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; Black SE, 2005, Q J ECON, V120, P669, DOI 10.1162/0033553053970179; Boomsma DI, 2001, BRIT MED J, V323, P1426, DOI 10.1136/bmj.323.7326.1426a; Bouchard TJ, 1998, HUM BIOL, V70, P257; Christensen K, 2006, BRIT MED J, V333, P1095, DOI 10.1136/bmj.38959.650903.7C; CONLEY D, 2003, POUND FLESH JUST PRO; Evans DM, 2000, GENESCREEN, V1, P77, DOI DOI 10.1046/J.1466-9218.2000.00027.X; HAY DA, 1984, ACTA GENET MED GEMEL, V33, P223, DOI 10.1017/S0001566000007261; HELLEKE EH, 2002, BRAIN, V125, P384; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Lawlor DA, 2006, PEDIATRICS, V117, pE894, DOI 10.1542/peds.2005-2412; Lin MJ, 2007, DEMOGRAPHY, V44, P335, DOI 10.1353/dem.2007.0013; MAUREEN HM, 2002, NEW ENGL J MED, V346, P149; MYRIANTHOPOULOS NC, 1976, ACTA GENET MED GEMEL, V25, P376, DOI 10.1017/S0001566000014458; OLSEN J, 1994, SCAND J SOC MED, V22, P213, DOI 10.1177/140349489402200310; Posthuma D, 2000, Twin Res, V3, P83, DOI 10.1375/136905200320565535; RECORD RG, 1970, ANN HUM GENET, V34, P11, DOI 10.1111/j.1469-1809.1970.tb00215.x; Regan TL, 2007, ECON INQ, V45, P721, DOI 10.1111/j.1465-7295.2007.00058.x; Ronalds GA, 2005, BMJ-BRIT MED J, V331, P1306, DOI 10.1136/bmj.38633.594387.3A; Shenkin SD, 2001, ARCH DIS CHILD, V85, P189, DOI 10.1136/adc.85.3.189; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401	24	20	20	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a438	10.1136/bmj.a438	http://dx.doi.org/10.1136/bmj.a438			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EN	18644771	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000258561000029
J	Hoch, JC; Maciejewski, MW; Gryk, MR				Hoch, Jeffrey C.; Maciejewski, Mark W.; Gryk, Michael R.			Comment on "magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain"	SCIENCE			English	Editorial Material							PROTON NMR-SPECTROSCOPY; WATER; PLASMA		[Hoch, Jeffrey C.; Maciejewski, Mark W.; Gryk, Michael R.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut	Hoch, JC (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	hoch@uchc.edu	Bulte, Jeff W.M./A-3240-2008	Bulte, Jeff W.M./0000-0003-1202-1610; Hoch, Jeffrey/0000-0002-9230-2019	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020125] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR020125-04, R01 RR020125] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BARKHUIJSEN H, 1987, J MAGN RESON, V73, P553, DOI 10.1016/0022-2364(87)90023-0; ENGAN T, 1990, NEW ENGL J MED, V322, P949, DOI 10.1056/NEJM199004053221402; FOSSEL ET, 1986, NEW ENGL J MED, V315, P1369, DOI 10.1056/NEJM198611273152201; HOCH JC, 1989, METHOD ENZYMOL, V176, P216; Hoch JC, 1996, NMR DATA PROCESSING; Koehl P, 1999, PROG NUCL MAG RES SP, V34, P257, DOI 10.1016/S0079-6565(99)00002-3; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; OKUNIEFF P, 1990, NEW ENGL J MED, V322, P953, DOI 10.1056/NEJM199004053221403; Stern AS, 2002, J AM CHEM SOC, V124, P1982, DOI 10.1021/ja011669o; Vanhamme L, 1998, J MAGN RESON, V132, P197, DOI 10.1006/jmre.1998.1425	10	9	9	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889								10.1126/science.1153058	http://dx.doi.org/10.1126/science.1153058			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669844	Green Accepted			2022-12-28	WOS:000258077700021
J	Belden, WJ; Dunlap, JC				Belden, William J.; Dunlap, Jay C.			SIRT1 is a circadian deacetylase for core clock components	CELL			English	Editorial Material							HISTONE ACETYLTRANSFERASE; TRANSCRIPTION; ACETYLATION	The transcriptional activator CLOCK is a histone acetyltransferase that is required for the circadian expression of many genes. Asher et al. (2008) and Nakahata et al. (2008) now demonstrate that the NAD(+)-dependent enzyme SIRT1 functions as a histone deacetylase that counteracts the activity of CLOCK. These results broaden our understanding of the impact of cellular metabolism on the circadian system.	[Belden, William J.; Dunlap, Jay C.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Dunlap, JC (corresponding author), Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA.	jay.c.dunlap@dartmouth.edu	Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985, P01GM068087] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM068087-08, R01 GM034985, P01 GM068087, R01 GM034985-24] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500	8	94	99	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					212	214		10.1016/j.cell.2008.07.010	http://dx.doi.org/10.1016/j.cell.2008.07.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662537	Green Accepted, Bronze			2022-12-28	WOS:000257891700011
J	Wagner, KD				Wagner, Karen Dineen			Baby food	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kwagner@utmb.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					371	372		10.1001/jama.300.4.371	http://dx.doi.org/10.1001/jama.300.4.371			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647970				2022-12-28	WOS:000257831200001
J	Holmes, C; Boche, D; Wilkinson, D; Yadegarfar, G; Hopkins, V; Bayer, A; Jones, RW; Bullock, R; Love, S; Neal, JW; Zotova, E; Nicoll, JAR				Holmes, Clive; Boche, Delphine; Wilkinson, David; Yadegarfar, Ghasem; Hopkins, Vivienne; Bayer, Anthony; Jones, Roy W.; Bullock, Roger; Love, Seth; Neal, James W.; Zotova, Elina; Nicoll, James A. R.			Long-term effects of A beta(42) immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial	LANCET			English	Article							AMYLOID-BETA PROTEIN; A-BETA-42 IMMUNIZATION; PEPTIDE; AD; IMMUNOTHERAPY; VACCINATION; ANTIBODIES; DEMENTIA; MEMORY; AN1792	Background Immunisation of patients with Alzheimer's disease with full-length amyloid-beta peptide (A beta(42)) can clear amyloid plaques from the brain. Our aim was to assess the relation between A beta(42) immune response, degree of plaque removal, and long-term clinical outcomes. Methods In June, 2003, consent for long-term clinical follow-up, post-mortem neuropathological examination, or both, was sought from 80 patients (or their carers) who had entered a phase I randomised, placebo-controlled trial of immunisation with A beta(42) (AN1792, Elan Pharmaceuticals) in September, 2000. The follow-up study was completed in September, 2006. Plaques were assessed in terms of the percentage area of the cortex with A beta immunostaining (A beta load) and in terms of characteristic histological features reflecting plaque removal. Survival of all 80 individuals until severe dementia or death was assessed with a Cox proportional hazard model. Findings 20 participants-15 in the AN1792 group, five in the placebo group-died before follow-up started. A further 22 patients-19 in the AN1792 group, three in the placebo group-died during follow-up. Nine of the deceased patients, all in the AN1792 group, had given consent for post-mortem analysis; one of these who did not die with Alzheimer's disease was excluded. in the remaining eight participants who received immunisation and who were examined neuropathologically, mean A beta load was lower than in an unimmunised control group that was matched for age at death (2.1% [SE 0.7] in treated participants vs 5.1% [0.9] in controls; mean difference 3.0%, 95% CI 0.6-5.4; p=0.02). Although there was considerable variation in A beta load and degree of plaque removal among immunised participants, the degree of plaque removal varied significantly with mean antibody response attained during the treatment study period (Kruskal-Wallis p=0.02). Seven of the eight immunised patients who underwent post-mortem assessment, including those with virtually complete plaque removal, had severe end stage dementia before death. In the whole cohort, there was no evidence of improved survival (hazard ratio 0.93, 95% CI 0.43-3.11; p=0.86) or of an improvement in the time to severe dementia (1.18, 0.45-3.11; p=0.73) in the AN1792 group versus the placebo group. Interpretation Although immunisation with A beta(42) resulted in clearance of amyloid plaques in patients with Alzheimer's disease, this clearance did not prevent progressive neurodegeneration.	[Holmes, Clive; Wilkinson, David; Hopkins, Vivienne] Moorgreen Hosp, Hampshire Partnership Trust, Memory Assessment & Res Ctr, Southampton SO30 3JB, Hants, England; [Holmes, Clive; Boche, Delphine; Wilkinson, David; Zotova, Elina; Nicoll, James A. R.] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [Yadegarfar, Ghasem] Univ Southampton, Sch Med, Publ Hlth Sci & Med Stat Grp RDSU, Southampton, Hants, England; [Nicoll, James A. R.] Southampton Univ Hosp NHS Trust, Dept Cellular Pathol, Southampton, Hants, England; [Yadegarfar, Ghasem] Isfahan Univ Med Sci, Dept Epidemiol & Biostat, Sch Hlth Sci, Esfahan, Iran; [Bayer, Anthony; Neal, James W.] Univ Wales Coll Cardiff, Dept Geriatr Med, Cardiff, Wales; [Bayer, Anthony; Neal, James W.] Univ Wales Coll Cardiff, Dept Pathol, Cardiff, Wales; [Jones, Roy W.] Royal United Hosp, Res Inst Care Elderly, Bath BA1 3NG, Avon, England; [Bullock, Roger] Victoria Hosp, Kingshill Res Ctr, Swindon, Wilts, England; [Love, Seth] Univ Bristol, Dept Neuropathol, Bristol, Avon, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Isfahan University Medical Science; Cardiff University; Cardiff University; University of Bristol	Holmes, C (corresponding author), Moorgreen Hosp, Hampshire Partnership Trust, Memory Assessment & Res Ctr, Botley Rd, Southampton SO30 3JB, Hants, England.	ch4@soton.ac.uk	Bayer, Antony/H-4434-2019; Love, Seth/E-6545-2012; Boche, Delphine/A-7589-2011; Yadegarfar, Ghasem G/G-3016-2017; Bayer, Antony/H-4376-2019; Nicoll, James/I-9253-2017	Bayer, Antony/0000-0002-7514-248X; Boche, Delphine/0000-0002-5884-130X; Yadegarfar, Ghasem G/0000-0002-5331-3890; Holmes, Clive/0000-0003-1999-6912; Nicoll, James/0000-0002-9444-7246; Love, Seth/0000-0001-8683-3625	Alzheimers Research UK [ART-PG2006-4, ART-ESG2005-3] Funding Source: researchfish; Medical Research Council [G0501033] Funding Source: Medline; MRC [G0501033] Funding Source: UKRI	Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Bombois S, 2007, ARCH NEUROL-CHICAGO, V64, P583, DOI 10.1001/archneur.64.4.583; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Esiri MM, 2001, LANCET, V357, P169; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 1997, Int Psychogeriatr, V9 Suppl 1, P163, DOI 10.1017/S1041610297004857; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Lee M, 2005, ANN NEUROL, V58, P430, DOI 10.1002/ana.20592; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mattson MP, 2003, SCIENCE, V301, P1847, DOI 10.1126/science.301.5641.1847; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; PRIDE MW, 2004, INT C ALZH DIS REL D; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Smith MA, 2002, LANCET, V359, P1864, DOI 10.1016/S0140-6736(02)08695-6; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Wilcock DM, 2007, NEUROSCIENCE, V144, P950, DOI 10.1016/j.neuroscience.2006.10.020; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	32	1083	1170	1	167	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					216	223		10.1016/S0140-6736(08)61075-2	http://dx.doi.org/10.1016/S0140-6736(08)61075-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640458				2022-12-28	WOS:000257763900031
J	Lind, L				Lind, Lars			Apolipoprotein B/A1 and risk of cardiovascular disease	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; A-I; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; LIPID MEASURES; FOLLOW-UP; PREDICTION; CHOLESTEROL; AMORIS; RATIO		Univ Uppsala Hosp, Dept Med, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital	Lind, L (corresponding author), Univ Uppsala Hosp, Dept Med, S-75185 Uppsala, Sweden.	lars.lind@medsci.uu.se						Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lind L, 2006, ARTERIOSCL THROM VAS, V26, P406, DOI 10.1161/01.ATV.0000197827.12431.d0; Lind L, 2007, ATHEROSCLEROSIS, V190, P378, DOI 10.1016/j.atherosclerosis.2006.02.027; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moller CS, 2006, J INTERN MED, V260, P22, DOI 10.1111/j.1365-2796.2006.01642.x; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Simes RJ, 2002, CIRCULATION, V105, P1162, DOI 10.1161/hc1002.105136; Walldius G, 2006, J INTERN MED, V259, P259, DOI 10.1111/j.1365-2796.2005.01610.x; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c	12	9	10	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					185	186		10.1016/S0140-6736(08)61050-8	http://dx.doi.org/10.1016/S0140-6736(08)61050-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640440				2022-12-28	WOS:000257763900008
J	Salvarani, C; Cantini, F; Hunder, GG				Salvarani, Carlo; Cantini, Fabrizio; Hunder, Gene G.			Polymyalgia rheumatica and giant-cell arteritis	LANCET			English	Review							PROSPECTIVE FOLLOW-UP; PLACEBO-CONTROLLED TRIAL; ERYTHROCYTE SEDIMENTATION-RATE; POPULATION-BASED COHORT; SERONEGATIVE SYMMETRICAL SYNOVITIS; POSITRON-EMISSION-TOMOGRAPHY; LARGE-VESSEL VASCULITIS; TEMPORAL ARTERITIS; DOUBLE-BLIND; PITTING EDEMA	Polymyalgia rheumatica and giant-cell arteritis are closely related disorders that affect people of middle age and older. They frequently occur together. Both are syndromes of unknown cause, but genetic and environmental factors might have a role in their pathogenesis. The symptoms of polymyalgia rheumatica seem to be related to synovitis of proximal joints and extra-articular synovial structures. Giant-cell arteritis primarily affects the aorta and its extracranial branches. The clinical findings in giant-cell arteritis are broad, but commonly include visual loss, headache, scalp tenderness, jaw claudication, cerebrovascular accidents, aortic arch syndrome, thoracic aorta aneurysm, and dissection. Glucocorticosteroids are the cornerstone of treatment of both polymyalgia rheumatica and giant-cell arteritis. Some patients have a chronic course and might need glucocorticosteroids for several years. Adverse events of glucocorticosteroids affect more than 50% of patients. Trials of steroid-sparing drugs have yielded conflicting results. A greater understanding of the molecular mechanisms involved in the pathogenesis should provide new targets for therapy.	[Salvarani, Carlo] Arcispedale S Maria Nuova, Rheumatol Unit, I-42100 Reggio Emilia, Italy; [Cantini, Fabrizio] Osped Prato, Rheumatol Unit, Div Med, Prato, Italy; [Hunder, Gene G.] Mayo Clin, Coll Med, Rochester, MN USA	IRCCS Arcispedale S. Maria Nuova; Prato Hospital; Mayo Clinic	Salvarani, C (corresponding author), Arcispedale S Maria Nuova, Rheumatol Unit, V Risorgimento N80, I-42100 Reggio Emilia, Italy.	salvarani.carlo@asmn.re.it	Di Comite, Gabriele/B-1026-2010; Salvarani, Carlo/K-2431-2018	Salvarani, Carlo/0000-0001-5426-5133				ACHKAR AA, 1994, ANN INTERN MED, V120, P987, DOI 10.7326/0003-4819-120-12-199406150-00003; AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550; ANDERSSON R, 1986, ACTA MED SCAND, V220, P465; AYOUB WT, 1985, AM J MED, V79, P309, DOI 10.1016/0002-9343(85)90309-2; Bajocchi G, 2007, CLIN EXP RHEUMATOL, V25, pS36; Bas-Lando M, 2007, CLIN EXP RHEUMATOL, V25, pS15; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Bley TA, 2005, ARTHRITIS RHEUM, V52, P2470, DOI 10.1002/art.21226; Blockmans D, 2007, RHEUMATOLOGY, V46, P672, DOI 10.1093/rheumatology/kel376; Blockmans D, 2006, ARTHRIT RHEUM-ARTHR, V55, P131, DOI 10.1002/art.21699; Bongartz T, 2006, CURR OPIN RHEUMATOL, V18, P10, DOI 10.1097/01.bor.0000197996.04709.4e; Boyev LR, 1999, AM J OPHTHALMOL, V128, P211, DOI 10.1016/S0002-9394(99)00101-4; Buckley L, 2001, ARTHRITIS RHEUM, V44, P1496; CALAMIA KT, 1980, CLIN RHEUM DIS, V6, P389; CALAMIA KT, 1981, ARTHRITIS RHEUM, V24, P1414, DOI 10.1002/art.1780241113; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; Cantini F, 2005, CLIN EXP RHEUMATOL, V23, P462; Cantini F, 2004, SEMIN ARTHRITIS RHEU, V33, P294, DOI 10.1016/j.semarthrit.2003.09.008; Cantini F, 1999, ANN RHEUM DIS, V58, P230, DOI 10.1136/ard.58.4.230; Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y; Cantini F, 2001, ARTHRITIS RHEUM, V44, P1155, DOI 10.1002/1529-0131(200105)44:5<1155::AID-ANR198>3.0.CO;2-N; Cantini F, 2001, J RHEUMATOL, V28, P1049; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; CASELLI RJ, 1988, NEUROLOGY, V38, P352, DOI 10.1212/WNL.38.3.352; CASELLI RJ, 1988, NEUROLOGY, V38, P685, DOI 10.1212/WNL.38.5.685; Catanoso MG, 2007, ARTHRIT RHEUM-ARTHR, V57, P1514, DOI 10.1002/art.23095; Chakrabarty A, 2000, J CLIN PATHOL, V53, P131, DOI 10.1136/jcp.53.2.131; Chaudhry IA, 2007, BRIT J OPHTHALMOL, V91, P715, DOI 10.1136/bjo.2006.108845; Chevalet P, 2000, J RHEUMATOL, V27, P1484; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; CHURCHILL MA, 1977, ANN INTERN MED, V87, P754, DOI 10.7326/0003-4819-87-6-754; Cid MC, 2002, CIRCULATION, V106, P1664, DOI 10.1161/01.CIR.0000030185.67510.C0; Davis PM, 2008, CLIN IMMUNOL, V126, P38, DOI 10.1016/j.clim.2007.08.019; DESILVA M, 1986, ANN RHEUM DIS, V45, P136, DOI 10.1136/ard.45.2.136; Duhaut P, 2004, PRESSE MED, V33, P1403, DOI 10.1016/S0755-4982(04)98939-7; Duhaut P, 1998, ARTHRITIS RHEUM-US, V41, P1960, DOI 10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X; Elling P, 1996, J RHEUMATOL, V23, P112; Esteban MJ, 2001, ARTHRITIS RHEUM-US, V44, P1387, DOI 10.1002/1529-0131(200106)44:6<1387::AID-ART232>3.0.CO;2-B; FRANZEN P, 1992, J RHEUMATOL, V19, P273; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Gonzalez-Gay MA, 2000, J RHEUMATOL, V27, P2179; Gonzalez-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z; Gonzalez-Gay MA, 2005, MEDICINE, V84, P277, DOI 10.1097/01.md.0000180043.19285.54; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Gonzalez-Gay MA, 2004, MEDICINE, V83, P342, DOI 10.1097/01.md.0000145369.25558.b5; Gonzalez-Gay MA, 2004, MEDICINE, V83, P335, DOI 10.1097/01.md.0000145366.40805.f8; Gonzalez-Gay MA, 2004, ARTHRIT RHEUM-ARTHR, V51, P652, DOI 10.1002/art.20523; Gonzalez-Gay MA, 2004, SEMIN ARTHRITIS RHEU, V33, P289, DOI 10.1016/j.semarthrit.2003.09.007; Gonzalez-Gay MA, 2004, ARTHRIT RHEUM-ARTHR, V51, P274, DOI 10.1002/art.20231; Gonzalez-Gay MA, 2003, SEMIN ARTHRITIS RHEU, V33, P38, DOI 10.1053/sarh.2002.50025; Gonzalez-Gay MA, 2007, MEDICINE, V86, P61, DOI 10.1097/md.0b013e31803d1764; Gran JT, 1997, J RHEUMATOL, V24, P1739; Hall JK, 2003, OPHTHALMOLOGY, V110, P543, DOI 10.1016/S0161-6420(02)01758-X; Hayreh SS, 1997, AM J OPHTHALMOL, V123, P285, DOI 10.1016/S0002-9394(14)70123-0; Hayreh SS, 2002, ACTA OPHTHALMOL SCAN, V80, P355, DOI 10.1034/j.1600-0420.2002.800403.x; Hayreh SS, 1998, AM J OPHTHALMOL, V125, P521, DOI 10.1016/S0002-9394(99)80193-7; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hernandez-Rodriguez J, 2004, RHEUMATOLOGY, V43, P294, DOI 10.1093/rheumatology/keh058; Hernandez-Rodriguez J, 2003, CIRCULATION, V107, P2428, DOI 10.1161/01.CIR.0000066907.83923.32; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; HOPKINSON ND, 1991, ANN RHEUM DIS, V50, P321, DOI 10.1136/ard.50.5.321; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; HUNDER GG, 1975, ANN INTERN MED, V82, P613, DOI 10.7326/0003-4819-82-5-613; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Karassa FB, 2005, ANN INTERN MED, V142, P359, DOI 10.7326/0003-4819-142-5-200503010-00011; Kariv R, 2000, MEDICINE, V79, P349, DOI 10.1097/00005792-200011000-00001; KLEIN RG, 1976, MAYO CLIN PROC, V51, P504; Kobayashi S, 2003, ARTHRIT RHEUM-ARTHR, V49, P594, DOI 10.1002/art.11195; Kremers HM, 2005, J RHEUMATOL, V32, P65; LARSON TS, 1984, ANN INTERN MED, V101, P594, DOI 10.7326/0003-4819-101-5-594; Le Hello C, 2001, J RHEUMATOL, V28, P1407; Lee CC, 1999, J RHEUMATOL, V26, P931; Lee MS, 2006, ARTHRITIS RHEUM, V54, P3306, DOI 10.1002/art.22141; LIE JT, 1986, ARCH PATHOL LAB MED, V110, P857; LIE JT, 1990, ARTHRITIS RHEUM-US, V33, P1074; Lopez-Hoyos M, 2004, RHEUMATOLOGY, V43, P655, DOI 10.1093/rheumatology/keh143; LOZANO E, 2007, ANN RHEUM DIS   0621; LUZAR MJ, 1982, J RHEUMATOL, V9, P957; MACHADO EBV, 1989, INT J EPIDEMIOL, V18, P836, DOI 10.1093/ije/18.4.836; Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754; Mazlumzadeh M, 2006, ARTHRITIS RHEUM, V54, P3310, DOI 10.1002/art.22163; MCCARTY DJ, 1985, JAMA-J AM MED ASSOC, V254, P2763, DOI 10.1001/jama.254.19.2763; Meliconi R, 1996, ARTHRITIS RHEUM-US, V39, P1199, DOI 10.1002/art.1780390719; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Niccoli L, 2002, SCAND J RHEUMATOL, V31, P103, DOI 10.1080/03009740252937649; Nordborg E, 2003, RHEUMATOLOGY, V42, P413, DOI 10.1093/rheumatology/keg116; Nuenninghoff DM, 2003, ARTHRITIS RHEUM-US, V48, P3532, DOI 10.1002/art.11480; ODUFFY JD, 1976, MAYO CLIN PROC, V51, P519; Olivieri I, 1997, J RHEUMATOL, V24, P249; Olivieri I, 2007, RHEUMATOL INT, V27, P927, DOI 10.1007/s00296-007-0331-8; Ostberg G, 1973, ACTA PATHOL MICROB S, V237, P1; Pego-Reigosa JM, 2005, ARTHRIT RHEUM-ARTHR, V53, P931, DOI 10.1002/art.21585; Pipitone N, 2005, BEST PRACT RES CL RH, V19, P277, DOI 10.1016/j.berh.2004.10.002; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; Rao JK, 1998, ANN INTERN MED, V129, P345, DOI 10.7326/0003-4819-129-5-199809010-00001; SALVARANI C, 1994, ARTHRITIS RHEUM, V37, P1621, DOI 10.1002/art.1780371111; SALVARANI C, 1995, ARTHRITIS RHEUM, V38, P369, DOI 10.1002/art.1780380311; SALVARANI C, 1987, CLIN EXP RHEUMATOL, V5, P205; Salvarani C, 1997, ANN INTERN MED, V127, P27, DOI 10.7326/0003-4819-127-1-199707010-00005; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P293, DOI 10.1002/art.21075; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P33, DOI 10.1002/art.20901; Salvarani C, 2004, BEST PRACT RES CL RH, V18, P705, DOI 10.1016/j.berh.2004.06.003; Salvarani C, 1999, ARTHRITIS RHEUM-US, V42, P1259, DOI 10.1002/1529-0131(199906)42:6<1259::AID-ANR24>3.0.CO;2-I; Salvarani C, 2004, ARTHRIT RHEUM-ARTHR, V51, P264, DOI 10.1002/art.20227; Salvarani C, 2003, J RHEUMATOL, V30, P760; Salvarani C, 1998, ARTHRITIS RHEUM, V41, P1221, DOI 10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W; Salvarani C, 1999, J RHEUMATOL, V26, P517; Salvarani C, 1996, ARTHRITIS RHEUM, V39, P73, DOI 10.1002/art.1780390110; Salvarani C, 2002, ANN INTERN MED, V137, P232, DOI 10.7326/0003-4819-137-4-200208200-00006; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; SALVARANI C, 1995, ANN INTERN MED, V123, P192, DOI 10.7326/0003-4819-123-3-199508010-00006; SALVARANI C, 1991, ARTHRITIS RHEUM, V34, P351, DOI 10.1002/art.1780340313; Salvarani C, 2001, ARTHRIT RHEUM-ARTHR, V45, P140, DOI 10.1002/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2; Salvarani C, 1999, ANN RHEUM DIS, V58, P303, DOI 10.1136/ard.58.5.303; Salvarani C, 2007, ANN INTERN MED, V146, P631, DOI 10.7326/0003-4819-146-9-200705010-00005; Salvarani C, 2006, ARTHRIT RHEUM-ARTHR, V55, P985, DOI 10.1002/art.22359; Sambrook PN, 2005, ANN RHEUM DIS, V64, P176, DOI 10.1136/ard.2003.018556; Schmidt WA, 2002, CLIN EXP RHEUMATOL, V20, P309; Smeeth L, 2006, ANN RHEUM DIS, V65, P1093, DOI 10.1136/ard.2005.046912; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; Spiera RF, 2001, CLIN EXP RHEUMATOL, V19, P495; Stanson AW, 2000, CLIN EXP RHEUMATOL, V18, pS43; Strand V, 2007, BULL HOSP JT DIS, V65, pS21; Taylor-Gjevre R, 2005, J RHEUMATOL, V32, P1279; Valstar MH, 2003, AM J MED, V114, P708, DOI 10.1016/S0002-9343(03)00134-7; Weyand CM, 2005, ANN NY ACAD SCI, V1062, P195, DOI 10.1196/annals.1358.023; Weyand CM, 1999, ARCH INTERN MED, V159, P577, DOI 10.1001/archinte.159.6.577; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; WEYAND CM, 1994, ANN INTERN MED, V121, P484, DOI 10.7326/0003-4819-121-7-199410010-00003; Weyand CM, 2002, ARTHRITIS RHEUM, V46, P457, DOI 10.1002/art.10071; Weyand CM, 2000, ARTHRITIS RHEUM, V43, P1041, DOI 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7; WILKINSON IM, 1972, ARCH NEUROL-CHICAGO, V27, P378, DOI 10.1001/archneur.1972.00490170010003; Younge BR, 2004, MAYO CLIN PROC, V79, P483, DOI 10.4065/79.4.483	135	502	527	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					234	245		10.1016/S0140-6736(08)61077-6	http://dx.doi.org/10.1016/S0140-6736(08)61077-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640460				2022-12-28	WOS:000257763900033
J	Fink, JM; Goppl, M; Baur, M; Bianchetti, R; Leek, PJ; Blais, A; Wallraff, A				Fink, J. M.; Goeppl, M.; Baur, M.; Bianchetti, R.; Leek, P. J.; Blais, A.; Wallraff, A.			Climbing the Jaynes-Cummings ladder and observing its root n nonlinearity in a cavity QED system	NATURE			English	Article							SINGLE QUANTUM-DOT; PHOTON NUMBER STATES; ELECTRODYNAMICS; SPECTROSCOPY; FIELD; COHERENCE; CIRCUIT; ATOM	The field of cavity quantum electrodynamics ( QED), traditionally studied in atomic systems(1-3), has gained new momentum by recent reports of quantum optical experiments with solid- state semiconducting(4-8) and superconducting(9-11) systems. In cavity QED, the observation of the vacuum Rabi mode splitting is used to investigate the nature of matter - light interaction at a quantum-mechanical level. However, this effect can, at least in principle, be explained classically as the normal mode splitting of two coupled linear oscillators(12). It has been suggested that an observation of the scaling of the resonant atom - photon coupling strength in the Jaynes - Cummings energy ladder(13) with the square root of photon number n is sufficient to prove that the system is quantum mechanical in nature(14). Here we report a direct spectroscopic observation of this characteristic quantum nonlinearity. Measuring the photonic degree of freedom of the coupled system, our measurements provide unambiguous spectroscopic evidence for the quantum nature of the resonant atom - field interaction in cavity QED. We explore atom - photon superposition states involving up to two photons, using a spectroscopic pump and probe technique. The experiments have been performed in a circuit QED set- up(15), in which very strong coupling is realized by the large dipole coupling strength and the long coherence time of a superconducting qubit embedded in a high- quality on- chip microwave cavity. Circuit QED systems also provide a natural quantum interface between flying qubits ( photons) and stationary qubits for applications in quantum information processing and communication(16).	[Fink, J. M.; Goeppl, M.; Baur, M.; Bianchetti, R.; Leek, P. J.; Wallraff, A.] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Blais, A.] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Sherbrooke	Fink, JM (corresponding author), ETH, Dept Phys, CH-8093 Zurich, Switzerland.	jfink@phys.ethz.ch; andreas.wallraff@phys.ethz.ch	Blais, Alexandre/E-3315-2010; Leek, Peter/C-7252-2016; Fink, Johannes M/C-1919-2008; Bianchetti, Romeo/D-6836-2016; Wallraff, Andreas J/C-2130-2009; Baur, Matthias/E-6479-2013	Blais, Alexandre/0000-0002-0591-2012; Leek, Peter/0000-0002-1410-5642; Fink, Johannes M/0000-0001-8112-028X; Wallraff, Andreas J/0000-0002-3476-4485; 				Bertet P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.143601; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Boca A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233603; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; Carmichael HJ, 1996, PHYS REV LETT, V77, P631, DOI 10.1103/PhysRevLett.77.631; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Englund D, 2007, NATURE, V450, P857, DOI 10.1038/nature06234; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Peter E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067401; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; Thompson RJ, 1998, PHYS REV A, V57, P3084, DOI 10.1103/PhysRevA.57.3084; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Varcoe BTH, 2000, NATURE, V403, P743, DOI 10.1038/35001526; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walls D. F., 1994, QUANTUM OPT; Walther H, 2006, REP PROG PHYS, V69, P1325, DOI 10.1088/0034-4885/69/5/R02; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; ZHU YF, 1990, PHYS REV LETT, V64, P2499, DOI 10.1103/PhysRevLett.64.2499	30	361	361	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					315	318		10.1038/nature07112	http://dx.doi.org/10.1038/nature07112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633413	Green Submitted			2022-12-28	WOS:000257665300034
J	Skotheim, JM; Di Talia, S; Siggia, ED; Cross, FR				Skotheim, Jan M.; Di Talia, Stefano; Siggia, Eric D.; Cross, Frederick R.			Positive feedback of G1 cyclins ensures coherent cell cycle entry	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; G1-SPECIFIC TRANSCRIPTION; FLUORESCENT PROTEIN; GENE-EXPRESSION; BUDDING YEAST; CDK ACTIVITY; CLN3; START; DIVISION	In budding yeast, Saccharomyces cerevisiae, the Start checkpoint integrates multiple internal and external signals into an all- or- none decision to enter the cell cycle. Here we show that Start behaves like a switch due to systems- level feedback in the regulatory network. In contrast to current models proposing a linear cascade of Start activation, transcriptional positive feedback of the G1 cyclins Cln1 and Cln2 induces the near- simultaneous expression of the similar to 200- gene G1/ S regulon. Nuclear Cln2 drives coherent regulon expression, whereas cytoplasmic Cln2 drives efficient budding. Cells with the CLN1 and CLN2 genes deleted frequently arrest as unbudded cells, incurring a large fluctuation- induced fitness penalty due to both the lack of cytoplasmic Cln2 and insufficient G1/ S regulon expression. Thus, positive- feedback- amplified expression of Cln1 and Cln2 simultaneously drives robust budding and rapid, coherent regulon expression. A similar G1/ S regulatory network in mammalian cells, comprised of non- orthologous genes, suggests either conservation of regulatory architecture or convergent evolution.	[Skotheim, Jan M.; Di Talia, Stefano; Siggia, Eric D.; Cross, Frederick R.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA	Rockefeller University	Skotheim, JM (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA.	skotheim@stanford.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820; Di Talia, Stefano/0000-0001-9758-7925	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078153, F32GM078769] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078153-01, F32 GM078769-01, F32 GM078769, R01 GM078153-02, F32 GM078769-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Edgington NP, 2001, J CELL SCI, V114, P4599; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kato M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r56; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; LORD PG, 1981, J CELL SCI, V50, P361; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; SIMCHEN G, 1972, EXP CELL RES, V75, P207, DOI 10.1016/0014-4827(72)90538-1; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	43	251	254	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					291	U12		10.1038/nature07118	http://dx.doi.org/10.1038/nature07118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633409	Green Accepted			2022-12-28	WOS:000257665300029
J	Rutherford, GW				Rutherford, George W.			Condoms in concentrated and generalised HIV epidemics	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; BEHAVIOR; DECLINE		Univ Calif San Francisco, Cochrane HIV AIDS Grp & Global Hlth Sci, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Rutherford, GW (corresponding author), Univ Calif San Francisco, Cochrane HIV AIDS Grp & Global Hlth Sci, San Francisco, CA 94105 USA.	grutherford@psg.ucsf.edu						[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; HATCHER RA, 2007, CONTRACEPTIVE TECHNO; Hayes R, 2006, SCIENCE, V311, P620, DOI 10.1126/science.1124072; HEARST N, EVIDENCE DEMANDS ACT; Low-Beer Daniel, 2003, Afr J AIDS Res, V2, P9, DOI 10.2989/16085906.2003.9626555; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Shelton JD, 2001, BRIT MED J, V323, P139, DOI 10.1136/bmj.323.7305.139; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					275	276		10.1016/S0140-6736(08)61092-2	http://dx.doi.org/10.1016/S0140-6736(08)61092-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657695				2022-12-28	WOS:000258042800011
J	Wilder-Smith, EP; Ng, ES				Wilder-Smith, Einar P.; Ng, Esther S.			The writing on the wall	LANCET			English	Editorial Material							ENCEPHALITIS		[Wilder-Smith, Einar P.; Ng, Esther S.] Natl Univ Singapore, Div Neurol, Singapore 119074, Singapore	National University of Singapore	Ng, ES (corresponding author), Natl Univ Singapore, Div Neurol, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.	u0302066@gmail.com		Wilder-Smith, Einar/0000-0003-3402-7503				Sansing LH, 2007, NAT CLIN PRACT NEURO, V3, P291, DOI 10.1038/ncpneuro0493; Tuzun E, 2007, NEUROLOGIST, V13, P261, DOI 10.1097/NRL.0b013e31813e34a5	2	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					344	344		10.1016/S0140-6736(08)61120-4	http://dx.doi.org/10.1016/S0140-6736(08)61120-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657715				2022-12-28	WOS:000258042800037
J	Wilson, D; Halperin, DT				Wilson, David; Halperin, Daniel T.			"Know your epidemic, know your response": a useful approach, if we get it right	LANCET			English	Editorial Material							SEXUAL RISK BEHAVIOR; HIV INCIDENCE; PARTNER REDUCTION; AIDS-PREVENTION; STRATEGIES; INFECTION; AFRICA; HEALTH; TRIAL; MEN		[Halperin, Daniel T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Wilson, David] World Bank, Washington, DC 20433 USA	Harvard University; Harvard T.H. Chan School of Public Health; The World Bank	Halperin, DT (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	daniel_halperin@harvard.edu						AUVERT B, IN PRESS PLOS 1; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Cheluget B, 2006, SEX TRANSM INFECT, V82, pI21, DOI 10.1136/sti.2005.015990; Chin James, 2007, AIDS PANDEMIC COLLIS; Coates TJ, 2008, AIDS, V22, P1079, DOI 10.1097/QAD.0b013e3282f8afb0; Cohen J, 2004, SCIENCE, V304, P1932, DOI 10.1126/science.304.5679.1932; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; EPSTEIN H, 2007, INVISIBLE CURE AFRIC; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; Halperin DT, 2007, S AFR J HIV MED, P19; Halperin DT, 2006, J HEALTH COMMUN, V11, P266, DOI 10.1080/10810730600630157; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; HALPERIN DT, 2008, NY TIMES        0101, pA19; HALPERIN DT, IN PRESS J ACQUIR IM; HANLEY M, 2008, MERCATORNET     0229; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; *HUM RIGHTS WATCH, 2008, EG COURT UPH HIV SEN; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; KIRBY D, IN PRESS SEX TRANSM; Klausner Jeffrey D, 2008, Futur HIV Ther, V2, P1, DOI 10.2217/17469600.2.1.1; Matovu JKB, 2007, AIDS BEHAV, V11, P71, DOI 10.1007/s10461-006-9170-y; Mekonnen Y, 2003, AIDS, V17, P223, DOI 10.1097/00002030-200301240-00013; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Pisani E, 2008, WISDOM WHORES BUREAU; PISANI E, 2007, GUARDIAN        1201; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; SHAFER LA, 2006, 16 INT AIDS C TOR CA; SHELTON J, IN PRESS LANCET; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; *SO AFR DEV COMM, 2006, EXP THINK TANK M HIV; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; TIMBERG C, 2007, WASHINGTON POST 0329, pA1; *UNAIDS, 2007, PRACT GUID INT HIV P; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Williamson LM, 2008, AIDS, V22, P1063, DOI 10.1097/QAD.0b013e3282f8af9b; Wilson D, 2004, BRIT MED J, V328, P848, DOI 10.1136/bmj.328.7444.848; *WORLD EC FOR, 2007, GLOB GEND GAP REP 20; 2007, USA TODAY       1201; 2006, TIMES INDIA     0920	48	135	135	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					423	426		10.1016/S0140-6736(08)60883-1	http://dx.doi.org/10.1016/S0140-6736(08)60883-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335OD	18687462				2022-12-28	WOS:000258299000005
J	Carter, EA				Carter, Emily A.			Challenges in modeling materials properties without experimental input	SCIENCE			English	Editorial Material							ELECTRONIC-STRUCTURE METHODS; DENSITY-FUNCTIONAL THEORY; SOLIDS		[Carter, Emily A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Carter, Emily A.] Princeton Univ, Program Appl & Computat Math, Princeton, NJ 08544 USA	Princeton University; Princeton University	Carter, EA (corresponding author), Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.	eac@princeton.edu	Carter, Emily Ann/AAV-8760-2020; Carter, Emily A/P-4075-2014	Carter, Emily Ann/0000-0001-7330-7554; Carter, Emily A/0000-0001-7330-7554				Ashcroft N.W., 1976, SOLID STATE PHYS; Attaccalite C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.114501; Botti S, 2007, REP PROG PHYS, V70, P357, DOI 10.1088/0034-4885/70/3/R02; Chwee TS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2937443; Foulkes WMC, 2001, REV MOD PHYS, V73, P33, DOI 10.1103/RevModPhys.73.33; Goedecker S, 1999, REV MOD PHYS, V71, P1085, DOI 10.1103/RevModPhys.71.1085; Harl J, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045136; Hayes RL, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.172104; Heyd J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1760074; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Huang P, 2008, ANNU REV PHYS CHEM, V59, P261, DOI 10.1146/annurev.physchem.59.032607.093528; Kleis J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.100201; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Kurth S, 1999, INT J QUANTUM CHEM, V75, P889, DOI 10.1002/(SICI)1097-461X(1999)75:4/5<889::AID-QUA54>3.0.CO;2-8; Lee MW, 2007, MOL PHYS, V105, P2493, DOI 10.1080/00268970701537947; LIECHTENSTEIN AI, 1995, PHYS REV B, V52, pR5467, DOI 10.1103/PhysRevB.52.R5467; Mosey NJ, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2943142; Onida G, 2002, REV MOD PHYS, V74, P601, DOI 10.1103/RevModPhys.74.601; Pickard CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045504; Pisani C, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1857479; Schutz M, 2001, J CHEM PHYS, V114, P661, DOI 10.1063/1.1330207; Usvyat D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075102; Voter AF, 2002, ANNU REV MATER RES, V32, P321, DOI 10.1146/annurev.matsci.32.112601.141541; Wagner LK, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/34/343201; Wang YA, 2000, PROG T CHEM, V5, P117; Watson D.G.M., 1998, ELS OCEAN ENGN BK S, V1, P558; Williamson AJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.246406; [No title captured]; [No title captured]	31	188	194	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					800	803		10.1126/science.1158009	http://dx.doi.org/10.1126/science.1158009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687955				2022-12-28	WOS:000258261000035
J	Shen, WX; Flajolet, M; Greengard, P; Surmeier, DJ				Shen, Weixing; Flajolet, Marc; Greengard, Paul; Surmeier, D. James			Dichotomous dopaminergic control of striatal synaptic plasticity	SCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM DEPRESSION; MEDIUM SPINY NEURONS; BASAL GANGLIA; STRIATOPALLIDAL NEURONS; DENDRITIC EXCITABILITY; MODULATION; INTERNEURONS; TRANSMISSION; ACTIVATION	At synapses between cortical pyramidal neurons and principal striatal medium spiny neurons (MSNs), postsynaptic D1 and D2 dopamine (DA) receptors are postulated to be necessary for the induction of long-term potentiation and depression, respectively-forms of plasticity thought to underlie associative learning. Because these receptors are restricted to two distinct MSN populations, this postulate demands that synaptic plasticity be unidirectional in each cell type. Using brain slices from DA receptor transgenic mice, we show that this is not the case. Rather, DA plays complementary roles in these two types of MSN to ensure that synaptic plasticity is bidirectional and Hebbian. In models of Parkinson's disease, this system is thrown out of balance, leading to unidirectional changes in plasticity that could underlie network pathology and symptoms.	[Shen, Weixing; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Northwestern University; Feinberg School of Medicine; Rockefeller University	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu		Greengard, Paul/0000-0002-4437-0893	NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [P50 MH074866, MH074866, P50 MH074866-05] Funding Source: Medline; NINDS NIH HHS [R01 NS034696, R37 NS034696, R01 NS034696-06, NS 34696] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034696, R01NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Dujardin K, 2003, CURR OPIN NEUROL, V16, pS11, DOI 10.1097/00019052-200312002-00003; Fino E, 2005, J NEUROSCI, V25, P11279, DOI 10.1523/JNEUROSCI.4476-05.2005; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GONAN F, 1997, J NEUROSCI, V17, P5972; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	28	787	798	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					848	851		10.1126/science.1160575	http://dx.doi.org/10.1126/science.1160575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687967	Green Accepted			2022-12-28	WOS:000258261000049
J	Mitnick, CD; Shin, SS; Seung, KJ; Rich, ML; Atwood, SS; Furin, JJ; Fitzmaurice, GM; Viru, FAA; Appleton, SC; Bayona, JN; Bonilla, CA; Chalco, K; Choi, S; Franke, MF; Fraser, HSF; Guerra, D; Hurtado, RM; Jazayeri, D; Joseph, K; Llaro, K; Mestanza, L; Mukherjee, JS; Munoz, M; Palacios, E; Sanchez, E; Sloutsky, A; Becerra, MC				Mitnick, Carole D.; Shin, Sonya S.; Seung, Kwonjune J.; Rich, Michael L.; Atwood, Sidney S.; Furin, Jennifer J.; Fitzmaurice, Garrett M.; Alcantara Viru, Felix A.; Appleton, Sasha C.; Bayona, Jaime N.; Bonilla, Cesar A.; Chalco, Katiuska; Choi, Sharon; Franke, Molly F.; Fraser, Hamish S. F.; Guerra, Dalia; Hurtado, Rocio M.; Jazayeri, Darius; Joseph, Keith; Llaro, Karim; Mestanza, Lorena; Mukherjee, Joia S.; Munoz, Maribel; Palacios, Eda; Sanchez, Epifanio; Sloutsky, Alexander; Becerra, Mercedes C.			Comprehensive treatment of extensively drug-resistant tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY-BASED TREATMENT; MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; MDR-TB; TREATMENT OUTCOMES; INTERFERON-GAMMA; SOUTH-AFRICA; THERAPY; PERU	Background: Extensively drug-resistant tuberculosis has been reported in 45 countries, including countries with limited resources and a high burden of tuberculosis. We describe the management of extensively drug-resistant tuberculosis and treatment outcomes among patients who were referred for individualized outpatient therapy in Peru. Methods: A total of 810 patients were referred for free individualized therapy, including drug treatment, resective surgery, adverse-event management, and nutritional and psychosocial support. We tested isolates from 651 patients for extensively drug-resistant tuberculosis and developed regimens that included five or more drugs to which the infecting isolate was not resistant. Results: Of the 651 patients tested, 48 (7.4%) had extensively drug-resistant tuberculosis; the remaining 603 patients had multidrug-resistant tuberculosis. The patients with extensively drug-resistant tuberculosis had undergone more treatment than the other patients (mean [+/-SD] number of regimens, 4.2+/-1.9 vs. 3.2+/-1.6; P<0.001) and had isolates that were resistant to more drugs (number of drugs, 8.4+/-1.1 vs. 5.3+/-1.5; P<0.001). None of the patients with extensively drug-resistant tuberculosis were coinfected with the human immunodeficiency virus (HIV). Patients with extensively drug-resistant tuberculosis received daily, supervised therapy with an average of 5.3+/-1.3 drugs, including cycloserine, an injectable drug, and a fluoroquinolone. Twenty-nine of these patients (60.4%) completed treatment or were cured, as compared with 400 patients (66.3%) with multidrug-resistant tuberculosis (P=0.36). Conclusions: Extensively drug-resistant tuberculosis can be cured in HIV-negative patients through outpatient treatment, even in those who have received multiple prior courses of therapy for tuberculosis.	[Mitnick, Carole D.; Fraser, Hamish S. F.; Becerra, Mercedes C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shin, Sonya S.; Atwood, Sidney S.; Furin, Jennifer J.; Fitzmaurice, Garrett M.; Hurtado, Rocio M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Seung, Kwonjune J.; Rich, Michael L.; Choi, Sharon; Jazayeri, Darius; Joseph, Keith; Mukherjee, Joia S.] Partners Hlth, Boston, MA USA; [Appleton, Sasha C.; Franke, Molly F.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sloutsky, Alexander] Massachusetts State Lab Inst, Boston, MA USA; [Alcantara Viru, Felix A.; Bayona, Jaime N.; Chalco, Katiuska; Guerra, Dalia; Llaro, Karim; Mestanza, Lorena; Munoz, Maribel; Palacios, Eda] Socios Salud, Lima, Peru; [Bonilla, Cesar A.] Peruvian Minist Hlth, Lima, Peru; [Sanchez, Epifanio] Hosp Nacl Sergio E Bernales, Lima, Peru	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Mitnick, CD (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		BONILLA-ASALDE, CÉSAR ANTONIO/AHH-6777-2022; Mitnick, Carole/GRO-1991-2022; Franke, Molly/AAK-7559-2020; Fraser, Hamish HS/E-3773-2013; Fraser, Hamish/AGP-6129-2022	BONILLA-ASALDE, CÉSAR ANTONIO/0000-0002-4470-1939; Mitnick, Carole/0000-0002-3455-658X; Franke, Molly/0000-0002-4890-5728; Fraser, Hamish/0000-0003-4383-2854; Atwood, Sidney/0000-0001-8865-6300	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI065836] Funding Source: NIH RePORTER; NHLBI NIH HHS [K01 HL080939-02, K01 HL080939-01, K01 HL080939-03, 5 K01 HL080939, K01 HL080939-04, K01 HL080939] Funding Source: Medline; NIAID NIH HHS [K01 AI065836, K01 AI065836-03, K01 AI065836-01A1, K01 AI065836-02] Funding Source: Medline; PHS HHS [5 K01 A1065836] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Chalco K, 2006, INT NURS REV, V53, P253, DOI 10.1111/j.1466-7657.2006.00490.x; Chauhan L S, 2007, J Indian Med Assoc, V105, P196; CHAUHAN LS, 2007, J INDIAN MED ASSOC, V105, P194; CHAUHAN LS, 2007, J INDIAN MED ASSOC, V105, P196; Condos R, 1997, LANCET, V349, P1513, DOI 10.1016/S0140-6736(96)12273-X; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; de Bruyn G, 2003, COCHRANE DB SYST REV, V1; Donald PR, 2001, SCAND J INFECT DIS, V33, P466, DOI 10.1080/00365540152029954; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Farnia P, 2008, J CLIN MICROBIOL, V46, P796, DOI 10.1128/JCM.01435-07; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Hamilton CD, 2007, CLIN INFECT DIS, V45, P338, DOI 10.1086/519292; Iseman MD, 2007, CLIN INFECT DIS, V45, P1415, DOI 10.1086/522988; Janulionis E, 2004, ANTIMICROB AGENTS CH, V48, P3133, DOI 10.1128/AAC.48.8.3133-3135.2004; Jouveshomme S, 1998, AM J RESP CRIT CARE, V157, P1609, DOI 10.1164/ajrccm.157.5.9709047; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Lan NTN, 2001, INT J TUBERC LUNG D, V5, P575; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lee CN, 1996, J CHEMOTHERAPY, V8, P137, DOI 10.1179/joc.1996.8.2.137; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Masjedi MR, 2006, CLIN INFECT DIS, V43, P841, DOI 10.1086/507542; Matrat S, 2006, ANTIMICROB AGENTS CH, V50, P4170, DOI 10.1128/AAC.00944-06; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Ministerio de Salud, 2001, ACT DOCTR NORM PROC; Ministerio de Salud, 2006, NORM TECN SAL CONTR; Mitchison DA, 2004, SEMIN RESP CRIT CARE, V25, P307, DOI 10.1055/s-2004-829503; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; NITTA AT, 1993, CLIN INFECT DIS, V16, P219, DOI 10.1093/clind/16.2.219; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Park SK, 2007, INT J INFECT DIS, V11, P434, DOI 10.1016/j.ijid.2006.12.004; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Partners In Health Harvard Medical School Bill & Melinda Gates Foundation, 2002, DOTS PLUS HDB GUID C; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Rich ML, 2006, INT J TUBERC LUNG D, V10, P290; RICH ML, 2003, PIH GUIDE MED MANAGE; Sato K, 2000, INT J ANTIMICROB AG, V16, P25, DOI 10.1016/S0924-8579(00)00163-1; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961; Spigelman M, 2006, LANCET, V367, P945, DOI 10.1016/S0140-6736(06)68388-8; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Timperi R, 2005, INT J TUBERC LUNG D, V9, P175; Vega F, 2004, INT J TUBERC LUNG D, V8, P749; Wang JY, 2007, J ANTIMICROB CHEMOTH, V59, P860, DOI 10.1093/jac/dkm061; WHO, 2001, REP M GROUND LARV BL; *WHO IUATLD GLOB P, 2008, WHOHTMTB2008394; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; 2006, MMWR MORB MORTAL WKL, V55, P301; 2006, MMWR MORB MORTAL WKL, V55, P1176	60	274	284	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					563	574		10.1056/NEJMoa0800106	http://dx.doi.org/10.1056/NEJMoa0800106			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687637	Green Accepted, Green Submitted			2022-12-28	WOS:000258216700004
J	Burris, S; Cameron, E				Burris, Scott; Cameron, Edwin			The case against criminalization of HIV transmission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION PROGRAMS; SEXUAL TRANSMISSION		[Burris, Scott] Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; [Burris, Scott] Johns Hopkins Univ, Ctr Law & Publ Hlth, Philadelphia, PA USA; [Burris, Scott] Georgetown Univ, Ctr Law & Publ Hlth, Philadelphia, PA USA; [Cameron, Edwin] Supreme Court Appeal S Africa, Bloemfontein, South Africa	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; Georgetown University	Burris, S (corresponding author), Temple Univ, Beasley Sch Law, 1719 N Broad St, Philadelphia, PA 19122 USA.	scott.burris@temple.edu		Burris, Scott/0000-0002-6013-5842				*AWARE HIV AIDS, 2004, REG WORKSH AD MOD LA; Burris S., 2007, ARIZONA STATE LAW J, V2007, P1; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Dodds C, 2006, INT J STD AIDS, V17, P315, DOI 10.1258/095646206776790114; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; HOLTGRAVE DR, 1995, PUBLIC HEALTH REP, V110, P134; KOVACH G, 2008, NY TIMES        0516; Lazzarini Z, 2002, J LAW MED ETHICS, V30, P239, DOI 10.1111/j.1748-720X.2002.tb00390.x; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Weait M, 2007, INTIMACY RESPONSIBIL, DOI [10.4324/9780203937938, DOI 10.4324/9780203937938]; WOLF LE, 2004, WHITTIER LAW REV, V25, P821; Worth H., 2005, SEX RES SOC POLICY, V2, P22, DOI [10.1525/srsp.2005.2.2.15, DOI 10.1525/SRSP.2005.2.2.15]	13	74	74	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					578	581		10.1001/jama.300.5.578	http://dx.doi.org/10.1001/jama.300.5.578			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677032				2022-12-28	WOS:000258188900021
J	Manning, KD				Manning, Kimberly D.			A person of status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kdmanni@emory.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					483	484		10.1001/jama.300.5.483	http://dx.doi.org/10.1001/jama.300.5.483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677015				2022-12-28	WOS:000258188900001
J	Yoshida, N; Omukai, K; Hernquist, L				Yoshida, Naoki; Omukai, Kazuyuki; Hernquist, Lars			Protostar formation in the early universe	SCIENCE			English	Article							INITIAL MASS FUNCTION; METAL-POOR STARS; 1ST STARS; PRIMORDIAL STARS; CDM UNIVERSE; GAS; FRAGMENTATION; ACCRETION; REDSHIFT; GALAXY	The nature of the first generation of stars in the universe remains largely unknown. Observations imply the existence of massive primordial stars early in the history of the universe, and the standard theory for the growth of cosmic structure predicts that structures grow hierarchically through gravitational instability. We have developed an ab initio computer simulation of the formation of primordial stars that follows the relevant atomic and molecular processes in a primordial gas in an expanding universe. The results show that primeval density fluctuations left over from the Big Bang can drive the formation of a tiny protostar with a mass 1% that of the Sun. The protostar is a seed for the subsequent formation of a massive primordial star.	[Yoshida, Naoki] Nagoya Univ, Dept Phys, Chikusa Ku, Aichi 4648602, Japan; [Omukai, Kazuyuki] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Hernquist, Lars] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Yoshida, N (corresponding author), Nagoya Univ, Dept Phys, Chikusa Ku, Furo Cho, Aichi 4648602, Japan.	nyoshida@a.phys.nagoya-u.ac.jp	Yoshida, Naoki/A-4305-2011	Yoshida, Naoki/0000-0001-7925-238X				Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; BROMM V, 2004, NEW ASTRON, V353, P364; Fan XH, 2003, ASTRON J, V125, P1649, DOI 10.1086/368246; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Gao L, 2007, SCIENCE, V317, P1527, DOI 10.1126/science.1146676; Iwamoto N, 2005, SCIENCE, V309, P451, DOI 10.1126/science.1112997; Iye M, 2006, NATURE, V443, P186, DOI 10.1038/nature05104; Johnson JL, 2006, MON NOT R ASTRON SOC, V366, P247, DOI 10.1111/j.1365-2966.2005.09846.x; Komiya Y, 2007, ASTROPHYS J, V658, P367, DOI 10.1086/510826; LARSON RB, 1969, MON NOT R ASTRON SOC, V145, P271, DOI 10.1093/mnras/145.3.271; Machida MN, 2008, ASTROPHYS J, V677, P813, DOI 10.1086/533434; Matsumoto T, 2003, ASTROPHYS J, V595, P913, DOI 10.1086/377367; Mckee CF, 2008, ASTROPHYS J, V681, P771, DOI 10.1086/587434; O'Shea BW, 2007, ASTROPHYS J, V654, P66, DOI 10.1086/509250; Omukai K, 2005, ASTROPHYS J, V626, P627, DOI 10.1086/429955; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; Omukai K, 2003, ASTROPHYS J, V589, P677, DOI 10.1086/374810; Ripamonti E, 2002, MON NOT R ASTRON SOC, V334, P401, DOI 10.1046/j.1365-8711.2002.05516.x; SPERGEL DN, 2007, ASTROPHYS J, V424, P406; Spolyar D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.051101; Uehara HY, 2000, ASTROPHYS J, V531, pL91, DOI 10.1086/312529; Walter F, 2003, NATURE, V424, P406, DOI 10.1038/nature01821; Yoshida N, 2007, ASTROPHYS J, V667, pL117, DOI 10.1086/522202; Yoshida N, 2006, ASTROPHYS J, V652, P6, DOI 10.1086/507978	29	294	294	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					669	671		10.1126/science.1160259	http://dx.doi.org/10.1126/science.1160259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669856	Green Accepted, Green Submitted			2022-12-28	WOS:000258077700037
J	Brandt, AM				Brandt, Allan M.			FDA regulation of tobacco - Pitfalls and possibilities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brandt, Allan M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brandt, Allan M.] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Brandt, AM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Brandt AM., 2007, CIGARETTE CENTURY RI; HARDY DR, 1970, WARN WHY	2	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					445	448		10.1056/NEJMp0803729	http://dx.doi.org/10.1056/NEJMp0803729			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331VC	18663229				2022-12-28	WOS:000258039700001
J	Braakman, I; Otsu, M				Braakman, Ineke; Otsu, Mieko			Biochemistry - Cargo load reduction	SCIENCE			English	Editorial Material							PROTEIN DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; ER; CYTOSOL; DEGRADATION; CALNEXIN; CELLS; EDEM		[Braakman, Ineke; Otsu, Mieko] Univ Utrecht, Bijvoet Ctr, Fac Sci, NL-3584 CA Utrecht, Netherlands	Utrecht University	Braakman, I (corresponding author), Univ Utrecht, Bijvoet Ctr, Fac Sci, NL-3584 CA Utrecht, Netherlands.	i.braakman@uu.nl						Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	18	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					499	500		10.1126/science.1162125	http://dx.doi.org/10.1126/science.1162125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653871				2022-12-28	WOS:000257888900028
J	Yoong, JKC				Yoong, Jon K. C.			Ankylosing spondylitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Singapore Gen Hosp, Singapore 169608, Singapore	Singapore General Hospital	Yoong, JKC (corresponding author), Singapore Gen Hosp, Singapore 169608, Singapore.	jonyoong@yahoo.com							0	0	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					404	404		10.1056/NEJMicm060672	http://dx.doi.org/10.1056/NEJMicm060672			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650516				2022-12-28	WOS:000257852100008
J	Deech, R				Deech, Ruth			30 years: from IVF to stem cells	NATURE			English	Editorial Material																			0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					280	281		10.1038/454280a	http://dx.doi.org/10.1038/454280a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	326ND	18633401	Bronze			2022-12-28	WOS:000257665300021
J	Mustard, JF; Murchie, SL; Pelkey, SM; Ehlmann, BL; Milliken, RE; Grant, JA; Bibring, JP; Poulet, F; Bishop, J; Dobrea, EN; Roach, L; Seelos, F; Arvidson, RE; Wiseman, S; Green, R; Hash, C; Humm, D; Malaret, E; McGovern, JA; Seelos, K; Clancy, T; Clark, R; Des Marais, D; Izenberg, N; Knudson, A; Langevin, Y; Martin, T; McGuire, P; Morris, R; Robinson, M; Roush, T; Smith, M; Swayze, G; Taylor, H; Titus, T; Wolff, M				Mustard, John F.; Murchie, S. L.; Pelkey, S. M.; Ehlmann, B. L.; Milliken, R. E.; Grant, J. A.; Bibring, J. -P.; Poulet, F.; Bishop, J.; Dobrea, E. Noe; Roach, L.; Seelos, F.; Arvidson, R. E.; Wiseman, S.; Green, R.; Hash, C.; Humm, D.; Malaret, E.; McGovern, J. A.; Seelos, K.; Clancy, T.; Clark, R.; Des Marais, D.; Izenberg, N.; Knudson, A.; Langevin, Y.; Martin, T.; McGuire, P.; Morris, R.; Robinson, M.; Roush, T.; Smith, M.; Swayze, G.; Taylor, H.; Titus, T.; Wolff, M.			Hydrated silicate minerals on mars observed by the Mars reconnaissance orbiter CRISM instrument	NATURE			English	Article							OLIVINE; DIVERSITY; REGION	Phyllosilicates, a class of hydrous mineral first definitively identified on Mars by the OMEGA ( Observatoire pour la Mineralogie, L'Eau, les Glaces et l'Activitie') instrument(1,2), preserve a record of the interaction of water with rocks on Mars. Global mapping showed that phyllosilicates are widespread but are apparently restricted to ancient terrains and a relatively narrow range of mineralogy ( Fe/ Mg and Al smectite clays). This was interpreted to indicate that phyllosilicate formation occurred during the Noachian ( the earliest geological era of Mars), and that the conditions necessary for phyllosilicate formation ( moderate to high pH and high water activity(3)) were specific to surface environments during the earliest era of Mars's history(4). Here we report results from the Compact Reconnaissance Imaging Spectrometer for Mars (CRISM)(5) of phyllosilicate- rich regions. We expand the diversity of phyllosilicate mineralogy with the identification of kaolinite, chlorite and illite or muscovite, and a new class of hydrated silicate ( hydrated silica). We observe diverse Fe/ Mg-OH phyllosilicates and find that smectites such as nontronite and saponite are the most common, but chlorites are also present in some locations. Stratigraphic relationships in the Nili Fossae region show olivine- rich materials overlying phyllosilicate- bearing units, indicating the cessation of aqueous alteration before emplacement of the olivine- bearing unit. Hundreds of detections of Fe/ Mg phyllosilicate in rims, ejecta and central peaks of craters in the southern highland Noachian cratered terrain indicate excavation of altered crust from depth. We also find phyllosilicate in sedimentary deposits clearly laid by water. These results point to a rich diversity of Noachian environments conducive to habitability.	[Mustard, John F.; Pelkey, S. M.; Ehlmann, B. L.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Murchie, S. L.; Seelos, F.; Humm, D.; McGovern, J. A.; Seelos, K.; Izenberg, N.; Taylor, H.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Milliken, R. E.; Dobrea, E. Noe; Green, R.; Martin, T.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Grant, J. A.] Smithsonian Inst, Ctr Earth & Planetary Studies, Natl Air & Space Museum, Washington, DC 20560 USA; [Bibring, J. -P.; Poulet, F.; Langevin, Y.] Ctr Univ Paris Sud, Inst Astrophys Spatiale, F-91405 Orsay, France; [Bishop, J.; Des Marais, D.; Roush, T.] Ames Res Ctr, Natl Aeronaut & Space Adm, Mountain View, CA 94043 USA; [Arvidson, R. E.; Wiseman, S.; Knudson, A.; McGuire, P.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Hash, C.; Malaret, E.] Appl Coherent Technol, Herndon, VA 22070 USA; [Clancy, T.; Swayze, G.; Wolff, M.] Space Sci Inst, Boulder, CO 80301 USA; [Clark, R.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [Morris, R.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Robinson, M.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Smith, M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Titus, T.] US Geol Survey, Flagstaff, AZ 86001 USA	Brown University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Washington University (WUSTL); United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of the Interior; United States Geological Survey	Mustard, JF (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	john_mustard@brown.edu	Smith, Michael/C-8875-2012; Seelos, Kimberly D/F-4647-2015; McGuire, Patrick C/D-2962-2013; Seelos, Frank/C-7875-2016; Izenberg, Noam R/F-3952-2015; Murchie, Scott L/E-8030-2015; Robinson, Mark/ABI-6841-2020; Humm, David C/B-8825-2016	Seelos, Kimberly D/0000-0001-7236-0580; McGuire, Patrick C/0000-0001-6592-4966; Seelos, Frank/0000-0001-9721-941X; Izenberg, Noam R/0000-0003-1629-6478; Murchie, Scott L/0000-0002-1616-8751; Humm, David C/0000-0003-1520-261X; Bishop, Janice/0000-0002-6681-9954; Grant, John/0000-0001-8276-1281				Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; BIBRING JP, 1989, NATURE, V341, P591, DOI 10.1038/341591a0; Bishop J, 2002, CLAY MINER, V37, P607, DOI 10.1180/0009855023740063; BISHOP JL, 2007, 7 INT C MARS PAS CAL; Calvin WM, 1998, GEOPHYS RES LETT, V25, P1597, DOI 10.1029/98GL01255; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; COSTARD F, 2006, 37 LUN PLAN SCI C HO; Ehlmann BL, 2008, NAT GEOSCI, V1, P355, DOI 10.1038/ngeo207; Frost RL, 2002, SPECTROCHIM ACTA A, V58, P1657, DOI 10.1016/S1386-1425(01)00637-0; Grant JA, 2008, GEOLOGY, V36, P195, DOI 10.1130/G24340A.1; Hamilton VE, 2005, GEOLOGY, V33, P433, DOI 10.1130/G21258.1; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Loizeau D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002877; Malin MC, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002808; Mangold N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002835; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Michalski JR, 2007, GEOLOGY, V35, P951, DOI 10.1130/G23854A.1; Milliken R., 2007, 7 INT MARS C; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002834; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; Pelkey SM, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002831; Poulet F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002179; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; POULET F, 2007, 7 INT C MARS; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Srodon J, 1999, ANNU REV EARTH PL SC, V27, P19, DOI 10.1146/annurev.earth.27.1.19; Velde B., 1995, Origin and mineralogy of clays: clays and the environment., P8; Wolff MJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002786	31	558	564	5	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2008	454	7202					305	309		10.1038/nature07097	http://dx.doi.org/10.1038/nature07097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633411				2022-12-28	WOS:000257665300032
J	Rehmann, H; Arias-Palomo, E; Hadders, MA; Schwede, F; Llorca, O; Bos, JL				Rehmann, Holger; Arias-Palomo, Ernesto; Hadders, Michael A.; Schwede, Frank; Llorca, Oscar; Bos, Johannes L.			Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B	NATURE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; DEPENDENT PROTEIN-KINASE; ELECTRON-MICROSCOPY; REGULATORY SUBUNIT; BINDING PROTEINS; ACTIVATION; RAS; PROGRAM; FAMILY; VISUALIZATION	Epac proteins are activated by binding of the second messenger cAMP and then act as guanine nucleotide exchange factors for Rap proteins(1,2). The Epac proteins are involved in the regulation of cell adhesion(3) and insulin secretion(4). Here we have determined the structure of Epac2 in complex with a cAMP analogue (Sp-cAMPS) and RAP1B by X- ray crystallography and single particle electron microscopy. The structure represents the cAMP activated state of the Epac2 protein with the RAP1B protein trapped in the course of the exchange reaction. Comparison with the inactive conformation reveals that cAMP binding causes conformational changes that allow the cyclic nucleotide binding domain to swing from a position blocking the Rap binding site towards a docking site at the Ras exchange motif domain.	[Rehmann, Holger; Bos, Johannes L.] Univ Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [Rehmann, Holger; Bos, Johannes L.] Univ Med Ctr, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Arias-Palomo, Ernesto; Llorca, Oscar] CSIC, CIB, Spanish Natl Res Council, E-28040 Madrid, Spain; [Hadders, Michael A.] Univ Utrecht, Bijvoet Ctr, Dept Crystal & Struct Chem, NL-3584 CH Utrecht, Netherlands; [Schwede, Frank] BIOLOG Life Sci Inst, D-28199 Bremen, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Utrecht University	Rehmann, H (corresponding author), Univ Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, Universiteitsweg 100, NL-3584 CG Utrecht, Netherlands.	h.rehmann@UMCutrecht.nl	Llorca, Oscar/P-2784-2019; Llorca, Oscar/K-1144-2014; Bustelo, Xose R./A-9526-2010; Arias Palomo, Ernesto/L-1853-2017; Garcia, Pedro/L-2808-2017	Llorca, Oscar/0000-0001-5705-0699; Llorca, Oscar/0000-0001-5705-0699; Bustelo, Xose R./0000-0001-9398-6072; Garcia, Pedro/0000-0001-6717-8717; Arias-Palomo, Ernesto/0000-0002-2706-7411	Autonomous Region of Madrid; Bremer Innovationsagentur; Spanish Ministry of Education and Science (MEC); Red Tematica de Investigacion cooperativa en Cancer (RTICC); Chemical Sciences and the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO)	Autonomous Region of Madrid; Bremer Innovationsagentur; Spanish Ministry of Education and Science (MEC)(Spanish Government); Red Tematica de Investigacion cooperativa en Cancer (RTICC); Chemical Sciences and the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank P. Gros for access to crystallization robots, M. Rensen- De Leeuw for technical assistance, A. Wittinghofer for reading the manuscript, the European Synchrotron Radiation Facility for providing synchrotron facilities, the scientists at ID23-1 for help with data collection, and the Galicia Supercomputer Centre (CESGA) and the Barcelona Supercomputing Centre for computing resources. H. R. is a recipient of the Hendrik Casimir-Karl Ziegler-Forschungspreis of the Nordrhein-Westfalischen Akademie der Wissenschaften and the Koninklijke Nederlandse Akademie van Wetenschappen. E.A.-P. and O.L. are supported by the Autonomous Region of Madrid, F. S. by the Bremer Innovationsagentur, O.L. by the Spanish Ministry of Education and Science (MEC) and the Red Tematica de Investigacion cooperativa en Cancer (RTICC), and J.L.B. by the Chemical Sciences and the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SCHOMBURG D, 1988, J MOL GRAPHICS, V6, P161, DOI 10.1016/0263-7855(88)80069-9; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; YAGURA TS, 1981, BIOCHEMISTRY-US, V20, P879, DOI 10.1021/bi00507a035; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	35	144	150	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2008	455	7209					124	U93		10.1038/nature07187	http://dx.doi.org/10.1038/nature07187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18660803				2022-12-28	WOS:000258890200050
J	Palopoli, MF; Rockman, MV; TinMaung, A; Ramsay, C; Curwen, S; Aduna, A; Laurita, J; Kruglyak, L				Palopoli, Michael F.; Rockman, Matthew V.; TinMaung, Aye; Ramsay, Camden; Curwen, Stephen; Aduna, Andrea; Laurita, Jason; Kruglyak, Leonid			Molecular basis of the copulatory plug polymorphism in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; NATURAL-POPULATIONS; TEMPORAL DYNAMICS; MATING-BEHAVIOR; EVOLUTION; MUCINS; RNAI; PREDICTION; PHYLOGENY	Heritable variation is the raw material for evolutionary change, and understanding its genetic basis is one of the central problems in modern biology. We investigated the genetic basis of a classic phenotypic dimorphism in the nematode Caenorhabditis elegans. Males from many natural isolates deposit a copulatory plug after mating, whereas males from other natural isolates - including the standard wild- type strain ( N2 Bristol) that is used in most research laboratories - do not deposit plugs(1). The copulatory plug is a gelatinous mass that covers the hermaphrodite vulva, and its deposition decreases the mating success of subsequent males(2). We show that the plugging polymorphism results from the insertion of a retrotransposon into an exon of a novel mucin- like gene, plg-1, whose product is a major structural component of the copulatory plug. The gene is expressed in a subset of secretory cells of the male somatic gonad, and its loss has no evident effects beyond the loss of male mate- guarding. Although C. elegans descends from an obligate- outcrossing, male - female ancestor(3,4), it occurs primarily as self- fertilizing hermaphrodites(5-7). The reduced selection on male - male competition associated with the origin of hermaphroditism may have permitted the global spread of a loss-of-function mutation with restricted pleiotropy.	[Palopoli, Michael F.; TinMaung, Aye; Ramsay, Camden; Curwen, Stephen; Aduna, Andrea; Laurita, Jason] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Rockman, Matthew V.; Kruglyak, Leonid] Princeton Univ, Carl Icahn Lab, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rockman, Matthew V.; Kruglyak, Leonid] Princeton Univ, Carl Icahn Lab, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Bowdoin College; Princeton University; Princeton University	Palopoli, MF (corresponding author), Bowdoin Coll, Dept Biol, 6500 Coll Stn, Brunswick, ME 04011 USA.	mpalopol@bowdoin.edu			NIH [P20 RR-016463, R01 HG004321, P50 GM071508]; INBRE Program of the National Center for Research Resources; NSF [0110994]; Howard Hughes Medical Institute under the Undergraduate Science Education Program; James S. McDonnell Foundation Centennial Fellowship; Jane Coffin Childs Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute under the Undergraduate Science Education Program(Howard Hughes Medical Institute); James S. McDonnell Foundation Centennial Fellowship; Jane Coffin Childs Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center, M. Ailion, E. Dolgin, A. Barrie` re, M.- A. Fe ' lix and P. McGrath for strains and reagents. Work at Bowdoin College was supported by college funds, by the NIH (grant P20 RR- 016463 from the INBRE Program of the National Center for Research Resources), the NSF (grant 0110994), and by an award to Bowdoin College by the Howard Hughes Medical Institute under the Undergraduate Science Education Program. Work at Princeton University was supported by grants from the NIH (R01 HG004321 to L. K. and P50 GM071508 to the Lewis- Sigler Institute), a James S. McDonnell Foundation Centennial Fellowship ( L. K.), and a Jane Coffin Childs Fellowship ( M. V. R.). Wethank S. Civillico for assistance in the laboratory, F. Hagen for experimental advice, and E. Anderson, H. Coller, L. Gordon and H. Seidel for comments on the manuscript.	BARKER DM, 1994, ANIM BEHAV, V48, P147, DOI 10.1006/anbe.1994.1221; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BARR MM, 2006, WORMBOOK; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2005, WORMBOOK, DOI 10.1895/wormbook.1.43.1; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRITTEN RJ, 1995, P NATL ACAD SCI USA, V92, P599, DOI 10.1073/pnas.92.2.599; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Chasnov JR, 2002, GENETICS, V160, P983; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Cutter AD, 2005, MOL BIOL EVOL, V22, P178, DOI 10.1093/molbev/msh267; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Fisher R.A., 1930, GENETICAL THEORY NAT; Ganko EW, 2001, GENOME RES, V11, P2066, DOI 10.1101/gr.196201; Hodgkin J, 1997, GENETICS, V146, P149; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; Lints R, 2002, GENE DEV, V16, P2390, DOI 10.1101/gad.1012602; Lints R., 2005, WORMATLAS; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Peden EM, 2005, CURR BIOL, V15, P394, DOI 10.1016/j.cub.2004.12.073; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stewart AD, 2002, GENETICS, V160, P975; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7	32	98	99	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2008	454	7207					1019	U66		10.1038/nature07171	http://dx.doi.org/10.1038/nature07171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18633349	Green Accepted			2022-12-28	WOS:000258591000044
J	El-Sadr, WM; Hoos, D				El-Sadr, Wafaa M.; Hoos, David			The President's Emergency Plan for AIDS Relief - Is the emergency over?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[El-Sadr, Wafaa M.] Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, New York, NY USA; [El-Sadr, Wafaa M.; Hoos, David] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [El-Sadr, Wafaa M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [El-Sadr, Wafaa M.] Harlem Hosp Med Ctr, Div Infect Dis, New York, NY USA; [Hoos, David] ICAP, Multicountry Columbia Antiretroviral Program, New York, NY USA	Columbia University; Columbia University; Columbia University	El-Sadr, WM (corresponding author), Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, New York, NY USA.							El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; Rosner David., 1995, HIVES SICKNESS PUBLI; *UNAIDS, 2003, PROGR REP GLOB RESP; *WHO, 2004, COR HLTH IND MOZ	4	30	30	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					553	555		10.1056/NEJMp0803762	http://dx.doi.org/10.1056/NEJMp0803762			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334IY	18669420	Green Published			2022-12-28	WOS:000258216700001
J	Boulle, A; Van Cutsem, G; Cohen, K; Hilderbrand, K; Mathee, S; Abrahams, M; Goemaere, E; Coetzee, D; Maartens, G				Boulle, Andrew; Van Cutsem, Gilles; Cohen, Karen; Hilderbrand, Katherine; Mathee, Shaheed; Abrahams, Musaed; Goemaere, Eric; Coetzee, David; Maartens, Gary			Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	38th World Conference on Lung Health of the International-Union-Against-Tuberculosis-and-Lung-Disease	NOV 08-12, 2007	Cape Town, SOUTH AFRICA	Int Union Against Tuberculosis & Lung Dis			HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; TUBERCULOSIS; REGIMENS; COHORT; HEPATOTOXICITY; KHAYELITSHA; ADHERENCE; TOXICITY	Context Rifampicin- based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well described. Objective To assess the effectiveness and tolerability of concomitant efavirenz- or nevirapine-based combination antiretroviral therapy and rifampicin- based antitubercular therapy. Design, Setting, and Participants Cohort analysis of prospectively collected routine clinical data in a community - based South African antiretroviral treatment program. Antiretroviral treatment- naive adults enrolled between May 2001 and June 2006 were included in the analysis, and were followed up until the end of 2006. Interventions Patients starting antiretroviral therapy with or without concurrent antitubercular therapy received either efavirenz or nevirapine at standard doses. Patients developing tuberculosis while taking antiretroviral therapy that included nevirapine were either changed to efavirenz or continued taking nevirapine. Main Outcome Measures Viral load of 400 copies/ mL or more after 6, 12, and 18 months of antiretroviral therapy; time to the first viral load of 400 copies/ mL or more; time to confirmed virological failure ( 2 consecutive values >= 5000 copies/ mL); time to death; and time to treatment- limiting toxicity were assessed. Results The analysis included 2035 individuals who started antiretroviral therapy with efavirenz ( 1074 with concurrent tuberculosis) and 1935 with nevirapine ( 209 with concurrent tuberculosis). There were no differences in time to death or substitution of either antiretroviral drug for toxicity with and without concurrent tuberculosis. Patients starting nevirapine with concurrent tuberculosis were at a higher risk of elevated viral load most notably at 6 months ( 16.3%; 95% confidence interval [ CI], 10.6%- 23.5%) than those without tuberculosis ( 8.3%; 95% CI, 6.7%- 10.0%; adjusted odds ratio [ OR], 2.1; 95% CI, 1.2- 3.4; and in the combined estimate, adjusted OR, 1.7; 95% CI, 1.2- 2.6). In the time-to-event analysis of confirmed virological failure ( 2 consecutive values of >= 5000 copies/ mL), patients starting nevirapine with concurrent tuberculosis developed virological failure sooner ( adjusted hazard ratio [ HR] 2.2; 95% CI, 1.3- 3.7). There were no differences between patients starting efavirenz with and without concurrent tuberculosis ( adjusted OR, 1.1; 95% CI, 0.8- 1.5 [ combined estimate] and adjusted HR, 1.1; 95% CI, 0.6- 2.0, respectively). There was no difference in time to virological rebound in patients free of tuberculosis and those developing tuberculosis during follow- up while taking nevirapine ( adjusted HR, 1.0; 95% CI, 0.5- 2.0) or efavirenz ( adjusted HR, 0.8; 95% CI, 0.4- 1.7). Conclusion In this cohort study, virological outcomes were inferior when nevirapine-based antiretroviral therapy was commenced while taking antitubercular treatment ( vs without concurrent tuberculosis) but comparable when starting efavirenz- based antiretroviral therapy ( vs without concurrent tuberculosis) or when tuberculosis developed while taking established nevirapine- or efavirenz- based therapies.	[Boulle, Andrew; Hilderbrand, Katherine; Coetzee, David] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Cohen, Karen; Maartens, Gary] Univ Cape Town, Div Clin Pharmacol, Dept Med, ZA-7925 Cape Town, South Africa; [Van Cutsem, Gilles; Hilderbrand, Katherine; Goemaere, Eric] Prov Govt Western Cape, Med Sans Frontieres, Cape Town, South Africa; [Mathee, Shaheed; Abrahams, Musaed] Prov Govt Western Cape, Site B Community Hlth Ctr, Dept Hlth, Cape Town, South Africa	University of Cape Town; University of Cape Town	Boulle, A (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	andrew.boulle@uct.ac.za	Boulle, Andrew/C-1413-2008; Cohen, Karen/D-4036-2017; Van Cutsem, Gilles/ABB-1171-2021; Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019	Boulle, Andrew/0000-0002-7713-8062; Van Cutsem, Gilles/0000-0002-8972-4480; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Cohen, Karen/0000-0002-1892-4207				BOULLE A, 2004, 15 INT AIDS C JUL 11; Boulle A, 2007, ANTIVIR THER, V12, P753; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; *CDCP, 2004, UPD GUID US RIF TREA; *CDCP, 2007, MAN DRUG INT TREATM; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Cohen K, 2008, J ANTIMICROB CHEMOTH, V61, P389, DOI 10.1093/jac/dkm484; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Cozzi-Lepri A, 2002, J INFECT DIS, V185, P1062, DOI 10.1086/339821; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Keiser Philip, 2002, HIV Clin Trials, V3, P296; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lopez-Cortes LF, 2002, CLIN PHARMACOKINET, V41, P681, DOI 10.2165/00003088-200241090-00004; Manosuthi W, 2008, HIV MED, V9, P294, DOI 10.1111/j.1468-1293.2008.00563.x; Manosuthi W, 2006, AIDS, V20, P131, DOI 10.1097/01.aids.0000196181.18916.9b; Manosuthi W, 2005, AIDS, V19, P1481, DOI 10.1097/01.aids.0000183630.27665.30; Manosuthi W, 2007, CLIN INFECT DIS, V44, P141, DOI 10.1086/510078; MARTIN DJ, 1995, J ACQ IMMUN DEF SYND, V8, P386; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; *NAT DEP HLTH, 2004, S AFR NAT ANT TREATM; Oliva J, 2003, AIDS, V17, P637, DOI 10.1097/00002030-200303070-00024; Patel A, 2004, JAIDS-J ACQ IMM DEF, V37, P1166, DOI 10.1097/01.qai.0000135956.96166.f0; Pedral-Sampaio Diana B., 2004, Braz J Infect Dis, V8, P211, DOI 10.1590/S1413-86702004000300004; *PROV ADM W CAP, 2006, 2005 HIV ANT PROV AR; *PROV GOV W CAP, 2004, ANT TREATM PROT; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Ramachandran G, 2006, JAIDS-J ACQ IMM DEF, V42, P36; Ribera E, 2001, J ACQ IMMUN DEF SYND, V28, P450, DOI 10.1097/00042560-200112150-00007; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; van Oosterhout JJ, 2007, ANTIVIR THER, V12, P515; World Health Organization, 2006, ANT THER HIV INF AD	36	155	162	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					530	539		10.1001/jama.300.5.530	http://dx.doi.org/10.1001/jama.300.5.530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	333YG	18677025	Bronze			2022-12-28	WOS:000258188900014
J	Chan, EYY				Chan, Emily Y. Y.			The untold stories of the Sichuan earthquake	LANCET			English	News Item							DISASTERS; IMPACT		Chinese Univ Hong Kong, Prince Wales Hosp, Sch Publ Hlth, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Chan, EYY (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Sch Publ Hlth, Hong Kong, Peoples R China.	emily.chan@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093				Alexander D, 1996, DISASTERS, V20, P231, DOI 10.1111/j.1467-7717.1996.tb01036.x; CHAN EYY, 2008, REPORT MED INTERVENT; HU LX, 2006, MIGRATION PATTERN, V71, P15; Jhung MA, 2007, AM J PREV MED, V33, P207, DOI 10.1016/j.amepre.2007.04.030; Ma Chun-Hua, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P375; Matsuoka T, 2000, PUBLIC HEALTH, V114, P249, DOI 10.1016/S0033-3506(00)00339-5; Miller AC, 2008, PREHOSPITAL DISASTER, V23, P185, DOI 10.1017/S1049023X00005835; *OFDA CRED, EM EV DAT TOP 10 COU; *OFDA CRED, INT DIS DAT EARTHQ C; Watts G, 2007, LANCET, V370, P1822, DOI 10.1016/S0140-6736(07)61763-2; 2008, TIMES LONDON    0517; 2006, NUTR HLTH STAT REPOR	12	48	52	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					359	362		10.1016/S0140-6736(08)61141-1	http://dx.doi.org/10.1016/S0140-6736(08)61141-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334AZ	18675675				2022-12-28	WOS:000258196000011
J	Kremer, JM				Kremer, Joel M.			COMET's path, and the new biologicals in rheumatoid arthritis	LANCET			English	Editorial Material							CONTROLLED-TRIAL; WORK DISABILITY; DOUBLE-BLIND; METHOTREXATE; EFFICACY; THERAPY; SAFETY		Albany Med Coll, Ctr Rheumatol, Albany, NY 12206 USA	Albany Medical College	Kremer, JM (corresponding author), Albany Med Coll, Ctr Rheumatol, Albany, NY 12206 USA.	jkremer@joint-docs.com						Allaire S, 2005, ARTHRIT RHEUM-ARTHR, V53, P603, DOI 10.1002/art.21326; Braun J, 2008, ARTHRITIS RHEUM-US, V58, P73, DOI 10.1002/art.23144; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; EMERY P, 2008, LANCET          0716, DOI DOI 10.1016/S01410-6736(08)61000-4; Genovese MC, 2005, J RHEUMATOL, V32, P1232; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Hamilton RA, 1997, BRIT J RHEUMATOL, V36, P86; Kremer JM, 2008, CURR OPIN RHEUMATOL, V20, P123, DOI 10.1097/BOR.0b013e3282f50eb1; Merkesdal S, 2005, ARTHRIT RHEUM-ARTHR, V53, P234, DOI 10.1002/art.21080; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P283, DOI 10.1002/art.10092; ODell JR, 1997, ARTHRITIS RHEUM, V40, P842, DOI 10.1002/art.1780400510; van der Bijl AE, 2007, ARTHRITIS RHEUM-US, V56, P2129, DOI 10.1002/art.22718; Verstappen SMM, 2004, ARTHRIT RHEUM-ARTHR, V51, P488, DOI 10.1002/art.20419	14	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					347	348		10.1016/S0140-6736(08)61001-6	http://dx.doi.org/10.1016/S0140-6736(08)61001-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18635257				2022-12-28	WOS:000258196000004
J	von Bernuth, H; Picard, C; Jin, ZB; Pankla, R; Xiao, H; Ku, CL; Chrabieh, M; Ben Mustapha, I; Ghandil, P; Camcioglu, Y; Vasconcelos, J; Sirvent, N; Guedes, M; Vitor, AB; Herrero-Mata, MJ; Arostegui, JI; Rodrigo, C; Alsina, L; Ruiz-Ortiz, E; Juan, M; Fortuny, C; Yague, J; Anton, J; Pascal, M; Chang, HH; Janniere, L; Rose, Y; Garty, BZ; Chapel, H; Issekutz, A; Marodi, L; Rodriguez-Gallego, C; Banchereau, J; Abel, L; Li, XX; Chaussabel, D; Puel, A; Casanova, JL				von Bernuth, Horst; Picard, Capucine; Jin, Zhongbo; Pankla, Rungnapa; Xiao, Hui; Ku, Cheng-Lung; Chrabieh, Maya; Ben Mustapha, Imen; Ghandil, Pegah; Camcioglu, Yildiz; Vasconcelos, Julia; Sirvent, Nicolas; Guedes, Margarida; Vitor, Artur Bonito; Herrero-Mata, Maria Jose; Arostegui, Juan Ignacio; Rodrigo, Carlos; Alsina, Laia; Ruiz-Ortiz, Estibaliz; Juan, Manel; Fortuny, Claudia; Yague, Jordi; Anton, Jordi; Pascal, Mariona; Chang, Huey-Hsuan; Janniere, Lucile; Rose, Yoann; Garty, Ben-Zion; Chapel, Helen; Issekutz, Andrew; Marodi, Laszlo; Rodriguez-Gallego, Carlos; Banchereau, Jacques; Abel, Laurent; Li, Xiaoxia; Chaussabel, Damien; Puel, Anne; Casanova, Jean-Laurent			Pyogenic bacterial infections in humans with MyD88 deficiency	SCIENCE			English	Article							MYELOID DIFFERENTIATION FACTOR-88; AERUGINOSA LUNG INFECTION; HERPES-SIMPLEX-VIRUS; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; HOST RESPONSE; MYD88-DEFICIENT MICE; PROTECTIVE IMMUNITY; HUMORAL IMMUNITY; CUTTING EDGE	MyD88 is a key downstream adapter for most Toll- like receptors ( TLRs) and interleukin- 1 receptors ( IL- 1Rs). MyD88 deficiency in mice leads to susceptibility to a broad range of pathogens in experimental settings of infection. We describe a distinct situation in a natural setting of human infection. Nine children with autosomal recessive MyD88 deficiency suffered from life- threatening, often recurrent pyogenic bacterial infections, including invasive pneumococcal disease. However, these patients were otherwise healthy, with normal resistance to other microbes. Their clinical status improved with age, but not due to any cellular leakiness in MyD88 deficiency. The MyD88- dependent TLRs and IL- 1Rs are therefore essential for protective immunity to a small number of pyogenic bacteria, but redundant for host defense to most natural infections.	[von Bernuth, Horst; Picard, Capucine; Ku, Cheng-Lung; Chrabieh, Maya; Ben Mustapha, Imen; Ghandil, Pegah; Janniere, Lucile; Rose, Yoann; Abel, Laurent; Puel, Anne; Casanova, Jean-Laurent] INSERM, U550, Paris, France; [von Bernuth, Horst; Picard, Capucine; Ku, Cheng-Lung; Chrabieh, Maya; Ben Mustapha, Imen; Ghandil, Pegah; Janniere, Lucile; Rose, Yoann; Abel, Laurent; Puel, Anne; Casanova, Jean-Laurent] Univ Paris 05, F-75270 Paris 06, France; [Picard, Capucine] Hop Necker Enfants Malad, Study Ctr Primary Immunodeficiencies, Assistance Publ Hop Paris, Paris, France; [Jin, Zhongbo; Pankla, Rungnapa; Banchereau, Jacques; Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Jin, Zhongbo] Baylor Univ, Waco, TX 76798 USA; [Pankla, Rungnapa] Khon Kaen Univ, Khon Kaen, Thailand; [Xiao, Hui; Li, Xiaoxia] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Ben Mustapha, Imen] Pasteur Inst Tunis, Tunis, Tunisia; [Camcioglu, Yildiz] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey; [Vasconcelos, Julia; Guedes, Margarida] Gen Hosp Santo Antonio, Oporto, Portugal; [Sirvent, Nicolas] Univ Hosp Archet 2, Nice, France; [Vitor, Artur Bonito] Hosp Sao Joao, Oporto, Portugal; [Herrero-Mata, Maria Jose; Ruiz-Ortiz, Estibaliz] Inst Invest Germans Trias & Pujol, LIRAD Banco Sangre & Tejidos, Barcelona, Spain; [Arostegui, Juan Ignacio; Juan, Manel; Yague, Jordi; Pascal, Mariona] IDIBAPS, Dept Immunol, Hosp Clin, Barcelona, Spain; [Rodrigo, Carlos] Autonomous Univ Barcelona, Hosp Germans Trias & Pujol, Barcelona, Spain; [Alsina, Laia; Fortuny, Claudia; Anton, Jordi] Univ Barcelona, Sant Joan Deu Hosp, Barcelona, Spain; [Chang, Huey-Hsuan] Inst Pasteur, Paris, France; [Chang, Huey-Hsuan] INSERM, U818, Paris, France; [Garty, Ben-Zion] Schneider Childrens Med Ctr, Petah Tiqwa, Israel; [Chapel, Helen] Univ Oxford, Oxford, England; [Chapel, Helen] Oxford Radcliffe Hosp, Oxford, England; [Issekutz, Andrew] Dalhousie Univ, Halifax, NS, Canada; [Marodi, Laszlo] Univ Debrecen, H-4012 Debrecen, Hungary; [Rodriguez-Gallego, Carlos] Gran Canaria Dr Negrin Hosp, Las Palmas Gran Canaria, Spain; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Baylor Scott & White Health; Baylor University; Khon Kaen University; Cleveland Clinic Foundation; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Istanbul University; Istanbul University - Cerrahpasa; CHU Nice; Sao Joao Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; University of Barcelona; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford; University of Oxford; Dalhousie University; University of Debrecen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), INSERM, U550, Paris, France.	jean-laurent.casanova@inserm.fr	Chaussabel, Damien/AAX-1909-2020; KU, Cheng-Lung/AAT-1033-2020; Picard, Capucine/H-3914-2017; chrabieh, maya/H-7370-2017; Ghandil, Pegah/K-4186-2018; Rodrigo, Carlos/F-7602-2017; Juan, Manel/Q-2931-2019; Sranujit, Rungnapa Pankla/AAB-9327-2020; von Bernuth, Horst/AAQ-9797-2021; RODRIGUEZ-GALLEGO, CARLOS/AAB-7516-2022; KU, Cheng-Lung/L-6073-2015; Casanova, Jean-Laurent/I-3418-2017; Anton, Jordi/A-9848-2017; Marodi, Laszlo/AAU-9915-2020; Alsina, Laia/AID-4372-2022; Pascal, Mariona/HCG-9380-2022; Puel, Anne/H-7305-2017; Abel, Laurent/H-8888-2017; Alsina, Laia/GQI-3516-2022	KU, Cheng-Lung/0000-0002-0643-2256; Picard, Capucine/0000-0001-8788-5056; chrabieh, maya/0000-0003-0772-4805; Ghandil, Pegah/0000-0001-7828-6465; Rodrigo, Carlos/0000-0003-1140-2585; von Bernuth, Horst/0000-0002-5812-7675; KU, Cheng-Lung/0000-0002-0643-2256; Anton, Jordi/0000-0002-8792-4219; Puel, Anne/0000-0003-2603-0323; Abel, Laurent/0000-0001-7016-6493; Juan, Manel/0000-0002-3064-1648; Xiao, Hui/0000-0001-5304-243X; Chaussabel, Damien/0000-0002-6131-7242; Arostegui, Juan Ignacio/0000-0003-4757-504X; Alsina, Laia/0000-0002-3559-0018; Casanova, Jean-Laurent/0000-0002-7782-4169; RUIZ-ORTIZ, ESTIBALIZ/0000-0002-3003-934X; Rodriguez-Gallego, Carlos/0000-0002-4344-8644	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19 AI057234-02, U19 AI057234] Funding Source: Medline; PHS HHS [U19 AIO57234-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; HIRSCH MS, 1970, J IMMUNOL, V104, P1160; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Power MR, 2006, CLIN EXP IMMUNOL, V146, P323, DOI 10.1111/j.1365-2249.2006.03210.x; Power MR, 2004, J BIOL CHEM, V279, P49315, DOI 10.1074/jbc.M402111200; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Smahi A, 2000, NATURE, V405, P466; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	29	574	582	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					691	696		10.1126/science.1158298	http://dx.doi.org/10.1126/science.1158298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669862	Green Accepted			2022-12-28	WOS:000258077700044
J	Guttmann, O; Wykes, V				Guttmann, Oliver; Wykes, Victoria			Complex regional pain syndrome type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Guttmann, Oliver; Wykes, Victoria] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Guttmann, O (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	vwykes@gmail.com							0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					508	508		10.1056/NEJMicm060173	http://dx.doi.org/10.1056/NEJMicm060173			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669429				2022-12-28	WOS:000258039700008
J	Omar, RZ; O'Sullivan, C; Petersen, I; Islam, A; Majeed, A				Omar, Rumana Z.; O'Sullivan, Caoimhe; Petersen, Irene; Islam, Amir; Majeed, Azeem			A model based on age, sex, and morbidity to explain variation in UK general practice prescribing: cohort study	BRITISH MEDICAL JOURNAL			English	Article							CROSS-SECTIONAL ANALYSIS; PATIENTS EXPECTATIONS; DOCTORS PERCEPTIONS; UNITED-KINGDOM; CARE GROUPS; QUESTIONNAIRE; BEHAVIOR; STATES	Objective To examine whether patient level morbidity based measure of clinical case mix explains variations in prescribing in general practice. Design Retrospective study of a cohort of patients followed for one year. Setting UK General Practice Research Database. Participants 129 general practices, with a total list size of 1032 072. Main outcome measures Each patient was assigned a morbidity group on the bases of diagnoses, age, and sex using the Johns Hopkins adjusted clinical group case mix system. Multilevel regression models were used to explain variability in prescribing, with age, sex, and morbidity as predictors. Results The median number of prescriptions issued annually to a patient is 2 (90% range 0 to 18). The number of prescriptions issued to a patient increases with age and morbidity. Age and sex explained only 10% of the total variation in prescribing compared with 80% after including morbidity. When variation in prescribing was split between practices and within practices, most of the variation was at the practice level. Morbidity explained both variations well. Conclusions Inclusion of a diagnosis based patient morbidity measure in prescribing models can explain a large amount of variability, both between practices and within practices. The use of patient based case mix systems may prove useful in allocation of budgets and therefore should be investigated further when examining prescribing patterns in general practices in the UK, particularly for specific therapeutic areas.	[Omar, Rumana Z.; O'Sullivan, Caoimhe] UCL, Dept Stat Sci, London WC1E 6BT, England; [Omar, Rumana Z.; O'Sullivan, Caoimhe] UCL Hosp, London W1P 9LL, England; [Omar, Rumana Z.; O'Sullivan, Caoimhe] UCL, Biomed Res Unit, Univ Coll London Hosp NHS Trust, London W1P 9LL, England; [Petersen, Irene; Islam, Amir] UCL, Dept Primary Care & Populat Sci, London W1P 9LL, England; [Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Imperial College London	Omar, RZ (corresponding author), UCL, Dept Stat Sci, Mortimer St, London WC1E 6BT, England.	rumana@stats.ucl.ac.uk	Petersen, Irene/C-5702-2009; Petersen, Irene/I-2751-2012	Petersen, Irene/0000-0002-0037-7524; Majeed, Azeem/0000-0002-2357-9858; Omar, Rumana/0000-0003-1483-1932	MRC [G0601726] Funding Source: UKRI; Medical Research Council [G0601726] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Ashworth M, 2007, J PUBLIC HEALTH-UK, V29, P40, DOI 10.1093/pubmed/fdl068; Bindman AB, 2007, BMJ-BRIT MED J, V334, P1261, DOI 10.1136/bmj.39203.658970.55; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Carthy P, 2000, FAM PRACT, V17, P36, DOI 10.1093/fampra/17.1.36; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Favato G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000592; Forrest CB, 2003, ARCH PEDIAT ADOL MED, V157, P279, DOI 10.1001/archpedi.157.3.279; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hollowell J, 1997, Popul Trends, P36; *J HOPK U, 2008, ACG CAS MIX SYST; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Machin D, 2005, DESIGN STUDIES MED R; Majeed A, 1999, BRIT MED J, V318, P772, DOI 10.1136/bmj.318.7186.772; MAJEED A, 1996, BRIT MED J, V13, P1274; National Audit Office, 2007, PRESCR COSTS PRIM CA; OSULLIVAN C, 2005, BR J GEN PRACT, V55, P529; OSULLIVAN C, 2004, FAM PRACT, V21, P355; RASBASH J, 2000, USERS GUIDE MLWIN VE; Scoggins A, 2006, PRESCRIBING PRIMARY; Snijders T.A., 1999, INTRO BASIC ADV MULT; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; StataCorp, 2005, STAT STAT SOFTW REL; Watkins C, 2003, QUAL SAF HEALTH CARE, V12, P29, DOI 10.1136/qhc.12.1.29; WEBB S, 1994, BRIT J GEN PRACT, V44, P165; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; 2007, GEN PRACTICE RES DAT	29	19	19	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a238	10.1136/bmj.a238	http://dx.doi.org/10.1136/bmj.a238			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18625598	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000258273000039
J	Asher, G; Gatfield, D; Stratmann, M; Reinke, H; Dibner, C; Kreppel, F; Mostoslavsky, R; Alt, FW; Schibler, U				Asher, Gad; Gatfield, David; Stratmann, Markus; Reinke, Hans; Dibner, Charna; Kreppel, Florian; Mostoslavsky, Raul; Alt, Frederick W.; Schibler, Ueli			SIRT1 regulates circadian clock gene expression through PER2 deacetylation	CELL			English	Article							HISTONE ACETYLATION; TRANSCRIPTION; PROTEIN; LIVER; MECHANISMS; REVEALS; NPAS2; MOUSE; CRYPTOCHROME; COORDINATION	The mammalian circadian timing system is composed of a central pacemaker in the suprachiasmatic nucleus of the brain that synchronizes countless subsidiary oscillators in peripheral tissues. The rhythm-generating mechanism is thought to rely on a feedback loop involving positively and negatively acting transcription factors. BMAL1 and CLOCK activate the expression of Period (Per) and Cryptochrome (Cry) genes, and once PER and CRY proteins accumulate to a critical level they form complexes with BMAL1-CLOCK heterodimers and thereby repress the transcription of their own genes. Here, we show that SIRT1, an NAD(+)- dependent protein deacetylase, is required for high-magnitude circadian transcription of several core clock genes, including Bmal1, Ror gamma, Per2, and Cry1. SIRT1 binds CLOCK-BMAL1 in a circadian manner and promotes the deacetylation and degradation of PER2. Given the NAD(+) dependence of SIRT1 deacetylase activity, it is likely that SIRT1 connects cellular metabolism to the circadian core clockwork circuitry.	[Asher, Gad; Gatfield, David; Stratmann, Markus; Reinke, Hans; Dibner, Charna; Schibler, Ueli] Univ Geneva, Dept Mol Biol Sci 3, CH-1211 Geneva 4, Switzerland; [Kreppel, Florian] Univ Ulm, Div Gene Therapy, D-89081 Ulm, Germany; [Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Ctr Blood Res, Boston, MA 02115 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Geneva; Ulm University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol Sci 3, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	ueli.schibler@molbio.unige.ch	ASHER, GAD/K-1333-2012; Jansen, Heiko T./A-5770-2008; Gatfield, David/C-2354-2011	Jansen, Heiko T./0000-0003-0178-396X; Gatfield, David/0000-0001-5114-2824; Asher, Gad/0000-0001-9403-7856	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Dzhagalov I, 2004, CELL MOL IMMUNOL, V1, P401; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Preitner Nicolas, 2003, Novartis Found Symp, V253, P89; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walker JR, 2005, METHOD ENZYMOL, V393, P366, DOI 10.1016/S0076-6879(05)93016-4; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	65	933	984	3	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					317	328		10.1016/j.cell.2008.06.050	http://dx.doi.org/10.1016/j.cell.2008.06.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662546	Bronze			2022-12-28	WOS:000257891700020
J	Baek, D; Villen, J; Shin, C; Camargo, FD; Gygi, SP; Bartel, DP				Baek, Daehyun; Villen, Judit; Shin, Chanseok; Camargo, Fernando D.; Gygi, Steven P.; Bartel, David P.			The impact of microRNAs on protein output	NATURE			English	Article							GROWTH-FACTOR-I; MESSENGER-RNAS; MIRNA TARGETS; CELL-CULTURE; CATHEPSIN-B; AMINO-ACIDS; C. ELEGANS; IDENTIFICATION; EXPRESSION; DETERMINANTS	MicroRNAs are endogenous similar to 23-nucleotide RNAs that can pair to sites in the messenger RNAs of protein- coding genes to downregulate the expression from these messages. MicroRNAs are known to influence the evolution and stability of many mRNAs, but their global impact on protein output had not been examined. Here we use quantitative mass spectrometry to measure the response of thousands of proteins after introducing microRNAs into cultured cells and after deleting mir- 223 in mouse neutrophils. The identities of the responsive proteins indicate that targeting is primarily through seed- matched sites located within favourable predicted contexts in 39 untranslated regions. Hundreds of genes were directly repressed, albeit each to a modest degree, by individual microRNAs. Although some targets were repressed without detectable changes in mRNA levels, those translationally repressed by more than a third also displayed detectable mRNA destabilization, and, for the more highly repressed targets, mRNA destabilization usually comprised the major component of repression. The impact of microRNAs on the proteome indicated that for most interactions microRNAs act as rheostats to make fine- scale adjustments to protein output.	[Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Baek, Daehyun; Shin, Chanseok; Camargo, Fernando D.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Baek, Daehyun; Shin, Chanseok; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Baek, Daehyun; Shin, Chanseok; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu; dbartel@wi.mit.edu		Villen, Judit/0000-0002-1005-1739	Damon Runyon postdoctoral fellowship; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	Damon Runyon postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.-J. Hong, T. Brummelkamp and S. Stehling-Sun for discussions, C. Bakalarski for writing and implementing the Vista algorithm for automated protein quantification, W. Johnston for technical assistance, and P. Wisniewski for cell sorting. This was supported by a Damon Runyon postdoctoral fellowship (C.S.) and grants from the NIH (D.P.B and S.P.G). D.P.B. is an investigator of the Howard Hughes Medical Institute.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BJERKNES R, 1995, J CLIN ENDOCR METAB, V80, P1948, DOI 10.1210/jc.80.6.1948; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Everley PA, 2006, J PROTEOME RES, V5, P1224, DOI 10.1021/pr0504891; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FU YK, 1991, J IMMUNOL, V146, P1602; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	48	2812	2922	4	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					64	U38		10.1038/nature07242	http://dx.doi.org/10.1038/nature07242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668037	Green Accepted			2022-12-28	WOS:000258890200037
J	Link, E; Parish, S; Armitage, J; Bowman, L; Heath, S; Matsuda, F; Gut, I; Lathrop, M; Collins, R				Link, E.; Parish, S.; Armitage, J.; Bowman, L.; Heath, S.; Matsuda, F.; Gut, I.; Lathrop, M.; Collins, R.		SEARCH Collaborative Grp	SLCO1B1 variants and statin-induced myopathy - A genomewide study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSPORTING POLYPEPTIDE 1B1; ATORVASTATIN; SIMVASTATIN; POLYMORPHISMS; ASSOCIATION; EFFICACY; SAFETY; CYP3A4	Background: Lowering low-density lipoprotein cholesterol with statin therapy results in substantial reductions in cardiovascular events, and larger reductions in cholesterol may produce larger benefits. In rare cases, myopathy occurs in association with statin therapy, especially when the statins are administered at higher doses and with certain other medications. Methods: We carried out a genomewide association study using approximately 300,000 markers (and additional fine-mapping) in 85 subjects with definite or incipient myopathy and 90 controls, all of whom were taking 80 mg of simvastatin daily as part of a trial involving 12,000 participants. Replication was tested in a trial of 40 mg of simvastatin daily involving 20,000 participants. Results: The genomewide scan yielded a single strong association of myopathy with the rs4363657 single-nucleotide polymorphism (SNP) located within SLCO1B1 on chromosome 12 (P=4 x 10(-9)). SLCO1B1 encodes the organic anion-transporting polypeptide OATP1B1, which has been shown to regulate the hepatic uptake of statins. The noncoding rs4363657 SNP was in nearly complete linkage disequilibrium with the nonsynonymous rs4149056 SNP (r(2) = 0.97), which has been linked to statin metabolism. The prevalence of the rs4149056 C allele in the population was 15%. The odds ratio for myopathy was 4.5 (95% confidence interval [CI], 2.6 to 7.7) per copy of the C allele, and 16.9 (95% CI, 4.7 to 61.1) in CC as compared with TT homozygotes. More than 60% of these myopathy cases could be attributed to the C variant. The association of rs4149056 with myopathy was replicated in the trial of 40 mg of simvastatin daily, which also showed an association between rs4149056 and the cholesterol-lowering effects of simvastatin. No SNPs in any other region were clearly associated with myopathy. Conclusions: We have identified common variants in SLCO1B1 that are strongly associated with an increased risk of statin-induced myopathy. Genotyping these variants may help to achieve the benefits of statin therapy more safely and effectively. (Current Controlled Trials number, ISRCTN74348595.).	[Link, E.; SEARCH Collaborative Grp] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England	University of Oxford	Link, E (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.		Matsuda, Fumihiko/B-9893-2009; Collins, Rory/ABA-8487-2020; Heath, Simon C/J-4138-2012; Rahimi, Kazem/Q-1279-2015; Lindley, Richard/B-8148-2013; Gut, Ivo/ABF-3188-2020	Heath, Simon C/0000-0002-9550-0897; Rahimi, Kazem/0000-0002-4807-4610; Lindley, Richard/0000-0002-0104-5679; Gut, Ivo/0000-0001-7219-632X; Tomlinson, Laurie/0000-0001-8848-9493; Anderson, Craig/0000-0002-7248-4863; Williams, John/0000-0001-5188-7957; Brown, Martin M/0000-0002-3273-1356; Bennett, Derrick/0000-0002-9170-8447; Wallendszus, Karl/0000-0003-0971-3026; Haynes, Richard/0000-0002-1179-0023; Farrer, Matthew/0000-0003-1159-5321; Offer, Alison/0000-0002-3367-3207; Martin, Seth/0000-0002-7021-7622; Hopewell, Jemma/0000-0002-3870-8018; Halliday, Alison/0000-0001-9828-3579; Emberson, Jonathan/0000-0001-7792-9422; Rose, Giuseppina/0000-0002-4264-4184	Medical Research Council; British Heart Foundation; National Health Service Genetic Knowledge Park; Centre National de Genotypage; Merck; Roche Vitamins; MRC [MC_U137686853, MC_EX_G0801669] Funding Source: UKRI; Medical Research Council [MC_U137686853, MC_EX_G0801669] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Health Service Genetic Knowledge Park; Centre National de Genotypage; Merck(Merck & Company); Roche Vitamins; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Medical Research Council, British Heart Foundation, National Health Service Genetic Knowledge Park, and Centre National de Genotypage. The SEARCH trial is funded by a research grant to the University of Oxford ( Oxford, United Kingdom) from Merck. The Heart Protection Study was funded by grants from Merck, Roche Vitamins, the Medical Research Council, and the British Heart Foundation. No potential conflict of interest relevant to this article was reported. We thank the participants in SEARCH.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2007, AM HEART J, V154, P815, DOI 10.1016/j.ahj.2007.06.034; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cannon CP, 2006, NEW ENGL J MED, V354, P778; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; *EL MED COMP, 2007, ZOC DAT; Fiegenbaum M, 2005, CLIN PHARMACOL THER, V78, P551, DOI 10.1016/j.clpt.2005.08.003; Frudakis TN, 2007, PHARMACOGENET GENOM, V17, P695, DOI 10.1097/FPC.0b013e328012d0a9; Gunderson KL, 2006, PHARMACOGENOMICS, V7, P641, DOI 10.2217/14622416.7.4.641; Kajinami K, 2004, AM J CARDIOL, V93, P104, DOI 10.1016/j.amjcard.2003.08.078; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; LI Y, 2007, MACH 1 0 SOFTWARE HA; Morimoto K, 2005, CLIN PHARMACOL THER, V77, pP21, DOI 10.1016/j.clpt.2004.11.081; Mulder AB, 2001, CLIN PHARMACOL THER, V70, P546, DOI 10.1067/mcp.2001.120251; Niemi M, 2005, CLIN PHARMACOL THER, V77, P468, DOI 10.1016/j.clpt.2005.01.018; Oh J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-7; Pasanen MK, 2006, EUR J CLIN PHARMACOL, V62, P409, DOI 10.1007/s00228-006-0123-1; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PEDERSEN TR, 2005, JAMA-J AM MED ASSOC, V294, P3092; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; SINNWELL JP, 2007, HAPLO STATS STAT ANA; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567	34	1431	1477	1	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2008	359	8					789	799						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339HL	18650507				2022-12-28	WOS:000258568600004
J	Kroes, GJ				Kroes, Geert-Jan			Frontiers in surface scattering simulations	SCIENCE			English	Editorial Material							BORN-OPPENHEIMER APPROXIMATION; METAL-SURFACE; MOLECULAR-DYNAMICS; H-2; DISSOCIATION; EXCITATION; MODEL; NO		[Kroes, Geert-Jan] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Kroes, GJ (corresponding author), Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, POB 9502, NL-2300 RA Leiden, Netherlands.							Beck MH, 2000, PHYS REP, V324, P1, DOI 10.1016/S0370-1573(99)00047-2; Beck RD, 2003, SCIENCE, V302, P98, DOI 10.1126/science.1088996; Behler J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036104; Busnengo HF, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.127601; Diaz C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.096102; Diekhoner L, 2002, J CHEM PHYS, V117, P5018, DOI 10.1063/1.1498476; Dohle M, 1998, SURF SCI, V409, P37, DOI 10.1016/S0039-6028(98)00194-0; Gergen B, 2001, SCIENCE, V294, P2521, DOI 10.1126/science.1066134; Gross A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206107; HAMMER B, 1994, PHYS REV LETT, V73, P1400, DOI 10.1103/PhysRevLett.73.1400; HEADGORDON M, 1995, J CHEM PHYS, V103, P10137, DOI 10.1063/1.469915; Juaristi JI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.116102; Juurlink LBF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208303; Katz G, 2005, J PHYS CHEM B, V109, P18876, DOI 10.1021/jp052107k; Katz G, 2004, J CHEM PHYS, V120, P3931, DOI 10.1063/1.1635360; Kluner T, 2002, J CHEM PHYS, V116, P42, DOI 10.1063/1.1420748; Kondov I, 2007, J PHYS CHEM C, V111, P11970, DOI 10.1021/jp072217m; KOPPEL H, 1984, ADV CHEM PHYS, V57, P59; Kroes GJ, 2002, ACCOUNTS CHEM RES, V35, P193, DOI 10.1021/ar010104u; Li SM, 2002, J CHEM PHYS, V117, P4499, DOI 10.1063/1.1498479; Lindenblatt M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216101; Luntz AC, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2000249; MIZIELINSKI MS, 2008, SURF SCI, V602, DOI DOI 10.1016/J.SUS.2008.06.015; Nave S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.173003; Nieto P, 2006, SCIENCE, V312, P86, DOI 10.1126/science.1123057; Shenvi N, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2357740; Trail JR, 2003, J CHEM PHYS, V119, P4539, DOI 10.1063/1.1593631; Wang ZS, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.226102; Watts E, 1999, J CHEM PHYS, V111, P9791, DOI 10.1063/1.480315; White JD, 2005, NATURE, V433, P503, DOI 10.1038/nature03213; Wodtke AM, 2004, INT REV PHYS CHEM, V23, P513, DOI 10.1080/01442350500037521	31	95	97	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					794	797		10.1126/science.1157717	http://dx.doi.org/10.1126/science.1157717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687953				2022-12-28	WOS:000258261000033
J	Service, RF				Service, Robert F.			Problem solved* (*sort of)	SCIENCE			English	News Item																			0	47	47	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					784	786		10.1126/science.321.5890.784	http://dx.doi.org/10.1126/science.321.5890.784			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687949				2022-12-28	WOS:000258261000029
J	Stowell, G				Stowell, Gillian			"Would you like to see the wound?"	BRITISH MEDICAL JOURNAL			English	Editorial Material												gillstowell@doctors.org.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a1064	10.1136/bmj.a1064	http://dx.doi.org/10.1136/bmj.a1064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18667472				2022-12-28	WOS:000258561000036
J	Wong, EHC; Hui, AC; Mok, VC; Leung, HW; Chan, RC; Wong, KS; Kwan, PK				Wong, Edward Ho Chung; Hui, Andrew C.; Mok, Vincent C.; Leung, Howan; Chan, Rickjason C.; Wong, Ka S.; Kwan, Patrick K.			A young man who kept failing over	LANCET			English	Editorial Material							SUBACUTE SCLEROSING-PANENCEPHALITIS		[Wong, Edward Ho Chung; Hui, Andrew C.; Mok, Vincent C.; Leung, Howan; Wong, Ka S.; Kwan, Patrick K.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Chan, Rickjason C.] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, EHC (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China.	dr_eddiewong@yahoo.com.hk	Wong, Ka Sing Lawrence/N-3434-2015; Mok, Vincent/N-6421-2015	Wong, Ka Sing Lawrence/0000-0002-2031-9866; Mok, Vincent/0000-0002-8102-8835; Kwan, Patrick/0000-0001-7310-276X				Anlar B, 1997, NEUROLOGY, V48, P526, DOI 10.1212/WNL.48.2.526; Garg RK, 2002, POSTGRAD MED J, V78, P63, DOI 10.1136/pmj.78.916.63; Ip P, 2004, PEDIATR NEUROL, V31, P46, DOI 10.1016/j.pediatrneurol.2003.11.010; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Miller C, 2004, ARCH DIS CHILD, V89, P1145, DOI 10.1136/adc.2003.038489	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 2	2008	372	9636					418	418		10.1016/S0140-6736(08)61163-0	http://dx.doi.org/10.1016/S0140-6736(08)61163-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18675693				2022-12-28	WOS:000258196000034
J	Armstrong, FA; Fontecilla-Camps, JC				Armstrong, Fraser A.; Fontecilla-Camps, Juan C.			Biochemistry - A natural choice for activating hydrogen	SCIENCE			English	Editorial Material							FE-ONLY HYDROGENASE; CRYSTAL-STRUCTURE; COORDINATION; RESOLUTION; SITE		[Armstrong, Fraser A.] Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford OX1 3QR, England; [Fontecilla-Camps, Juan C.] Univ Grenoble 1, Inst Biol Struct LCCP, CEA, CNRS, F-38027 Grenoble 1, France	University of Oxford; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Armstrong, FA (corresponding author), Univ Oxford, Inorgan Chem Lab, Dept Chem, S Parks Rd, Oxford OX1 3QR, England.	fraser.armstrong@chem.ox.ac.uk; juan-carlos.fontecilla@ibs.fr			Biotechnology and Biological Sciences Research Council [BB/D52222X/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; RAWSON JM, 1995, COORDIN CHEM REV, V139, P313, DOI 10.1016/0010-8545(94)01117-T; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978	7	52	52	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					498	499		10.1126/science.1161326	http://dx.doi.org/10.1126/science.1161326			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653870				2022-12-28	WOS:000257888900027
J	Cooper, DA; Steigbigel, RT; Gatell, JM; Rockstroh, JK; Katlama, C; Yeni, P; Lazzarin, A; Clotet, B; Kumar, PN; Eron, JE; Schechter, M; Markowitz, M; Loutfy, MR; Lennox, JL; Zhao, J; Chen, J; Ryan, DM; Rhodes, RR; Killar, JA; Gilde, LR; Strohmaier, KM; Meibohm, AR; Miller, MD; Hazuda, DJ; Nessly, ML; DiNubile, MJ; Isaacs, RD; Teppler, H; Nguyen, BY				Cooper, David A.; Steigbigel, Roy T.; Gatell, Jose M.; Rockstroh, Jurgen K.; Katlama, Christine; Yeni, Patrick; Lazzarin, Adriano; Clotet, Bonaventura; Kumar, Princy N.; Eron, Joseph E.; Schechter, Mauro; Markowitz, Martin; Loutfy, Mona R.; Lennox, Jeffrey L.; Zhao, Jing; Chen, Joshua; Ryan, Desmond M.; Rhodes, Rand R.; Killar, John A.; Gilde, Lucinda R.; Strohmaier, Kim M.; Meibohm, Anne R.; Miller, Michael D.; Hazuda, Daria J.; Nessly, Michael L.; DiNubile, Mark J.; Isaacs, Robin D.; Teppler, Hedy; Nguyen, Bach-Yen		BENCHMRK Study Teams	Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTEGRASE INHIBITOR RALTEGRAVIR; TREATMENT-EXPERIENCED PATIENTS; STRAND TRANSFER; EFFICACY; ENFUVIRTIDE; PREVALENCE; THERAPY; TRIALS; SAFETY	Background We evaluated the efficacy of raltegravir and the development of viral resistance in two identical trials involving patients who were infected with human immunodeficiency virus type 1 (HIV-1) with triple-class drug resistance and in whom antiretroviral therapy had failed. Methods We conducted subgroup analyses of the data from week 48 in both studies according to baseline prognostic factors. Genotyping of the integrase gene was performed in raltegravir recipients who had virologic failure. Results Virologic responses to raltegravir were consistently superior to responses to placebo, regardless of the baseline values of HIV-1 RNA level; CD4 cell count; genotypic or phenotypic sensitivity score; use or nonuse of darunavir, enfuvirtide, or both in optimized background therapy; or demographic characteristics. Among patients in the two studies combined who were using both enfuvirtide and darunavir for the first time, HIV-1 RNA levels of less than 50 copies per milliliter were achieved in 89% of raltegravir recipients and 68% of placebo recipients. HIV-1 RNA levels of less than 50 copies per milliliter were achieved in 69% and 80% of the raltegravir recipients and in 47% and 57% of the placebo recipients using either darunavir or enfuvirtide for the first time, respectively. At 48 weeks, 105 of the 462 raltegravir recipients (23%) had virologic failure. Genotyping was performed in 94 raltegravir recipients with virologic failure. Integrase mutations known to be associated with phenotypic resistance to raltegravir arose during treatment in 64 patients (68%). Forty-eight of these 64 patients (75%) had two or more resistance-associated mutations. Conclusions When combined with an optimized background regimen in both studies, a consistently favorable treatment effect of raltegravir over placebo was shown in clinically relevant subgroups of patients, including those with baseline characteristics that typically predict a poor response to antiretroviral therapy: a high HIV-1 RNA level, low CD4 cell count, and low genotypic or phenotypic sensitivity score.	[Zhao, Jing; Chen, Joshua; Ryan, Desmond M.; Rhodes, Rand R.; Killar, John A.; Gilde, Lucinda R.; Strohmaier, Kim M.; Meibohm, Anne R.; Miller, Michael D.; Hazuda, Daria J.; Nessly, Michael L.; DiNubile, Mark J.; Isaacs, Robin D.; Teppler, Hedy; Nguyen, Bach-Yen] Merck Res Labs, N Wales, PA 19454 USA; [Cooper, David A.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Steigbigel, Roy T.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Gatell, Jose M.] Univ Barcelona, Barcelona, Spain; [Rockstroh, Jurgen K.] Univ Bonn, D-5300 Bonn, Germany; [Katlama, Christine] Univ Paris 06, Grp Hosp Pitie Salpetriere, Paris, France; [Yeni, Patrick] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Lazzarin, Adriano] Ist Sci San Raffaele, I-20132 Milan, Italy; [Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fdn Irsicaixa, Barcelona, Spain; [Kumar, Princy N.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Eron, Joseph E.] Univ N Carolina, Chapel Hill, NC USA; [Schechter, Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Markowitz, Martin] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Loutfy, Mona R.] Univ Toronto, Toronto, ON, Canada; [Lennox, Jeffrey L.] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Merck & Company; University of New South Wales Sydney; Kirby Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Barcelona; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; Universidade Federal do Rio de Janeiro; Rockefeller University; University of Toronto; Emory University	Nguyen, BY (corresponding author), Merck Res Labs, POB 1000,UG3D-56, N Wales, PA 19454 USA.	bachyen_nguyen@merck.com	Montaner, Julio/K-7621-2012; Gatell, Jose M/ABC-3607-2020; Schechter, Mauro/AAG-7445-2020; Lennox, Jeffrey/D-1654-2014; Soriano, Vicente/O-5730-2018; LAZZARIN, Adriano/K-3607-2018	Lennox, Jeffrey/0000-0002-2064-5565; Soriano, Vicente/0000-0002-4624-5199; CAUDA, Roberto/0000-0002-1498-4229; Kozal, Michael/0000-0002-3100-8254; LAZZARIN, Adriano/0000-0003-2551-7754				Clotet B, 2008, LANCET, V371, P116; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; *FOOOD DRUG ADM, 2007, ANT DRUGS ADV COMM M; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Lalezari JP, 2003, NEW ENGL J MED, V349, P1100; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Montaner J, 2005, HIV CLIN TRIALS, V6, P281, DOI 10.1310/0XH7-F2V2-1K0R-NU2W; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tozzi V, 2006, ANTIVIR THER, V11, P553; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	19	415	434	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					355	365		10.1056/NEJMoa0708978	http://dx.doi.org/10.1056/NEJMoa0708978			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650513	Green Submitted, Green Published			2022-12-28	WOS:000257852100004
J	Zhang, KZ; Kaufman, RJ				Zhang, Kezhong; Kaufman, Randal J.			From endoplasmic-reticulum stress to the inflammatory response	NATURE			English	Review							UNFOLDED-PROTEIN RESPONSE; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; DOUBLE-EDGED-SWORD; ER STRESS; TRANSMEMBRANE PROTEIN; CELL-SURVIVAL; NITRIC-OXIDE; TRANSLATIONAL CONTROL; PARKINSONS-DISEASE	The endoplasmic reticulum is responsible for much of a cell's protein synthesis and folding, but it also has an important role in sensing cellular stress. Recently, it has been shown that the endoplasmic reticulum mediates a specific set of intracellular signalling pathways in response to the accumulation of unfolded or misfolded proteins, and these pathways are collectively known as the unfolded-protein response. New observations suggest that the unfolded-protein response can initiate inflammation, and the coupling of these responses in specialized cells and tissues is now thought to be fundamental in the pathogenesis of inflammatory diseases. The knowledge gained from this emerging field will aid in the development of therapies for modulating cellular stress and inflammation.	[Zhang, Kezhong; Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Kaufman, RJ (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kaufmanr@umich.edu		Zhang, Kezhong/0000-0002-6062-235X	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01 HL057346-100006, HL057346, R01 HL052173-12, HL052173, P01 HL057346-11A18575, R01 HL052173, P01 HL057346, R01 HL052173-11] Funding Source: Medline; NIDDK NIH HHS [R37 DK042394-11, R37 DK042394-10, R01 DK042394-09, DK042394, R01 DK042394, R37 DK042394] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK042394] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeLegge MH, 2008, NUTR CLIN PRACT, V23, P35, DOI 10.1177/011542650802300135; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; Lees JR, 2007, J CLIN INVEST, V117, P297, DOI 10.1172/JCI31254; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; Lin WS, 2006, BRAIN, V129, P1306, DOI 10.1093/brain/awl044; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mathers J, 2004, BIOCHEM SOC SYMP, V71, P157, DOI 10.1042/bss0710157; MEYER M, 1992, EMBO J, V11, P2991, DOI 10.1002/j.1460-2075.1992.tb05369.x; MORI K, 1993, CELL, V74, P743; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P449, DOI 10.1097/01.WCB.0000054216.21675.AC; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; SONG B, IN PRESS J CLIN INVE; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Tabata Y, 2007, AM J PHYSIOL-CELL PH, V293, pC411, DOI 10.1152/ajpcell.00095.2007; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P553, DOI 10.1089/ars.2006.1524; Williams KJ, 2002, SCIENCE, V297, P521, DOI 10.1126/science.297.5581.521; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamuro A, 2006, NEUROCHEM RES, V31, P657, DOI 10.1007/s11064-006-9062-6; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	82	1424	1506	4	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					455	462		10.1038/nature07203	http://dx.doi.org/10.1038/nature07203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650916	Green Submitted, Green Accepted			2022-12-28	WOS:000257860300040
J	Shah, SJ; Gheorghiade, M				Shah, Sanjiv J.; Gheorghiade, Mihai			Heart failure with preserved ejection fraction - Treat now by treating comorbidities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTOLIC FUNCTION; OUTCOMES; REGISTRY; TRIAL; MANAGEMENT; UPDATE		[Shah, Sanjiv J.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, 201 E Huron St,Galter 10-240, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Shah, Sanjiv J./AFQ-9480-2022					Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Hogg K, 2006, HEART FAIL REV, V11, P141, DOI 10.1007/s10741-006-9488-6; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; JUDGE KW, 1991, J AM COLL CARDIOL, V18, P377, DOI 10.1016/0735-1097(91)90589-2; O'Connor CM, 2000, AM J CARDIOL, V86, P863, DOI 10.1016/S0002-9149(00)01107-3; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	15	125	129	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					431	433		10.1001/jama.300.4.431	http://dx.doi.org/10.1001/jama.300.4.431			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647986				2022-12-28	WOS:000257831200021
J	Clauset, A; Erwin, DH				Clauset, Aaron; Erwin, Douglas H.			The evolution and distribution of species body size	SCIENCE			English	Article							COPES RULE; EXTINCTION; MASS	The distribution of species body size within taxonomic groups exhibits a heavy right tail extending over many orders of magnitude, where most species are much larger than the smallest species. We provide a simple model of cladogenetic diffusion over evolutionary time that omits explicit mechanisms for interspecific competition and other microevolutionary processes, yet fully explains the shape of this distribution. We estimate the model's parameters from fossil data and find that it robustly reproduces the distribution of 4002 mammal species from the late Quaternary. The observed fit suggests that the asymmetric distribution arises from a fundamental trade-off between the short-term selective advantages (Cope's rule) and long-term selective risks of increased species body size in the presence of a taxon-specific lower limit on body size.	[Clauset, Aaron; Erwin, Douglas H.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Erwin, Douglas H.] Natl Museum Nat Hist, Dept Paleobiol, MRC 121, Washington, DC 20013 USA	The Santa Fe Institute; Smithsonian Institution; Smithsonian National Museum of Natural History	Clauset, A (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	aaronc@santafe.edu	Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614				Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; ALROY J, 2008, PALEOBIOLOGY DATABAS; Brown J.H., 1995, MACROECOLOGY; Brown JH, 1996, AM NAT, V147, P1092, DOI 10.1086/285895; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Deperet C.J.J., 1909, TRANSFORMATIONS ANIM; DIAL KP, 1988, ECOLOGY, V69, P1620, DOI 10.2307/1941660; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Gaudin Timothy J., 2006, P1; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Kozlowski J, 2002, FUNCT ECOL, V16, P540, DOI 10.1046/j.1365-2435.2002.00647.x; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Ludwig D, 1996, ECOL APPL, V6, P1067, DOI 10.2307/2269591; McKinney M.L., 1990, P75; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; PEARSON OP, 1948, SCIENCE, V108, P44, DOI 10.1126/science.108.2793.44; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; SMITH FA, 2007, MACROECOLOGICAL DATA; STANLEY SM, 1975, P NATL ACAD SCI USA, V72, P646, DOI 10.1073/pnas.72.2.646; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; VANVALEN L, 1973, EVOLUTION, V27, P27, DOI 10.1111/j.1558-5646.1973.tb05914.x; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799	27	118	118	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					399	401		10.1126/science.1157534	http://dx.doi.org/10.1126/science.1157534			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635801	Green Submitted			2022-12-28	WOS:000257713900048
J	Evans, JA				Evans, James A.			Electronic publication and the narrowing of science and scholarship	SCIENCE			English	Article							JOURNALS; NETWORKS; PATTERNS; PRINT	Online journals promise to serve more information to more dispersed audiences and are more efficiently searched and recalled. But because they are used differently than print-scientists and scholars tend to search electronically and follow hyperlinks rather than browse or peruse-electronically available journals may portend an ironic change for science. Using a database of 34 million articles, their citations (1945 to 2005), and online availability (1998 to 2005), I show that as more journal issues came online, the articles referenced tended to be more recent, fewer journals and articles were cited, and more of those citations were to fewer journals and articles. The forced browsing of print archives may have stretched scientists and scholars to anchor findings deeply into past and present scholarship. Searching online is more efficient and following hyperlinks quickly puts researchers in touch with prevailing opinion, but this may accelerate consensus and narrow the range of findings and ideas built upon.	[Evans, James A.] Univ Chicago, Dept Sociol, Chicago, IL 60615 USA	University of Chicago	Evans, JA (corresponding author), Univ Chicago, Dept Sociol, 1126 E 59th St, Chicago, IL 60615 USA.	jevans@uchicago.edu	McBee, David J/F-3968-2012					Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERGER J, 2007, NY TIMES        1003; Black S, 2005, LIBR RESOUR TECH SER, V49, P19; Darwin C, 1867, ORIGIN SPECIES; De Groote SL, 2003, J MED LIBR ASSOC, V91, P231; Dellavalle RP, 2003, SCIENCE, V302, P787, DOI 10.1126/science.1088234; FRIEDLANDER A, 2002, DIMENSIONS USE SCHOL; HAUSMAN J, 1984, ECONOMETRICA, V52, P909, DOI 10.2307/1911191; Manning C. D., 1999, FDN NATURAL LANGUAGE; McLuhan Marshall, 1964, UNDERST MEDIA; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; NEWTON I, 1883, PRINCIPIA; PRICE DJD, 1965, SCIENCE, V149, P510; REDDY R, 2001, DIGITAL LIB UNVERSAL; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Shirky C, 2005, ONTOLOGY IS OVERRATE; SIMON HA, 1955, BIOMETRIKA, V42, P425; Tenopir C, 2004, J MED LIBR ASSOC, V92, P233; Tenopir C., 2004, SERIALS LIBR, V46, P20, DOI DOI 10.1300/J123v46n01_14; Tenopir C., 2003, USE USERS ELECT LIB	20	206	210	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					395	399		10.1126/science.1150473	http://dx.doi.org/10.1126/science.1150473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635800				2022-12-28	WOS:000257713900047
J	Stierle, A				Stierle, Andreas			Tracking corrosion cracking	SCIENCE			English	Editorial Material							MICROSCOPY		[Stierle, Andreas] Max Planck Inst Metallforsch, D-70569 Stuttgart, Germany	Max Planck Society	Stierle, A (corresponding author), Max Planck Inst Metallforsch, D-70569 Stuttgart, Germany.	stierle@mf.mpg.de	Stierle, Andreas/Q-2679-2018	Stierle, Andreas/0000-0002-0303-6282				BLOME C, 2007, J SYNCHROTRON RADIAT, V879, P1254; Bruemmer SM, 2001, SURF INTERFACE ANAL, V31, P571, DOI 10.1002/sia.1084; Huang YL, 2008, MATER LETT, V62, P1863, DOI 10.1016/j.matlet.2007.10.040; Jakobsen B, 2006, SCIENCE, V312, P889, DOI 10.1126/science.1124141; King A, 2008, SCIENCE, V321, P382, DOI 10.1126/science.1156211; Koch G.H., 2001, FHWARD01156 OFF INFR; Larson BC, 2002, NATURE, V415, P887, DOI 10.1038/415887a; Renner FU, 2006, NATURE, V439, P707, DOI 10.1038/nature04465; Schroer CG, 2003, APPL PHYS LETT, V82, P1485, DOI 10.1063/1.1556960; Stock SR, 2008, INT MATER REV, V53, P129, DOI 10.1179/174328008X277803; Welzel U, 2007, Z KRISTALLOGR, V222, P160, DOI 10.1524/zkri.2007.222.3-4.160	11	16	16	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					349	350		10.1126/science.1160939	http://dx.doi.org/10.1126/science.1160939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635783				2022-12-28	WOS:000257713900028
J	Kaveri, SV; Lacroix-Desmazes, S; Bayry, J				Kaveri, Srini V.; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh			The antiinflammatory IgG	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FC		Univ Paris 06, Inst Natl Sante & Rech Med, Paris, France; Univ Paris 05, Ctr Rech Cordeliers, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kaveri, SV (corresponding author), Univ Paris 06, Inst Natl Sante & Rech Med, Paris, France.		Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447				Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360	6	65	66	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					307	309		10.1056/NEJMcibr0803649	http://dx.doi.org/10.1056/NEJMcibr0803649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326KD	18635437				2022-12-28	WOS:000257656600013
J	Peters, HP; Brossard, D; de Cheveigne, S; Dunwoody, S; Kallfass, M; Miller, S; Tsuchida, S				Peters, Hans Peter; Brossard, Dominique; de Cheveigne, Suzanne; Dunwoody, Sharon; Kallfass, Monika; Miller, Steve; Tsuchida, Shoji			Science communication - Interactions with the mass media	SCIENCE			English	Editorial Material							BARRIERS		[Peters, Hans Peter; Kallfass, Monika] Forschungszentrum Julich, Program Grp Humans Environm Technol, D-52425 Julich, Germany; [Brossard, Dominique; Dunwoody, Sharon] Univ Wisconsin, Sch Journalism & Mass Commun, Madison, WI 53706 USA; [de Cheveigne, Suzanne] Ecole Hautes Etud Sci Sociales, CNRS, Shadyc Soc Hist Anthropol Dynam Culturelles, F-13236 Marseille, France; [Miller, Steve] UCL, London WC1E 6BT, England; [Tsuchida, Shoji] Kansai Univ, Dept Psychol, Osaka 5648680, Japan	Helmholtz Association; Research Center Julich; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); University of London; University College London; Kansai University	Peters, HP (corresponding author), Forschungszentrum Julich, Program Grp Humans Environm Technol, Postfach 1913, D-52425 Julich, Germany.	h.p.peters@fz-juelich.de	Dunwoody, Sharon/J-5064-2019; Peters, Hans Peter/K-6517-2012	Dunwoody, Sharon/0000-0002-4605-5299; Peters, Hans Peter/0000-0002-8777-4329; Miller, Steven/0000-0002-7159-6871				DECHEVEIGNE S, 1997, HERMES COGNIT COMMUN, V21, P121; DUNWOODY S, 1985, J COMMUN, V35, P26, DOI 10.1111/j.1460-2466.1985.tb01882.x; Geller G, 2005, GENET MED, V7, P198, DOI 10.1097/01.GIM.0000156699.78856.23; Hartz J., 1997, WORLDS APART DISTANC; PETERS HP, 1995, MEDIA CULT SOC, V17, P31, DOI 10.1177/016344395017001003; Royal Society, 2006, SCI COMM SURV FACT A; Willems J, 2003, NATURE, V422, P470, DOI 10.1038/422470a	7	139	145	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					204	205		10.1126/science.1157780	http://dx.doi.org/10.1126/science.1157780			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	324IS	18625578				2022-12-28	WOS:000257512900023
J	Renggli, V; De Ryck, I; Jacob, S; Yeneneh, H; Sirgu, S; Sebuyira, LM; Pfitzer, A; Downing, J; Portillo, C; Murray, J; Gove, S; Colebunders, R				Renggli, V.; De Ryck, I.; Jacob, S.; Yeneneh, H.; Sirgu, S.; Sebuyira, L. Mpanga; Pfitzer, A.; Downing, J.; Portillo, C.; Murray, J.; Gove, S.; Colebunders, R.			HIV education for health-care professionals in high prevalence countries: time to integrate a pre-service approach into training	LANCET			English	Editorial Material									[Renggli, V.; De Ryck, I.; Colebunders, R.] Inst Trop Med, B-2000 Antwerp, Belgium; [Jacob, S.] Univ Washington, Int Training & Educ Ctr HIV, Seattle, WA 98195 USA; [Yeneneh, H.; Murray, J.] Emory Univ, Sch Nursing, Carter Ctr, Ethiopia Publ Hlth Training Initiat, Atlanta, GA 30322 USA; [Sirgu, S.] WHO, Country Off, Addis Ababa, Ethiopia; [Sebuyira, L. Mpanga] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Pfitzer, A.] Johns Hopkins Univ, Jhpiego Corp, Baltimore, MD USA; [Downing, J.] African Palliat Care Assoc, Kampala, Uganda; [Portillo, C.] Univ Calif San Francisco, Sch Nursing, Dept Community Hlth Syst, San Francisco, CA 94143 USA; [Gove, S.] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Colebunders, R.] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Washington; University of Washington Seattle; Emory University; World Health Organization; Makerere University; Jhpiego; Johns Hopkins University; University of California System; University of California San Francisco; World Health Organization; University of Antwerp	Colebunders, R (corresponding author), Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium.	bcoleb@itg.be	Pfitzer, Anne/H-3177-2019; Pfitzer, Anne/GPF-5485-2022	Downing, Julia/0000-0002-3450-785X; Jacob, Shevin/0000-0003-2425-9394				DOWNING J, 2006, THESIS MANCHESTER ME; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Idigbe E O, 2006, SAHARA J, V3, P488; McCarthy EA, 2006, PLOS MED, V3, P989, DOI 10.1371/journal.pmed.0030304; NTAMBWE M, 2006, BMJ-BRIT MED J, V333, P98; Quach L, 2005, AIDS PATIENT CARE ST, V19, P335, DOI 10.1089/apc.2005.19.335; Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246; *WHO, EFF TEACH GUID ED HE; *WHO, IMAI IMCI CHRON HIV; *WHO, GLOB AIDS TREATM EM; World Health Organization, UN ACC 2010; World Health Organization, WORLD HLTH REP 2006; World Health Organization (WHO), WHO REC CLIN MENT SU	13	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					341	343		10.1016/S0140-6736(08)61119-8	http://dx.doi.org/10.1016/S0140-6736(08)61119-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657714				2022-12-28	WOS:000258042800036
J	Bellamy, JE; Pugh, H; Sanders, DJ				Bellamy, J. E.; Pugh, H.; Sanders, D. J.			Lesson of the week - The trouble with blood pressure cuffs	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Bellamy, J. E.; Pugh, H.; Sanders, D. J.] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Bellamy, JE (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	jebellamy2105@aol.com						Bur A, 2000, CRIT CARE MED, V28, P371, DOI 10.1097/00003246-200002000-00014; HASSAN MA, 1993, BRIT J ANAESTH, V71, P169; Higgins JR, 2001, LANCET, V357, P131, DOI 10.1016/S0140-6736(00)03552-2; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; SHENNAN AH, 1999, BAILLIERE CLIN OB GY, V1, P1; STANLEY TE, 1994, ANAESTHESIA, P1120; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2008	337	7668							a431	10.1136/bmj.39577.688229.47	http://dx.doi.org/10.1136/bmj.39577.688229.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350OM	18669564				2022-12-28	WOS:000259362100033
J	Jewkes, R; Nduna, M; Levin, J; Jama, N; Dunkle, K; Puren, A; Duvvury, N				Jewkes, Rachel; Nduna, M.; Levin, J.; Jama, N.; Dunkle, K.; Puren, A.; Duvvury, N.			Impact of Stepping Stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTIMATE-PARTNER VIOLENCE; EASTERN-CAPE; FILTER-PAPER; INTERVENTIONS; INFECTIONS; WOMEN; RISK; MEN; ADOLESCENTS; PREVENTION	Objective To assess the impact of Stepping Stones, a HIV prevention programme, on incidence of HIV and herpes simplex type 2 (HSV-2) and sexual behaviour. Design Cluster randomised controlled trial. Setting 70 villages (clusters) in the Eastern Cape province of South Africa. Participants 1360 men and 1416 women aged 15-26 years, who were mostly attending schools. Intervention Stepping Stones, a 50 hour programme, aims to improve sexual health by using participatory learning approaches to build knowledge, risk awareness, and communication skills and to stimulate critical reflection. Villages were randomised to receive either this or a three hour intervention on HIV and safer sex. Interviewers administered questionnaires at baseline and 12 and 24 months and blood was tested for HIV and HSV-2. Main outcome measures Primary outcome measure: incidence of HIV. Other outcomes: incidence of HSV-2, unwanted pregnancy, reported sexual practices, depression, and substance misuse. Results There was no evidence that Stepping Stones lowered the incidence of HIV (adjusted incidence rate ratio 0.95, 95% confidence interval 0.67 to 1.35). The programme was associated with a reduction of about 33% in the incidence of HSV-2 (0.67, 0.46 to 0.97; P=0.036)-that is, Stepping Stones reduced the number of new HSV-2 infections over a two year period by 34.9 (1.6 to 68.2) per 1000 people exposed. Stepping Stones significantly improved a number of reported risk behaviours in men, with a lower proportion of men reporting perpetration of intimate partner violence across two years of follow-up and less transactional sex and problem drinking at 12 months. In women desired behaviour changes were not reported and those in the Stepping Stones programme reported more transactional sex at 12 months. Conclusion Stepping Stones did not reduce incidence of HIV but had an impact on several risk factors for HIV-notably, HSV-2 and, perpetration of intimate partner violence. Trial Registration Clinical Trials.gov NCT00332878.	[Jewkes, Rachel; Jama, N.] MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa; [Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Nduna, M.] Univ Witwatersrand, Dept Psychol, Johannesburg, South Africa; [Levin, J.] MRC, Biostat Unit, Pretoria, South Africa; [Dunkle, K.] Emory Univ, Atlanta, GA 30322 USA; [Puren, A.] Natl Inst Communicable Dis, Johannesburg, South Africa; [Duvvury, N.] Int Ctr Res Women, Gender Violence & Rights Team, Washington, DC USA	University of Witwatersrand; University of Witwatersrand; Emory University; National Institute for Communicable Diseases (NICD)	Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, Private Bag X385, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za	Duvvury, Nata/C-3995-2011; Dunkle, Kristin/AAU-5488-2020; Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Duvvury, Nata/0000-0002-6616-808X; Dunkle, Kristin/0000-0003-3071-5544; Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Shai, Nwabisa/0000-0003-4171-9129; Jewkes, Rachel/0000-0002-4330-6267	National Institute of Mental Health [MH 64882-01]; South African Medical Research Council; Harry F Guggenheim Foundation; Emory Center for AIDS Research [P30 A1050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064882] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Harry F Guggenheim Foundation; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institute of Mental Health grant No MH 64882-01 and South African Medical Research Council. KD was funded from the Harry F Guggenheim Foundation and by the Emory Center for AIDS Research (P30 A1050409).	CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; COOMBES Y, 2004, EVALUATING HLTH PROM; Cornwall, 1998, STEPPING STONES S AF; DiClemente RJ, 2007, J PEDIATR PSYCHOL, V32, P888, DOI 10.1093/jpepsy/jsm056; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Earl A, 2007, HEALTH PSYCHOL, V26, P496, DOI 10.1037/0278-6133.26.4.496; Foshee VA, 2004, AM J PUBLIC HEALTH, V94, P619, DOI 10.2105/AJPH.94.4.619; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hogrefe WR, 2002, CLIN DIAGN LAB IMMUN, V9, P1338, DOI 10.1128/CDLI.9.6.1338-1342.2002; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; JEWKES R, 2002, STEPPING STONES S AF; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Lyles CM, 2007, AM J PUBLIC HEALTH, V97, P133, DOI 10.2105/AJPH.2005.076182; Murray DM, 1998, DESIGN ANAL GROUP RA; Nascimento, 2007, ENGAGING MEN BOYS TR; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Robin L, 2004, J ADOLESCENT HEALTH, V34, P3, DOI 10.1016/S1054-139X(03)00244-1; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Sarge-Njie R, 2006, SCAND J INFECT DIS, V38, P1050, DOI 10.1080/00365540600801645; SHAW M, 2002, REALISING RIGHTS TRA; WALLACE T, 2006, EVALUATING STEPPING; Welbourn Alice, 1995, STRATEGIES HOPE TRAI, V1; World Health Organization, 2004, RAP HIV TESTS GUID U	30	512	516	0	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2008	337	7666							a506	10.1136/bmj.a506	http://dx.doi.org/10.1136/bmj.a506			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	340TZ	18687720	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000258669200026
J	Meyer-Lindenberg, A				Meyer-Lindenberg, Andreas			Trust me on this	SCIENCE			English	Editorial Material							BORDERLINE PERSONALITY-DISORDER; CHILDHOOD; MECHANISMS		Univ Heidelberg, Cent Inst Mental Hlth, D-68159 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Meyer-Lindenberg, A (corresponding author), Univ Heidelberg, Cent Inst Mental Hlth, J5, D-68159 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de	Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123				Adolphs R, 2000, J NEUROSCI, V20, P2683; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schmahl C, 2006, ARCH GEN PSYCHIAT, V63, P659, DOI 10.1001/archpsyc.63.6.659; Torgersen S, 2000, COMPR PSYCHIAT, V41, P416, DOI 10.1053/comp.2000.16560; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	16	31	36	4	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					778	780		10.1126/science.1162908	http://dx.doi.org/10.1126/science.1162908			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	334ZQ	18687945				2022-12-28	WOS:000258261000025
J	Redman, BK; Merz, JF				Redman, Barbara K.; Merz, Jon F.			Scientific misconduct: Do the punishments fit the crime?	SCIENCE			English	Editorial Material									[Merz, Jon F.] Univ Penn, Sch Med, Dept Med Eth, Philadelphia, PA 19104 USA; [Redman, Barbara K.] Wayne State Univ, Coll Nursing, Detroit, MI 48202 USA; [Redman, Barbara K.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Wayne State University; University of Pennsylvania; Pennsylvania Medicine	Merz, JF (corresponding author), Univ Penn, Sch Med, Dept Med Eth, Philadelphia, PA 19104 USA.	ae9080@wayne.edu; merz@mail.med.upenn.edu		Merz, Jon/0000-0002-0612-7104	RMOD NIH HHS [RFA-RM-06-002] Funding Source: Medline	RMOD NIH HHS		LAPIDUS JB, 1990, ETHICS HIGHER ED, P283; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; WOOLF P, 1981, HASTINGS CENT REP, V11, P9, DOI 10.2307/3561291	3	17	19	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					775	775		10.1126/science.1158052	http://dx.doi.org/10.1126/science.1158052			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	334ZQ	18687942				2022-12-28	WOS:000258261000022
J	Miller, JR; Simon, P				Miller, John R.; Simon, Patrice			Materials science - Electrochemical capacitors for energy management	SCIENCE			English	Editorial Material							ELECTROLYTE		[Miller, John R.] JME Inc, Shaker Hts, OH 44120 USA; [Simon, Patrice] Univ Toulouse 3, CIRIMAT, CNRS, UMR 5085, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Miller, JR (corresponding author), JME Inc, 17210 Parkland Dr, Shaker Hts, OH 44120 USA.	jmecapacitor@att.net; simon@chimie.ups-tlse.fr	SIMON, Patrice/N-6777-2016; Miller, John J/GZG-5663-2022	SIMON, Patrice/0000-0002-0461-8268; 				Balducci A, 2005, ELECTROCHIM ACTA, V50, P2233, DOI 10.1016/j.electacta.2004.10.006; Chmiola J, 2006, SCIENCE, V313, P1760, DOI [10.1126/science.1132195, 10.1126/science/1132195]; Conway BE, 2013, ELECTROCHEMICAL SUPE; Hong MS, 2002, ELECTROCHEM SOLID ST, V5, pA227, DOI 10.1149/1.1506463; Kazaryan SA, 2006, J ELECTROCHEM SOC, V153, pA1655, DOI 10.1149/1.2212057; Mastragostino M, 2002, SOLID STATE IONICS, V148, P493, DOI 10.1016/S0167-2738(02)00093-0; Materials E., 1987, P S EL MAT PROC EN C, P582; MORIMOTO T, 2007, INT C ADV CAP 28 30	8	3917	4013	27	1483	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					651	652		10.1126/science.1158736	http://dx.doi.org/10.1126/science.1158736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669852				2022-12-28	WOS:000258077700031
J	Annas, GJ				Annas, George J.			Doctors, drugs, and driving - Tort liability for patient-caused accidents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Kaplan J., 2006, Morbidity and Mortality Weekly Report, V55, P1293; KOWALCZYK L, 2007, BOSTON GLOBE    1211, pB1; MCEVOY V, 2008, BOSTON GLOBE    0204, pA15	3	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					521	525		10.1056/NEJMhle0802548	http://dx.doi.org/10.1056/NEJMhle0802548			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331VC	18669432				2022-12-28	WOS:000258039700013
J	Handschin, C; Spiegelman, BM				Handschin, Christoph; Spiegelman, Bruce M.			The role of exercise and PGC1 alpha in inflammation and chronic disease	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; OXIDATIVE-PHOSPHORYLATION; ANTIOXIDANT DEFENSE; METABOLIC SYNDROME; GENE-EXPRESSION; PLASTICITY; OBESITY	Inadequate physical activity is linked to many chronic diseases. But the mechanisms that tie muscle activity to health are unclear. The transcriptional coactivator PGC1 alpha has recently been shown to regulate several exercise-associated aspects of muscle function. We propose that this protein controls muscle plasticity, suppresses a broad inflammatory response and mediates the beneficial effects of exercise.	[Handschin, Christoph] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland; [Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Handschin, C (corresponding author), Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland.	christoph.handschin@access.uzh.ch; bruce_spiegelman@dfci.harvard.edu	Handschin, Christoph/E-6886-2015	Handschin, Christoph/0000-0003-0603-1097	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054477] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK054477-09A1, R01 DK054477] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002; Brown WJ, 2007, AM J PREV MED, V33, P404, DOI 10.1016/j.amepre.2007.07.029; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Febbraio MA, 2007, J APPL PHYSIOL, V103, P376, DOI 10.1152/japplphysiol.00414.2007; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Fraser GE, 2001, ARCH INTERN MED, V161, P1645, DOI 10.1001/archinte.161.13.1645; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gleeson M, 2004, J SPORT SCI, V22, P115, DOI 10.1080/0264041031000140590; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Gleeson M, 2006, EXERC IMMUNOL REV, V12, P34; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Handschin C., 2005, DRUG DISCOV TODAY, V2, P151; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Matter CM, 2007, CIRCULATION, V115, P946, DOI 10.1161/CIRCULATIONAHA.106.685230; McCracken Melissa, 2007, Prev Chronic Dis, V4, pA25; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Nieman David C, 2003, Curr Sports Med Rep, V2, P239; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perusse L, 1999, NUTR REV, V57, pS31, DOI 10.1111/j.1753-4887.1999.tb01785.x; Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rippe JM, 1998, J AM DIET ASSOC, V98, pS31, DOI 10.1016/S0002-8223(98)00708-1; Roubenoff R, 2007, NUTR REV, V65, pS208, DOI 10.1111/j.1753-4887.2007.tb00364.x; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tansey MG, 2008, FRONT BIOSCI-LANDMRK, V13, P709, DOI 10.2741/2713; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77; Zhou JR, 2007, AM J CLIN NUTR, V86, p817S, DOI 10.1093/ajcn/86.3.817S; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	75	720	754	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					463	469		10.1038/nature07206	http://dx.doi.org/10.1038/nature07206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650917	Green Accepted			2022-12-28	WOS:000257860300041
J	Krahn, M; Naglie, G				Krahn, Murray; Naglie, Gary			The next step in guideline development - Incorporating patient preferences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ATRIAL-FIBRILLATION; COMMITTEE; MEDICINE		[Naglie, Gary] Toronto Hosp, Toronto, ON M5T 2S8, Canada; [Krahn, Murray] Toronto Gen Res Inst, Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Krahn, Murray] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Krahn, M (corresponding author), Toronto Gen Hosp, Div Clin Decis Making & HCR, EN 14-207, Toronto, ON M5G 2C4, Canada.	murray.krahn@theta.utoronto.ca		Krahn, Murray/0000-0001-5836-397X; Naglie, Gary/0000-0002-6274-0894				Bensing J, 2000, PATIENT EDUC COUNS, V39, P17, DOI 10.1016/S0738-3991(99)00087-7; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chong CA, 2007, J GEN INTERN MED, V22, P38; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; DALY J, 2005, CALIFORNIA MILBANK B, V12; DAVIS D, 2007, HDB CLIN PRACTICE GU, P34; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Laine C, 1996, JAMA-J AM MED ASSOC, V275, P152, DOI 10.1001/jama.275.2.152; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; Ryan M, 2001, Health Technol Assess, V5, P1; Samanta A, 2003, J ROY SOC MED, V96, P133, DOI 10.1258/jrsm.96.3.133; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P22, DOI 10.1186/1478-4505-4-22; Tracy C Shawn, 2003, BMC Fam Pract, V4, P13, DOI 10.1186/1471-2296-4-13	15	196	202	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					436	438		10.1001/jama.300.4.436	http://dx.doi.org/10.1001/jama.300.4.436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647988				2022-12-28	WOS:000257831200023
J	Turgeon, SC; Creaser, RA				Turgeon, Steven C.; Creaser, Robert A.			Cretaceous oceanic anoxic event 2 triggered by a massive magmatic episode	NATURE			English	Article							CENOMANIAN-TURONIAN BOUNDARY; ISOTOPE STRATIGRAPHY; DYSOXIC EVENTS; VOLCANISM; EXTINCTIONS; MADAGASCAR; ATLANTIC; END	Oceanic anoxic events ( OAEs) were episodes of widespread marine anoxia during which large amounts of organic carbon were buried on the ocean floor under oxygen- deficient bottom waters(1,2). OAE2, occurring at the Cenomanian/ Turonian boundary ( about 93.5 Myr ago)(3), is the most widespread and best defined OAE of the mid-Cretaceous. Although the enhanced burial of organic matter can be explained either through increased primary productivity or enhanced preservation scenarios(1,2), the actual trigger mechanism, corresponding closely to the onset of these episodes of increased carbon sequestration, has not been clearly identified. It has been postulated that large- scale magmatic activity initially triggered OAE2 ( refs 4, 5), but a direct proxy of magmatism preserved in the sedimentary record coinciding closely with the onset of OAE2 has not yet been found. Here we report seawater osmium isotope ratios in organic- rich sediments from two distant sites. We find that at both study sites the marine osmium isotope record changes abruptly just at or before the onset of OAE2. Using a simple two-component mixing equation, we calculate that over 97 per cent of the total osmium content in contemporaneous seawater at both sites is magmatic in origin, a similar to 30-50-fold increase relative to pre-OAE conditions. Furthermore, the magmatic osmium isotope signal appears slightly before the OAE2 - as indicated by carbon isotope ratios - suggesting a time- lag of up to similar to 23 kyr between magmatism and the onset of significant organic carbon burial, which may reflect the reaction time of the global ocean system. Our marine osmium isotope data are indicative of a widespread magmatic pulse at the onset of OAE2, which may have triggered the subsequent deposition of large amounts of organic matter.	[Turgeon, Steven C.; Creaser, Robert A.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T2G 2E2, Canada	University of Alberta	Turgeon, SC (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T2G 2E2, Canada.	turgeonsc@ualberta.ca		Creaser, Robert/0000-0002-7672-035X				ALVAREZ W, 1984, SCIENCE, V223, P1183, DOI 10.1126/science.223.4641.1183; ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; BARRON EJ, 1983, EARTH-SCI REV, V19, P305, DOI 10.1016/0012-8252(83)90001-6; Cohen AS, 2002, GEOLOGY, V30, P267, DOI 10.1130/0091-7613(2002)030<0267:NGEFTO>2.0.CO;2; FORSTER A, 2007, PALEOCEANOGRAPHY, V22; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hardas P, 2007, MAR MICROPALEONTOL, V66, P52, DOI 10.1016/j.marmicro.2007.07.007; JARVIS I, 1988, Cretaceous Research, V9, P3, DOI 10.1016/0195-6671(88)90003-1; JENKYNS HC, 2007, PALEOCEANOGRAPHY, V22; KAIHO K, 1994, PALAEOGEOGR PALAEOCL, V111, P29, DOI 10.1016/0031-0182(94)90346-8; Kerr AC, 1998, J GEOL SOC LONDON, V155, P619, DOI 10.1144/gsjgs.155.4.0619; Kuroda J, 2007, EARTH PLANET SC LETT, V256, P211, DOI 10.1016/j.epsl.2007.01.027; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; LAMOLDA MA, 1994, CRETACEOUS RES, V15, P143, DOI 10.1006/cres.1994.1007; MCARTHUR JM, 1994, PALAEOGEOGR PALAEOCL, V108, P95, DOI 10.1016/0031-0182(94)90024-8; Pegram WJ, 1999, GEOCHIM COSMOCHIM AC, V63, P4053, DOI 10.1016/S0016-7037(99)00308-7; Peucker-Ehrenbrink B, 2000, TERRA NOVA, V12, P205, DOI 10.1046/j.1365-3121.2000.00295.x; Ravizza G, 2003, SCIENCE, V302, P1392, DOI 10.1126/science.1089209; SCHLANGER S O, 1976, Geologie en Mijnbouw, V55, P179; Schlanger S.O., 1987, GEOLOGICAL SOC LONDO, V29, P371, DOI DOI 10.1144/GSL.SP.1987.026.01.24; Selby D, 2003, CHEM GEOL, V200, P225, DOI 10.1016/S0009-2541(03)00199-2; Sharma M, 2007, GEOCHIM COSMOCHIM AC, V71, P4655, DOI 10.1016/j.gca.2007.06.062; Sinton CW, 1997, ECON GEOL BULL SOC, V92, P836, DOI 10.2113/gsecongeo.92.7-8.836; Snow L. J., 2005, PALEOCEANOGRAPHY, V20; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; SUZUKI K, 2007, JAP GEOSC UN M 19 24; Torsvik TH, 1998, EARTH PLANET SC LETT, V164, P221, DOI 10.1016/S0012-821X(98)00206-4; Tsikos H, 2004, J GEOL SOC LONDON, V161, P711, DOI 10.1144/0016-764903-077; Turgeon S, 2006, CHEM GEOL, V234, P321, DOI 10.1016/j.chemgeo.2006.05.008; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4	30	324	339	5	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					323	U29		10.1038/nature07076	http://dx.doi.org/10.1038/nature07076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633415				2022-12-28	WOS:000257665300036
J	Macklin, R				Macklin, Ruth			The art of medicine - Standard of care: an evolution in ethical thinking	LANCET			English	Editorial Material									Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Macklin, R (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	macklin@aecom.yu.edu						Lie RK, 2006, LANCET, V368, P522, DOI 10.1016/S0140-6736(06)69160-5; *UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; WHO/UNAIDS, 2004, AIDS, V18, pW1	3	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					284	285		10.1016/S0140-6736(08)61098-3	http://dx.doi.org/10.1016/S0140-6736(08)61098-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18663793				2022-12-28	WOS:000258042800015
J	Lata, S; Schoehn, G; Jain, A; Pires, R; Piehler, J; Gottlinger, HG; Weissenhorn, W				Lata, Suman; Schoehn, Guy; Jain, Ankur; Pires, Ricardo; Piehler, Jacob; Goettlinger, Heinrich G.; Weissenhorn, Winfried			Helical structures of ESCRT-III are disassembled by VPS4	SCIENCE			English	Article							LATE-BUDDING DOMAINS; PROTEINS; CYTOKINESIS; AUTOINHIBITION; TRAFFICKING; RECOGNITION; MACHINERY; FILAMENTS; RELEASE; CHMP3	During intracellular membrane trafficking and remodeling, protein complexes known as the ESCRTs ( endosomal sorting complexes required for transport) interact with membranes and are required for budding processes directed away from the cytosol, including the budding of intralumenal vesicles to form multivesicular bodies; for the budding of some enveloped viruses; and for daughter cell scission in cytokinesis. We found that the ESCRT- III proteins CHMP2A and CHMP3 ( charged multivesicular body proteins 2A and 3) could assemble in vitro into helical tubular structures that expose their membrane interaction sites on the outside of the tubule, whereas the AAA- type adenosine triphosphatase VPS4 could bind on the inside of the tubule and disassemble the tubes upon adenosine triphosphate hydrolysis. CHMP2A and CHMP3 copolymerized in solution, and their membrane targeting was cooperatively enhanced on planar lipid bilayers. Such helical CHMP structures could thus assemble within the neck of an inwardly budding vesicle, catalyzing late steps in budding under the control of VPS4.	[Lata, Suman; Schoehn, Guy; Pires, Ricardo; Weissenhorn, Winfried] Univ Grenoble 1, European Mol Biol Lab, CNRS, Unit Viral Host Cell Interact,UMR 5233, F-38042 Grenoble 9, France; [Schoehn, Guy] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct UMR 5075, F-38027 Grenoble 1, France; [Jain, Ankur; Piehler, Jacob] Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Goettlinger, Heinrich G.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Program Mol Med, Worcester, MA 01605 USA	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Goethe University Frankfurt; University of Massachusetts System; University of Massachusetts Worcester	Weissenhorn, W (corresponding author), Univ Grenoble 1, European Mol Biol Lab, CNRS, Unit Viral Host Cell Interact,UMR 5233, 6 Rue Jules Horowitz, F-38042 Grenoble 9, France.	weissenhorn@embl.fr	Vieira-Pires, Ricardo/J-5232-2013	Vieira-Pires, Ricardo/0000-0003-1830-3715; Gottlinger, Heinrich/0000-0003-4124-5824; Schoehn, Guy/0000-0002-1459-3201	Deutsche Forschungsgemeinschaft [SPP 1175]; Agence Nationale de la Recherche sur le SIDA; Universite Joseph Fourier; Agence Nationale de la Recherche; CNRS; NIH [AI29873]; European Molecular Biology Organization; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029873, R37AI029873] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence Nationale de la Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); Universite Joseph Fourier; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Siebert (Institut de Biologie Structurale) for advice on UROX. This work was supported by Deutsche Forschungsgemeinschaft (SPP 1175) (W.W.), the Agence Nationale de la Recherche sur le SIDA (W.W.) Universite Joseph Fourier (W.W.), the Agence Nationale de la Recherche (G.S.) the CNRS (G.S.), the NIH (grant AI29873, H.G.), and by postdoctoral fellowships from the European Molecular Biology Organization (S.L.) and the International Human Frontier Science Program Organization (S.L.). The EM map has been deposited at the European Bioinformatics Institute accession code EMD-1536.	Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dukes JD, 2008, BIOCHEM J, V411, P233, DOI 10.1042/BJ20071296; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	26	238	244	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1354	1357		10.1126/science.1161070	http://dx.doi.org/10.1126/science.1161070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18687924	Green Accepted			2022-12-28	WOS:000258914300050
J	Lingard, L; Albert, M; Levinson, W				Lingard, Lorelei; Albert, Mathieu; Levinson, Wendy			Qualitative research - Grounded theory, mixed methods, and action research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REFLEXIVITY; BENEFITS		[Lingard, Lorelei] Univ Toronto, Sickkids Learning Inst, Toronto, ON M5G 2C4, Canada; [Lingard, Lorelei] Univ Toronto, Dept Paediat, Toronto, ON M5G 2C4, Canada; [Lingard, Lorelei; Albert, Mathieu] Univ Toronto, Wilson Ctr Res Educ, Toronto, ON M5G 2C4, Canada; [Albert, Mathieu] Univ Toronto, Dept Psychiat, Toronto, ON M5G 2C4, Canada; [Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto	Lingard, L (corresponding author), Univ Toronto, Sickkids Learning Inst, 200 Elizabeth St,Eaton S 1-565, Toronto, ON M5G 2C4, Canada.	lorelei.lingard@utoronto.ca	jittitaworn, wareerat/G-9191-2016; Albert, Mathieu/A-6685-2008; Lingard, Lorelei/G-3322-2011	Albert, Mathieu/0000-0003-1008-7085				BLUMER H, 1968, SYMBOLIC INTERACTION; Bridges J, 2003, INT J NURS STUD, V40, P599, DOI 10.1016/S0020-7489(03)00040-3; Creswell J.W., 2015, RES DESIGN QUANTITAT; Gibson N., 2001, NATURE QUALITATIVE E, P161; Glaser B.G., 1965, AWARENESS DYING; Green L., 2003, COMMUNITY BASED PART, P419; Green SE, 2007, SOC SCI MED, V64, P150, DOI 10.1016/j.socscimed.2006.08.025; Hall WA, 2001, QUAL HEALTH RES, V11, P257, DOI 10.1177/104973201129119082; Kennedy TJT, 2007, J GEN INTERN MED, V22, P1080, DOI 10.1007/s11606-007-0179-3; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; McGhee G, 2007, J ADV NURS, V60, P334, DOI 10.1111/j.1365-2648.2007.04436.x; Meyer J., 2006, QUALITATIVE RES HLTH, VThird, P121; Morgan DL, 2007, J MIX METHOD RES, V1, P48, DOI 10.1177/2345678906292462; Morgan DL, 1998, QUAL HEALTH RES, V8, P362, DOI 10.1177/104973239800800307; Strauss A., 1997, GROUNDED THEORY PRAC; Strauss A., 1998, BASICS QUALITATIVE R; Winter R., 2001, HDB ACTION RES HLTH	17	273	276	4	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2008	337	7667							a567	10.1136/bmj.39602.690162.47	http://dx.doi.org/10.1136/bmj.39602.690162.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346FD	18687728				2022-12-28	WOS:000259053100030
J	Haydar, AA; Morgan-Hughes, G; Roobottom, C				Haydar, Ali A.; Morgan-Hughes, Gareth; Roobottom, Carl			Rational imaging - Investigating severe interscapular pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPUTED-TOMOGRAPHY; PULMONARY-EMBOLISM; AORTIC DISSECTION; ANGIOGRAPHY	This article explores the radiological investigations for identifying the cause of severe interscapular pain, focusing on how to exclude acute myocardial infarction, aortic dissection, and pulmonary embolism	[Haydar, Ali A.; Roobottom, Carl] Peninsula Radiol Acad, Plymouth PL6 5WR, Devon, England; [Morgan-Hughes, Gareth] Derriford Hosp, Dept Cardiol, Plymouth PL6 8DH, Devon, England	University of Plymouth; Derriford Hospital	Haydar, AA (corresponding author), Peninsula Radiol Acad, Plymouth PL6 5WR, Devon, England.	drahaydar@hotmail.com						Gibson NS, 2005, CURR OPIN PULM MED, V11, P380; Hayter RG, 2006, RADIOLOGY, V238, P841, DOI 10.1148/radiol.2383041528; HEILER GV, 1998, AM COLL CARDIOL, V31, P1011; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101; Rubinshtein R, 2007, CIRCULATION, V115, P1762, DOI 10.1161/CIRCULATIONAHA.106.618389; SABIA P, 1991, CIRCULATION S1, V84, P85; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367	8	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 16	2008	337	7666							a688	10.1136/bmj.a688	http://dx.doi.org/10.1136/bmj.a688			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18644773				2022-12-28	WOS:000258669200030
J	Cohen, D				Cohen, Deborah			AIDS conference: more junket medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2008	337	7665							a1191	10.1136/bmj.a1191	http://dx.doi.org/10.1136/bmj.a1191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EO	18684756				2022-12-28	WOS:000258561100038
J	Motzer, RJ; Escudier, B; Oudard, S; Hutson, TE; Porta, C; Bracarda, S; Grunwald, V; Thompson, JA; Figlin, RA; Hollaender, N; Urbanowitz, G; Berg, WJ; Kay, A; Lebwohl, D; Ravaud, A				Motzer, Robert J.; Escudier, Bernard; Oudard, Stephane; Hutson, Thomas E.; Porta, Camillo; Bracarda, Sergio; Gruenwald, Viktor; Thompson, John A.; Figlin, Robert A.; Hollaender, Norbert; Urbanowitz, Gladys; Berg, William J.; Kay, Andrea; Lebwohl, David; Ravaud, Alain		RECORD-1 Study Grp	Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial	LANCET			English	Article							MAMMALIAN TARGET; INTERFERON-ALPHA; INHIBITOR; MTOR	Background Everolimus (RAD001) is an orally administered inhibitor of the mammalian target of rapamycin (mTOR), a therapeutic target for metastatic renal cell carcinoma. We dida phase III, randomised, double-blind, placebo-controlled trial of everolimus in patients with metastatic renal cell carcinoma whose disease had progressed on vascular endothelial growth factor-targeted therapy. Methods Patients with metastatic renal cell carcinoma which had progressed on sunitinib, sorafenib, or both, were randomly assigned in a two to one ratio to receive everolimus 10 mg once daily (n=272) or placebo (n=138), in conjunction with best supportive care. Randomisation was done centrally via an interactive voice response system using a validated computer system, and was stratified by Memorial Sloan-Kettering Cancer Center prognostic score and previous anticancer therapy, with a permuted block size of six. The primary endpoint was progression-free survival, assessed via a blinded, independent central review. The study was designed to be terminated after 290 events of progression. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00410124. Findings All randomised patients were included in efficacy analyses. The results of the second interim analysis indicated a significant difference in efficacy between arms and the trial was thus halted early after 191 progression events had been observed (101 [37%] events in the everolimus group, 90 [65%] in the placebo group; hazard ratio 0 - 30, 95% CI 0.22-0.40, p < 0.0001; median progression-free survival 4.0 [95% CI 3.7-5.5] vs 1.9 [1.8-1.9] months). Stomatitis (107 [40%] patients in the everolimus group vs 11 [8%] in the placebo group), rash (66 [25%] vs six [4%]), and fatigue (53 [20%] vs 22 [16%]) were the most commonly reported adverse events, but were mostly mild or moderate in severity. Pneumonitis (any grade) was detected in 22 (8%) patients in the everolimus group, of whom eight had pneumonitis of grade 3 severity Interpretation Treatment with everolimus prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma that had progressed on other targeted therapies.	[Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Escudier, Bernard] Inst Gustave Roussy, Villejuif, France; [Oudard, Stephane] Hop Europeen Georges Pompidou, Paris, France; [Hutson, Thomas E.] Baylor Sammons Canc Ctr, Dallas, TX USA; [Porta, Camillo] San Matteo Univ Hosp Fdn, IRCCS, Pavia, Italy; [Bracarda, Sergio] Azienda Osped, Perugia, Italy; [Gruenwald, Viktor] Hannover Med Sch, D-3000 Hannover, Germany; [Thompson, John A.] Canc Care Alliance, Seattle, WA USA; [Figlin, Robert A.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Hollaender, Norbert; Urbanowitz, Gladys; Berg, William J.; Kay, Andrea; Lebwohl, David] Novartis Oncol, Florham Pk, NJ USA; [Ravaud, Alain] Hop St Andre CHU, Bordeaux, France	Memorial Sloan Kettering Cancer Center; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; IRCCS Fondazione San Matteo; University of Pavia; University of Perugia; Azienda Ospedaliera di Perugia; Hannover Medical School; Seattle Cancer Care Alliance; City of Hope; Novartis; CHU Bordeaux	Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	motzerr@mskcc.org	Grünwald, Viktor/D-9601-2012; Toon, Christopher W/G-3610-2012; Chevreau, Christine/A-5565-2015; Porta, Camillo/AAB-9482-2020; Hutson, Thomas/AAS-9639-2020; Thompson, John A/T-7985-2019	Hutson, Thomas/0000-0002-4529-4212; Thompson, John A/0000-0002-0872-7306; Porta, Camillo/0000-0003-2412-1563; Calvo, Emiliano/0000-0003-4921-829X; Bracarda, Sergio/0000-0002-0703-2959; OUDARD, Stephane/0000-0003-0893-285X; Motzer, Robert/0000-0001-6925-2327; groenewegen, gerard/0000-0002-0752-1744; Ravaud, Alain/0000-0001-9455-6744				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Amato RJ, 2006, J CLIN ONCOL, V24, p224S; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cella D, 2007, VALUE HEALTH, V10, P285, DOI 10.1111/j.1524-4733.2007.00183.x; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; Coppin C, 2008, COCHRANE DB SYST REV, V2; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jac J, 2007, J CLIN ONCOL, V25; Johnson JR, 2003, J CLIN ONCOL, V21, P1404, DOI 10.1200/JCO.2003.08.072; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tanaka Chiaki, 2008, J Clin Oncol, V26, P1596, DOI 10.1200/JCO.2007.14.1127; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337	24	2427	2496	3	145	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					449	456		10.1016/S0140-6736(08)61039-9	http://dx.doi.org/10.1016/S0140-6736(08)61039-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335OD	18653228				2022-12-28	WOS:000258299000028
J	Cheson, BD; Leonard, JP				Cheson, Bruce D.; Leonard, John P.			Drug therapy: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PHASE-II TRIAL; CHRONIC LYMPHOCYTIC-LEUKEMIA; IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY; HUMANIZED ANTI-CD22 ANTIBODY; REFRACTORY LOW-GRADE; ADVANCED FOLLICULAR LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; PROGRESSION-FREE SURVIVAL; IODINE I-131 TOSITUMOMAB		[Cheson, Bruce D.] Georgetown Univ Hosp, Div Hematol Oncol, Washington, DC 20007 USA; [Leonard, John P.] Weill Cornell Med Coll, Ctr Lymphoma & Myeloma, New York, NY USA	Georgetown University; Cornell University	Cheson, BD (corresponding author), Georgetown Univ Hosp, Div Hematol Oncol, 3800 Reservoir Rd NW, Washington, DC 20007 USA.	bdc4@georgetown.edu	Leonard, John/M-4379-2014	Leonard, John/0000-0002-5083-1115				Advani R, 2006, BLOOD, V108, p209A; Alas S, 2001, CANCER RES, V61, P5137; Ansell SM, 2002, J CLIN ONCOL, V20, P3885, DOI 10.1200/JCO.2002.10.143; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Bennett JM, 2005, BLOOD, V105, P4576, DOI 10.1182/blood-2004-12-4690; Bohen SP, 2003, P NATL ACAD SCI USA, V100, P1926, DOI 10.1073/pnas.0437875100; Byrd JC, 2005, BLOOD, V105, P49, DOI 10.1182/blood-2004-03-0796; Byrd JC, 2006, BLOOD, V108, p14A, DOI 10.1182/blood.V108.11.32.32; Byrd JC, 2007, CLIN CANCER RES, V13, P4448, DOI 10.1158/1078-0432.CCR-06-1463; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chaperot L, 1999, EXP HEMATOL, V27, P479, DOI 10.1016/S0301-472X(98)00059-9; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coiffier B, 1998, BLOOD, V92, P1927; Coiffier B, 2008, BLOOD, V111, P1094, DOI 10.1182/blood-2007-09-111781; Coiffier B, 2006, BLOOD, V108, p804A, DOI 10.1182/blood.V108.11.2842.2842; Colombat P, 2006, BLOOD, V108, p147A; Croonian lecture, 1900, P R SOC LOND, V66, P424, DOI [DOI 10.1098/RSPL.1899.0121, 10.1098/rspl.1899.0121]; CZUCZMAN M, IN PRESS ANN ONCOL; Czuczman MS, 2005, J CLIN ONCOL, V23, P4390, DOI 10.1200/JCO.2005.09.018; Czuczman MS, 2004, J CLIN ONCOL, V22, P4711, DOI 10.1200/JCO.2004.04.020; Czuczman MS, 2005, J CLIN ONCOL, V23, P694, DOI 10.1200/JCO.2005.02.172; CZUCZMAN MS, 2005, J CLIN ONCOL, V23, P248, DOI DOI 10.1200/JCO.2004.04.020; Czuczman MS, 2007, J CLIN ONCOL, V25, P4285, DOI 10.1200/JCO.2006.09.2882; Davis TA, 1999, J CLIN ONCOL, V17, P1851, DOI 10.1200/JCO.1999.17.6.1851; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; DeNardo GL, 1998, J CLIN ONCOL, V16, P3246, DOI 10.1200/JCO.1998.16.10.3246; Farag SS, 2004, BLOOD, V103, P1472, DOI 10.1182/blood-2003-07-2548; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Fisher RI, 2005, J CLIN ONCOL, V23, P8447, DOI 10.1200/JCO.2005.03.1674; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Foran JM, 2000, J CLIN ONCOL, V18, P317, DOI 10.1200/JCO.2000.18.2.317; Forstpointner R, 2004, BLOOD, V104, P3064, DOI 10.1182/blood-2004-04-1323; Forstpointner R, 2006, BLOOD, V108, P4003, DOI 10.1182/blood-2006-04-016725; Ghielmini M, 2004, BLOOD, V103, P4416, DOI 10.1182/blood-2003-10-3411; Gisselbrecht C, 2007, BLOOD, V110, p159A, DOI 10.1182/blood.V110.11.517.517; Golay J, 2000, BLOOD, V95, P3900; Gopal AK, 2003, BLOOD, V102, P2351, DOI 10.1182/blood-2003-02-0622; Gordan LN, 2005, J CLIN ONCOL, V23, P1096, DOI 10.1200/JCO.2005.12.171; Gordon LI, 2004, BLOOD, V103, P4429, DOI 10.1182/blood-2003-11-3883; Grillo-Lopez AJ, 2002, INT J HEMATOL, V76, P385, DOI 10.1007/BF02982803; Grillo-Lopez AJ, 2000, SEMIN ONCOL, V27, P9, DOI 10.1053/sonc.2000.20444; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hagenbeek A, 2005, BLOOD, V106, p270B; Hagenbeek A, 2007, BLOOD, V110, p198A, DOI 10.1182/blood.V110.11.643.643; Hainsworth JD, 2003, J CLIN ONCOL, V21, P1746, DOI 10.1200/JCO.2003.09.027; Hainsworth JD, 2005, J CLIN ONCOL, V23, P1088, DOI 10.1200/JCO.2005.12.191; Hainsworth JD, 2002, J CLIN ONCOL, V20, P4261, DOI 10.1200/JCO.2002.08.674; Herold M, 2007, J CLIN ONCOL, V25, P1986, DOI 10.1200/JCO.2006.06.4618; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Hochster HS, 2005, BLOOD, V106, p106A; Horning SJ, 2005, J CLIN ONCOL, V23, P712, DOI 10.1200/JCO.2005.07.040; Horwitz SM, 2004, BLOOD, V103, P777, DOI 10.1182/blood-2003-04-1257; Howard OM, 2002, J CLIN ONCOL, V20, P1288, DOI 10.1200/JCO.20.5.1288; Huhn D, 2001, BLOOD, V98, P1326, DOI 10.1182/blood.V98.5.1326; Igarashi T, 2002, ANN ONCOL, V13, P928, DOI 10.1093/annonc/mdf155; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaminski MS, 2005, NEW ENGL J MED, V352, P441, DOI 10.1056/NEJMoa041511; Kaminski MS, 2000, BLOOD, V96, P1259, DOI 10.1182/blood.V96.4.1259.h8001259_1259_1266; Kaminski MS, 2001, J CLIN ONCOL, V19, P3918, DOI 10.1200/JCO.2001.19.19.3918; Keating MJ, 2005, J CLIN ONCOL, V23, P4079, DOI 10.1200/JCO.2005.12.051; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; Kim DH, 2006, BLOOD, V108, P2720, DOI 10.1182/blood-2006-01-009480; Kimby E, 1994, Ann Oncol, V5 Suppl 2, P67; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krishnan A, 2008, J CLIN ONCOL, V26, P90, DOI 10.1200/JCO.2007.11.9248; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Leonard JP, 2007, ANN ONCOL, V18, P1216, DOI 10.1093/annonc/mdm114; Leonard JP, 2005, J CLIN ONCOL, V23, P5044, DOI 10.1200/JCO.2005.13.821; Leonard JP, 2003, J CLIN ONCOL, V21, P3051, DOI 10.1200/JCO.2003.01.082; Leonard JP, 2004, CLIN CANCER RES, V10, P5327, DOI 10.1158/1078-0432.CCR-04-0294; Link BK, 2001, BLOOD, V98, p606A; Liu YY, 2007, BLOOD, V110, P339, DOI 10.1182/blood-2006-09-049189; Lundin J, 2002, BLOOD, V100, P768, DOI 10.1182/blood-2002-01-0159; Maloney DG, 1997, J CLIN ONCOL, V15, P3266, DOI 10.1200/JCO.1997.15.10.3266; MALONEY DG, 1994, BLOOD, V84, P2457; Maloney DG, 1997, BLOOD, V90, P2188; MARCUS RE, IN PRESS J CLIN ONCO; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; MEEKER TC, 1985, BLOOD, V65, P1349, DOI 10.1182/blood.V65.6.1349.bloodjournal6561349; Micallef INM, 2006, CANCER-AM CANCER SOC, V107, P2826, DOI 10.1002/cncr.22342; MILLER RA, 1982, NEW ENGL J MED, V306, P517, DOI 10.1056/NEJM198203043060906; MILLER RA, 1989, NEW ENGL J MED, V321, P851, DOI 10.1056/NEJM198909283211302; Morschhauser F, 2005, BLOOD, V106, p683A; Morschhauser F, 2007, BLOOD, V110, P54, DOI 10.1182/blood-2007-01-068056; Mounier N, 2003, BLOOD, V101, P4279, DOI 10.1182/blood-2002-11-3442; Nademanee A, 2005, BLOOD, V106, P2896, DOI 10.1182/blood-2005-03-1310; NADLER LM, 1981, J CLIN INVEST, V67, P134, DOI 10.1172/JCI110005; Nguyen DT, 1999, EUR J HAEMATOL, V62, P76, DOI 10.1111/j.1600-0609.1999.tb01725.x; Nyman H, 2007, BLOOD, V109, P4930, DOI 10.1182/blood-2006-09-047068; Pathan NI, 2008, BLOOD, V111, P1594, DOI 10.1182/blood-2007-03-082024; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Piro LD, 1999, ANN ONCOL, V10, P655, DOI 10.1023/A:1008389119525; Press OW, 2006, J CLIN ONCOL, V24, P4143, DOI 10.1200/JCO.2006.05.8198; Press OW, 2005, BLOOD, V106, p107A; Rai KR, 2001, BLOOD, V98, p365A; RANKIN EM, 1985, BLOOD, V65, P1373, DOI 10.1182/blood.V65.6.1373.bloodjournal6561373; Romaguera, 2006, J CLIN ONCOL, V24, P724, DOI 10.1200/JCO.2006.12.002; Romaguera JE, 2005, J CLIN ONCOL, V23, P7013, DOI 10.1200/JCO.2005.01.1825; Ruf P, 2001, BLOOD, V98, P2526, DOI 10.1182/blood.V98.8.2526; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Stein R, 2004, CLIN CANCER RES, V10, P2868, DOI 10.1158/1078-0432.CCR-03-0493; Stein R, 2006, BLOOD, V108, P2736, DOI 10.1182/blood-2006-04-017921; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Treon SP, 2001, J IMMUNOTHER, V24, P272, DOI 10.1097/00002371-200105000-00012; van Oers MHJ, 2006, BLOOD, V108, P3295, DOI 10.1182/blood-2006-05-021113; Vose JM, 2001, J CLIN ONCOL, V19, P389, DOI 10.1200/JCO.2001.19.2.389; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Winter, 2007, BLOOD, V109, P2292; Winter JN, 2006, BLOOD, V107, P4207, DOI 10.1182/blood-2005-10-4222; Wiseman GA, 2002, BLOOD, V99, P4336, DOI 10.1182/blood.V99.12.4336; Witzig TE, 2005, J CLIN ONCOL, V23, P1103, DOI 10.1200/JCO.2005.12.052; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; Witzig TE, 1999, J CLIN ONCOL, V17, P3793, DOI 10.1200/JCO.1999.17.12.3793; Witzig TE, 2002, J CLIN ONCOL, V20, P2453, DOI 10.1200/JCO.2002.11.076; Zhao XB, 2007, BLOOD, V110, P2569, DOI 10.1182/blood-2006-12-062927	117	315	383	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					613	626		10.1056/NEJMra0708875	http://dx.doi.org/10.1056/NEJMra0708875			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687642				2022-12-28	WOS:000258216700009
J	Belongia, EA; Shay, DK				Belongia, Edward A.; Shay, David K.			Influenza vaccine for community-acquired pneumonia	LANCET			English	Editorial Material							ETIOLOGY; ADULTS; INFECTION; OLDER		[Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Shay, David K.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Belongia, EA (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI 54449 USA.	belongia.edward@marshfieldclinic.org		Belongia, Edward/0000-0001-7478-0415; Shay, David/0000-0001-9619-4820				Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749; Crocetti E, 2001, EUR J EPIDEMIOL, V17, P163, DOI 10.1023/A:1017978420601; de Roux AD, 2004, CHEST, V125, P1343, DOI 10.1378/chest.125.4.1343; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; Flamaing J, 2003, EUR J CLIN MICROBIOL, V22, P720, DOI 10.1007/s10096-003-1042-z; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Kaye M, 2006, EPIDEMIOL INFECT, V134, P792, DOI 10.1017/S0950268805005364; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; van den Hoeven AM, 2007, INFECTION, V35, P65, DOI 10.1007/s15010-007-6112-1	14	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 2	2008	372	9636					352	354		10.1016/S0140-6736(08)61137-X	http://dx.doi.org/10.1016/S0140-6736(08)61137-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18675671				2022-12-28	WOS:000258196000007
J	Rodgers, H; Sudlow, M				Rodgers, Helen; Sudlow, Mark			Commentary: Controversies in NICE guidance on acute stroke and transient ischaemic attack	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rodgers, Helen; Sudlow, Mark] Univ Newcastle Upon Tyne, Sch Med, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Rodgers, Helen; Sudlow, Mark] N Tyneside Gen Hosp, N Shields NE29 8NH, England	Newcastle University - UK	Rodgers, H (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	helen.rodgers@newcastle.ac.uk	Rodgers, Helen/K-4358-2012					Department of Health, 2007, NAT STROK STRAT; *NAT I HLTH CLIN E, 2008, STROK DIAGN IN MAN A; *STROK UN TRIAL CO, 1995, COCHRANE DB SYST REV	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a833	10.1136/bmj.a833	http://dx.doi.org/10.1136/bmj.a833			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18653634				2022-12-28	WOS:000258561000034
J	Oberdoerffer, S; Moita, LF; Neems, D; Freitas, RP; Hacohen, N; Rao, A				Oberdoerffer, Shalini; Moita, Luis Ferreira; Neems, Daniel; Freitas, Rui P.; Hacohen, Nir; Rao, Anjana			Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL	SCIENCE			English	Article							PRE-MESSENGER-RNA; CELLS; ACTIVATION; BINDING; SYSTEM; EXPORT	The transition from naive to activated T cells is marked by alternative splicing of pre- mRNA encoding the transmembrane phosphatase CD45. Using a short hairpin RNA interference screen, we identified heterogeneous ribonucleoprotein L- like ( hnRNPLL) as a critical inducible regulator of CD45 alternative splicing. HnRNPLL was up- regulated in stimulated T cells, bound CD45 transcripts, and was both necessary and sufficient for CD45 alternative splicing. Depletion or overexpression of hnRNPLL in B and T cell lines and primary T cells resulted in reciprocal alteration of CD45RA and RO expression. Exon array analysis suggested that hnRNPLL acts as a global regulator of alternative splicing in activated T cells. Induction of hnRNPLL during hematopoietic cell activation and differentiation may allow cells to rapidly shift their transcriptomes to favor proliferation and inhibit cell death.	[Oberdoerffer, Shalini; Neems, Daniel; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Moita, Luis Ferreira; Freitas, Rui P.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02129 USA; [Hacohen, Nir] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA.	arao@idi.harvard.edu	Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013	Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X	NCI NIH HHS [R01 CA042471, CA42471, R01 CA042471-23] Funding Source: Medline; NHLBI NIH HHS [T32 HL066987] Funding Source: Medline; NIAID NIH HHS [AI44432, R01 AI040127-19, U19 AI070352, R01 AI044432-09, R21 AI071060-01, R01 AI044432, R21 AI071060, R21 AI071060-02, AI40127, R01 AI040127-18, R01 AI080875, R01 AI080875-01, R01 AI040127, R01 AI044432-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471, R37CA042471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080875, R01AI044432, R01AI040127, R21AI071060, U19AI070352] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Holmes N, 2006, IMMUNOLOGY, V117, P145, DOI 10.1111/j.1365-2567.2005.02265.x; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Salmond RJ, 2008, INT IMMUNOL, V20, P819, DOI 10.1093/intimm/dxn040; Shur I, 2004, GENE, V334, P113, DOI 10.1016/j.gene.2004.03.012; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105	19	143	148	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					686	691		10.1126/science.1157610	http://dx.doi.org/10.1126/science.1157610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669861	Green Accepted			2022-12-28	WOS:000258077700043
J	Hyde, JS; Lindberg, SM; Linn, MC; Ellis, AB; Williams, CC				Hyde, Janet S.; Lindberg, Sara M.; Linn, Marcia C.; Ellis, Amy B.; Williams, Caroline C.			Diversity - Gender similarities characterize math performance	SCIENCE			English	Editorial Material							SEX-DIFFERENCES; ACHIEVEMENT; MATHEMATICS; WOMEN		[Hyde, Janet S.; Lindberg, Sara M.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Linn, Marcia C.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ellis, Amy B.; Williams, Caroline C.] Univ Wisconsin, Dept Curriculum & Instruct, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison	Hyde, JS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	jshyde@wisc.edu	Ellis, Amy/HHS-6792-2022	Lindberg, Sara/0000-0002-0040-8386				Au W., 2007, ED RES, V36, P258, DOI [DOI 10.3102/0013189X07306523, 10.3102/0013189x07306523]; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Frome PM, 1998, J PERS SOC PSYCHOL, V74, P435, DOI 10.1037/0022-3514.74.2.435; Furnham A, 2002, J GENET PSYCHOL, V163, P24, DOI 10.1080/00221320209597966; Halpern CT, 2007, PREV SCI, V8, P1, DOI 10.1007/s11121-006-0046-1; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; HEDGES LV, 1993, REV EDUC RES, V63, P94, DOI 10.3102/00346543063001094; HYDE JS, 1990, PSYCHOL BULL, V107, P139, DOI 10.1037/0033-2909.107.2.139; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Li Q, 1999, EDUC RES, V41, P63, DOI 10.1080/0013188990410106; MEECE JL, 1982, PSYCHOL BULL, V91, P324, DOI 10.1037/0033-2909.91.2.324; National Academy of Sciences National Academy of Engineering Institute of Medicine of the National Academies, 2006, BIAS BARR FULF POT W; *NSF, 2006, SCI ENG IND 2006; Roth K, 2006, EDUC LEADERSHIP, V64, P16; SHIELDS SA, 1975, AM PSYCHOL, V30, P739, DOI 10.1037/h0076948; Webb NL, 2007, APPL MEAS EDUC, V20, P7, DOI 10.1207/s15324818ame2001_2	16	509	517	1	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					494	495		10.1126/science.1160364	http://dx.doi.org/10.1126/science.1160364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	329RS	18653867				2022-12-28	WOS:000257888900024
J	Warner, J; Nomani, E				Warner, James; Nomani, Erum			Giving consent in dementia research	LANCET			English	Editorial Material							ALZHEIMERS-DISEASE; PARTICIPATION		[Warner, James; Nomani, Erum] St Charles Hosp, London W10 6DZ, England	Imperial College London	Warner, J (corresponding author), St Charles Hosp, London W10 6DZ, England.	j.warner@imperial.ac.uk						Brodaty H, 1999, ALZ DIS ASSOC DIS, V13, P71, DOI 10.1097/00002093-199904000-00003; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT; JEFFERSON AL, 2008, J AM GERIATR SO 0512; Karlawish J, 2008, AM J GERIAT PSYCHIAT, V16, P568, DOI 10.1097/JGP.0b013e318172b406; Karlawish J, 2008, AM J GERIAT PSYCHIAT, V16, P240, DOI 10.1097/JGP.0b013e318162992d; LANDHUIS E, 2008, AD RES PARTICIPATI 1; Lowin A, 2001, INT J GERIATR PSYCH, V16, P1143, DOI 10.1002/gps.499; Medical Research Council, 2007, MRC ETH GUID MED RES; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Warner J, 2008, J MED ETHICS, V34, P167, DOI 10.1136/jme.2006.019786	10	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					183	185		10.1016/S0140-6736(08)61049-1	http://dx.doi.org/10.1016/S0140-6736(08)61049-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	327YH	18640439				2022-12-28	WOS:000257763900007
J	Bass, AH; Gilland, EH; Baker, R				Bass, Andrew H.; Gilland, Edwin H.; Baker, Robert			Evolutionary origins for social vocalization in a vertebrate hindbrain-spinal compartment	SCIENCE			English	Article							TELEOST FISH; VOCAL CONTROL; MUSCLES; NEURONS; MOTOR; NUCLEUS; NERVE; MORPHOGENESIS; NEUROANATOMY; PATHWAYS	The macroevolutionary events leading to neural innovations for social communication, such as vocalization, are essentially unexplored. Many fish vocalize during female courtship and territorial defense, as do amphibians, birds, and mammals. Here, we map the neural circuitry for vocalization in larval fish and show that the vocal network develops in a segment-like region across the most caudal hindbrain and rostral spinal cord. Taxonomic analysis demonstrates a highly conserved pattern between fish and all major lineages of vocal tetrapods. We propose that the vocal basis for acoustic communication among vertebrates evolved from an ancestrally shared developmental compartment already present in the early fishes.	[Bass, Andrew H.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Gilland, Edwin H.] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; [Baker, Robert] NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA; [Bass, Andrew H.; Gilland, Edwin H.; Baker, Robert] Marine Biol Lab, Woods Hole, MA 02543 USA; [Bass, Andrew H.] Univ Calif Bodega, Marine Lab, Bodega Bay, CA 94923 USA	Cornell University; Howard University; New York University; Marine Biological Laboratory - Woods Hole	Bass, AH (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	ahb3@cornell.edu		Baker, Robert/0000-0001-7920-1769; Gilland, Edwin/0000-0002-9426-1919	NIDCD NIH HHS [R01 DC000092, R01 DC000092-33] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000092] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; BASS AH, 1990, J NEUROBIOL, V21, P1155, DOI 10.1002/neu.480210802; BASS AH, 1994, J NEUROSCI, V14, P4025; Bass AH, 1997, BRAIN BEHAV EVOLUT, V50, P3, DOI 10.1159/000113351; Cambronero F, 2000, J COMP NEUROL, V427, P522, DOI 10.1002/1096-9861(20001127)427:4<522::AID-CNE3>3.0.CO;2-Y; Darwin C., 1981, DESCENT MAN SELECTIO; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Huang RJ, 1999, ANAT EMBRYOL, V200, P137, DOI 10.1007/s004290050268; Jurgens U, 2007, BRAIN RES, V1148, P90, DOI 10.1016/j.brainres.2007.02.020; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; KENNEDY MC, 1981, BRAIN RES, V218, P337, DOI 10.1016/0006-8993(81)91311-1; KITAMURA S, 1987, EXP NEUROL, V97, P592, DOI 10.1016/0014-4886(87)90116-6; Knapp R, 1999, J NEUROBIOL, V38, P475, DOI 10.1002/(SICI)1097-4695(199903)38:4<475::AID-NEU4>3.0.CO;2-7; Kubke MF, 2005, J NEUROPHYSIOL, V94, P2379, DOI 10.1152/jn.00257.2005; MOORE BA, 1991, J MORPHOL, V210, P227, DOI 10.1002/jmor.1052100303; MORITA Y, 1987, J COMP NEUROL, V264, P231, DOI 10.1002/cne.902640208; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; RUBSAMEN R, 1986, J COMP PHYSIOL A, V159, P689, DOI 10.1007/BF00612041; Straka H, 2006, J COMP NEUROL, V494, P228, DOI 10.1002/cne.20801; TRACY HC, 1959, J COMP NEUROL, V111, P27, DOI 10.1002/cne.901110103; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; White SA, 2006, J NEUROSCI, V26, P10376, DOI 10.1523/JNEUROSCI.3379-06.2006; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Zornik E, 2007, J COMP NEUROL, V501, P303, DOI 10.1002/cne.21145	29	126	127	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					417	421		10.1126/science.1157632	http://dx.doi.org/10.1126/science.1157632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635807	Green Accepted			2022-12-28	WOS:000257713900054
J	Shiraki, K; Sakurai, H				Shiraki, Katsuya; Sakurai, Hiroyuki			Sclerosing peritonitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shiraki, Katsuya; Sakurai, Hiroyuki] Mie Univ, Sch Med, Tsu, Mie 5148507, Japan	Mie University	Shiraki, K (corresponding author), Mie Univ, Sch Med, Tsu, Mie 5148507, Japan.	katsuyas@clin.medic.mie-u.ac.jp							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					293	293		10.1056/NEJMicm072475	http://dx.doi.org/10.1056/NEJMicm072475			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326KD	18635434				2022-12-28	WOS:000257656600009
J	Mazzali, PA; Valenti, S; Della Valle, M; Chincarini, G; Sauer, DN; Benetti, S; Pian, E; Piran, T; D'Elia, V; Elias-Rosa, N; Margutti, R; Pasotti, F; Antonelli, LA; Bufano, F; Campana, S; Cappellaro, E; Covino, S; D'Avanzo, P; Fiore, F; Fugazza, D; Gilmozzi, R; Hunter, D; Maguire, K; Maiorano, E; Marziani, P; Masetti, N; Mirabel, F; Navasardyan, H; Nomoto, K; Palazzi, E; Pastorello, A; Panagia, N; Pellizza, LJ; Sari, R; Smartt, S; Tagliaferri, G; Tanaka, M; Taubenberger, S; Tominaga, N; Trundle, C; Turatto, M				Mazzali, Paolo A.; Valenti, Stefano; Della Valle, Massimo; Chincarini, Guido; Sauer, Daniel N.; Benetti, Stefano; Pian, Elena; Piran, Tsvi; D'Elia, Valerio; Elias-Rosa, Nancy; Margutti, Raffaella; Pasotti, Francesco; Antonelli, L. Angelo; Bufano, Filomena; Campana, Sergio; Cappellaro, Enrico; Covino, Stefano; D'Avanzo, Paolo; Fiore, Fabrizio; Fugazza, Dino; Gilmozzi, Roberto; Hunter, Deborah; Maguire, Kate; Maiorano, Elisabetta; Marziani, Paola; Masetti, Nicola; Mirabel, Felix; Navasardyan, Hripsime; Nomoto, Ken'ichi; Palazzi, Eliana; Pastorello, Andrea; Panagia, Nino; Pellizza, L. J.; Sari, Re'em; Smartt, Stephen; Tagliaferri, Gianpiero; Tanaka, Masaomi; Taubenberger, Stefan; Tominaga, Nozomu; Trundle, Carrie; Turatto, Massimo			The metamorphosis of supernova SN 2008D/XRF 080109: A link between supernovae and GRBs/hypernovae	SCIENCE			English	Article							GAMMA-RAY BURSTS; LIGHT CURVES; MODEL; IA; EXPLOSIONS	The only supernovae (SNe) to show gamma-ray bursts ( GRBs) or early x-ray emission thus far are overenergetic, broad- lined type Ic SNe ( hypernovae, HNe). Recently, SN 2008D has shown several unusual features: (i) weak x-ray flash (XRF), (ii) an early, narrow optical peak, (iii) disappearance of the broad lines typical of SN Ic HNe, and (iv) development of helium lines as in SNe Ib. Detailed analysis shows that SN 2008D was not a normal supernova: Its explosion energy (E approximate to 6 x 10(51) erg) and ejected mass [similar to 7 times the mass of the Sun ( M.)] are intermediate between normal SNe Ibc and HNe. We conclude that SN 2008D was originally a similar to 30 M. star. When it collapsed, a black hole formed and a weak, mildly relativistic jet was produced, which caused the XRF. SN 2008D is probably among the weakest explosions that produce relativistic jets. Inner engine activity appears to be present whenever massive stars collapse to black holes.	[Mazzali, Paolo A.; Sauer, Daniel N.; Elias-Rosa, Nancy; Taubenberger, Stefan] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Mazzali, Paolo A.; Benetti, Stefano; Bufano, Filomena; Cappellaro, Enrico; Marziani, Paola; Navasardyan, Hripsime] OAPd, Ist Nazl Astrofis, I-35122 Padua, Italy; [Mazzali, Paolo A.; Nomoto, Ken'ichi; Tanaka, Masaomi; Tominaga, Nozomu] Univ Tokyo, Dept Astron, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Mazzali, Paolo A.; Nomoto, Ken'ichi] Univ Tokyo, Res Ctr Early Universe, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Valenti, Stefano; Hunter, Deborah; Maguire, Kate; Pastorello, Andrea; Smartt, Stephen; Trundle, Carrie] Queens Univ Belfast, Astrophys Res Ctr, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; [Valenti, Stefano] Univ Ferrara, Dipartimento Fis, I-44100 Ferrara, Italy; [Della Valle, Massimo] Osserv Astron Capodimonte, Ist Nazl Astrofis, I-80131 Naples, Italy; [Della Valle, Massimo; Gilmozzi, Roberto] European So Observ, D-85748 Garching, Germany; [Della Valle, Massimo] Int Ctr Relativist Astrophys Network, I-65122 Pescara, Italy; [Chincarini, Guido; Margutti, Raffaella; Pasotti, Francesco] Univ Milano Bicocca, Dept Phys, I-20126 Milan, Italy; [Chincarini, Guido; Campana, Sergio; Covino, Stefano; D'Avanzo, Paolo; Fugazza, Dino; Tagliaferri, Gianpiero] Brera Astron Observ, Ist Nazl Astrofis, I-23807 Merate, LC, Italy; [Pian, Elena] Osserv Astron Trieste, Ist Nazl Astrofis, I-34131 Trieste, Italy; [Piran, Tsvi; Sari, Re'em] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [D'Elia, Valerio; Antonelli, L. Angelo; Fiore, Fabrizio] Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Monte Porzio Catone, Italy; [Maiorano, Elisabetta; Masetti, Nicola; Palazzi, Eliana] Ist Astrofis Spaziale & Fis Cosmica, Ist Nazl Astrofis, I-40129 Bologna, Italy; [Mirabel, Felix] European So Observ, Santiago 3107, Chile; [Nomoto, Ken'ichi] Univ Tokyo, Inst Phys & Math Universe, Chiba 2778582, Japan; [Panagia, Nino] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Panagia, Nino; Turatto, Massimo] Osserv Astrofis Catania, Ist Nazl Astrofis, I-95123 Catania, Italy; [Pellizza, L. J.] Inst Astron & Fis Espacio, RA-1428 Buenos Aires, DF, Argentina	Max Planck Society; University of Padua; University of Tokyo; University of Tokyo; Queens University Belfast; University of Ferrara; Istituto Nazionale Astrofisica (INAF); European Southern Observatory; University of Milano-Bicocca; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Hebrew University of Jerusalem; Istituto Nazionale Astrofisica (INAF); European Southern Observatory; University of Tokyo; Space Telescope Science Institute; Istituto Nazionale Astrofisica (INAF); Instituto de Astronomia y Fisica del Espacio (IAFE)	Mazzali, PA (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85748 Garching, Germany.	mazzali@mpa-garching.mpg.de	Maguire, Kate/HHN-6122-2022; Palazzi, Eliana/N-4746-2015; Sauer, Daniel N/A-3033-2012; Tagliaferri, Gianpiero/ABD-7556-2021; Elias-Rosa, Nancy/D-3759-2014; Tanaka, Masaomi/A-4354-2011; Campana, Sergio/AAL-6012-2020; Della Valle, Massimo/AAE-8884-2021; Valenti, Stefano/M-5924-2017; Covino, Stefano/AAQ-5188-2021	Maguire, Kate/0000-0002-9770-3508; Sauer, Daniel N/0000-0002-0317-5063; Tagliaferri, Gianpiero/0000-0003-0121-0723; Elias-Rosa, Nancy/0000-0002-1381-9125; Campana, Sergio/0000-0001-6278-1576; Della Valle, Massimo/0000-0003-3142-5020; Valenti, Stefano/0000-0001-8818-0795; Covino, Stefano/0000-0001-9078-5507; Cappellaro, Enrico/0000-0001-5008-8619; Benetti, Stefano/0000-0002-3256-0016; Pian, Elena/0000-0001-8646-4858; Masetti, Nicola/0000-0001-9487-7740; Palazzi, Eliana/0000-0002-8691-7666; Maiorano, Elisabetta/0000-0003-2593-4355; Marziani, Paola/0000-0002-6058-4912; Fiore, Fabrizio/0000-0002-4031-4157; BUFANO, Filomena/0000-0002-3429-2481; Turatto, Massimo/0000-0002-9719-3157; D'Elia, Valerio/0000-0002-7320-5862; Mazzali, Paolo/0000-0001-6876-8284; Pellizza, Leonardo J./0000-0001-7436-6046; Tominaga, Nozomu/0000-0001-8537-3153; Antonelli, Lucio Angelo/0000-0002-5037-9034; D'Avanzo, Paolo/0000-0001-7164-1508; Fugazza, Dino Pierluigi/0000-0001-9942-277X	STFC [PP/C506805/1, PP/D508212/1, ST/G000921/1, PP/E003303/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G000921/1, PP/C506805/1, PP/E003303/1, PP/D508212/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; BERGER E, 2008, 7159 GCN; Bucciantini N, 2008, MON NOT R ASTRON SOC, V383, pL25, DOI 10.1111/j.1745-3933.2007.00403.x; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; Cappellaro E, 1999, ASTRON ASTROPHYS, V351, P459; Cappellaro E, 1997, ASTRON ASTROPHYS, V328, P203; CIOCCHIATTI A, 1997, ASTROPHYS J, V491, P375; DENG J, 2008, 7160 GCN; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Iwamoto K, 1998, NATURE, V395, P672, DOI 10.1038/27155; LUCY LB, 1991, ASTROPHYS J, V383, P308, DOI 10.1086/170787; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Maeda K, 2003, ASTROPHYS J, V593, P931, DOI 10.1086/376591; Maeda K, 2008, SCIENCE, V319, P1220, DOI 10.1126/science.1149437; Maeda K, 2006, ASTROPHYS J, V645, P1331, DOI 10.1086/504581; Mazzali PA, 2005, SCIENCE, V308, P1284, DOI 10.1126/science.1111384; Mazzali PA, 2002, ASTROPHYS J, V572, pL61, DOI 10.1086/341504; Mazzali PA, 2000, ASTROPHYS J, V545, P407, DOI 10.1086/317808; Mazzali PA, 1998, MON NOT R ASTRON SOC, V295, P428, DOI 10.1046/j.1365-8711.1998.01323.x; Mazzali PA, 2006, NATURE, V442, P1018, DOI 10.1038/nature05081; Mazzali PA, 2006, ASTROPHYS J, V645, P1323, DOI 10.1086/504415; MODJAZ M, 2008, 7212 GCN; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; Sauer DN, 2006, MON NOT R ASTRON SOC, V369, P1939, DOI 10.1111/j.1365-2966.2006.10438.x; Soderberg AM, 2008, NATURE, V453, P469, DOI 10.1038/nature06997; Stritzinger M, 2002, ASTRON J, V124, P2100, DOI 10.1086/342544; Tominaga N, 2005, ASTROPHYS J, V633, pL97, DOI 10.1086/498570; VALENTI S, 2008, 7171 GCN	30	173	174	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1185	1188		10.1126/science.1158088	http://dx.doi.org/10.1126/science.1158088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18653846	Green Published, Green Submitted			2022-12-28	WOS:000258754400037
J	Davis, PM; Lewenstein, BV; Simon, DH; Booth, JG; Connolly, MJL				Davis, Philip M.; Lewenstein, Bruce V.; Simon, Daniel H.; Booth, James G.; Connolly, Mathew J. L.			Open access publishing, article downloads, and citations: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							USAGE STATISTICS; IMPACT; SCIENCE; ADVANTAGE	Objective To measure the effect of free access to the scientific literature on article downloads and citations. Design Randomised controlled trial. Setting 11 journals published by the American Physiological Society. Participants 1619 research articles and reviews. Main outcome measures Article readership (measured as downloads of full text, PDFs, and abstracts) and number of unique visitors (internet protocol addresses). Citations to articles were gathered from the Institute for Scientific Information after one year. Interventions Random assignment on online publication of articles published in 11 scientific journals to open access (treatment) or subscription access (control). Results Articles assigned to open access were associated with 89% more full text downloads (95% confidence interval 76% to 103%), 42% more PDF downloads (32% to 52%), and 23% more unique visitors (16% to 30%), but 24% fewer abstract downloads (-29% to -19%) than subscription access articles in the first six months after publication. Open access articles were no more likely to be cited than subscription access articles in the first year after publication. Fifty nine percent of open access articles (146 of 247) were cited nine to 12 months after publication compared with 63% (859 of 1372) of subscription access articles. Logistic and negative binomial regression analysis of article citation counts confirmed no citation advantage for open access articles. Conclusions Open access publishing may reach more readers than subscription access publishing. No evidence was found of a citation advantage for open access articles in the first year after publication. The citation advantage from open access reported widely in the literature may be an artefact of other causes.	[Davis, Philip M.; Lewenstein, Bruce V.] Cornell Univ, Dept Commun, Ithaca, NY 14853 USA; [Simon, Daniel H.] Cornell Univ, Dept Appl Econ & Management, Ithaca, NY 14853 USA; [Booth, James G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Connolly, Mathew J. L.] Cornell Univ Lib, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Davis, PM (corresponding author), Cornell Univ, Dept Commun, Ithaca, NY 14853 USA.	pmd8@cornell.edu	Davis, Philip M/A-5693-2009; Lewenstein, Bruce V/U-3854-2017	Davis, Philip M/0000-0002-1893-5360; Lewenstein, Bruce V/0000-0002-1272-372X	Andrew W Mellon Foundation	Andrew W Mellon Foundation	Grant from the Andrew W Mellon Foundation.	Antelman K, 2004, COLL RES LIBR, V65, P372, DOI 10.5860/crl.65.5.372; Aronson JK, 2005, BMJ-BRIT MED J, V330, P759, DOI 10.1136/bmj.330.7494.759; Bergstrom T. C., 2007, OFTEN EC SELF ARCH; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; Clarke T, 2003, NATURE, V423, P373, DOI 10.1038/423373a; Cole J. R., 1973, SOCIAL STRATIFICATIO; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Crane D., 1972, INVISIBLE COLL DIFFU; Cronin B., 1984, CITATION PROCESS ROL; Davis PM, 2007, SCIENTOMETRICS, V71, P203, DOI 10.1007/s11192-007-1661 -8; Davis PM, 2006, J AM SOC INF SCI TEC, V57, P1243, DOI 10.1002/asi.20405; Davis PM, 2004, PORTAL-LIBR ACAD, V4, P379, DOI 10.1353/pla.2004.0046; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Hagstrom W., 1965, SCI COMMUNITY; HARNAD S., 2004, D LIB MAGAZINE VIRGI, V10, DOI [10.1045/june2004-harnad, DOI 10.1045/JUNE2004-HARNAD]; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; KAPLAN N, 1965, AM DOC, V16, P179, DOI 10.1002/asi.5090160305; Kurtz M., 2007, ASTROPHYS J, P1, DOI [10.48550/arXiv.0709.0896, DOI 10.48550/ARXIV.0709.0896]; Kurtz MJ, 2005, INFORM PROCESS MANAG, V41, P1395, DOI 10.1016/j.ipm.2005.03.010; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Metcalfe, 2005, B AM ASTRON SOC, V37, P555; Metcalfe TS, 2006, SOL PHYS, V239, P549, DOI 10.1007/s11207-006-0262-7; Moed HF, 2007, J AM SOC INF SCI TEC, V58, P2047, DOI 10.1002/asi.20663; Moed HF, 2005, J AM SOC INF SCI TEC, V56, P1088, DOI 10.1002/asi.20200; Perneger TV, 2004, BRIT MED J, V329, P546, DOI 10.1136/bmj.329.7465.546; PRICE DJD, 1986, LITTLE SCI BIG SCI, P119; PRICE DJS, 1986, LITTLE SCI BIG SCI, V119, P34; Schwarz Greg J., 2004, B AM ASTRONOMICAL SO, V36, P1654; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Simkin MV, 2007, J AM SOC INF SCI TEC, V58, P1661, DOI 10.1002/asi.20653; Simkin MV, 2005, SCIENTOMETRICS, V62, P367, DOI 10.1007/s11192-005-0028-2; WREN JD, 2005, BRIT MED J, V330, P1097	34	240	242	3	82	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a568	10.1136/bmj.a568	http://dx.doi.org/10.1136/bmj.a568			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EO	18669565	Green Published, hybrid			2022-12-28	WOS:000258561100034
J	Kinnersley, P; Edwards, A; Hood, K; Ryan, R; Prout, H; Cadbury, N; MacBeth, F; Butow, P; Butler, C				Kinnersley, Paul; Edwards, Adrian; Hood, Kerry; Ryan, Rebecca; Prout, Hayley; Cadbury, Naomi; MacBeth, Fergus; Butow, Phyllis; Butler, Christopher			Interventions before consultations to help patients address their information needs by encouraging question asking: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; SHARED DECISION-MAKING; TITER MEASLES-VACCINE; FEMALE-MALE MORTALITY; DIPHTHERIA-TETANUS-PERTUSSIS; COMMUNICATION-SKILLS; EDMONSTON-ZAGREB; CANCER CONSULTATION; GUINEA-BISSAU; PATIENTS PARTICIPATION	Objective To assess the effects on patients, clinicians, and the healthcare system of interventions before consultations to help patients or their representatives gather information in consultations by question asking. Design Systematic review with meta-analysis. Data sources Electronic literature searches of seven databases and hand searching of one journal and bibliographies of relevant articles. Review methods Inclusion criteria included randomised controlled trials. Main outcome measures Primary outcomes were question asking; patients' anxiety, knowledge, and satisfaction; and length of consultation. Results 33 randomised trials of variable quality involving 8244 patients were identified. A few studies showed positive effects. Meta-analyses showed small and statistically significant increases in question asking (standardised mean difference 0.27, 95% confidence interval 0.19 to 0.36) and patients' satisfaction (0.09, 0.03 to 0.16). Non-statistically significant changes occurred in patients' anxiety before consultations (weighted mean difference -1.56, -7.10 to 3.97), patients' anxiety after consultations (standardised mean difference -0.08, -0.22 to 0.06), patients' knowledge (-0.34, -0.94 to 0.25), and length of consultation (0.10, -0.05 to 0.25). Interventions comprising written materials had similar effects on question asking, consultation length, and patients' satisfaction as those comprising the coaching of patients. Interventions with additional training of clinicians had little further effect than those targeted at patients alone for patients' satisfaction and consultation length. Conclusions Interventions for patients before consultations produce small benefits for patients. This may be because patients and clinicians have established behaviours in consultations that are difficult to change. Alternatively small increases in question asking may not be sufficient to make notable changes to other outcomes.	[Kinnersley, Paul; Edwards, Adrian; Hood, Kerry; Prout, Hayley; Cadbury, Naomi; Butler, Christopher] Cardiff Univ, Sch Med, Neuadd Meirionydd, Cardiff CF14 4XN, Wales; [Ryan, Rebecca] La Trobe Univ, Australian Inst Primary Care, Cochrane Consumers & Commun Review Grp, Bundoora, Vic 3086, Australia; [MacBeth, Fergus] Llandough Hosp, Clin Effectiveness Support Unit Wales Roseway, Penarth, S Glam, Wales; [Butow, Phyllis] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Cardiff University; La Trobe University; University of Sydney	Kinnersley, P (corresponding author), Cardiff Univ, Sch Med, Neuadd Meirionydd, Cardiff CF14 4XN, Wales.	kinnersley@cf.ac.uk	Butler, Christopher C/B-5048-2009; Hood, Kerenza/C-2528-2008	Hood, Kerenza/0000-0002-5268-8631				AABY P, 1986, J PEDIATR-US, V109, P40, DOI 10.1016/S0022-3476(86)80569-8; Aaby P, 2006, VACCINE, V24, P2764, DOI 10.1016/j.vaccine.2006.01.004; Aaby P, 2004, VACCINE, V22, P3014, DOI 10.1016/j.vaccine.2004.02.009; AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, PEDIATR INFECT DIS J, V22, P798, DOI 10.1097/01.inf.0000083821.33187.b5; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 1998, LANCET, V352, P1229, DOI 10.1016/S0140-6736(05)60575-2; AABY P, 1984, J INFECTION, V8, P13, DOI 10.1016/S0163-4453(84)93192-X; AABY P, 1997, PROSPECTIVE COMMUNIT, P276; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Aaby P, 2006, VACCINE, V24, P4701, DOI 10.1016/j.vaccine.2006.03.038; ANDERSON LA, 1991, PATIENT EDUC COUNS, V17, P99, DOI 10.1016/0738-3991(91)90014-V; [Anonymous], 1977, Bull World Health Organ, V55, P21; BEISECKER AE, 1990, MED CARE, V28, P19, DOI 10.1097/00005650-199001000-00004; Boberg EW, 2003, PATIENT EDUC COUNS, V49, P233, DOI 10.1016/S0738-3991(02)00183-0; Bolman C, 2005, PATIENT EDUC COUNS, V56, P240, DOI 10.1016/j.pec.2004.02.018; BOREHAM P, 1978, SOC SCI MED-MED SOC, V12, P409; Brown R, 1999, BRIT J CANCER, V80, P242, DOI 10.1038/sj.bjc.6690346; Brown RF, 2001, BRIT J CANCER, V85, P1273, DOI 10.1054/bjoc.2001.2073; Bruera E, 2003, J PAIN SYMPTOM MANAG, V25, P412, DOI 10.1016/S0885-3924(02)00686-3; Butow P, 2004, J CLIN ONCOL, V22, P4401, DOI 10.1200/JCO.2004.66.155; BUTOW PN, 1994, ANN ONCOL, V5, P199, DOI 10.1093/oxfordjournals.annonc.a058793; Cegala DJ, 2000, PATIENT EDUC COUNS, V41, P209, DOI 10.1016/S0738-3991(00)00093-8; Cegala DJ, 2003, PATIENT EDUC COUNS, V50, P91, DOI 10.1016/S0738-3991(03)00087-9; Cegala DJ, 2000, ARCH FAM MED, V9, P57, DOI 10.1001/archfami.9.1.57; CISSE B, 2001, THESIS LONDON SCH HY; Clarke M, 2003, COCHRANE REV HDB 4 2; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Davison BJ, 1997, CANCER NURS, V20, P187, DOI 10.1097/00002820-199706000-00004; Davison BJ, 2002, CANCER NURS, V25, P417, DOI 10.1097/00002820-200212000-00001; de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; DULOU AD, 1995, AM J EPIDEMIOL, V142, P643, DOI 10.1093/oxfordjournals.aje.a117688; Edwards A, 2008, PATIENT EDUC COUNS, V71, P4, DOI 10.1016/j.pec.2007.11.026; Edwards A, 2006, HEALTH EXPECT, V9, P307, DOI 10.1111/j.1369-7625.2006.00401.x; EGBERT LD, 1964, NEW ENGL J MED, V270, P825, DOI 10.1056/NEJM196404162701606; Elwyn G, 1999, BRIT J GEN PRACT, V49, P477; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; *EXP PROGR IMM, 1992, WKLY EPIDEMIOL REC, V67, P357; FADEN RR, 1981, MED CARE, V19, P718, DOI 10.1097/00005650-198107000-00003; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; FALLOWFIELD LJ, 1994, BRIT MED J, V309, P448, DOI 10.1136/bmj.309.6952.448; FINNEY JW, 1990, J APPL BEHAV ANAL, V23, P207, DOI 10.1901/jaba.1990.23-207; Fleissig A, 2000, BRIT MED J, V321, P632, DOI 10.1136/bmj.321.7261.632; Fleissig A, 1999, PATIENT EDUC COUNS, V38, P69, DOI 10.1016/S0738-3991(98)00124-4; Ford S, 1995, EUR J CANCER, V31A, P2264, DOI 10.1016/0959-8049(95)00336-3; FREDERIKSON LG, 1995, PATIENT EDUC COUNS, V25, P51, DOI 10.1016/0738-3991(94)00696-J; Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527; Garly ML, 1999, INT J EPIDEMIOL, V28, P347, DOI 10.1093/ije/28.2.347; Garly ML, 2001, VACCINE, V19, P1951, DOI 10.1016/S0264-410X(00)00431-X; Gaston CM, 2005, SOC SCI MED, V61, P2252, DOI 10.1016/j.socscimed.2005.04.015; Grais RF, 2006, EPIDEMIOL INFECT, V134, P845, DOI 10.1017/S0950268805005716; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; HALL AJ, 1990, INT J EPIDEMIOL, V19, P777, DOI 10.1093/ije/19.4.777; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; Harrington J, 2004, PATIENT EDUC COUNS, V52, P7, DOI 10.1016/S0738-3991(03)00017-X; Hornberger J, 1997, J GEN INTERN MED, V12, P597, DOI 10.1046/j.1525-1497.1997.07119.x; HOSKINS EW, 1993, THESIS U OXFORD; JADAD AR, 1995, BRIT MED J, V311, P746, DOI 10.1136/bmj.311.7007.746a; Jefford M, 2002, LANCET ONCOL, V3, P629, DOI 10.1016/S1470-2045(02)00877-X; Jenkins V, 2001, BRIT J CANCER, V84, P48, DOI 10.1054/bjoc.2000.1573; Jenkins V, 2002, J CLIN ONCOL, V20, P765, DOI 10.1200/JCO.20.3.765; JENSEN TG, 1994, VACCINE, V12, P1026, DOI 10.1016/0264-410X(94)90340-9; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kidd J, 2004, PATIENT EDUC COUNS, V52, P107, DOI 10.1016/S0738-3991(03)00018-1; Kim YM, 2003, PATIENT EDUC COUNS, V50, P113; KINDELAN K, 1987, PSYCHOL HEALTH, V1, P399; Kinnersley P, 1999, BRIT J GEN PRACT, V49, P711; Kinnersley P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004565.pub2; Kivits J, 2006, J HEALTH PSYCHOL, V11, P269, DOI 10.1177/1359105306061186; KORSCH BM, 1968, PEDIATRICS, V42, P855; Kramer AWM, 2004, MED EDUC, V38, P158, DOI 10.1111/j.1365-2923.2004.01747.x; Krupat E, 2000, PATIENT EDUC COUNS, V39, P49, DOI 10.1016/S0738-3991(99)00090-7; Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; LEWIS CC, 1991, PEDIATRICS, V88, P351; Leydon GM, 2000, WESTERN J MED, V173, P26, DOI 10.1136/ewjm.173.1.26; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Little P, 2004, BMJ-BRIT MED J, V328, P441, DOI 10.1136/bmj.37999.716157.44; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maguire P, 1996, EUR J CANCER, V32A, P1486, DOI 10.1016/0959-8049(96)00059-7; MAGUIRE P, 1986, BRIT MED J, V292, P1573, DOI 10.1136/bmj.292.6535.1573; MAKOUL G, 1995, SOC SCI MED, V41, P1241, DOI 10.1016/0277-9536(95)00061-B; Maly RC, 1999, J FAM PRACTICE, V48, P356; MARKOWITZ LE, 1990, NEW ENGL J MED, V322, P580, DOI 10.1056/NEJM199003013220903; Martinali J, 2001, PATIENT EDUC COUNS, V42, P231, DOI 10.1016/S0738-3991(00)00126-9; MARTINS CL, 2002, OSVALDO CRUZ; McCann S, 1996, PATIENT EDUC COUNS, V27, P227, DOI 10.1016/0738-3991(95)00830-6; McCann S, 1996, PSYCHOL HEALTH, V11, P857, DOI 10.1080/08870449608400281; Mckenzie J, 2000, BRIT MED J, V321, P632; Middleton JF, 2006, BMJ-BRIT MED J, V332, P1238, DOI 10.1136/bmj.38841.444861.7C; Neighbour R, 2004, INNER CONSULTATION, V2nd; Oliver JW, 2001, J CLIN ONCOL, V19, P2206, DOI 10.1200/JCO.2001.19.8.2206; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; Post DM, 2001, J NATL MED ASSOC, V93, P6; Roter D, 2000, PATIENT EDUC COUNS, V39, P5, DOI 10.1016/S0738-3991(99)00086-5; ROTER DL, 1977, HEALTH EDUC QUART, V5, P281, DOI 10.1177/109019817700500402; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; ROTER DL, 1984, HEALTH PSYCHOL, V3, P395, DOI 10.1037/0278-6133.3.5.395; SAMB B, 1995, PEDIATR INFECT DIS J, V14, P203, DOI 10.1097/00006454-199503000-00007; Sander RW, 1996, J FAM PRACTICE, V43, P468; Silverman J., 2016, SKILLS COMMUNICATING; Sniadack DH, 1999, B WORLD HEALTH ORGAN, V77, P545; STARFIELD B, 1981, AM J PUBLIC HEALTH, V71, P127, DOI 10.2105/AJPH.71.2.127; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Stimson G. V., 1975, GOING SEE DOCTOR CON; SVARSTAD BL, 1974, THESIS U WISCINSON; TABAK ER, 1988, PATIENT EDUC COUNS, V12, P37, DOI 10.1016/0738-3991(88)90036-5; Tennstedt SL, 2000, CLIN GERIATR MED, V16, P61, DOI 10.1016/S0749-0690(05)70008-2; THOMPSON SC, 1990, HEALTH PSYCHOL, V9, P390, DOI 10.1037/0278-6133.9.4.390; Tuckett D., 1985, M EXPERTS APPROACH S; Veirum JE, 2005, VACCINE, V23, P1197, DOI 10.1016/j.vaccine.2004.02.053; WAITZKIN H, 1984, JAMA-J AM MED ASSOC, V252, P2441, DOI 10.1001/jama.252.17.2441; WHITTLE H, 1988, LANCET, V2, P811; WHITTLE HC, 1990, LANCET, V336, P1046, DOI 10.1016/0140-6736(90)92501-8; Wilkinson Connie Rasmussen, 2002, Lippincotts Case Manag, V7, P86, DOI 10.1097/00129234-200205000-00002; Wilson A, 2002, BRIT J GEN PRACT, V52, P1012; 1982, WEEKLY EPIDEMIOL REC, V57, P89	124	111	112	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a485	10.1136/bmj.a485	http://dx.doi.org/10.1136/bmj.a485			32	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EO	18632672	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000258561100032
J	Gardner, JM; DeVoss, JJ; Friedman, RS; Wong, DJ; Tan, YX; Zhou, XY; Johannes, KP; Su, MA; Chang, HY; Krummel, MF; Anderson, MS				Gardner, James M.; DeVoss, Jason J.; Friedman, Rachel S.; Wong, David J.; Tan, Ying X.; Zhou, Xuyu; Johannes, Kellsey P.; Su, Maureen A.; Chang, Howard Y.; Krummel, Matthew F.; Anderson, Mark S.			Deletional tolerance mediated by extrathymic Aire-expressing cells	SCIENCE			English	Article							THYMIC EPITHELIAL-CELLS; PROMISCUOUS GENE-EXPRESSION; T-CELLS; SELF; ANTIGEN; IDENTIFICATION; PROTEIN; MICE	The prevention of autoimmunity requires the elimination of self-reactive T cells during their development and maturation. The expression of diverse self-antigens by stromal cells in the thymus is essential to this process and depends, in part, on the activity of the autoimmune regulator (Aire) gene. Here we report the identification of extrathymic Aire-expressing cells (eTACs) resident within the secondary lymphoid organs. These stromally derived eTACs express a diverse array of distinct self-antigens and are capable of interacting with and deleting naive autoreactive T cells. Using two-photon microscopy, we observed stable antigen-specific interactions between eTACs and autoreactive T cells. We propose that such a secondary network of self- antigen-expressing stromal cells may help reinforce immune tolerance by preventing the maturation of autoreactive T cells that escape thymic negative selection.	[Gardner, James M.; DeVoss, Jason J.; Tan, Ying X.; Zhou, Xuyu; Johannes, Kellsey P.; Su, Maureen A.; Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94122 USA; [Friedman, Rachel S.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Wong, David J.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Canc Biol Program, Stanford, CA 94305 USA; [Su, Maureen A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94122 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco	Anderson, MS (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94122 USA.	manderson@diabetes.ucsf.edu	Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; Su, Maureen/0000-0002-3680-9982; Gardner, James/0000-0003-3470-9520	NIAID NIH HHS [P01 AI035297-170009, P01 AI035297-150009, K08 AI076429-05, P01 AI035297-159001, P01 AI035297-169001, P01 AI035297, P01 AI035297-179001, K08 AI076429, P01 AI035297-160009] Funding Source: Medline; NIDDK NIH HHS [P30 DK063720, P30 DK063720-05] Funding Source: Medline; NIGMS NIH HHS [T32 GM007618] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076429, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Halonen M, 2001, J HISTOCHEM CYTOCHEM, V49, P197, DOI 10.1177/002215540104900207; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Jarchum I, 2008, CLIN IMMUNOL, V127, P359, DOI 10.1016/j.clim.2008.01.015; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lin MS, 2000, J CLIN INVEST, V105, P207, DOI 10.1172/JCI8075; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Marinkovich MP, 1996, J INVEST DERMATOL, V106, P734, DOI 10.1111/1523-1747.ep12345782; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NAGATA M, 1994, J IMMUNOL, V152, P2042; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	22	351	362	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					843	847		10.1126/science.1159407	http://dx.doi.org/10.1126/science.1159407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687966	Green Accepted			2022-12-28	WOS:000258261000048
J	Goldston, D				Goldston, David			Financial planning	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com						Goldston D, 2007, NATURE, V449, P962, DOI 10.1038/449962a	1	0	0	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					680	680		10.1038/454680a	http://dx.doi.org/10.1038/454680a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	334NH	18685673	Bronze			2022-12-28	WOS:000258228000010
J	Gutierrez, OM; Mannstadt, M; Isakova, T; Rauh-Hain, JA; Tamez, H; Shah, A; Smith, K; Lee, H; Thadhani, R; Juppner, H; Wolf, M				Gutierrez, Orlando M.; Mannstadt, Michael; Isakova, Tamara; Rauh-Hain, Jose Alejandro; Tamez, Hector; Shah, Anand; Smith, Kelsey; Lee, Hang; Thadhani, Ravi; Juppner, Harald; Wolf, Myles			Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; VITAMIN-D; VASCULAR CALCIFICATION; ONCOGENIC OSTEOMALACIA; MINERAL METABOLISM; PHOSPHATE; SURVIVAL; FGF23; RACE	Background: Fibroblast growth factor 23 (FGF-23) is a hormone that increases the rate of urinary excretion of phosphate and inhibits renal production of 1,25-dihydroxyvitamin D, thus helping to mitigate hyperphosphatemia in patients with kidney disease. Hyperphosphatemia and low 1,25-dihydroxyvitamin D levels are associated with mortality among patients with chronic kidney disease, but the effect of the level of FGF-23 on mortality is unknown. Methods: We examined mortality according to serum phosphate levels in a prospective cohort of 10,044 patients who were beginning hemodialysis treatment and then analyzed FGF-23 levels and mortality in a nested case-control sample of 200 subjects who died and 200 who survived during the first year of hemodialysis treatment. We hypothesized that increased FGF-23 levels at the initiation of hemodialysis would be associated with increased mortality. Results: Serum phosphate levels in the highest quartile (>5.5 mg per deciliter [1.8 mmol per liter]) were associated with a 20% increase in the multivariable adjusted risk of death, as compared with normal levels (3.5 to 4.5 mg per deciliter [1.1 to 1.4 mmol per liter]) (hazard ratio, 1.2; 95% confidence interval [CI], 1.1 to 1.4). Median C-terminal FGF-23 (cFGF-23) levels were significantly higher in case subjects than in controls (2260 vs. 1406 reference units per milliliter, P<0.001). Multivariable adjusted analyses showed that increasing FGF-23 levels were associated with a monotonically increasing risk of death when examined either on a continuous scale (odds ratio per unit increase in log-transformed cFGF-23 values, 1.8; 95% CI, 1.4 to 2.4) or in quartiles, with quartile 1 as the reference category (odds ratio for quartile 2, 1.6 [95% CI, 0.8 to 3.3]; for quartile 3, 4.5 [95% CI, 2.2 to 9.4]; and for quartile 4, 5.7 [95% CI, 2.6 to 12.6]). Conclusions: Increased FGF-23 levels appear to be independently associated with mortality among patients who are beginning hemodialysis treatment. Future studies might investigate whether FGF-23 is a potential biomarker that can be used to guide strategies for the management of phosphorus balance in patients with chronic kidney disease.	[Gutierrez, Orlando M.; Isakova, Tamara; Rauh-Hain, Jose Alejandro; Tamez, Hector; Shah, Anand; Smith, Kelsey; Thadhani, Ravi; Wolf, Myles] Massachusetts Gen Hosp, Renal Unit, Boston, MA 02114 USA; [Mannstadt, Michael; Juppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Juppner, Harald] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Juppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wolf, M (corresponding author), Univ Miami, Div Nephrol & Hypertens, Miller Sch Med, 1120 NW 14th St, Miami, FL 33136 USA.	mwolf2@med.miami.edu	Mannstadt, Michael/AAO-1124-2020	Mannstadt, Michael/0000-0003-0867-9778	NCRR NIH HHS [K23 RR017376, K30RR02229207, K23RR017376] Funding Source: Medline; NIDDK NIH HHS [R37 DK046718, R21DK071674, R21 DK071674, K08 DK081669, R01 DK076116, R01DK076116, R37 DK046718-17] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR017376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076116, R21DK071674, R37DK046718, K08DK081669] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Cozzolino M, 2005, KIDNEY INT, V68, P429, DOI 10.1111/j.1523-1755.2005.00421.x; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Foley RN, 2007, J AM SOC NEPHROL, V18, P2575, DOI 10.1681/ASN.2006121411; Frankenfield DL, 2003, J AM SOC NEPHROL, V14, P180, DOI 10.1097/01.ASN.0000037400.83593.E6; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, KIDNEY INT, V73, P956, DOI 10.1038/ki.2008.4; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Koiwa F, 2005, THER APHER DIAL, V9, P336, DOI 10.1111/j.1744-9987.2005.00293.x; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; RITZ E, 1973, KIDNEY INT, V4, P116, DOI 10.1038/ki.1973.90; Robinson BM, 2006, J AM SOC NEPHROL, V17, P2910, DOI 10.1681/ASN.2005101078; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Shigematsu T, 2004, AM J KIDNEY DIS, V44, P250, DOI 10.1053/j.ajkd.2004.04.029; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tonelli, 2007, CIRCULATION, V116, pE556, DOI 10.1161/CIRCULATIONAHA.107.187927; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; *US REN DAT SYST, 2004, USRDS 2003 ANN DAT R; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Wolf M, 2008, J AM SOC NEPHROL, V19, P1379, DOI 10.1681/ASN.2007091002; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	39	1304	1365	2	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					584	592		10.1056/NEJMoa0706130	http://dx.doi.org/10.1056/NEJMoa0706130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687639	Green Accepted			2022-12-28	WOS:000258216700006
J	Ananworanich, J; Puthanakit, T; Saphonn, V; Cooper, DA; Ruxrungtham, K				Ananworanich, Jintanat; Puthanakit, Thanyawee; Saphonn, Vonthanak; Cooper, David A.; Ruxrungtham, Kiat			Lessons from a multicentre paediatric HIV trial	LANCET			English	Editorial Material									[Ananworanich, Jintanat; Puthanakit, Thanyawee; Cooper, David A.; Ruxrungtham, Kiat] HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand; [Saphonn, Vonthanak] Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia; [Cooper, David A.] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand	University of New South Wales Sydney; Kirby Institute; Chulalongkorn University	Ananworanich, J (corresponding author), HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand.	jintanat.a@hivnat.org	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Puthanakit, Thanywee/0000-0003-1873-1867	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075408] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI075408] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		UNAIDS, 2006, REP GLOB AIDS EP; VOLARI A, 2007, 4 IAS C HIV PATH TRE; World Health Organisation, 2006, ANT THER HIV INF INF	3	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 2	2008	372	9636					356	357		10.1016/S0140-6736(08)61139-3	http://dx.doi.org/10.1016/S0140-6736(08)61139-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334AZ	18675673	Green Accepted			2022-12-28	WOS:000258196000009
J	Gruene, P; Rayner, DM; Redlich, B; van der Meer, AFG; Lyon, JT; Meijer, G; Fielicke, A				Gruene, Philipp; Rayner, David M.; Redlich, Britta; van der Meer, Alexander F. G.; Lyon, Jonathan T.; Meijer, Gerard; Fielicke, Andre			Structures of neutral Au-7, Au-19, and Au-20 clusters in the gas phase	SCIENCE			English	Article							DENSITY-FUNCTIONAL CALCULATIONS; ION MOBILITY MEASUREMENTS; GOLD CLUSTERS; NANOCLUSTERS; ADSORPTION; OXIDATION; TITANIA; ANIONS; CO	The catalytic properties of gold nanoparticles are determined by their electronic and geometric structures. We revealed the geometries of several small neutral gold clusters in the gas phase by using vibrational spectroscopy between 47 and 220 wavenumbers. A two- dimensional structure for neutral Au-7 and a pyramidal structure for neutral Au-20 can be unambiguously assigned. The reduction of the symmetry when a corner atom is cut from the tetrahedral Au-20 cluster is directly reflected in the vibrational spectrum of Au-19.	[Gruene, Philipp; Lyon, Jonathan T.; Meijer, Gerard; Fielicke, Andre] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Rayner, David M.] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Redlich, Britta; van der Meer, Alexander F. G.] Inst Plasma Phys Rijnhuizen, FOM, NL-3439 MN Nieuwegein, Netherlands	Max Planck Society; Fritz Haber Institute of the Max Planck Society; National Research Council Canada	Fielicke, A (corresponding author), Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany.	fielicke@fhi-berlin.mpg.de	Redlich, Britta/F-9689-2015; Meijer, Gerard/D-2141-2009; Fielicke, Andre/A-5298-2009	Meijer, Gerard/0000-0001-9669-8340; Fielicke, Andre/0000-0003-0400-0932; Lyon, Jonathan/0000-0003-2143-1216				AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Bonacic-Koutecky V, 2002, J CHEM PHYS, V117, P3120, DOI 10.1063/1.1492800; Bulusu S, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2352755; Bulusu S, 2006, P NATL ACAD SCI USA, V103, P8326, DOI 10.1073/pnas.0600637103; Campbell CT, 2004, SCIENCE, V306, P234, DOI 10.1126/science.1104246; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Edwards PP, 2007, ANGEW CHEM INT EDIT, V46, P5480, DOI 10.1002/anie.200700428; Fielicke A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1872834; Fielicke A, 2005, EUR PHYS J D, V34, P83, DOI 10.1140/epjd/e2005-00124-7; Fielicke A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023401; Furche F, 2002, J CHEM PHYS, V117, P6982, DOI 10.1063/1.1507582; Gilb S, 2002, J CHEM PHYS, V116, P4094, DOI 10.1063/1.1445121; Gloess AN, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2894303; Hakkinen H, 2000, PHYS REV B, V62, pR2287, DOI 10.1103/PhysRevB.62.R2287; HAMMER B, 1995, NATURE, V376, P238, DOI 10.1038/376238a0; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Huang W, 2008, ACS NANO, V2, P897, DOI 10.1021/nn800074b; Lechtken A, 2007, ANGEW CHEM INT EDIT, V46, P2944, DOI 10.1002/anie.200604760; Lemire C, 2004, ANGEW CHEM INT EDIT, V43, P118, DOI 10.1002/anie.200352538; Li J, 2003, SCIENCE, V299, P864, DOI 10.1126/science.1079879; Li ZY, 2008, NATURE, V451, P46, DOI 10.1038/nature06470; Mills G, 2003, J CHEM PHYS, V118, P4198, DOI 10.1063/1.1542879; OEPTS D, 1995, INFRARED PHYS TECHN, V36, P297, DOI 10.1016/1350-4495(94)00074-U; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Wang JL, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035418; Xing XP, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165423; Yoon B, 2005, SCIENCE, V307, P403, DOI 10.1126/science.1104168	27	485	489	8	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					674	676		10.1126/science.1161166	http://dx.doi.org/10.1126/science.1161166			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669858	Green Submitted			2022-12-28	WOS:000258077700039
J	Renema, W; Bellwood, DR; Braga, JC; Bromfield, K; Hall, R; Johnson, KG; Lunt, P; Meyer, CP; McMonagle, LB; Morley, RJ; O'Dea, A; Todd, JA; Wesselingh, FP; Wilson, MEJ; Pandolfi, JM				Renema, W.; Bellwood, D. R.; Braga, J. C.; Bromfield, K.; Hall, R.; Johnson, K. G.; Lunt, P.; Meyer, C. P.; McMonagle, L. B.; Morley, R. J.; O'Dea, A.; Todd, J. A.; Wesselingh, F. P.; Wilson, M. E. J.; Pandolfi, J. M.			Hopping hotspots: Global shifts in marine Biodiversity	SCIENCE			English	Review							INDO-PACIFIC; DIVERSIFICATION; DIVERSITY; EVOLUTION; PATTERNS; ORIGINS; LABRIDAE; PHYLOGEOGRAPHY; BIOGEOGRAPHY; SPECIATION	Hotspots of high species diversity are a prominent feature of modern global biodiversity patterns. Fossil and molecular evidence is starting to reveal the history of these hotspots. There have been at least three marine biodiversity hotspots during the past 50 million years. They have moved across almost half the globe, with their timing and locations coinciding with major tectonic events. The birth and death of successive hotspots highlights the link between environmental change and biodiversity patterns. The antiquity of the taxa in the modern Indo- Australian Archipelago hotspot emphasizes the role of pre- Pleistocene events in shaping modern diversity patterns.	[Renema, W.; Wesselingh, F. P.] Natl Museum Nat Hist, NL-2300 RA Leiden, Netherlands; [Bellwood, D. R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Braga, J. C.] Univ Granada, Dept Estratig & Paleontol, Granada 18002, Spain; [Renema, W.; Bromfield, K.; Pandolfi, J. M.] Univ Queensland, Australian Res Council Ctr Excellence Coral Reef, Ctr Marine Studies, Brisbane, Qld 4072, Australia; [Hall, R.; Morley, R. J.] Univ London Royal Holloway & Bedford New Coll, SE Asia Res Grp, Egham TW20 0EX, Surrey, England; [Johnson, K. G.; McMonagle, L. B.; Todd, J. A.] Nat Hist Museum, Dept Paleontol, London SW7 5BD, England; [Lunt, P.] Murphy Oil, Kuala Lumpur 50088, Malaysia; [Meyer, C. P.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; [McMonagle, L. B.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Morley, R. J.] Palynova, Littleport CB6 1PY, England; [O'Dea, A.] Smithsonian Trop Res Inst, Balboa, Panama; [Wilson, M. E. J.] Curtin Univ Technol, Dept Appl Geol, Perth, WA 6845, Australia	James Cook University; University of Granada; University of Queensland; University of London; Royal Holloway University London; Natural History Museum London; Smithsonian Institution; Smithsonian National Museum of Natural History; Durham University; Smithsonian Institution; Smithsonian Tropical Research Institute; Curtin University	Renema, W (corresponding author), Natl Museum Nat Hist, NL-2300 RA Leiden, Netherlands.	Renema@naturalis.nl	Wesselingh, Frank/C-1367-2018; O'Dea, Aaron/D-4114-2011; Hall, Robert/AAN-3441-2020; Wilson, Moyra/C-5151-2015; Bellwood, David/E-2497-2011; Pandolfi, John M/A-3121-2009; Renema, Willem/E-2851-2016; Braga, Juan Carlos/K-3786-2017; Todd, Jonathan/M-7064-2019	Wesselingh, Frank/0000-0003-3655-0701; Hall, Robert/0000-0003-1693-6914; Wilson, Moyra/0000-0001-5226-7952; Pandolfi, John M/0000-0003-3047-6694; Renema, Willem/0000-0002-1627-5995; Braga, Juan Carlos/0000-0002-2657-0584; Todd, Jonathan/0000-0002-0433-1611; O'Dea, Aaron/0000-0001-5495-4764; Meyer, Christopher/0000-0003-2501-7952				Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bernardi G, 2004, MAR BIOL, V144, P369, DOI 10.1007/s00227-003-1199-0; Beu A.G., 2005, Scripta Geologica (Leiden), V130, P1; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; Briggs JC, 2005, J BIOGEOGR, V32, P1517, DOI 10.1111/j.1365-2699.2005.01266.x; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Dercourt J, 2000, ATLAS PERITETHYS PAL; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1365-2699.1999.00126.x; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Harzhauser M, 2002, PALAEOGEOGR PALAEOCL, V183, P103, DOI 10.1016/S0031-0182(01)00464-3; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Hoeksema Bert W., 2007, V29, P117; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; Karlson RH, 2004, NATURE, V429, P867, DOI 10.1038/nature02685; Kay E. Alison, 1996, P211; Klanten SO, 2004, MOL PHYLOGENET EVOL, V32, P221, DOI 10.1016/j.ympev.2003.11.008; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1999, EVOLUTION, V53, P806, DOI 10.1111/j.1558-5646.1999.tb05374.x; McCafferty S, 2002, MOL ECOL, V11, P1377, DOI 10.1046/j.1365-294X.2002.01533.x; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Morley R.J., 2000, ORIGIN EVOLUTION TRO; NOTTINGER L, 2007, CG2007A06, P1; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Plaziat Jean-Claude, 2001, Wetlands Ecology and Management, V9, P161, DOI 10.1023/A:1011118204434; POTTS DC, 1985, 5TH P INT COR REEF C, V4, P127; Read CI, 2006, MOL PHYLOGENET EVOL, V38, P808, DOI 10.1016/j.ympev.2005.08.001; Renema Willem, 2007, V29, P179; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rosen B.R., 1981, P103; Veron JEN, 2002, CORALS WORLD; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Williams ST, 2004, EVOLUTION, V58, P2227; Williams ST, 2007, BIOL J LINN SOC, V92, P573, DOI 10.1111/j.1095-8312.2007.00854.x; Wilson Moyra E. J., 1998, P165	45	348	359	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					654	657		10.1126/science.1155674	http://dx.doi.org/10.1126/science.1155674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669854				2022-12-28	WOS:000258077700033
J	Teitel, AD; Rubin, J				Teitel, Ariel D.; Rubin, Josh			Horizontal pendular nystagmus in a patient with ocular albinism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Teitel, Ariel D.; Rubin, Josh] New York Med Coll, Valhalla, NY 10595 USA	New York Medical College	Teitel, AD (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.	arielteitel@nyc.rr.com		Teitel, Ariel/0000-0001-5021-9551					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					E5	E5		10.1056/NEJMicm060858	http://dx.doi.org/10.1056/NEJMicm060858			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669422				2022-12-28	WOS:000258039700009
J	Cross, M				Cross, Michael			How the internet is changing health care	BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelcross@fastmail.fm						BIRNSTEEL L, 2008, E HLTH 2 0 WEB 2 0 H; *CAB OFF, 2007, POW INF; Darzi A., 2008, HIGH QUALITY CARE AL; Guistini D., 2006, BRIT MED J, V333, P1283, DOI [doi:10.1136/bmj.39062.555405.80, DOI 10.1136/BMJ.39062.555405.80]; Keen Andrew, 2007, CULT AMATEUR; *NHS CONF, 2008, DISR INN WHAT DOES I; *ORG EC COOP DEV, 2008, SHAP POL FUT INT EC; Stilgoe J., 2008, TALKING CURE	8	7	7	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a883	10.1136/bmj.a883	http://dx.doi.org/10.1136/bmj.a883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335EG	18647776				2022-12-28	WOS:000258273000032
J	Wagner, K; Janousek, J; Delaubert, V; Zou, HX; Harb, C; Treps, N; Morizur, JF; Lam, PK; Bachor, HA				Wagner, Katherine; Janousek, Jiri; Delaubert, Vincent; Zou, Hongxin; Harb, Charles; Treps, Nicolas; Morizur, Jean Francois; Lam, Ping Koy; Bachor, Hans A.			Entangling the spatial properties of laser beams	SCIENCE			English	Article							QUANTUM; ENTANGLEMENT	Position and momentum were the first pair of conjugate observables explicitly used to illustrate the intricacy of quantum mechanics. We have extended position and momentum entanglement to bright optical beams. Applications in optical metrology and interferometry require the continuous measurement of laser beams, with the accuracy fundamentally limited by the uncertainty principle. Techniques based on spatial entanglement of the beams could overcome this limit, and high-quality entanglement is required. We report a value of 0.51 for inseparability and 0.62 for the Einstein- Podolsky- Rosen criterion, both normalized to a classical limit of 1. These results are a conclusive optical demonstration of macroscopic position and momentum quantum entanglement and also confirm that the resources for spatial multimode protocols are available.	[Wagner, Katherine; Janousek, Jiri; Delaubert, Vincent; Zou, Hongxin; Morizur, Jean Francois; Lam, Ping Koy; Bachor, Hans A.] Australian Natl Univ, Australian Res Council Ctr Excellence Quantumatom, Canberra, ACT 0200, Australia; [Delaubert, Vincent; Treps, Nicolas; Morizur, Jean Francois] Univ Paris 06, Lab Kastler Brossel, ENS, CNRS, F-75252 Paris, France; [Harb, Charles] Australian Def Force Acad, Canberra, ACT, Australia	Australian National University; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Australian Defense Force Academy	Bachor, HA (corresponding author), Australian Natl Univ, Australian Res Council Ctr Excellence Quantumatom, GPO Box 4, Canberra, ACT 0200, Australia.	hans.bachor@anu.edu.au	Treps, Nicolas/L-6621-2015; Lam, Ping Koy/A-5276-2008; Treps, Nicolas/AAM-3115-2021	Treps, Nicolas/0000-0002-1413-3715; Lam, Ping Koy/0000-0002-4421-601X; Treps, Nicolas/0000-0002-1413-3715; Bachor, Hans/0000-0001-8866-9486; Harb, Charles/0000-0001-6409-2723				Bowen WP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.043601; Bowen WP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.253601; Boyer V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143601; Dong RF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/410; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Fiurasek J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.050302; Giovannetti V, 2001, NATURE, V412, P417, DOI 10.1038/35086525; Glockl O, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012306; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Howell JC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.210403; Hsu MTL, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013802; Hsu MTL, 2004, J OPT B-QUANTUM S O, V6, P495, DOI 10.1088/1464-4266/6/12/003; Iakoubovskii K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.064105; Korolkova N, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052306; Lassen M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083602; Lassen M, 2006, J EUR OPT SOC-RAPID, V1, DOI 10.2971/jeos.2006.06003; Laurat J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022313; McKenzie K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.231102; MEYER G, 1988, APPL PHYS LETT, V53, P1045, DOI 10.1063/1.100061; REID MD, 1989, PHYS REV A, V40, P913, DOI 10.1103/PhysRevA.40.913; Silberhorn C, 2001, PHYS REV LETT, V86, P4267, DOI 10.1103/PhysRevLett.86.4267; SOKOLOV V, 2007, QUANTUM IMAGING, P239; Treps N, 2003, SCIENCE, V301, P940, DOI 10.1126/science.1086489; Ursin R, 2007, NAT PHYS, V3, P481, DOI 10.1038/nphys629; Yonezawa H, 2004, NATURE, V431, P430, DOI 10.1038/nature02858	26	69	71	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					541	543		10.1126/science.1159663	http://dx.doi.org/10.1126/science.1159663			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653887	Green Submitted			2022-12-28	WOS:000257888900041
J	Wang, W; Fang, HQ; Groom, L; Cheng, AW; Zhang, WR; Liu, J; Wang, XH; Li, KT; Han, PD; Zheng, M; Yin, JH; Wang, WD; Mattson, MP; Kao, JPY; Lakatta, EG; Sheu, SS; Ouyang, KF; Chen, J; Dirksen, RT; Cheng, HP				Wang, Wang; Fang, Huaqiang; Groom, Linda; Cheng, Aiwu; Zhang, Wanrui; Liu, Jie; Wang, Xianhua; Li, Kaitao; Han, Peidong; Zheng, Ming; Yin, Jinhu; Wang, Weidong; Mattson, Mark P.; Kao, Joseph P. Y.; Lakatta, Edward G.; Sheu, Shey-Shing; Ouyang, Kunfu; Chen, Ju; Dirksen, Robert T.; Cheng, Heping			Superoxide flashes in single mitochondria	CELL			English	Article							PERMEABILITY TRANSITION PORE; OXIDATIVE STRESS; CYCLOPHILIN-D; CA2+ SPARKS; CALCIUM; RELEASE; CELLS; ROS; OSCILLATIONS; MODULATION	In quiescent cells, mitochondria are the primary source of reactive oxygen species (ROS), which are generated by leakiness of the electron transport chain (ETC). High levels of ROS can trigger cell death, whereas lower levels drive diverse and important cellular functions. We show here by employing a newly developed mitochondrial matrix-targeted superoxide indicator, that individual mitochondria undergo spontaneous bursts of superoxide generation, termed "superoxide flashes.'' Superoxide flashes occur randomly in space and time, exhibit all-or-none properties, and provide a vital source of superoxide production across many different cell types. Individual flashes are triggered by transient openings of the mitochondrial permeability transition pore stimulating superoxide production by the ETC. Furthermore, we observe a flurry of superoxide flash activity during reoxygenation of cardiomyocytes after hypoxia, which is inhibited by the cardioprotective compound adenosine. We propose that superoxide flashes could serve as a valuable biomarker for a wide variety of oxidative stress-related diseases.	[Wang, Wang; Lakatta, Edward G.] NIA, NIH, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Cheng, Aiwu; Mattson, Mark P.] NIA, NIH, Neurosci Lab, Baltimore, MD 21224 USA; [Yin, Jinhu; Wang, Weidong] NIA, NIH, Genet Lab, Baltimore, MD 21224 USA; [Fang, Huaqiang; Zhang, Wanrui; Liu, Jie; Wang, Xianhua; Li, Kaitao; Han, Peidong; Zheng, Ming; Cheng, Heping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Fang, Huaqiang; Zhang, Wanrui; Liu, Jie; Wang, Xianhua; Li, Kaitao; Han, Peidong; Zheng, Ming; Cheng, Heping] Peking Univ, Natl Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Groom, Linda; Sheu, Shey-Shing; Dirksen, Robert T.] Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Kao, Joseph P. Y.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ouyang, Kunfu; Chen, Ju] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University; Peking University; University of Rochester; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Wang, W (corresponding author), NIA, NIH, Cardiovasc Sci Lab, Baltimore, MD 21224 USA.	wangwang@umich.edu; chengp@pku.edu.cn	cheng, heping/A-7299-2011; wang, wang/GWQ-7272-2022; Lakatta, Edward G/AAL-1447-2020; Mattson, Mark P/F-6038-2012; Chen, Ju/E-5579-2011; Wang, Weidong/AAV-2446-2021; Heping, Cheng/AAE-2680-2019; ouyang, kunfu/B-3073-2011; Sheu, Shey-Shing/Y-4009-2019	Heping, Cheng/0000-0002-9604-6702; ouyang, kunfu/0000-0003-0292-375X; Sheu, Shey-Shing/0000-0003-3838-3601; Lakatta, Edward/0000-0002-4772-0035; Wang, Weidong/0000-0002-0658-7928; Kao, Joseph/0000-0002-8875-2180; Wang, Wang/0000-0001-9093-412X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333, R01HL093671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, R29AR044657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000235, Z01AG000661, ZIAAG000317, ZIAAG000313] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [R01 HL033333, HL-33333, R01 HL033333-12, R01 HL093671] Funding Source: Medline; NIAMS NIH HHS [AR44657, R01 AR044657, R01 AR044657-11, R29 AR044657] Funding Source: Medline; NIGMS NIH HHS [R01 GM056481, R01 GM056481-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; DYPBUKT JM, 1994, J BIOL CHEM, V269, P30553; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Isaeva EV, 2005, J PHYSIOL-LONDON, V565, P855, DOI 10.1113/jphysiol.2005.086280; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Montero M, 2004, BRIT J PHARMACOL, V141, P263, DOI 10.1038/sj.bjp.0705609; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakamura K, 2001, J BIOL CHEM, V276, P34402, DOI 10.1074/jbc.M103766200; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Otani H, 2004, ANTIOXID REDOX SIGN, V6, P449, DOI 10.1089/152308604322899521; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Ramesh V, 1998, ANN NY ACAD SCI, V853, P341, DOI 10.1111/j.1749-6632.1998.tb08295.x; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Takahashi A, 2001, BIOTECHNIQUES, V30, P804, DOI 10.2144/01304rv01; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774; Wallace D C, 2001, Novartis Found Symp, V235, P247; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	57	568	586	3	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					279	290		10.1016/j.cell.2008.06.017	http://dx.doi.org/10.1016/j.cell.2008.06.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662543	Green Accepted, Bronze			2022-12-28	WOS:000257891700017
J	Nurse, P				Nurse, Paul			Life, logic and information	NATURE			English	Article									[Nurse, Paul] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Nurse, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	nurse@mail.rockefeller.edu	Martinez, Octavio/B-7375-2009						0	136	139	4	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					424	426		10.1038/454424a	http://dx.doi.org/10.1038/454424a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650911				2022-12-28	WOS:000257860300035
J	Steigbigel, RT; Cooper, DA; Kumar, PN; Eron, JE; Schechter, M; Markowitz, M; Loutfy, MR; Lennox, JL; Gatell, JM; Rockstroh, JK; Katlama, C; Yeni, P; Lazzarin, A; Clotet, B; Zhao, J; Chen, J; Ryan, DM; Rhodes, RR; Killar, JA; Gilde, LR; Strohmaier, KM; Meibohm, AR; Miller, MD; Hazuda, DJ; Nessly, ML; DiNubile, MJ; Isaacs, RD; Nguyen, B; Teppler, H				Steigbigel, Roy T.; Cooper, David A.; Kumar, Princy N.; Eron, Joseph E.; Schechter, Mauro; Markowitz, Martin; Loutfy, Mona R.; Lennox, Jeffrey L.; Gatell, Jose M.; Rockstroh, Jurgen K.; Katlama, Christine; Yeni, Patrick; Lazzarin, Adriano; Clotet, Bonaventura; Zhao, Jing; Chen, Joshua; Ryan, Desmond M.; Rhodes, Rand R.; Killar, John A.; Gilde, Lucinda R.; Strohmaier, Kim M.; Meibohm, Anne R.; Miller, Michael D.; Hazuda, Daria J.; Nessly, Michael L.; DiNubile, Mark J.; Isaacs, Robin D.; Nguyen, Bach-Yen; Teppler, Hedy		BENCHMRK Study Teams	Raltegravir with optimized background therapy for resistant HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREATMENT-EXPERIENCED PATIENTS; RECONSTITUTION INFLAMMATORY SYNDROME; ANTIRETROVIRAL DRUG-RESISTANCE; INTEGRASE INHIBITOR RALTEGRAVIR; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; IMMUNE RECONSTITUTION; HIV-1-INFECTED PATIENTS; SALVAGE THERAPY; PROTEASE INHIBITORS	Background Raltegravir (MK-0518) is an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase active against HIV-1 susceptible or resistant to older antiretroviral drugs. Methods We conducted two identical trials in different geographic regions to evaluate the safety and efficacy of raltegravir, as compared with placebo, in combination with optimized background therapy, in patients infected with HIV-1 that has triple-class drug resistance in whom antiretroviral therapy had failed. Patients were randomly assigned to raltegravir or placebo in a 2:1 ratio. Results In the combined studies, 699 of 703 randomized patients (462 and 237 in the raltegravir and placebo groups, respectively) received the study drug. Seventeen of the 699 patients (2.4%) discontinued the study before week 16. Discontinuation was related to the study treatment in 13 of these 17 patients: 7 of the 462 raltegravir recipients (1.5%) and 6 of the 237 placebo recipients (2.5%). The results of the two studies were consistent. At week 16, counting noncompletion as treatment failure, 355 of 458 raltegravir recipients (77.5%) had HIV-1 RNA levels below 400 copies per milliliter, as compared with 99 of 236 placebo recipients (41.9%, P<0.001). Suppression of HIV-1 RNA to a level below 50 copies per milliliter was achieved at week 16 in 61.8% of the raltegravir recipients, as compared with 34.7% of placebo recipients, and at week 48 in 62.1% as compared with 32.9% (P<0.001 for both comparisons). Without adjustment for the length of follow-up, cancers were detected in 3.5% of raltegravir recipients and in 1.7% of placebo recipients. The overall frequencies of drug-related adverse events were similar in the raltegravir and placebo groups. Conclusions In HIV-infected patients with limited treatment options, raltegravir plus optimized background therapy provided better viral suppression than optimized background therapy alone for at least 48 weeks.	[Zhao, Jing; Chen, Joshua; Ryan, Desmond M.; Rhodes, Rand R.; Killar, John A.; Gilde, Lucinda R.; Strohmaier, Kim M.; Meibohm, Anne R.; Miller, Michael D.; Hazuda, Daria J.; Nessly, Michael L.; DiNubile, Mark J.; Isaacs, Robin D.; Nguyen, Bach-Yen; Teppler, Hedy] Merck Res Labs, N Wales, PA 19454 USA; [Steigbigel, Roy T.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Cooper, David A.] Univ New S Wales, Sydney, NSW, Australia; [Kumar, Princy N.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Eron, Joseph E.] Univ N Carolina, Chapel Hill, NC USA; [Schechter, Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Markowitz, Martin] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Loutfy, Mona R.] Univ Toronto, Toronto, ON, Canada; [Lennox, Jeffrey L.] Emory Univ, Sch Med, Atlanta, GA USA; [Gatell, Jose M.] Univ Barcelona, Barcelona, Spain; [Rockstroh, Jurgen K.] Univ Bonn, D-5300 Bonn, Germany; [Katlama, Christine] Univ Paris 06, Grp Hosp Pitie Salpetriere, Paris, France; [Yeni, Patrick] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Lazzarin, Adriano] Ist Sci San Raffaele, I-20132 Milan, Italy; [Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fdn Irsicaixa, Barcelona, Spain	Merck & Company; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New South Wales Sydney; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; Universidade Federal do Rio de Janeiro; Rockefeller University; University of Toronto; Emory University; University of Barcelona; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Teppler, H (corresponding author), Merck Res Labs, POB 1000,UG3D-56, N Wales, PA 19454 USA.	hedy_teppler@merck.com	Soriano, Vicente/O-5730-2018; Schechter, Mauro/AAG-7445-2020; Lennox, Jeffrey/D-1654-2014; Gatell, Jose M/ABC-3607-2020; Montaner, Julio/K-7621-2012; LAZZARIN, Adriano/K-3607-2018	Soriano, Vicente/0000-0002-4624-5199; Lennox, Jeffrey/0000-0002-2064-5565; CAUDA, Roberto/0000-0002-1498-4229; LAZZARIN, Adriano/0000-0003-2551-7754; Kozal, Michael/0000-0002-3100-8254				Arici C, 2001, INT J STD AIDS, V12, P573, DOI 10.1258/0956462011923741; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bezemer D, 2006, ANTIVIR THER, V11, P173; Cahn P, 2007, LANCET, V369, P1235, DOI 10.1016/S0140-6736(07)60571-6; Cahn P, 2006, CLIN INFECT DIS, V43, P1347, DOI 10.1086/508352; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; de Bethune MP, 2006, CURR MED RES OPIN, V22, P2603, DOI 10.1185/030079906X154114; De Clercq Erik, 2005, Expert Opin Emerg Drugs, V10, P241, DOI 10.1517/14728214.10.2.241; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gathe J, 2006, CLIN INFECT DIS, V43, P1337, DOI 10.1086/508353; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Gentz M, 2006, AIDS PATIENT CARE ST, V20, P741, DOI 10.1089/apc.2006.20.741; GRINSZTEJN B, 2007, 47 INT C ANT AG CHEM; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Gulick RM, 2003, CLIN MICROBIOL INFEC, V9, P186, DOI 10.1046/j.1469-0691.2003.00570.x; Gulick RM, 2007, J INFECT DIS, V196, P304, DOI 10.1086/518797; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Hoffmann C, 2005, ONKOLOGIE, V28, P35, DOI 10.1159/000082291; Hornberger J, 2006, AIDS RES HUM RETROV, V22, P240, DOI 10.1089/aid.2006.22.240; Karmochkine M, 2000, ANTIVIR RES, V47, P179, DOI 10.1016/S0166-3542(00)00110-8; Kassahun K, 2007, DRUG METAB DISPOS, V35, P1657, DOI 10.1124/dmd.107.016196; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kijak GH, 2001, ANTIVIR THER, V6, P71; Knysz Brygida, 2006, Postepy Hig Med Dosw (Online), V60, P547; Knysz Brygida, 2006, Postepy Hig Med Dosw (Online), V60, P181; Kolber MA, 2004, IUBMB LIFE, V56, P301, DOI 10.1080/1521-6540400000843; Lalezari JP, 2003, NEW ENGL J MED, V349, P1100; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Lorenzi P, 1999, AIDS, V13, pF17, DOI 10.1097/00002030-199902040-00001; Luber Andrew D, 2005, Expert Rev Anti Infect Ther, V3, P815, DOI 10.1586/14787210.3.5.815; Machouf N, 2006, J MED VIROL, V78, P608, DOI 10.1002/jmv.20582; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; Markowitz J, 2007, JAIDS-J ACQ IMM DEF, V44, P492; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Mermet I, 2007, EUR J DERMATOL, V17, P149, DOI 10.1684/ejd.2007.0129; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Molina JM, 2007, JAIDS-J ACQ IMM DEF, V46, P24; Napravnik S, 2007, AIDS, V21, P825, DOI 10.1097/QAD.0b013e32805e8764; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Poveda E, 2007, J ANTIMICROB CHEMOTH, V60, P885, DOI 10.1093/jac/dkm276; Powles T, 2003, LEUKEMIA LYMPHOMA, V44, P1417, DOI 10.1080/1042819031000083280; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Robertson J, 2006, CLIN INFECT DIS, V42, P1639, DOI 10.1086/503903; Robertson P, 2003, HEMATOL ONCOL CLIN N, V17, P703, DOI 10.1016/S0889-8588(03)00047-9; Ross L, 2001, AIDS RES HUM RETROV, V17, P1379, DOI 10.1089/088922201753197042; Savarino A, 2006, EXPERT OPIN INV DRUG, V15, P1507, DOI 10.1517/13543784.15.12.1507; Temesgen Z, 2006, LANCET INFECT DIS, V6, P496, DOI 10.1016/S1473-3099(06)70550-3; Torti C, 2005, CLIN INFECT DIS, V40, P1828, DOI 10.1086/429917; Tozzi V, 2006, ANTIVIR THER, V11, P553; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Turner D, 2006, AIDS REV, V8, P17; Vallejo A, 2004, ANTIVIR RES, V61, P129, DOI 10.1016/S0166-3542(03)00154-2; Van Laethem K, 2007, J CLIN VIROL, V39, P43, DOI 10.1016/j.jcv.2007.02.003; Venkataramana A, 2006, NEUROLOGY, V67, P383, DOI 10.1212/01.wnl.0000227922.22293.93; Viani RM, 2006, J INFECT DIS, V194, P1505, DOI 10.1086/508749; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Welles SL, 2007, JAIDS-J ACQ IMM DEF, V44, P329, DOI 10.1097/QAI.0b013e31802f1296; Youle M, 2006, HIV CLIN TRIALS, V7, P86, DOI 10.1310/2XVK-PBGL-735N-WH72; RALTEGRAVIR NDA 22 1	70	560	581	2	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					339	354		10.1056/NEJMoa0708975	http://dx.doi.org/10.1056/NEJMoa0708975			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650512	Green Submitted, Green Published			2022-12-28	WOS:000257852100003
J	Doody, RS; Gavrilova, SI; Sano, M; Thomas, RG; Aisen, PS; Bachurin, SO; Seely, L; Hung, D				Doody, Rachelle S.; Gavrilova, Svetlana I.; Sano, Mary; Thomas, Ronald G.; Aisen, Paul S.; Bachurin, Sergey O.; Seely, Lynn; Hung, David		Dimebon Investigators	Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study	LANCET			English	Article							MINI-MENTAL STATE; CONTROLLED TRIAL; DONEPEZIL; AD; GALANTAMINE; PREVALENCE; INVENTORY; DEMENTIA; EFFICACY; 1-YEAR	Background Although treatments for Alzheimer's disease sometimes improve cognition, functional ability, or behaviour compared with baseline levels, such improvements are inconsistent across studies and measures, and effects diminish over time. More effective treatments are needed. We assessed the safety, tolerability and efficacy of dimebon in the treatment of patients with mild-to-moderate Alzheimer's disease. Methods We enrolled 183 patients with mild-to-moderate Alzheimer's disease (mini-mental state examination [MMSE] scores 10-24) at 11 sites in Russia. Patients were randomly assigned by a computer-generated randomisation scheme to receive oral dimebon, 20 mg three times a day (60 mg/day [n=89]), or matched placebo (n=94). Other antidementia drugs were not allowed. The primary outcome measure assessed cognition, the difference in mean change from baseline to week 26, or last completed observation on the cognitive subscale of the Alzheimer's disease assessment scale (ADAS-cog). All patients and study personnel were blinded throughout the study. We compared dimebon with placebo with an intention-to-treat analysis, with last observation carried forward (ITT-LOCF) imputation. Analyses were repeated on the fully evaluable population, defined as all patients in the intention-to-treat population who had an ADAS-cog at week 26 and at least 80% compliance. 134 patients (68 in dimebon group, 66 in placebo group) enrolled in the 6-month blinded extension phase of the study. This trial is registered with Clinicaltrials.gov, number NCT00377715. Findings 155 (85%) patients completed the trial (78 [88%] in dimebon group, 77 [82%] in placebo group). Treatment with dimebon resulted in significant benefits in ADAS-cog compared with placebo (ITT-LOCF) at week 26 (mean drug-placebo difference -4.0 [95% CI -5.73 to -2.28]; p<0.0001). Results of the ITT-LOCF and the evaluable population analyses were much the same for all measures. Patients given dimebon were significantly improved over baseline for ADAS-cog (mean difference -1.9 [-2.92 to -0.85]; p=0.0005). Dimebon was well tolerated: dry mouth and depressed mood or depression were the most common adverse events associated with dimebon (12 [14%] patients for each symptom by week 26). The percentage of patients who had adverse events in the two groups did not differ. Interpretation Dimebon was safe, well tolerated, and significantly improved the clinical course of patients with mild-to-moderate Alzheimer's disease.	[Doody, Rachelle S.] Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, Dept Neurol, Houston, TX 77030 USA; [Gavrilova, Svetlana I.] Russian Acad Med Sci, Alzheimers Dis & Related Disorders Res Ctr, Moscow, Russia; [Sano, Mary] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA; [Thomas, Ronald G.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Aisen, Paul S.] Georgetown Univ, Sch Med, Memory Disorders Program, Washington, DC USA; [Bachurin, Sergey O.] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Seely, Lynn; Hung, David] Medivat Inc, San Francisco, CA USA	Baylor College of Medicine; Russian Academy of Medical Sciences; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; Georgetown University; Russian Academy of Sciences; Institute of Physiologically Active Compounds of the Russian Academy of Sciences	Doody, RS (corresponding author), Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, Dept Neurol, 6550 Fannin St,Suite 1801, Houston, TX 77030 USA.	rdoody@bcm.tmc.edu	Sergey, Bachurin/I-1708-2018; Gavrilova, Svetlana/B-4548-2016	Gavrilova, Svetlana/0000-0001-6683-0240				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bachurin S, 2001, ANN NY ACAD SCI, V939, P425; Bachurin SO, 2003, ANN NY ACAD SCI, V993, P334, DOI 10.1111/j.1749-6632.2003.tb07541.x; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; ESTELLE F, 1994, NEW ENGL J MED, V330, P1663; Farlow M, 2000, EUR NEUROL, V44, P236, DOI 10.1159/000008243; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Grigor'ev VV, 2003, B EXP BIOL MED+, V136, P474, DOI 10.1023/B:BEBM.0000017097.75818.14; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Karlawish JHT, 1998, ARCH NEUROL-CHICAGO, V55, P1420, DOI 10.1001/archneur.55.11.1420; Lermontova NN, 2001, B EXP BIOL MED+, V132, P1079; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Mohs RC, 2001, NEUROLOGY, V57, P481, DOI 10.1212/WNL.57.3.481; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; REISINGER TJG, 1997, DIELECTR NEWSLETT, V11, P3; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489	27	372	414	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					207	215		10.1016/S0140-6736(08)61074-0	http://dx.doi.org/10.1016/S0140-6736(08)61074-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640457				2022-12-28	WOS:000257763900030
J	Weaver, M; Krasnow, MA				Weaver, Molly; Krasnow, Mark A.			Dual origin of tissue-specific progenitor cells in Drosophila tracheal remodeling	SCIENCE			English	Article							BRANCHING MORPHOGENESIS; STEM-CELLS; SYSTEM; METAMORPHOSIS; MELANOGASTER; DISTINCT; LARVAL; FATE; GENE; FGF	During Drosophila metamorphosis, most larval cells die. Pupal and adult tissues form from imaginal cells, tissue- specific progenitors allocated in embryogenesis that remain quiescent during embryonic and larval life. Clonal analysis and fate mapping of single, identified cells show that tracheal system remodeling at metamorphosis involves a classical imaginal cell population and a population of differentiated, functional larval tracheal cells that reenter the cell cycle and regain developmental potency. In late larvae, both populations are activated and proliferate, spread over and replace old branches, and diversify into various stalk and coiled tracheolar cells under control of fibroblast growth factor signaling. Thus, Drosophila pupal/ adult tissue progenitors can arise both by early allocation of multipotent cells and late return of differentiated cells to a multipotent state, even within a single tissue.	[Weaver, Molly; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Weaver, Molly; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	krasnow@cmgm.stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM047735] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047735] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arias A.M., 1993, DEV DROSOPHILA, P609; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Dor Y, 2004, CELL CYCLE, V3, P1104; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fuse N, 1996, DEVELOPMENT, V122, P1059; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Guha A, 2005, DEV BIOL, V287, P192, DOI 10.1016/j.ydbio.2005.09.005; Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105; Harbecke R, 1996, INT J DEV BIOL, V40, P197; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Klapper R, 2000, MECH DEVELOP, V95, P47, DOI 10.1016/S0925-4773(00)00328-2; Kylsten P, 1997, DEV BIOL, V192, P509, DOI 10.1006/dbio.1997.8770; Ohshiro T, 1997, DEVELOPMENT, V124, P3975; PIHAN J C, 1968, Archives de Zoologie Experimentale et Generale, V109, P287; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025; SHAFIQ SA, 1963, Q J MICROSC SCI, V104, P135; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Whitten J., 1980, Genetics and Biology of Drosophila, V2d, P499; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zelzer E, 2000, BIOESSAYS, V22, P219, DOI 10.1002/(SICI)1521-1878(200003)22:3<219::AID-BIES3>3.0.CO;2-A	26	48	50	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1496	1499		10.1126/science.1158712	http://dx.doi.org/10.1126/science.1158712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18669822	Green Accepted			2022-12-28	WOS:000259121800043
J	Kuhlemann, J; Rohling, EJ; Krumrei, I; Kubik, P; Ivy-Ochs, S; Kucera, M				Kuhlemann, J.; Rohling, E. J.; Krumrei, I.; Kubik, P.; Ivy-Ochs, S.; Kucera, M.			Regional synthesis of Mediterranean atmospheric circulation during the last glacial maximum	SCIENCE			English	Article							SEA-SURFACE TEMPERATURES; NORTH-ATLANTIC; GENERAL-CIRCULATION; MODEL SIMULATIONS; CLIMATIC CHANGES; POLLEN DATA; VARIABILITY; EUROPE; RECONSTRUCTIONS; REGIMES	Atmospheric circulation leaves few direct traces in the geological record, making reconstructions of this crucial element of the climate system inherently difficult. We produced a regional Mediterranean synthesis of paleo- proxy data from the sea surface to alpine altitudes. This provides a detailed observational context for change in the three- dimensional structure of atmospheric circulation between the Last Glacial Maximum ( LGM, similar to 23,000 to 19,000 years ago) and the present. The synthesis reveals evidence for frequent cold polar air incursions, topographically channeled into the northwestern Mediterranean. Anomalously steep vertical temperature gradients in the central Mediterranean imply local convective precipitation. We find the LGM patterns to be analogous, though amplified, to previously reconstructed phases of enhanced meridional winter circulation during the Maunder Minimum ( the Little Ice Age).	[Kuhlemann, J.; Krumrei, I.; Kucera, M.] Univ Tubingen, Inst Geosci, D-72076 Tubingen, Germany; [Rohling, E. J.] Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Ivy-Ochs, S.] ETH, Inst Particle Phys, CH-8093 Zurich, Switzerland	Eberhard Karls University of Tubingen; NERC National Oceanography Centre; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kuhlemann, J (corresponding author), Univ Tubingen, Inst Geosci, Sigwartstr 10, D-72076 Tubingen, Germany.	kuhlemann@uni-tuebingen.de	Rohling, Eelco J/B-9736-2008; Kucera, Michal/B-9277-2009; Kucera, Michal/ABH-6065-2020; Kucera, Michal/AAE-8115-2020	Rohling, Eelco J/0000-0001-5349-2158; Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018	German Science Foundation [DFG project KU1298/7]; UK Natural Environment Research Council's thematic program Quantifying the Earth System (QUEST); Natural Environment Research Council [NE/D001846/1] Funding Source: researchfish; NERC [NE/D001846/1] Funding Source: UKRI	German Science Foundation(German Research Foundation (DFG)); UK Natural Environment Research Council's thematic program Quantifying the Earth System (QUEST)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We gratefully acknowledge funding by the German Science Foundation (DFG project KU1298/7) and the UK Natural Environment Research Council's thematic program Quantifying the Earth System (QUEST).	BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cacho I, 2002, J MARINE SYST, V33, P253, DOI 10.1016/S0924-7963(02)00061-1; Cassou C, 2004, J CLIMATE, V17, P1055, DOI 10.1175/1520-0442(2004)017<1055:NAWCRS>2.0.CO;2; CONKRIGHT M, 1998, 15 NODC; Florineth D, 2000, QUATERNARY RES, V54, P295, DOI 10.1006/qres.2000.2169; Hayes A, 2005, QUATERNARY SCI REV, V24, P999, DOI 10.1016/j.quascirev.2004.02.018; Jacobeit J, 2001, CLIMATIC CHANGE, V48, P219, DOI 10.1023/A:1005619023045; Jost A, 2005, CLIM DYNAM, V24, P577, DOI 10.1007/s00382-005-0009-4; JUSTINO F, 2005, GEOPHYS RES LETT, V32; Kageyama M, 2006, QUATERNARY SCI REV, V25, P2082, DOI 10.1016/j.quascirev.2006.02.010; Kageyama M, 1999, CLIM DYNAM, V15, P773, DOI 10.1007/s003820050315; Kerschner H, 2000, ANN GLACIOL-SER, V31, P80, DOI 10.3189/172756400781820237; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; LAINE A, 2008, CLIM DYN; Larrasoana JC, 2003, CLIM DYNAM, V21, P689, DOI 10.1007/s00382-003-0355-z; Luterbacher J, 2006, DEV EARTH ENV SCI, V4, P27; Masson-Delmotte V, 2006, CLIM DYNAM, V26, P513, DOI [10.1007/s00382-005-0081-9, 10.1007/S00382-005-0081-9]; Messerli B, 1967, GEOGR HELV, V22, P105, DOI DOI 10.5194/GH-22-105-1967; Peyron O, 1998, QUATERNARY RES, V49, P183, DOI 10.1006/qres.1997.1961; PFLAUMANN U, 2003, PALAEOCEANOGRAPHY, V18; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Ramstein G, 2007, CLIM PAST, V3, P331, DOI 10.5194/cp-3-331-2007; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; Rohling EJ, 1998, PALEOCEANOGRAPHY, V13, P316, DOI 10.1029/98PA00671; STEINER D, 2008, CLIM CHANGE; Wu HB, 2007, CLIM DYNAM, V29, P211, DOI 10.1007/s00382-007-0231-3; Xoplaki E, 2004, CLIM DYNAM, V23, P63, DOI 10.1007/s00382-004-0422-0	27	181	181	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1338	1340		10.1126/science.1157638	http://dx.doi.org/10.1126/science.1157638			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18669823				2022-12-28	WOS:000258914300045
J	Liu, J; Bartesaghi, A; Borgnia, MJ; Sapiro, G; Subramaniam, S				Liu, Jun; Bartesaghi, Alberto; Borgnia, Mario J.; Sapiro, Guillermo; Subramaniam, Sriram			Molecular architecture of native HIV-1 gp120 trimers	NATURE			English	Article							ENVELOPE GLYCOPROTEIN; IMMUNODEFICIENCY; NEUTRALIZATION; REPLICATION; RECEPTOR; COMPLEX; LACKING; EPITOPE; V1; V2	The envelope glycoproteins (Env) of human and simian immunodeficiency viruses ( HIV and SIV, respectively) mediate virus binding to the cell surface receptor CD4 on target cells to initiate infection(1). Env is a heterodimer of a transmembrane glycoprotein (gp41) and a surface glycoprotein ( gp120), and forms trimers on the surface of the viral membrane. Using cryo- electron tomography combined with three- dimensional image classification and averaging, we report the three- dimensional structures of trimeric Env displayed on native HIV- 1 in the unliganded state, in complex with the broadly neutralizing antibody b12 and in a ternary complex with CD4 and the 17b antibody. By fitting the known crystal structures(2,3) of the monomeric gp120 core in the b12- and CD4/17b-bound conformations into the density maps derived by electron tomography, we derive molecular models for the native HIV- 1 gp120 trimer in unliganded and CD4- bound states. We demonstrate that CD4 binding results in a major reorganization of the Env trimer, causing an outward rotation and displacement of each gp120 monomer. This appears to be coupled with a rearrangement of the gp41 region along the central axis of the trimer, leading to closer contact between the viral and target cell membranes. Our findings elucidate the structure and conformational changes of trimeric HIV- 1 gp120 relevant to antibody neutralization and attachment to target cells.	[Liu, Jun; Bartesaghi, Alberto; Borgnia, Mario J.; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sapiro, Guillermo] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	ss1@nih.gov		Subramaniam, Sriram/0000-0003-4231-4115; Borgnia, Mario/0000-0001-9159-1413	National Cancer Institute; National Science Foundation and the Department of Defense; NATIONAL CANCER INSTITUTE [ZIABC010825, ZIABC010412] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation and the Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Bess and J. Lifson for providing purified, AT-2 treated HIV-1 BaL virus; P. Kwong for providing purified preparations of Fab fragments of the neutralizing antibodies b12 and 17b; S. Fellini and colleagues for assistance with use of the high- performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov); E. Tyler for assistance with figures; T. M. Chou for assistance with microscope maintenance; and A. Bennett, J. Milne and T. White for comments on the manuscript. This work was supported by funds from the intramural programme of the National Cancer Institute (to S.S.), and from the National Science Foundation and the Department of Defense (to G.S.).	Ashish, 2008, J BIOL CHEM, V283, P2761, DOI 10.1074/jbc.M708325200; Bartesaghi A, 2008, J STRUCT BIOL, V162, P436, DOI 10.1016/j.jsb.2008.02.008; Bennett A, 2007, J BIOL CHEM, V282, P27754, DOI 10.1074/jbc.M702025200; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Johnson WE, 2002, J VIROL, V76, P2075, DOI 10.1128/JVI.76.5.2075-2086.2002; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Subramaniam S, 2005, CURR OPIN MICROBIOL, V8, P316, DOI 10.1016/j.mib.2005.04.012; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443	30	603	637	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					109	U76		10.1038/nature07159	http://dx.doi.org/10.1038/nature07159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668044	Green Accepted			2022-12-28	WOS:000258890200047
J	Canfield, DE; Poulton, SW; Knoll, AH; Narbonne, GM; Ross, G; Goldberg, T; Strauss, H				Canfield, Donald E.; Poulton, Simon W.; Knoll, Andrew H.; Narbonne, Guy M.; Ross, Gerry; Goldberg, Tatiana; Strauss, Harald			Ferruginous conditions dominated later neoproterozoic deep-water chemistry	SCIENCE			English	Article							GRAND-CANYON; CHUAR GROUP; OXYGENATION; EVOLUTION; IRON; SULFATE; SULFUR; ANOXIA; RECORD; CYCLE	Earth's surface chemical environment has evolved from an early anoxic condition to the oxic state we have today. Transitional between an earlier Proterozoic world with widespread deep- water anoxia and a Phanerozoic world with large oxygen- utilizing animals, the Neoproterozoic Era [ 1000 to 542 million years ago ( Ma)] plays a key role in this history. The details of Neoproterozoic Earth surface oxygenation, however, remain unclear. We report that through much of the later Neoproterozoic (< 742 +/- 6 Ma), anoxia remained widespread beneath the mixed layer of the oceans; deeper water masses were sometimes sulfidic but were mainly Fe2+- enriched. These ferruginous conditions marked a return to ocean chemistry not seen for more than one billion years of Earth history.	[Canfield, Donald E.] Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense, Denmark; [Canfield, Donald E.] Univ So Denmark, Inst Biol, DK-5230 Odense, Denmark; [Poulton, Simon W.; Goldberg, Tatiana] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Knoll, Andrew H.] Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; [Narbonne, Guy M.] Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada; [Ross, Gerry] Kupaa Farm, Kula, HI 96790 USA; [Strauss, Harald] Univ Munster, Inst Geol Palaontol, D-48149 Munster, Germany	University of Southern Denmark; University of Southern Denmark; Newcastle University - UK; Harvard University; Queens University - Canada; University of Munster	Canfield, DE (corresponding author), Univ So Denmark, Nord Ctr Earth Evolut, Campusvej 55, DK-5230 Odense, Denmark.	dec@biology.sdu.dk	Canfield, Don/C-1735-2012; Narbonne, Guy M/I-7518-2012	Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X; Goldberg, Tatiana/0000-0001-6919-9976	Natural Environment Research Council [NE/C518465/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Dehler CM, 2001, SEDIMENT GEOL, V141, P465, DOI 10.1016/S0037-0738(01)00087-2; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Goldberg T, 2007, PALAEOGEOGR PALAEOCL, V254, P175, DOI 10.1016/j.palaeo.2007.03.015; GREEN JW, 1989, GEOL MAG, V126, P567, DOI 10.1017/S0016756800022858; Hoffman PF, 2005, S AFR J GEOL, V108, P557, DOI 10.2113/108.4.557; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOLLAND HD, 1982, CHEM EVOLUTION ATMOS; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Karlstrom KE, 2000, GEOLOGY, V28, P619, DOI 10.1130/0091-7613(2000)028<0619:CGOTGC>2.3.CO;2; Kimura H, 2001, GEOLOGY, V29, P995, DOI 10.1130/0091-7613(2001)029<0995:OAATPC>2.0.CO;2; KIRSCHVINK JL, 1991, AAPG BULL, V75, P610; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; Lehmann B, 2007, GEOLOGY, V35, P403, DOI 10.1130/G23543A.1; Lyons TW, 2006, GEOCHIM COSMOCHIM AC, V70, P5698, DOI 10.1016/j.gca.2006.08.021; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; OEHLER DZ, 1979, SCIENCE, V205, P388, DOI 10.1126/science.205.4404.388; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; Schroder S, 2007, J GEOL SOC LONDON, V164, P175, DOI 10.1144/0016-76492005-022; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2008, P NATL ACAD SCI USA, V105, P7376, DOI 10.1073/pnas.0802168105; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2	32	532	581	5	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2008	321	5891					949	952		10.1126/science.1154499	http://dx.doi.org/10.1126/science.1154499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18635761	Bronze			2022-12-28	WOS:000258436700035
J	Rodriguez, JJL; Ferri, CP; Acosta, D; Guerra, M; Huang, YG; Jacob, KS; Krishnamoorthy, ES; Salas, A; Sosa, AL; Acosta, I; Dewey, ME; Gaona, C; Jotheeswaran, AT; Li, SR; Rodriguez, D; Rodriguez, G; Kumar, PS; Valhuerdi, A; Prince, M				Rodriguez, Juan J. Llibre; Ferri, Cleusa P.; Acosta, Daisy; Guerra, Mariella; Huang, Yueqin; Jacob, K. S.; Krishnamoorthy, E. S.; Salas, Aquiles; Sosa, Ana Luisa; Acosta, Isaac; Dewey, Michael E.; Gaona, Ciro; Jotheeswaran, A. T.; Li, Shuran; Rodriguez, Diana; Rodriguez, Guillermina; Kumar, P. Senthil; Valhuerdi, Adolfo; Prince, Martin		10-66 Dementia Res Grp	Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey	LANCET			English	Article							ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DEVELOPING-COUNTRY; MENTAL-HEALTH; 2 COMMUNITIES; MORTALITY; SUBTYPES; YORUBA; CARE; AGE	Background Studies have suggested that the prevalence of dementia is lower in developing than in developed regions. We investigated the prevalence and severity of dementia in sites in low-income and middle-income countries according to two definitions of dementia diagnosis. Methods We undertook one-phase cross-sectional surveys of all residents aged 65 years and older (n=14 960) in 11 sites in seven low-income and middle-income countries (China, India, Cuba, Dominican Republic, Venezuela, Mexico, and Peru). Dementia diagnosis was made according to the culturally and educationally sensitive, 10/66 dementia diagnostic algorithm, which had been prevalidated in 25 Latin American, Asian, and African centres; and by computerised application of the dementia criterion from the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). We also compared prevalence of DSM-IV dementia in each of the study sites with that from estimates in European studies. Findings The prevalence of DSM-IV dementia varied widely, from 0.3% (95% CI 0.1-0.5) in rural India to 6.3% (5.0-7.7) in Cuba. After standardisation for age and sex, DSM-IV prevalence in urban Latin American sites was four-fifths of that in Europe (standardised morbidity ratio 80 [95% CI 70-91]), but in China the prevalence was only half (56 [32-91] in rural China), and in India and rural Latin America a quarter or less of the European prevalence (18 [5-34] in rural India). 10/66 dementia prevalence was higher than that of DSM-IV dementia, and more consistent across sites, varying between 5.6% (95% CI 4.2-7.0) in rural China and 11.7% (10.3-13.1) in the Dominican Republic. The validity of the 847 of 1345 cases of 10/66 dementia not confirmed by DSM-IV was supported by high levels of associated disability (mean WHO Disability Assessment Schedule II score 33.7 [SD 28.6]). Interpretation As compared with the 10/66 dementia algorithm, the DSM-IV dementia criterion might underestimate dementia prevalence, especially in regions with low awareness of this emerging public-health problem. Funding Wellcome Trust (UK); WHO; the US Alzheimer's Association; and Fondo Nacional De Ciencia, Y Tecnologia, Consejo De Desarrollo Cientifico Y Humanistico, and Universidad Central De Venezuela (Venezuela).	[Ferri, Cleusa P.; Dewey, Michael E.; Prince, Martin] Kings Coll London, Ctr Publ Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London SE5 8AF, England; [Valhuerdi, Adolfo] Univ Hosp, Faustino Perez, Matanzas, Cuba; [Rodriguez, Guillermina] Minist Protecc Social 6th Dist, Direcc Gen Salud Publ, Santo Domingo, Dominican Rep; [Guerra, Mariella; Rodriguez, Diana] Inst Mem & Desordenes Relacionados, Lima, Peru; [Rodriguez, Juan J. Llibre] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Acosta, Daisy] Univ Nacl Pedro Henriquez Urena, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Mariella] Univ Peruana Cayetano Heredia, Lima, Peru; [Huang, Yueqin; Li, Shuran] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.; Kumar, P. Senthil] Christian Med Coll & Hosp, Vellore 632004, Tamil Nadu, India; [Krishnamoorthy, E. S.; Jotheeswaran, A. T.] Ctr Clin Neurosci, Inst Neurol Sci, Voluntary Hlth Serv, Madras, Tamil Nadu, India; [Salas, Aquiles] Cent Univ Venezuela, Dept Med, Caracas Univ Hosp, Fac Med, Caracas, Venezuela; [Sosa, Ana Luisa; Acosta, Isaac] Univ Nacl Autonoma Mexico, Cognit & Behav Unit, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico; [Gaona, Ciro] Clin Loira, Caracas, Venezuela	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Universidad Peruana Cayetano Heredia; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Central Venezuela; Universidad Nacional Autonoma de Mexico	Prince, M (corresponding author), Kings Coll London, Ctr Publ Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, De Crespigny Pk, London SE5 8AF, England.	Martin.Prince@iop.kcl.ac.uk	Rodriguez, Juan J Llibre/D-2380-2010; Dewey, Michael E/E-2049-2010; Castillo, Gilberto Isaac Acosta/CAA-2728-2022; Sosa, Ana L/A-8593-2012; Castillo, Gilberto Isaac Acosta/AAY-5476-2020; Guerra, Mariella/E-3582-2010; Prince, Martin J/A-9170-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Ferri, Cleusa Pinheiro/B-2922-2010	Rodriguez, Juan J Llibre/0000-0002-8215-3160; Dewey, Michael E/0000-0002-7522-3677; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Prince, Martin J/0000-0003-1379-7146; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Guerra, Mariella/0000-0001-8923-349X; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; GAONA MD, MSc, CIRO/0000-0002-8839-5531	Wellcome Trust [GR08002, GR066133, 080002, 066133] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BALDERESCHI M, 1994, NEUROLOGY, V44, P239, DOI 10.1212/WNL.44.2.239; Chandra V, 1998, NEUROLOGY, V51, P1000, DOI 10.1212/WNL.51.4.1000; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Dunn G, 1999, BRIT J PSYCHIAT, V174, P95, DOI 10.1192/bjp.174.2.95; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Ferri CP, 2004, INT PSYCHOGERIATR, V16, P441, DOI 10.1017/S1041610204000833; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Ganguli M, 1996, Int Psychogeriatr, V8, P507, DOI 10.1017/S1041610296002852; HALL KS, 1993, INT J METHOD PSYCH, V3, P1; HENDRIE HC, 1995, AM J PSYCHIAT, V152, P1485; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jacob KS, 2007, INT PSYCHOGERIATR, V19, P669, DOI 10.1017/S1041610207005297; Lobo A, 2000, NEUROLOGY, V54, pS4; Molero AE, 2007, NEUROEPIDEMIOLOGY, V29, P107, DOI 10.1159/000109824; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nitrini R, 2005, INT J GERIATR PSYCH, V20, P247, DOI 10.1002/gps.1274; OConnor DW, 1996, NEUROLOGY, V47, P1194, DOI 10.1212/WNL.47.5.1194; Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098; Perkins AJ, 2002, INT J GERIATR PSYCH, V17, P566, DOI 10.1002/gps.643; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Prince M, 2003, INT J EPIDEMIOL, V32, P1078, DOI 10.1093/ije/dyg321; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2000, INT J GERIATR PSYCH, V15, P21, DOI 10.1002/(SICI)1099-1166(200001)15:1<21::AID-GPS71>3.0.CO;2-5; Prince M, 1997, TROP MED INT HEALTH, V2, P993, DOI 10.1046/j.1365-3156.1997.d01-156.x; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2007, WORLD PSYCHIATRY, V6, P5; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Rehm J., 1999, INT J METH PSYCH RES, V8, P110, DOI DOI 10.1002/MPR.61; REISBERG B, 2007, DIAGNOSTIC ISSUES DE, P27; RITCHIE K, 1992, INT J EPIDEMIOL, V21, P763, DOI 10.1093/ije/21.4.763; Scazufca M, 2008, INT PSYCHOGERIATR, V20, P394, DOI 10.1017/S1041610207005625; Shaji KS, 2003, INT J GERIATR PSYCH, V18, P1, DOI 10.1002/gps.649; Zhang ZX, 2006, NEUROEPIDEMIOLOGY, V27, P177, DOI 10.1159/000096131; Zhou DF, 2006, ACTA NEUROL SCAND, V114, P273, DOI 10.1111/j.1600-0404.2006.00641.x	37	213	238	0	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					464	474		10.1016/S0140-6736(08)61002-8	http://dx.doi.org/10.1016/S0140-6736(08)61002-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335OD	18657855	Green Published			2022-12-28	WOS:000258299000030
J	Wood, E; Hogg, RS; Lima, VD; Kerr, T; Yip, B; Marshall, BDL; Montaner, JSG				Wood, Evan; Hogg, Robert S.; Lima, Viviane Dias; Kerr, Thomas; Yip, Benita; Marshall, Brandon D. L.; Montaner, Julio S. G.			Highly active antiretroviral therapy and survival in HIV-Infected injection drug users	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE PROGRESSION; CELL COUNT; ADHERENCE; HAART; CARE; ACCESS; ADULTS; ERA	Context Highly active antiretroviral therapy ( HAART) is often withheld from injection drug users ( IDUs) infected with the human immunodeficiency virus ( HIV) based on the belief that their unstable lifestyles may predetermine a markedly inferior outcome with HAART. However, long- term evaluations of HIV treatment outcomes among IDUs in comparison with other risk groups are not available. Objective To compare survival rates among HIV- infected patients initiating HAART with and without a history of injection drug use. Design, Setting, and Patients Population- based, prospective cohort study ( HAART Observational Medical Evaluation and Research [ HOMER]) of 3116 antiretroviral-naive HIV- infected patients in a province- wide HIV/ AIDS treatment program in British Columbia, Canada. Of the 3116 patients, 915 were IDUs ( 29.4%), 579 were female ( 18.6%), and the median age was 39.4 years ( interquartile range, 33.3- 46.4 years). Treatment with HAART was initiated between August 1, 1996, and June 30, 2006. The median duration of follow- up was 5.3 years ( interquartile range, 2.8- 8.3 years) for IDUs and 4.3 years ( interquartile range, 2.0- 7.6 years) for non- IDUs. Patients were followed up until June 30, 2007. Data were analyzed between November 1, 2007, and May 26, 2008. Main Outcome Measure All- cause mortality. Results Overall, 622 individuals died ( 20.0%) during the study period ( 232 IDUs and 390 non- IDUs), for a crude mortality rate of 20.0% ( 95% confidence interval [ CI], 18.4%- 21.5%). At 84 months after the initiation of HAART, the product limit estimate of the cumulative all- cause mortality rate was similar between the 915 IDUs ( 26.5%; 95% CI, 23.2%- 29.8%) and 2201 non- IDUs ( 21.6%; 95% CI, 16.9%- 26.2%) ( Wilcoxon P=. 47). In multivariate time- updated Cox regression, the hazard ratio of mortality was similar between IDUs and non- IDUs ( 1.09; 95% CI, 0.92- 1.29). Conclusion In this study population, injection drug use was not associated with decreased survival among HIV- infected patients initiating HAART.	[Wood, Evan; Lima, Viviane Dias; Kerr, Thomas; Montaner, Julio S. G.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Wood, Evan; Lima, Viviane Dias; Kerr, Thomas; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Simon Fraser University	Montaner, JSG (corresponding author), Univ British Columbia, AIDS Res Program, 667-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@cfenet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012; Marshall, Brandon/B-4895-2010	Hogg, Robert S/0000-0003-3463-5488; Marshall, Brandon/0000-0002-0134-7052				Aceijas C, 2006, ADDICTION, V101, P1246, DOI 10.1111/j.1360-0443.2006.01509.x; ALLISON PD, 2004, SURVIVAL ANAL USING; Ball AL, 2007, INT J DRUG POLICY, V18, P241, DOI 10.1016/j.drugpo.2007.07.001; Bruce RD, 2007, INFECT DIS CLIN N AM, V21, P149, DOI 10.1016/j.idc.2007.03.009; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Collett D, 1994, MODELLING SURVIVAL D; Ding L, 2005, ARCH INTERN MED, V165, P618, DOI 10.1001/archinte.165.6.618; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Loughlin A, 2004, AIDS CARE, V16, P485, DOI 10.1080/09540120410001683411; Maisels L, 2001, AIDS PATIENT CARE ST, V15, P185, DOI 10.1089/10872910151133701; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V22, P369; Mocroft A, 2004, AIDS, V18, P2333, DOI 10.1097/00002030-200411190-00018; PARMAR M, 1995, SURVIVAL ANAL PRACTI; Poundstone KE, 2001, AIDS, V15, P1115, DOI 10.1097/00002030-200106150-00006; *PUBL HLTH AG CAN, EST HIV PREV INC CAN; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Tyndall MW, 2007, INT J DRUG POLICY, V18, P281, DOI 10.1016/j.drugpo.2006.11.009; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; Wood E, 2003, J INFECT DIS, V188, P1164, DOI 10.1086/378703; Wood E, 2007, LANCET, V370, P8, DOI 10.1016/S0140-6736(07)61025-3; World Health Organization, INT STAT CLASS DIS R, V10th	27	181	183	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					550	554		10.1001/jama.300.5.550	http://dx.doi.org/10.1001/jama.300.5.550			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	333YG	18677027	Bronze			2022-12-28	WOS:000258188900016
J	Catto, G				Catto, Graeme			Acting as an expert witness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Gen Med Council, London, England		Catto, G (corresponding author), Gen Med Council, London, England.	opce@gmc-uk.org						*CHIEF MED OFF, 2006, BEAR GOOD WITN; *GEN MED COUNC, 2008, ACT EXP WITN; General Medical Council, GOOD MED PRACT	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a933	10.1136/bmj.a933	http://dx.doi.org/10.1136/bmj.a933			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18653630				2022-12-28	WOS:000258561000023
J	Lehman, TJA				Lehman, Thomas J. A.			Are withdrawal trials in paediatric rheumatic disease helpful?	LANCET			English	Editorial Material									Hosp Special Surg, Div Pediat Rheumatol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Lehman, TJA (corresponding author), Hosp Special Surg, Div Pediat Rheumatol, 535 E 70th St, New York, NY 10021 USA.	goldscout@aol.com						*BRIST MYERS SQUIB, ORENCIA AB; Fernandes R, 2008, J PEDIATR-US, V152, P527, DOI 10.1016/j.jpeds.2007.09.024; Irvine EJ, 2006, GASTROENTEROLOGY, V130, P1538, DOI 10.1053/j.gastro.2005.11.058; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Lehman Thomas J A, 2007, Arthritis Rheum, V56, P2815, DOI 10.1002/art.22837; Rothner AD, 2006, HEADACHE, V46, P101, DOI 10.1111/j.1526-4610.2006.00313.x; RUPERTO N, 2008, LANCET          0715, DOI DOI 10.1016/S0140-6736(08)60998-8	8	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					348	350		10.1016/S0140-6736(08)60999-X	http://dx.doi.org/10.1016/S0140-6736(08)60999-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18632148				2022-12-28	WOS:000258196000005
J	Freeth, T; Jones, A; Steele, JM; Bitsakis, Y				Freeth, Tony; Jones, Alexander; Steele, John M.; Bitsakis, Yanis			Calendars with Olympiad display and eclipse prediction on the Antikythera Mechanism	NATURE			English	Article								Previous research on the Antikythera Mechanism established a highly complex ancient Greek geared mechanism with front and back output dials(1-7). The upper back dial is a 19- year calendar, based on the Metonic cycle, arranged as a five- turn spiral(1,6,8). The lower back dial is a Saros eclipse- prediction dial, arranged as a four- turn spiral of 223 lunar months, with glyphs indicating eclipse predictions(6). Here we add surprising findings concerning these back dials. Though no month names on the Metonic calendar were previously known, we have now identified all 12 months, which are unexpectedly of Corinthian origin. The Corinthian colonies of northwestern Greece or Syracuse in Sicily are leading contenders - the latter suggesting a heritage going back to Archimedes. Calendars with excluded days to regulate month lengths, described in a first century BC source(9), have hitherto been dismissed as implausible(10,11). We demonstrate their existence in the Antikythera calendar, and in the process establish why the Metonic dial has five turns. The upper subsidiary dial is not a 76- year Callippic dial as previously thought(8), but follows the four- year cycle of the Olympiad and its associated Panhellenic Games. Newly identified index letters in each glyph on the Saros dial show that a previous reconstruction needs modification(6). We explore models for generating the unusual glyph distribution, and show how the eclipse times appear to be contradictory. We explain the four turns of the Saros dial in terms of the full moon cycle and the Exeligmos dial as indicating a necessary correction to the predicted eclipse times. The new results on the Metonic calendar, Olympiad dial and eclipse prediction link the cycles of human institutions with the celestial cycles embedded in the Mechanism's gearwork.	[Freeth, Tony; Bitsakis, Yanis] Antikythera Mech Res Project, Cardiff CF23 5QP, Wales; [Freeth, Tony] Images First Ltd, London W5 4SE, England; [Jones, Alexander] Inst Study Ancient World, New York, NY 10028 USA; [Steele, John M.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Bitsakis, Yanis] Ctr Hist & Palaeog, GR-10560 Athens, Greece	Durham University	Freeth, T (corresponding author), Antikythera Mech Res Project, 3 Tyrwhitt Crescent,Roath Pk, Cardiff CF23 5QP, Wales.	tony@images-first.com		Freeth, Tony/0000-0001-9375-4247				Aaboe A., 1972, Journal for the History of Astronomy, V3, P105; BRITTON JP, 1993, ROLLE ASTRONOMIE KUL, P61; Cabanes P., 1988, NIKEPHOROS, V1, P49; DILLON M, 1997, PILGRIMS PILGRIMAGE, P99; ECONOMOU NA, 2000, ANTIKYTHERA MECH AST; EDMUNDS M, 2008, ANTIKYTHERA MECH RES; Evans James, 2006, GEMINOS INTRO PHENOM; Freeth T, 2006, NATURE, V444, P587, DOI 10.1038/nature05357; HADLAND R, 2008, ANTIKYTHERA MECH RES; HANNAH R, 2005, GREEK ROMAN CALENDAR, V170; Hultsch F., 1878, PAPPI ALEXANDRINI CO, V3; Jones Alexander, 2000, Z PAPYROLOG EPIGRAPH, V129, P141; Keyes C. W., 1928, LOEB CLASSICAL LIB, V213; Malzbender T., 2006, POLYNOMIAL TEXTURE M; NEUGEBAUER O, 1975, HIST ANCIENT MATH AS, V617; PRICE DJD, 1974, T AM PHILOS SOC, V64, P1; Steele JM, 2000, ARCH HIST EXACT SCI, V54, P421, DOI 10.1007/s004070050007; Toomer Gerald J., 1984, PTOLEMYS ALMAGEST; TRUMPY C., 1997, BIBLIOTHEK KLASSISCH, V98; Wright M. T., 2003, ANTIQUARIAN HOROLOGY, Vxxvii, P270; Wright M. T., 2006, ANTIQUARIAN HOROLOGY, V29, P319; Wright MT, 2005, B SCI INSTRUM SOC, V85, P2; WRIGHT MT, 2005, ANTIQUAR HOROL, V29, P51; WRIGHT MT, 2005, B SCI INSTRUMENT SOC, V87, P8	24	71	71	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					614	617		10.1038/nature07130	http://dx.doi.org/10.1038/nature07130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668103				2022-12-28	WOS:000258026500041
J	Berwick, D				Berwick, Donald			A transatlantic review of the NHS at 60	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REGIONAL-VARIATIONS; CARE		Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, D (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	dberwick@ihi.org						Darzi A., 2008, HIGH QUALITY CARE AL; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Leatherman S, 2008, QUEST QUALITY REFINI	4	18	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2008	337	7663							a838	10.1136/bmj.a838	http://dx.doi.org/10.1136/bmj.a838			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335EG	18640956				2022-12-28	WOS:000258273000037
J	Ben-Shahar, TR; Heeger, S; Lehane, C; East, P; Flynn, H; Skehel, M; Uhlmann, F				Ben-Shahar, Tom Rolef; Heeger, Sebastian; Lehane, Chris; East, Philip; Flynn, Helen; Skehel, Mark; Uhlmann, Frank			Eco1-dependent cohesin acetylation during establishment of sister chromatid cohesion	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; ATP HYDROLYSIS; FISSION YEAST; S-PHASE; CHROMOSOMES; PROTEIN; ASSOCIATION; RESOLUTION; STABILITY	Replicated chromosomes are held together by the chromosomal cohesin complex from the time of their synthesis in S phase onward. This requires the replication fork- associated acetyl transferase Eco1, but Eco1's mechanism of action is not known. We identified spontaneous suppressors of the thermosensitive eco1-1 allele in budding yeast. An acetylation- mimicking mutation of a conserved lysine in cohesin's Smc3 subunit makes Eco1 dispensable for cell growth, and we show that Smc3 is acetylated in an Eco1- dependent manner during DNA replication to promote sister chromatid cohesion. A second set of eco1-1 suppressors inactivate the budding yeast ortholog of the cohesin destabilizer Wapl. Our results indicate that Eco1 modifies cohesin to stabilize sister chromatid cohesion in parallel with a cohesion establishment reaction that is in principle Eco1- independent.	[Ben-Shahar, Tom Rolef; Heeger, Sebastian; Lehane, Chris; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; [East, Philip] Canc Res UK London Res Inst, Bioinformat & Biostat Serv, London WC2A 3PX, England; [Flynn, Helen; Skehel, Mark] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK; Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk		Uhlmann, Frank/0000-0002-3527-6619; East, Philip/0000-0001-5801-5713; Flynn, Helen/0000-0001-7002-9130				Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nasmyth K, 2004, PHILOS T R SOC B, V359, P99, DOI 10.1098/rstb.2003.1417; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876	28	358	361	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					563	566		10.1126/science.1157774	http://dx.doi.org/10.1126/science.1157774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653893				2022-12-28	WOS:000257888900048
J	Grant, RM; Hamer, D; Hope, T; Johnston, R; Lange, J; Lederman, MM; Lieberman, J; Miller, CJ; Moore, JP; Mosier, DE; Richman, DD; Schooley, RT; Springer, MS; Veazey, RS; Wainberg, MA				Grant, Robert M.; Hamer, Dean; Hope, Thomas; Johnston, Rowena; Lange, Joep; Lederman, Michael M.; Lieberman, Judy; Miller, Christopher J.; Moore, John P.; Mosier, Donald E.; Richman, Douglas D.; Schooley, Robert T.; Springer, Marty S.; Veazey, Ronald S.; Wainberg, Mark A.			Perspective - Whither or wither microbicides?	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; VAGINAL MICROBICIDE; DRUG-RESISTANCE; NONOXYNOL-9; HIV; STRATEGIES		[Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94518 USA; [Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94518 USA; [Hamer, Dean] NCI, NIH, Bethesda, MD 20817 USA; [Hope, Thomas] Northwestern Univ, Chicago, IL 60611 USA; [Johnston, Rowena] Fdn AIDS Res amfAR, New York, NY 10005 USA; [Lange, Joep] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lederman, Michael M.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA; [Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Mosier, Donald E.] Scripps Res Inst, La Jolla, CA 92037 USA; [Richman, Douglas D.] San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Richman, Douglas D.; Schooley, Robert T.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Springer, Marty S.] Merck & Co Inc, Rahway, NJ 07090 USA; [Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; University of Amsterdam; Academic Medical Center Amsterdam; Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis; Cornell University; Scripps Research Institute; University of California System; University of California San Diego; Merck & Company; Tulane University; McGill University	Grant, RM (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94518 USA.		Lieberman, Judy/A-2717-2015; Johnston, Rowena/R-4173-2019	Grant, Robert/0000-0002-0851-7085; Johnston, Rowena/0000-0002-5027-737X	NIAID NIH HHS [U19 AI076981, U19 AI076981-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076981] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Coplan PM, 2004, SCIENCE, V304, P1911, DOI 10.1126/science.1100441; De Clercq E, 2004, CHEM BIODIVERS, V1, P44, DOI 10.1002/cbdv.200490012; Duran AS, 2007, AIDS, V21, P199, DOI 10.1097/QAD.0b013e328011770b; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; FLEXNER C, 1991, ANTIMICROB AGENTS CH, V35, P2544, DOI 10.1128/AAC.35.12.2544; HEERA J, 2008, 15 C RETR OPP INF 3; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Malcolm Karl, 2004, Biotechnol Genet Eng Rev, V21, P81; Martinez J, 2006, ANTIVIR RES, V71, P343, DOI 10.1016/j.antiviral.2006.05.013; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; MEYLAN PRA, 1994, ANTIMICROB AGENTS CH, V38, P2910, DOI 10.1128/AAC.38.12.2910; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; SAAG M, 2007, 4 INT AIDS SOC C HIV; Shattock RJ, 2002, NAT MED, V8, P425, DOI 10.1038/nm0502-425; Stafford MK, 1998, J ACQ IMMUN DEF SYND, V17, P327, DOI 10.1097/00042560-199804010-00006; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; van de Wijgert JHHM, 2007, AIDS, V21, P2369, DOI 10.1097/QAD.0b013e3282ef83fd; Ward H, 1996, SEX TRANSM DIS, V23, P413, DOI 10.1097/00007435-199609000-00012	19	108	116	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					532	534		10.1126/science.1160355	http://dx.doi.org/10.1126/science.1160355			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653884	Green Accepted			2022-12-28	WOS:000257888900038
J	Lee, K; Zhang, Y; Lee, SE				Lee, Kihoon; Zhang, Yu; Lee, Sang Eun			Saccharomyces cerevisiae ATM orthologue suppresses break-induced chromosome translocations	NATURE			English	Article							DOUBLE-STRAND BREAK; DNA-DAMAGE CHECKPOINT; TELOMERE LENGTH; MRE11 COMPLEX; GENOMIC INSTABILITY; BUDDING YEAST; S-PHASE; CHROMATIN; RECOMBINATION; REPAIR	Chromosome translocations are frequently associated with many types of blood-related cancers and childhood sarcomas. Detection of chromosome translocations assists in diagnosis, treatment and prognosis of these diseases(1); however, despite their importance to such diseases, the molecular mechanisms leading to chromosome translocations are not well understood. The available evidence indicates a role for non-homologous end joining (NHEJ) of DNA double-strand breaks (DSBs) in their origin(1-3). Here we develop a yeast-based system that induces a reciprocal chromosome translocation by formation and ligation of breaks on two different chromosomes. We show that interchromosomal end joining is efficiently suppressed by the Tel1- and Mre11-Rad50-Xrs2-dependent pathway; this is distinct from the role of Tel1 in telomeric integrity and from Mec1- and Tel1- dependent checkpoint controls. Suppression of DSB-induced chromosome translocations depends on the kinase activity of Tel1 and Dun1, and the damage-induced phosphorylation of Sae2 and histone H2AX proteins. Tel1- and Sae2-dependent tethering and promotion of 59 to 39 degradation of broken chromosome ends discourage error-prone NHEJ and interchromosomal NHEJ, preserving chromosome integrity on DNA damage. Our results indicate that, like human ATM, Tel1 serves as a key regulator for chromosome integrity in the pathway that reduces the risk for DSB-induced chromosome translocations, and are probably pertinent to the oncogenic chromosome translocations in ATM-deficient cells.	[Lee, Kihoon; Zhang, Yu; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Lee, Kihoon; Zhang, Yu; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Lee, SE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA.	lees4@uthscsa.edu		Zhang, Yu/0000-0002-6525-2458				ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Bassing CH, 2004, CELL CYCLE, V3, P149; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chakhparonian M, 2005, CURR GENET, V48, P310, DOI 10.1007/s00294-005-0020-7; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Mallory JC, 2003, DNA REPAIR, V2, P1041, DOI 10.1016/S1568-7864(03)00115-0; Moreau S, 1999, MOL CELL BIOL, V19, P556; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	30	58	58	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					543	U12		10.1038/nature07054	http://dx.doi.org/10.1038/nature07054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650924				2022-12-28	WOS:000257860300057
J	Xue, L				Xue, Lan			The prizes and pitfalls of progress	NATURE			English	Editorial Material									[Xue, Lan] Tsinghua Univ, Sch Publ Policy & Management, Beijing 100084, Peoples R China; [Xue, Lan] Tsinghua Univ, China Inst Sci & Technol Policy, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xue, L (corresponding author), Tsinghua Univ, Sch Publ Policy & Management, Beijing 100084, Peoples R China.	xuelan@tsinghua.edu.cn						Leadbeater C., 2007, ATLAS IDEAS ASIAN IN; Sulston J., 2008, TIMES           0705; XIE Y, 2008, CHINESE YOUTH D 0625	3	15	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					398	401		10.1038/454398a	http://dx.doi.org/10.1038/454398a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650892				2022-12-28	WOS:000257860300021
J	Sudarsan, N; Lee, ER; Weinberg, Z; Moy, RH; Kim, JN; Link, KH; Breaker, RR				Sudarsan, N.; Lee, E. R.; Weinberg, Z.; Moy, R. H.; Kim, J. N.; Link, K. H.; Breaker, R. R.			Riboswitches in eubacteria sense the second messenger cyclic di-GMP	SCIENCE			English	Article							VIBRIO-CHOLERAE; DIGUANYLATE CYCLASE; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; MOTILITY; BACTERIA; RECEPTOR; DOMAIN	Cyclic di-guanosine monophosphate (di-GMP) is a circular RNA dinucleotide that functions as a second messenger in diverse species of bacteria to trigger wide-ranging physiological changes, including cell differentiation, conversion between motile and biofilm lifestyles, and virulence gene expression. However, the mechanisms by which cyclic di-GMP regulates gene expression have remained a mystery. We found that cyclic di-GMP in many bacterial species is sensed by a riboswitch class in messenger RNA that controls the expression of genes involved in numerous fundamental cellular processes. A variety of cyclic di-GMP regulons are revealed, including some riboswitches associated with virulence gene expression, pilus formation, and flagellum biosynthesis. In addition, sequences matching the consensus for cyclic di-GMP riboswitches are present in the genome of a bacteriophage.	[Sudarsan, N.; Link, K. H.; Breaker, R. R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Lee, E. R.; Weinberg, Z.; Kim, J. N.; Breaker, R. R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Moy, R. H.; Breaker, R. R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Moy, Ryan/0000-0002-0507-8590; Weinberg, Zasha/0000-0002-6681-3624; Breaker, Ronald/0000-0002-2165-536X	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR19895-02, S10 RR019895] Funding Source: Medline; NHLBI NIH HHS [N01HV28186, HV28186] Funding Source: Medline; NIDDK NIH HHS [R33 DK07027] Funding Source: Medline; NIGMS NIH HHS [GM 068819, T32 GM007223, R01 GM068819, T32GM007223] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM068819] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Beyhan S, 2007, MOL MICROBIOL, V63, P995, DOI 10.1111/j.1365-2958.2006.05568.x; Breaker RR, 2008, SCIENCE, V319, P1795, DOI 10.1126/science.1152621; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07	22	508	548	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					411	413		10.1126/science.1159519	http://dx.doi.org/10.1126/science.1159519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635805	Green Accepted			2022-12-28	WOS:000257713900052
J	Sloan, VS				Sloan, Victor S.			The content of their character	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sloan, Victor S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sloan, VS (corresponding author), Celgene Corp, 106 Allen Rd,Suite 402, Basking Ridge, NJ 07920 USA.	vsloan@celgene.com						Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; *US DEP HHS, 2005, NAT HEALTHC QUAL REP	2	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					142	143		10.7326/0003-4819-149-2-200807150-00012	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626055				2022-12-28	WOS:000257853700010
J	Reeves, S; Kuper, A; Hodges, BD				Reeves, Scott; Kuper, Ayelet; Hodges, Brian David			Qualitative research - Qualitative research methodologies: ethnography	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reeves, Scott] Univ Toronto, Dept Psychiat, Li Ka Shing Knowledge Inst, Ctr Fac Dev, Toronto, ON M5G 2C4, Canada; [Reeves, Scott; Kuper, Ayelet; Hodges, Brian David] Univ Toronto, Wilson Ctr Res Educ, Dept Psychiat, Toronto, ON M5G 2C4, Canada; [Kuper, Ayelet] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Reeves, S (corresponding author), Univ Toronto, Dept Psychiat, Li Ka Shing Knowledge Inst, Ctr Fac Dev, 200 Elizabeth St,Eaton S 1-565, Toronto, ON M5G 2C4, Canada.	scott.reeves@utoronto.ca		Reeves, Scott/0000-0002-0573-0622				Allen D, 1997, SOCIOL HEALTH ILL, V19, P498; Becker Howard, 1961, BOYS WHITE STUDENT C; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Costello J, 2001, J ADV NURS, V35, P59, DOI 10.1046/j.1365-2648.2001.01822.x; Denzin Norman Kent, 1970, RES ACT SOCIOLOGY; Geertz Clifford, 1973, INTERPRETATION CULTU; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Hammersley M., 1992, WHATS WRONG ETHNOGRA; Hine C., 2000, VIRTUAL ETHNOGRAPHY; Osterlund C, 2007, J MANAGE INFORM SYST, V23, P81, DOI 10.2753/MIS0742-1222230405; Reed-Danahay D, 1997, AUTOETHNOGRAPHY; Spradley J. P., 2016, PARTICIPANT OBSERVAT; Strauss A., 1963, HOSP MODERN SOC, P147; STRONG P, 1977, CEREMONIAL ORDER CLI; Taxis K, 2003, QUAL SAF HEALTH CARE, V12, P343, DOI 10.1136/qhc.12.5.343	15	253	255	10	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2008	337	7668							a1020	10.1136/bmj.a1020	http://dx.doi.org/10.1136/bmj.a1020			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350OM	18687725				2022-12-28	WOS:000259362100032
J	Clary, DC				Clary, David C.			Quantum dynamics of chemical reactions	SCIENCE			English	Editorial Material							BIMOLECULAR REACTIONS; SCATTERING; ENERGY; PROPAGATION; SURFACES; MOTION; STATES		[Clary, David C.] Univ Oxford, Dept Phys & Theoret Chem, Oxford OX1 3QZ, England	University of Oxford	Clary, DC (corresponding author), Univ Oxford, Dept Phys & Theoret Chem, Oxford OX1 3QZ, England.	david.clary@chem.ox.ac.uk	Clary, David C/AAC-3903-2019	Clary, David C/0000-0003-4439-741X				Althorpe SC, 2003, ANNU REV PHYS CHEM, V54, P493, DOI 10.1146/annurev.physchem.54.011002.103750; Aoiz FJ, 2002, J CHEM PHYS, V116, P10692, DOI 10.1063/1.1478693; CLARY DC, 1990, ANNU REV PHYS CHEM, V41, P61; CLARY DC, 1991, J CHEM PHYS, V95, P7298, DOI 10.1063/1.461407; Collins MA, 2002, THEOR CHEM ACC, V108, P313, DOI 10.1007/s00214-002-0383-5; Dai DX, 2003, SCIENCE, V300, P1730, DOI 10.1126/science.1084041; Dybala-Defratyka A, 2007, P NATL ACAD SCI USA, V104, P10774, DOI 10.1073/pnas.0702188104; Friesner RA, 2005, P NATL ACAD SCI USA, V102, P6648, DOI 10.1073/pnas.0408036102; Gray SK, 1999, J PHYS CHEM A, V103, P9448, DOI 10.1021/jp991601j; Hu WF, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2213961; Kerkeni B, 2005, MOL PHYS, V103, P1745, DOI 10.1080/00268970500044764; Kerkeni BN, 2006, PHYS CHEM CHEM PHYS, V8, P917, DOI 10.1039/b514563p; Krylov AI, 2008, ANNU REV PHYS CHEM, V59, P433, DOI 10.1146/annurev.physchem.59.032607.093602; KUPPERMANN A, 1980, CHEM PHYS LETT, V74, P257, DOI 10.1016/0009-2614(80)85153-0; Liu XH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.133201; Lopez JG, 2007, J AM CHEM SOC, V129, P9976, DOI 10.1021/ja0717360; Meyer HD, 2003, THEOR CHEM ACC, V109, P251, DOI 10.1007/s00214-003-0439-1; MEYER HD, 1990, CHEM PHYS LETT, V165, P73, DOI 10.1016/0009-2614(90)87014-I; Miller WH, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2211608; PACK RT, 1987, J CHEM PHYS, V87, P3888, DOI 10.1063/1.452944; Pogrebnya SK, 2000, PHYS CHEM CHEM PHYS, V2, P693, DOI 10.1039/a908080e; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; ROMELT J, 1980, CHEM PHYS LETT, V74, P263, DOI 10.1016/0009-2614(80)85154-2; SCHATZ GC, 1973, J CHEM PHYS, V58, P4023, DOI 10.1063/1.1679760; SCHINKE R, 1980, J CHEM PHYS, V72, P3754, DOI 10.1063/1.439589; SCHLIK T, 2002, MOL MODELING SIMULAT; Shalashilin DV, 2001, J CHEM PHYS, V115, P5367, DOI 10.1063/1.1394939; Skodje RT, 2004, INT REV PHYS CHEM, V23, P253, DOI 10.1080/01442350412331284616; Skouteris D, 2000, COMPUT PHYS COMMUN, V133, P128, DOI 10.1016/S0010-4655(00)00167-3; Strazisar BR, 2000, SCIENCE, V290, P958, DOI 10.1126/science.290.5493.958; TROE J, 1994, J CHEM SOC FARADAY T, V90, P2303, DOI 10.1039/ft9949002303; Wang Q, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2362823; Wang XG, 2008, P NATL ACAD SCI USA, V105, P6227, DOI 10.1073/pnas.0710840105; Wu T, 2004, SCIENCE, V306, P2227, DOI 10.1126/science.1104085; Yang MH, 2002, J CHEM PHYS, V117, P9539, DOI 10.1063/1.1524181; Yuan KJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.103202; ZHANG DH, 1994, J CHEM PHYS, V101, P1146, DOI 10.1063/1.467808; Zhang DH, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217439; Zhang XB, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162532	40	49	49	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					789	791		10.1126/science.1157718	http://dx.doi.org/10.1126/science.1157718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687951				2022-12-28	WOS:000258261000031
J	Klein, ML; Shinoda, W				Klein, Michael L.; Shinoda, Wataru			Large-scale molecular dynamics simulations of self-assembling systems	SCIENCE			English	Editorial Material							CHEMISTRY; COMPUTER; POWER; MODEL		[Klein, Michael L.] Univ Penn, Dept Chem, Ctr Mol Modeling, Philadelphia, PA 19104 USA; [Shinoda, Wataru] Natl Inst Adv Ind Sci & Technol, Res Inst Computat Sci, Tsukuba, Ibaraki 3058568, Japan	University of Pennsylvania; National Institute of Advanced Industrial Science & Technology (AIST)	Klein, ML (corresponding author), Univ Penn, Dept Chem, Ctr Mol Modeling, Philadelphia, PA 19104 USA.	klein@lrsm.upenn.edu; w.shinoda@aist.go.jp	Shinoda, Wataru/M-9948-2018	Shinoda, Wataru/0000-0002-3388-9227	NIGMS NIH HHS [GM 40712] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040712] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; ARKHIPOV A, 2008, BIOPHYS J, DOI DOI 10.1529/BIOPHYSJ.107.121160; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Borrell B, 2008, NATURE, V451, P240, DOI 10.1038/451240a; Carter EA, 2008, SCIENCE, V321, P800, DOI 10.1126/science.1158009; Cooper VR, 2008, J AM CHEM SOC, V130, P1304, DOI 10.1021/ja0761941; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Head-Gordon M, 2008, PHYS TODAY, V61, P58, DOI 10.1063/1.2911179; Kitao A, 2006, P NATL ACAD SCI USA, V103, P4894, DOI 10.1073/pnas.0510285103; MARKOFF J, 2008, NY TIMES        0609; Mirijanian DT, 2008, P NATL ACAD SCI USA, V105, P1204, DOI 10.1073/pnas.0707500105; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Neri M, 2008, BIOPHYS J, V94, P71, DOI 10.1529/biophysj.107.116301; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Sanbonmatsu KY, 2007, J STRUCT BIOL, V157, P470, DOI 10.1016/j.jsb.2006.10.023; Shelley JC, 2001, J PHYS CHEM B, V105, P4464, DOI 10.1021/jp010238p; Shih AY, 2007, J STRUCT BIOL, V157, P579, DOI 10.1016/j.jsb.2006.08.006; Shinoda W, 2007, MOL SIMULAT, V33, P27, DOI 10.1080/08927020601054050; SMIT B, 1990, NATURE, V348, P624, DOI 10.1038/348624a0; Studt F, 2008, SCIENCE, V320, P1320, DOI 10.1126/science.1156660; Treptow W, 2008, J PHYS CHEM B, V112, P3277, DOI 10.1021/jp709675e; van Meel JA, 2008, MOL SIMULAT, V34, P259, DOI 10.1080/08927020701744295; Vanden-Eijnden E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2833040; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	25	333	343	5	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					798	800		10.1126/science.1157834	http://dx.doi.org/10.1126/science.1157834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687954				2022-12-28	WOS:000258261000034
J	Jones, PA; Archer, TK; Baylin, SB; Beck, S; Berger, S; Bernstein, BE; Carpten, JD; Clark, SJ; Costello, JF; Doerge, RW; Esteller, M; Feinberg, AP; Gingeras, TR; Greally, JM; Henikoff, S; Herman, JG; Jackson-Grusby, L; Jenuwein, T; Jirtle, RL; Kim, YJ; Laird, PW; Lim, B; Martienssen, R; Polyak, K; Stunnenberg, H; Tlsty, TD; Tycko, B; Ushijima, T; Zhu, JD; Pirrotta, V; Allis, CD; Elgin, SC; Rine, J; Wu, C				Jones, Peter A.; Archer, Trevor K.; Baylin, Stephen B.; Beck, Stephan; Berger, Shelley; Bernstein, Bradley E.; Carpten, John D.; Clark, Susan J.; Costello, Joseph F.; Doerge, Rebecca W.; Esteller, Manel; Feinberg, Andrew P.; Gingeras, Thomas R.; Greally, John M.; Henikoff, Steven; Herman, James G.; Jackson-Grusby, Laurie; Jenuwein, Thomas; Jirtle, Randy L.; Kim, Young-Joon; Laird, Peter W.; Lim, Bing; Martienssen, Robert; Polyak, Kornelia; Stunnenberg, Henk; Tlsty, Thea Dorothy; Tycko, Benjamin; Ushijima, Toshikazu; Zhu, Jingde; Pirrotta, Vincenzo; Allis, C. David; Elgin, Sarah C.; Rine, Jasper; Wu, Carl		Amer Assoc Canc Res Human Epigenom; European Union Network Excellence	Moving AHEAD with an international human epigenome project	NATURE			English	Editorial Material							DNA METHYLATION; HUMAN GENOME; ARABIDOPSIS-THALIANA; CELLS; TRANSCRIPTION; PLURIPOTENT		[Jones, Peter A.; Laird, Peter W.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Archer, Trevor K.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Baylin, Stephen B.; Herman, James G.] Johns Hopkins Univ, Baltimore, MD 21231 USA; [Beck, Stephan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Berger, Shelley] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Carpten, John D.] TGen, Phoenix, AZ 85004 USA; [Clark, Susan J.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Doerge, Rebecca W.] Purdue Univ, W Lafayette, IN 47907 USA; [Esteller, Manel] Spanish Natl Canc Ctr, Madrid, Spain; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Oncol & Mol Biol, Baltimore, MD 21205 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD 21205 USA; [Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA; [Greally, John M.] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Jackson-Grusby, Laurie] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jenuwein, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Jirtle, Randy L.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Kim, Young-Joon] Yonsei Univ, Seoul 120719, South Korea; [Lim, Bing] Genome Inst Singapore, Singapore 138672, Singapore; [Martienssen, Robert] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Polyak, Kornelia] Dana Farber Canc Inst, Boston, MA 02115 USA; [Stunnenberg, Henk] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Tlsty, Thea Dorothy] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Tycko, Benjamin] Columbia Univ, New York, NY 10032 USA; [Ushijima, Toshikazu] Natl Canc Ctr, Tokyo 1040045, Japan; [Zhu, Jingde] Shanghai Canc Inst, Shanghai 200032, Peoples R China; [Pirrotta, Vincenzo] Rutgers State Univ, Piscataway, NJ 08854 USA; [Allis, C. David] Rockefeller Univ, New York, NY 10021 USA; [Elgin, Sarah C.] Washington Univ, St Louis, MO 63130 USA; [Rine, Jasper] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Wu, Carl] NCI, Bethesda, MD 20892 USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Johns Hopkins University; Wellcome Trust Sanger Institute; The Wistar Institute; Harvard University; Massachusetts General Hospital; Translational Genomics Research Institute; Garvan Institute of Medical Research; University of California System; University of California San Francisco; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centro Nacional de Investigaciones Oncologicas (CNIO); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Affymetrix; Yeshiva University; Albert Einstein College of Medicine; Fred Hutchinson Cancer Center; Harvard University; Harvard Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Duke University; Yonsei University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Cold Spring Harbor Laboratory; Harvard University; Dana-Farber Cancer Institute; Radboud University Nijmegen; University of California System; University of California San Francisco; Columbia University; National Cancer Center - Japan; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rockefeller University; Washington University (WUSTL); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jones, PA (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA.	jones_p@ccnt.hsc.usc.edu	Greally, John/AAF-9540-2019; Esteller, Manel/L-5956-2014; Stunnenberg, Hendrik G./D-6875-2012; Clark, Susan J/U-7365-2019; Archer, Trevor K/E-5191-2019; Feinberg, Andrew/AAY-7666-2020; Clark, Susan J/B-2272-2008; Ushijima, Toshikazu/AAP-5742-2021; Laird, Peter W/G-8683-2012; Clark, Stewart/A-3462-2012	Greally, John/0000-0001-6069-7960; Esteller, Manel/0000-0003-4490-6093; Stunnenberg, Hendrik G./0000-0002-0066-1576; Clark, Susan J/0000-0001-5925-5030; Clark, Susan J/0000-0001-5925-5030; Ushijima, Toshikazu/0000-0003-3405-7817; Laird, Peter W/0000-0001-9117-3641; Clark, Stewart/0000-0003-4792-7738; Berger, Shelley/0000-0001-5398-4400; Elgin, Sarah C. R./0000-0002-5176-2510; Gingeras, Thomas/0000-0001-9106-3573; Henikoff, Steven/0000-0002-7621-8685; Feinberg, Andrew/0000-0002-8364-1991; Archer, Trevor K/0000-0001-7651-3644	Intramural NIH HHS [Z01 ES071006-09] Funding Source: Medline; NCI NIH HHS [R37 CA054358-18, R01 CA135454] Funding Source: Medline; NICHD NIH HHS [R01 HD050760] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050760] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA135454, R37CA054358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; FEINBERG AP, WORKSH DEF EP ADDR V; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Lieb JD, 2006, CYTOGENET GENOME RES, V114, P1, DOI 10.1159/000091922; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	16	123	132	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					711	715		10.1038/454711a	http://dx.doi.org/10.1038/454711a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685699	Green Submitted, Green Accepted			2022-12-28	WOS:000258228000034
J	Kashiyama, Y; Miyashita, H; Ohkubo, S; Ogawa, NO; Chikaraishi, Y; Takano, Y; Suga, H; Toyofuku, T; Nomaki, H; Kitazato, H; Nagata, T; Ohkouchi, N				Kashiyama, Y.; Miyashita, H.; Ohkubo, S.; Ogawa, N. O.; Chikaraishi, Y.; Takano, Y.; Suga, H.; Toyofuku, T.; Nomaki, H.; Kitazato, H.; Nagata, T.; Ohkouchi, N.			Evidence of global chlorophyll d	SCIENCE			English	Article							D-PRODUCING CYANOBACTERIUM		[Kashiyama, Y.; Ogawa, N. O.; Chikaraishi, Y.; Takano, Y.; Suga, H.; Toyofuku, T.; Nomaki, H.; Kitazato, H.; Ohkouchi, N.] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Miyashita, H.; Ohkubo, S.] Kyoto Univ, Dept Interdisciplinary Environm, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Nagata, T.] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyoto University; Kyoto University	Kashiyama, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	chiro@jamstec.go.jp	Chikaraishi, Yoshito/O-5250-2019; Ohkouchi, Naohiko/B-2071-2008; Ohkubo, Satoshi/N-6795-2014; Kashiyama, Yuichiro/AAW-1036-2020; Ogawa, Nanako O/AAJ-6456-2020; Takashi, Toyofuku/E-4441-2011	Chikaraishi, Yoshito/0000-0002-7506-1524; Ohkubo, Satoshi/0000-0002-2485-2561; Kashiyama, Yuichiro/0000-0001-7337-2209; Takashi, Toyofuku/0000-0001-8095-6077; OGAWA, Nanako O/0000-0002-3823-6444; Ohkouchi, Naohiko/0000-0002-6355-7469				Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Miyachi S, 1997, Z NATURFORSCH C, V52, P636; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Mizoguchi T, 2006, PHOTOCH PHOTOBIO SCI, V5, P291, DOI 10.1039/b514088a; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105	7	55	57	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					658	658		10.1126/science.1158761	http://dx.doi.org/10.1126/science.1158761			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669855				2022-12-28	WOS:000258077700034
J	Jackson, PK				Jackson, Peter K.			The hunt for cyclin	CELL			English	Editorial Material							CELL-CYCLE; MESSENGER-RNA; DEPENDENT KINASES; PROTEIN-SYNTHESIS; DESTRUCTION BOX; M-PHASE; EGGS; TRANSLATION; PROTEOLYSIS; EXTRACTS		[Jackson, Peter K.] Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA; [Jackson, Peter K.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94305 USA	Roche Holding; Genentech; Stanford University	Jackson, PK (corresponding author), Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA.	pjackson@gene.com		Jackson, Peter/0000-0002-1742-2539				EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hunt T, 2002, BIOSCIENCE REP, V22, P465, DOI 10.1023/A:1022077317801; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; ROSENTHAL ET, 1980, CELL, V20, P487, DOI 10.1016/0092-8674(80)90635-2; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670	15	7	7	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					199	202		10.1016/j.cell.2008.07.011	http://dx.doi.org/10.1016/j.cell.2008.07.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662532	Bronze			2022-12-28	WOS:000257891700006
J	Meister, G				Meister, Gunter			Molecular biology - RNA interference in the nucleus	SCIENCE			English	Editorial Material							ELEGANS; ARGONAUTES; PATHWAYS; REVEALS		Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Meister, G (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	meister@biochem.mpg.de						Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; HUTVAGNER G, 2007, NAT REV MOL CELL BIO; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	9	7	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					496	497		10.1126/science.1161854	http://dx.doi.org/10.1126/science.1161854			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653868				2022-12-28	WOS:000257888900025
J	Huber, M				Huber, Matthew			A hotter greenhouse?	SCIENCE			English	Editorial Material							SEA-SURFACE TEMPERATURES; EOCENE; CLIMATE; TEX86; CALIBRATION; OCEAN		Purdue Univ, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Huber, M (corresponding author), Purdue Univ, W Lafayette, IN 47906 USA.	huberm@purdue.edu	Huber, Matthew/A-7677-2008	Huber, Matthew/0000-0002-2771-9977				Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; Beerling DJ, 2000, PALAEOGEOGR PALAEOCL, V161, P395, DOI 10.1016/S0031-0182(00)00095-X; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; DUTTON A, 2008, GEOLOGY, pE152; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Harrington GJ, 2007, J GEOL SOC LONDON, V164, P323, DOI 10.1144/0016-76492006-027; Huber M, 2000, PALEOCEANOGRAPHY, V15, P443, DOI 10.1029/1999PA000455; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Kim JH, 2008, GEOCHIM COSMOCHIM AC, V72, P1154, DOI 10.1016/j.gca.2007.12.010; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Matthews HD, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002733; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Schouten S, 2007, ORG GEOCHEM, V38, P1537, DOI 10.1016/j.orggeochem.2007.05.014; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; Sexton PF, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001291; Sharkey TD, 2000, SCIENCE, V287, P435, DOI 10.1126/science.287.5452.435; Shellito CJ, 2003, PALAEOGEOGR PALAEOCL, V193, P113, DOI 10.1016/S0031-0182(02)00718-6; Sluijs A, 2007, NATURE, V450, P1218, DOI 10.1038/nature06400; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Tripati AK, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000937; Turich C, 2007, GEOCHIM COSMOCHIM AC, V71, P3272, DOI 10.1016/j.gca.2007.04.013; Zachos JC, 2006, GEOLOGY, V34, P737, DOI 10.1130/G22522.1; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2002, NATURE, V419, P897, DOI 10.1038/419897b	28	81	83	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					353	354		10.1126/science.1161170	http://dx.doi.org/10.1126/science.1161170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635786				2022-12-28	WOS:000257713900031
J	Smale, DA; Brown, KM; Barnes, DKA; Fraser, KPP; Clarke, A				Smale, Dan A.; Brown, Kirsty M.; Barnes, David K. A.; Fraser, Keiron P. P.; Clarke, Andrew			Ice scour disturbance in Antarctic waters	SCIENCE			English	Article							PENINSULA; DIVERSITY; BENTHOS		[Smale, Dan A.; Brown, Kirsty M.; Barnes, David K. A.; Fraser, Keiron P. P.; Clarke, Andrew] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Barnes, DKA (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	dkab@bas.ac.uk	Smale, Dan/B-3240-2011; Smale, Daniel/Y-2909-2019	Smale, Daniel/0000-0003-4157-541X; Fraser, Keiron/0000-0001-5491-8376	Natural Environment Research Council [dml011000, bas010015] Funding Source: researchfish; NERC [dml011000, bas010015] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Gutt J, 2003, MAR ECOL PROG SER, V253, P77, DOI 10.3354/meps253077; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991	6	60	62	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					371	371		10.1126/science.1158647	http://dx.doi.org/10.1126/science.1158647			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635794				2022-12-28	WOS:000257713900039
J	Bernet, ML; Miniati, F; Lilly, SJ; Kronberg, PP; Dessauges-Zavadsky, M				Bernet, Martin L.; Miniati, Francesco; Lilly, Simon J.; Kronberg, Philipp P.; Dessauges-Zavadsky, Miroslava			Strong magnetic fields in normal galaxies at high redshift	NATURE			English	Article							ROTATION MEASURE DISTRIBUTION; FARADAY-ROTATION; ABSORPTION-LINES; ALPHA SYSTEMS; TELESCOPE	The origin and growth of magnetic fields in galaxies is still something of an enigma(1). It is generally assumed that seed fields are amplified over time through the dynamo effect(2-5), but there are few constraints on the timescale. It was recently demonstrated that field strengths as traced by rotation measures of distant ( and hence ancient) quasars are comparable to those seen today(6), but it was unclear whether the high fields were in the unusual environments of the quasars themselves or distributed along the lines of sight. Here we report high- resolution spectra that demonstrate that the quasars with strong Mg II absorption lines are unambiguously associated with larger rotation measures. Because Mg II absorption occurs in the haloes of normal galaxies(7-11) along the sightlines to the quasars, this association requires that organized fields of surprisingly high strengths are associated with normal galaxies when the Universe was only about one- third of its present age.	[Bernet, Martin L.; Miniati, Francesco; Lilly, Simon J.] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Kronberg, Philipp P.] Los Alamos Natl Lab, IGPP, Los Alamos, NM 87545 USA; [Kronberg, Philipp P.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Dessauges-Zavadsky, Miroslava] Univ Geneva, Observ Geneva, CH-1290 Sauverny, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Toronto; University of Geneva	Miniati, F (corresponding author), ETH, Dept Phys, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	fm@phys.ethz.ch		Dessauges-Zavadsky, Miroslava/0000-0003-0348-2917				Beck R, 1996, ANNU REV ASTRON ASTR, V34, P155, DOI 10.1146/annurev.astro.34.1.155; Beck R, 2004, ASTROPHYS SPACE SCI, V289, P293, DOI 10.1023/B:ASTR.0000014957.31590.50; BERNET ML, 2005, THESIS ETH ZURICH; CHURCHILL CW, 2005, P IAU C C, V19, P24; Dekker H, 2000, P SOC PHOTO-OPT INS, V4008, P534, DOI 10.1117/12.395512; Gaensler BM, 2005, SCIENCE, V307, P1610, DOI 10.1126/science.1108832; Han JL, 2006, ASTROPHYS J, V642, P868, DOI 10.1086/501444; Kacprzak GG, 2008, ASTRON J, V135, P922, DOI 10.1088/0004-6256/135/3/922; Kronberg PP, 2008, ASTROPHYS J, V676, P70, DOI 10.1086/527281; KRONBERG PP, 1982, ASTROPHYS J, V263, P518, DOI 10.1086/160523; KRONBERG PP, 1994, REP PROG PHYS, V57, P325, DOI 10.1088/0034-4885/57/4/001; KRONBERG PP, 1992, ASTROPHYS J, V387, P528, DOI 10.1086/171104; KRONBERG PP, 1990, ASTROPHYS J, V355, pL31, DOI 10.1086/185731; Kulsrud RM, 1999, ANNU REV ASTRON ASTR, V37, P37, DOI 10.1146/annurev.astro.37.1.37; Kulsrud RM, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/4/046901; Nestor DB, 2005, ASTROPHYS J, V628, P637, DOI 10.1086/427547; OREN AL, 1995, ASTROPHYS J, V445, P624, DOI 10.1086/175726; PARKER EN, 1992, ASTROPHYS J, V401, P137, DOI 10.1086/172046; Peroux C, 2007, MON NOT R ASTRON SOC, V382, P177, DOI 10.1111/j.1365-2966.2007.12235.x; Prochaska JX, 2006, ASTROPHYS J, V648, P95, DOI 10.1086/505737; Rao SM, 2006, ASTROPHYS J, V636, P610, DOI 10.1086/498132; Rees MJ, 2006, ASTRON NACHR, V327, P395, DOI 10.1002/asna.200610540; Steidel CC, 1995, ESO ASTROPHY SYMP, P139; WATSON AM, 1991, MON NOT R ASTRON SOC, V248, P58, DOI 10.1093/mnras/248.1.58; WELTER GL, 1984, ASTROPHYS J, V279, P19, DOI 10.1086/161862; ZELDOVICH YB, 1983, MAGNETIC FIELDS ASTR, P37; Zibetti S, 2007, ASTROPHYS J, V658, P161, DOI 10.1086/511300	27	245	245	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2008	454	7202					302	304		10.1038/nature07105	http://dx.doi.org/10.1038/nature07105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633410	Green Submitted			2022-12-28	WOS:000257665300031
J	Camporese, G; Bernardi, E; Prandoni, P; Noventa, F; Verlato, F; Simioni, P; Ntita, K; Salmistraro, G; Frangos, C; Rossi, F; Cordova, R; Franz, F; Zucchetta, P; Kontothanassis, D; Andreozzi, GM				Camporese, Giuseppe; Bernardi, Enrico; Prandoni, Paolo; Noventa, Franco; Verlato, Fabio; Simioni, Paolo; Ntita, Kadimashi; Salmistraro, Giovanna; Frangos, Christos; Rossi, Franco; Cordova, Rosamaria; Franz, Francesca; Zucchetta, Pietro; Kontothanassis, Dimitrios; Andreozzi, Giuseppe Maria		KANT Knee Arthroscopy Nadroparin T	Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; MAJOR ORTHOPEDIC-SURGERY; ANTERIOR CRUCIATE LIGAMENT; QUALITY-OF-LIFE; VENOUS THROMBOEMBOLISM; DIAGNOSTIC MANAGEMENT; RECOMBINANT HIRUDIN; PREVENTION; ENOXAPARIN; FONDAPARINUX	Background: Knee arthroscopy, the most common orthopedic operation worldwide, carries a definite risk for deep venous thrombosis; however, postsurgical thromboprophylaxis is not routinely recommended. Objective: To evaluate whether low-molecular-weight heparin (LMWH) better prevents deep venous thrombosis and does not cause more complications than graduated compression stockings in adults having knee arthroscopy. Design: Assessor-blind, randomized, controlled trial. Setting: The Department of Knee Surgery, Abano Terme Clinic, Abano Terme (knee surgery, random assignment, and bleeding event survey), and the Unit- of Angiology, University Hospital of Padua, Padua (efficacy outcomes evaluation, follow-up,* data management, and analysis), Italy. Patients: 1761 consecutive patients undergoing knee arthroscopy between March 2002 and January 2006. Intervention: Patients were randomly assigned to wear full-length graduated compression stocking for 7 days (660 patients) or to receive a once-daily subcutaneous injection of LMWH (nadroparin, 3800 anti-Xa IU) for 7 days (657 patients) or 14 days (444 patients). The data and safety monitoring board prematurely stopped the 14-day heparin group after the second interim analysis. Measurements: Combined incidence of asymptornatic proximal deep venous thrombosis, symptomatic venous thromboembolism, and all-cause mortality (primary efficacy end point) and combined incidence of major and clinically relevant bleeding events (primary safety end point). All patients had bilateral whole-leg ultrasonography at the end of the allocated prophylactic regimen or earlier if indicated. All patients with normal findings were followed for 3 months, and none was lost to follow-up. Results: The 3-month cumulative incidence of asymptornatic proximal deep venous thrombosis, symptomatic venous thromboembolism, and all-cause mortality was 3.2% (21 of 660 patients) in the stockings group, 0.9% (6 of 657 patients) in the 7-day LMWH group (absolute difference, 2.3 percentage points [95% CI, 0.7 to 4.0 percentage points]; P = 0.005), and 0.9% (4 of 444 patients) in the prematurely stopped 14-day LMWH group. The cumulative incidence of major or clinically relevant bleeding events was 0.3% (2 of 660 patients) in the stockings group, 0.9% (6 of 657 patients) in the 7-day LMWH group (absolute difference, -0.6 percentage point [CI, -1.5 to 0.2 percentage points]), and 0.5% (2 of 444 patients) in the 14-day LMWH group. Limitations: The study was not double-blind or double-dummy. Almost half of the events making up the composite outcome measure were distal deep venous thromboses. Stockings were used instead of placebo because of local prophylaxis policies. Conclusion: In patients undergoing knee arthroscopy, prophylactic LMWH for 1 week reduced a composite end point of asymptomatic proximal deep venous thrombosis, symptomatic venous thromboembolism, and all-cause mortality more than did graduated compression stockings.	[Camporese, Giuseppe] Univ Hosp Padua, Unit Angiol, I-35128 Padua, Italy; Abano Terme Clin, Abano Terme, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova	Camporese, G (corresponding author), Univ Hosp Padua, Unit Angiol, Via Giustiniani 2, I-35128 Padua, Italy.	giuseppe.camporese@sanita.padova.it	Noventa, Franco/C-1202-2008; Zucchetta, Pietro/I-7102-2012; Simioni, Paolo/AAC-5416-2022; SIMIONI, PAOLO/AAC-5438-2022	Noventa, Franco/0000-0003-4622-5523; SIMIONI, PAOLO/0000-0002-6744-383X				Agu O, 1999, BRIT J SURG, V86, P992, DOI 10.1046/j.1365-2168.1999.01195.x; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Amaragiri SV, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001484; [Anonymous], POINTS CONS CLIN INV; Atri M, 1996, AM J ROENTGENOL, V166, P1361, DOI 10.2214/ajr.166.6.8633448; Bauer KA, 2001, NEW ENGL J MED, V345, P1305, DOI 10.1056/NEJMoa011099; BAXTER GM, 1992, CLIN RADIOL, V46, P198, DOI 10.1016/S0009-9260(05)80445-3; Bergqvist D, 2002, ARCH INTERN MED, V162, P2173, DOI 10.1001/archinte.162.19.2173; Bounameaux H, 2004, J THROMB HAEMOST, V2, P2260, DOI 10.1111/j.1538-7836.2004.01030.x; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; CAMPORESE G, 2005, J THROMB HAEMOST S1, V1, pP1618; Camporese G, 2003, J THROMB HAEMOST S1, V1; CAMPORESE G, 2007, J THROMB HAEMOST S1, V5; Cogo A, 1998, BRIT MED J, V316, P17, DOI 10.1136/bmj.316.7124.17; Cullison TR, 1996, ARTHROSCOPY, V12, P657, DOI 10.1016/S0749-8063(96)90166-8; Dahl OE, 2000, ACTA ORTHOP SCAND, V71, P47, DOI 10.1080/00016470052943883; Delis KT, 2001, THROMB HAEMOSTASIS, V86, P817; Demers C, 1998, ARCH INTERN MED, V158, P47, DOI 10.1001/archinte.158.1.47; Durica S, 1997, THROMB HAEMOST S, V77, P183; Elashoff J, 2005, NQUERY ADVISOR VERSI; Elias A, 2003, THROMB HAEMOSTASIS, V89, P221; Eriksson BI, 1997, NEW ENGL J MED, V337, P1329, DOI 10.1056/NEJM199711063371901; Eriksson BI, 1996, LANCET, V347, P635, DOI 10.1016/S0140-6736(96)91200-3; Eriksson BI, 2001, NEW ENGL J MED, V345, P1298, DOI 10.1056/NEJMoa011100; Ettema HB, 2005, ACTA ORTHOP, V76, P99, DOI 10.1080/00016470510030409; Gaitini D, 2006, J CLIN ULTRASOUND, V34, P289, DOI 10.1002/jcu.20236; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Goodacre S, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-6; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Hoppener MR, 2006, ACTA ORTHOP, V77, P767, DOI 10.1080/17453670610012962; Hoppener MR, 2005, J THROMB HAEMOST, V3, P185, DOI 10.1111/j.1538-7836.2004.01091.x; HULL R, 1993, NEW ENGL J MED, V329, P1370, DOI 10.1056/NEJM199311043291902; Ilahi OA, 2005, ARTHROSCOPY, V21, P727, DOI 10.1016/j.arthro.2005.03.007; *IT NAT HLTH SERV, 2008, ROM MIN SAL; Jaureguito JW, 1999, AM J SPORT MED, V27, P707, DOI 10.1177/03635465990270060401; Kahn SR, 2005, ARCH INTERN MED, V165, P1173, DOI 10.1001/archinte.165.10.1173; Kahn SR, 2004, J THROMB HAEMOST, V2, P2146, DOI 10.1111/j.1538-7836.2004.00957.x; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Labropoulos N, 1999, J VASC SURG, V30, P787, DOI 10.1016/S0741-5214(99)70002-9; LACHIN JM, 1977, BIOMETRICS, V33, P315, DOI 10.2307/2529781; Lassen MR, 2002, LANCET, V359, P1715, DOI 10.1016/S0140-6736(02)08652-X; Leclerc JR, 1996, ANN INTERN MED, V124, P619, DOI 10.7326/0003-4819-124-7-199604010-00001; Leizorovicz A, 2003, ANGIOLOGY, V54, P19, DOI 10.1177/000331970305400103; Lombardi AV, 2007, ORTHOPEDICS, V30, pS46; Marlovits S, 2007, ARTHROSCOPY, V23, P696, DOI 10.1016/j.arthro.2007.02.001; Michot M, 2002, ARTHROSCOPY, V18, P257, DOI 10.1053/jars.2002.30013; MORITZ JE, 2003, ORTHOPEDICS, V26, pS237; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Ramos J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005259.pub2; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Rosendaal FR, 1997, THROMB HAEMOSTASIS, V78, P1; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Schellong SM, 2007, J THROMB HAEMOST, V5, P1431, DOI 10.1111/j.1538-7836.2007.02570.x; Schellong SM, 2004, CURR OPIN PULM MED, V10, P350, DOI 10.1097/01.mcp.0000136402.24828.0e; Schellong SM, 2003, THROMB HAEMOSTASIS, V89, P228; Schwarz T, 2002, CLIN APPL THROMB-HEM, V8, P45, DOI 10.1177/107602960200800106; Stevens SM, 2004, ANN INTERN MED, V140, P985, DOI 10.7326/0003-4819-140-12-200406150-00007; STRINGER MD, 1989, J BONE JOINT SURG BR, V71, P492, DOI 10.1302/0301-620X.71B3.2785998; Turpie AGG, 2004, CHEST, V126, P501, DOI 10.1378/chest.126.2.501; Turpie AGG, 2002, ARCH INTERN MED, V162, P1833, DOI 10.1001/archinte.162.16.1833; Turpie AGG, 2002, LANCET, V359, P1721, DOI 10.1016/S0140-6736(02)08648-8; van Korlaar IM, 2004, THROMB RES, V114, P11, DOI 10.1016/j.thromres.2004.04.007; Warkentin TE, 2004, CHEST, V126, p311S, DOI 10.1378/chest.126.3_suppl.311S; Williams JS, 1995, ARTHROSCOPY, V11, P701, DOI 10.1016/0749-8063(95)90113-2; Wirth T, 2001, ARTHROSCOPY, V17, P393, DOI 10.1053/jars.2001.21247; 1990, JAMA, V263, P2753	70	94	103	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					73	82		10.7326/0003-4819-149-2-200807150-00003	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626046				2022-12-28	WOS:000257853700001
J	Kaldor, JM; Delpech, V; Guy, RJ				Kaldor, Jolin M.; Delpech, Valerie; Guy, Rebecca J.			AIDS case reporting: do we still need it?	LANCET			English	Editorial Material							IMPACT		[Kaldor, Jolin M.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia; [Delpech, Valerie] Hlth Protect Agcy, Ctr Infect, London, England; [Guy, Rebecca J.] Burnet Inst, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Health Protection Agency; Burnet Institute	Kaldor, JM (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia.	jkaldor@nchecr.unsw.edu.au	Kaldor, John M/D-4545-2011	delpech, valerie/0000-0002-9952-8109; Guy, Rebecca/0000-0002-2929-4634				ANCELLEPARK RA, 1995, LANCET, V345, P789, DOI 10.1016/S0140-6736(95)90667-3; Australian Government Department of Health, 2004, AUSTR NAT NOT DIS CA; Brannstrom J, 2005, INT J STD AIDS, V16, P702, DOI 10.1258/095646205774357262; BROOKMEYER R, 1989, STAT MED, V8, P23, DOI 10.1002/sim.4780080105; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P19; *CDCP, 2007, HIV AIDS SURV REP 20, V17; Centers for Disease Control and Prevention, 1982, MMWR-MORBID MORTAL W, V31, P507; CURRAN JW, 1984, NEW ENGL J MED, V310, P69, DOI 10.1056/NEJM198401123100201; Diaz T, 2005, AIDS, V19, pS31, DOI 10.1097/01.aids.0000172875.67262.21; *EUROHIV, 2007, 74 EURHIV EUR CTR EP; Forbes Anna, 1996, AIDS Policy Law, VBonus Report, P1; KEGELES SM, 1990, AIDS, V4, P585, DOI 10.1097/00002030-199006000-00016; Law M, 2003, HIV Med, V4, P1, DOI 10.1046/j.1468-1293.2003.00138.x; *MAP, 2004, AIDS AS FAC FACTS CO; McDonald AM, 2003, AUST NZ J PUBL HEAL, V27, P608, DOI 10.1111/j.1467-842X.2003.tb00607.x; *NAT CTR HIV EP CL, 2006, HIV AIDS VIR HEP SEX; Sladden Tim, 2005, Pac Health Dialog, V12, P23; *UK COLL GROUP HIV, 2007, TEST TIM HIV OTH SEX; *US PRES EM PLAN A, 2006, BRING HOP SUPPL ANT; *WHO, 1994, WKLY EPIDEMIOL REC, V69, P273; *WHO, 2006, PROGR GLOB ACC HIV A; *WHO, 2007, GUID PROV IN HIV TES; *WHO REG OFF AFR, HIV AIDS EP SURV REP; World Health Organization, 1997, Weekly Epidemiological Record, V72, P357; 1996, COMMUN DIS REP CDR R, V6, pR1	26	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					181	183		10.1016/S0140-6736(08)61006-5	http://dx.doi.org/10.1016/S0140-6736(08)61006-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	18684500				2022-12-28	WOS:000262340900033
J	Sekitani, T; Noguchi, Y; Hata, K; Fukushima, T; Aida, T; Someya, T				Sekitani, Tsuyoshi; Noguchi, Yoshiaki; Hata, Kenji; Fukushima, Takanori; Aida, Takuzo; Someya, Takao			A rubberlike stretchable active matrix using elastic conductors	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; WALLED CARBON NANOTUBES; THIN-FILM TRANSISTORS; LARGE-AREA; ORGANIC TRANSISTORS; HIGH-MOBILITY; ELECTRONICS; PERFORMANCE; COMPOSITES; PRESSURE	By using an ionic liquid of 1- butyl- 3- methylimidazolium bis( trifluoromethanesulfonyl) imide, we uniformly dispersed single- walled carbon nanotubes ( SWNTs) as chemically stable dopants in a vinylidene fluoride- hexafluoropropylene copolymer matrix to form a composite film. We found that the SWNT content can be increased up to 20 weight percent without reducing the mechanical flexibility or softness of the copolymer. The SWNT composite film was coated with dimethyl-siloxane- based rubber, which exhibited a conductivity of 57 siemens per centimeter and a stretchability of 134%. Further, the elastic conductor was integrated with printed organic transistors to fabricate a rubberlike active matrix with an effective area of 20 by 20 square centimeters. The active matrix sheet can be uniaxially and biaxially stretched by 70% without mechanical or electrical damage. The elastic conductor allows for the construction of electronic integrated circuits, which can be mounted anywhere, including arbitrary curved surfaces and movable parts, such as the joints of a robot's arm.	[Sekitani, Tsuyoshi; Noguchi, Yoshiaki; Someya, Takao] Univ Tokyo, Sch Engn, Quantum Phase Elect Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Hata, Kenji] Natl Inst Adv Ind Sci & Technol, Res Ctr Adv Carbon Mat, Tsukuba, Ibaraki 3058565, Japan; [Fukushima, Takanori; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Fukushima, Takanori; Aida, Takuzo] Natl Museum Emerging Sci & Innovat, Nanospace Project Exploratory Res Adv Technol Sol, Japan Sci & Technol Agcy, Koto Ku, Tokyo 1350064, Japan; [Someya, Takao] Univ Tokyo, Collaborat Inst Nano Quantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Someya, T (corresponding author), Univ Tokyo, Sch Engn, Quantum Phase Elect Ctr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	someya@ap.t.u-tokyo.ac.jp	Hata, Kenji/B-3262-2009; Aida, Takuzo/I-9117-2012; Fukushima, Takanori/D-2474-2015; Ishida, Mari/AAU-3379-2020; Someya, Takao/H-3052-2015; Sekitani, Tsuyoshi/G-4599-2018	Hata, Kenji/0000-0003-1623-391X; Fukushima, Takanori/0000-0001-5586-9238; Someya, Takao/0000-0003-3051-1138; 	Grant-in-Aid for Scientific Research; Special Coordination Funds for Promoting and Technology	Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Special Coordination Funds for Promoting and Technology	This study was partially supported by the Grant-in-Aid for Scientific Research (Kakenhi, Wakate S), the Special Coordination Funds for Promoting and Technology. We thank T. Sakurai and M. Takamiya of University of Tokyo for invaluable discussion; Y. Komatsu of Daikin for fluorinated copolymer; and A. Kosaka of Exploratory Research for Advanced Technology- Solution Oriented Research for Science and Technology Nanospace Project, Japan Science and Technology Agency, for technical support. T. Someya and T. Sekitani have filed a provisional U. S. patent (61/064,024) on this work.	Bao Z, 1996, APPL PHYS LETT, V69, P4108, DOI 10.1063/1.117834; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Dimitrakopoulos CD, 1999, SCIENCE, V283, P822, DOI 10.1126/science.283.5403.822; DODABALAPUR A, 1995, SCIENCE, V268, P270, DOI 10.1126/science.268.5208.270; Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289; Fukushima T, 2007, CHEM-EUR J, V13, P5048, DOI 10.1002/chem.200700554; GARNIER F, 1994, SCIENCE, V265, P1684, DOI 10.1126/science.265.5179.1684; Haggenmueller R, 2000, CHEM PHYS LETT, V330, P219, DOI 10.1016/S0009-2614(00)01013-7; Hamedi M, 2007, NAT MATER, V6, P357, DOI [10.1038/nmat1884, 10.1038/nma11884]; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Kato Y, 2007, IEEE T ELECTRON DEV, V54, P202, DOI 10.1109/TED.2006.888678; Katz HE, 2004, CHEM MATER, V16, P4748, DOI 10.1021/cm049781j; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Klauk H, 1999, IEEE T ELECTRON DEV, V46, P1258, DOI 10.1109/16.766895; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Lacour SP, 2005, P IEEE, V93, P1459, DOI 10.1109/JPROC.2005.851502; Mitzi DB, 2004, NATURE, V428, P299, DOI 10.1038/nature02389; Park C, 2002, CHEM PHYS LETT, V364, P303, DOI 10.1016/S0009-2614(02)01326-X; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Sekitani T, 2007, NAT MATER, V6, P413, DOI 10.1038/nmat1903; Service RF, 2004, SCIENCE, V304, P675, DOI 10.1126/science.304.5671.675; Shim BS, 2007, CHEM MATER, V19, P5467, DOI 10.1021/cm070442a; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366; Stutzmann N, 2003, SCIENCE, V299, P1881, DOI 10.1126/science.1081279; Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131	29	1128	1202	36	988	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1468	1472		10.1126/science.1160309	http://dx.doi.org/10.1126/science.1160309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18687922				2022-12-28	WOS:000259121800034
J	Tian, DC; Wang, Q; Zhang, PF; Araki, H; Yang, SH; Kreitman, M; Nagylaki, T; Hudson, R; Bergelson, J; Chen, JQ				Tian, Dacheng; Wang, Qiang; Zhang, Pengfei; Araki, Hitoshi; Yang, Sihai; Kreitman, Martin; Nagylaki, Thomas; Hudson, Richard; Bergelson, Joy; Chen, Jian-Qun			Single-nucleotide mutation rate increases close to insertions/deletions in eukaryotes	NATURE			English	Article							HUMAN GENOME; HOT-SPOT; SEQUENCE; RECOMBINATION; SUBSTITUTION; EVOLUTION; GENE; DNA; POLYMORPHISM; SPECIFICITY	Mutation hotspots are commonly observed in genomic sequences and certain human disease loci(1-7), but general mechanisms for their formation remain elusive(7-11). Here we investigate the distribution of single- nucleotide changes around insertions/ deletions ( indels) in six independent genome comparisons, including primates, rodents, fruitfly, rice and yeast. In each of these genomic comparisons, nucleotide divergence ( D) is substantially elevated surrounding indels and decreases monotonically to near-background levels over several hundred bases. D is significantly correlated with both size and abundance of nearby indels. In comparisons of closely related species, derived nucleotide substitutions surrounding indels occur in significantly greater numbers in the lineage containing the indel than in the one containing the ancestral ( non- indel) allele; the same holds within species for single- nucleotide mutations surrounding polymorphic indels. We propose that heterozygosity for an indel is mutagenic to surrounding sequences, and use yeast genome- wide polymorphism data to estimate the increase in mutation rate. The consistency of these patterns within and between species suggests that indel- associated substitution is a general mutational mechanism.	[Tian, Dacheng; Wang, Qiang; Zhang, Pengfei; Araki, Hitoshi; Yang, Sihai; Bergelson, Joy; Chen, Jian-Qun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Biol, Nanjing 210093, Peoples R China; [Araki, Hitoshi] EAWAG Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland; [Kreitman, Martin; Nagylaki, Thomas; Hudson, Richard; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Chicago	Tian, DC (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Biol, Nanjing 210093, Peoples R China.	dtian@nju.edu.cn; chenjq@nju.edu.cn	Yang, Sihai/A-1434-2013	Bergelson, Joy/0000-0001-7893-7387; Chen, Jian-Qun/0000-0003-4376-5655	NSFC [30470924, 30470122, 30570987]; NBRPC [2005CCA02100]; 111 Project	NSFC(National Natural Science Foundation of China (NSFC)); NBRPC(National Basic Research Program of China); 111 Project(Ministry of Education, China - 111 Project)	We thank A. Kondrashov (a reviewer) for suggesting the 3-species test and the possibility of a signature for indel-caused substitutions; M. Long and X. Gao for comments; and T. Petes for informing us about genome- wide measures of recombination in yeast. This study was supported by NSFC (30470924, 30470122 & 30570987) and Pre-program for NBRPC (2005CCA02100) to D.T. or J.-Q.C. and by 111 Project.	Arndt PF, 2005, J MOL EVOL, V60, P748, DOI 10.1007/s00239-004-0222-5; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Check E, 2005, NATURE, V437, P1084, DOI 10.1038/4371084a; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hedrich K, 2004, MOVEMENT DISORD, V19, P1146, DOI 10.1002/mds.20234; Iacobuzio-Donahue CA, 2004, CLIN CANCER RES, V10, P1597, DOI 10.1158/1078-0432.CCR-1121-3; JUKES T H, 1969, P21; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Longman-Jacobsen N, 2003, GENE, V312, P257, DOI 10.1016/S0378-1119(03)00621-8; Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mortazavi Y, 2003, BLOOD, V101, P2833, DOI 10.1182/blood-2002-07-2095; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Silva JC, 2002, TRENDS GENET, V18, P544, DOI 10.1016/S0168-9525(02)02757-9; Strickberger M. W., 2000, EVOLUTION; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	28	202	207	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2008	455	7209					105	U70		10.1038/nature07175	http://dx.doi.org/10.1038/nature07175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18641631				2022-12-28	WOS:000258890200046
J	Horton, R; Das, P				Horton, Richard; Das, Pam			Putting prevention at the forefront of HIV/AIDS	LANCET			English	Editorial Material							HIV PREVENTION		[Horton, Richard; Das, Pam] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							BERTOZZI SM, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60889-2; Cohen J, 2008, SCIENCE, V319, P888, DOI 10.1126/science.319.5865.888; Compston Alastair, LANCET, V372, P1502, DOI [DOI 10.1016/S0140-6736(08)60885-5, 10.1016/S0140-6736(08)61620-7, DOI 10.1016/S0140-6736(08)61620-7]; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; GUPTA GR, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60887-9; Lagakos SW, 2008, NEW ENGL J MED, V358, P1543, DOI 10.1056/NEJMp0802028; MERSON MH, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60884-3; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; PIOT P, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60888-0; Pisani E, 2008, WISDOM WHORES BUREAU; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x	13	44	45	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					421	422		10.1016/S0140-6736(08)60882-X	http://dx.doi.org/10.1016/S0140-6736(08)60882-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335OD	18687463				2022-12-28	WOS:000258299000004
J	Potenza, L; Luppi, M; Barozzi, P; Rossi, G; Cocchi, S; Codeluppi, M; Pecorari, M; Masetti, M; Di Benedetto, F; Gennari, W; Portolani, M; Gerunda, GE; Lazzarotto, T; Landini, MP; Schulz, TF; Torelli, G; Guaraldi, G				Potenza, Leonardo; Luppi, Mario; Barozzi, Patrizia; Rossi, Giulio; Cocchi, Stefania; Codeluppi, Mauro; Pecorari, Monica; Masetti, Michele; Di Benedetto, Fabrizio; Gennari, William; Portolani, Marinella; Gerunda, Giorgio Enrico; Lazzarotto, Tiziana; Landini, Maria Paola; Schulz, Thomas F.; Torelli, Giuseppe; Guaraldi, Giovanni			Brief report: HHV-6A in syncytial giant-cell hepatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-HERPESVIRUS-6 VARIANT-A; HUMAN HERPESVIRUS-6 VARIANT; PRIMARY INFECTION; TRANSPLANTATION; FEATURES; CYTOMEGALOVIRUS; TRANSFORMATION; ENCEPHALITIS; REACTIVATION; DIAGNOSIS	Syncytial giant-cell hepatitis is a rare but severe form of hepatitis that is associated with autoimmune diseases, drug reactions, and viral infections. We used serologic, molecular, and immunohistochemical methods to search for an infectious cause in a case of syncytial giant-cell hepatitis that developed in a liver-transplant recipient who had latent infection with variant B of human herpesvirus 6 (HHV-6B) and who had received the organ from a donor with variant A latent infection (HHV-6A). At the onset of the disease, the detection of HHV-6A (but not HHV-6B) DNA in plasma, in affected liver tissue, and in single micromanipulated syncytial giant cells with the use of two different polymerase-chain-reaction (PCR) assays indicated the presence of active HHV-6A infection in the patient. Expression of the HHV-6A-specific early protein, p41/38, but not of the HHV-6B-specific late protein, p101, was demonstrated only in liver syncytial giant cells in the absence of other infectious pathogens. The same markers of HHV-6A active infection were documented in serial follow-up samples from the patient and disappeared only at the resolution of syncytial giant-cell hepatitis. Neither HHV-6B DNA nor late protein was identified in the same follow-up samples from the patient. Thus, HHV-6A may be a cause of syncytial giant-cell hepatitis.	[Potenza, Leonardo; Luppi, Mario; Barozzi, Patrizia; Torelli, Giuseppe] Univ Modena & Reggio Emilia, Azienda Osped Policlin, Dept Hematol & Oncol, I-41100 Modena, Italy; [Rossi, Giulio; Pecorari, Monica; Gennari, William; Portolani, Marinella] Univ Modena & Reggio Emilia, Integrated Dept Diagnost & Lab Serv & Legal Med, Azienda Osped Policlin, I-41100 Modena, Italy; [Cocchi, Stefania; Codeluppi, Mauro; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Internal Med & Med Specialties, Azienda Osped Policlin, I-41100 Modena, Italy; [Masetti, Michele; Di Benedetto, Fabrizio; Gerunda, Giorgio Enrico] Univ Modena & Reggio Emilia, Liver & Multivisceral Transplant Ctr, Azienda Osped Policlin, I-41100 Modena, Italy; [Lazzarotto, Tiziana; Landini, Maria Paola] Univ Bologna, Dept Clin & Expt Med, Bologna, Italy; [Lazzarotto, Tiziana; Landini, Maria Paola] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Schulz, Thomas F.] Hannover Med Sch, Dept Virol, D-3000 Hannover, Germany	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Hannover Medical School	Luppi, M (corresponding author), Univ Modena & Reggio Emilia, Azienda Osped Policlin, Dept Hematol & Oncol, Via del Pozzo 71, I-41100 Modena, Italy.	mario.luppi@unimore.it	Pecorari, Monica/AAB-3829-2019; Rossi, Giulio/K-6217-2016; Gerunda, Giorgio Enrico/J-8658-2016; Potenza, Leonardo/P-9579-2016; Schulz, Thomas/AAA-1634-2019; Luppi, Mario/J-3668-2016; Di Benedetto, Fabrizio/B-8388-2015; Masetti, Michele/AAT-4638-2020; Guaraldi, Giovanni/J-9467-2018; Cocchi, Stefania/AAF-4140-2019; Barozzi, Patrizia/Q-2638-2016; Rossi, Giulio/C-5576-2011; Comoli, Patrizia/K-2732-2018; Rossi, Antonio/K-7054-2016	Pecorari, Monica/0000-0003-2332-2160; Rossi, Giulio/0000-0001-8855-1218; Gerunda, Giorgio Enrico/0000-0003-2898-1886; Potenza, Leonardo/0000-0002-2738-6105; Luppi, Mario/0000-0002-0373-1154; Di Benedetto, Fabrizio/0000-0002-6718-8760; Masetti, Michele/0000-0003-2259-8675; Barozzi, Patrizia/0000-0002-8936-1114; Comoli, Patrizia/0000-0001-5964-0553; Schulz, Thomas/0000-0001-8792-5345; Guaraldi, Giovanni/0000-0002-5724-3914; Rossi, Antonio/0000-0003-3295-0345				Barozzi P, 2003, NAT MED, V9, P975, DOI 10.1038/nm0703-975a; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Boutolleau D, 2006, J CLIN VIROL, V35, P257, DOI 10.1016/j.jcv.2005.08.002; Bultmann BD, 2003, VIRCHOWS ARCH, V442, P8, DOI 10.1007/s00428-002-0732-8; De Bolle L, 2005, CLIN MICROBIOL REV, V18, P217, DOI 10.1128/CMR.18.1.217-245.2005; Demetris AJ, 1997, HEPATOLOGY, V25, P658; DEVANEY K, 1992, HEPATOLOGY, V16, P327, DOI 10.1002/hep.1840160208; Fimmel CJ, 1998, AM J GASTROENTEROL, V93, P1931, DOI 10.1111/j.1572-0241.1998.00548.x; Kuntzen T, 2005, EUR J GASTROEN HEPAT, V17, P1131, DOI 10.1097/00042737-200510000-00020; LAU JYN, 1992, J HEPATOL, V15, P216, DOI 10.1016/0168-8278(92)90039-R; Ljungman P, 2002, J INFECT DIS, V186, pS99, DOI 10.1086/342962; Luppi M, 1998, AM J PATHOL, V153, P815, DOI 10.1016/S0002-9440(10)65623-4; Maciejewski J. P., 2006, CLIN HEMATOLOGY, P967; MacKenzie J, 1999, BRIT J CANCER, V81, P898, DOI 10.1038/sj.bjc.6690783; Maric I, 2004, MODERN PATHOL, V17, P1427, DOI 10.1038/modpathol.3800179; Moreno A, 2006, HUM PATHOL, V37, P1344, DOI 10.1016/j.humpath.2006.05.003; Mori Y, 2002, J VIROL, V76, P6750, DOI 10.1128/JVI.76.13.6750-6761.2002; PAPPO O, 1994, AM J SURG PATHOL, V18, P804, DOI 10.1097/00000478-199408000-00007; Pedersen SM, 2006, J VIROL, V80, P9916, DOI 10.1128/JVI.02693-05; PHILLIPS MJ, 1991, NEW ENGL J MED, V324, P4550; Portolani M, 2005, J MED VIROL, V77, P244, DOI 10.1002/jmv.20443; Randhawa PS, 1997, AM J SURG PATHOL, V21, P847, DOI 10.1097/00000478-199707000-00014; Razonable RR, 2003, J INFECT DIS, V187, P1801, DOI 10.1086/375194; Razonable RR, 2002, J INFECT DIS, V185, P110, DOI 10.1086/324772; ROBERTS E, 1993, LANCET, V341, P640, DOI 10.1016/0140-6736(93)90411-9; SECCHIERO P, 1995, J INFECT DIS, V171, P273, DOI 10.1093/infdis/171.2.273; Singh Nina, 2002, Transpl Infect Dis, V4, P59, DOI 10.1034/j.1399-3062.2002.t01-1-02001.x; Wang FZ, 1999, J MED VIROL, V57, P134, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt;134::AID-JMV8&gt;3.0.CO;2-Q; Wang FZ, 1996, BLOOD, V88, P3615, DOI 10.1182/blood.V88.9.3615.bloodjournal8893615; Ward KN, 2007, J CLIN MICROBIOL, V45, P1298, DOI 10.1128/JCM.02115-06; WARD KN, 1993, J MED VIROL, V39, P44, DOI 10.1002/jmv.1890390109; YASUKAWA M, 1993, J VIROL, V67, P6259, DOI 10.1128/JVI.67.10.6259-6264.1993; Zerr DM, 2005, CLIN INFECT DIS, V40, P932, DOI 10.1086/428060; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	34	56	60	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					593	602		10.1056/NEJMoa074479	http://dx.doi.org/10.1056/NEJMoa074479			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687640	Bronze			2022-12-28	WOS:000258216700007
J	Burgio, KL; Kraus, SR; Menefee, S; Borello-France, D; Corton, M; Johnson, HW; Mallett, V; Norton, P; FitzGerald, MP; Dandreo, KJ; Richter, HE; Rozanski, T; Albo, M; Zyczynski, HM; Lemack, GE; Chai, TC; Khandwala, S; Baker, J; Brubaker, L; Stoddard, AM; Goode, PS; Nielsen-Omeis, B; Nager, CW; Kenton, K; Tennstedt, SL; Kusek, JW; Chang, TD; Nyberg, LM; Steers, W				Burgio, Kathryn L.; Kraus, Stephen R.; Menefee, Shawn; Borello-France, Diane; Corton, Marlene; Johnson, Harry W.; Mallett, Veronica; Norton, Peggy; FitzGerald, Mary P.; Dandreo, Kimberly J.; Richter, Holly E.; Rozanski, Thomas; Albo, Michael; Zyczynski, Halina M.; Lemack, Gary E.; Chai, Toby C.; Khandwala, Salil; Baker, Jan; Brubaker, Linda; Stoddard, Anne M.; Goode, Patricia S.; Nielsen-Omeis, Betsy; Nager, Charles W.; Kenton, Kimberly; Tennstedt, Sharon L.; Kusek, John W.; Chang, T. Debuene; Nyberg, Leroy M.; Steers, William		Urinary Incontinence Treatment Net	Behavioral therapy to enable women with urge incontinence to discontinue drug treatment	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; URINARY-INCONTINENCE; OLDER WOMEN; OVERACTIVE BLADDER; CLINICAL-TRIALS; TOLTERODINE; IMPACT	Background: Women with urge urinary incontinence are commonly treated with antimuscarinic medications, but many discontinue therapy. Objective: To determine whether combining antimuscarinic drug therapy with supervised behavioral training, compared with drug therapy alone, improves the ability of women with urge incontinence to achieve clinically important reductions in incontinence episodes and to sustain these improvements after discontinuing drug therapy. Design: 2-stage, multicenter, randomized clinical trial conducted from July 2004 to January 2006. Setting: 9 university-affiliated outpatient clinics. Patients: 307 women with urge-predominant incontinence. Intervention: 10 weeks of open-label, extended-release tolterodine alone (n = 153) or combined with behavioral training (n = 154), followed by discontinuation of therapy and follow-up at 8 months. Measurements: The primary outcome, measured at 8 months, was no receipt of drugs or other therapy for urge incontinence and a 70% or greater reduction in frequency of incontinence episodes. Secondary outcomes were reduction in incontinence, self-reported satisfaction and improvement, and scores on validated questionnaires measuring symptom distress and bother and health-related quality of life. Study staff who performed outcome evaluations, but not participants and interventionists, were blinded to group assignment. Results: 237 participants completed the trial. According to life-table estimates, the rate of successful discontinuation of therapy at 8 months was the same in the combination therapy and drug therapy alone groups (41% in both groups; difference, 0 percentage points [95% CI, -12 to 12 percentage points]). A higher proportion of participants who received combination therapy than drug therapy alone achieved a 70% or greater reduction in incontinence at 10 weeks (69% vs. 58%; difference, 11 percentage points [CI, -0.3 to 22.1 percentage points]). Combination therapy yielded better outcomes over time on the Urogenital Distress Inventory and the Overactive Bladder Questionnaire (both P <0.001) at both time points for patient satisfaction and perceived improvement but not health-related quality of life. Adverse events were uncommon (12 events in 6 participants [3 in each group]). Limitations: Behavioral therapy components (daily bladder diary and recommendations for fluid management) in the group receiving drug therapy alone may have attenuated between-group differences. Assigned treatment was completed by 68% of participants, whereas 8-month outcome status was assessed on 77%. Conclusion: The addition of behavioral training to drug therapy may reduce incontinence frequency during active treatment but does not improve the ability to discontinue drug therapy and maintain improvement in urinary incontinence. Combination therapy has a beneficial effect on patient satisfaction, perceived improvement, and reduction of other bladder symptoms.	[Burgio, Kathryn L.] Univ Alabama Birmingham, Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA; Dept Vet Affairs, Birmingham, AL USA; Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA; Duquesne Univ, Pittsburgh, PA 15219 USA; SW Texas State Univ, Dallas, TX USA; Univ Maryland, Baltimore, MD 21201 USA; Oakwood Hosp, Dearborn, MI USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; New England Res Inst, Watertown, MA 02172 USA; NIDDKD, NIH, Bethesda, MD 20892 USA; Univ Virginia Hlth Syst, Charlottesville, VA USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University; Texas State University System; Texas State University San Marcos; University System of Maryland; University of Maryland Baltimore; Beaumont Health; Utah System of Higher Education; University of Utah; Loyola University Chicago; HealthCore, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia	Burgio, KL (corresponding author), Univ Alabama Birmingham, Birmingham Vet Affairs Med Ctr, 11G 700 S 19th St, Birmingham, AL 35233 USA.	kburgio@aging.uab.edu		Chai, Toby/0000-0002-1119-546X; Wadie, Bassem/0000-0002-6977-6849; Brubaker, Linda/0000-0002-8598-2589; Richter, Holly E/0000-0001-7741-5771	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060379, U01DK060380, U01DK058234, U01DK060395, U01DK058225, U01DK060397, U01DK058229, U01DK060401, U01DK060393, U01DK058231] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK58234, U01 DK60397, U01 DK58225, U01 DK60393, U01 DK58229, U01 DK060395, U01 DK058229, U01 DK60401, U01 DK058231, U01 DK060401, U01 DK60395, U01 DK058225, U01 DK60380, U01 DK060397, U01 DK058234, U01 DK060380, U01 DK60379, U01 DK060379, U01 DK58231, U01 DK060393] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Andersson KE, 2004, LANCET NEUROL, V3, P46, DOI 10.1016/S1474-4422(03)00622-7; Borello-France D, 2004, CLIN OBSTET GYNECOL, V47, P70, DOI 10.1097/00003081-200403000-00010; Burgio KL, 2006, NEUROUROL URODYNAM, V25, P411, DOI 10.1002/nau.20243; Burgio KL, 2000, J AM GERIATR SOC, V48, P370, DOI 10.1111/j.1532-5415.2000.tb04692.x; Burgio KL, 2002, JAMA-J AM MED ASSOC, V288, P2293, DOI 10.1001/jama.288.18.2293; Burgio KL, 2004, GASTROENTEROLOGY, V126, pS82, DOI 10.1053/j.gastro.2003.10.042; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Carey LM, 2005, AM J PHYS MED REHAB, V84, P428, DOI 10.1097/01.PHM.0000159971.12096.7F; COYNE KA, 2002, SUMMARY VALIDATION O; Coyne KS, 2003, BJU INT, V92, P731, DOI 10.1046/j.1464-410X.2003.04463.x; FANTL JA, 1996, AHCPR PUBLICATION; Goode PS, 2002, J AM GERIATR SOC, V50, P808, DOI 10.1046/j.1532-5415.2002.50204.x; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Mattiasson A, 2003, BJU INT, V91, P54, DOI 10.1046/j.1464-410X.2003.03076.x; Millard RJ, 2004, NEUROUROL URODYNAM, V23, P48, DOI 10.1002/nau.10167; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Schmidt R.A., 2011, HUMAN KINETICS; Seim A, 1996, SCAND J UROL NEPHROL, V30, P465, DOI 10.3109/00365599609182325; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Steers W, 2007, CONTEMP CLIN TRIALS, V28, P48, DOI 10.1016/j.cct.2006.06.002; Wagner TH, 1998, UROLOGY, V51, P355, DOI 10.1016/S0090-4295(97)00623-7; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yu YF, 2005, VALUE HEALTH, V8, P495, DOI 10.1111/j.1524-4733.2005.00041.x	25	86	87	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					161	169		10.7326/0003-4819-149-3-200808050-00005	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18678843	Green Accepted			2022-12-28	WOS:000258342900002
J	Wilper, AP; Woolhandler, S; Lasser, KE; McCormick, D; Bor, DH; Himmelstein, DU				Wilper, Andrew P.; Woolhandler, Steffie; Lasser, Karen E.; McCormick, Danny; Bor, David H.; Himmelstein, David U.			A national study of chronic disease prevalence and access to care in uninsured US adults	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-INSURANCE COVERAGE; MORTALITY; OUTCOMES; DEATH; RISK	Background: No recent national studies have assessed chronic illness prevalence or access to care among persons without insurance in the United States. Objective: To compare reports of chronic conditions and access to care among U. S. adults, by self-reported insurance status. Design: Population-based survey. Setting: National Health and Nutritional Examination Survey (1999 2004). Participants: 12 486 patients age 18 to 64 years. Measurements: Estimates of national rates of cardiovascular disease, hypertension, diabetes, hypercholesterolemia, active asthma or chronic obstructive pulmonary disease, previous cancer, and measures of access to care. Results: On the basis of National Health and Nutrition Examination Survey (1999-2004) responses, an estimated 11.4 million (95% CI, 9.8 million to 13.0 million) working-age Americans with chronic conditions were uninsured, including 16.1% (CI, 12.6% to 19.6%) of the 7.8 million with cardiovascular disease, 15.5% (CI, 13.4% to 17.6%) of the 38.2 million with hypertension, and 16.6% (CI, 13.2% to 20.0%) of the 8.5 million with diabetes. After the authors controlled for age, sex, and race or ethnicity, chronically ill patients without insurance were more likely than those with coverage to have not visited a health professional (22.6% vs. 6.2%) and to not have a standard site for care (26.1% vs. 6.2%) but more likely to identify their standard site for care as an emergency department (7.1% vs. 1.1%) (P <0.001 for all comparisons). Limitation: The study was cross-sectional and used self-reported insurance and disease status. Conclusion: Millions of U.S. working-age adults with chronic conditions do not have insurance and have poorer access to medical care than their insured counterparts.	[Wilper, Andrew P.; Woolhandler, Steffie; Lasser, Karen E.; McCormick, Danny; Bor, David H.; Himmelstein, David U.] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Cambridge, MA 02139 USA	Harvard University; Cambridge Health Alliance	Wilper, AP (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, 1493 Cambridge St, Cambridge, MA 02139 USA.	awilper@hsph.harvard.edu		Lasser, Karen/0000-0003-3777-6075	PHS HHS [5T32 HP110011] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1985, PREV MED, V14, P312; [Anonymous], 2006, AN REP GUID; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Cannon M, 2004, COVER UNINSURED WEEK; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; COLLINS SR, 2006, GAPS HLTH INSURANCE; *EC REP PRES, TRANSM C FEBR 2004, P197; Fowler-Brown A, 2007, J GEN INTERN MED, V22, P502, DOI 10.1007/s11606-007-0127-2; Geynan JP, 2007, ANN FAM MED, V5, P257, DOI 10.1370/afm.649; *I MED, 2002, CAR COV TOO LITT TOO; KORN EL, 2009, ANAL HLTH SURVEYS; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; *NAT CTR HLTH STAT, SURV OP MAN BROCH CO; Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; SWARTZ K, 2006, REINSURING HLTH WHY; *US BUR CENS CTR P, 2004, HLTH INS COV STAT TY; *US BUR CENS CTR P, 2002, HLTH INS COV STAT TY; *US BUR CES, CURR POP SURV 1988 2; *US BUR CES, CURR POP SURV 2000 2; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388; WESTERFIELD DL, 2003, INSURING UNINSURED A	30	137	138	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					170	176		10.7326/0003-4819-149-3-200808050-00006	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18678844	Green Published			2022-12-28	WOS:000258342900003
J	Andersen, AN; Pinborg, A; Loft, A				Andersen, A. Nyboe; Pinborg, A.; Loft, A.			Neonatal outcome in singletons conceived after ART	LANCET			English	Editorial Material							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTION; BIRTH-WEIGHT; INFERTILITY; TECHNOLOGY; COHORT; TWINS; RISK		[Andersen, A. Nyboe; Pinborg, A.; Loft, A.] Univ Copenhagen Hosp, Rigshosp, Fertil Clin, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Andersen, AN (corresponding author), Univ Copenhagen Hosp, Rigshosp, Fertil Clin, DK-2100 Copenhagen, Denmark.	anders.nyboe.andersen@rh.regionh.dk		Pinborg, Anja/0000-0002-8340-104X				Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Draper ES, 1999, LANCET, V353, P1746, DOI 10.1016/S0140-6736(98)08500-6; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Kallen B, 2005, FERTIL STERIL, V84, P605, DOI 10.1016/j.fertnstert.2005.03.035; Nygren KG, 2007, ACTA OBSTET GYN SCAN, V86, P774, DOI 10.1080/00016340701446231; Ombelet W, 2006, HUM REPROD, V21, P1025, DOI 10.1093/humrep/dei419; Pinborg A, 2005, HUM REPROD, V20, P2821, DOI 10.1093/humrep/dei142; ROMUNDSTAD LB, 2008, LANCET          0731; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; Sutcliffe AG, 2007, LANCET, V370, P351, DOI 10.1016/S0140-6736(07)60456-5; Thomson F, 2005, BJOG-INT J OBSTET GY, V112, P632, DOI 10.1111/j.1471-0528.2004.00489.x; Zhu JL, 2006, BMJ-BRIT MED J, V333, P679, DOI 10.1136/bmj.38919.495718.AE	14	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2008	372	9640					694	695		10.1016/S0140-6736(08)61042-9	http://dx.doi.org/10.1016/S0140-6736(08)61042-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344YZ	18674813				2022-12-28	WOS:000258964500006
J	Holmes, N				Holmes, Nick			Immunology - A splicing switch for T cells	SCIENCE			English	Editorial Material							CD45; EXPRESSION; ISOFORMS		Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Holmes, N (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	nh106@cam.ac.uk						Boxall S, 2004, HUM MOL GENET, V13, P2377, DOI 10.1093/hmg/ddh276; Gomez-Lira M, 2003, J NEUROIMMUNOL, V140, P216, DOI 10.1016/S0165-5728(03)00208-X; Hargreaves M, 1997, IMMUNOLOGY, V91, P323, DOI 10.1046/j.1365-2567.1997.00267.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Salmond RJ, 2008, INT IMMUNOL, V20, P819, DOI 10.1093/intimm/dxn040; ten Dam GB, 2000, J IMMUNOL, V164, P5287, DOI 10.4049/jimmunol.164.10.5287; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822	12	3	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					646	647		10.1126/science.1162294	http://dx.doi.org/10.1126/science.1162294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669848				2022-12-28	WOS:000258077700027
J	Frank, CG; Sanyal, S; Rush, JS; Waechter, CJ; Menon, AK				Frank, Christian G.; Sanyal, Sumana; Rush, Jeffrey S.; Waechter, Charles J.; Menon, Anant K.			Does Rft1 flip an N-glycan lipid precursor?	NATURE			English	Letter							WATER-SOLUBLE ANALOG; TRANSMEMBRANE MOVEMENT; ENDOPLASMIC-RETICULUM; P-DOLICHOL; ER; PROTEIN; FLOP		[Frank, Christian G.; Sanyal, Sumana; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Rush, Jeffrey S.; Waechter, Charles J.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	Cornell University; University of Kentucky	Frank, CG (corresponding author), CIMERA, Fdn Caubet, Mallorca 07110, Illes Balears, Spain.	akm2003@med.cornell.edu	Sanyal, Sumana/AAF-5155-2020; Sanyal, Sumana/I-7975-2013	Sanyal, Sumana/0000-0002-6230-5366; Menon, Anant Kumar/0000-0001-6924-2698	NIGMS NIH HHS [R01 GM036065, R01 GM071041] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071041, R01GM036065] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; Helenius J, 2002, SEMIN CELL DEV BIOL, V13, P171, DOI 10.1016/S1084-9521(02)00045-9; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Menon AK, 2000, CURR BIOL, V10, P241, DOI 10.1016/S0960-9822(00)00356-0; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195; SANYAL S, IN PRESS BIOCHEMISTR; Schenk B, 2001, J CLIN INVEST, V108, P1687, DOI 10.1172/JCI200113419; SCHENK B, 2001, GLYCOBIOLOGY, V11, P61; SNIDER MD, 1984, CELL, V36, P753, DOI 10.1016/0092-8674(84)90355-6; Vehring S, 2007, EUKARYOT CELL, V6, P1625, DOI 10.1128/EC.00198-07; Vishwakarma RA, 2005, CHEM COMMUN, P453, DOI 10.1039/b413196g	14	48	49	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					E3	E4		10.1038/nature07165	http://dx.doi.org/10.1038/nature07165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668045				2022-12-28	WOS:000258026500035
J	Kamerow, D				Kamerow, Douglas			Should we screen for childhood dyslipidaemia?	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Manchester, Lancs, England	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Manchester, Lancs, England.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a886	10.1136/bmj.a886	http://dx.doi.org/10.1136/bmj.a886			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335EG	18650230				2022-12-28	WOS:000258273000035
J	De Wulf, P; Visintin, R				De Wulf, Peter; Visintin, Rosella			Cdc14B and APC/C tackle DNA damage	CELL			English	Editorial Material							CELL-CYCLE	Mitotic exit in budding yeast is regulated by the proteins Cdc14, APC/C(Cdh1), and Plk1. In this issue, Bassermann and colleagues (2008) show that this network of proteins has been rewired in human cells to control the cell cycle in response to DNA damage.	[De Wulf, Peter; Visintin, Rosella] IFOM IEO Campus, European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Visintin, R (corresponding author), IFOM IEO Campus, European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	rosella.visintin@ifom-ieo-campus.it	Visintin, Rosella/J-9690-2012	De Wulf, Peter/0000-0001-9772-5881; Visintin, Rosella/0000-0001-6758-9946				Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Di Fiore B, 2008, CHROMOSOMA, V117, P333, DOI 10.1007/s00412-008-0152-x; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Krasinska L, 2007, EXP CELL RES, V313, P1225, DOI 10.1016/j.yexcr.2006.12.022; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308	8	6	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					210	212		10.1016/j.cell.2008.07.004	http://dx.doi.org/10.1016/j.cell.2008.07.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662536	Bronze			2022-12-28	WOS:000257891700010
J	Nakahata, Y; Kaluzova, M; Grimaldi, B; Sahar, S; Hirayama, J; Chen, D; Guarente, LP; Sassone-Corsi, P				Nakahata, Yasukazu; Kaluzova, Milota; Grimaldi, Benedetto; Sahar, Saurabh; Hirayama, Jun; Chen, Danica; Guarente, Leonard P.; Sassone-Corsi, Paolo			The NAD(+)-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control	CELL			English	Article							HISTONE ACETYLATION; GENE-EXPRESSION; REGULATOR CLOCK; MAMMALIAN CLOCK; PROTEIN SIR2; LIFE-SPAN; TRANSCRIPTION; METABOLISM; MOUSE; YEAST	Circadian rhythms govern a large array of metabolic and physiological functions. The central clock protein CLOCK has HAT properties. It directs acetylation of histone H3 and of its dimerization partner BMAL1 at Lys537, an event essential for circadian function. We show that the HDAC activity of the NAD(+)- dependent SIRT1 enzyme is regulated in a circadian manner, correlating with rhythmic acetylation of BMAL1 and H3 Lys9/Lys14 at circadian promoters. SIRT1 associates with CLOCK and is recruited to the CLOCK: BMAL1 chromatin complex at circadian promoters. Genetic ablation of the Sirt1 gene or pharmacological inhibition of SIRT1 activity lead to disturbances in the circadian cycle and in the acetylation of H3 and BMAL1. Finally, using liver-specific SIRT1 mutant mice we show that SIRT1 contributes to circadian control in vivo. We propose that SIRT1 functions as an enzymatic rheostat of circadian function, transducing signals originated by cellular metabolites to the circadian clock.	[Nakahata, Yasukazu; Kaluzova, Milota; Grimaldi, Benedetto; Sahar, Saurabh; Hirayama, Jun; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Chen, Danica; Guarente, Leonard P.] MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT)	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	psc@uci.edu	Jansen, Heiko T./A-5770-2008; Sassone-Corsi, Paolo/H-6182-2011	Jansen, Heiko T./0000-0003-0178-396X; Nakahata, Yasukazu/0000-0003-3814-5822; Hirayama, Jun/0000-0002-8485-3320; Grimaldi, Benedetto/0000-0002-2589-9302	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011119] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG011119-18, R37 AG011119] Funding Source: Medline; NIGMS NIH HHS [R01-GM081634-01, R01 GM081634] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chen Z, 2007, CELL CYCLE, V6, P2906, DOI 10.4161/cc.6.23.5041; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chopra VS, 2005, BIOESSAYS, V27, P119, DOI 10.1002/bies.20191; Collis SJ, 2007, CHROMOSOMA, V116, P331, DOI 10.1007/s00412-007-0108-6; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Grimaldi B, 2007, COLD SPRING HARB SYM, V72, P105, DOI 10.1101/sqb.2007.72.049; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hardin PE, 2006, CELL, V125, P424, DOI 10.1016/j.cell.2006.04.010; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wade PA, 1997, CURR BIOL, V7, pR82, DOI 10.1016/S0960-9822(06)00042-X; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	74	989	1033	2	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					329	340		10.1016/j.cell.2008.07.002	http://dx.doi.org/10.1016/j.cell.2008.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662547	Green Accepted, Bronze			2022-12-28	WOS:000257891700021
J	Trotter, JA; Williams, IS; Barnes, CR; Lecuyer, C; Nicoll, RS				Trotter, Julie A.; Williams, Ian S.; Barnes, Christopher R.; Lecuyer, Christophe; Nicoll, Robert S.			Did cooling oceans trigger Ordovician biodiversification? Evidence from conodont thermometry	SCIENCE			English	Article							OXYGEN ISOTOPIC COMPOSITION; ATMOSPHERIC CO2; BRACHIOPODS; DELTA-O-18; EVOLUTION; SEAWATER; GEOCHEMISTRY; GLACIATION; PHOSPHATE; CALCITE	The Ordovician Period, long considered a supergreenhouse state, saw one of the greatest radiations of life in Earth's history. Previous temperature estimates of up to similar to 70 degrees C have spawned controversial speculation that the oxygen isotopic composition of seawater must have evolved over geological time. We present a very different global climate record determined by ion microprobe oxygen isotope analyses of Early Ordovician- Silurian conodonts. This record shows a steady cooling trend through the Early Ordovician reaching modern equatorial temperatures that were sustained throughout the Middle and Late Ordovician. This favorable climate regime implies not only that the oxygen isotopic composition of Ordovician seawater was similar to that of today, but also that climate played an overarching role in promoting the unprecedented increases in biodiversity that characterized this period.	[Trotter, Julie A.; Williams, Ian S.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Trotter, Julie A.] CSIRO Petr Resources, N Ryde, NSW 1670, Australia; [Barnes, Christopher R.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 2Y2, Canada; [Lecuyer, Christophe] Univ Lyon 1, Lab Paleoenvironn & Paleobiosphere, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Nicoll, Robert S.] Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Victoria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Australian National University	Trotter, JA (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Mills Rd, Canberra, ACT 0200, Australia.	julie.trotter@anu.edu.au	Barnes, Christopher R/J-7975-2016; Williams, Ian S/F-4302-2012; Lecuyer, Christophe/AAO-8154-2021; SHRIMP, ANU/F-5312-2011; Trotter, Julie/H-5981-2014; Lecuyer, Christophe/C-8297-2012	Williams, Ian S/0000-0003-4465-6493; Trotter, Julie/0000-0002-0505-488X; Lecuyer, Christophe/0000-0001-9513-2492				Azmy K, 1998, GEOL SOC AM BULL, V110, P1499, DOI 10.1130/0016-7606(1998)110<1499:OACICO>2.3.CO;2; Bassett D, 2007, PALAIOS, V22, P98, DOI 10.2110/palo.2005.p05-089r; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Brenchley PJ, 2004, CRIT MOM PERSP EARTH, P81; BRENCHLEY PJ, 1994, GEOLOGY, V22, P295, DOI 10.1130/0091-7613(1994)022<0295:BAIEFA>2.3.CO;2; Came RE, 2007, NATURE, V449, P198, DOI 10.1038/nature06085; Cocks LRM, 2004, CRIT MOM PERSP EARTH, P61; Gregory R. T., 1991, GEOCHEM SOC SPEC PUB, V3, P65; GREGORY RT, 1981, J GEOPHYS RES, V86, P2737, DOI 10.1029/JB086iB04p02737; Joachimski MM, 2002, GEOLOGY, V30, P711, DOI 10.1130/0091-7613(2002)030<0711:CAOSIC>2.0.CO;2; Joachimski MM, 2006, GEOLOGY, V34, P277, DOI 10.1130/G22198.1; Joachimski MM, 2004, INT J EARTH SCI, V93, P542, DOI 10.1007/s00531-004-0405-8; Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; Kauffman Erle G., 1993, P315; Lecuyer C, 1998, GEOCHIM COSMOCHIM AC, V62, P2429, DOI 10.1016/S0016-7037(98)00170-7; Lecuyer C, 1999, GEOCHIM COSMOCHIM AC, V63, P351, DOI 10.1016/S0016-7037(98)00277-4; Muehlenbachs K, 1998, CHEM GEOL, V145, P263, DOI 10.1016/S0009-2541(97)00147-2; Noble PJ, 2004, CRIT MOM PERSP EARTH, P97; Peterson KJ, 2005, GEOLOGY, V33, P929, DOI 10.1130/G21697.1; Saltzman MR, 2005, GEOLOGY, V33, P109, DOI 10.1130/G21219.1; Schmitz B, 2008, NAT GEOSCI, V1, P49, DOI 10.1038/ngeo.2007.37; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski J. John Jr, 1995, P393; Shaviv NirJ., 2003, GSA TODAY, V137, P4, DOI DOI 10.1130/1052-5173(2003)013; Shields GA, 2003, GEOCHIM COSMOCHIM AC, V67, P2005, DOI 10.1016/S0016-7037(02)01116-X; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; VEIZER J, 1986, GEOCHIM COSMOCHIM AC, V50, P1679, DOI 10.1016/0016-7037(86)90130-4; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678; Wenzel B, 2000, GEOCHIM COSMOCHIM AC, V64, P1859, DOI 10.1016/S0016-7037(00)00337-9; Xu C, 2006, GEOL J, V41, P289, DOI 10.1002/gj.1051; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	32	417	461	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					550	554		10.1126/science.1155814	http://dx.doi.org/10.1126/science.1155814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653889				2022-12-28	WOS:000257888900044
J	Kishimoto, M; Antonucci, R; Blaes, O; Lawrence, A; Boisson, C; Albrecht, M; Leipski, C				Kishimoto, Makoto; Antonucci, Robert; Blaes, Omer; Lawrence, Andy; Boisson, Catherine; Albrecht, Marcus; Leipski, Christian			The characteristic blue spectra of accretion disks in quasars as uncovered in the infrared	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; CONTINUUM ENERGY-DISTRIBUTIONS; SEYFERT-GALAXIES; POLARIZATION; ULTRAVIOLET; MODELS; EDGE; BUMP; EMISSION; STELLAR	Quasars are thought to be powered by supermassive black holes accreting surrounding gas(1-3). Central to this picture is a putative accretion disk which is believed to be the source of the majority of the radiative output(2-4). It is well known, however, that the most extensively studied disk model(5) - an optically thick disk which is heated locally by the dissipation of gravitational binding energy is apparently contradicted by observations in a few major respects(6,7). In particular, the model predicts a specific blue spectral shape asymptotically from the visible to the near-infrared(5,8), but this is not generally seen in the visible wavelength region where the disk spectrum is observable(9-13). A crucial difficulty has been that, towards the infrared, the disk spectrum starts to be hidden under strong, hot dust emission from much larger but hitherto unresolved scales, and thus has essentially been impossible to observe. Here we report observations of polarized light interior to the dust-emitting region that enable us to uncover this near-infrared disk spectrum in several quasars. The revealed spectra show that the near-infrared disk spectrum is indeed as blue as predicted. This indicates that, at least for the outer near-infrared-emitting radii, the standard picture of the locally heated disk is approximately correct.	[Kishimoto, Makoto] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Kishimoto, Makoto; Lawrence, Andy] Univ Edinburgh, Royal Observ, Scottish Univ Phys Alliance, Astron Inst, Edinburgh EH9 3HJ, Midlothian, Scotland; [Antonucci, Robert; Blaes, Omer; Leipski, Christian] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Boisson, Catherine] Univ Paris 07, LUTH, FRE 2462, CNRS,Observ Paris,Sect Meudon, F-92195 Meudon, France; [Albrecht, Marcus] Univ Catolica Norte, Inst Astron, Antofagasta 1270709, Chile	Max Planck Society; University of Edinburgh; University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Universidad Catolica del Norte	Kishimoto, M (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	mk@mpifr-bonn.mpg.de	Kishimoto, Makoto/AAK-1587-2021	Albrecht, Marcus/0000-0002-4707-3712				Agol E, 2000, ASTROPHYS J, V528, P161, DOI 10.1086/308177; Antonucci R, 1999, ASTR SOC P, V161, P193; ANTONUCCI RRJ, 1983, NATURE, V303, P158, DOI 10.1038/303158a0; Bentz MC, 2006, ASTROPHYS J, V644, P133, DOI 10.1086/503537; Blaes OM, 2003, LES HOUCH S, V78, P137; CRISTIANI S, 1990, ASTRON ASTROPHYS, V227, P385; Davis SW, 2007, ASTROPHYS J, V668, P682, DOI 10.1086/521393; FRANCIS PJ, 1991, ASTROPHYS J, V373, P465, DOI 10.1086/170066; Goodman J, 2003, MON NOT R ASTRON SOC, V339, P937, DOI 10.1046/j.1365-8711.2003.06241.x; Hubeny I, 2000, ASTROPHYS J, V533, P710, DOI 10.1086/308708; IMPEY CD, 1995, ASTROPHYS J, V440, P80, DOI 10.1086/175249; Kishimoto M, 2005, MON NOT R ASTRON SOC, V364, P640, DOI 10.1111/j.1365-2966.2005.09577.x; Kishimoto M, 2004, MON NOT R ASTRON SOC, V354, P1065, DOI 10.1111/j.1365-2966.2004.08268.x; Kishimoto M, 2003, MON NOT R ASTRON SOC, V345, P253, DOI 10.1046/j.1365-8711.2003.06934.x; Koratkar A, 1999, PUBL ASTRON SOC PAC, V111, P1, DOI 10.1086/316294; MALKAN M, 1989, NATO ASIC P, V290, P19; MALKAN MA, 1983, ASTROPHYS J, V275, P477, DOI 10.1086/161549; MALKAN MA, 1983, ASTROPHYS J, V268, P582, DOI 10.1086/160981; NEUGEBAUER G, 1987, ASTROPHYS J SUPPL S, V63, P615, DOI 10.1086/191175; SALPETER EE, 1964, ASTROPHYS J, V140, P796, DOI 10.1086/147973; SANDERS DB, 1989, ASTROPHYS J, V347, P29, DOI 10.1086/168094; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; SHIELDS GA, 1978, NATURE, V272, P706, DOI 10.1038/272706a0; SHLOSMAN I, 1987, NATURE, V329, P810, DOI 10.1038/329810a0; Smith JE, 2004, MON NOT R ASTRON SOC, V350, P140, DOI 10.1111/j.1365-2966.2004.07610.x; Smith JE, 2002, MON NOT R ASTRON SOC, V335, P773, DOI 10.1046/j.1365-8711.2002.05665.x; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; WEBB W, 1993, ASTROPHYS J, V419, P494, DOI 10.1086/173503; Zheng W, 1997, ASTROPHYS J, V475, P469, DOI 10.1086/303560	30	97	97	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					492	494		10.1038/nature07114	http://dx.doi.org/10.1038/nature07114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650919	Green Submitted			2022-12-28	WOS:000257860300045
J	Chamberlain, SR; Menzies, L; Hampshire, A; Suckling, J; Fineberg, NA; del Campo, N; Aitken, M; Craig, K; Owen, AM; Bullmore, ET; Robbins, TW; Sahakian, BJ				Chamberlain, Samuel R.; Menzies, Lara; Hampshire, Adam; Suckling, John; Fineberg, Naomi A.; del Campo, Natalia; Aitken, Mike; Craig, Kevin; Owen, Adrian M.; Bullmore, Edward T.; Robbins, Trevor W.; Sahakian, Barbara J.			Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives	SCIENCE			English	Article							PREFRONTAL CORTEX; INHIBITION; HUMANS	Obsessive-compulsive disorder (OCD) is characterized by repetitive thoughts and behaviors associated with underlying dysregulation of frontostriatal circuitry. Central to neurobiological models of OCD is the orbitofrontal cortex, a neural region that facilitates behavioral flexibility after negative feedback (reversal learning). We identified abnormally reduced activation of several cortical regions, including the lateral orbitofrontal cortex, during reversal learning in OCD patients and their clinically unaffected close relatives, supporting the existence of an underlying previously undiscovered endophenotype for this disorder.	[Chamberlain, Samuel R.; Menzies, Lara; Suckling, John; Fineberg, Naomi A.; del Campo, Natalia; Craig, Kevin; Bullmore, Edward T.; Sahakian, Barbara J.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 0QQ, England; [Chamberlain, Samuel R.; Menzies, Lara; Suckling, John; del Campo, Natalia; Aitken, Mike; Craig, Kevin; Bullmore, Edward T.; Robbins, Trevor W.; Sahakian, Barbara J.] Univ Cambridge, BCNI, Cambridge CB2 3EB, England; [Chamberlain, Samuel R.; Menzies, Lara; Fineberg, Naomi A.; Craig, Kevin] Queen Elizabeth II Hosp, Natl OCD Treatment Serv, Welwyn Garden City AL7 4HQ, Herts, England; [Hampshire, Adam; Owen, Adrian M.] MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Aitken, Mike; Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Bullmore, Edward T.] Addenbrookes Hosp, Clin Unit Cambridge, GlaxoSmithKline, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge	Chamberlain, SR (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Box 189, Cambridge CB2 0QQ, England.	srchamb@gmail.com	Robbins, Trevor W/A-7551-2008; Bullmore, Ed/C-1706-2012; Owen, Adrian M/B-4997-2015; Chamberlain, Samuel R/A-7839-2008; Fineberg, Naomi/ABI-5522-2020; Suckling, John/ABD-7246-2021; Sahakian, Barbara/AAW-1198-2020	Bullmore, Ed/0000-0002-8955-8283; Chamberlain, Samuel R/0000-0001-7014-8121; Suckling, John/0000-0002-5098-1527; Sahakian, Barbara/0000-0001-7352-1745; Menzies, Lara/0000-0003-3710-501X; Aitken Deakin, Michael/0000-0001-9763-8999; Robbins, Trevor/0000-0003-0642-5977	Medical Research Council [MC_U105559847, G0001354, U1055.01.002.00001.01] Funding Source: Medline; Wellcome Trust [G001354] Funding Source: Medline; MRC [MC_U105559847] Funding Source: UKRI; Medical Research Council [G0001354B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Chamberlain Samuel R, 2006, Curr Psychiatry Rep, V8, P458, DOI 10.1007/s11920-006-0051-x; Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hollander E, 1996, J CLIN PSYCHIAT, V57, P3; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Suckling J, 2004, HUM BRAIN MAPP, V22, P193, DOI 10.1002/hbm.20027	18	377	386	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					421	422		10.1126/science.1154433	http://dx.doi.org/10.1126/science.1154433			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635808				2022-12-28	WOS:000257713900055
J	Meyer, JC; Girit, CO; Crommie, MF; Zettl, A				Meyer, Jannik C.; Girit, C. O.; Crommie, M. F.; Zettl, A.			Imaging and dynamics of light atoms and molecules on graphene	NATURE			English	Article							FIELD ELECTRON-MICROSCOPY; CARBON NANOTUBES; SINGLE ATOMS; DEFECTS; SURFACE; RESOLUTION; CLUSTERS; CRYSTALS; OXYGEN	Observing the individual building blocks of matter is one of the primary goals of microscopy. The invention of the scanning tunnelling microscope(1) revolutionized experimental surface science in that atomic- scale features on a solid- state surface could finally be readily imaged. However, scanning tunnelling microscopy has limited applicability due to restrictions in, for example, sample conductivity, cleanliness, and data acquisition rate. An older microscopy technique, that of transmission electron microscopy (TEM)(2,3), has benefited tremendously in recent years from subtle instrumentation advances, and individual heavy ( high-atomic-number) atoms can now be detected by TEM4-7 even when embedded within a semiconductor material(8,9). But detecting an individual low- atomic- number atom, for example carbon or even hydrogen, is still extremely challenging, if not impossible, via conventional TEM owing to the very low contrast of light elements(2,3,10) (-12). Here we demonstrate a means to observe, by conventional TEM, even the smallest atoms and molecules: on a clean single- layer graphene membrane, adsorbates such as atomic hydrogen and carbon can be seen as if they were suspended in free space. We directly image such individual adatoms, along with carbon chains and vacancies, and investigate their dynamics in real time. These techniques open a way to reveal dynamics of more complex chemical reactions or identify the atomic- scale structure of unknown adsorbates. In addition, the study of atomic- scale defects in graphene may provide insights for nanoelectronic applications of this interesting material.	[Meyer, Jannik C.; Girit, C. O.; Crommie, M. F.; Zettl, A.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Meyer, Jannik C.; Girit, C. O.; Crommie, M. F.; Zettl, A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Meyer, JC (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	email@jannikmeyer.de; azettl@berkeley.edu	Zettl, Alex K/O-4925-2016; Girit, Çağlar/AFT-1507-2022; Girit, Çağlar/D-4845-2014; Meyer, Jannik C/H-8541-2012	Zettl, Alex K/0000-0001-6330-136X; Girit, Çağlar/0000-0001-8953-9261; Girit, Çağlar/0000-0001-8953-9261; Meyer, Jannik C/0000-0003-4023-0778				Amara H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.115423; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; BOUKHVALOV DW, 2007, PHYS REV B, V77; Buseck P., 1988, HIGH RESOLUTION TRAN; CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338; DOYLE PA, 1968, ACTA CRYSTALL A-CRYS, VA 24, P390, DOI 10.1107/S0567739468000756; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; HASHIMOTO H, 1973, J ELECTRON MICROSC, V22, P123; Hornekaer L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156104; IIJIMA S, 1977, OPTIK, V48, P193; ITO A, 2007, CHEM REACTION SINGLE; Jeloaica L, 1999, CHEM PHYS LETT, V300, P157, DOI 10.1016/S0009-2614(98)01337-2; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Kisielowski C, 2001, ULTRAMICROSCOPY, V89, P243, DOI 10.1016/S0304-3991(01)00090-0; Liu Z, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088304; LUI Z, 2007, NATURE NANOTECHNOL, V2, P422; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Nellist PD, 1996, SCIENCE, V274, P413, DOI 10.1126/science.274.5286.413; Nordlund K, 1996, PHYS REV LETT, V77, P699, DOI 10.1103/PhysRevLett.77.699; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Sha XW, 2002, SURF SCI, V496, P318, DOI 10.1016/S0039-6028(01)01602-8; Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521; Smith BW, 2001, J APPL PHYS, V90, P3509, DOI 10.1063/1.1383020; Spence J.C.H., 2003, HIGH RESOLUTION ELEC, V3rd; Suenaga K, 2007, NAT NANOTECHNOL, V2, P358, DOI 10.1038/nnano.2007.141; VAINSHTEIN BK, 1950, DOKL AKAD NAUK SSSR+, V72, P53; van Benthem K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1991989; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	409	418	6	393	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2008	454	7202					319	322		10.1038/nature07094	http://dx.doi.org/10.1038/nature07094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633414	Green Submitted			2022-12-28	WOS:000257665300035
J	Tinetti, ME; Baker, DI; King, M; Gottschalk, M; Murphy, TE; Acampora, D; Carlin, BP; Leo-Summers, L; Allore, HG				Tinetti, Mary E.; Baker, Dorothy I.; King, Mary; Gottschalk, Margaret; Murphy, Terrence E.; Acampora, Denise; Carlin, Bradley P.; Leo-Summers, Linda; Allore, Heather G.			Effect of dissemination of evidence in reducing injuries from falls	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OLDER PERSONS; RISK-FACTORS; BIOMEDICAL-RESEARCH; PUBLIC-HEALTH; MANAGEMENT; PREVENTION; INTERVENTIONS	Background: Falling is a common and morbid condition among elderly persons. Effective strategies to prevent falls have been identified but are underutilized. Methods: Using a nonrandomized design, we compared rates of injuries from falls in a region of Connecticut where clinicians had been exposed to interventions to change clinical practice (intervention region) and in a region where clinicians had not been exposed to such interventions (usual-care region). The interventions encouraged primary care clinicians and staff members involved in home care, outpatient rehabilitation, and senior centers to adopt effective risk assessments and strategies for the prevention of falls (e.g., medication reduction and balance and gait training). The outcomes were rates of serious fall-related injuries (hip and other fractures, head injuries, and joint dislocations) and fall-related use of medical services per 1000 person-years among persons who were 70 years of age or older. The interventions occurred from 2001 to 2004, and the evaluations took place from 2004 to 2006. Results: Before the interventions, the adjusted rates of serious fall-related injuries (per 1000 person-years) were 31.2 in the usual-care region and 31.9 in the intervention region. During the evaluation period, the adjusted rates were 31.4 and 28.6, respectively (adjusted rate ratio, 0.91; 95% Bayesian credibility interval, 0.88 to 0.94). Between the preintervention period and the evaluation period, the rate of fall-related use of medical services increased from 68.1 to 83.3 per 1000 person-years in the usual-care region and from 70.7 to 74.2 in the intervention region (adjusted rate ratio, 0.89; 95% credibility interval, 0.86 to 0.92). The percentages of clinicians who received intervention visits ranged from 62% (131 of 212 primary care offices) to 100% (26 of 26 home care agencies). Conclusions: Dissemination of evidence about fall prevention, coupled with interventions to change clinical practice, may reduce fall-related injuries in elderly persons.	[Tinetti, Mary E.; Baker, Dorothy I.; Murphy, Terrence E.; Acampora, Denise; Leo-Summers, Linda; Allore, Heather G.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Tinetti, Mary E.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Gottschalk, Margaret] Yale New Haven Med Ctr, Dept Rehabil Serv, New Haven, CT 06504 USA; [King, Mary] Hartford Hosp, Div Geriatr Med & Gerontol, Hartford, CT 06115 USA; [Carlin, Bradley P.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	Yale University; Yale University; Yale University; Hartford Hospital; University of Minnesota System; University of Minnesota Twin Cities	Tinetti, ME (corresponding author), 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu	Murphy, Terrence E/A-9394-2009	Allore, Heather/0000-0001-7685-8175	NATIONAL INSTITUTE ON AGING [P60AG010469] Funding Source: NIH RePORTER; NIA NIH HHS [P60 AG010469, P60AG10469] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AG HEALTHC RES QU, PUT PREV PRACT STEP; Baker DI, 2005, J AM GERIATR SOC, V53, P675, DOI 10.1111/j.1532-5415.2005.53218.x; Banerjee S., 2004, HIERARCHICAL MODELIN; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Bishop CE, 2002, HEALTH AFFAIR, V21, P215, DOI 10.1377/hlthaff.21.6.215; Brown CJ, 2005, PHYS THER, V85, P394, DOI 10.1093/ptj/85.5.394; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Chou WC, 2006, J GEN INTERN MED, V21, P117, DOI [10.1007/s11606-006-0244-3, 10.1111/j.1525-1497.2005.00298.x]; *CTR MED MED SERV, PHYS QUAL REP IN PQR; Englander F, 1996, J FORENSIC SCI, V41, P733; Fortinsky RH, 2004, J AM GERIATR SOC, V52, P1522, DOI 10.1111/j.1532-5415.2004.52416.x; Fortinsky RH, 2008, J AM GERIATR SOC, V56, P737, DOI 10.1111/j.1532-5415.2007.01630.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; *HLTH RES SERV ADM, PRIM CAR SERV AR PCS; Institute of Medicine, 2001, CROSSING QUALITY CHA; *JOINT COMM ACCR H, NAT PAT SAF GOALS 20; Lawson A. B., 2003, DIS MAPPING WINBUGS; Murphy TE, 2008, CONTEMP CLIN TRIALS, V29, P343, DOI 10.1016/j.cct.2007.10.004; *NAT CTR HLTH STAT, INJ DAT RES; National Center for Health Statistics, CLASS DIS FUNCT DIS; National Center for Injury Prevention and Control, WEB BAS INJ STAT QUE; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Reuben DB, 2003, J AM GERIATR SOC, V51, P1787, DOI 10.1046/j.1532-5415.2003.51565.x; Rosenberg RN, 2003, JAMA-J AM MED ASSOC, V289, P1305, DOI 10.1001/jama.289.10.1305; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tinetti ME, 2006, GERONTOLOGIST, V46, P717, DOI 10.1093/geront/46.6.717; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; U.S. Census Bureau, ZIP COD TAB AR ZCTAS; *US BUR CENS, CENS US 2000; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Waller LA, 1997, J AM STAT ASSOC, V92, P607, DOI 10.2307/2965708; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352; 2006, REPORT C INCREASING; 2004, MMWR MORB MORTAL WKL, V53, P66	45	173	179	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					252	261		10.1056/NEJMoa0801748	http://dx.doi.org/10.1056/NEJMoa0801748			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326KD	18635430	Green Accepted			2022-12-28	WOS:000257656600005
J	Weatherall, DJ				Weatherall, David J.			Who killed Cockrobin? The limitations of pathobiography	LANCET			English	Editorial Material									Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Weatherall, DJ (corresponding author), Weatherall Inst Mol Med, Oxford OX3 9DS, England.	liz.rose@imm.ox.ac.uk							0	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					108	109		10.1016/S0140-6736(08)61021-1	http://dx.doi.org/10.1016/S0140-6736(08)61021-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18630341				2022-12-28	WOS:000257552400014
J	Kuper, A; Lingard, L; Levinson, W				Kuper, Ayelet; Lingard, Lorelei; Levinson, Wendy			Qualitative research - Critically appraising qualitative research	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kuper, Ayelet; Levinson, Wendy] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Kuper, Ayelet; Lingard, Lorelei] Univ Toronto, Wilson Ctr Res Educ, Toronto, ON M4N 3M5, Canada; [Lingard, Lorelei] Univ Toronto, Dept Paediat, Toronto, ON M4N 3M5, Canada; [Lingard, Lorelei] SickKids Learning Inst, Toronto, ON, Canada; [Lingard, Lorelei] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kuper, A (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, 2075 Bayview Ave,Room HG 08, Toronto, ON M4N 3M5, Canada.	ayelet94@post.harvard.edu	Lingard, Lorelei/G-3322-2011					Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Holden JD, 2001, J EVAL CLIN PRACT, V7, P65, DOI 10.1046/j.1365-2753.2001.00280.x; Kuzel AJ., 1999, DOING QUALITATIVE RE, V2, P33, DOI DOI 10.1111/J.1365-2929.2006; LINGARD L, 2007, QUALITATIVE RES MED; MAUTHNER M, 2002, ETHICS QUALITATIVE R; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Seale C., 1999, QUALITY QUALITATIVE; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Wallerstein N, 1999, SOC SCI MED, V49, P39, DOI 10.1016/S0277-9536(99)00073-8	9	417	418	5	61	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2008	337	7671							a1035	10.1136/bmj.a1035	http://dx.doi.org/10.1136/bmj.a1035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354EP	18687726				2022-12-28	WOS:000259622000035
J	Hodges, BD; Kuper, A; Reeves, S				Hodges, Brian David; Kuper, Ayelet; Reeves, Scott			Qualitative research - Discourse analysis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hodges, Brian David; Reeves, Scott] Univ Toronto, Dept Psychiat, Wilson Ctr Res Educ, Toronto, ON M5G 2C4, Canada; [Kuper, Ayelet] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Kuper, Ayelet] Univ Toronto, Wilson Ctr Res Educ, Toronto, ON M4N 3M5, Canada; [Reeves, Scott] Univ Toronto, Dept Psychiat, Li Ka Shing Knowledge Inst, Ctr Fac Dev, Toronto, ON M5G 2C4, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute	Hodges, BD (corresponding author), Univ Toronto, Dept Psychiat, Wilson Ctr Res Educ, 200 Elizabeth St,Eaton S 1-565, Toronto, ON M5G 2C4, Canada.	brian.hodges@utoronto.ca						Ford-Sumner Susan, 2006, Nurse Res, V14, P7; Foucault M, 1972, ARCHAEOLOGY KNOWLEDG; Foucault M., 1965, HIST MADNESS; Lacson RC, 2006, J BIOMED INFORM, V39, P541, DOI 10.1016/j.jbi.2005.12.009; Lingard L, 2004, QUAL SAF HEALTH CARE, V13, P330, DOI 10.1136/qshc.2003.008425; Lingard L, 2003, MED EDUC, V37, P612, DOI 10.1046/j.1365-2923.2003.01553.x; McHoul A., 1993, FOUCAULT PRIMER DISC; Rogers R, 2005, REV EDUC RES, V75, P365, DOI 10.3102/00346543075003365; Sacks H, 1995, LECT CONVERSATION; Shaw S, 2005, J ROY SOC MED, V98, P496, DOI 10.1258/jrsm.98.11.496; Speed E, 2006, SOC SCI MED, V62, P28, DOI 10.1016/j.socscimed.2005.05.025; STONE Mary Specker, 1997, TECHNICAL COMMUNICAT, V2, P201, DOI DOI 10.1207/S15427625TCQ0602_; TENHAVE P, 1995, HUM STUD, V18, P245; Zellig S, 1951, METHODS STRUCTURAL L	14	67	67	0	38	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 6	2008	337	7669							a879	10.1136/bmj.a879	http://dx.doi.org/10.1136/bmj.a879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	351JP	18687729				2022-12-28	WOS:000259420900037
J	Bennett, MR; Pang, WL; Ostroff, NA; Baumgartner, BL; Nayak, S; Tsimring, LS; Hasty, J				Bennett, Matthew R.; Pang, Wyming Lee; Ostroff, Natalie A.; Baumgartner, Bridget L.; Nayak, Sujata; Tsimring, Lev S.; Hasty, Jeff			Metabolic gene regulation in a dynamically changing environment	NATURE			English	Article							MESSENGER-RNA DECAY; SACCHAROMYCES-CEREVISIAE; FLUCTUATING ENVIRONMENTS; GLUCOSE REPRESSION; SOFT LITHOGRAPHY; YEAST; EXPRESSION; BIOLOGY; NETWORKS; PROTEINS	Natural selection dictates that cells constantly adapt to dynamically changing environments in a context- dependent manner. Gene- regulatory networks often mediate the cellular response to perturbation(1-3), and an understanding of cellular adaptation will require experimental approaches aimed at subjecting cells to a dynamic environment that mimics their natural habitat(4-9). Here we monitor the response of Saccharomyces cerevisiae metabolic gene regulation to periodic changes in the external carbon source by using a microfluidic platform that allows precise, dynamic control over environmental conditions. We show that the metabolic system acts as a low- pass filter that reliably responds to a slowly changing environment, while effectively ignoring fast fluctuations. The sensitive low- frequency response was significantly faster than in predictions arising from our computational modelling, and this discrepancy was resolved by the discovery that two key galactose transcripts possess half- lives that depend on the carbon source. Finally, to explore how induction characteristics affect frequency response, we compare two S. cerevisiae strains and show that they have the same frequency response despite having markedly different induction properties. This suggests that although certain characteristics of the complex networks may differ when probed in a static environment, the system has been optimized for a robust response to a dynamically changing environment.	[Bennett, Matthew R.; Pang, Wyming Lee; Ostroff, Natalie A.; Baumgartner, Bridget L.; Nayak, Sujata; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bennett, Matthew R.; Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@ucsd.edu	Bennett, Matthew/B-3700-2008	Bennett, Matthew/0000-0002-4975-8854; Tsimring, Lev/0000-0003-0709-3548	National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082168] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Groisman for useful discussions regarding microfluidic design; D. Volfson and C. Grilly for aid in development and testing of image segmentation and tracking algorithms, and M. Ferry for his suggestions on microbiology. This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health.	Andrade RP, 2005, BIOCHEM BIOPH RES CO, V332, P254, DOI 10.1016/j.bbrc.2005.04.119; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; de Atauri P., 2004, Systems Biology, V1, P28, DOI 10.1049/sb:20045013; de la Cruz BJ, 2002, YEAST, V19, P887, DOI 10.1002/yea.884; Demir O, 2006, COMPUT BIOL CHEM, V30, P179, DOI 10.1016/j.compbiolchem.2006.02.004; DOUGLAS HC, 1966, GENETICS, V54, P911; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Scheffler IE, 1998, INT J BIOCHEM CELL B, V30, P1175, DOI 10.1016/S1357-2725(98)00086-7; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thattai M, 2003, BIOPHYS J, V85, P744, DOI 10.1016/S0006-3495(03)74517-2; Verma M, 2005, BIOCHEM J, V388, P843, DOI 10.1042/BJ20041883; Whitesides GM, 2004, ABSTR PAP AM CHEM S, V227, pU113; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	27	229	234	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1119	1122		10.1038/nature07211	http://dx.doi.org/10.1038/nature07211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18668041	Green Accepted			2022-12-28	WOS:000258719600038
J	Herrero, JL; Roberts, MJ; Delicato, LS; Gieselmann, MA; Dayan, P; Thiele, A				Herrero, J. L.; Roberts, M. J.; Delicato, L. S.; Gieselmann, M. A.; Dayan, P.; Thiele, A.			Acetylcholine contributes through muscarinic receptors to attentional modulation in V1	NATURE			English	Article							PRIMARY VISUAL-CORTEX; CHOLINERGIC MODULATION; SELECTIVE ATTENTION; PARIETAL CORTEX; MACAQUE MONKEY; AREAS V1; PERFORMANCE; RELEASE; CELLS; V4	Attention exerts a strong influence over neuronal processing in cortical areas(1,2). It selectively increases firing rates(2-4) and affects tuning properties(1,5), including changing receptive field locations and sizes(3,6). Although these effects are well studied, their cellular mechanisms are poorly understood. To study the cellular mechanisms, we combined iontophoretic pharmacological analysis of cholinergic receptors with single cell recordings in V1 while rhesus macaque monkeys ( Macaca mulatta) performed a task that demanded top- down spatial attention. Attending to the receptive field of the V1 neuron under study caused an increase in firing rates. Here we show that this attentional modulation was enhanced by low doses of acetylcholine. Furthermore, applying the muscarinic antagonist scopolamine reduced attentional modulation, whereas the nicotinic antagonist mecamylamine had no systematic effect. These results demonstrate that muscarinic cholinergic mechanisms play a central part in mediating the effects of attention in V1.	[Herrero, J. L.; Roberts, M. J.; Delicato, L. S.; Gieselmann, M. A.; Thiele, A.] Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Dayan, P.] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	Newcastle University - UK; University of London; University College London	Thiele, A (corresponding author), Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alex.thiele@ncl.ac.uk	Roberts, Mark/C-7011-2018; Delicato, Louise/AAT-1921-2020	Delicato, Louise/0000-0001-8271-2324; Dayan, Peter/0000-0003-3476-1839; Thiele, Alexander/0000-0003-4894-0213; Roberts, Mark/0000-0001-7513-1281	BBSRC [BBS/B/09325]; Wellcome Trust [070380/Z/03/Z]; Gatsby Charitable Foundation; BBSRC [BB/F021399/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021399/1, BBS/B/09325] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the BBSRC (BBS/B/09325), the Wellcome Trust (070380/Z/03/Z) and the Gatsby Charitable Foundation.	Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Davidson MC, 2000, J NEUROPHYSIOL, V83, P1536, DOI 10.1152/jn.2000.83.3.1536; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Fournier GN, 2004, NEUROSCIENCE, V126, P257, DOI 10.1016/j.neuroscience.2004.04.002; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Furey ML, 2008, NEUROPSYCHOPHARMACOL, V33, P913, DOI 10.1038/sj.npp.1301461; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nelson CL, 2005, NEUROSCIENCE, V132, P347, DOI 10.1016/j.neuroscience.2004.12.007; Nobili L, 1997, VISION RES, V37, P3559, DOI 10.1016/S0042-6989(97)00076-X; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; RUSSCHEN FT, 1985, J COMP NEUROL, V242, P1, DOI 10.1002/cne.902420102; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	30	325	327	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1110	1114		10.1038/nature07141	http://dx.doi.org/10.1038/nature07141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18633352	Green Accepted			2022-12-28	WOS:000258719600036
J	Alexander, DTL; Crozier, PA; Anderson, JR				Alexander, Duncan T. L.; Crozier, Peter A.; Anderson, James R.			Brown carbon spheres in East Asian outflow and their optical properties	SCIENCE			English	Article							HUMIC-LIKE SUBSTANCES; LIGHT-ABSORPTION; REFRACTIVE-INDEX; COMBUSTION; AEROSOLS; HULIS; SOOT	Atmospheric aerosols play a substantial role in climate change through radiative forcing. Combustion-produced carbonaceous particles are the main light-absorbing aerosols; thus, quantifying their optical properties is essential for determining the magnitude of direct forcing. By using the electron energy-loss spectrum in the transmission electron microscope, we quantified the optical properties of individual, submicrometer amorphous carbon spheres that are ubiquitous in East Asian-Pacific outflow. The data indicate that these common spheres are brown, not black, with a mean refractive index of 1.67 - 0.27i (where i = root 1) at a wavelength of 550 nanometers. The results suggest that brown carbon aerosols should be explicitly included in radiative forcing models.	[Crozier, Peter A.] Arizona State Univ, Sch Mat, Tempe, AZ 85287 USA; [Alexander, Duncan T. L.] Arizona State Univ, LeRoy Eyring Ctr Solid State Sci, Tempe, AZ 85287 USA; [Anderson, James R.] Arizona State Univ, Dept Mech & Aerosp Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Crozier, PA (corresponding author), Arizona State Univ, Sch Mat, POB 878706, Tempe, AZ 85287 USA.	crozier@asi.edu	Alexander, Duncan T. L./E-9703-2015; Alexander, Duncan/W-3847-2019	Alexander, Duncan T. L./0000-0003-4350-8587; Alexander, Duncan/0000-0003-4350-8587; Crozier, Peter A./0000-0002-1837-2481				Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Bergstrom RW, 2007, ATMOS CHEM PHYS, V7, P5937, DOI 10.5194/acp-7-5937-2007; Bohren C., 2008, ABSORPTION SCATTERIN; Bond TC, 2006, AEROSOL SCI TECH, V40, P27, DOI 10.1080/02786820500421521; Chen YZ, 2005, ENERG FUEL, V19, P1644, DOI 10.1021/ef049736y; Clarke AD, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004378; Dinar E, 2008, FARADAY DISCUSS, V137, P279, DOI 10.1039/b703111d; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Faeth GM, 1995, COMBUST SCI TECHNOL, V108, P207, DOI 10.1080/00102209508960399; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; HALLETT J, 1989, AEROSOL SCI TECH, V10, P70, DOI 10.1080/02786828908959222; Hand JL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005728; Havers N, 1998, J ATMOS CHEM, V29, P45, DOI 10.1023/A:1005875225800; Hoffer A, 2006, ATMOS CHEM PHYS, V6, P3563, DOI 10.5194/acp-6-3563-2006; HORVATH H, 1993, ATMOS ENVIRON A-GEN, V27, P293, DOI 10.1016/0960-1686(93)90104-7; Huebert BJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003550; Kirchstetter TW, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004999; Lukacs H, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008151; MCCARTNEY JT, 1958, FUEL, V37, P272; MILLIKAN RC, 1961, J OPT SOC AM, V51, P698, DOI 10.1364/JOSA.51.000698; PLUCHINO AB, 1980, APPL OPTICS, V19, P3370, DOI 10.1364/AO.19.003370; Posfai M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004169; RAETHER H, 1967, SURF SCI, V8, P233, DOI 10.1016/0039-6028(67)90085-4; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; RITCHIE RH, 1957, PHYS REV, V106, P874, DOI 10.1103/PhysRev.106.874; Roessler DM, 1981, PARTICULATE CARBON F, P57; Sorensen CM, 2001, AEROSOL SCI TECH, V35, P648, DOI 10.1080/027868201316900007; Sun HL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029797; van Poppel LH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024461; Vander Wal R. L., 2004, COMBUST FLAME, V136, P129, DOI [DOI 10.1016/J.COMBUSTFLAME.2003.09.008, DOI 10.1016/J.C0MBUSTFLAME.2003.09.008]	30	338	351	18	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					833	836		10.1126/science.1155296	http://dx.doi.org/10.1126/science.1155296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687964				2022-12-28	WOS:000258261000045
J	Hall, HI; Song, RG; Rhodes, P; Prejean, J; An, Q; Lee, LM; Karon, J; Brookmeyer, R; Kaplan, EH; McKenna, MT; Janssen, RS				Hall, H. Irene; Song, Ruiguang; Rhodes, Philip; Prejean, Joseph; An, Qian; Lee, Lisa M.; Karon, John; Brookmeyer, Ron; Kaplan, Edward H.; McKenna, Matthew T.; Janssen, Robert S.		HIV Incidence Surveillance Grp	Estimation of HIV incidence in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE PROGRESSION; SURVEILLANCE DATA; AIDS EPIDEMIC; RISK; PREVENTION; INFECTION; HIV/AIDS; INFORMATION; BEHAVIORS; TRENDS	Context Incidence of human immunodeficiency virus ( HIV) in the United States has not been directly measured. New assays that differentiate recent vs long- standing HIV infections allow improved estimation of HIV incidence. Objective To estimate HIV incidence in the United States. Design, Setting, and Patients Remnant diagnostic serum specimens from patients 13 years or older and newly diagnosed with HIV during 2006 in 22 states were tested with the BED HIV- 1 capture enzyme immunoassay to classify infections as recent or long- standing. Information on HIV cases was reported to the Centers for Disease Control and Prevention through June 2007. Incidence of HIV in the 22 states during 2006 was estimated using a statistical approach with adjustment for testing frequency and extrapolated to the United States. Results were corroborated with back-calculation of HIV incidence for 1977- 2006 based on HIV diagnoses from 40 states and AIDS incidence from 50 states and the District of Columbia. Main Outcome Measure Estimated HIV incidence. Results An estimated 39 400 persons were diagnosed with HIV in 2006 in the 22 states. Of 6864 diagnostic specimens tested using the BED assay, 2133 ( 31%) were classified as recent infections. Based on extrapolations from these data, the estimated number of new infections for the United States in 2006 was 56 300 ( 95% confidence interval [ CI], 48 200- 64 500); the estimated incidence rate was 22.8 per 100 000 population ( 95% CI, 19.5- 26.1). Forty- five percent of infections were among black individuals and 53% among men who have sex with men. The back- calculation ( n= 1.230 million HIV/ AIDS cases reported by the end of 2006) yielded an estimate of 55 400 ( 95% CI, 50 000- 60 800) new infections per year for 2003- 2006 and indicated that HIV incidence increased in the mid- 1990s, then slightly declined after 1999 and has been stable thereafter. Conclusions This study provides the first direct estimates of HIV incidence in the United States using laboratory technologies previously implemented only in clinic-based settings. New HIV infections in the United States remain concentrated among men who have sex with men and among black individuals.	[Hall, H. Irene; Song, Ruiguang; Rhodes, Philip; Prejean, Joseph; Lee, Lisa M.; McKenna, Matthew T.; Janssen, Robert S.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [An, Qian] Ginn Grp Inc, Peachtree City, GA USA; [Karon, John] Emergint Corp, Louisville, KY USA; [Brookmeyer, Ron] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kaplan, Edward H.] Yale Univ, Sch Management, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [Kaplan, Edward H.] Yale Univ, Sch Med, New Haven, CT USA; [Kaplan, Edward H.] Yale Univ, Sch Engn & Appl Sci, New Haven, CT USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; Yale University; Yale University	Hall, HI (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, MS E-47,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	ixh1@cdc.gov		Kaplan, Edward/0000-0002-8722-7667; Lee, Lisa M/0000-0002-3397-3269	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038209] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD038209-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aalen OO, 1997, STAT MED, V16, P2191, DOI 10.1002/(SICI)1097-0258(19971015)16:19&lt;2191::AID-SIM645&gt;3.0.CO;2-5; Anderson JE, 2000, AM J PUBLIC HEALTH, V90, P1089, DOI 10.2105/AJPH.90.7.1089; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], 1999, GUID DEF PUBL HLTH R; Bellocco R, 2000, STAT MED, V19, P297, DOI 10.1002/(SICI)1097-0258(20000215)19:3&lt;297::AID-SIM340&gt;3.0.CO;2-6; BIGGAR RJ, 1993, CLIN INFECT DIS, V17, pS219, DOI 10.1093/clinids/17.Supplement_1.S219; Bishop YM., 2007, DISCRETE MULTIVARIAT; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P595; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2007, US BED HIV 1 CAPT EI; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P540; Centers for Disease Control and Prevention, 2007, HIV AIDS SURVEILLANC, P17; Centers for Disease Control and Prevention, 2006, HIV COUNS TEST CDC S; Centers for Disease Control and Prevention, 1999, COMP HIV PREV INT EV; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Cui JS, 2000, STAT MED, V19, P1165, DOI 10.1002/(SICI)1097-0258(20000515)19:9&lt;1165::AID-SIM419&gt;3.0.CO;2-7; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Hall HI, 2007, AM J PUBLIC HEALTH, V97, P1060, DOI 10.2105/AJPH.2006.087551; Hall HI, 2005, PUBLIC HEALTH REP, V120, P89, DOI 10.1177/003335490512000115; *I MED, 2000, NO TIM LOS GETT MOR; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jarlais DCD, 2005, AIDS, V19, pS20, DOI 10.1097/01.aids.0000192066.86410.8c; *JOINT UN PROGR HI, 2007, AIDS EP UPD 07; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Lee LM, 2007, PUBLIC HEALTH REP, V122, P72, DOI 10.1177/00333549071220S111; *MAN INC, 1995, APL PLUS 3 COMP PROG; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MARSCHNER IC, 1994, STAT MED, V13, P1959, DOI 10.1002/sim.4780131908; *NAT CTR HLTH STAT, 2006, BRIDG RAC VINT 2006; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; ROSENBERG PS, 1994, STAT MED, V13, P1975, DOI 10.1002/sim.4780131909; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sanchez T., 2006, MMWR MORB MORTAL WKL, V55, P752; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Santibanez SS, 2006, J URBAN HEALTH, V83, P86, DOI 10.1007/s11524-005-9009-2; *SAS I INC, 2002, SAS WIND COMP PROGR; Song RG, 2005, STAT MED, V24, P453, DOI 10.1002/sim.1935; *UNAIDS, 2005, M UNAIDS REF GROUP E; *US BUR CENS, 2006, POP EST ENT DAT SET; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd	46	1020	1049	0	63	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					520	529		10.1001/jama.300.5.520	http://dx.doi.org/10.1001/jama.300.5.520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	333YG	18677024	Green Accepted			2022-12-28	WOS:000258188900013
J	Lo, J; You, SM; Canavan, B; Liebau, J; Beltrani, G; Koutkia, P; Hemphill, L; Lee, H; Grinspoon, S				Lo, Janet; You, Sung Min; Canavan, Bridget; Liebau, James; Beltrani, Greg; Koutkia, Polyxeni; Hemphill, Linda; Lee, Hang; Grinspoon, Steven			Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	90th Annual Meeting of the Endocrine-Society	JUN 15-18, 2008	San Francisco, CA	Endocrine Soc			HUMAN-IMMUNODEFICIENCY-VIRUS; INTIMA-MEDIA THICKNESS; SEVERE GH DEFICIENCY; INFECTED PATIENTS; BODY-COMPOSITION; ADIPOSE-TISSUE; INSULIN SENSITIVITY; ADULTS; MEN; LIPODYSTROPHY	Context Antiretroviral therapy can be associated with visceral adiposity and metabolic complications, increasing cardiovascular risk, and reduced growth hormone ( GH) secretion may be a contributing factor. Objective To investigate the effects of low- dose physiological GH administrationon body composition, glucose, and cardiovascular parameters in patients with human immunodeficiency virus ( HIV) having abdominal fat accumulation and relative GH deficiency. Design, Setting, and Patients A randomized, double- blind, placebo- controlled trial of 56 patients with HIV, abdominal fat accumulation, and reduced GH secretion ( peak GH < 7.5 ng/mL) conducted at a US academic medical center between November 2003 and October 2007. Intervention Patients were randomly assigned to receive either subcutaneous GH or matching placebo titrated to the upper quartile of normal insulin like growth factor 1 ( IGF- 1) range for 18 months. Starting dose was 2 mu g/kg/d and increased to maximum dose of 6 mu g/kg/d ( average dose, 0.33 mg/d). Main Outcome Measures Change in body composition assessed by computed tomographic scan and dual- energy x- ray absorptiometry. Secondary outcomes included glucose, IGF- 1, blood pressure ( BP), and lipids. Treatment effect was the difference in the change between GH and placebo groups, using all available data. Results Fifty- five patients ( 26 with GH and 29 with placebo) were included in the safety analyses and 52 patients ( 25 with GH and 27 with placebo) were included in the efficacy analyses. Visceral adipose tissue area ( treatment effect [ last- value- carried-forward analysis {n= 56}, - 19 cm(2); 95% confidence interval {CI}, - 37 to - 0.3 cm(2)], - 19 cm(2); 95% CI, - 38 to - 0.5 cm(2); P=. 049); trunk fat (- 0.8 kg; 95% CI, - 1.5 to - 0.04 kg; P=. 04); diastolic BP (- 7 mm Hg; 95% CI, - 11 to - 2 mm Hg; P=. 006); and triglycerides (- 7 mg/ dL, P=. 002) improved but 2- hour glucose levels on glucose tolerance testing increased in the GH group vs the placebo group ( treatment effect, 22 mg/ dL; 95% CI, 6- 37 mg/ dL; P=. 009). The IGF- 1 levels increased ( treatment effect, 129 ng/ mL; 95% CI, 95- 164 ng/ mL; P <. 001). Adverse events were not increased for GH vs placebo ( 23%; 95% CI, 9%- 44% vs 28%; 95% CI, 13%- 47%; P=. 70). Conclusions In HIV- associated abdominal fat accumulation and relative GH deficiency, low- dose GH received for 18 months resulted in significantly reduced visceral fat and truncal obesity, triglycerides, and diastolic BP, but 2- hour glucose levels on glucose tolerance testing were increased. Trial Registration clinicaltrials. gov Identifier: NCT00100698.	[Lo, Janet; You, Sung Min; Canavan, Bridget; Liebau, James; Beltrani, Greg; Koutkia, Polyxeni; Grinspoon, Steven] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA; [Hemphill, Linda] Boston Heart Fdn, Boston, MA USA; [Lee, Hang] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Grinspoon, S (corresponding author), Massachusetts Gen Hosp, Program Nutr Metab, 55 Fruit St,LON207, Boston, MA 02114 USA.	sgrinspoon@partners.org	Hron, Bridget/AFU-8589-2022	Hron, Bridget/0000-0002-6482-0150	NCRR NIH HHS [M01 RR001066-270437, M01 RR001066, M01 RR01066-25S1] Funding Source: Medline; NHLBI NIH HHS [F32 HL088991, F32 HL088991-01] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561, P30 DK040561-13, R01 DK063639, R01 DK063639-01, R01 DK63639] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL088991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063639, P30DK040561] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; BLACKETT PR, 1982, METABOLISM, V31, P117, DOI 10.1016/0026-0495(82)90121-4; Brandou F, 2006, CLIN ENDOCRINOL, V65, P423, DOI 10.1111/j.1365-2265.2006.02578.x; Carr DB, 2005, DIABETES, V54, P340, DOI 10.2337/diabetes.54.2.340; Colao A, 2005, J CLIN ENDOCR METAB, V90, P5146, DOI 10.1210/jc.2005-0597; Colao A, 2005, J CLIN ENDOCR METAB, V90, P2056, DOI 10.1210/jc.2004-2247; DEBOER H, 1992, J CLIN ENDOCR METAB, V75, P833, DOI 10.1210/jc.75.3.833; Delate T, 2001, CLIN INFECT DIS, V32, pE47, DOI 10.1086/318492; Djurhuus CB, 2004, AM J PHYSIOL-ENDOC M, V286, pE488, DOI 10.1152/ajpendo.00199.2003; Dolan SE, 2006, ARCH INTERN MED, V166, P1225, DOI 10.1001/archinte.166.11.1225; Falutz J, 2005, AIDS, V19, P1279, DOI 10.1097/01.aids.0000180099.35146.30; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; FRIEDMAN M, 1974, METABOLISM, V23, P905, DOI 10.1016/0026-0495(74)90039-0; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Fujimoto WY, 2007, DIABETES, V56, P1680, DOI 10.2337/db07-0009; Grunfeld C, 2007, JAIDS-J ACQ IMM DEF, V45, P286; Hadigan C, 2004, ANN INTERN MED, V140, P786, DOI 10.7326/0003-4819-140-10-200405180-00008; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Hew FL, 1996, J CLIN ENDOCR METAB, V81, P555, DOI 10.1210/jc.81.2.555; Hoffman DJ, 2005, OBES RES, V13, P66, DOI 10.1038/oby.2005.9; Hwu CM, 1997, J CLIN ENDOCR METAB, V82, P3285, DOI 10.1210/jc.82.10.3285; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727; JOHANSSON JO, 1995, METABOLISM, V44, P1126, DOI 10.1016/0026-0495(95)90004-7; Kotler DP, 2004, JAIDS-J ACQ IMM DEF, V35, P239, DOI 10.1097/00126334-200403010-00004; Koutkia P, 2006, AIDS, V20, P855, DOI 10.1097/01.aids.0000218549.85081.8f; Koutkia P, 2005, J CLIN ENDOCR METAB, V90, P32, DOI 10.1210/jc.2004-1342; Koutkia P, 2004, JAMA-J AM MED ASSOC, V292, P210, DOI 10.1001/jama.292.2.210; Lo J, 2006, J CLIN ENDOCR METAB, V91, P1677, DOI 10.1210/jc.2005-2775; Lo JC, 2004, CLIN INFECT DIS, V39, P732, DOI 10.1086/422725; Lo JC, 2001, J CLIN ENDOCR METAB, V86, P3480, DOI 10.1210/jc.86.8.3480; MERIMEE TJ, 1972, METABOLISM, V21, P1053, DOI 10.1016/0026-0495(72)90036-4; Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830; OTTOSSON M, 1995, J CLIN ENDOCR METAB, V80, P936, DOI 10.1210/jc.80.3.936; Park HS, 2005, DIABETIC MED, V22, P266, DOI 10.1111/j.1464-5491.2004.01395.x; RICHELSEN B, 1994, AM J PHYSIOL, V266, pE211, DOI 10.1152/ajpendo.1994.266.2.E211; Rietschel P, 2001, J CLIN ENDOCR METAB, V86, P504, DOI 10.1210/jc.86.2.504; ROSEN T, 1993, CLIN ENDOCRINOL, V38, P63, DOI 10.1111/j.1365-2265.1993.tb00974.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Schwarz JM, 2002, J CLIN ENDOCR METAB, V87, P942, DOI 10.1210/jc.87.2.942; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; SNYDER S, 2004, FORUM COLLABORATIVE; Soares DV, 2005, METABOLISM, V54, P321, DOI 10.1016/j.metabol.2004.09.011; Svensson J, 2002, J CLIN ENDOCR METAB, V87, P2121, DOI 10.1210/jc.87.5.2121; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750	45	65	67	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					509	519		10.1001/jama.300.5.509	http://dx.doi.org/10.1001/jama.300.5.509			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	333YG	18677023	Green Accepted			2022-12-28	WOS:000258188900012
J	Ruperto, N; Lovell, DJ; Quartier, P; Paz, E; Rubio-Perez, N; Silva, CA; Abud-Mendoza, C; Burgos-Vargas, R; Gerloni, V; Melo-Gomes, JA; Saad-Magalhaes, C; Sztajnbok, F; Goldenstein-Schainberg, C; Scheinberg, M; Penades, IC; Fischbach, M; Orozco, J; Hashkes, PJ; Hom, C; Jung, L; Lepore, L; Oliveira, S; Wallace, CA; Sigal, LH; Block, AJ; Covucci, A; Martini, A; Giannini, EH				Ruperto, Nicolino; Lovell, Daniel J.; Quartier, Pierre; Paz, Eliana; Rubio-Perez, Nadina; Silva, Clovis A.; Abud-Mendoza, Carlos; Burgos-Vargas, Ruben; Gerloni, Valeria; Melo-Gomes, Jose A.; Saad-Magalhaes, Claudia; Sztajnbok, Flavio; Goldenstein-Schainberg, Claudia; Scheinberg, Morton; Calvo Penades, Immaculada; Fischbach, Michael; Orozco, Javier; Hashkes, Philip J.; Hom, Christine; Jung, Lawrence; Lepore, Loredana; Oliveira, Sheila; Wallace, Carol A.; Sigal, Leonard H.; Block, Alon J.; Covucci, Allison; Martini, Alberto; Giannini, Edward H.		PRINTO; PRCSG	Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial	LANCET			English	Article							QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; PEDIATRIC RHEUMATOLOGY; PRELIMINARY DEFINITION; METHOTREXATE; ETANERCEPT; EFFICACY	Background Some children with juvenile idiopathic arthritis either do not respond, or are intolerant to, treatment with disease-modifying antirheumatic drugs, including anti-tumour necrosis factor (TNF) drugs. We aimed to assess the safety and efficacy of abatacept, a selective T-cell costimulation modulator, in children with juvenile idiopathic arthritis who had failed previous treatments. Methods We did a double-blind, randomised controlled withdrawal trial between February, 2004, and June, 2006. We enrolled 190 patients aged 6-17 years, from 45 centres, who had a history of active juvenile idiopathic arthritis; at least five active joints; and an inadequate response to, or intolerance to, at least one disease-modifying antirheumatic drug. All 190 patients were given 10 mg/kg of abatacept intravenously in the open-label period of 4 months. Of the 170 patients who completed this lead-in course, 47 did not respond to the treatment according to predefined American College of Rheumatology (ACR) paediatric criteria and were excluded. Of the patients who did respond to abatacept, arthritis, and 62 were randomly assigned to receive placebo at the same dose and timing. The primary endpoint was time to flare of arthritis. Flare was defined as worsening of 30% or more in at least three of six core variables, with at least 30% improvement in no more than one variable. We analysed all patients who were treated as per protocol. This trial is registered, number NCT00095173. Findings Flares of arthritis occurred in 33 of 62 (53%) patients who were given placebo and 12 of 60 (20%) abatacept patients during the double-blind treatment (p=0.0003). Median time to flare of arthritis was 6 months for patients given placebo (insufficient events to calculate IQR); insufficient events had occurred in the abatacept group for median time to flare to be assessed (p=0.0002). The risk of flare in patients who contined abatacept was less than a third of that for controls during that double-blind period (hazard ratio 0.31, 95% CI 0.16-0.95). During the double-blind period, the frequency of adverse events did not differ in the two treatment groups, Adverse events were recorded in 37 abatacept recipients (62%) and 34 (55%) placebo recipients (p=0.47); only two serious adverse events were reported, bouth in controls (p=0.50). Interpretation Selective modulation of T-cell costimulation with abatacept is a rational alternative treatment for children with juvenile idiopathic arthritis. Funding Bristol-Myers Squibb.	[Ruperto, Nicolino; Martini, Alberto] IRCCS Ist G Gaslini Pediat 2, PRINTO, I-16147 Genoa, Italy; [Lovell, Daniel J.; Giannini, Edward H.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Quartier, Pierre] Hop Necker Enfants Malad, Paris, France; [Paz, Eliana] Inst Salud Nino, Lima, Peru; [Rubio-Perez, Nadina] Hosp Univ JE Gonzalez, Monterrey, Mexico; [Silva, Clovis A.] Inst Crianca Hosp Clin, Sao Paulo, Brazil; [Abud-Mendoza, Carlos] Hosp Gen Dr Ignacio Morones Prieto, San Luis Potosi, Mexico; [Burgos-Vargas, Ruben] Hosp Gen Mexico City, Dept Rheumatol, Mexico City, DF, Mexico; [Burgos-Vargas, Ruben] Hosp Gen Mexico City, Fac Med, Mexico City, DF, Mexico; [Burgos-Vargas, Ruben] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Gerloni, Valeria] Gaetano Pini Inst, Milan, Italy; [Melo-Gomes, Jose A.] Inst Portugues Reumatol Paediat Rheumatol, Lisbon, Portugal; [Saad-Magalhaes, Claudia] Univ Estadual Paulista, Fac Med Botucatu, Botucatu, SP, Brazil; [Sztajnbok, Flavio] Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil; [Goldenstein-Schainberg, Claudia] Univ Sao Paulo, Sao Paulo, Brazil; [Scheinberg, Morton] Hosp Israelita Albert Einstein, Res Inst, Sao Paulo, Brazil; [Calvo Penades, Immaculada] Hosp La Fe, E-46009 Valencia, Spain; [Fischbach, Michael] Hop Univ Hautepierre, Strasbourg, France; [Orozco, Javier] Hosp San Javier, Guadalajara, Jalisco, Mexico; [Hashkes, Philip J.] Cleveland Clin Fdn, Dept Rheumat Dis, Cleveland, OH 44195 USA; [Hom, Christine] Maria Fareri Childrens Hosp, NYMC, Dept Pediat, New York, NY USA; [Jung, Lawrence] Creighton Univ, Med Ctr, Omaha, NE USA; [Lepore, Loredana] Univ Trieste, Paediat Clin, Trieste, Italy; [Oliveira, Sheila] Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Wallace, Carol A.] Childrens Hosp & Reg Med Ctr, Seattle, WA USA; [Sigal, Leonard H.; Block, Alon J.; Covucci, Allison] Bristol Myers Squibb Co, Princeton, NJ USA; [Ruperto, Nicolino; Martini, Alberto] Univ Genoa, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Cincinnati Children's Hospital Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Hospital Central Dr. Ignacio Morones Prieto; Hospital General de Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; ASST Gaetano Pini CTO; Universidade Estadual Paulista; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Hospital Universitari i Politecnic La Fe; CHU Strasbourg; Cleveland Clinic Foundation; Creighton University; University of Trieste; Seattle Children's Hospital; Bristol-Myers Squibb; University of Genoa	Ruperto, N (corresponding author), IRCCS Ist G Gaslini Pediat 2, PRINTO, Largo Gaslini 5, I-16147 Genoa, Italy.	nicolaruperto@ospedale-gaslini.ge.it	Silva, Clovis Artur Almeida/J-3640-2017; Scheinberg, Morton/AAU-8142-2020; Ruperto, Nicolino/K-3349-2018; Blanco, Francisco J./C-3192-2014; Sampaio, Magda/AAU-6748-2020; Oliveira, Sheila/F-5213-2016; Burgos-Vargas, Ruben/AAZ-1295-2020; Sztajnbok, Flavio/AAK-1469-2020; /C-3367-2013	Ruperto, Nicolino/0000-0001-8407-7782; Blanco, Francisco J./0000-0001-9821-7635; Sampaio, Magda/0000-0002-1924-4043; Oliveira, Sheila/0000-0002-2426-716X; Burgos-Vargas, Ruben/0000-0003-1058-8955; Abud-Mendoza, Carlos/0000-0002-3749-5831; /0000-0002-7631-7093; Quartier, Pierre/0000-0002-1769-549X; Goldenstein-Schainberg, Claudia/0000-0003-3306-9699; MARTINI, Alberto/0000-0001-7642-1459				Brunner HI, 2002, J RHEUMATOL, V29, P1058; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; GIANNINI EH, 1992, NEW ENGL J MED, V326, P1043, DOI 10.1056/NEJM199204163261602; Horneff G, 2004, ANN RHEUM DIS, V63, P1638, DOI 10.1136/ard.2003.014886; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; LOVELL DJ, IN PRESS N ENGL J ME; Oliveira S, 2007, ARTHRIT RHEUM-ARTHR, V57, P35, DOI 10.1002/art.22473; Petty Ross E., 1998, Journal of Rheumatology, V25, P1991; Quartier P, 2003, ARTHRITIS RHEUM, V48, P1093, DOI 10.1002/art.10885; Ravelli A, 2000, J RHEUMATOL, V27, P1830; Ravelli A, 2008, J RHEUMATOL, V35, P553; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Ruperto N, 2004, CURR OPIN RHEUMATOL, V16, P566, DOI 10.1097/01.bor.0000130286.54383.ea; Ruperto N, 2004, ARTHRITIS RHEUM-US, V50, P2191, DOI 10.1002/art.20288; Ruperto N, 1997, J RHEUMATOL, V24, P945; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS1; Ruperto N, 2007, ARTHRITIS RHEUM-US, V56, P3096, DOI 10.1002/art.22838; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Yamada A, 2002, J AM SOC NEPHROL, V13, P559, DOI 10.1681/ASN.V132559; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7	25	354	385	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					383	391		10.1016/S0140-6736(08)60998-8	http://dx.doi.org/10.1016/S0140-6736(08)60998-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18632147				2022-12-28	WOS:000258196000029
J	Teitelbaum, MS				Teitelbaum, Michael S.			Research funding - Structural disequilibria in biomedical research	SCIENCE			English	Editorial Material							NIH		Alfred P Sloan Fdn, New York, NY 10011 USA		Teitelbaum, MS (corresponding author), Alfred P Sloan Fdn, 630 5th Ave, New York, NY 10011 USA.	teitelbaum@sloan.org						Bunton SA, 2007, ACAD MED, V82, P281, DOI 10.1097/ACM.0b013e3180307e87; FREEMAN R, 2008, NAT BUR EC RES C INN; Goldman CA, 2000, PHD FACTORY TRAINING; Heinig SJ, 2007, NEW ENGL J MED, V357, P1042, DOI 10.1056/NEJMsb071774; Korn D, 2002, SCIENCE, V296, P1401, DOI 10.1126/science.1072486; National Research Council, 1998, TRENDS EARL CAR LIF; National Science Board (NSB), 2008, SCI ENG IND 2008; *NIH, 2007, SUCC RAT NIH EXT DAT; *NIH, NIH EXT DAT BOOK 200; *NIH, 2006, PRES ASS IND RES I P; The National Research Council, 2000, ADDR NAT CHANG NEEDS; Weiner N., 1948, CYBERNETICS CONTROL; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931	13	42	42	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					644	645		10.1126/science.1160272	http://dx.doi.org/10.1126/science.1160272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	332IW	18669847				2022-12-28	WOS:000258077700026
J	Dasen, JS; De Camilli, A; Wang, B; Tucker, PW; Jessell, TM				Dasen, Jeremy S.; De Camilli, Alessandro; Wang, Bin; Tucker, Philip W.; Jessell, Thomas M.			Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1	CELL			English	Article							ETS GENE PEA3; POOL IDENTITY; EARLY VERTEBRATES; SUBTYPE IDENTITY; SKELETAL-MUSCLES; NERVOUS-SYSTEM; SPECIFICATION; EXPRESSION; EVOLUTION; LIMB	The precision with which motor neurons innervate target muscles depends on a regulatory network of Hox transcription factors that translates neuronal identity into patterns of connectivity. We show that a single transcription factor, FoxP1, coordinates motor neuron subtype identity and connectivity through its activity as a Hox accessory factor. FoxP1 is expressed in Hox-sensitive motor columns and acts as a dose-dependent determinant of columnar fate. Inactivation of Foxp1 abolishes the output of the motor neuron Hox network, reverting the spinal motor system to an ancestral state. The loss of FoxP1 also changes the pattern of motor neuron connectivity, and in the limb motor axons appear to select their trajectories and muscle targets at random. Our findings show that FoxP1 is a crucial determinant of motor neuron diversification and connectivity, and clarify how this Hox regulatory network controls the formation of a topographic neural map.	[Dasen, Jeremy S.; De Camilli, Alessandro] NYU, Sch Med, Dept Physiol & Neurosci, Smilow Neurosci Program, New York, NY 10016 USA; [Wang, Bin; Tucker, Philip W.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Biochem, New York, NY 10032 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Mol Biophys, New York, NY 10032 USA	New York University; University of Texas System; University of Texas Austin; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Dasen, JS (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Smilow Neurosci Program, New York, NY 10016 USA.	jeremy.dasen@nyumc.org; tmj1@columbia.edu			NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA031534] Funding Source: Medline; PHS HHS [5R01033245] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; FETCHO JR, 1992, BRAIN BEHAV EVOLUT, V40, P82, DOI 10.1159/000113905; Force A, 2002, J EXP ZOOL, V294, P30, DOI 10.1002/jez.10091; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Funakoshi K, 2007, BRAIN BEHAV EVOLUT, V69, P105, DOI 10.1159/000095199; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kusakabe R, 2005, DEV DYNAM, V234, P824, DOI 10.1002/dvdy.20587; Landgraf M, 2006, SEMIN CELL DEV BIOL, V17, P3, DOI 10.1016/j.semcdb.2005.11.007; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LASKOWSKI MB, 1987, J NEUROSCI, V7, P252; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; RPICE SR, 2002, CELL, V109, P205; Shah V, 2004, DEV DYNAM, V231, P43, DOI 10.1002/dvdy.20103; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Tamura S, 2003, GENE EXPR PATTERNS, V3, P193, DOI 10.1016/S1567-133X(03)00003-6; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Turney BW, 2003, J ANAT, V202, P83, DOI 10.1046/j.1469-7580.2003.00131.x; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225	45	255	257	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					304	316		10.1016/j.cell.2008.06.019	http://dx.doi.org/10.1016/j.cell.2008.06.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662545	Bronze			2022-12-28	WOS:000257891700019
J	Brown, A				Brown, Andrew			John Templeton (1912-2008) - Obituary	NATURE			English	Biographical-Item												laptop@thewormbook.com							0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2008	454	7202					290	290		10.1038/454290a	http://dx.doi.org/10.1038/454290a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633408				2022-12-28	WOS:000257665300028
J	Guthrie, B; Saultz, JW; Freeman, GK; Haggerty, JL				Guthrie, Bruce; Saultz, John W.; Freeman, George K.; Haggerty, Jeannie L.			Continuity of care matters	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-CARE		[Guthrie, Bruce] Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland; [Saultz, John W.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Freeman, George K.] Univ London St Georges Hosp, Community Hlth Sci Div, London, England; [Haggerty, Jeannie L.] Univ Sherbrooke, Dept Sci Sante Communautaire, Quebec City, PQ, Canada; [Haggerty, Jeannie L.] Univ Sherbrooke, Dept Family Med, Quebec City, PQ, Canada	University of Dundee; Oregon Health & Science University; St Georges University London; University of Sherbrooke; University of Sherbrooke	Guthrie, B (corresponding author), Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022; Haggerty, Jeannie/GSD-7271-2022	Guthrie, Bruce/0000-0003-4191-4880	Harkness fellowship from the Commonwealth Fund	Harkness fellowship from the Commonwealth Fund	All four authors have researched continuity in primary and secondary care. BG, JWS, and GKF are practising family physicians. The paper draws on their knowledge of the research literature, including systematic and narrative reviews conducted by them (JWS, JLH, GKF), policy and research scoping work (JLH, GKF), and review and summary of multiproject research programmes in the UK and Canada (BG, JLH, GKF). BG wrote the first draft, which was separately revised by JWS, JLH, and GKF, with BG coordinating rewriting and agreement of the final article. BG is the guarantor During the initial writing, BG was supported by a Harkness fellowship from the Commonwealth Fund, The views presented here are those of the authors.	Adair CE, 2005, PSYCHIAT SERV, V56, P1061, DOI 10.1176/appi.ps.56.9.1061; Balint M., 1957, DOCTOR; BARR M, 2006, ADV MED HOME PATIENT; Boulton M, 2006, BRIT J GEN PRACT, V56, P749; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Guthrie Bruce, 2006, BMC Fam Pract, V7, P11, DOI 10.1186/1471-2296-7-11; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Kearley KE, 2001, BRIT J GEN PRACT, V51, P712; Lester H, 2007, BRIT MED J, V335, P1130, DOI 10.1136/bmj.39385.406192.AD; Nutting Paul A, 2003, Ann Fam Med, V1, P149, DOI 10.1370/afm.63; *ROYAL COLL GEN PR, 2004, FUT ACC GEN PRACT BA; Royal College of General Practitioners, 2004, FUT GEN PRACT; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Schers H, 2002, BRIT J GEN PRACT, V52, P459; Solberg LI, 2006, ANN FAM MED, V4, P109, DOI 10.1370/afm.424; Starfield B, 2004, PEDIATRICS, V113, P1493; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Windridge K, 2004, BRIT J GEN PRACT, V54, P364	19	107	109	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2008	337	7669							a867	10.1136/bmj.a867	http://dx.doi.org/10.1136/bmj.a867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351JP	18687724				2022-12-28	WOS:000259420900031
J	Angelopoulos, V; McFadden, JP; Larson, D; Carlson, CW; Mende, SB; Frey, H; Phan, T; Sibeck, DG; Glassmeier, KH; Auster, U; Donovan, E; Mann, IR; Rae, IJ; Russell, CT; Runov, A; Zhou, XZ; Kepko, L				Angelopoulos, Vassilis; McFadden, James P.; Larson, Davin; Carlson, Charles W.; Mende, Stephen B.; Frey, Harald; Phan, Tai; Sibeck, David G.; Glassmeier, Karl-Heinz; Auster, Uli; Donovan, Eric; Mann, Ian R.; Rae, I. Jonathan; Russell, Christopher T.; Runov, Andrei; Zhou, Xu-Zhi; Kepko, Larry			Tail reconnection triggering substorm onset	SCIENCE			English	Article							MAGNETOSPHERIC SUBSTORMS; MAGNETIC RECONNECTION; GEOTAIL OBSERVATIONS; CURRENT SHEET; MAGNETOTAIL; CLUSTER; GROWTH; PHASE	Magnetospheric substorms explosively release solar wind energy previously stored in Earth's magnetotail, encompassing the entire magnetosphere and producing spectacular auroral displays. It has been unclear whether a substorm is triggered by a disruption of the electrical current flowing across the near- Earth magnetotail, at similar to 10 R-E ( R-E: Earth radius, or 6374 kilometers), or by the process of magnetic reconnection typically seen farther out in the magnetotail, at similar to 20 to 30 R-E. We report on simultaneous measurements in the magnetotail at multiple distances, at the time of substorm onset. Reconnection was observed at 20 R-E, at least 1.5 minutes before auroral intensification, at least 2 minutes before substorm expansion, and about 3 minutes before near- Earth current disruption. These results demonstrate that substorms are likely initiated by tail reconnection.	[Angelopoulos, Vassilis; Russell, Christopher T.; Runov, Andrei; Zhou, Xu-Zhi] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, ESS, Los Angeles, CA 90095 USA; [McFadden, James P.; Larson, Davin; Carlson, Charles W.; Mende, Stephen B.; Frey, Harald; Phan, Tai] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Sibeck, David G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Glassmeier, Karl-Heinz; Auster, Uli] TUBS, D-38106 Braunschweig, Germany; [Donovan, Eric] Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada; [Mann, Ian R.; Rae, I. Jonathan] Univ Alberta, Dept Phys, Edmonton, AB T6G 2M7, Canada; [Kepko, Larry] Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Calgary; University of Alberta; University System Of New Hampshire; University of New Hampshire	Angelopoulos, V (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, ESS, Los Angeles, CA 90095 USA.	vassilis@ucla.edu	Zhou, Xuzhi/D-1831-2011; Russell, Christopher T/E-7745-2012; Rae, Jonathan/D-8132-2013; Kepko, Larry/D-7747-2012; Sibeck, David G/D-4424-2012	Zhou, Xuzhi/0000-0003-4953-1761; Russell, Christopher T/0000-0003-1639-8298; Rae, Jonathan/0000-0002-2637-4786; Kepko, Larry/0000-0002-4911-8208; Donovan, Eric/0000-0002-8557-4155; Angelopoulos, Vassilis/0000-0001-7024-1561; Frey, Harald/0000-0001-8955-3282				Aikio AT, 1999, J GEOPHYS RES-SPACE, V104, P12263, DOI 10.1029/1999JA900118; AKASOFU SI, 1964, PLANET SPACE SCI, V12, P273, DOI 10.1016/0032-0633(64)90151-5; Angelopoulos V, 1997, GEOPHYS RES LETT, V24, P2271, DOI 10.1029/97GL02355; ANGELOPOULOS V, IN PRESS SPACE SCI R; AUSTER U, IN PRESS SPACE SCI R; Axford WI, 1999, PHYS CHEM EARTH PT C, V24, P147, DOI 10.1016/S1464-1917(98)00022-1; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; Birn J, 1997, J GEOPHYS RES-SPACE, V102, P2325, DOI 10.1029/96JA03032; Chaston CC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029144; CORONITI FV, 1985, J GEOPHYS RES-SPACE, V90, P7427, DOI 10.1029/JA090iA08p07427; Fujimoto M, 1997, SPACE SCI REV, V80, P325, DOI 10.1023/A:1004934306623; Kepko L, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010285; Liou K, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000179; Lui ATY, 1996, J GEOPHYS RES-SPACE, V101, P13067, DOI 10.1029/96JA00079; Lysak RL, 1996, J GEOPHYS RES-SPACE, V101, P5085, DOI 10.1029/95JA03712; MAYNAUD PN, 1980, GEOPHYS MONOGR, V22; MCPHERRON RL, 1979, REV GEOPHYS, V17, P657, DOI 10.1029/RG017i004p00657; MENDE S, 2008, IN PRESS SPACE SCI R; Mende SB, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009787; MILLING DK, 2008, IN PRESS GEOPHYS RES; Nagai T, 2001, J GEOPHYS RES-SPACE, V106, P25929, DOI 10.1029/2001JA900038; Nagai T, 1998, J GEOPHYS RES-SPACE, V103, P4419, DOI 10.1029/97JA02190; OHTANI S, 1991, GEOPH MONOG SERIES, V64, P131; Oieroset M, 2001, NATURE, V412, P414, DOI 10.1038/35086520; ROSTOKER G, 1980, J GEOPHYS RES-SPACE, V85, P1663, DOI 10.1029/JA085iA04p01663; Runov A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016730; RUSSELL CT, 1973, SPACE SCI REV, V15, P205, DOI 10.1007/BF00169321; SAITO T, 1969, SPACE SCI REV, V10, P319, DOI 10.1007/BF00203620; SANNY J, 1994, J GEOPHYS RES-SPACE, V99, P5805, DOI 10.1029/93JA03235; Semenov VS, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011181; Sergeev VA, 2005, ANN GEOPHYS-GERMANY, V23, P2183, DOI 10.5194/angeo-23-2183-2005; SERGEEV VA, 1995, J GEOPHYS RES-SPACE, V100, P19121, DOI 10.1029/95JA01471; SIBECK DG, 2008, IN PRESS SPACE SCI R; TSYGANENKO NA, 1995, J GEOPHYS RES-SPACE, V100, P5599, DOI 10.1029/94JA03193	34	483	494	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2008	321	5891					931	935		10.1126/science.1160495	http://dx.doi.org/10.1126/science.1160495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18653845				2022-12-28	WOS:000258436700030
J	Karpowich, NK; Wang, DN				Karpowich, Nathan K.; Wang, Da-Neng			Symmetric transporters for asymmetric transport	SCIENCE			English	Editorial Material							NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; ESCHERICHIA-COLI; BINDING-SITE; MECHANISM; CARRIER		[Karpowich, Nathan K.; Wang, Da-Neng] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Karpowich, Nathan K.; Wang, Da-Neng] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Karpowich, NK (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	karpowic@saturn.med.nyu.edu; wang@saturn.med.nyu.edu		Wang, Da-Neng/0000-0002-6496-4699	NIDDK NIH HHS [DK053973, R01 DK053973, R01 DK053973-09] Funding Source: Medline; NIGMS NIH HHS [R21 GM075936, R21 GM075936-02S1, GM075936, GM075026, U54 GM075026-040010, U54 GM075026] Funding Source: Medline; NIMH NIH HHS [R01 MH083840, MH083840, R01 MH083840-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, R21GM075936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083840] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; CAMMACK JN, 1994, NEURON, V13, P949, DOI 10.1016/0896-6273(94)90260-7; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7; Loo DDF, 1999, J PHYSIOL-LONDON, V518, P195, DOI 10.1111/j.1469-7793.1999.0195r.x; PATLAK CLIFFORD S., 1957, BULL MATH BIOPHYS, V19, P209, DOI 10.1007/BF02477764; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; VIDAVER GA, 1966, J THEOR BIOL, V10, P301, DOI 10.1016/0022-5193(66)90128-7; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	17	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					781	782		10.1126/science.1161495	http://dx.doi.org/10.1126/science.1161495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687947	Green Accepted			2022-12-28	WOS:000258261000027
J	Mermin, J; Musinguzi, J; Opio, A; Kirungi, W; Ekwaru, JP; Hladik, W; Kaharuza, F; Downing, R; Bunnell, R				Mermin, Jonathan; Musinguzi, Joshua; Opio, Alex; Kirungi, Wilford; Ekwaru, John Paul; Hladik, Wolfgang; Kaharuza, Frank; Downing, Robert; Bunnell, Rebecca			Risk factors for recent HIV infection in Uganda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	15th Conference on Retroviruses and Opportunistic Infections	FEB 03-06, 2008	Boston, MA				SEXUALLY-TRANSMITTED-DISEASES; POPULATION-BASED COHORT; BED-ENZYME IMMUNOASSAY; INJECTION-DRUG USERS; PREVALENCE; RAKAI; WOMEN; TRENDS; SEROPREVALENCE; SURVEILLANCE	Context Studies of factors associated with acquiring human immunodeficiency virus ( HIV) are often based on prevalence data that might not reflect recent infections. Objective To determine demographic, biological, and behavioral factors for recent HIV infection in Uganda. Design and Setting Nationally representative household survey of cross- sectional design conducted in Uganda from August 2004 through January 2005; data were analyzed until November 2007. Participants There were 11 454 women and 9905 men aged 15 to 59 years who were eligible. Questionnaires were completed for 10 826 women ( 95%) and 8830 men ( 89%); of those interviewed, blood specimens were collected for 10 227 women ( 94%) and 8298 men ( 94%). Main Outcome Measure Specimens seropositive for HIV were tested with the BED IgG capture- based enzyme immunosorbent assay to identify recent seroconversions ( median, 155 days) using normalized optical density of 0.8 and adjustments. Results Of the 1023 HIV infections with BED results, 172 ( 17%) tested as recent. In multivariate analysis, risk factors associated with recent HIV infection included female sex ( adjusted odds ratio [ aOR], 2.4; 95% confidence interval [ CI], 1.1- 5.2); current marital status ( widowed vs never married, aOR, 6.1; 95% CI, 2.8- 13.3; divorced vs never married, aOR, 3.0; 95% CI, 1.5- 6.1); geographic region ( north central Uganda vs central Uganda/ Kampala, aOR, 2.6; 95% CI, 1.7- 4.1); number of sex partners in past year ( >= 2 compared with none; aOR, 2.9; 95% CI, 1.6- 5.5); herpes simplex virus type 2 infection ( aOR, 3.9; 95% CI, 2.6- 5.8); report of a sexually transmitted disease in the past year ( aOR, 1.7; 95% CI, 1.2- 2.4); and being an uncircumcised man ( aOR, 2.5; 95% CI, 1.1- 5.3). Among married participants, recent HIV infection was associated with never using condoms with partners outside of marriage ( aOR, 3.2; 95% CI, 1.7- 6.1) compared with individuals having no outside partners. The risk of incident HIV infection for married individuals who used condoms with at least 1 outside partner was similar to that of those who did not have any partners outside of marriage ( aOR, 1.0; 95% CI, 0.3- 2.7). Conclusion A survey of individuals in Uganda who were tested with an HIV assay used to establish recent infection identified risk factors, which offers opportunities for prevention initiatives.	[Mermin, Jonathan] CDC Kenya, Kenya Med Res Inst, Coordinating Off Global Hlth, Nairobi, Kenya; [Mermin, Jonathan; Ekwaru, John Paul; Hladik, Wolfgang; Kaharuza, Frank; Downing, Robert; Bunnell, Rebecca] Ctr Dis Control & Prevent CDC Uganda, Global AIDS Program, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Entebbe, Uganda; [Musinguzi, Joshua; Opio, Alex; Kirungi, Wilford] CDC Kenya, Uganda Minist Hlth, Nairobi, Kenya	Kenya Medical Research Institute	Mermin, J (corresponding author), CDC Kenya, Kenya Med Res Inst, Coordinating Off Global Hlth, Mbagathi Rd Off Mbagathi Way, Nairobi, Kenya.	jhm7@cdc.gov	Mermin, Jonathan/J-9847-2012					Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Baryarama F, 2004, JAIDS-J ACQ IMM DEF, V37, P1180, DOI 10.1097/01.qai.0000127063.76701.bb; BATTER V, 1994, AIDS, V8, P811, DOI 10.1097/00002030-199406000-00014; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Changalucha J, 2002, AIDS, V16, P661, DOI 10.1097/00002030-200203080-00019; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gregson S, 1998, AIDS, V12, P2049, DOI 10.1097/00002030-199815000-00017; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; *INT HIV AIDS ALL, POS PREV PREV STRAT; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jiang Y, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000304696.62508.8a; *JOINT UN PROGR HI, 2007 AIDS EP UPD; *JOINT UN PROGR HI, 3 5 IN TREAT 3 MILL; Karim SSA, 2007, SAMJ S AFR MED J, V97, P190; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; *OFF US GLOB AIDS, INT REC US BED CAPT; Pappas G, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-16; Parekh BS, 2005, INDIAN J MED RES, V121, P510; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roehr B, 2005, BRIT MED J, V330, P496, DOI 10.1136/bmj.330.7490.496-a; Saidel T, 1996, AM J EPIDEMIOL, V144, P214, DOI 10.1093/oxfordjournals.aje.a008916; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Stoneburner R, 1998, AIDS, V12, P226; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; *UNAIDS, 2006, WKLY EPIDEMIOL REC, V81, P40; *UNAIDS WHO WORK G, GUID MEAS NAT HIV PR; Wawer MJ, 1997, AIDS, V11, P1023, DOI 10.1097/00002030-199708000-00011; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; Wolday D, 2007, J INTERN MED, V261, P132, DOI 10.1111/j.1365-2796.2006.01740.x	50	102	104	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					540	549		10.1001/jama.300.5.540	http://dx.doi.org/10.1001/jama.300.5.540			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	333YG	18677026				2022-12-28	WOS:000258188900015
J	Winther-Jensen, B; Winther-Jensen, O; Forsyth, M; MacFarlane, DR				Winther-Jensen, Bjorn; Winther-Jensen, Orawan; Forsyth, Maria; MacFarlane, Douglas R.			High rates of oxygen reduction over a vapor phase-polymerized PEDOT electrode	SCIENCE			English	Article							CONDUCTING POLYMERS; FUEL-CELLS; OXIDATION; CATALYST; ELECTROCATALYSIS; BEHAVIOR; PEMFC; ANODE; CO	The air electrode, which reduces oxygen (O-2), is a critical component in energy generation and storage applications such as fuel cells and metal/ air batteries. The highest current densities are achieved with platinum ( Pt), but in addition to its cost and scarcity, Pt particles in composite electrodes tend to be inactivated by contact with carbon monoxide ( CO) or by agglomeration. We describe an air electrode based on a porous material coated with poly( 3,4- ethylenedioxythiophene) ( PEDOT), which acts as an O-2 reduction catalyst. Continuous operation for 1500 hours was demonstrated without material degradation or deterioration in performance. O-2 conversion rates were comparable with those of Pt- catalyzed electrodes of the same geometry, and the electrode was not sensitive to CO. Operation was demonstrated as an air electrode and as a dissolved O-2 electrode in aqueous solution.	[Winther-Jensen, Bjorn; Winther-Jensen, Orawan; Forsyth, Maria; MacFarlane, Douglas R.] Monash Univ, Australian Ctr Electromat Sci, Clayton, Vic 3800, Australia	Monash University	Winther-Jensen, B (corresponding author), Monash Univ, Australian Ctr Electromat Sci, Clayton, Vic 3800, Australia.	bjorn.winther-jensen@eng.monash.edu.au	MacFarlane, Douglas R/A-9642-2008; Forsyth, Maria/ABH-8102-2020; Macfarlane, Douglas/AAY-7545-2020; Forsyth, Maria/D-8342-2012; Winther-Jensen, Bjorn/AHE-2187-2022	MacFarlane, Douglas R/0000-0001-5963-9659; Winther-Jensen, Bjorn/0000-0001-6102-1639; Forsyth, Maria/0000-0002-4273-8105				Agnolucci P, 2007, INT J HYDROGEN ENERG, V32, P3526, DOI 10.1016/j.ijhydene.2007.02.016; Arico AS, 2001, FUEL CELLS, V1, P133; ATTA NF, 1990, J CHEM SOC CHEM COMM, P1347, DOI 10.1039/c39900001347; Chao WK, 2008, J POWER SOURCES, V177, P637, DOI 10.1016/j.jpowsour.2007.11.047; DELEEUW DM, 1994, SYNTHETIC MET, V66, P263, DOI 10.1016/0379-6779(94)90076-0; Garsuch A, 2008, J ELECTROCHEM SOC, V155, pB236, DOI 10.1149/1.2825168; Halseid R, 2008, J POWER SOURCES, V176, P435, DOI 10.1016/j.jpowsour.2007.08.067; Ham DJ, 2008, CATAL TODAY, V132, P117, DOI 10.1016/j.cattod.2007.12.076; Ivnitski D, 2006, ELECTROCHEM COMMUN, V8, P1204, DOI 10.1016/j.elecom.2006.05.024; JAKOBS RCM, 1985, ELECTROCHIM ACTA, V30, P1313, DOI 10.1016/0013-4686(85)85008-8; Jorgensen K., 2008, Utilities Policy, V16, P72, DOI 10.1016/j.jup.2007.11.005; Khomenko VG, 2005, ELECTROCHIM ACTA, V50, P1675, DOI 10.1016/j.electacta.2004.10.024; LEE JS, 1990, J CATAL, V125, P157, DOI 10.1016/0021-9517(90)90086-Y; Lefebvre MC, 1999, J ELECTROCHEM SOC, V146, P2054, DOI 10.1149/1.1391891; Liu RX, 2000, J PHYS CHEM B, V104, P3518, DOI 10.1021/jp992943s; Mohamad AA, 2006, J POWER SOURCES, V159, P752, DOI 10.1016/j.jpowsour.2005.10.110; Proietti E, 2008, J ELECTROCHEM SOC, V155, pB340, DOI 10.1149/1.2838162; Pucher E, 2006, ELEKTROTECH INFORMAT, V123, P410, DOI 10.1007/s00502-006-0381-8; Saito Y, 2004, J PHOTOCH PHOTOBIO A, V164, P153, DOI 10.1016/j.jphotochem.2003.11.017; SOMASUNDRUM M, 1993, J CHEM SOC CHEM COMM, P1629, DOI 10.1039/c39930001629; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Teratani T, 2008, IEEJ T ELECTR ELECTR, V3, P162, DOI 10.1002/tee.20252; TOURILLON G, 1984, J PHYS CHEM-US, V88, P5281, DOI 10.1021/j150666a034; *U HOUST, 2007, SCIENCEDAILY    1031; Winter M, 2004, CHEM REV, V104, P4245, DOI 10.1021/cr020730k; Winther-Jensen B, 2004, MACROMOLECULES, V37, P4538, DOI 10.1021/ma049864l; Winther-Jensen B, 2008, POLYMER, V49, P481, DOI 10.1016/j.polymer.2007.11.055; Winther-Jensen B, 2007, ORG ELECTRON, V8, P796, DOI 10.1016/j.orgel.2007.07.009; Yu XW, 2007, J POWER SOURCES, V172, P145, DOI 10.1016/j.jpowsour.2007.07.048; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569	30	400	421	5	384	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					671	674		10.1126/science.1159267	http://dx.doi.org/10.1126/science.1159267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669857				2022-12-28	WOS:000258077700038
J	Byrne, CJ; Eldrup, M				Byrne, Cormac J.; Eldrup, Morten			Materials science - Bulk metallic glasses	SCIENCE			English	Editorial Material									[Byrne, Cormac J.; Eldrup, Morten] Tech Univ Denmark, Mat Res Dept, Riso Natl Lab, DK-4000 Roskilde, Denmark	Technical University of Denmark	Byrne, CJ (corresponding author), Tech Univ Denmark, Mat Res Dept, Riso Natl Lab, POB 49, DK-4000 Roskilde, Denmark.	cormac.byrne@risoe.dk						Brothers AH, 2007, MRS BULL, V32, P639, DOI 10.1557/mrs2007.126; Duan G, 2007, ADV MATER, V19, P4272, DOI 10.1002/adma.200700969; Guo H, 2007, NAT MATER, V6, P735, DOI 10.1038/nmat1984; Hofmann DC, 2008, NATURE, V451, P1085, DOI 10.1038/nature06598; Liu YH, 2007, SCIENCE, V315, P1385, DOI 10.1126/science.1136726; Lu ZP, 2007, MATER TRANS, V48, P2476, DOI 10.2320/matertrans.MJ200762; Lu ZP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.245503; Lu ZP, 2004, J MATER SCI, V39, P3965, DOI 10.1023/B:JMSC.0000031478.73621.64; Nishiyama N, 2002, APPL PHYS LETT, V80, P568, DOI 10.1063/1.1445475; Ponnambalam V, 2004, J MATER RES, V19, P1320, DOI [10.1557/JMR.2004.0176, 10.1557/jmr.2004.0176]; Pryds NH, 2004, MAT SCI ENG A-STRUCT, V375, P186, DOI 10.1016/j.msea.2003.10.147; Schroers J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255506; Schroers J, 2005, JOM-US, V57, P35, DOI 10.1007/s11837-005-0093-2; Schroers J, 2007, SCRIPTA MATER, V57, P341, DOI 10.1016/j.scriptamat.2007.04.033; Shen J, 2007, J MATER RES, V22, P3067, DOI 10.1557/JMR.2007.0410; Sheng HW, 2007, NAT MATER, V6, P192, DOI 10.1038/nmat1839; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Telford M, 2004, MATER TODAY, V7, P36, DOI 10.1016/S1369-7021(04)00124-5	18	115	118	4	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					502	503		10.1126/science.1158864	http://dx.doi.org/10.1126/science.1158864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653873				2022-12-28	WOS:000257888900030
J	Kruger, M; Moser, M; Ussar, S; Thievessen, I; Luber, CA; Forner, F; Schmidt, S; Zanivan, S; Fassler, R; Mann, M				Krueger, Marcus; Moser, Markus; Ussar, Siegfried; Thievessen, Ingo; Luber, Christian A.; Forner, Francesca; Schmidt, Sarah; Zanivan, Sara; Faessler, Reinhard; Mann, Matthias			SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function	CELL			English	Article							SITE-SPECIFIC PHOSPHORYLATION; AMINO-ACIDS; PROTEIN-TURNOVER; STABLE-ISOTOPES; CULTURE SILAC; INTEGRIN ACTIVATION; SIGNALING NETWORKS; MEMBRANE SKELETON; MASS-SPECTROMETRY; IN-VIVO	Stable isotope labeling by amino acids in cell culture (SILAC) has become a versatile tool for quantitative, mass spectrometry (MS)-based proteomics. Here, we completely label mice with a diet containing either the natural or the (13)C(6)-substituted version of lysine. Mice were labeled over four generations with the heavy diet, and development, growth, and behavior were not affected. MS analysis of incorporation levels allowed for the determination of incorporation rates of proteins from blood cells and organs. The F2 generation was completely labeled in all organs tested. SILAC analysis from various organs lacking expression of beta 1 integrin, beta-Parvin, or the integrin tail-binding protein Kindlin-3 confirmed their absence and disclosed a structural defect of the red blood cell membrane skeleton in Kindlin-3-deficient erythrocytes. The SILAC-mouse approach is a versatile tool by which to quantitatively compare proteomes from knockout mice and thereby determine protein functions under complex in vivo conditions.	[Moser, Markus; Ussar, Siegfried; Thievessen, Ingo; Schmidt, Sarah; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Krueger, Marcus; Luber, Christian A.; Forner, Francesca; Zanivan, Sara; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de; mmann@biochem.mpg.de	Ussar, Siegfried/AAL-4331-2021; Zanivan, Sara/GOV-5505-2022; Mann, Matthias/A-3454-2013; Zanivan, Sara/C-4340-2008	Ussar, Siegfried/0000-0001-7575-0920; Mann, Matthias/0000-0003-1292-4799; Zanivan, Sara/0000-0002-9880-9099				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Benevenga NJ, 1995, NUTR REQUIREMENTS LA, P192; BERLIN NI, 1959, PHYSIOL REV, V39, P577, DOI 10.1152/physrev.1959.39.3.577; Beynon RJ, 2005, MOL CELL PROTEOMICS, V4, P857, DOI 10.1074/mcp.R400010-MCP200; Bier DM, 1997, EUR J PEDIATR, V156, pS2, DOI 10.1007/PL00014265; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Coffman R L, 1982, Immunol Rev, V69, P5; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; DELAUNAY J, 1995, FEBS LETT, V369, P34, DOI 10.1016/0014-5793(95)00460-Q; DIETZ WH, 1982, METABOLISM, V31, P749, DOI 10.1016/0026-0495(82)90070-1; Doherty MK, 2006, EXPERT REV PROTEOMIC, V3, P97, DOI 10.1586/14789450.3.1.97; Doherty MK, 2005, PROTEOMICS, V5, P522, DOI 10.1002/pmic.200400959; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; GREGG CT, 1973, LIFE SCI, V13, P775, DOI 10.1016/0024-3205(73)90068-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishihama Y, 2005, NAT BIOTECHNOL, V23, P617, DOI 10.1038/nbt1086; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; McClatchy DB, 2007, J PROTEOME RES, V6, P2005, DOI 10.1021/pr060599n; Moebius J, 2005, MOL CELL PROTEOMICS, V4, P1754, DOI 10.1074/mcp.M500209-MCP200; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; MOORE S, 1958, FED PROC, V17, P1107; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Peters LL, 1998, GENOMICS, V54, P348, DOI 10.1006/geno.1998.5537; Pratt JM, 2002, PROTEOMICS, V2, P157, DOI 10.1002/1615-9861(200202)2:2<157::AID-PROT157>3.0.CO;2-M; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; RYBICKI AC, 1995, BLOOD, V86, P3583, DOI 10.1182/blood.V86.9.3583.bloodjournal8693583; Schoenheimer R, 1935, Science, V82, P156, DOI 10.1126/science.82.2120.156; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Southgate CD, 1996, NAT GENET, V14, P227, DOI 10.1038/ng1096-227; Taouatas N, 2008, NAT METHODS, V5, P405, DOI 10.1038/NMETH.1204; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Wolfe RR., 2005, ISOTOPE TRACERS META, V2; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Zhang YL, 2007, NUCLEIC ACIDS RES, V35, pD771, DOI 10.1093/nar/gkl784	56	514	532	2	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					353	364		10.1016/j.cell.2008.05.033	http://dx.doi.org/10.1016/j.cell.2008.05.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662549	Bronze, Green Accepted			2022-12-28	WOS:000257891700023
J	Unal, E; Heidinger-Pauli, JM; Kim, W; Guacci, V; Onn, I; Gygi, SP; Koshland, DE				Unal, Elcin; Heidinger-Pauli, Jill M.; Kim, Woong; Guacci, Vincent; Onn, Itay; Gygi, Steven P.; Koshland, Douglas E.			A molecular determinant for the establishment of sister chromatid cohesion	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; PROTEINS; BINDING; REPAIR; ACETYLTRANSFERASE; CONDENSATION; RESOLUTION; COMPLEXES	Chromosome segregation, transcriptional regulation, and repair of DNA double- strand breaks require the cohesin protein complex. Cohesin holds the replicated chromosomes ( sister chromatids) together to mediate sister chromatid cohesion. The mechanism of how cohesion is established is unknown. We found that in budding yeast, the head domain of the Smc3p subunit of cohesin is acetylated by the Eco1p acetyltransferase at two evolutionarily conserved residues, promoting the chromatin- bound cohesin to tether sister chromatids. Smc3p acetylation is induced in S phase after the chromatin loading of cohesin and is suppressed in G(1) and G(2)/M. Smc3 head acetylation and its cell cycle regulation provide important insights into the biology and mechanism of cohesion establishment.	[Unal, Elcin; Heidinger-Pauli, Jill M.; Guacci, Vincent; Onn, Itay; Koshland, Douglas E.] Carnegie Inst, Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Unal, Elcin; Heidinger-Pauli, Jill M.; Guacci, Vincent; Onn, Itay; Koshland, Douglas E.] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; [Unal, Elcin; Heidinger-Pauli, Jill M.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Kim, Woong; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Carnegie Institution for Science; Johns Hopkins University; Harvard University; Harvard Medical School	Koshland, DE (corresponding author), Carnegie Inst, Howard Hughes Med Inst, 3520 San Martin Dr, Baltimore, MD 21218 USA.	koshland@ciwemb.edu	Onn, Itay/AAA-7949-2020	Onn, Itay/0000-0002-7689-5520; Unal, Elcin/0000-0002-6768-609X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Brands A, 2005, CURR BIOL, V15, pR50, DOI 10.1016/j.cub.2004.12.052; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Noble D, 2006, CELL CYCLE, V5, P2528, DOI 10.4161/cc.5.21.3405; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	30	324	328	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					566	569		10.1126/science.1157880	http://dx.doi.org/10.1126/science.1157880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653894				2022-12-28	WOS:000257888900049
J	Cao, Q; Kim, HS; Pimparkar, N; Kulkarni, JP; Wang, CJ; Shim, M; Roy, K; Alam, MA; Rogers, JA				Cao, Qing; Kim, Hoon-sik; Pimparkar, Ninad; Kulkarni, Jaydeep P.; Wang, Congjun; Shim, Moonsub; Roy, Kaushik; Alam, Muhammad A.; Rogers, John A.			Medium-scale carbon nanotube thin-film integrated circuits on flexible plastic substrates	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; LARGE-AREA; ORGANIC TRANSISTORS; HIGH-RESOLUTION; ALIGNED ARRAYS; LOGIC GATES; ELECTRONICS; DIELECTRICS; NETWORKS; POLYMERS	The ability to form integrated circuits on flexible sheets of plastic enables attributes (for example conformal and flexible formats and lightweight and shock resistant construction) in electronic devices that are difficult or impossible to achieve with technologies that use semiconductor wafers or glass plates as substrates(1). Organic small-molecule and polymer-based materials represent the most widely explored types of semiconductors for such flexible circuitry(2). Although these materials and those that use films or nanostructures of inorganics have promise for certain applications, existing demonstrations of them in circuits on plastic indicate modest performance characteristics that might restrict the application possibilities. Here we report implementations of a comparatively high-performance carbon-based semiconductor consisting of sub-monolayer, random networks of single-walled carbon nanotubes to yield small-to medium-scale integrated digital circuits, composed of up to nearly 100 transistors on plastic substrates. Transistors in these integrated circuits have excellent properties: mobilities as high as 80 cm(2)V(-1) s(-1), subthreshold slopes as low as 140 m V dec(-1), operating voltages less than 5 V together with deterministic control over the threshold voltages, on/off ratios as high as 10(5), switching speeds in the kilohertz range even for coarse (similar to 100-mu m) device geometries, and good mechanical flexibility - all with levels of uniformity and reproducibility that enable high- yield fabrication of integrated circuits. Theoretical calculations, in contexts ranging from heterogeneous percolative transport through the networks to compact models for the transistors to circuit level simulations, provide quantitative and predictive understanding of these systems. Taken together, these results suggest that sub-monolayer films of single-walled carbon nanotubes are attractive materials for flexible integrated circuits, with many potential areas of application in consumer and other areas of electronics.	[Cao, Qing; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Kim, Hoon-sik; Wang, Congjun; Shim, Moonsub; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Pimparkar, Ninad; Kulkarni, Jaydeep P.; Roy, Kaushik; Alam, Muhammad A.] Purdue Univ, Sch Elect & Comp Engn, Network Computat Nanotechnol, W Lafayette, IN 47907 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rogers, JA (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	jrogers@uiuc.edu	Wang, Congjun/A-9608-2010; Kulkarni, Jaydeep/AAX-9218-2020; Shim, Moonsub/A-7875-2009; Rogers, John/L-2798-2016; Cao, Qing/E-7420-2012; huang, yonggang/O-6236-2019; Wang, Congjun/AAH-9483-2020	Shim, Moonsub/0000-0001-7781-1029; Wang, Congjun/0000-0002-3831-2929; Kulkarni, Jaydeep/0000-0002-0258-6776				Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Beecher P, 2007, J APPL PHYS, V102, DOI 10.1063/1.2770835; Blanchet GB, 2003, APPL PHYS LETT, V82, P463, DOI 10.1063/1.1533110; Bradley K, 2003, NANO LETT, V3, P1353, DOI 10.1021/nl0344864; BREKNER MJ, 1987, J POLYM SCI POL CHEM, V25, P2479, DOI 10.1002/pola.1987.080250913; Briseno AL, 2006, NATURE, V444, P913, DOI 10.1038/nature05427; Chason M, 2005, P IEEE, V93, P1348, DOI 10.1109/JPROC.2005.850306; Chen J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1888054; Chen ZH, 2006, SCIENCE, V311, P1735, DOI 10.1126/science.1122797; Chimot N, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2798583; Crone B, 2000, NATURE, V403, P521, DOI 10.1038/35000530; Duan XF, 2003, NATURE, V425, P274, DOI 10.1038/nature01996; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Fujii S, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1939073; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Hausmann DM, 2002, CHEM MATER, V14, P4350, DOI 10.1021/cm020357x; Javey A, 2002, NAT MATER, V1, P241, DOI 10.1038/nmat769; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Kang SJ, 2007, NAT NANOTECHNOL, V2, P230, DOI 10.1038/nnano.2007.77; Kim DH, 2008, IEEE ELECTR DEVICE L, V29, P73, DOI 10.1109/LED.2007.910770; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Kocabas C, 2007, NANO LETT, V7, P1195, DOI 10.1021/nl062907m; Kumar S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.066802; Li YM, 2001, J PHYS CHEM B, V105, P11424, DOI 10.1021/jp012085b; Maria J, 2006, J VAC SCI TECHNOL B, V24, P828, DOI 10.1116/1.2184321; Menard E, 2007, CHEM REV, V107, P1117, DOI 10.1021/cr050139y; PHILOFSKY E, 1970, SOLID STATE ELECTRON, V13, P1391, DOI 10.1016/0038-1101(70)90172-3; Pimparkar N, 2007, IEEE ELECTR DEVICE L, V28, P157, DOI 10.1109/LED.2006.889219; PLUMMER JD, 2002, SILICON VLSI TECHNOL, pCH4; Rabaey JM., 2002, DIGITAL INTEGRATED C; Reuss RH, 2005, P IEEE, V93, P1239, DOI 10.1109/JPROC.2005.851237; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Seidel R, 2004, NANO LETT, V4, P831, DOI 10.1021/nl049776e; Sekitani T, 2007, NAT MATER, V6, P413, DOI 10.1038/nmat1903; Shim M, 2006, J AM CHEM SOC, V128, P7522, DOI 10.1021/ja058551i; Singh TB, 2006, ANNU REV MATER RES, V36, P199, DOI 10.1146/annurev.matsci.36.022805.094757; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Snow ES, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1854721; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Yoon MH, 2005, J AM CHEM SOC, V127, P10388, DOI 10.1021/JA052488f; Zhou LS, 2006, IEEE T ELECTRON DEV, V53, P380, DOI 10.1109/TED.2005.861727; Zhou YX, 2004, NANO LETT, V4, P2031, DOI 10.1021/nl048905o	43	938	1005	5	714	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					495	U4		10.1038/nature07110	http://dx.doi.org/10.1038/nature07110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650920				2022-12-28	WOS:000257860300046
J	Mikhael, J; Roth, J; Helden, L; Bechinger, C				Mikhael, Jules; Roth, Johannes; Helden, Laurent; Bechinger, Clemens			Archimedean-like tiling on decagonal quasicrystalline surfaces	NATURE			English	Article							PHASE; FIELDS	Monolayers on crystalline surfaces often form complex structures with physical and chemical properties that differ strongly from those of their bulk phases(1). Such hetero-epitactic overlayers are currently used in nanotechnology and understanding their growth mechanism is important for the development of new materials and devices. In comparison with crystals, quasicrystalline surfaces exhibit much larger structural and chemical complexity leading, for example, to unusual frictional(2), catalytical(3) or optical properties(4,5). Deposition of thin films on such substrates can lead to structures that may have typical quasicrystalline properties. Recent experiments have indeed showed 5-fold symmetries in the diffraction pattern of metallic layers adsorbed on quasicrystals(6,7). Here we report a real-space investigation of the phase behaviour of a colloidal monolayer interacting with a quasicrystalline decagonal substrate created by interfering five laser beams. We find a pseudomorphic phase that shows both crystalline and quasicrystalline structural properties. It can be described by an archimedean-like tiling(8,9) consisting of alternating rows of square and triangular tiles. The calculated diffraction pattern of this phase is in agreement with recent observations of copper adsorbed on icosahedral Al(70)Pd(21)Mn(9) surfaces(10). In addition to establishing a link between archimedean tilings and quasicrystals, our experiments allow us to investigate in real space how single-element monolayers can form commensurate structures on quasicrystalline surfaces.	[Mikhael, Jules; Helden, Laurent; Bechinger, Clemens] Univ Stuttgart, Inst Phys 2, D-70569 Stuttgart, Germany; [Roth, Johannes] Univ Stuttgart, Inst Theoret & Angew Phys, D-70569 Stuttgart, Germany; [Bechinger, Clemens] Max Planck Inst Met Res, D-70569 Stuttgart, Germany	University of Stuttgart; University of Stuttgart; Max Planck Society	Bechinger, C (corresponding author), Univ Stuttgart, Inst Phys 2, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	c.bechinger@physik.uni-stuttgart.de						Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; Bechinger C, 2001, PHYS REV LETT, V86, P930, DOI 10.1103/PhysRevLett.86.930; Bilki B, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045437; Brunner M, 2002, EUROPHYS LETT, V58, P926, DOI 10.1209/epl/i2002-00105-4; BURNS MM, 1990, SCIENCE, V249, P749, DOI 10.1126/science.249.4970.749; Curtarolo S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.136104; David S, 2001, IEEE J QUANTUM ELECT, V37, P1427, DOI 10.1109/3.958365; Dubois JM, 2001, J PHYS-CONDENS MAT, V13, P7753, DOI 10.1088/0953-8984/13/34/318; Engel M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225505; Fournee V, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.033406; Franke KJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett89.156104; Freedman B, 2007, NAT MATER, V6, P776, DOI 10.1038/nmat1981; Guinier A., 1994, XRAY DIFFRACTION CRY; Janot C., 1994, QUASICRYSTALS PRIMER; Keys AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235503; Ledieu J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035420; Ledieu J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.135507; Ledieu J, 2001, SURF SCI, V492, pL729, DOI 10.1016/S0039-6028(01)01463-7; Matsui T, 2007, NATURE, V446, P517, DOI 10.1038/nature05620; Park JY, 2005, SCIENCE, V309, P1354, DOI 10.1126/science.1113239; Pearce P., 1978, STRUCTURE NATURE IS; Roichman Y, 2005, OPT EXPRESS, V13, P5434, DOI 10.1364/OPEX.13.005434; Sharma HR, 2007, ADV PHYS, V56, P403, DOI 10.1080/00018730701269773; Sharma HR, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045428; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Tsai AP, 2001, APPL CATAL A-GEN, V214, P237, DOI 10.1016/S0926-860X(01)00500-2; Yethiraj A, 2007, SOFT MATTER, V3, P1099, DOI 10.1039/b704251p; Zoorob ME, 2000, NATURE, V404, P740, DOI 10.1038/35008023	29	179	184	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					501	504		10.1038/nature07074	http://dx.doi.org/10.1038/nature07074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650921	Green Submitted			2022-12-28	WOS:000257860300047
J	Palmieri, C; Coombes, RC; Kim, SB; Cleator, S				Palmieri, Carlo; Coombes, R. Charles; Kim, Sung-Bae; Cleator, Suzy			Ethnicity and breast cancer research	LANCET			English	Editorial Material							RECEPTOR POLYMORPHISMS		[Palmieri, Carlo; Coombes, R. Charles; Cleator, Suzy] Univ London Imperial Coll Sci Technol & Med, Canc Res UK Labs, Dept Canc Med, London W12 0NN, England; [Kim, Sung-Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Div Oncol,Dept Med, Seoul, South Korea	Cancer Research UK; Imperial College London; University of Ulsan; Asan Medical Center	Palmieri, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Canc Res UK Labs, Dept Canc Med, London W12 0NN, England.	c.palmieri@imperial.ac.uk		Coombes, Raoul Charles/0000-0002-4811-1100				BUCHANA D, 2008, NAT CONS BREAST CTR; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Lehrnbecher T, 1999, BLOOD, V94, P4220, DOI 10.1182/blood.V94.12.4220.424k08_4220_4232; McBride R, 2007, CANCER-AM CANCER SOC, V110, P1201, DOI 10.1002/cncr.22884; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; NEMOTO T, 1977, J NATL CANCER I, V58, P193, DOI 10.1093/jnci/58.2.193; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					188	189		10.1016/S0140-6736(08)61052-1	http://dx.doi.org/10.1016/S0140-6736(08)61052-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640442				2022-12-28	WOS:000257763900010
J	Turner, NC; Jones, AL				Turner, Nicholas C.; Jones, Alison L.			Management of breast cancer - Part II	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EXTENDED ADJUVANT THERAPY; BONE-MINERAL DENSITY; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; TAMOXIFEN; CHEMOTHERAPY; TRASTUZUMAB; TRIAL; ANASTROZOLE; PREDICTORS		[Turner, Nicholas C.] Royal Free Hosp NHS Fdn Trust, Dept Med Oncol, London NW3 2QG, England; [Turner, Nicholas C.; Jones, Alison L.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Jones, Alison L.] UCL Hosp NHS Fdn Trust, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London	Turner, NC (corresponding author), Royal Free Hosp NHS Fdn Trust, Dept Med Oncol, London NW3 2QG, England.	nicholas.turner@icr.ac.uk		Turner, Nicholas/0000-0001-8937-0873				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bliss JM, 2007, JNCI-J NATL CANCER I, V99, P516, DOI 10.1093/jnci/djk109; Bundred NJ, 2008, CANCER-AM CANCER SOC, V112, P1001, DOI 10.1002/cncr.23259; Coleman RE, 2007, LANCET ONCOL, V8, P119, DOI 10.1016/S1470-2045(07)70003-7; CUZICK J, 2007, BREAST CANC RES T S1, V106; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Eastell R, 2008, J CLIN ONCOL, V26, P1051, DOI 10.1200/JCO.2007.11.0726; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Jakesz R, 2007, JNCI-J NATL CANCER I, V99, P1845, DOI 10.1093/jnci/djm246; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Lin NU, 2008, J CLIN ONCOL, V26, P798, DOI 10.1200/JCO.2007.15.0946; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McArthur HL, 2007, NEW ENGL J MED, V357, P94, DOI 10.1056/NEJMc070065; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; PETO R, 2007, BREAST CANC RES T S1, V106; Pritchard KI, 2008, J CLIN ONCOL, V26, P736, DOI 10.1200/JCO.2007.15.4716; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Smith IE, 2006, J CLIN ONCOL, V24, P2444, DOI 10.1200/JCO.2005.05.3694; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	31	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a540	10.1136/bmj.a540	http://dx.doi.org/10.1136/bmj.a540			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18621762	Green Published			2022-12-28	WOS:000257962000043
J	Ettema, TJG; Andersson, SGE				Ettema, Thijs J. G.; Andersson, Siv G. E.			Comment on "A 3-hydroxypropionate/4-hydroxybutyrate autotrophic carbon dioxide assimilation pathway in Archaea"	SCIENCE			English	Editorial Material							GENES		[Ettema, Thijs J. G.; Andersson, Siv G. E.] Uppsala Univ, Dept Mol Evolut, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden	Uppsala University	Ettema, TJG (corresponding author), Uppsala Univ, Dept Mol Evolut, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden.	thijs.ettema@ebc.uu.se						Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; DeLong E, 2006, PLOS BIOL, V4, P2412, DOI 10.1371/journal.pbio.0040437; Gerhardt A, 2000, ARCH MICROBIOL, V174, P189, DOI 10.1007/s002030000195; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Stintzi A, 1999, J BACTERIOL, V181, P4118, DOI 10.1128/JB.181.13.4118-4124.1999; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	10	9	9	3	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887								10.1126/science.1158766	http://dx.doi.org/10.1126/science.1158766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635779				2022-12-28	WOS:000257713900021
J	King, A; Johnson, G; Engelberg, D; Ludwig, W; Marrow, J				King, A.; Johnson, G.; Engelberg, D.; Ludwig, W.; Marrow, J.			Observations of intergranular stress corrosion cracking in a grain-mapped polycrystal	SCIENCE			English	Article							AUSTENITIC STAINLESS-STEEL; BOUNDARY PLANE; DIFFRACTION	Nondestructive three-dimensional mapping of grain shape, crystallographic orientation, and grain boundary geometry by diffraction contrast tomography (DCT) provides opportunities for the study of the interaction between intergranular stress corrosion cracking and microstructure. A stress corrosion crack was grown through a volume of sensitized austenitic stainless steel mapped with DCT and observed in situ by synchrotron tomography. Several sensitization-resistant crack-bridging boundaries were identified, and although they have special geometric properties, they are not the twin variant boundaries usually maximized during grain boundary engineering.	[King, A.; Johnson, G.; Engelberg, D.; Marrow, J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [King, A.; Johnson, G.; Ludwig, W.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Ludwig, W.] Inst Nacl Sci Appliquees Lyon, Villeurbanne, France	University of Manchester; European Synchrotron Radiation Facility (ESRF); Institut National des Sciences Appliquees de Lyon - INSA Lyon	King, A (corresponding author), Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.	andrew.king@esrf.fr	Marrow, Thomas James/S-4439-2019; Marrow, Thomas J/J-8840-2014; Ludwig, Wolfgang/G-5823-2012	Marrow, Thomas James/0000-0001-6120-9826; Marrow, Thomas J/0000-0001-6120-9826; Ludwig, Wolfgang/0000-0002-3256-3831; Engelberg, Dirk/0000-0002-0519-7354	Engineering and Physical Sciences Research Council [EP/C002946/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Babout L, 2006, MATER SCI TECH-LOND, V22, P1068, DOI 10.1179/174328406X114090; BRUEMMER SM, 1994, J NUCL MATER, V216, P348, DOI 10.1016/0022-3115(94)90020-5; Busby JT, 2002, J NUCL MATER, V302, P20, DOI 10.1016/S0022-3115(02)00719-5; Diard O, 2002, COMP MATER SCI, V25, P73, DOI 10.1016/S0927-0256(02)00251-3; FRANK E, 1988, BEHAV THER, V19, P403, DOI 10.1016/S0005-7894(88)80012-1; Huang YZ, 2006, ACTA MATER, V54, P635, DOI 10.1016/j.actamat.2005.10.011; Jivkov AP, 2007, THEOR APPL FRACT MEC, V48, P187, DOI 10.1016/j.tafmec.2007.08.007; Jivkov AP, 2006, COMP MATER SCI, V38, P442, DOI 10.1016/j.commatsci.2006.03.012; Larson BC, 2002, NATURE, V415, P887, DOI 10.1038/415887a; Lehockey EM, 2004, CORROS SCI, V46, P2383, DOI 10.1016/j.corsci.2004.01.019; Lewis AC, 2006, MAT SCI ENG A-STRUCT, V418, P11, DOI 10.1016/j.msea.2005.09.088; Ludwig W, 2008, J APPL CRYSTALLOGR, V41, P302, DOI 10.1107/S0021889808001684; ORTNER Sr, 1991, ACTA METALL MATER, V39, P341, DOI 10.1016/0956-7151(91)90313-P; Poulsen H. H., 2004, 3 DIMENSIONAL XRAY D; Randle V, 1998, ACTA MATER, V46, P1459, DOI 10.1016/S1359-6454(97)00338-8; Randle V, 2006, J MICROSC-OXFORD, V222, P69, DOI 10.1111/j.1365-2818.2006.01575.x; Randle V, 2006, SCRIPTA MATER, V54, P1011, DOI 10.1016/j.scriptamat.2005.11.050; Rodrigues O., 1840, J MATH PURE APPL, V5, P380; SCOTT P, 1994, J NUCL MATER, V211, P101, DOI 10.1016/0022-3115(94)90360-3; Scott PM, 2000, CORROSION, V56, P771, DOI 10.5006/1.3280580	20	347	353	14	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					382	385		10.1126/science.1156211	http://dx.doi.org/10.1126/science.1156211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635797	Green Submitted			2022-12-28	WOS:000257713900043
J	Murphy, AM; Cameron, DE				Murphy, Anne M.; Cameron, Duke E.			The Blalock-Taussig-Thomas Collaboration - A model for medical progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONGENITAL HEART-DISEASE; TETRALOGY; DEFECTS; FALLOT; YOUNG		[Murphy, Anne M.] Johns Hopkins Univ, Sch Med, Helen B Taussig Div Pediat Cardiol, Dept Pediat, Baltimore, MD USA; [Cameron, Duke E.] Johns Hopkins Univ, Sch Med, Div Cardiac Surg, Dept Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Murphy, AM (corresponding author), Ross Bldg Room 1144,720 Rutland Ave, Baltimore, MD 21205 USA.	amurphy2@jhmi.edu						BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189, DOI 10.1001/jama.1945.02860200029009; Dorfman AL, 2006, J CARDIOVASC MAGN R, V8, P645, DOI 10.1080/10976640600721544; FERENCZ C, 1989, J AM COLL CARDIOL, V14, P756, DOI 10.1016/0735-1097(89)90122-8; Galantowicz M, 2008, ANN THORAC SURG, V85, P2063, DOI 10.1016/j.athoracsur.2008.02.009; LILLEHEI CW, 1956, ARCH SURG-CHICAGO, V73, P526, DOI 10.1001/archsurg.1956.01280030152018; MCNAMARA DG, 1984, JAMA-J AM MED ASSOC, V251, P2139; Patel HT, 2005, CURR OPIN PEDIATR, V17, P568, DOI 10.1097/01.mop.0000172813.56766.52; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pigula FA, 1999, CIRCULATION, V100, P157; Pihkala J, 1999, PEDIATR CLIN N AM, V46, P441, DOI 10.1016/S0031-3955(05)70128-0; Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083; Williams JA, 2007, ANN THORAC SURG, V84, P2070, DOI 10.1016/j.athoracsur.2007.06.067	12	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					328	330		10.1001/jama.300.3.328	http://dx.doi.org/10.1001/jama.300.3.328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325ZB	18632547	Bronze			2022-12-28	WOS:000257626600027
J	Coale, KH; Johnson, KS; Fitzwater, SE; Gordon, RM; Tanner, S; Chavez, FP; Ferioli, L; Sakamoto, C; Rogers, P; Millero, F; Steinberg, P; Nightingale, P; Cooper, D; Cochlan, WP; Landry, MR; Constantinou, J; Rollwagen, G; Trasvina, A; Kudela, R				Coale, KH; Johnson, KS; Fitzwater, SE; Gordon, RM; Tanner, S; Chavez, FP; Ferioli, L; Sakamoto, C; Rogers, P; Millero, F; Steinberg, P; Nightingale, P; Cooper, D; Cochlan, WP; Landry, MR; Constantinou, J; Rollwagen, G; Trasvina, A; Kudela, R			A massive phytoplankton bloom induced by an ecosystem-scale iron fertilization experiment in the equatorial Pacific Ocean	NATURE			English	Article							SUB-ARCTIC PACIFIC; PRODUCTIVITY; LIMITATION; WATERS; ZINC; SEA	The seeding of an expanse of surface waters in the equatorial Pacific Ocean with low concentrations of dissolved iron triggered a massive phytoplankton bloom which consumed large quantities of carbon dioxide and nitrate that these microscopic plants cannot fully utilize under natural conditions. These and other observations provide unequivocal support for the hypothesis that phytoplankton growth in this oceanic region is limited by iron bioavailability.	MONTEREY BAY AQUARIUM RES INST, MOSS LANDING, CA 95039 USA; UNIV MIAMI, KEY BISCAYNE, FL 33149 USA; UNIV E ANGLIA, SCH ENVIRONM SCI, NORWICH NR4 7TJ, NORFOLK, ENGLAND; UNIV SO CALIF, HANCOCK INST MARINE STUDIES, LOS ANGELES, CA 90089 USA; UNIV HAWAII MANOA, DEPT OCEANOG, HONOLULU, HI 96822 USA; CICESE OCEANOG FIS, ENSENADA, BAJA CALIFORNIA, MEXICO	Monterey Bay Aquarium Research Institute; University of East Anglia; University of Southern California; University of Hawaii System; University of Hawaii Manoa; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Coale, KH (corresponding author), MOSS LANDING MARINE LABS, POB 450, MOSS LANDING, CA 95039 USA.		Rogers, Paul/AAV-6876-2021; Nightingale, Philip D/I-4324-2012; Rollwagen-Bollens, Gretchen/Q-5520-2017; Johnson, Kenneth S/F-9742-2011; Landry, Michael/HGF-1043-2022	Rogers, Paul/0000-0002-1182-9231; Nightingale, Philip D/0000-0001-7177-5469; Rollwagen-Bollens, Gretchen/0000-0002-5127-5720; Johnson, Kenneth S/0000-0001-5513-5584; 				BANSE K, 1995, NATURE, V375, P112, DOI 10.1038/375112a0; BANSE K, 1990, LIMNOL OCEANOGR, V35, P772, DOI 10.4319/lo.1990.35.3.0772; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BOOTH BC, 1987, BOT MAR, V30, P101, DOI 10.1515/botm.1987.30.2.101; BRULAND KW, 1979, ANAL CHIM ACTA, V105, P233, DOI 10.1016/S0003-2670(01)83754-5; BRULAND KW, 1991, LIMNOL OCEANOGR, V36, P1555, DOI 10.4319/lo.1991.36.8.1555; Chavez FP, 1995, DAHL WS ENV, V18, P149; CHAVEZ FP, 1991, LIMNOL OCEANOGR, V36, P1816, DOI 10.4319/lo.1991.36.8.1816; CHAVEZ FP, IN PRESS DEEP SEA RE; Chavez FP, 1989, GLOBAL BIOGEOCHEM CY, V3, P27, DOI 10.1029/GB003i001p00027; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; COALE KH, 1991, LIMNOL OCEANOGR, V36, P1851, DOI 10.4319/lo.1991.36.8.1851; Cooper DJ, 1996, NATURE, V383, P511, DOI 10.1038/383511a0; CSANADY GT, 1978, OCEAN DUMPING IND WA, P109; DEBAAR HJW, 1990, MAR ECOL-PROG SER, V65, P34; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Dugdale RC, 1990, GLOBAL BIOGEOCHEM CY, V4, P13, DOI 10.1029/GB004i001p00013; FASHAM MJR, 1995, DEEP-SEA RES PT I, V42, P1111, DOI 10.1016/0967-0637(95)00054-A; FITZWATER SE, IN PRESS DEEP SEA RE, V43; FROST BW, 1991, LIMNOL OCEANOGR, V36, P1616, DOI 10.4319/lo.1991.36.8.1616; Huntley M. E., 1992, AM NAT, V140, P210; JOHNSON KS, 1994, MAR CHEM, V46, P319, DOI 10.1016/0304-4203(94)90029-9; JOHNSON KS, 1996, EOS, V76, pOS154; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; LANDRY MR, 1995, MAR ECOL PROG SER, V120, P53, DOI 10.3354/meps120053; LANDRY MR, IN PRESS LIMNOL OCEA; LATASA M, IN PRESS LIMNOL OCEA; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1989, DEEP-SEA RES, V36, P649, DOI 10.1016/0198-0149(89)90144-1; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; Martin JH, 1990, GLOBAL BIOGEOCHEM CY, V4, P5, DOI 10.1029/GB004i001p00005; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MILLIMAN JD, 1993, DEEP SEA RES 2, V40; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; OBATA H, 1993, ANAL CHEM, V65, P1524, DOI 10.1021/ac00059a007; PAFFENHOFER GA, 1979, J MAR RES, V37, P35; PRICE NM, 1994, LIMNOL OCEANOGR, V39, P520, DOI 10.4319/lo.1994.39.3.0520; PRICE NM, 1991, DEEP-SEA RES, V38, P1361, DOI 10.1016/0198-0149(91)90011-4; RUETER JG, 1981, LIMNOL OCEANOGR, V26, P67, DOI 10.4319/lo.1981.26.1.0067; SANDERSON MP, 1995, DEEP-SEA RES PT II, V42, P431, DOI 10.1016/0967-0645(95)00042-O; SIEGENTHALER U, 1986, ROLE AIR SEA EXCHANG, P209; WATSON AJ, 1994, NATURE, V371, P143, DOI 10.1038/371143a0; Yung YL, 1996, SCIENCE, V271, P962, DOI 10.1126/science.271.5251.962; ZHUANG GS, 1993, DEEP-SEA RES PT I, V40, P1413, DOI 10.1016/0967-0637(93)90120-R	46	1180	1249	7	475	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 10	1996	383	6600					495	501		10.1038/383495a0	http://dx.doi.org/10.1038/383495a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VL755	18680864				2022-12-28	WOS:A1996VL75500041
J	Andrews, ZB; Liu, ZW; Walllingford, N; Erion, DM; Borok, E; Friedman, JM; Tschop, MH; Shanabrough, M; Cline, G; Shulman, GI; Coppola, A; Gao, XB; Horvath, TL; Diano, S				Andrews, Zane B.; Liu, Zhong-Wu; Walllingford, Nicholas; Erion, Derek M.; Borok, Erzsebet; Friedman, Jeffery M.; Tschop, Matthias H.; Shanabrough, Marya; Cline, Gary; Shulman, Gerald I.; Coppola, Anna; Gao, Xiao-Bing; Horvath, Tamas L.; Diano, Sabrina			UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals	NATURE			English	Article							GROWTH-HORMONE SECRETAGOGUE; ACTIVATED PROTEIN-KINASE; BETA-CELL DYSFUNCTION; FATTY-ACID OXIDATION; ARCUATE NUCLEUS; UNCOUPLING PROTEIN-2; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; MESSENGER-RNA; POMC NEURONS	The gut-derived hormone ghrelin exerts its effect on the brain by regulating neuronal activity. Ghrelin-induced feeding behaviour is controlled by arcuate nucleus neurons that co-express neuropeptide Y and agouti-related protein (NPY/AgRP neurons). However, the intracellular mechanisms triggered by ghrelin to alter NPY/AgRP neuronal activity are poorly understood. Here we show that ghrelin initiates robust changes in hypothalamic mitochondrial respiration in mice that are dependent on uncoupling protein 2 (UCP2). Activation of this mitochondrial mechanism is critical for ghrelin-induced mitochondrial proliferation and electric activation of NPY/AgRP neurons, for ghrelin-triggered synaptic plasticity of pro-opiomelanocortin-expressing neurons, and for ghrelin-induced food intake. The UCP2-dependent action of ghrelin on NPY/AgRP neurons is driven by a hypothalamic fatty acid oxidation pathway involving AMPK, CPT1 and free radicals that are scavenged by UCP2. These results reveal a signalling modality connecting mitochondria-mediated effects of G-protein-coupled receptors on neuronal function and associated behaviour.	[Andrews, Zane B.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Andrews, Zane B.; Liu, Zhong-Wu; Walllingford, Nicholas; Erion, Derek M.; Borok, Erzsebet; Shanabrough, Marya; Coppola, Anna; Gao, Xiao-Bing; Horvath, Tamas L.; Diano, Sabrina] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Cline, Gary; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Horvath, Tamas L.; Diano, Sabrina] Yale Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Liu, Zhong-Wu] Yunyang Med Coll, Dept Neurobiol, Shiyan 442000, Hubei, Peoples R China; [Friedman, Jeffery M.] Rockefeller Univ, Genet Mol Lab, Howard Hughes Med Inst, New York, NY 10021 USA; [Tschop, Matthias H.] Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA	Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Rockefeller University; University System of Ohio; University of Cincinnati	Horvath, TL (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu; sabrina.diano@yale.edu	Tschoep, Matthias H/I-5443-2014; Gao, Xiao-Bing/C-3121-2011; Wallingford, Nicholas/J-1367-2018; Shulman, Gerald I./P-7176-2019; Liu, Zhong-Wu/C-2794-2011	Gao, Xiao-Bing/0000-0002-2035-4936; Wallingford, Nicholas/0000-0003-2279-0480; Shulman, Gerald I./0000-0003-1529-5668; Tschoep, Matthias/0000-0002-4744-371X; Andrews, Zane B./0000-0002-9097-7944	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [R01 AG022880] Funding Source: Medline; NIDDK NIH HHS [R01 DK040936] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022880] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Horvath B, 2002, BIOCHEM PHARMACOL, V64, P369, DOI 10.1016/S0006-2952(02)01167-X; Horvath TL, 1999, J NEUROSCI, V19, P10417; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	39	535	556	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2008	454	7206					846	851		10.1038/nature07181	http://dx.doi.org/10.1038/nature07181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18668043	Green Accepted			2022-12-28	WOS:000258398600027
J	Knox, JJ				Knox, Jennifer J.			Progression-free survival as endpoint in metastatic RCC?	LANCET			English	Editorial Material							INTERFERON-ALPHA; CARCINOMA		Univ Toronto, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Knox, JJ (corresponding author), Univ Toronto, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada.	jennifer.knox@uhn.on.ca						Bast RC, 2007, GYNECOL ONCOL, V107, P173, DOI 10.1016/j.ygyno.2007.08.092; Bukowski RM, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.5154; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Figlin RA, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5024; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Johnson JR, 2003, J CLIN ONCOL, V21, P1404, DOI 10.1200/JCO.2003.08.072; MOTZER RJ, 2008, LANCET          0723, DOI DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Negrier S, 2007, CANCER-AM CANCER SOC, V110, P2468, DOI 10.1002/cncr.23056; Ng R, 2008, ANN ONCOL, V19, P481, DOI 10.1093/annonc/mdm486; Pignatti F, 2002, CRIT REV ONCOL HEMAT, V42, P123, DOI 10.1016/S1040-8428(02)00009-4; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071	13	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					427	429		10.1016/S0140-6736(08)61040-5	http://dx.doi.org/10.1016/S0140-6736(08)61040-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335OD	18653227				2022-12-28	WOS:000258299000006
J	Papaloizou, JCB				Papaloizou, J. C. B.			Planetary system formation	SCIENCE			English	Editorial Material							MIGRATION; EVOLUTION; DISKS		Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WE, England	University of Cambridge	Papaloizou, JCB (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WE, England.	j.c.b.papaloizou@damtp.cam.ac.uk						Alibert Y, 2005, ASTROPHYS J, V626, pL57, DOI 10.1086/431325; BODENHEIMER P, 1986, ICARUS, V67, P391, DOI 10.1016/0019-1035(86)90122-3; Bouvier J., 2007, PROTOSTARS PLANETS E, P479; Kley W, 2005, ASTRON ASTROPHYS, V437, P727, DOI 10.1051/0004-6361:20052656; Marcy GW, 1998, ANNU REV ASTRON ASTR, V36, P57, DOI 10.1146/annurev.astro.36.1.57; Mayer L, 2004, ASTROPHYS J, V609, P1045, DOI 10.1086/421288; Papaloizou JCB, 2006, REP PROG PHYS, V69, P119, DOI 10.1088/0034-4885/69/1/R03; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Thommes EW, 2008, SCIENCE, V321, P814, DOI 10.1126/science.1159723; Udry S, 2003, ASTRON ASTROPHYS, V407, P369, DOI 10.1051/0004-6361:20030843; Udry S, 2007, PROTOSTARS PLANETS 5, P685; Winn JN, 2007, ASTROPHYS J, V665, pL167, DOI 10.1086/521362	13	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					777	778		10.1126/science.1161556	http://dx.doi.org/10.1126/science.1161556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687944				2022-12-28	WOS:000258261000024
J	Thommes, EW; Matsumura, S; Rasio, FA				Thommes, Edward W.; Matsumura, Soko; Rasio, Frederic A.			Gas disks to gas giants: Simulating the birth of planetary systems	SCIENCE			English	Article							DETERMINISTIC MODEL; ORBITAL MIGRATION; PROTOPLANETARY; ACCRETION; DYNAMICS; JUPITER; SATURN; STARS	The ensemble of now more than 250 discovered planetary systems displays a wide range of masses, orbits and, in multiple systems, dynamical interactions. These represent the end point of a complex sequence of events, wherein an entire protostellar disk converts itself into a small number of planetary bodies. Here, we present self-consistent numerical simulations of this process, which produce results in agreement with some of the key trends observed in the properties of the exoplanets. Analogs to our own solar system do not appear to be common, originating from disks near the boundary between barren and (giant) planet-forming.	[Thommes, Edward W.] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Thommes, Edward W.; Matsumura, Soko; Rasio, Frederic A.] Northwestern Univ, Evanston, IL 60208 USA	University of Guelph; Northwestern University	Thommes, EW (corresponding author), Univ Guelph, Guelph, ON N1G 2W1, Canada.	thommes@northwestern.edu		Rasio, Frederic/0000-0002-7132-418X; Matsumura, Soko/0000-0003-0582-8707				Adams FC, 2003, ICARUS, V163, P290, DOI 10.1016/S0019-1035(03)00081-2; Beer ME, 2004, MON NOT R ASTRON SOC, V354, P763, DOI 10.1111/j.1365-2966.2004.08237.x; Bryden G, 2000, ASTROPHYS J, V544, P481, DOI 10.1086/317165; Chambers JE, 2006, ASTROPHYS J, V652, pL133, DOI 10.1086/510407; CHATTERJEE S, 2007, ARXIV ASTROPHYS; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; Fischer DA, 2003, ASTR SOC P, V294, P117; Gaudi BS, 2008, SCIENCE, V319, P927, DOI 10.1126/science.1151947; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; HAYASHI C, 1981, SUP PROG THEOR PHYS, P35; Hollenbach D., 2000, PROTOSTARS PLANETS; Ida S, 2008, ASTROPHYS J, V673, P487, DOI 10.1086/523754; Ida S, 2004, ASTROPHYS J, V604, P388, DOI 10.1086/381724; IDA S, 2008, ARXIV ASTROPHYS; Ikoma M, 2000, ASTROPHYS J, V537, P1013, DOI 10.1086/309050; JURIC M, 2007, ARXIV ASTROPHYS; Kuchner MJ, 2002, ASTROPHYS J, V574, pL87, DOI 10.1086/342370; LEE AT, 2008, ARXIV ASTROPHYS; Lee MH, 2002, ASTROPHYS J, V567, P596, DOI 10.1086/338504; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Marcy G, 2005, PROG THEOR PHYS SUPP, P24, DOI 10.1143/PTPS.158.24; Morbidelli A, 2007, ICARUS, V191, P158, DOI 10.1016/j.icarus.2007.04.001; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Sari R, 2004, ASTROPHYS J, V606, pL77, DOI 10.1086/421080; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Thommes EW, 2007, ASTROPHYS J, V656, pL25, DOI 10.1086/512080; Thommes EW, 2005, ASTROPHYS J, V626, P1033, DOI 10.1086/429913; Thommes EW, 1999, NATURE, V402, P635, DOI 10.1038/45185; Udry S, 2007, PROTOSTARS PLANETS 5, P685	39	107	107	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					814	817		10.1126/science.1159723	http://dx.doi.org/10.1126/science.1159723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687958	Green Submitted			2022-12-28	WOS:000258261000039
J	Strathdee, SA; Magis-Rodriguez, C				Strathdee, Steffanie A.; Magis-Rodriguez, Carlos			Mexico's evolving HIV epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FEMALE SEX WORKERS; US BORDER CITIES; INFECTION; TIJUANA		[Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, Div Int Hlth & Cross Cultural Med, La Jolla, CA 92093 USA; [Magis-Rodriguez, Carlos] SIDA, Ctr Nacl Prevent & Control, Mexico City, DF, Mexico	University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Sch Med, Div Int Hlth & Cross Cultural Med, 9500 Gilman Dr,Mailstop 0622, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X	FOGARTY INTERNATIONAL CENTER [R25TW007500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA019829, R01DA019829, R21DA024381, R01DA023877] Funding Source: NIH RePORTER; FIC NIH HHS [R25TW0075, R25 TW007500-01A1, R25 TW007500] Funding Source: Medline; NIDA NIH HHS [R01 DA023877-01A1, R01 DA019829, R01 DA023877, R01DA019829, R37 DA019829, R01 DA019829-01A1, R21 DA024381, R21 DA024381-03] Funding Source: Medline; NIMH NIH HHS [R01MH065849, R01 MH065849] Funding Source: Medline; PHS HHS [R21024381] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bautista-Arredondo S, 2006, AIDS, V20, P101, DOI 10.1097/01.aids.0000198096.08444.53; Brouwer KC, 2006, J URBAN HEALTH, V83, P299, DOI 10.1007/s11524-005-9027-0; BROUWER KC, DEPORTATION US MEXIC; GAYET CMC, 2007, PRACTICAS SEXUALES P; Hirsch JS, 2007, AM J PUBLIC HEALTH, V97, P986, DOI 10.2105/AJPH.2006.088492; Magis-Rodriguez C, 2004, JAIDS-J ACQ IMM DEF, V37, pS215, DOI 10.1097/01.qai.0000141252.16099.af; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; Patterson TL, 2008, J INFECT DIS, V197, P728, DOI 10.1086/527379; PATTERSON TL, 2008, 17 INT C AIDS AUG 3; RITIENI A, 2006, PREVALENCE HIV INFEC; *SECR SAL, 2007, PAN EP VIH SIDA ITS; STRATHDEE SA, 2008, 17 INT C AIDS AUG 3; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, SEX TRANSM DIS, V35, P263, DOI 10.1097/OLQ.0b013e31815b0; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001	15	100	100	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					571	573		10.1001/jama.300.5.571	http://dx.doi.org/10.1001/jama.300.5.571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677029	Green Accepted			2022-12-28	WOS:000258188900018
J	Gornall, J				Gornall, Jonathan			Three doctors and the GMC	BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL MEDICAL COUNCIL; CHILD PROTECTION WORK; PEDIATRICIANS; MISCONDUCT; COMPLAINTS; SOUTHALL; CNEP					Jgornall@mac.com						Catto G, 2008, BMJ-BRIT MED J, V336, P231, DOI 10.1136/bmj.39471.698426.3A; Crawford M, 2005, ARCH DIS CHILD, V90, P218; Dyer C, 2002, BRIT MED J, V325, P1054; DYER C, 2005, BRIT MED J, V331, P1426; Dyer O, 2004, BRIT MED J, V329, P366, DOI 10.1136/bmj.329.7462.366-a; Dyer O, 2008, BRIT MED J, V336, P911, DOI 10.1136/bmj.39559.342859.DB; Dyer O, 2007, BRIT MED J, V335, P1174, DOI 10.1136/bmj.39420.690845.DB; *GEN MED COUNC, 2008, DET FITN PRACT PAN D; GORNALL J, 2005, HOSP DOCTOR     0714; GORNALL J, 2007, BRIT MED J, V334, P765; Hall DMB, 2008, BRIT MED J, V336, P231, DOI 10.1136/bmj.39471.702141.3A; Hey E, 2000, BRIT MED J, V321, P752, DOI 10.1136/bmj.321.7263.752; Hey E, 2006, LANCET, V367, P1032, DOI 10.1016/S0140-6736(06)68445-6; Hey E, 2002, ARCH DIS CHILD, V86, P1, DOI 10.1136/adc.86.1.1; HINSLIFF G, 2008, OBSERVER        0413; Marcovitch H, 2002, BRIT MED J, V324, P167; Mayor S, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745; MCDONAGH M, 2007, INDEPENDENT     1209; NICHOLSON R, 1998, BRIT MED J, V317, P811; *PROF CHILD AB, 2008, STAT HEAR GMC CNEP S; *PROF CHILD AB, 2008, 3 QUART DOCT DIS GMC; SPEIGHT N, OBSERVER        1209; TIBBETTS G, 2007, DAILY TELEGRAPH 1206; Wheatley R, 2007, BMJ-BRIT MED J, V335, P1265, DOI 10.1136/bmj.39427.640069.DE; Williams C, 2007, PEDIATRICS, V119, P800, DOI 10.1542/peds.2006-1980; 2006, TRANSCRIPT D SOUTHAL	26	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a907	10.1136/bmj.a907	http://dx.doi.org/10.1136/bmj.a907			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18653629				2022-12-28	WOS:000258561000022
J	Swain, S; Turner, C; Tyrrell, P; Rudd, A				Swain, Sharon; Turner, Claire; Tyrrell, Pippa; Rudd, Anthony		Guideline Dev Grp	Guidelines - Diagnosis and initial management of acute stroke and transient ischaemic attack: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENDARTERECTOMY; SURGERY		[Swain, Sharon; Turner, Claire] Royal Coll Physicians, Natl Collaborating Ctr Chron Condit, London NW1 4LE, England; [Tyrrell, Pippa] Univ Manchester, Manchester, Lancs, England; [Tyrrell, Pippa] Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England; [Rudd, Anthony] St Thomas Hosp, London SE1 7EH, England	Royal College of Physicians; University of Manchester; Salford Royal NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Swain, S (corresponding author), Royal Coll Physicians, Natl Collaborating Ctr Chron Condit, London NW1 4LE, England.	Sharon.Swain@rcplondon.ac.uk		Tyrrell, Pippa/0000-0001-9609-1231	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Chronic Conditions was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	National Audit Office, 2005, RED BRAIN DAM FAST A; National Institute for Health and Clinical Excellence, 2007, ALT TREATM AC ISCH S; National Institute for Health and Clinical Excellence, 2008, STROK DIAGN IN MAN A; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Nor AM, 2004, STROKE, V35, P1355, DOI 10.1161/01.STR.0000128529.63156.c5; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2004, STROKE, V35, P2855, DOI 10.1161/01.STR.0000147040.20446.f6; *ROYAL COLL PHYS L, 2005, NAT SENT STROK AUD 2	8	24	30	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a786	10.1136/bmj.a786	http://dx.doi.org/10.1136/bmj.a786			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18653633				2022-12-28	WOS:000258561000033
J	Talley, NJ				Talley, Nicholas J.			Is it time to screen and treat H pylori to prevent gastric cancer?	LANCET			English	Editorial Material							GASTROESOPHAGEAL-REFLUX DISEASE; RANDOMIZED CONTROLLED-TRIAL; INFECTION; GUIDELINES; ASIA		Mayo Clin Jacksonville, Dept Internal Med, Jacksonville, FL 32224 USA	Mayo Clinic	Talley, NJ (corresponding author), Mayo Clin Jacksonville, Dept Internal Med, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	Talley.nicholas@mayo.edu	Talley, Nicholas J/D-5399-2013	Talley, Nicholas J/0000-0003-2537-3092				Aldana LP, 2002, HELICOBACTER, V7, P306; Anderson LA, 2008, GUT, V57, P734, DOI 10.1136/gut.2007.132662; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Ford AC, 2005, GASTROENTEROLOGY, V129, P1910, DOI 10.1053/j.gastro.2005.09.016; Fujioka T, 2007, J GASTROENTEROL, V42, P3, DOI 10.1007/s00535-006-1938-3; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Moayyedi P, 2001, GASTROENTEROLOGY, V121, P1120, DOI 10.1053/gast.2001.29332; Rokkas T, 2007, CLIN GASTROENTEROL H, V5, P1413, DOI 10.1016/j.cgh.2007.08.010; Talley NJ, 2008, AM J GASTROENTEROL, V103, P510, DOI 10.1111/j.1572-0241.2008.01819.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vakil N, 2006, ALIMENT PHARM THERAP, V24, P55, DOI 10.1111/j.1365-2036.2006.02964.x; Wright ME, 2007, CANCER, V109, P891, DOI 10.1002/cncr.22482	15	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 2	2008	372	9636					350	352		10.1016/S0140-6736(08)61136-8	http://dx.doi.org/10.1016/S0140-6736(08)61136-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18675670				2022-12-28	WOS:000258196000006
J	Boyd, RW				Boyd, Robert W.			Physics - Let quantum mechanics improve your images	SCIENCE			English	Editorial Material							ENTANGLEMENT; DIFFRACTION; LIGHT		[Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14620 USA; [Boyd, Robert W.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14620 USA	University of Rochester; University of Rochester	Boyd, RW (corresponding author), Univ Rochester, Inst Opt, Rochester, NY 14620 USA.	boyd@optics.rochester.edu						Bennink RS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033601; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; Boyer V, 2008, SCIENCE, V321, P544, DOI 10.1126/science.1158275; GATTI A, 2008, PROGR OPTICS, V51, P69; Howell JC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.210403; Kolobov MI, 1999, REV MOD PHYS, V71, P1539, DOI 10.1103/RevModPhys.71.1539; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Mancini S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120401; MORRIS GM, 1984, APPL OPTICS, V23, P3152, DOI 10.1364/AO.23.003152; REID MD, 1988, PHYS REV LETT, V60, P2731, DOI 10.1103/PhysRevLett.60.2731; STREKALOV DV, 1995, PHYS REV LETT, V74, P3600, DOI 10.1103/PhysRevLett.74.3600; Wagner K, 2008, SCIENCE, V321, P541, DOI 10.1126/science.1159663; White AG, 1998, PHYS REV A, V58, P605, DOI 10.1103/PhysRevA.58.605	13	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					501	502		10.1126/science.1161439	http://dx.doi.org/10.1126/science.1161439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653872				2022-12-28	WOS:000257888900029
J	Zlotorynski, E; Agami, R				Zlotorynski, Eitan; Agami, Reuven			A PASport to cellular proliferation	CELL			English	Editorial Material							MICRORNAS; MECHANISMS; EXPRESSION	The use of alternative polyadenylation sites produces mRNA isoforms with different 3' untranslated regions. A recent report in Science (Sandberg et al., 2008) suggests that alternative polyadenylation is connected to microRNA-mediated regulation of gene expression as part of a global program for cellular proliferation.	[Zlotorynski, Eitan; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1006 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Agami, R (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1006 CX Amsterdam, Netherlands.	ragami@nki.nl	agami, reuven/GOG-8289-2022	Agami, Reuven/0000-0002-2848-2473				Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	10	7	7	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					208	210		10.1016/j.cell.2008.07.003	http://dx.doi.org/10.1016/j.cell.2008.07.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662535	Bronze			2022-12-28	WOS:000257891700009
J	Korobkin, R; Rajkumar, R				Korobkin, Russell; Rajkumar, Rahul			The Genetic Information Nondiscrimination Act - A half-step toward risk sharing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Korobkin, Russell] Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA; [Korobkin, Russell] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90024 USA; [Rajkumar, Rahul] Brigham & Womens Hosp, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital	Korobkin, R (corresponding author), Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA.							HIMMELSTEIN DU, 2005, HLTH AFF MILLWOOD S, P64	1	23	23	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					335	337		10.1056/NEJMp0804352	http://dx.doi.org/10.1056/NEJMp0804352			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650511				2022-12-28	WOS:000257852100002
J	Winchester, S				Winchester, Simon			The man who unveiled China	NATURE			English	Editorial Material												simonwinchester@mac.com						MCNEILL WH, 1987, NATURE, V326, P751, DOI 10.1038/326751a0	1	0	0	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					409	411		10.1038/454409a	http://dx.doi.org/10.1038/454409a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	329IC	18650901				2022-12-28	WOS:000257860300026
J	Heard, KJ				Heard, Kennon J.			Acetylcysteine for acetaminophen poisoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS N-ACETYLCYSTEINE; INDUCED HEPATIC-NECROSIS; PARACETAMOL ACETAMINOPHEN; STATUS EPILEPTICUS; COVALENT BINDING; OXYGEN-TRANSPORT; OVERDOSE; MANAGEMENT; CYSTEAMINE; FAILURE	A 25- year- old man presents to the emergency department with a toothache. During the evaluation, the physician determines that the patient has been taking large doses of over- the- counter acetaminophen along with an acetaminophen - hydrocodone product for the past 5 days. His daily dose of acetaminophen has been 12 g per day ( maximum recommended dose, 4 g per day). He has no other medical problems and typically consumes two beers a day. The patient has no symptoms beyond his toothache, is not icteric, and has no hepatomegaly or right- upper- quadrant tenderness. His serum acetaminophen concentration 8 hours after the most recent dose is undetectable. His serum alanine aminotransferase concentration is 75 IU per liter, his serum bilirubin concentration is 1.2 mg per deciliter ( 20.5 mu mol per liter), and his international normalized ratio ( INR) is 1.1. The emergency department physician contacts the regional poison- control center, which recommends treatment with acetylcysteine.	[Heard, Kennon J.] Denver Hlth, Rocky Mt Poison & Drug Ctr, Denver, CO 80208 USA; [Heard, Kennon J.] Univ Colorado, Sch Med, Denver, CO 80202 USA	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Heard, KJ (corresponding author), Denver Hlth, Rocky Mt Poison & Drug Ctr, 777 Bannock St,MS 0180, Denver, CO 80208 USA.	kennon.heard@rmpdc.org	Hug, Balthasar L./G-1568-2010		NIDA NIH HHS [K08 DA020573-02, K08 DA020573, DA020573] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA020573] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Appelboam AV, 2002, EMERG MED J, V19, P594, DOI 10.1136/emj.19.6.594; Bailey B, 2004, ANN EMERG MED, V44, P401, DOI 10.1016/j.annemergmed.2004.05.014; Bailey B, 1998, ANN EMERG MED, V31, P710, DOI 10.1016/S0196-0644(98)70229-X; Betten DP, 2007, ANN EMERG MED, V50, P272, DOI 10.1016/j.annemergmed.2006.11.010; Bizovi K., 2002, GOLDFRANKS TOXICOLOG, P480; BROK J, 2006, COCHRANE DB SYST REV, V2; Daly FFS, 2004, ANN EMERG MED, V44, P393, DOI 10.1016/j.annemergmed.2004.05.005; DAVIDSON DG, 1966, BRIT MED J, V2, P497, DOI 10.1136/bmj.2.5512.497; Devlin J, 1997, CRIT CARE MED, V25, P236, DOI 10.1097/00003246-199702000-00007; Gunnell D, 2000, SUICIDE LIFE-THREAT, V30, P313; HARRISON PM, 1990, LANCET, V335, P1572, DOI 10.1016/0140-6736(90)91388-Q; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; Hershkovitz E, 1996, ISRAEL J MED SCI, V32, P1102; Horowitz RS, 1997, J TOXICOL-CLIN TOXIC, V35, P447, DOI 10.3109/15563659709001226; JOLLOW DJ, 1974, PHARMACOLOGY, V12, P251, DOI 10.1159/000136547; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Jones AL, 1998, J TOXICOL-CLIN TOXIC, V36, P277, DOI 10.3109/15563659809028022; Kao LW, 2003, ANN EMERG MED, V42, P741, DOI 10.1016/S0196-0644(03)00508-0; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; Kerr F, 2005, ANN EMERG MED, V45, P402, DOI 10.1016/j.annemergmed.2004.08.040; Lai MW, 2006, CLIN TOXICOL, V44, P803, DOI 10.1080/15563650600907165; MAKIN AJ, 1995, GASTROENTEROLOGY, V109, P1907, DOI 10.1016/0016-5085(95)90758-0; MILLER LF, 1983, SEMIN ONCOL, V10, P76; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; *NAT POIS INF SERV, 1998, MAN AC PAR POIS GUID; POTTER WZ, 1974, PHARMACOLOGY, V12, P129, DOI 10.1159/000136531; PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097; PRESCOTT LF, 1974, LANCET, V1, P588, DOI 10.1016/s0140-6736(74)92649-x; PRESCOTT LF, 1974, LANCET, V1, P998; PRESCOTT LF, 1977, LANCET, V2, P432; PRESCOTT LF, 1976, LANCET, V2, P109; REYNARD K, 1992, LANCET, V340, P675, DOI 10.1016/0140-6736(92)92211-W; RIGGS BS, 1989, OBSTET GYNECOL, V74, P247; RUMACK BH, 1981, ARCH INTERN MED, V141, P380, DOI 10.1001/archinte.141.3.380; RUMACK BH, 1984, AM J DIS CHILD, V138, P428, DOI 10.1001/archpedi.1984.02140430006003; RUMACK BH, 1978, PEDIATRICS, V62, P898; Schiodt FV, 1997, NEW ENGL J MED, V337, P1112, DOI 10.1056/NEJM199710163371602; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; SMILKSTEIN MJ, 1991, ANN EMERG MED, V20, P1058, DOI 10.1016/S0196-0644(05)81352-6; Sung L, 1997, PEDIATRICS, V100, P389, DOI 10.1542/peds.100.3.389; Trey C, 1970, Prog Liver Dis, V3, P282; Tsai CL, 2005, CLIN THER, V27, P336, DOI 10.1016/j.clinthera.2005.03.002; Ward RM, 2001, PEDIATRICS, V108, P1020; Wolf SJ, 2007, ANN EMERG MED, V50, P292, DOI 10.1016/j.annemergmed.2007.06.014; Woo OF, 2000, ANN EMERG MED, V35, P363, DOI 10.1016/S0196-0644(00)70055-2; Yip L, 1998, CRIT CARE MED, V26, P40, DOI 10.1097/00003246-199801000-00014; Yip L, 2003, NEW ENGL J MED, V348, P2471, DOI 10.1056/NEJM200306123482422; 2005, MED LETT DRUGS THER, V47, P70	49	258	268	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					285	292		10.1056/NEJMct0708278	http://dx.doi.org/10.1056/NEJMct0708278			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KD	18635433	Green Accepted			2022-12-28	WOS:000257656600008
J	Shai, I; Schwarzfuchs, D; Henkin, Y; Shahar, DR; Witkow, S; Greenberg, I; Golan, R; Fraser, D; Bolotin, A; Vardi, H; Tangi-Rozental, O; Zuk-Ramot, R; Sarusi, B; Brickner, D; Schwartz, Z; Sheiner, E; Marko, R; Katorza, E; Thiery, J; Fiedler, GM; Bluher, M; Stumvoll, M; Stampfer, MJ				Shai, Iris; Schwarzfuchs, Dan; Henkin, Yaakov; Shahar, Danit R.; Witkow, Shula; Greenberg, Ilana; Golan, Rachel; Fraser, Drora; Bolotin, Arkady; Vardi, Hilel; Tangi-Rozental, Osnat; Zuk-Ramot, Rachel; Sarusi, Benjamin; Brickner, Dov; Schwartz, Ziva; Sheiner, Einat; Marko, Rachel; Katorza, Esther; Thiery, Joachim; Fiedler, Georg Martin; Blueher, Matthias; Stumvoll, Michael; Stampfer, Meir J.		DIRECT Grp	Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; HEART-DISEASE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; FOOD-FREQUENCY; OBESITY; OVERWEIGHT; NUTRITION; HEALTH	Background: Trials comparing the effectiveness and safety of weight-loss diets are frequently limited by short follow-up times and high dropout rates. Methods: In this 2-year trial, we randomly assigned 322 moderately obese subjects (mean age, 52 years; mean body-mass index [the weight in kilograms divided by the square of the height in meters], 31; male sex, 86%) to one of three diets: low-fat, restricted-calorie; Mediterranean, restricted-calorie; or low-carbohydrate, non-restricted-calorie. Results: The rate of adherence to a study diet was 95.4% at 1 year and 84.6% at 2 years. The Mediterranean-diet group consumed the largest amounts of dietary fiber and had the highest ratio of monounsaturated to saturated fat (P<0.05 for all comparisons among treatment groups). The low-carbohydrate group consumed the smallest amount of carbohydrates and the largest amounts of fat, protein, and cholesterol and had the highest percentage of participants with detectable urinary ketones (P<0.05 for all comparisons among treatment groups). The mean weight loss was 2.9 kg for the low-fat group, 4.4 kg for the Mediterranean-diet group, and 4.7 kg for the low-carbohydrate group (P<0.001 for the interaction between diet group and time); among the 272 participants who completed the intervention, the mean weight losses were 3.3 kg, 4.6 kg, and 5.5 kg, respectively. The relative reduction in the ratio of total cholesterol to high-density lipoprotein cholesterol was 20% in the low-carbohydrate group and 12% in the low-fat group (P=0.01). Among the 36 subjects with diabetes, changes in fasting plasma glucose and insulin levels were more favorable among those assigned to the Mediterranean diet than among those assigned to the low-fat diet (P<0.001 for the interaction among diabetes and Mediterranean diet and time with respect to fasting glucose levels). Conclusions: Mediterranean and low-carbohydrate diets may be effective alternatives to low-fat diets. The more favorable effects on lipids (with the low-carbohydrate diet) and on glycemic control (with the Mediterranean diet) suggest that personal preferences and metabolic considerations might inform individualized tailoring of dietary interventions. (ClinicalTrials.gov number, NCT00160108.).	[Shai, Iris; Shahar, Danit R.; Witkow, Shula; Greenberg, Ilana; Golan, Rachel; Fraser, Drora; Bolotin, Arkady; Vardi, Hilel; Tangi-Rozental, Osnat] Ben Gurion Univ Negev, S Daniel Abraham Int Ctr Hlth & Nutr, Dept Epidemiol & Hlth Syst Evaluat, IL-84105 Beer Sheva, Israel; [Schwarzfuchs, Dan; Zuk-Ramot, Rachel; Sarusi, Benjamin; Brickner, Dov; Schwartz, Ziva; Sheiner, Einat; Marko, Rachel; Katorza, Esther] Nucl Res Ctr Negev, Dimona, Israel; [Henkin, Yaakov] Soroka Univ, Med Ctr, Dept Cardiol, Beer Sheva, Israel; [Thiery, Joachim; Fiedler, Georg Martin] Univ Hosp Leipzig, Inst Lab Med, Leipzig, Germany; [Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Leipzig University; Leipzig University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Shai, I (corresponding author), Ben Gurion Univ Negev, S Daniel Abraham Int Ctr Hlth & Nutr, Dept Epidemiol & Hlth Syst Evaluat, POB 653, IL-84105 Beer Sheva, Israel.	irish@bgu.ac.il	Moller, Kirsten/A-4751-2009; Golan, Rachel/AAA-5961-2021; SHEINER, EYAL/F-1488-2012; Castelnuovo, Gianluca/AAC-1780-2019; Fiedler, Georg Martin/C-8341-2011; Shahar, Danit R/B-4280-2012; Manzoni, Gian Mauro/L-3891-2019; Stumvoll, Michael/ABE-1121-2021	Moller, Kirsten/0000-0003-3058-1072; Castelnuovo, Gianluca/0000-0003-2633-9822; Fiedler, Georg Martin/0000-0001-5689-4574; Manzoni, Gian Mauro/0000-0003-3384-0359; Stumvoll, Michael/0000-0001-6225-8240; Shai, Iris/0000-0001-9050-4605; Shahar, Danit/0000-0003-1000-1819				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Atkins RC, 2002, DR ATKINS NEW DIET R; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Covas MI, 2006, ANN INTERN MED, V145, P333, DOI 10.7326/0003-4819-145-5-200609050-00006; Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; GARDNER CD, 2007, JAMA-J AM MED ASSOC, V298, P178; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Krauss RM, 2000, CIRCULATION, V102, P2284; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lara-Castro C, 2004, J CLIN ENDOCR METAB, V89, P4197, DOI 10.1210/jc.2004-0683; Malik VS, 2007, NAT CLIN PRACT CARD, V4, P34, DOI 10.1038/ncpcardio0726; Mayer-Davis EJ, 2004, ANN EPIDEMIOL, V14, P763, DOI 10.1016/j.annepidem.2004.02.004; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; Nordmann, 2006, ARCH INTERN MED, V166, P932; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Okie S, 2007, NEW ENGL J MED, V357, P1465, DOI 10.1056/NEJMp078152; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Schwenke DC, 2005, CURR OPIN LIPIDOL, V16, P55, DOI 10.1097/00041433-200502000-00010; Serra-Majem L, 2006, NUTR REV, V64, pS27, DOI 10.1301/nr.2006.feb.S27-S47; Shai I, 2005, J NUTR, V135, P573, DOI 10.1093/jn/135.3.573; Shai I, 2004, PUBLIC HEALTH NUTR, V7, P745, DOI 10.1079/PHN2004599; Shai I, 2003, PUBLIC HEALTH NUTR, V6, P401, DOI 10.1079/PHN2002445; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Thomas H, 2006, HEALTH EDUC RES, V21, P783, DOI 10.1093/her/cyl143; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; WILLETT WC, 2001, HARVARD MED SCH GUID; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	35	1254	1282	5	309	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					229	241		10.1056/NEJMoa0708681	http://dx.doi.org/10.1056/NEJMoa0708681			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KD	18635428	Bronze			2022-12-28	WOS:000257656600003
J	Bedri, A; Gudetta, B; Isehak, A; Kumbi, S; Lulseged, S; Mengistu, Y; Bhore, AV; Bhosale, R; Varadhrajan, V; Gupte, N; Sastry, J; Suryavanshi, N; Tripathy, S; Mmiro, F; Mubiru, M; Onyango, C; Taylor, A; Musoke, P; Nakabiito, C; Abashawl, A; Adamu, R; Antelman, G; Bollinger, RC; Bright, P; Chaudhary, MA; Coberly, J; Guay, L; Fowler, MG; Gupta, A; Hassen, E; Jackson, JB; Moulton, LH; Nayak, U; Omer, SB; Propper, L; Ram, M; Rexroad, V; Ruff, AJ; Shankar, A; Zwerski, S				Bedri, Abubaker; Gudetta, Berhanu; Isehak, Abdulhamid; Kumbi, Solomon; Lulseged, Sileshi; Mengistu, Yohannes; Bhore, Arvind V.; Bhosale, Ramesh; Varadhrajan, Venkat; Gupte, Nikhil; Sastry, Jayagowri; Suryavanshi, Nishi; Tripathy, Srikanth; Mmiro, Francis; Mubiru, Michael; Onyango, Carolyne; Taylor, Adrian; Musoke, Philippa; Nakabiito, Clemensia; Abashawl, Aida; Adamu, Rahel; Antelman, Gretchen; Bollinger, Robert C.; Bright, Patricia; Chaudhary, Mohammad A.; Coberly, Jacqueline; Guay, Laura; Fowler, Mary Glenn; Gupta, Amita; Hassen, Elham; Jackson, J. Brooks; Moulton, Lawrence H.; Nayak, Uma; Omer, Saad B.; Propper, Lidia; Ram, Malathi; Rexroad, Vivian; Ruff, Andrea J.; Shankar, Anita; Zwerski, Sheryl		Six Week Extended Dose Nevirapine	Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials	LANCET			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; SINGLE; INTRAPARTUM; ZIDOVUDINE; PROPHYLAXIS; RESISTANCE; LAMIVUDINE; VARIANTS; KAMPALA	Background UNICEF/WHO recommends that infants born to HIVinfected mothers who do not have access to acceptable, feasible, affordable, sustainable, and safe replacement feeding should be exclusively breastfed for at least 6 months. The aim of three trials in Ethiopia, India, and Uganda was to assess whether daily nevirapine given to breastfed infants through 6 weeks of age can decrease HIV transmission via breastfeeding. Methods HIV-infected women breastfeeding their infants were eligible for participation. Participants were randomly assigned to receive either single-dose nevirapine (nevirapine 200 mg to women in labour and nevirapine 2 mg/kg to newborns after birth) or 6 week extended-dose nevirapine (nevirapine 200 mg to women in labour and nevirapine 2 mg/kg to newborn babies after birth plus nevirapine 5 mg daily from days 8-42 for the infant). The randomisation sequences were generated by computer at a central data coordinating Centre. The primary endpoint was HIV infection at 6 months of age in infants who were HIV PCR negative at birth. Analyses were by modified intention to treat, excluding infants with missing specimens and those with indeterminate or confirmed HIV infection at birth. These studies are registered with ClinicalTrials.gov, numbers NCT00074399, NCT00061321, and NCT00639938. Findings 2024 liveborn infants randomised in the study had at least one specimen tested before 6 months of age (1047 infants in the single-dose group and 977 infants in the extended-dose group). The modified intention-to-treat population included 986 infants in the single-dose group and 901 in the extended-dose group. At 6 months, 87 children in the single-dose group and 62 in the extended-dose group were infected with HIV (relative risk 0.80, 95% CI 0 . 58.1. 10; p=0. 16). At 6 weeks of age, 54 children in the single-dose group and 25 in the extended-dose group were HIV positive (0.54, 0 . 34-0.85; p=0.009). 393 infants in the single-dose group and 346 in the extended-dose group experienced grade 3 or 4 serious adverse events during the study (p=0. 54). Interpretation Although a 6-week regimen of daily nevirapine might be associated with a reduction in the risk of HIV transmission at 6 weeks of age, the lack of a significant reduction in the primary endpoint-risk of HIV transmission at 6 months-suggests that a longer course of daily infant nevirapine to prevent HIV transmission via breast milk might be more effective where access to affordable and safe replacement feeding is not yet available and where the risks of replacement feeding are high. Funding US National Institutes of Health; US National Institute of Allergy and Infectious Diseases; Fogarty International Center.	[Abashawl, Aida; Adamu, Rahel; Antelman, Gretchen; Bollinger, Robert C.; Bright, Patricia; Chaudhary, Mohammad A.; Coberly, Jacqueline; Guay, Laura; Fowler, Mary Glenn; Gupta, Amita; Hassen, Elham; Jackson, J. Brooks; Moulton, Lawrence H.; Nayak, Uma; Omer, Saad B.; Propper, Lidia; Ram, Malathi; Rexroad, Vivian; Ruff, Andrea J.; Shankar, Anita] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Clin Global Hlth Educ, Baltimore, MD 21286 USA; [Zwerski, Sheryl] NIAID, Div Aids, NIH, Bethesda, MD USA; [Bedri, Abubaker; Gudetta, Berhanu; Isehak, Abdulhamid; Kumbi, Solomon; Lulseged, Sileshi; Mengistu, Yohannes] Univ Addis Ababa, Addis Ababa, Ethiopia; [Bhore, Arvind V.; Bhosale, Ramesh; Varadhrajan, Venkat] BJ Med Coll, Pune, Maharashtra, India; [Gupte, Nikhil; Sastry, Jayagowri; Suryavanshi, Nishi] Pune MIT, Pune, Maharashtra, India; [Tripathy, Srikanth] Natl AIDS Res Inst, Pune, Maharashtra, India; [Mmiro, Francis; Mubiru, Michael; Onyango, Carolyne; Taylor, Adrian] Makerere Univ, Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Nakabiito, Clemensia] Makerere Univ, Minist Hlth, Kampala, Uganda	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Addis Ababa University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Dr. Vishwanath Karad MIT World Peace University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Makerere University; Makerere University	Bollinger, RC (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Clin Global Hlth Educ, Phipps 540,600 N Wolfe St, Baltimore, MD 21286 USA.	rcb@jhmi.edu	Tefera, Endale/AAC-5030-2019; Bharadwaj, Renu/I-1979-2019; Omer, Saad B/K-1182-2012	Tefera, Endale/0000-0002-5053-6298; Bharadwaj, Renu/0000-0002-4286-7337; Omer, Saad B/0000-0002-5383-3474; Bollinger, Robert/0000-0002-6798-6834; Moulton, Lawrence/0000-0001-7041-7387; Gupta, Amita/0000-0001-7036-2718; Tripathy, Srikanth/0000-0002-8363-2606; Antelman, Gretchen/0000-0001-7906-9964; Kadam, Abhay/0000-0002-6972-853X; jackson, brooks/0000-0001-9458-135X	FIC NIH HHS [D43-TW0000] Funding Source: Medline; NIAID NIH HHS [R01AI45462, R01AI3857601A, R01AI34235] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [N01TW000000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034235, R01AI038576, R01AI045462] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARENDT V, 2007, 4 IAS C HIV PATH TRE; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Flys TS, 2007, J INFECT DIS, V195, P711, DOI 10.1086/511433; Flys TS, 2006, JAIDS-J ACQ IMM DEF, V42, P610, DOI 10.1097/01.qai.0000221686.67810.20; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; KUMWENDA NI, 2008, N ENGL J MED    0604; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; NAM JM, 1992, BIOMETRICS, V48, P389, DOI 10.2307/2532298; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; *PER HIV GUID WORK, PHS TASK FORC REC US; Phadke MA, 2003, J NUTR, V133, P3153, DOI 10.1093/jn/133.10.3153; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Read JS, 2007, PEDIATRICS, V120, pE1547, DOI 10.1542/peds.2007-2951; Rollins N, 2004, JAIDS-J ACQ IMM DEF, V35, P188, DOI 10.1097/00126334-200402010-00014; Rothman K, 1986, MODERN EPIDEMIOLOGY; Saba J, 2002, LANCET, V359, P1178; Taha TE, 2004, JAMA-J AM MED ASSOC, V292, P202, DOI 10.1001/jama.292.2.202; Taha TE, 2003, LANCET, V362, P1171, DOI 10.1016/S0140-6736(03)14538-2; UNAIDS, 2006 REP GLOB AIDS E; VIOLARI A, 2007, 4 IAS C HIV PATH TRE; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2	29	199	202	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					300	313						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657709				2022-12-28	WOS:000258042800031
J	Cooper, DA				Cooper, David A.			Life and death in the cART era	LANCET			English	Editorial Material									Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2052, Australia	University of New South Wales Sydney; Kirby Institute	Cooper, DA (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2052, Australia.	dcooper@nchecr.unsw.edu.au						Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; 2008, INSIGHT NEWS     FEB	5	26	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					266	267		10.1016/S0140-6736(08)61086-7	http://dx.doi.org/10.1016/S0140-6736(08)61086-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657689				2022-12-28	WOS:000258042800005
J	Kurth, T; Schurks, M; Logroscino, G; Gaziano, JM; Buring, JE				Kurth, Tobias; Schurks, Markus; Logroscino, Giancarlo; Gaziano, J. Michael; Buring, Julie E.			Migraine, vascular risk, and cardiovascular events in women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE ASPIRIN; ISCHEMIC-STROKE; DISEASE; HEADACHE; PREVENTION	Objectives To evaluate whether the association between migraine with aura and increased risk of cardiovascular disease is modified by vascular risk groups as measured by the Framingham risk score for coronary heart disease. Design Prospective cohort study. Setting Women's health study, United States. Participants 27 519 women who were free from cardiovascular disease at baseline with available information on the Framingham risk score and migraine status. Main outcome measures Time to major cardiovascular disease event (non-fatal myocardial infarction, non-fatal ischaemic stroke, death from ischaemic cardiovascular disease), myocardial infarction, and ischaemic stroke. Results At baseline, 3577 (13.0%) women reported, active migraine, of whom 1418 (39.6%) reported migraine with aura. During 11.9 years of follow-up, there were 697 cardiovascular disease events. We stratified participants based on 10 year risk of coronary heart disease estimated from the Framingham risk score (1%, 2-4%, 5-9%, and >= 10%). Compared with women without migraine, the age adjusted hazard ratios in women with active migraine with aura were 1.93 (95% confidence interval 1.45 to 2.56) for major cardiovascular disease, 1.80 (1.16 to 2.79) for ischaemic stroke, and 1.94 (1.27 to 2.95) for myocardial infarction. When stratified by Framingham risk score, the association between migraine with aura and major cardiovascular disease was strongest in the lowest risk score group. There was a diametric association pattern for ischaemic stroke and myocardial infarction. Compared with women without migraine, the age adjusted hazard ratios in women who reported migraine with aura in the lowest Framingham risk score group were 3.88 (1.87 to 8.08) for ischaemic stroke and 1.29 (0.40 to 4.21) for myocardial infarction. Hazard ratios in women with migraine with aura in the highest Framingham risk score group were 1.00 (0.24 to 4.14) for ischaemic stroke and 3.34 (1.50 to 7.46) for myocardial infarction. Women with migraine without aura were not at increased risk of ischaemic stroke or myocardial infarction in any of the Framingham risk score groups. Conclusion The association between migraine with aura and cardiovascular disease varies by vascular risk status. Information on history of migraine and vascular risk status might help to identify women at increased risk for specific future cardiovascular disease events. Trial registration Clinical trials NCT00000479.	[Kurth, Tobias; Schurks, Markus; Gaziano, J. Michael; Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Kurth, Tobias; Gaziano, J. Michael; Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02115 USA; [Kurth, Tobias; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Logroscino, Giancarlo] Univ Bari, Sch Med, Dept Neurol & Psychiat, Bari, Italy; [Gaziano, J. Michael] Boston VA Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Universita degli Studi di Bari Aldo Moro; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School	Kurth, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02115 USA.	tkurth@rics.bwh.harvard.edu	LOGROSCINO, GIANCARLO/K-5148-2016; Potter, Joseph E/A-3122-2008; Kurth, Tobias/A-9243-2012	LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Kurth, Tobias/0000-0001-7169-2620	National Heart. Lung, and Blood Institute [HL-043851, HL-080467]; National Cancer Institute [CA-47988]; Donald W Reynolds Foundation; Leducq Foundation; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart. Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Leducq Foundation(Leducq Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The women's health study is supported by grants and from the National Heart. Lung, and Blood Institute (HL-043851 and HL-080467). and the National Cancer Institute (CA-47988). The research for this work was supported by grants from the Donald W Reynolds Foundation, the Leducq Foundation, and the Doris Duke Charitable Foundation.	Ahmed B, 2006, AM J MED, V119, P670, DOI 10.1016/j.amjmed.2006.03.023; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bensenor IM, 2001, CEPHALALGIA, V21, P175, DOI 10.1046/j.0333-1024.2001.00194.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Goadsby PJ, 2002, CEPHALALGIA, V22, P107, DOI 10.1046/j.1468-2982.2002.00323.x; HENRICH JB, 1989, J CLIN EPIDEMIOL, V42, P773, DOI 10.1016/0895-4356(89)90075-9; *INT HEAD SOC HEAD, 1988, CEPHALALGIA S7, V8, pS1; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kurth T, 2008, CEPHALALGIA, V28, P49, DOI 10.1111/j.1468-2982.2007.01467.x; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2007, ARCH INTERN MED, V167, P795, DOI 10.1001/archinte.167.8.795; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Longoni M, 2006, NEUROL SCI, V27, pS107, DOI 10.1007/s10072-006-0582-2; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rose KM, 2007, NEUROLOGY, V68, P1694, DOI 10.1212/01.wnl.0000261916.42871.05; Rose KM, 2004, NEUROLOGY, V63, P2233, DOI 10.1212/01.WNL.0000147289.50605.DC; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Sternfeld B, 1995, NEUROLOGY, V45, P2135, DOI 10.1212/WNL.45.12.2135; Tietjen GE, 2007, THROMB RES, V119, P217, DOI 10.1016/j.thromres.2005.12.020; Totaro R, 1997, CEPHALALGIA, V17, P191, DOI 10.1046/j.1468-2982.1997.1703191.x; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed	32	170	172	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2008	337	7666							a636	10.1136/bmj.a636	http://dx.doi.org/10.1136/bmj.a636			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18687721	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000258669200024
J	Rosengarten, M; Michael, M; Mykhalovskiy, E; Imrie, J				Rosengarten, Marsha; Michael, Mike; Mykhalovskiy, Eric; Imrie, John			The challenges of technological innovation in HIV	LANCET			English	Editorial Material							PREVENTION		[Rosengarten, Marsha; Michael, Mike] Univ London Goldsmiths Coll, Ctr Study Invent & Social Proc, Dept Sociol, London SE14 6NW, England; [Mykhalovskiy, Eric] York Univ, Dept Sociol, Toronto, ON M3J 2R7, Canada; [Rosengarten, Marsha; Imrie, John] Univ New S Wales, Natl Ctr HIV Social Res, Sydney, NSW, Australia; [Imrie, John] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa	University of London; Goldsmiths University London; York University - Canada; University of New South Wales Sydney; University of Kwazulu Natal	Rosengarten, M (corresponding author), Univ London Goldsmiths Coll, Ctr Study Invent & Social Proc, Dept Sociol, London SE14 6NW, England.	m.rosengarten@gold.ac.uk		rosengarten, marsha/0000-0003-3820-4810				Chesney M, 2003, AIDS PATIENT CARE ST, V17, P169, DOI 10.1089/108729103321619773; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; Kippax S, 2003, SOC SCI MED, V57, P1, DOI 10.1016/S0277-9536(02)00303-9; Law John, 1999, ACTOR NETWORK THEORY; Michael Mike, 2000, RECONNECTING CULTURE; Mol Annemarie, 2003, BODY MULTIPLE ONTOLO; Mykhalovskiy Eric, 2004, SOCIAL THEORY HLTH, V2, P315, DOI DOI 10.1057/PALGRAVE.STH.8700037; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Stekler J, 2007, J INFECT DIS, V196, P336, DOI 10.1086/519173	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 2	2008	372	9636					357	358		10.1016/S0140-6736(08)61140-X	http://dx.doi.org/10.1016/S0140-6736(08)61140-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334AZ	18675674	Green Accepted, Green Submitted			2022-12-28	WOS:000258196000010
J	Llovet, JM; Ricci, S; Mazzaferro, V; Hilgard, P; Gane, E; Blanc, JF; de Oliveira, AC; Santoro, A; Raoul, JL; Forner, A; Schwartz, M; Porta, C; Zeuzem, S; Bolondi, L; Greten, TF; Galle, PR; Seitz, JF; Borbath, I; Haussinger, D; Giannaris, T; Shan, M; Moscovici, M; Voliotis, D; Bruix, J				Llovet, Josep M.; Ricci, Sergio; Mazzaferro, Vincenzo; Hilgard, Philip; Gane, Edward; Blanc, Jean-Frederic; Cosme de Oliveira, Andre; Santoro, Armando; Raoul, Jean-Luc; Forner, Alejandro; Schwartz, Myron; Porta, Camillo; Zeuzem, Stefan; Bolondi, Luigi; Greten, Tim F.; Galle, Peter R.; Seitz, Jean-Francois; Borbath, Ivan; Haussinger, Dieter; Giannaris, Tom; Shan, Minghua; Moscovici, Marius; Voliotis, Dimitris; Bruix, Jordi		SHARP Investigators Study Grp	Sorafenib in advanced hepatocellular carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	43rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	JUN 01-05, 2007	Chicago, IL	Amer Soc Clin Oncol (ASCO)			PHASE-II; RAF/MEK/ERK PATHWAY; MANAGEMENT; ANGIOGENESIS; COMBINATION; BEVACIZUMAB; ACTIVATION; APOPTOSIS; KINASES; TRIALS	Background No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma. Methods In this multicenter, phase 3, double-blind, placebo-controlled trial, we randomly assigned 602 patients with advanced hepatocellular carcinoma who had not received previous systemic treatment to receive either sorafenib (at a dose of 400 mg twice daily) or placebo. Primary outcomes were overall survival and the time to symptomatic progression. Secondary outcomes included the time to radiologic progression and safety. Results At the second planned interim analysis, 321 deaths had occurred, and the study was stopped. Median overall survival was 10.7 months in the sorafenib group and 7.9 months in the placebo group (hazard ratio in the sorafenib group, 0.69; 95% confidence interval, 0.55 to 0.87; P<0.001). There was no significant difference between the two groups in the median time to symptomatic progression (4.1 months vs. 4.9 months, respectively, P=0.77). The median time to radiologic progression was 5.5 months in the sorafenib group and 2.8 months in the placebo group (P<0.001). Seven patients in the sorafenib group (2%) and two patients in the placebo group (1%) had a partial response; no patients had a complete response. Diarrhea, weight loss, hand-foot skin reaction, and hypophosphatemia were more frequent in the sorafenib group. Conclusions In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than for those given placebo.	[Llovet, Josep M.; Forner, Alejandro; Bruix, Jordi] Hosp Clin Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Inst Invest Biomed August Pi & Sunyer,Ctr Invest, E-08036 Barcelona, Spain; [Llovet, Josep M.; Schwartz, Myron] Mt Sinai Sch Med, New York, NY USA; [Ricci, Sergio] St Chiara Univ Hosp, Pisa, Italy; [Mazzaferro, Vincenzo] Natl Canc Inst, I-20133 Milan, Italy; [Hilgard, Philip] Univ Hosp Essen, Essen, Germany; [Gane, Edward] Auckland City Hosp, Auckland, New Zealand; [Blanc, Jean-Frederic] Ctr Hosp Univ Hop St Andre, Bordeaux, France; [Cosme de Oliveira, Andre] Hosp Clin Sao Paulo, Sao Paulo, Brazil; [Santoro, Armando] Inst Clin Humanitas, Milan, Italy; [Raoul, Jean-Luc] European Univ Brittany, Inst Cancerol Rennes, Rennes, France; [Porta, Camillo] IRCCS San Matteo Univ Hosp, Pavia, Italy; [Zeuzem, Stefan] JW Goethe Univ Hosp, Frankfurt, Germany; [Bolondi, Luigi] Univ Bologna, Bologna, Italy; [Greten, Tim F.] Hannover Med Sch, D-30623 Hannover, Germany; [Galle, Peter R.] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Seitz, Jean-Francois] Univ Mediterranee, Hop Enfants La Timone, Marseille, France; [Borbath, Ivan] Clin Univ St Luc, B-1200 Brussels, Belgium; [Haussinger, Dieter] Univ Klinikum Dusseldorf, Dusseldorf, Germany; [Giannaris, Tom] Bayer Healthcare Pharmaceut, Toronto, ON, Canada; [Moscovici, Marius] Bayer Schering Pharma, Milan, Italy	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Duisburg Essen; Auckland City Hospital; CHU Bordeaux; Universidade de Sao Paulo; IRCCS Fondazione San Matteo; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Bologna; Hannover Medical School; Johannes Gutenberg University of Mainz; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Llovet, JM (corresponding author), Hosp Clin Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Inst Invest Biomed August Pi & Sunyer,Ctr Invest, Villarroel 170, E-08036 Barcelona, Spain.	jmllovet@clinic.ub.es; jbruix@clinic.ub.es	Porta, Camillo/AAB-9482-2020; Llovet, Josep M/D-4340-2014; Greten, Tim F/B-3127-2015; Santoro, Armando/J-9594-2018; Llovet, Josep M/ABB-6264-2021; bennouna, jaafar/K-9350-2015; Gridelli, Cesare/K-7909-2016; Mazzaferro, Vincenzo/AAL-4707-2020; Forner, Alejandro/C-8884-2016; Zeuzem, Stefan/AAE-7435-2019; Hug, Balthasar L./G-1568-2010; Mazzaferro, Vincenzo/C-2726-2017; Galle, Peter R/T-5292-2018; Galle, Peter/ABE-2872-2021	Llovet, Josep M/0000-0003-0547-2667; Greten, Tim F/0000-0002-0806-2535; Santoro, Armando/0000-0003-1709-9492; Llovet, Josep M/0000-0003-0547-2667; Forner, Alejandro/0000-0002-9014-4950; Mazzaferro, Vincenzo/0000-0002-4013-8085; Galle, Peter R/0000-0001-8294-0992; Galle, Peter/0000-0001-8294-0992; Borbath, Ivan/0000-0001-7598-214X; FARINATI, FABIO/0000-0002-2944-1374; Van Vlierberghe, Hans/0000-0003-0647-9238; Porta, Camillo/0000-0003-2412-1563; Bennouna, Jaafar/0000-0002-5034-1108; Reeves, Helen/0000-0003-0359-9795; Raoul, Jean-Luc/0000-0001-6305-8953; Bruix, Jordi/0000-0002-9826-0753				Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; CEREZO FJM, 1994, J HEPATOL, V20, P702, DOI 10.1016/S0168-8278(05)80138-2; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; CHILD CG, 1964, LIVER PORTAL HYPERTE, V1, P50; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Escudier B, 2007, NEW ENGL J MED, V357, P203; Faivre SJ, 2007, J CLIN ONCOL, V25; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; LAI CL, 1993, HEPATOLOGY, V17, P389; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lopez PM, 2006, ALIMENT PHARM THER, V23, P1535, DOI 10.1111/j.1365-2036.2006.02932.x; O'Dwyer PJ, 2006, J CLIN ONCOL, V24, p213S; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Philip PA, 2005, J CLIN ONCOL, V23, P6657, DOI 10.1200/JCO.2005.14.696; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Schwartz JD, 2006, J CLIN ONCOL, V24, p213S; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THOMAS MB, 2007, J CLIN ONCOL S, V25, pS214; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wood, 2006, COMMUNITY ONCOL, V3, P558; Yeo W, 2005, JNCI-J NATL CANCER I, V97, P1532, DOI 10.1093/jnci/dji315; Yount S, 2002, J PAIN SYMPTOM MANAG, V24, P32, DOI 10.1016/S0885-3924(02)00422-0; Zhu AX, 2006, J CLIN ONCOL, V24, P1898, DOI 10.1200/JCO.2005.04.9130; ZHU AX, 2007, J CLIN ONCOL S, V25, pS231	35	9146	9588	37	709	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					378	390		10.1056/NEJMoa0708857	http://dx.doi.org/10.1056/NEJMoa0708857			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	329FK	18650514				2022-12-28	WOS:000257852100006
J	Ekstrom, LB; Roelfsema, PR; Arsenault, JT; Bonmassar, G; Vanduffel, W				Ekstrom, Leeland B.; Roelfsema, Pieter R.; Arsenault, John T.; Bonmassar, Giorgio; Vanduffel, Wim			Bottom-up dependent gating of frontal signals in early visual cortex	SCIENCE			English	Article							EYE FIELD; INTRACORTICAL MICROSTIMULATION; ATTENTION INCREASES; SPATIAL ATTENTION; SQUIRREL-MONKEYS; MACAQUE MONKEYS; SINGLE NEURONS; OWL MONKEYS; AREA V4; CONNECTIONS	The frontal eye field (FEF) is one of several cortical regions thought to modulate sensory inputs. Moreover, several hypotheses suggest that the FEF can only modulate early visual areas in the presence of a visual stimulus. To test for bottom-up gating of frontal signals, we microstimulated subregions in the FEF of two monkeys and measured the effects throughout the brain with functional magnetic resonance imaging. The activity of higher-order visual areas was strongly modulated by FEF stimulation, independent of visual stimulation. In contrast, FEF stimulation induced a topographically specific pattern of enhancement and suppression in early visual areas, but only in the presence of a visual stimulus. Modulation strength depended on stimulus contrast and on the presence of distractors. We conclude that bottom-up activation is needed to enable top-down modulation of early visual cortex and that stimulus saliency determines the strength of this modulation.	[Ekstrom, Leeland B.; Arsenault, John T.; Bonmassar, Giorgio; Vanduffel, Wim] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Ekstrom, Leeland B.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Ekstrom, Leeland B.] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Roelfsema, Pieter R.] Royal Netherlands Acad Arts & Sci, Dept Vis & Cognit, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Dept Expt Neurophysiol, Ctr Neurogenom & cognit Res, NL-1081 HV Amsterdam, Netherlands; [Arsenault, John T.; Vanduffel, Wim] Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; [Vanduffel, Wim] Harvard Univ, Sch Med, Dept Radiol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; KU Leuven; Harvard University	Vanduffel, W (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	wim@nmr.mgh.harvard.edu	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034	NCRR NIH HHS [P41RR14075, P41 RR014075-13, P41 RR014075] Funding Source: Medline; NIBIB NIH HHS [R01 EB000790, R01 EB000790-05] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Fukushima K., 1988, IEEE COMPUT, V21, P65; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; van der Velde F, 2001, J COGNITIVE NEUROSCI, V13, P479, DOI 10.1162/08989290152001907; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005	29	246	246	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					414	417		10.1126/science.1153276	http://dx.doi.org/10.1126/science.1153276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635806	Green Accepted			2022-12-28	WOS:000257713900053
J	Hoegh-Guldberg, O; Hughes, L; McIntyre, S; Lindenmayer, DB; Parmesan, C; Possingham, HP; Thomas, CD				Hoegh-Guldberg, O.; Hughes, L.; McIntyre, S.; Lindenmayer, D. B.; Parmesan, C.; Possingham, H. P.; Thomas, C. D.			Assisted colonization and rapid climate change	SCIENCE			English	Editorial Material							EVOLUTIONARY RESPONSES; CORAL-REEFS; CONSEQUENCES; FORESTS; DEBATE; ERA		[Hoegh-Guldberg, O.] Univ Queensland, Ctr Marine Studies, Australian Res Council Ctr Excellence Reef Studie, St Lucia, Qld 4072, Australia; [Hoegh-Guldberg, O.] Univ Queensland, Coral Reef Targeted Res Project, St Lucia, Qld 4072, Australia; [Hughes, L.] Macquarie Univ, Sch Biol Sci, N Ryde, NSW 2109, Australia; [McIntyre, S.] CSIRO Sustainable Ecosyst, Canberra, ACT 2601, Australia; [Lindenmayer, D. B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Parmesan, C.] Univ Texas Austin, Austin, TX 78712 USA; [Possingham, H. P.] Univ Queensland, Ctr Ecol, Ctr Appl Environm Decis Anal, Brisbane, Qld 4072, Australia; [Thomas, C. D.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Queensland; University of Queensland; Macquarie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; University of Texas System; University of Texas Austin; University of Queensland; University of York - UK	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Ctr Marine Studies, Australian Res Council Ctr Excellence Reef Studie, St Lucia, Qld 4072, Australia.	oveh@uq.edu.au; lhughes@rna.bio.mq.edu.au; Sue.McIntyre@csiro.au; david.lindenmayer@anu.edu.au; parmesan@uts.cc.utexas.edu; h.possingham@uq.edu.au; cdt2@york.ac.uk	Thomas, Chris D/A-1460-2014; Thomas, Chris D/A-1894-2012; POSSINGHAM, HUGH/R-8310-2019; Hoegh-Guldberg, Ove/ABA-5420-2020; Hoegh-Guldberg, Ove/H-6169-2011; Parmesan, Camille/GVT-5674-2022; McIntyre, Sue/F-1885-2010; Possingham, Hugh/B-1337-2008; Lindenmayer, David B/P-7183-2017	Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; POSSINGHAM, HUGH/0000-0001-7755-996X; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; McIntyre, Sue/0000-0002-0399-750X; Possingham, Hugh/0000-0001-7755-996X; Lindenmayer, David B/0000-0002-4766-4088; Hughes, Lesley/0000-0003-0313-9780; Parmesan, Camille/0000-0002-1515-274X				Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Blumstein DT, 2002, J BIOGEOGR, V29, P685, DOI 10.1046/j.1365-2699.2002.00717.x; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Kingsolver JG, 2007, J EVOLUTION BIOL, V20, P892, DOI 10.1111/j.1420-9101.2007.01318.x; Manning AD, 2007, CONSERV SCI PRACT, V1, P349; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rosenhead J., 1989, RATIONAL ANAL PROBLE, P193; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464	23	607	624	9	452	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					345	346		10.1126/science.1157897	http://dx.doi.org/10.1126/science.1157897			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635780				2022-12-28	WOS:000257713900025
J	Martinez, JL				Martinez, Jose L.			Antibiotics and antibiotic resistance genes in natural environments	SCIENCE			English	Editorial Material							MULTIDRUG-RESISTANCE; QUINOLONE RESISTANCE; EFFLUX PUMPS; MEXEF-OPRN; OVEREXPRESSION; DISSEMINATION; BACTERIA; AGENTS; SOIL		CSIC, Dept Biotecnol Microbiana, Ctr Nacl Biotecnol, Darwin 3,Campus UAM, E-28049 Madrid, Spain; CIBERESP, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Martinez, JL (corresponding author), CSIC, Dept Biotecnol Microbiana, Ctr Nacl Biotecnol, Darwin 3,Campus UAM, E-28049 Madrid, Spain.	jlmtnez@cnb.csic.es	Martinez, Jose L/C-4100-2008; Martinez, Jose L/A-4725-2013	Martinez, Jose L/0000-0001-8813-7607				Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Demaneche S, 2008, P NATL ACAD SCI USA, V105, P3957, DOI 10.1073/pnas.0800072105; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Franklin K, 2001, ANTIMICROB AGENTS CH, V45, P2238, DOI 10.1128/AAC.45.8.2238-2244.2001; Gerber M, 2008, J MED MICROBIOL, V57, P776, DOI 10.1099/jmm.0.47739-0; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Hernandez A, 1998, APPL ENVIRON MICROB, V64, P4317; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Linares JF, 2005, J BACTERIOL, V187, P1384, DOI 10.1128/JB.187.4.1384-1391.2005; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Macinga David R., 1999, Frontiers in Bioscience, V4, pD132, DOI 10.2741/Macinga; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Smith DL, 2005, PLOS MED, V2, P731, DOI 10.1371/journal.pmed.0020232; Waksman SA, 1940, J BACTERIOL, V40, P581, DOI 10.1128/JB.40.4.581-600.1940	27	1117	1232	45	842	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					365	367		10.1126/science.1159483	http://dx.doi.org/10.1126/science.1159483			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635792				2022-12-28	WOS:000257713900037
J	Allan, RP; Soden, BJ				Allan, Richard P.; Soden, Brian J.			Atmospheric warming and the amplification of precipitation extremes	SCIENCE			English	Article							CLIMATE; MODELS; TRENDS	Climate models suggest that extreme precipitation events will become more common in an anthropogenically warmed climate. However, observational limitations have hindered a direct evaluation of model- projected changes in extreme precipitation. We used satellite observations and model simulations to examine the response of tropical precipitation events to naturally driven changes in surface temperature and atmospheric moisture content. These observations reveal a distinct link between rainfall extremes and temperature, with heavy rain events increasing during warm periods and decreasing during cold periods. Furthermore, the observed amplification of rainfall extremes is found to be larger than that predicted by models, implying that projections of future changes in rainfall extremes in response to anthropogenic global warming may be underestimated.	[Allan, Richard P.] Univ Reading, Environm Syst Sci Ctr, Reading RG6 6AL, Berks, England; [Soden, Brian J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	University of Reading; University of Miami	Allan, RP (corresponding author), Univ Reading, Environm Syst Sci Ctr, Reading RG6 6AL, Berks, England.	r.p.allan@reading.ac.uk	Soden, Brian/ABC-3659-2021; Allan, Richard/B-5782-2008	Allan, Richard/0000-0003-0264-9447; Soden, Brian/0000-0001-9693-8236	UK Natural Environment Research Council [NE/C51785X/1]; National Centre for Earth Observation; National Oceanic and Atmospheric Administration Climate Prediction Office; NASA Energy and Water Cycle Study; Natural Environment Research Council [NE/C51785X/1, earth010002, earth010004] Funding Source: researchfish; NERC [earth010002, earth010004] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Centre for Earth Observation; National Oceanic and Atmospheric Administration Climate Prediction Office(National Oceanic Atmospheric Admin (NOAA) - USA); NASA Energy and Water Cycle Study; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Thanks to the World Climate Research Programme for enabling the Program for Climate Model Diagnosis and Intercomparison model archive (www-pcmdi.llnl.gov). R. A. was supported by the UK Natural Environment Research Council grants NE/C51785X/1 and the National Centre for Earth Observation. B. S. was supported by grants from National Oceanic and Atmospheric Administration Climate Prediction Office and NASA Energy and Water Cycle Study. Global Precipitation Climatology Project (GPCP) data were extracted from www.ncdc.noaa.gov; SSM/I data were provided by Remote Sensing Systems. Comments by K. Hodges and two anonymous reviewers helped to improve the manuscript.	Allan RP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031460; Allan RP, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007304; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Chou C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030327; Chung CE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030491; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Meehl GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023680; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mishchenko MI, 2007, SCIENCE, V315, P1543, DOI 10.1126/science.1136709; Neelin JD, 2006, P NATL ACAD SCI USA, V103, P6110, DOI 10.1073/pnas.0601798103; Pall P, 2007, CLIM DYNAM, V28, P351, DOI 10.1007/S00382-006-0180-2; Ramanathan V, 2007, NATURE, V448, P575, DOI 10.1038/nature06019; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Robertson FR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016416; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Soden BJ, 2005, SCIENCE, V310, P841, DOI 10.1126/science.1115602; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Trenberth KE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030524; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Wilcox EM, 2007, J CLIMATE, V20, P53, DOI 10.1175/JCLI3987.1; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Yang FL, 2003, J CLIMATE, V16, P2419, DOI 10.1175/2779.1; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	27	972	1031	23	444	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1481	1484		10.1126/science.1160787	http://dx.doi.org/10.1126/science.1160787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18687921				2022-12-28	WOS:000259121800038
J	Kanan, MW; Nocera, DG				Kanan, Matthew W.; Nocera, Daniel G.			In situ formation of an oxygen-evolving catalyst in neutral water containing phosphate and Co2+	SCIENCE			English	Article							COUPLED ELECTRON-TRANSFER; PHOTOSYSTEM-II; SOLAR-ENERGY; OXIDATION; ARCHITECTURE; PHOTOSYNTHESIS; MECHANISMS	The utilization of solar energy on a large scale requires its storage. In natural photosynthesis, energy from sunlight is used to rearrange the bonds of water to oxygen and hydrogen equivalents. The realization of artificial systems that perform "water splitting" requires catalysts that produce oxygen from water without the need for excessive driving potentials. Here we report such a catalyst that forms upon the oxidative polarization of an inert indium tin oxide electrode in phosphate- buffered water containing cobalt (II) ions. A variety of analytical techniques indicates the presence of phosphate in an approximate 1: 2 ratio with cobalt in this material. The pH dependence of the catalytic activity also implicates the hydrogen phosphate ion as the proton acceptor in the oxygen- producing reaction. This catalyst not only forms in situ from earth- abundant materials but also operates in neutral water under ambient conditions.	[Kanan, Matthew W.; Nocera, Daniel G.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Nocera, DG (corresponding author), MIT, Dept Chem, 6-335, Cambridge, MA 02139 USA.	nocera@mit.edu			NSF Chemical Bonding Center [CHE- 0802907]; Ruth L. Kirchenstein National Research Service Award; NIH [F32GM07782903]	NSF Chemical Bonding Center(National Science Foundation (NSF)); Ruth L. Kirchenstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NSF Chemical Bonding Center ( CHE- 0802907). M. W. K. is supported by a Ruth L. Kirchenstein National Research Service Award postdoctoral fellowship provided by NIH ( F32GM07782903). We thank E. Shaw for obtaining XPS spectra, G. Henoch for providing the videos in the supporting online material, and Y. Surendranath for many productive discussions.	Barber J, 2007, PHILOS T R SOC A, V365, P1007, DOI 10.1098/rsta.2006.1962; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; Betley TA, 2008, INORG CHEM, V47, P1849, DOI 10.1021/ic701972n; BOCKRIS JO, 1984, J ELECTROCHEM SOC, V131, P290, DOI 10.1149/1.2115565; Bomben K.D., 1992, HDB XRAY PHOTOELECTR; BRUNSCHWIG BS, 1983, J AM CHEM SOC, V105, P4832, DOI 10.1021/ja00352a050; CASEY WH, 1991, J COLLOID INTERF SCI, V146, P586, DOI 10.1016/0021-9797(91)90225-W; Chang CJ, 2004, J AM CHEM SOC, V126, P10013, DOI 10.1021/ja049115j; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Eisenberg R, 2008, INORG CHEM, V47, P1697, DOI 10.1021/ic800155g; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Irebo T, 2007, J AM CHEM SOC, V129, P15462, DOI 10.1021/ja073012u; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; SHAFIROVICH VY, 1980, NOUV J CHIM, V4, P81; Tarasevich M. R., 1980, ELECTRODES CONDUCTIV; Trasatti S., 1994, ELECTROCHEMISTRY NOV; Yagi M, 2005, J PHYS CHEM B, V109, P21489, DOI 10.1021/jp0550208; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186	22	3394	3458	52	2466	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1072	1075		10.1126/science.1162018	http://dx.doi.org/10.1126/science.1162018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18669820				2022-12-28	WOS:000258594900035
J	Neese, B; Chu, BJ; Lu, SG; Wang, Y; Furman, E; Zhang, QM				Neese, Bret; Chu, Baojin; Lu, Sheng-Guo; Wang, Yong; Furman, E.; Zhang, Q. M.			Large electrocaloric effect in ferroelectric polymers near room temperature	SCIENCE			English	Article							DEPENDENCE; THICKNESS; BEHAVIOR	Applying an electrical field to a polar polymer may induce a large change in the dipolar ordering, and if the associated entropy changes are large, they can be explored in cooling applications. With the use of the Maxwell relation between the pyroelectric coefficient and the electrocaloric effect (ECE), it was determined that a large ECE can be realized in the ferroelectric poly(vinylidene fluoride-trifluoroethylene) [P(VDF-TrFE)] copolymer at temperatures above the ferroelectric-paraelectric transition (above 70 degrees C), where an isothermal entropy change of more than 55 joules per kilogram per kelvin degree and adiabatic temperature change of more than 12 degrees C were observed. We further showed that a similar level of ECE near room temperature can be achieved by working with the relaxor ferroelectric polymer of P(VDF-TrFE-chlorofluoroethylene).	[Neese, Bret; Chu, Baojin; Lu, Sheng-Guo; Furman, E.; Zhang, Q. M.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Wang, Yong; Zhang, Q. M.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Neese, Bret; Chu, Baojin] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, QM (corresponding author), Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA.	qxz1@psu.edu	Chu, Baojin/A-7623-2009					ANDERSON RA, 1981, FERROELECTRICS, V33, P91, DOI 10.1080/00150198108008073; ANDERSON RA, 1981, FERROELECTRICS, V32, P13, DOI 10.1080/00150198108238667; BROSSAT T, 1979, CR ACAD SCI B PHYS, V288, P53; Cheng ZY, 2000, IEEE T ULTRASON FERR, V47, P1296, DOI 10.1109/58.883518; Ducharme S, 2000, PHYS REV LETT, V84, P175, DOI 10.1103/PhysRevLett.84.175; FURUKAWA T, 1984, FERROELECTRICS, V57, P63, DOI 10.1080/00150198408012752; Giguere A, 1999, PHYS REV LETT, V83, P2262, DOI 10.1103/PhysRevLett.83.2262; Gschneidner KA, 1999, MATER SCI FORUM, V315-3, P69, DOI 10.4028/www.scientific.net/MSF.315-317.69; HASKEL D, 2007, PHYS REV LETT, V98; JONA F, 1993, FERROELECTRIC CRYSTA, P134; LANG SB, 1976, FERROELECTRICS, V11, P519, DOI 10.1080/00150197608237787; Lines M. E., 1977, PRINCIPLES APPL FERR, P148; Mischenko AS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2405889; Mischenko AS, 2006, SCIENCE, V311, P1270, DOI 10.1126/science.1123811; Nalwa H.S., 1995, FERROELECTRIC POLYM; Pecharsky VK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.197204; Provenzano V, 2004, NATURE, V429, P853, DOI 10.1038/nature02657; Tegus O, 2002, NATURE, V415, P150, DOI 10.1038/415150a; TUTTLE BA, 1981, FERROELECTRICS, V37, P603, DOI 10.1080/00150198108223496; Wada H, 2001, APPL PHYS LETT, V79, P3302, DOI 10.1063/1.1419048; Xia F, 2002, ADV MATER, V14, P1574, DOI 10.1002/1521-4095(20021104)14:21<1574::AID-ADMA1574>3.0.CO;2-#; Xia F, 2001, APPL PHYS LETT, V78, P1122, DOI 10.1063/1.1351848; Zhang QM, 2001, J APPL PHYS, V89, P2613, DOI 10.1063/1.1344585; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; ZHANG QM, 2004, ELECTROACTIVE POLYM, pCH4	25	840	886	34	744	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					821	823		10.1126/science.1159655	http://dx.doi.org/10.1126/science.1159655			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687960				2022-12-28	WOS:000258261000041
J	Evans, CC; Fleming, JD				Evans, Colby C.; Fleming, John D.			Allergic contact dermatitis from a henna tattoo	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Evans, Colby C.; Fleming, John D.] St Johns Inst Dermatol, London SE1 7EH, England	University of London; King's College London	Evans, CC (corresponding author), St Johns Inst Dermatol, London SE1 7EH, England.	colbyevans@hotmail.com							0	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					627	627		10.1056/NEJMicm062327	http://dx.doi.org/10.1056/NEJMicm062327			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687643				2022-12-28	WOS:000258216700010
J	Shcheprova, Z; Baldi, S; Frei, SB; Gonnet, G; Barral, Y				Shcheprova, Zhanna; Baldi, Sandro; Frei, Stephanie Buvelot; Gonnet, Gaston; Barral, Yves			A mechanism for asymmetric segregation of age during yeast budding	NATURE			English	Article							NUCLEAR-PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; GENE DELETION; PROTEIN; LOCALIZATION; DYNAMICS; COMPARTMENTALIZATION; PLASMID; MOTHER	Ageing and the mortality that ensues are sustainable for the species only if age is reset in newborns. In budding yeast, buds are made young whereas ageing factors, such as carbonylated proteins and DNA circles, remain confined to the ageing mother cell. The mechanisms of this confinement and their relevance are poorly understood. Here we show that a septin-dependent, lateral diffusion barrier forms in the nuclear envelope and limits the translocation of pre-existing nuclear pores into the bud. The retention of DNA circles within the mother cell depends on the presence of the diffusion barrier and on the anchorage of the circles to pores mediated by the nuclear basket. In accordance with the diffusion barrier ensuring the asymmetric segregation of nuclear age-determinants, the barrier mutant bud6 Delta fails to properly reset age in buds. Our data involve septin-dependent diffusion barriers in the confinement of ageing factors to one daughter cell during asymmetric cell division.	[Shcheprova, Zhanna; Baldi, Sandro; Frei, Stephanie Buvelot; Barral, Yves] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; [Gonnet, Gaston] ETH, Inst Computat Sci, Dept Comp Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Barral, Y (corresponding author), ETH, Inst Biochem, Dept Biol, Schafmattstr 18, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch		Barral, Yves/0000-0002-0989-3373; Baldi, Sandro/0000-0002-9689-5317				Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; BARTON AA, 1950, J GEN MICROBIOL, V4, P84, DOI 10.1099/00221287-4-1-84; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Belgareh N, 1997, J CELL BIOL, V136, P747, DOI 10.1083/jcb.136.4.747; BREITENBACH M, 2003, TOPICS CURRENT GENET, V3, P61; Bucci M, 1997, J CELL BIOL, V136, P1185, DOI 10.1083/jcb.136.6.1185; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Falcon AA, 2003, J BIOL CHEM, V278, P41607, DOI 10.1074/jbc.M307025200; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gillespie CS, 2004, J THEOR BIOL, V229, P189, DOI 10.1016/j.jtbi.2004.03.015; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Guthrie C, 1991, GUIDE YEAST GENETICS; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Megee PC, 1999, SCIENCE, V285, P254, DOI 10.1126/science.285.5425.254; Mino A, 1998, BIOCHEM BIOPH RES CO, V251, P732, DOI 10.1006/bbrc.1998.9541; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214; Oakes M, 1998, J CELL BIOL, V143, P23, DOI 10.1083/jcb.143.1.23; PELHAM H R B, 1991, Current Opinion in Cell Biology, V3, P585, DOI 10.1016/0955-0674(91)90027-V; Pruyne D, 2000, J CELL SCI, V113, P365; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scott-Drew S, 2002, CELL BIOL INT, V26, P393, DOI 10.1006/cbir.2002.0867; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141	47	238	242	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					728	U64		10.1038/nature07212	http://dx.doi.org/10.1038/nature07212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18660802				2022-12-28	WOS:000258228000037
J	Walensky, RP; Arbelaez, C; Reichmann, WM; Walls, RM; Katz, JN; Block, BL; Dooley, M; Hetland, A; Kimmel, S; Solomon, JD; Losina, E				Walensky, Rochelle P.; Arbelaez, Christian; Reichmann, William M.; Walls, Ron M.; Katz, Jeffrey N.; Block, Brian L.; Dooley, Matthew; Hetland, Adam; Kimmel, Simeon; Solomon, Jessica D.; Losina, Elena			Revising expectations from rapid HIV tests in the emergency department	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASE; PREVENTION GUIDELINES; SEVERITY INDEX; UNITED-STATES; IMPLEMENTATION; OUTCOMES	Background: Expanded HIV screening efforts in the United States have increased the use of rapid HIV tests in emergency departments. The reported sensitivity and specificity of rapid HIV tests exceed 99%. Objective: To assess whether a reactive rapid oral HIV test result correctly identifies adults with HIV infection in the emergency department. Design: Diagnostic test performance assessment within the framework of a randomized, clinical trial. Setting: Brigham and Women's Hospital emergency department (Boston, Massachusetts) from 7 February to 1 October 2007. Patients: 849 adults with valid rapid oral HIV test results. Intervention: Rapid HIV testing with the OraQuick ADVANCE Rapid HIV-1/2 Antibody Test (OraSure Technologies, Bethlehem, Pennsylvania). Patients with reactive rapid test results were offered enzyme-linked immunoassay, Western blot, and plasma HIV-1 RNA testing for confirmation. Measurements: Specificity and positive likelihood ratio. Results: 39 patients had reactive results (4.6% [95% CI, 3.2% to 6.0%]). On confirmation, 5 patients were HIV-infected (prevalence, 0.6% [CI, 0.1% to 1.1%]) and 26 were non-HIV-infected (8 patients declined confirmation). The estimated rapid test specificity was 96.9% (CI, 95.7% to 98.1%). Sensitivity analyses of the true HIV status of unconfirmed cases and test sensitivity resulted in a positive likelihood ratio of 8 to 32. Western blot alone as a confirmation test provided conclusive HIV status in only 50.0% (CI, 30.8% to 69.2%) of patients at first follow-up. The addition of HIV-1 RNA testing to the confirmation protocol improved this rate to 96.2% (CI, 88.8% to 100.0%). Limitation: Test sensitivity cannot be assessed because nonreactive OraQuick test results were not confirmed. Conclusion: Although patients with a reactive oral OraQuick HIV screening test in the emergency department had an 8- to 32-fold increased odds of HIV infection compared with the pretest odds, the specificity of the test was lower than anticipated.	[Walensky, Rochelle P.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02114 USA; Partners AIDS Res, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital	Walensky, RP (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Brigham & Womens Hosp, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	rwalensky@partners.org	Block, Brian/L-4001-2019	Block, Brian/0000-0002-0779-1170; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073445, R01MH065869] Funding Source: NIH RePORTER; NIAMS NIH HHS [K24 AR002123, K24 AR002123-08] Funding Source: Medline; NIMH NIH HHS [R01 MH073445, R01 MH65869, R01 MH065869] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARBELAEZ C, 2007, 38 AM COLL EM PHYS S; BRANSON B, 2006, 13 C RETR OPP INF DE; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; CDC, REV REC HIV TEST AD; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P1287; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Eitel DR, 2003, ACAD EMERG MED, V10, P1070, DOI 10.1197/S1069-6563(03)00350-6; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI 10.1111/j.1553-2712.2007.tb02335.x; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; Kimmel AD, 2005, ANTIVIR THER, V10, P41; LYONS J, 2007, FDA APPROVED RAPID H; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Mehta SD, 2007, ACAD EMERG MED, V14, P250, DOI [10.1197/j.aem.2006.10.106, 10.1111/j.1553-2712.2007.tb01782.x]; *ORASURE TECHN, ORAQUICK ADVANCE RAP; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Rothman RE, 2004, ANN EMERG MED, V44, P31, DOI 10.1016/j.annemergmed.2004.01.016; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Wuerz RC, 2001, ACAD EMERG MED, V8, P170, DOI 10.1111/j.1553-2712.2001.tb01283.x; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x	22	69	69	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					153	160		10.7326/0003-4819-149-3-200808050-00003	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18678842	Green Accepted			2022-12-28	WOS:000258342900001
J	Kerr, T; Montaner, J; Wood, E				Kerr, Thomas; Montaner, Julio; Wood, Evan			Supervised injecting facilities: time for scale-up?	LANCET			English	Editorial Material							HARM REDUCTION		St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Kerr, T (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					Beletsky L, 2008, AM J PUBLIC HEALTH, V98, P231, DOI 10.2105/AJPH.2006.103747; CLEMENT T, 2008, COMMUNICATION   0529; Csete J., 2007, CLOSED REASON INT NA; Expert Advisory Committee on Supervised Injection Site Research, 2008, VANC INS SERV OTH SU; *INT NARC CONTR BO, 2008, REP INT NARC CONTR B; Kimber J, 2003, DRUG ALCOHOL REV, V22, P227, DOI 10.1080/095952301000116951; Lloyd C, 2007, INT J DRUG POLICY, V18, P5, DOI 10.1016/j.drugpo.2006.12.010; *MSIC COMM, 2003, FIN REP SYDN MED SUP; PIPER B, 2007, DRUG POLICY NEW 1107; Scotland's Future Forum, 2008, APPR ALC DRUGS SCOTL; Strathdee SA, 2007, ADDICTION, V102, P848, DOI 10.1111/j.1360-0443.2007.01859.x; UNAIDS, 2005, INT HIV PREV UNAIDS; *WHO, 2005, POL PROGR GUID HIV A; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; 2008, BBC NEWS        0530	15	17	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					354	355		10.1016/S0140-6736(08)61138-1	http://dx.doi.org/10.1016/S0140-6736(08)61138-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334AZ	18675672				2022-12-28	WOS:000258196000008
J	Van Damme, L; Govinden, R; Mirembe, FM; Guedou, F; Solomon, S; Becker, ML; Pradeep, BS; Krishnan, AK; Alary, M; Pande, B; Ramjee, G; Deese, J; Crucitti, T; Taylor, D				Van Damme, Lut; Govinden, Roshini; Mirembe, Florence M.; Guedou, Fernand; Solomon, Suniti; Becker, Marissa L.; Pradeep, B. S.; Krishnan, A. K.; Alary, Michel; Pande, Bina; Ramjee, Gita; Deese, Jennifer; Crucitti, Tania; Taylor, Doug		CS Study Grp	Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-I SAFETY; MALE CIRCUMCISION; ACCEPTABILITY; MICROBICIDE; TOLERANCE; TRIAL; WOMEN; MEN	Background: Women make up more than 50% of adults living with human immunodeficiency virus (HIV) infection or the acquired immunodeficiency syndrome (AIDS) in sub-Saharan Africa. Thus, female-initiated HIV prevention methods are urgently needed. Methods: We performed a randomized, double-blind, placebo-controlled trial of cellulose sulfate, an HIV-entry inhibitor formulated as a vaginal gel, involving women at high risk for HIV infection at three African and two Indian sites. The primary end point was newly acquired infection with HIV type 1 or 2. The secondary end point was newly acquired gonococcal or chlamydial infection. The primary analysis was based on a log-rank test of no difference in the distribution of time to HIV infection, stratified according to site. Results: A total of 1398 women were enrolled and randomly assigned to receive cellulose sulfate gel (706 participants) or placebo (692 participants) and had follow-up HIV test data. There were 41 newly acquired HIV infections, 25 in the cellulose sulfate group and 16 in the placebo group, with an estimated hazard ratio of infection for the cellulose sulfate group of 1.61 (P=0.13). This result, which is not significant, is in contrast to the interim finding that led to the trial being stopped prematurely (hazard ratio, 2.23; P=0.02) and the suggestive result of a preplanned secondary (adherence-based) analysis (hazard ratio, 2.18; P=0.03). No significant effect of cellulose sulfate as compared with placebo was found on the risk of gonorrheal infection (hazard ratio, 1.10; 95% confidence interval [CI], 0.74 to 1.62) or chlamydial infection (hazard ratio, 0.71; 95% CI, 0.47 to 1.08). Conclusions: Cellulose sulfate did not prevent HIV infection and may have increased the risk of HIV acquisition. (ClinicalTrials.gov number, NCT00153777; and Current Controlled Trials number, ISRCTN95638385.).	[Van Damme, Lut] CONRAD, Arlington, VA USA; [Van Damme, Lut; Deese, Jennifer; Taylor, Doug] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Govinden, Roshini; Ramjee, Gita] MRC, HIV Prevent Res Unit, Durban, South Africa; [Mirembe, Florence M.; Pande, Bina] Makerere Univ, Kampala, Uganda; [Guedou, Fernand; Alary, Michel] Univ Quebec, Ctr Hosp Affilie, Quebec City, PQ, Canada; [Solomon, Suniti; Krishnan, A. K.] YR Gaitonde Ctr AIDS Res & Educ YRG CARE, Madras, Tamil Nadu, India; [Becker, Marissa L.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Pradeep, B. S.] St Johns Med Coll, Inst Populat Hlth & Clin Res, Bangalore, Karnataka, India; [Crucitti, Tania] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium	Makerere University; Laval University; University of Quebec; University of Manitoba; St. John's National Academy of Health Sciences; St. John's Medical College; Institute of Tropical Medicine (ITM)	Van Damme, L (corresponding author), FHI, 4401 Wilson Blvd,Suite 700, Arlington, VA 22203 USA.	lvandamme@fhi.org	Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AAH-1902-2021; Govinden, Roshni/ABC-5540-2021; Crucitti, Tania/AEQ-9792-2022	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Mendonca, Kevin/0000-0001-9930-5231; Becker, Marissa/0000-0002-9235-0547; deese, jennifer/0000-0003-1535-1076; Corneli, Amy/0000-0002-4629-4329				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; CELUM C, 2008, 15 C RETR OPP INF BO; *CONRAD, 2007, INV BROCH SOD CELL S; Doh AS, 2007, CONTRACEPTION, V76, P245, DOI 10.1016/j.contraception.2007.05.083; El-Sadr WM, 2006, AIDS, V20, P1109, DOI 10.1097/01.aids.0000226950.72223.5f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; HALPERN V, 2007, LAT BREAK SESS 4 IAS; Institute of Medicine, 2008, METH CHALL BIOM HIV; Jespers V, 2007, SEX TRANSM DIS, V34, P519, DOI 10.1097/01.olq.0000253340.76118.89; JOHANSSON E, 2008, MICR 2008 C DELH IND; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Malonza IM, 2005, AIDS, V19, P2157, DOI 10.1097/01.aids.0000194797.59046.8f; Mauck C, 2001, CONTRACEPTION, V64, P377, DOI 10.1016/S0010-7824(01)00270-0; Mauck C, 2001, CONTRACEPTION, V64, P383, DOI 10.1016/S0010-7824(01)00271-2; Mauck CK, 2008, OBSTET GYNECOL, V111, P739, DOI 10.1097/AOG.0b013e3181644598; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; SAIFUDDIN M, 2008, LAT BREAK SESS MICR; Schwartz JL, 2006, CONTRACEPTION, V74, P133, DOI 10.1016/j.contraception.2006.02.008; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; *UNAIDS, 2007 AIDS EP UPD; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260	27	352	356	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					463	472		10.1056/NEJMoa0707957	http://dx.doi.org/10.1056/NEJMoa0707957			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669425				2022-12-28	WOS:000258039700004
J	Polizzotto, ML; Kocar, BD; Benner, SG; Sampson, M; Fendorf, S				Polizzotto, Matthew L.; Kocar, Benjamin D.; Benner, Shawn G.; Sampson, Michael; Fendorf, Scott			Near-surface wetland sediments as a source of arsenic release to ground water in Asia	NATURE			English	Article							REDUCING BACTERIA; ORGANIC-MATTER; DRINKING-WATER; BANGLADESH; MEKONG; CONTAMINATION; MOBILITY; CAMBODIA; DELTA; EXTRACTION	Tens of millions of people in south and southeast Asia routinely consume ground water that has unsafe arsenic levels(1,2). Arsenic is naturally derived from eroded Himalayan sediments, and is believed to enter solution following reductive release from solid phases under anaerobic conditions. However, the processes governing aqueous concentrations and locations of arsenic release to pore water remain unresolved, limiting our ability to predict arsenic concentrations spatially (between wells) and temporally (future concentrations) and to assess the impact of human activities on the arsenic problem(3-9). This uncertainty is partly attributed to a poor understanding of groundwater flow paths altered by extensive irrigation pumping in the Ganges-Brahmaputra delta(10), where most research has focused. Here, using hydrologic and (bio)geochemical measurements, we show that on the minimally disturbed Mekong delta of Cambodia, arsenic is released from near-surface, river-derived sediments and transported, on a centennial timescale, through the underlying aquifer back to the river. Owing to similarities in geologic deposition, aquifer source rock and regional hydrologic gradients(11-15), our results represent a model for understanding pre-disturbance conditions for other major deltas in Asia. Furthermore, the observation of strong hydrologic influence on arsenic behaviour indicates that release and transport of arsenic are sensitive to continuing and impending anthropogenic disturbances. In particular, groundwater pumping for irrigation, changes in agricultural practices, sediment excavation, levee construction and upstream dam installations will alter the hydraulic regime and/or arsenic source material and, by extension, influence groundwater arsenic concentrations and the future of this health problem.	[Polizzotto, Matthew L.; Kocar, Benjamin D.; Fendorf, Scott] Stanford Univ, Sch Earth & Atmospher Sci, Stanford, CA 94305 USA; [Benner, Shawn G.] Boise State Univ, Dept Geosci, Boise, ID 83705 USA; [Sampson, Michael] Resource Dev Int Cambodia, Phnom Penh, Cambodia	Stanford University; Idaho; Boise State University	Fendorf, S (corresponding author), Stanford Univ, Sch Earth & Atmospher Sci, Stanford, CA 94305 USA.	fendorf@stanford.edu	张, 楠/B-1010-2010; Benner, Shawn/A-2557-2012	Benner, Shawn/0000-0003-4024-5777; Fendorf, Scott/0000-0002-9177-1809				Aggarwal PK, 2003, SCIENCE, V300, p584B, DOI 10.1126/science.1081789; Berg M, 2001, ENVIRON SCI TECHNOL, V35, P2621, DOI 10.1021/es010027y; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Harvey CF, 2006, CHEM GEOL, V228, P112, DOI 10.1016/j.chemgeo.2005.11.025; Harvey CF, 2003, SCIENCE, V300, p584D, DOI 10.1126/science.1082685; Harvey CF, 2002, SCIENCE, V298, P1602, DOI 10.1126/science.1076978; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; *JAP INT COOP AG, 2002, STUD GROUNDW DEV SO; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; McArthur JM, 2004, APPL GEOCHEM, V19, P1255, DOI 10.1016/j.apgeochem.2004.02.001; Nguyen VL, 2000, J ASIAN EARTH SCI, V18, P427; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Pederick RL, 2007, J ENVIRON SCI HEAL A, V42, P1763, DOI 10.1080/10934520701564269; Polizzotto ML, 2005, P NATL ACAD SCI USA, V102, P18819, DOI 10.1073/pnas.0509539103; Polya DA, 2005, MINERAL MAG, V69, P807, DOI 10.1180/0026461056950290; Postma D, 2007, GEOCHIM COSMOCHIM AC, V71, P5054, DOI 10.1016/j.gca.2007.08.020; Rowland HAL, 2007, GEOBIOLOGY, V5, P281, DOI 10.1111/j.1472-4669.2007.00100.x; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; Stanger G, 2005, ENVIRON GEOCHEM HLTH, V27, P341, DOI 10.1007/s10653-005-3991-x; STUTE M, IN PRESS WAT RESOUR; Swartz CH, 2004, GEOCHIM COSMOCHIM AC, V68, P4539, DOI 10.1016/j.gca.2004.04.020; Ta TKO, 2002, QUATERNARY SCI REV, V21, P1807, DOI 10.1016/S0277-3791(02)00007-0; Tamura T, 2007, J ASIAN EARTH SCI, V29, P585, DOI 10.1016/j.jseaes.2006.03.009; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2003, SCIENCE, V300, p584C, DOI 10.1126/science.1081057; Yu WH, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001327	28	438	458	13	441	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					505	U5		10.1038/nature07093	http://dx.doi.org/10.1038/nature07093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650922				2022-12-28	WOS:000257860300048
J	Shoback, D				Shoback, Dolores			Hypoparathyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FAMILIAL ISOLATED HYPOPARATHYROIDISM; CALCIUM-SENSING RECEPTOR; PREPROPARATHYROID HORMONE GENE; TERM-FOLLOW-UP; PARATHYROID-HORMONE; RECESSIVE HYPOPARATHYROIDISM; SYMPTOMATIC HYPOCALCEMIA; TRANSCRIPTION FACTOR; TOTAL THYROIDECTOMY; DIGEORGE-SYNDROME		Univ Calif San Francisco, Dept Vet Affairs Med Ctr, Endocrine Res Unit, San Francisco, CA 94121 USA	University of California System; University of California San Francisco	Shoback, D (corresponding author), Univ Calif San Francisco, Dept Vet Affairs Med Ctr, Endocrine Res Unit, 111N,4150 Clement St, San Francisco, CA 94121 USA.	dolores.shoback@ucsf.edu						Ali A, 2007, HUM MOL GENET, V16, P265, DOI 10.1093/hmg/ddl454; Alimohammadi M, 2008, NEW ENGL J MED, V358, P1018, DOI 10.1056/NEJMoa0706487; Angelopoulos NG, 2006, J BONE MINER METAB, V24, P138, DOI 10.1007/s00774-005-0660-1; Arlt W, 2002, EUR J ENDOCRINOL, V146, P215, DOI 10.1530/eje.0.1460215; ARNOLD A, 1990, J CLIN INVEST, V86, P1084, DOI 10.1172/JCI114811; Asari R, 2008, ARCH SURG-CHICAGO, V143, P132, DOI 10.1001/archsurg.2007.55; Bastepe M, 2008, ADV EXP MED BIOL, V626, P27; Baumber L, 2005, J MED GENET, V42, P443, DOI 10.1136/jmg.2004.026898; Bowl MR, 2005, J CLIN INVEST, V115, P2822, DOI 10.1172/JCI24156; BRICKMAN AS, 2002, MANUAL ENDOCRINOLOGY, P293; Brown EM, 2007, NAT CLIN PRACT ENDOC, V3, P122, DOI 10.1038/ncpendmet0388; CARPENTER TO, 1983, NEW ENGL J MED, V309, P873, DOI 10.1056/NEJM198310133091501; Cassandrini D, 2006, J CHILD NEUROL, V21, P983, DOI 10.1177/08830738060210111001; CHOLST IN, 1984, NEW ENGL J MED, V310, P1221, DOI 10.1056/NEJM198405103101904; Cooper MS, 2008, BRIT MED J, V336, P1298, DOI 10.1136/bmj.39582.589433.BE; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; de Seze S, 1972, Semin Arthritis Rheum, V2, P71, DOI 10.1016/0049-0172(72)90016-9; Ding CL, 2001, J CLIN INVEST, V108, P1215, DOI 10.1172/JCI13180; Dittmar M, 2003, J CLIN ENDOCR METAB, V88, P2983, DOI 10.1210/jc.2002-021845; Egbuna OI, 2008, BEST PRACT RES CL RH, V22, P129, DOI 10.1016/j.berh.2007.11.006; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; GODDARD CJR, 1990, BRIT J HOSP MED, V43, P72; Goldmuntz E, 2005, CLIN PERINATOL, V32, P963, DOI 10.1016/j.clp.2005.09.006; GOLTZMAN D, 2006, PRIMER METABOLIC BON, P216; HALABE A, 1994, CLIN ENDOCRINOL, V40, P303; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Kifor O, 2004, J CLIN ENDOCR METAB, V89, P548, DOI 10.1210/jc.2003-031054; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Koontz SL, 2004, AM J OBSTET GYNECOL, V190, P1773, DOI 10.1016/j.ajog.2004.02.050; Labarthe F, 2006, EUR J PEDIATR, V165, P389, DOI 10.1007/s00431-005-0052-5; LEBOWITZ MR, 1992, SEMIN NEPHROL, V12, P146; Lienhardt A, 2001, J CLIN ENDOCR METAB, V86, P5313, DOI 10.1210/jc.86.11.5313; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Marx SJ, 2001, NEW ENGL J MED, V344, P240; OKANO K, 1982, J CLIN ENDOCR METAB, V55, P238, DOI 10.1210/jcem-55-2-238; Page C, 2007, J LARYNGOL OTOL, V121, P237, DOI 10.1017/S0022215106003501; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; Parvari R, 2007, HORM RES, V67, P12, DOI 10.1159/000095944; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; PORTER RH, 1978, NEW ENGL J MED, V298, P577, DOI 10.1056/NEJM197803162981101; Rude R K, 1997, Curr Ther Endocrinol Metab, V6, P546; SANJAD SA, 1991, ARCH DIS CHILD, V66, P193, DOI 10.1136/adc.66.2.193; Sunthornthepvarakul T, 1999, J CLIN ENDOCR METAB, V84, P3792, DOI 10.1210/jc.84.10.3792; Thakker RV, 2004, REV ENDOCR METAB DIS, V5, P37, DOI 10.1023/B:REMD.0000016123.21743.fe; Thomee C, 2005, J CLIN ENDOCR METAB, V90, P2487, DOI 10.1210/jc.2004-2450; Thomusch O, 2003, SURGERY, V133, P180, DOI 10.1067/msy.2003.61; TOHME JF, 1993, ENDOCRIN METAB CLIN, V22, P363, DOI 10.1016/S0889-8529(18)30171-3; Tong Garrison M, 2005, J Intensive Care Med, V20, P3, DOI 10.1177/0885066604271539; Toumba Meropi, 2007, Pediatr Endocrinol Rev, V5, P642; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Winer KK, 2003, J CLIN ENDOCR METAB, V88, P4214, DOI 10.1210/jc.2002-021736; Winer KK, 1996, JAMA-J AM MED ASSOC, V276, P631, DOI 10.1001/jama.276.8.631; Winslow CP, 1998, AM J OTOLARYNG, V19, P401, DOI 10.1016/S0196-0709(98)90045-X; Yamamoto M, 2000, J CLIN ENDOCR METAB, V85, P4583, DOI 10.1210/jc.85.12.4583; Zarnegar R, 2003, ENDOCRIN METAB CLIN, V32, P483, DOI 10.1016/S0889-8529(03)00009-4; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	57	366	391	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					391	403		10.1056/NEJMcp0803050	http://dx.doi.org/10.1056/NEJMcp0803050			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650515				2022-12-28	WOS:000257852100007
J	McNamee, D; James, A; Kleinert, S				McNamee, David; James, Astrid; Kleinert, Sabine			Protocol review at The Lancet	LANCET			English	Editorial Material									[McNamee, David; James, Astrid; Kleinert, Sabine] The Lancet, London NW1 7BY, England		McNamee, D (corresponding author), The Lancet, London NW1 7BY, England.							Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Carter R, 2004, LANCET, V364, P402, DOI 10.1016/S0140-6736(04)16785-8; De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; Horton R, 1997, LANCET, V349, P6, DOI 10.1016/S0140-6736(05)62158-7; McNamee D, 2001, LANCET, V357, P1819, DOI 10.1016/S0140-6736(00)05011-X	5	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					189	190		10.1016/S0140-6736(08)61053-3	http://dx.doi.org/10.1016/S0140-6736(08)61053-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640443				2022-12-28	WOS:000257763900011
J	McQueen, MJ; Hawken, S; Wang, XY; Ounpuu, S; Sniderman, A; Probstfield, J; Steyn, K; Sanderson, JE; Hasani, M; Volkova, E; Kazmi, K; Yusuf, S				McQueen, Matthew J.; Hawken, Steven; Wang, Xingyu; Ounpuu, Stephanie; Sniderman, Allan; Probstfield, Jeffrey; Steyn, Krisela; Sanderson, John E.; Hasani, Mohammad; Volkova, Emilia; Kazmi, Khawar; Yusuf, Salim		INTERHEART Study Investigators	Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study	LANCET			English	Article							CORONARY-HEART-DISEASE; A-I; CARDIOVASCULAR-DISEASE; HDL-CHOLESTEROL; PREDICTION; RATIO; PREVENTION; PARAMETERS; MANAGEMENT; THERAPY	Background Whether lipoproteins are better markers than lipids and lipoproteins for coronary heart disease is widely debated. our aim was to compare the apolipoproteins and cholesterol as indices for risk of acute myocardial infarction. Methods We did a large, standardised case-control study of acute myocardial infarction in 12461 cases and 14637 age-matched (plus or minus 5 years) and sex-matched controls in 52 countries. Non-fasting blood samples were available from 9345 cases and 12120 controls. Concentrations of plasma lipids, lipoproteins, and apolipoproteins were measured, and cholesterol and apolipoprotein ratios were calculated. Odds ratios (OR) and 95% CI, and population-attributable risks (PARs) were calculated for each measure overall and for each ethnic group by comparison of the top four quintiles with the lowest quintile. Findings The apolipoprotein B100 (ApoB)/apolipoprotein A1 (ApoA1) ratio had the highest PAR (54%) and the highest OR with each 1 SD difference (1.59, 95% CI 1.53-1.64). The PAR for ratio of LDL cholesterol/HDL cholesterol was 37%. PAR for total cholesterol/HDL cholesterol was 32%, which was substantially lower than that of the ApoB/ApoA1 ratio (p<0.0001). These results were consistent in all ethnic groups, men and women, and for all ages. Interpretation The non-fasting ApoB/ApoA1 ratio was superior to any of the cholesterol ratios for estimation of the risk of acute myocardial infarction in all ethnic groups, in both sexes, and at all ages, and it should be introduced into worldwide clinical practice.	[McQueen, Matthew J.; Ounpuu, Stephanie; Yusuf, Salim] Populat Hlth Res Inst, Hamilton, ON, Canada; [McQueen, Matthew J.; Ounpuu, Stephanie; Yusuf, Salim] McMaster Univ, Hamilton, ON, Canada; [Hawken, Steven] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Wang, Xingyu] Beijing Hypertens League Inst, Beijing, Peoples R China; [Sniderman, Allan] McGill Univ, Montreal, PQ, Canada; [Probstfield, Jeffrey] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Steyn, Krisela] MRC, Cape Town, South Africa; [Steyn, Krisela] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Sanderson, John E.] Univ Birmingham, The Medical School, Birmingham, W Midlands, England; [Hasani, Mohammad] Islamic Azad Univ, Tehran, Iran; [Volkova, Emilia] Ural State Med Acad, Chelyabinsk, Russia; [Kazmi, Khawar] Aga Khan Univ Hosp, Karachi, Pakistan	Population Health Research Institute; McMaster University; University of Ottawa; Chinese Hypertension League; McGill University; University of Washington; University of Washington Seattle; University of Cape Town; University of Birmingham; Islamic Azad University; South Ural State Medical University; Ural State Medical University; Aga Khan University	McQueen, MJ (corresponding author), Hamilton Gen Hosp, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	mcquemat@hhsc.ca		Yusuf, Salim/0000-0003-4776-5601; Hawken, Steven/0000-0002-3341-9022; Varigos, John/0000-0001-6722-3135; Sanderson, John/0000-0002-4407-0487				Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Chien KL, 2007, J LIPID RES, V48, P2499, DOI 10.1194/jlr.M700213-JLR200; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Genest J, 2003, CAN MED ASSOC J, V169, P921; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; *LIPID STUD GROUP, 1998, NEW ENGL J MED, P1349; Lu WQ, 2003, DIABETES CARE, V26, P16, DOI 10.2337/diacare.26.1.16; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Ounpuu S, 2001, AM HEART J, V141, P711, DOI 10.1067/mhj.2001.114974; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Tremblay AJ, 2007, CLIN BIOCHEM, V40, P25, DOI 10.1016/j.clinbiochem.2006.06.014; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Walldius G, 2004, CLIN CHEM LAB MED, V42, P1355, DOI 10.1515/CCLM.2004.254; Wilhelmsen L, 1997, EUR HEART J, V18, P572; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	23	576	605	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					224	233		10.1016/S0140-6736(08)61076-4	http://dx.doi.org/10.1016/S0140-6736(08)61076-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640459				2022-12-28	WOS:000257763900032
J	Lee, C; Wei, XD; Kysar, JW; Hone, J				Lee, Changgu; Wei, Xiaoding; Kysar, Jeffrey W.; Hone, James			Measurement of the elastic properties and intrinsic strength of monolayer graphene	SCIENCE			English	Article							CARBON NANOTUBES; MODULUS	We measured the elastic properties and intrinsic breaking strength of free-standing monolayer graphene membranes by nanoindentation in an atomic force microscope. The force-displacement behavior is interpreted within a framework of nonlinear elastic stress-strain response, and yields second- and third-order elastic stiffnesses of 340 newtons per meter (N m(-1)) and -690 N m(-1), respectively. The breaking strength is 42 N m(-1) and represents the intrinsic strength of a defect-free sheet. These quantities correspond to a Young's modulus of E = 1.0 terapascals, third-order elastic stiffness of D = -2.0 terapascals, and intrinsic strength of sigma(int) = 130 gigapascals for bulk graphite. These experiments establish graphene as the strongest material ever measured, and show that atomically perfect nanoscale materials can be mechanically tested to deformations well beyond the linear regime.	[Lee, Changgu; Wei, Xiaoding; Kysar, Jeffrey W.; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Lee, Changgu; Hone, James] Columbia Univ, Def Adv Res Projects Agcy Ctr Integrated Micro Na, New York, NY 10027 USA; [Kysar, Jeffrey W.] Columbia Univ, Ctr Nanostruct Mat, New York, NY 10027 USA; [Hone, James] Columbia Univ, Ctr Elect Transport Mol Nanostruct, New York, NY 10027 USA	Columbia University; Columbia University; United States Department of Defense; Defense Advanced Research Projects Agency (DARPA); Columbia University; Columbia University	Hone, J (corresponding author), Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.	jh2228@columbia.edu	Wei, Xiaoding/A-9952-2011; Hone, James C/E-1879-2011	Wei, Xiaoding/0000-0002-5173-4923; Hone, James C/0000-0002-8084-3301				ALJISHI R, 1982, PHYS REV B, V26, P4514, DOI 10.1103/PhysRevB.26.4514; Bhatia NM, 1968, INT J NONLIN MECH, V3, P307, DOI [DOI 10.1016/0020-7462(68)90004-8, 10.1016/0020-7462(68)90004-8]; BLAKSLEE OL, 1970, J APPL PHYS, V41, P3373, DOI 10.1063/1.1659428; Demczyk BG, 2002, MAT SCI ENG A-STRUCT, V334, P173, DOI 10.1016/S0921-5093(01)01807-X; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Frank IW, 2007, J VAC SCI TECHNOL B, V25, P2558, DOI 10.1116/1.2789446; Griffith A.A., 1921, PHILOS T R SOC A, V221, P163, DOI 10.1098/rsta.1921.0006; Huang Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245413; Khare R, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.075412; Komaragiri U, 2005, J APPL MECH-T ASME, V72, P203, DOI 10.1115/1.1827246; Krishnan A., 1998, Physical Review B (Condensed Matter), V58, P14013, DOI 10.1103/PhysRevB.58.14013; Lawn P.R, 1993, CAMBRIDGE SOLID STAT, Vsecond; Liu F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064120; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Nye JF, 1985, PHYS PROPERTIES CRYS; Poot M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857472; Salvetat JP, 1999, PHYS REV LETT, V82, P944, DOI 10.1103/PhysRevLett.82.944; Stolyarova E, 2007, P NATL ACAD SCI USA, V104, P9209, DOI 10.1073/pnas.0703337104; THURSTON RN, 1964, PHYS REV, V133, P1604; Tombler TW, 2000, NATURE, V405, P769, DOI 10.1038/35015519; Wan KT, 2003, THIN SOLID FILMS, V425, P150, DOI 10.1016/S0040-6090(02)01103-3; Xie SS, 2000, J PHYS CHEM SOLIDS, V61, P1153, DOI 10.1016/S0022-3697(99)00376-5; Yakobson BI, 1996, PHYS REV LETT, V76, P2511, DOI 10.1103/PhysRevLett.76.2511; Yakobson BI, 2001, TOP APPL PHYS, V80, P287; Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552; Zhao QZ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144105	26	15264	16064	329	9096	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					385	388		10.1126/science.1157996	http://dx.doi.org/10.1126/science.1157996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635798				2022-12-28	WOS:000257713900044
J	Moster, D; Lie, RT; Markestad, T				Moster, Dag; Lie, Rolv Terje; Markestad, Trond			Long-term medical and social consequences of preterm birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-ADULTS BORN; QUALITY-OF-LIFE; SCHOOL-AGED CHILDREN; WEIGHT INFANTS; BEHAVIORAL OUTCOMES; CEREBRAL-PALSY; PREVALENCE; RISK; ASSOCIATION; DISORDERS	Background: Advances in perinatal care have increased the number of premature babies who survive. There are concerns, however, about the ability of these children to cope with the demands of adulthood. Methods: We linked compulsory national registries in Norway to identify children of different gestational-age categories who were born between 1967 and 1983 and to follow them through 2003 in order to document medical disabilities and outcomes reflecting social performance. Results: The study included 903,402 infants who were born alive and without congenital anomalies (1822 born at 23 to 27 weeks of gestation, 2805 at 28 to 30 weeks, 7424 at 31 to 33 weeks, 32,945 at 34 to 36 weeks, and 858,406 at 37 weeks or later). The proportions of infants who survived and were followed to adult life were 17.8%, 57.3%, 85.7%, 94.6%, and 96.5%, respectively. Among the survivors, the prevalence of having cerebral palsy was 0.1% for those born at term versus 9.1% for those born at 23 to 27 weeks of gestation (relative risk for birth at 23 to 27 weeks of gestation, 78.9; 95% confidence interval [CI], 56.5 to 110.0); the prevalence of having mental retardation, 0.4% versus 4.4% (relative risk, 10.3; 95% CI, 6.2 to 17.2); and the prevalence of receiving a disability pension, 1.7% versus 10.6% (relative risk, 7.5; 95% CI, 5.5 to 10.0). Among those who did not have medical disabilities, the gestational age at birth was associated with the education level attained, income, receipt of Social Security benefits, and the establishment of a family, but not with rates of unemployment or criminal activity. Conclusions: In this cohort of people in Norway who were born between 1967 and 1983, the risks of medical and social disabilities in adulthood increased with decreasing gestational age at birth.	[Moster, Dag; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Markestad, Trond] Univ Bergen, Sect Pediat, Dept Clin Med, N-5020 Bergen, Norway; [Moster, Dag; Markestad, Trond] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Lie, Rolv Terje] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH)	Moster, D (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, POB 7804, N-5020 Bergen, Norway.	dag.moster@smis.uib.no	Fahimifar, Sepideh/M-5303-2019					Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Allin M, 2006, J NEUROL NEUROSUR PS, V77, P495, DOI 10.1136/jnnp.2005.075465; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bjerager M, 1995, ACTA PAEDIATR, V84, P1339, DOI 10.1111/j.1651-2227.1995.tb13565.x; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; Dinesen SJ, 2001, ARCH DIS CHILD-FETAL, V85, pF165, DOI 10.1136/fn.85.3.F165; Elgen I, 2002, ARCH DIS CHILD-FETAL, V87, pF128, DOI 10.1136/fn.87.2.F128; Ericson A, 1998, ARCH DIS CHILD-FETAL, V78, pF171, DOI 10.1136/fn.78.3.F171; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; HACK M, 1992, J DEV BEHAV PEDIATR, V13, P412; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hille ETM, 2001, LANCET, V357, P1641, DOI 10.1016/S0140-6736(00)04818-2; HUNT JV, 1988, PEDIATRICS, V82, P596; Indredavik MS, 2004, ARCH DIS CHILD-FETAL, V89, pF445, DOI 10.1136/adc.2003.038943; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; LEE J, 1994, INT J EPIDEMIOL, V23, P201, DOI 10.1093/ije/23.1.201; Lefebvre F, 2005, ACTA PAEDIATR, V94, P733, DOI 10.1080/08035250510025987; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Lindstrom K, 2007, PEDIATRICS, V120, P936, DOI 10.1542/peds.2007-2439; Lindstrom K, 2007, PEDIATRICS, V120, P70, DOI 10.1542/peds.2006-3260; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; *MIN JUST POL, 2003, KRIM PERS POL PAT BE; *MIN LAB SOC INCL, 2008, FIN SOC ASS; *MIN LAB SOC INCL, 2008, NORW SOC INS SCHEM; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; *STAT NORW, 2007, STAT NORW I COUNTS; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Wilson-Costello D, 2007, SEMIN FETAL NEONAT M, V12, P344, DOI 10.1016/j.siny.2007.06.010; Wilson-Costello D, 2007, PEDIATRICS, V119, P37, DOI 10.1542/peds.2006-1416; World Health Organisation, 2008, INT CLASS DIS ICD	40	876	913	1	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					262	273		10.1056/NEJMoa0706475	http://dx.doi.org/10.1056/NEJMoa0706475			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KD	18635431	Bronze			2022-12-28	WOS:000257656600006
J	Rhodes, T; Simic, M; Baros, S; Platt, L; Zikic, B				Rhodes, Tim; Simic, Milena; Baros, Sladjana; Platt, Lucy; Zikic, Bojan			Police violence and sexual risk among female and transvestite sex workers in Serbia: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIV RISK; FUTURE-RESEARCH; DRUG-USERS; CONDOM USE; HEALTH; WOMEN; POWER; REDUCTION; MORTALITY; SURVIVAL	Objective To explore female and transvestite sex workers' perceptions of risk in the sex work environment in Serbia. Design Qualitative interview study. Setting Street based locations for sex work in Belgrade and Pancevo, Serbia. Participants 31 female and transvestite sex workers. Results Violence, including police violence, was reported as a primary concern in relation to risk. Violence was linked to unprotected sex and the reduced capacity for avoiding sexual risk. Participants reported that coerced sex was routinely provided to the police in exchange for freedom from detainment, arrest, or fine, and was enforced by the perceived threat of violence, sometimes realised. Accounts contained multiple instances of physical and sexual assault, presented as abuses of police authority, and described policing as a form of moral punishment. This was largely through non-physicalt means but was also enforced through physical violence, especially towards transvestite and Roma sex workers, whose experience of police violence was reported as relentless and brutal and connected with broader social forces of discrimination in this setting, especially towards Roma. Conclusion Preventing violence towards sex workers, which can link with vulnerability to sexually transmitted infections, is a priority in Serbia. This requires monitoring perpetrators of violence, providing legal support to sex workers, and creating safer environments for sex work.	[Rhodes, Tim; Simic, Milena; Platt, Lucy] Univ London London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 7HT, England; [Baros, Sladjana; Zikic, Bojan] Univ Belgrade, Dept Ethnol & Anthropol, Belgrade, Serbia	University of London; London School of Hygiene & Tropical Medicine; University of Belgrade	Rhodes, T (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, Keppel St, London WC1E 7HT, England.	tim.rhodes@lshtm.ac.uk	Rhodes, Tim/DNJ-9679-2022	Platt, Lucy/0000-0002-0943-0045; Rhodes, Tim/0000-0003-2400-9838	Department for International Development (UK); The Department of Health (UK)	Department for International Development (UK); The Department of Health (UK)	Department for International Development (UK). The Department of Health (UK) provide core funding to the Centre for Research on Drugs and Health Behaviour at the London School of Hygiene and Tropical Medicine, UK. All authors declare independence from these funding agencies.	BARNARD MA, 2003, SOCIOL HLTH ILLN, V15, P683; Blanchard JF, 2005, J INFECT DIS, V191, pS139, DOI 10.1086/425273; Blankenship KM, 2002, J LAW MED ETHICS, V30, P548, DOI 10.1111/j.1748-720X.2002.tb00425.x; Bogdanovic D, 2007, CROAT MED J, V48, P720; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; Choi SYP, 2008, SEX TRANSM DIS, V35, P141, DOI 10.1097/OLQ.0b013e31815407c3; Choi SYP, 2007, CULT HEALTH SEX, V9, P489, DOI 10.1080/13691050701220446; Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; Cohan D, 2006, SEX TRANSM INFECT, V82, P418, DOI 10.1136/sti.2006.020628; Cooper H, 2004, AM J PUBLIC HEALTH, V94, P1109, DOI 10.2105/AJPH.94.7.1109; DJENOVIC D, 2007, SERBIA VIOLENCE CONT; DJILAS A, 1993, FOREIGN AFF, V72, P81, DOI 10.2307/20045624; Epele ME, 2002, CULT MED PSYCHIAT, V26, P33, DOI 10.1023/A:1015237130328; GOODYEAR MDE, 2007, PROTECTION SEX WORKE, V334, P52; GORDY E, 1999, CULTURE POWER NATL D; *HUM RIGHTS WATCH, 2000, SERB VIOL STUD ESC; Jackson L. A., 2007, Critical Public Health, V17, P257, DOI 10.1080/09581590701549535; Jacobs D, 1998, AM J SOCIOL, V103, P837, DOI 10.1086/231291; Jayasree AK, 2004, REPROD HEALTH MATTER, V12, P58, DOI 10.1016/S0968-8080(04)23111-1; Kabakchieva E, 2002, INT J STD AIDS, V13, P184, DOI 10.1258/0956462021924893; Lersch KM, 2005, AGGRESS VIOLENT BEH, V10, P552, DOI 10.1016/j.avb.2004.10.002; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Miles M., 2013, QUALITATIVE DATA ANA; Miller CL, 2008, INT J DRUG POLICY, V19, P324, DOI 10.1016/j.drugpo.2007.06.002; NIKOLICRASTANOV.V, 2000, WOMEN VIOLENCE WAR W; Olujic MB, 1998, MED ANTHROPOL Q, V12, P31, DOI 10.1525/maq.1998.12.1.31; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Potterat JJ, 2004, AM J EPIDEMIOL, V159, P778, DOI 10.1093/aje/kwh110; Ravi A, 2007, WOMEN HEALTH ISS, V17, P210, DOI 10.1016/j.whi.2007.02.009; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T, 2006, J URBAN HEALTH, V83, P911, DOI 10.1007/s11524-006-9085-y; Sanders T, 2004, URBAN STUD, V41, P1703, DOI 10.1080/0042098042000243110; Sanders T, 2004, SOCIOL HEALTH ILL, V26, P557, DOI 10.1111/j.0141-9889.2004.00405.x; Sanders T, 2007, BRIT J SOCIOL, V58, P1, DOI 10.1111/j.1468-4446.2007.00136.x; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Silverman D., 2017, DOING QUALITATIVE RE, V5th; SKOLNICK JH, 1996, LAW POLICE EXCESSIVE; Werb D, 2008, INT J DRUG POLICY, V19, P332, DOI 10.1016/j.drugpo.2007.08.004; Westmarland L, 2001, BRIT J CRIMINOL, V41, P523, DOI 10.1093/bjc/41.3.523; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; *WORLD BANK, 2000, ROM TRANS CENTR E EU; World Health Organization, 2007, 3 MIL GLOB CAMP VIOL	45	110	112	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2008	337	7669							a811	10.1136/bmj.a811	http://dx.doi.org/10.1136/bmj.a811			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	351JP	18667468	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000259420900035
J	Selbach, M; Schwanhausser, B; Thierfelder, N; Fang, Z; Khanin, R; Rajewsky, N				Selbach, Matthias; Schwanhaeusser, Bjoern; Thierfelder, Nadine; Fang, Zhuo; Khanin, Raya; Rajewsky, Nikolaus			Widespread changes in protein synthesis induced by microRNAs	NATURE			English	Article							MASS-SPECTROMETRY; AMINO-ACIDS; RNA; IDENTIFICATION; TARGETS; DETERMINANTS; DEGRADATION; REPRESSION; PROTEOMICS; TURNOVER	Animal microRNAs ( miRNAs) regulate gene expression by inhibiting translation and/ or by inducing degradation of target messenger RNAs. It is unknown how much translational control is exerted by miRNAs on a genome- wide scale. We used a new proteomic approach to measure changes in synthesis of several thousand proteins in response to miRNA transfection or endogenous miRNA knockdown. In parallel, we quantified mRNA levels using microarrays. Here we show that a single miRNA can repress the production of hundreds of proteins, but that this repression is typically relatively mild. A number of known features of the miRNA- binding site such as the seed sequence also govern repression of human protein synthesis, and we report additional target sequence characteristics. We demonstrate that, in addition to downregulating mRNA levels, miRNAs also directly repress translation of hundreds of genes. Finally, our data suggest that a miRNA can, by direct or indirect effects, tune protein synthesis from thousands of genes.	[Selbach, Matthias; Schwanhaeusser, Bjoern; Thierfelder, Nadine; Fang, Zhuo; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Khanin, Raya] Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Glasgow	Selbach, M (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	matthias.selbach@mdc-berlin.de; rajewsky@mdc-berlin.de	Selbach, Matthias/C-5988-2008	Rajewsky, Nikolaus/0000-0002-4785-4332	DAAD scholarship	DAAD scholarship(Deutscher Akademischer Austausch Dienst (DAAD))	We thank J. Cox and M. Mann for early access to the MaxQuant software package, N. D. Socci for discussions, S. Schmidt, G. Born and N. Huebner for the hybridizations at the MDC microarray facility, C. Sommer for technical assistance, M. Huska and M. Andrade-Navarro for setting up the pSILAC website, P. Sharp for a CXCR4 luciferase construct, M. Peter for the IMP-1 reporters, and the Bundesministerium fur Bildung und Forschung for funding mass spectrometry instrumentation. R. K. gratefully acknowledges a DAAD scholarship for research stays at the MDC. pSILAC and microarray data can be queried at http://psilac.mdc-berlin.de.	Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; HE L, 2004, NAT REV GENET, V5, P522; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hofacker IL, 2007, NAT GENET, V39, P1191, DOI 10.1038/ng1007-1191; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; SCHWANHAEUSSER B, IN PRESS PROTEOMICS; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707	49	2657	2758	6	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					58	63		10.1038/nature07228	http://dx.doi.org/10.1038/nature07228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668040				2022-12-28	WOS:000258890200036
J	Vickers, AJ; Basch, E; Kattan, MW				Vickers, Andrew J.; Basch, Ethan; Kattan, Michael W.			Against diagnosis	ANNALS OF INTERNAL MEDICINE			English	Article							PLASMINOGEN-ACTIVATOR; CANCER; BENEFIT; BREAST	The act of diagnosis requires that patients be placed in a binary category of either having or not having a certain disease. Accordingly, the diseases of particular concern for industrialized countries-such as type 2 diabetes, obesity, or depression-require that a somewhat arbitrary cut-point be chosen on a continuous scale of measurement (for example, a fasting glucose level >6.9 mmol/L [>125 mg/dL] for type 2 diabetes). These cut-points do not adequately reflect disease biology, may inappropriately treat patients on either side of the cut-point as 2 homogenous risk groups, fail to incorporate other risk factors, and are invariable to patient preference. This article discusses risk prediction as an alternative to diagnosis: Patient risk factors (blood pressure, age) are combined into a single statistical model (risk for a cardiovascular event within 10 years) and the results are used in shared decision making about possible treatments. The authors compare and contrast the diagnostic and risk prediction approaches and attempt to identify the types of medical problem to which each is best suited.	[Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Cleveland Clin, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cleveland Clinic Foundation	Vickers, AJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	vickersa@mskcc.org	Kattan, Michael/AAF-9735-2021	Kattan, Michael/0000-0002-3840-4161; Vickers, Andrew/0000-0003-1525-6503	NCI NIH HHS [P50 CA092629, P50 CA092629-08, P50-CA92629] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA092629] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Elston CW, 2000, EUR J CANCER, V36, P1769, DOI 10.1016/S0959-8049(00)00181-7; Greenstone CL, 2007, NEW ENGL J MED, V356, P2407, DOI 10.1056/NEJMcps062271; GROOPMAN J, 2007, NY TIMES        0707; Haas GP, 2007, JNCI-J NATL CANCER I, V99, P1484, DOI 10.1093/jnci/djm153; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kent DM, 2003, STROKE, V34, P464, DOI 10.1161/01.STR.0000051506.43212.8B; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; Marchionni L, 2008, ANN INTERN MED, V148, P358, DOI 10.7326/0003-4819-148-5-200803040-00208; Vickers AJ, 2008, CANCER, V112, P1862, DOI 10.1002/cncr.23365	10	56	56	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					200	203		10.7326/0003-4819-149-3-200808050-00010	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18678847	Green Accepted			2022-12-28	WOS:000258342900007
J	Emery, P; Breedveld, FC; Hall, S; Durez, P; Chang, DJ; Robertson, D; Singh, A; Pedersen, RD; Koenig, AS; Freundlich, B				Emery, Paul; Breedveld, Ferdinand C.; Hall, Stephen; Durez, Patrick; Chang, David J.; Robertson, Deborah; Singh, Amitabh; Pedersen, Ronald D.; Koenig, Andrew S.; Freundlich, Bruce			Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; DISEASE-ACTIVITY; WORK DISABILITY; CLINICAL-TRIAL; FOLLOW-UP; RADIOGRAPHIC PROGRESSION; REMISSION; THERAPY; SULFASALAZINE; HYDROXYCHLOROQUINE	Background Remission and radiographic non-progression are goals in the treatment of early rheumatoid arthritis. The aim of the combination of methotrexate and etanercept in active early rheumatoid arthritis (COMET) trial is to compare remission and radiographic non-progression in patients treated with methotrexate monotherapy or with methotrexate plus etanercept. Methods 542 outpatients who were methotrexate-naive and had had early moderate-to-severe rheumatoid arthritis for 3-24 months were randomly assigned to receive either methotrexate alone titrated up from 7.5 mg a week to a maximum of 20 mg a week by week 8 or methotrexate (same titration) plus etanercept 50 mg a week. Coprimary endpoints at 52 weeks were remission measured with the disease activity score in 28 joints (DAS28) and radiographic non-progression measured with modified total Sharp score. Treatment was allocated with a computerised randomisation and enrolment system, which masked both participants and carers. Analysis was done by modified intention to treat with last observation carried forward for missing data. This study is registered with ClinicalTrials. gov, number NCT00195494). Findings 274 participants were randomly assigned to receive combined treatment and 268 methotrexate alone. 132 of 265 (50%, 95% Cl 44-56%) patients who took combined treatment and were available for assessment achieved clinical remission compared with 73 of 263 (28%, 23-33%) taking methotrexate alone (effect difference 22.05%, 95%Cl 13.96-30.15%, p<0.0001). 487 evaluable patients had severe disease (DAS28>5.1). 196 of 246 (80%, 75-85%) and 135 of 230 (59%, 53-65%), respectively, achieved radiographic non-progression (20.98%, 12.97-29.09%, p<0.0001). Serious adverse events were similar between groups. Interpretation Both clinical remission and radiographic non-progression are achievable goals in patients with early severe rheumatoid arthritis within 1 year of combined treatment with etanercept plus methotrexate. Funding Wyeth Research.	[Emery, Paul] Univ Leeds, Leeds Teaching Hosp Trust, Chapel Allerton Hosp, Leeds Inst Mol Med, Leeds LS7 4SA, W Yorkshire, England; [Breedveld, Ferdinand C.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Hall, Stephen] Cabrini Hlth Hosp, Malvern, Vic, Australia; [Durez, Patrick] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium; [Chang, David J.] GlasoSmithKline, Global Clin Dev, King Of Prussia, PA USA; [Robertson, Deborah; Singh, Amitabh; Pedersen, Ronald D.; Koenig, Andrew S.; Freundlich, Bruce] Wyeth Res, Collegeville, PA USA	Chapel Allerton Hospital; University of Leeds; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Cabrini Health; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; GlaxoSmithKline; Pfizer	Emery, P (corresponding author), Univ Leeds, Leeds Teaching Hosp Trust, Chapel Allerton Hosp, Leeds Inst Mol Med, Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England.	p.emery@leeds.ac.uk	emery, paul/B-3560-2013	durez, patrick/0000-0002-7156-2356	Arthritis Research UK [18475] Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		Allaire S, 2005, ARTHRIT RHEUM-ARTHR, V53, P603, DOI 10.1002/art.21326; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Bruce B, 2003, J RHEUMATOL, V30, P167; Bruce Bonnie, 2003, Health Qual Life Outcomes, V1, P20, DOI 10.1186/1477-7525-1-20; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Combe B, 2007, BEST PRACT RES CL RH, V21, P27, DOI 10.1016/j.berh.2006.08.011; Dougados M, 1999, ANN RHEUM DIS, V58, P220, DOI 10.1136/ard.58.4.220; EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944; Genovese MC, 2005, J RHEUMATOL, V32, P1232; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; HUBERT HB, 1993, J RHEUMATOL, V20, P480; Kirwan JR, 1999, J RHEUMATOL, V26, P720; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Merkesdal S, 2005, ARTHRIT RHEUM-ARTHR, V53, P234, DOI 10.1002/art.21080; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Prevoo MLL, 1996, BRIT J RHEUMATOL, V35, P1101; Puolakka K, 2004, ARTHRITIS RHEUM, V50, P55, DOI 10.1002/art.11436; Sokka T, 2006, CLIN EXP RHEUMATOL, V24, pS74; Sokka T, 2003, ARTHRITIS RHEUM, V48, P59, DOI 10.1002/art.10731; Symmons D, 2006, RHEUMATOLOGY, V45, P558, DOI 10.1093/rheumatology/kei169; van der Bijl AE, 2007, ARTHRITIS RHEUM-US, V56, P2129, DOI 10.1002/art.22718; van der Heijde D, 2007, ARTHRITIS RHEUM, V56, P3928, DOI 10.1002/art.23141; van der Heijde D, 2008, ANN RHEUM DIS, V67, P182, DOI 10.1136/ard.2007.076166; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P49, DOI 10.1002/art.20775; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van der Heijde D, 2001, ANN RHEUM DIS, V60, pIII47; van der Heijde D, 2000, J RHEUMATOL, V27, P261; VANDERHEIJDE D, 2007, ARTHRITIS RHEUM S9, V56, pS151; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; VANDERHEIJDE DMFM, 1992, ARTHRITIS RHEUM-US, V35, P26; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177; Verstappen SMM, 2004, ARTHRIT RHEUM-ARTHR, V51, P488, DOI 10.1002/art.20419; WOLFE F, 1985, J RHEUMATOL, V12, P245	39	607	649	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					375	382		10.1016/S0140-6736(08)61000-4	http://dx.doi.org/10.1016/S0140-6736(08)61000-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18635256				2022-12-28	WOS:000258196000028
J	Friedman, SD				Friedman, Seth D.			Comment on "magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain"	SCIENCE			English	Editorial Material									Univ Washington, Dept Radiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Friedman, SD (corresponding author), Univ Washington, Dept Radiol, 1959 NE Pacific St, Seattle, WA 98195 USA.	sethf@u.washington.edu		friedman, seth/0000-0001-8785-7215	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH069848] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH069848, K01 MH069848-05] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffin JL, 2002, NMR BIOMED, V15, P375, DOI 10.1002/nbm.792; Hofmann L, 2001, MAGNET RESON MED, V46, P855, DOI 10.1002/mrm.1269; Hull WE, 1999, MAGNET RESON MED, V42, P984, DOI 10.1002/(SICI)1522-2594(199911)42:5<984::AID-MRM23>3.0.CO;2-P; Jansen JFA, 2006, MAGN RESON MED, V56, P666, DOI 10.1002/mrm.20968; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Mlynarik V, 2008, MAGN RESON MED, V59, P52, DOI 10.1002/mrm.21447; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; WOODS BT, 1992, ADV EXP MED BIOL, V318, P267	12	26	28	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889								10.1126/science.1153484	http://dx.doi.org/10.1126/science.1153484			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669845	Green Accepted			2022-12-28	WOS:000258077700022
J	Garcia-Barriocanal, J; Rivera-Calzada, A; Varela, M; Sefrioui, Z; Iborra, E; Leon, C; Pennycook, SJ; Santamaria, J				Garcia-Barriocanal, J.; Rivera-Calzada, A.; Varela, M.; Sefrioui, Z.; Iborra, E.; Leon, C.; Pennycook, S. J.; Santamaria, J.			Colossal ionic conductivity at interfaces of epitaxial ZrO2 : Y2O3/SrTiO3 heterostructures	SCIENCE			English	Article							OXIDE FUEL-CELLS; ELECTRICAL-CONDUCTIVITY; THIN-FILMS; ELECTROLYTES; TEMPERATURE; GLASSES; CONDUCTORS; CRYSTALS; ZIRCONIA; ENERGY		[Garcia-Barriocanal, J.; Rivera-Calzada, A.; Sefrioui, Z.; Leon, C.; Santamaria, J.] Univ Complutense Madrid, Grp Fis Mat Complejos, E-28040 Madrid, Spain; [Varela, M.; Pennycook, S. J.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Iborra, E.] Univ Politecn Madrid, Escuela Tecn Super Ingn Telecommun, E-28040 Madrid, Spain	Complutense University of Madrid; United States Department of Energy (DOE); Oak Ridge National Laboratory; Universidad Politecnica de Madrid; ETS de Ingenieros de Telecomunicacion	Santamaria, J (corresponding author), Univ Complutense Madrid, Grp Fis Mat Complejos, E-28040 Madrid, Spain.	jacsan@fis.ucm.es	Sefrioui, Zouhair/C-2728-2017; Leon, Carlos/A-5587-2008; Pennycook, Stephen/AAA-1112-2019; SANTAMARIA, JACOBO/K-3887-2014; Iborra, Enrique/A-4148-2016; Varela, Maria/E-2472-2014; Rivera-Calzada, Alberto/C-4802-2013; Varela, Maria/H-2648-2012; Santamaria, Jacobo/N-8783-2016	Sefrioui, Zouhair/0000-0002-6703-3339; Leon, Carlos/0000-0002-3262-1843; Pennycook, Stephen/0000-0002-3210-6323; SANTAMARIA, JACOBO/0000-0003-4594-2686; Iborra, Enrique/0000-0002-1385-1379; Varela, Maria/0000-0002-6582-7004; Rivera-Calzada, Alberto/0000-0001-6744-590X; Santamaria, Jacobo/0000-0003-4594-2686				ANGELL CA, 1990, CHEM REV, V90, P523, DOI 10.1021/cr00101a006; Azad S, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1894615; Brandon NP, 2003, ANNU REV MATER RES, V33, P183, DOI 10.1146/annurev.matsci.33.022802.094122; CAVA RJ, 1984, PHYS REV B, V30, P6896, DOI 10.1103/PhysRevB.30.6896; Fergus JW, 2006, J POWER SOURCES, V162, P30, DOI 10.1016/j.jpowsour.2006.06.062; Fleig J, 2004, SOLID STATE IONICS, V174, P261, DOI 10.1016/j.ssi.2004.07.035; Goodenough JB, 2003, ANNU REV MATER RES, V33, P91, DOI 10.1146/annurev.matsci.33.022802.091651; Habasaki J, 2004, J CHEM PHYS, V120, P8195, DOI 10.1063/1.1690236; Huang H, 2007, J ELECTROCHEM SOC, V154, pB20, DOI 10.1149/1.2372592; JONSCHER AK, 1977, NATURE, V267, P673, DOI 10.1038/267673a0; Kalabukhov A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121404; Kosacki I, 2005, SOLID STATE IONICS, V176, P1319, DOI 10.1016/j.ssi.2005.02.021; Kosacki I., 1998, ELECTROCHEM SOC P, V97-24, P631; Kremer F., 2003, BROADBAND DIELECTRIC, P81; LEE WK, 1991, PHYS REV LETT, V67, P1559, DOI 10.1103/PhysRevLett.67.1559; LI P, 1993, PHYS REV B, V48, P10063, DOI 10.1103/PhysRevB.48.10063; Maier J, 2000, SOLID STATE IONICS, V131, P13, DOI 10.1016/S0167-2738(00)00618-4; Nernst W., 1899, Z ELEKTROCHEM, V6, P41; Ngai KL, 1996, PHYS REV LETT, V76, P1296, DOI 10.1103/PhysRevLett.76.1296; Ngai KL, 1998, PHYS REV LETT, V80, P1018, DOI 10.1103/PhysRevLett.80.1018; Ngai KL, 1999, J CHEM PHYS, V110, P10576, DOI 10.1063/1.478989; Ohly C, 2006, J AM CERAM SOC, V89, P2845, DOI 10.1111/j.1551-2916.2006.01178.x; Ormerod RM, 2003, CHEM SOC REV, V32, P17, DOI 10.1039/b105764m; Peters A, 2007, SOLID STATE IONICS, V178, P67, DOI 10.1016/j.ssi.2006.12.004; Pimenov A, 1998, SOLID STATE IONICS, V109, P111, DOI 10.1016/S0167-2738(98)00082-4; Rivera A, 2001, APPL PHYS LETT, V78, P610, DOI 10.1063/1.1343852; Sata N, 2000, NATURE, V408, P946, DOI 10.1038/35050047; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Siemons W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196802; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Suzuki T, 2002, J AM CERAM SOC, V85, P1492, DOI 10.1111/j.1151-2916.2002.tb00302.x; SWANSON H, 1954, NSB539 CIRC, V3, P44; Wallis DJ, 1997, J AM CERAM SOC, V80, P781, DOI 10.1111/j.1151-2916.1997.tb02899.x; Yoo Y, 2006, J POWER SOURCES, V160, P202, DOI 10.1016/j.jpowsour.2005.12.050	34	573	600	7	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					676	680		10.1126/science.1156393	http://dx.doi.org/10.1126/science.1156393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669859				2022-12-28	WOS:000258077700040
J	Romundstad, LB; Romundstad, PR; Sunde, A; von During, V; Skjaerven, R; Gunnell, D; Vatten, LJ				Romundstad, Liv Bente; Romundstad, Pal R.; Sunde, Arne; von During, Vidar; Skjaerven, Rolv; Gunnell, David; Vatten, Lars J.			Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study	LANCET			English	Article							IN-VITRO FERTILIZATION; BIRTH-WEIGHT; PREGNANCY OUTCOMES; INCREASED RISK; INFERTILITY; EMBRYO; SINGLETONS; DELIVERY; IVF/ICSI	Background Research suggests that singleton births following assisted fertilisation. are associated with adverse outcomes; however, these results might be confounded by factors that affect both fertility and pregnancy outcome. We therefore compared pregnancy outcomes in women who had singleton pregnancies conceived both spontaneously and after assisted fertilisation. Methods In a population-based cohort study, we assessed differences in birthweight, gestational age, and odds ratios (OR) of small for gestational age babies, premature births, and perinatal deaths in singletons (gestation >= 22 weeks or birthweigh >= 500 g) born to 2546 Norwegian women (> 20 years) who had conceived at least one child spontaneously and another after assisted fertilisation among 1200 922 births after spontaneous conception and 8229 after assisted fertilisation. Findings In the whole study population, assisted-fertilisation conceptions were associated with lower mean birthweight (difference 25 g, 95% CI 14 to 35), shorter duration of gestation (2 . 0 days, 1 . 6 to 2 . 3) and increased risks of small for gestational age (OR 1.26, 1.10 to 1.44), and perinatal death (1.31, 1.05 to 1.65) than were spontaneous conceptions. In the sibling-relationship comparisons, the spontaneous versus the assisted-fertilisation conceptions- showed a difference of only 9 g (-18 to 36) in birthweight and 0 . 6 days (-0 . 5 to 1. 7) in gestational age. For assisted fertilisation versus spontaneous conception in the sibling-relationship comparisons, the OR for small for gestational age was 0 . 99 (0.62 to 1. 57) and that for perinatal mortality was 0 . 36 (0 . 20 to 0 . 67). Interpretation Birthweight, gestational age, and risks of small for gestational age babies, and preterm delivery did not differ among infants of women who had conceived both spontaneously and after assisted fertilisation. The adverse outcomes of assisted fertilisation that we noted compared with those in the general population could therefore be attributable to the factors leading to infertility, rather than to factors related to the reproductive technology. Funding St Olavs University Hospital, Trondheim, Norway, and the Norwegian Research Council.	[Romundstad, Liv Bente; Sunde, Arne; von During, Vidar] St Olavs Univ Hosp, Dept Obstet & Gynaecol, IVF Unit, NO-7006 Trondheim, Norway; [Romundstad, Liv Bente; Romundstad, Pal R.; Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Skjaerven, Rolv] Med Birth Registry Norway, Bergen, Norway; [Skjaerven, Rolv] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Gunnell, David] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Vatten, Lars J.] Int Agcy Res Canc, F-69372 Lyon, France	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bristol; World Health Organization; International Agency for Research on Cancer (IARC)	Romundstad, LB (corresponding author), St Olavs Univ Hosp, Dept Obstet & Gynaecol, IVF Unit, NO-7006 Trondheim, Norway.	libero@ntnu.no	Vatten, Lars/AFK-2073-2022; Gunnell, David/ABE-6653-2020; Vatten, Lars/AAF-9380-2022	Gunnell, David/0000-0002-0829-6470; Romundstad, Pal Richard/0000-0003-2061-4336	St Olavs University Hospital, Trondheim, Norway; Norwegian Research Council	St Olavs University Hospital, Trondheim, Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was financially supported by St Olavs University Hospital, Trondheim, Norway, and the Norwegian Research Council.	Allen VM, 2006, J OBSTET GYNAECOL CA, V28, P220, DOI 10.1016/S1701-2163(16)32112-0; Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Draper ES, 1999, LANCET, V353, P1746, DOI 10.1016/S0140-6736(98)08500-6; ERTZEID G, 1992, J REPROD FERTIL, V96, P649, DOI 10.1530/jrf.0.0960649; GHAZI HA, 1991, FERTIL STERIL, V55, P726; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Henriksen TB, 1997, OBSTET GYNECOL, V89, P594; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; McDonald SD, 2005, J OBSTET GYNAECOL CA, V27, P449, DOI 10.1016/S1701-2163(16)30527-8; McEvoy TG, 2001, REPRODUCTION, V122, P507, DOI 10.1530/rep.0.1220507; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Romundstad LB, 2006, HUM REPROD, V21, P2353, DOI 10.1093/humrep/del153; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Sutcliffe AG, 2007, LANCET, V370, P351, DOI 10.1016/S0140-6736(07)60456-5; WILLIAMS MA, 1991, FERTIL STERIL, V56, P668; World Health Organization, 2006, NEON PER MORT COUNTR; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	24	259	271	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2008	372	9640					737	743		10.1016/S0140-6736(08)61041-7	http://dx.doi.org/10.1016/S0140-6736(08)61041-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344YZ	18674812				2022-12-28	WOS:000258964500030
J	Forman, D; Pisani, P				Forman, David; Pisani, Paola			Gastric cancer in Japan - Honing treatment, seeking causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Forman, David] Univ Leeds, Ctr Biostat & Epidemiol, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Pisani, Paola] Univ Oxford, Canc Epidemiol Unit, Oxford, England	University of Leeds; University of Oxford	Forman, D (corresponding author), Univ Leeds, Ctr Biostat & Epidemiol, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England.							[Anonymous], 2021, CANC INCIDENCE 5 CON; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Joossens JV, 1996, INT J EPIDEMIOL, V25, P494, DOI 10.1093/ije/25.3.494; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	4	19	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					448	451		10.1056/NEJMp0804354	http://dx.doi.org/10.1056/NEJMp0804354			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669423				2022-12-28	WOS:000258039700002
J	Piot, C; Croisille, P; Staat, P; Thibault, H; Rioufol, G; Mewton, N; Elbelghiti, R; Cung, TT; Bonnefoy, E; Angoulvant, D; Macia, C; Raczka, F; Sportouch, C; Gahide, G; Finet, G; Andre-Fouet, X; Revel, D; Kirkorian, G; Monassier, J; Derumeaux, G; Ovize, M				Piot, Christophe; Croisille, Pierre; Staat, Patrick; Thibault, Helene; Rioufol, Gilles; Mewton, Nathan; Elbelghiti, Rachid; Cung, Thien Tri; Bonnefoy, Eric; Angoulvant, Denis; Macia, Christophe; Raczka, Franck; Sportouch, Catherine; Gahide, Gerald; Finet, Gerard; Andre-Fouet, Xavier; Revel, Didier; Kirkorian, Gilbert; Monassier, Jean-Pierre; Derumeaux, Genevieve; Ovize, Michel			Effect of cyclosporine on reperfusion injury in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CELL-DEATH; CYCLOPHILIN-D; HOSPITAL DISCHARGE; PORE; HEART; SIZE; APOPTOSIS; ISCHEMIA; MYOCYTES	Background: Experimental evidence suggests that cyclosporine, which inhibits the opening of mitochondrial permeability-transition pores, attenuates lethal myocardial injury that occurs at the time of reperfusion. In this pilot trial, we sought to determine whether the administration of cyclosporine at the time of percutaneous coronary intervention (PCI) would limit the size of the infarct during acute myocardial infarction. Methods: We randomly assigned 58 patients who presented with acute ST-elevation myocardial infarction to receive either an intravenous bolus of 2.5 mg of cyclosporine per kilogram of body weight (cyclosporine group) or normal saline (control group) immediately before undergoing PCI. Infarct size was assessed in all patients by measuring the release of creatine kinase and troponin I and in a subgroup of 27 patients by performing magnetic resonance imaging (MRI) on day 5 after infarction. Results: The cyclosporine and control groups were similar with respect to ischemia time, the size of the area at risk, and the ejection fraction before PCI. The release of creatine kinase was significantly reduced in the cyclosporine group as compared with the control group (P=0.04). The release of troponin I was not significantly reduced (P=0.15). On day 5, the absolute mass of the area of hyperenhancement (i.e., infarcted tissue) on MRI was significantly reduced in the cyclosporine group as compared with the control group, with a median of 37 g (interquartile range, 21 to 51) versus 46 g (interquartile range, 20 to 65; P=0.04). No adverse effects of cyclosporine administration were detected. Conclusions: In our small, pilot trial, administration of cyclosporine at the time of reperfusion was associated with a smaller infarct by some measures than that seen with placebo. These data are preliminary and require confirmation in a larger clinical trial. .	[Piot, Christophe; Cung, Thien Tri; Macia, Christophe; Raczka, Franck; Sportouch, Catherine; Gahide, Gerald] Hop Arnaud Villeneuve, Montpellier, France; [Croisille, Pierre; Staat, Patrick; Thibault, Helene; Rioufol, Gilles; Mewton, Nathan; Bonnefoy, Eric; Angoulvant, Denis; Finet, Gerard; Andre-Fouet, Xavier; Revel, Didier; Kirkorian, Gilbert; Derumeaux, Genevieve; Ovize, Michel] Univ Lyon 1, Hospices Civils Lyon, F-69365 Lyon, France; [Elbelghiti, Rachid; Monassier, Jean-Pierre] Serv Cardiol, Mulhouse, France; [Thibault, Helene; Rioufol, Gilles; Angoulvant, Denis; Finet, Gerard; Derumeaux, Genevieve; Ovize, Michel] INSERM, Unite 886, F-69008 Lyon, France	Universite de Montpellier; CHU de Montpellier; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ovize, M (corresponding author), Hop L Pradel, Hospices Civils Lyon, 59 Blvd Pinel, F-69394 Lyon 03, France.	ovize@sante.univ-lyon1.fr	Revel, Didier/M-4553-2014; Angoulvant, Denis/Q-9743-2019; DERUMEAUX, Genevieve A/T-2489-2018; angoulvant, denis/A-6239-2009; Croisille, Pierre/H-4928-2014; Ovize, michel/AAL-9247-2020	Angoulvant, Denis/0000-0003-0788-8092; DERUMEAUX, Genevieve A/0000-0003-1471-1631; Croisille, Pierre/0000-0003-4019-3460; Piot, Christophe/0000-0001-7497-0294; Thibault, Helene/0000-0001-9784-0425; Sportouch, Catherine/0000-0001-5079-5874				Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Argaud L, 2004, CARDIOVASC RES, V61, P115, DOI 10.1016/j.cardiores.2003.11.003; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Bueno OF, 2004, CIRC RES, V94, P91, DOI 10.1161/01.RES.0000107197.99679.77; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1990, BIOCHEM J, V266, P33, DOI 10.1042/bj2660033; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Di Lisa F, 2003, BASIC RES CARDIOL, V98, P235, DOI 10.1007/s00395-003-0415-x; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Ergin A, 2004, AM J MED, V117, P219, DOI 10.1016/j.amjmed.2004.03.017; FIELD BJ, 1972, CIRCULATION, V46, P679; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; HACKEL DB, 1984, CIRCULATION, V70, P824, DOI 10.1161/01.CIR.70.5.824; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Inada T, 2004, ADV ASTRONAUT SCI, V117, P27; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; KLONER RA, 1993, J AM COLL CARDIOL, V21, P537, DOI 10.1016/0735-1097(93)90700-B; Mahrholdt H, 2002, CIRCULATION, V106, P2322, DOI 10.1161/01.CIR.0000036368.63317.1C; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NAZARETH W, 1991, J MOL CELL CARDIOL, V23, P1351, DOI 10.1016/0022-2828(91)90181-K; Obasanjo-Blackshire K, 2006, CARDIOVASC RES, V71, P672, DOI 10.1016/j.cardiores.2006.05.026; Oka N, 2008, J THORAC CARDIOV SUR, V135, P123, DOI 10.1016/j.jtcvs.2007.05.009; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Rehwald WG, 2002, CIRCULATION, V105, P224, DOI 10.1161/hc0202.102016; REIMER KA, 1979, LAB INVEST, P40633; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; ROBERTS R, 1975, CIRCULATION, V52, P743, DOI 10.1161/01.CIR.52.5.743; Shan K, 2004, CIRCULATION, V109, P1328, DOI 10.1161/01.CIR.0000120294.67948.E3; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Zhao ZQ, 2004, AM J PHYSIOL-HEART C, V286, pH477; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	47	990	1034	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					473	481		10.1056/NEJMoa071142	http://dx.doi.org/10.1056/NEJMoa071142			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669426	Bronze			2022-12-28	WOS:000258039700005
J	Chapman, HN				Chapman, Henry N.			Focus on X-ray diffraction	SCIENCE			English	Editorial Material							PHASE-RETRIEVAL; MICROSCOPY		Univ Hamburg, Ctr Free Elect Laser Sci, D-22607 Hamburg, Germany; DESY, D-22607 Hamburg, Germany	University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Chapman, HN (corresponding author), Univ Hamburg, Ctr Free Elect Laser Sci, Notkestr 85, D-22607 Hamburg, Germany.	henry.chapman@desy.de	FRS, Henry N Chapman/G-2153-2010	FRS, Henry N Chapman/0000-0002-4655-1743				Abbey B, 2008, NAT PHYS, V4, P394, DOI 10.1038/nphys896; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Chapman HN, 1996, ULTRAMICROSCOPY, V66, P153, DOI 10.1016/S0304-3991(96)00084-8; Elser V, 2003, J OPT SOC AM A, V20, P40, DOI 10.1364/JOSAA.20.000040; Kang HC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127401; Miao J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174104; Rodenburg JM, 2008, ADV IMAG ELECT PHYS, V150, P87, DOI 10.1016/S1076-5670(07)00003-1; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; Spence J. C. H., 2007, SCI MICROSCOPY, P1196; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573	12	10	10	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					352	353		10.1126/science.1161183	http://dx.doi.org/10.1126/science.1161183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635785	Green Published			2022-12-28	WOS:000257713900030
J	Koh, K; Joiner, WJ; Wu, MN; Yue, ZF; Smith, CJ; Sehgal, A				Koh, Kyunghee; Joiner, William J.; Wu, Mark N.; Yue, Zhifeng; Smith, Corinne J.; Sehgal, Amita			Identification of SLEEPLESS, a sleep-promoting factor	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; REDUCED SLEEP; DEPRIVATION; HOMEOSTASIS; NARCOLEPSY; MUTATION; MODELS; MUTANT; GENES; REST	Sleep is an essential process conserved from flies to humans. The importance of sleep is underscored by its tight homeostatic control. Through a forward genetic screen, we identified a gene, sleepless, required for sleep in Drosophila. The sleepless gene encodes a brain-enriched, glycosylphosphatidylinositol-anchored protein. Loss of SLEEPLESS protein caused an extreme (> 80%) reduction in sleep; a moderate reduction in SLEEPLESS had minimal effects on baseline sleep but markedly reduced the amount of recovery sleep after sleep deprivation. Genetic and molecular analyses revealed that quiver, a mutation that impairs Shaker-dependent potassium current, is an allele of sleepless. Consistent with this finding, Shaker protein levels were reduced in sleepless mutants. We propose that SLEEPLESS is a signaling molecule that connects sleep drive to lowered membrane excitability.	[Koh, Kyunghee; Joiner, William J.; Yue, Zhifeng; Smith, Corinne J.; Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA; [Wu, Mark N.] Univ Penn, Div Sleep Med, Dept Neurol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Koh, Kyunghee/0000-0003-0847-8204	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [P01 AG017628-070004, P01 AG017628, AG017628] Funding Source: Medline; NINDS NIH HHS [R01 NS072431] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hu WP, 2007, SLEEP, V30, P247; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Humphreys JM, 1996, GENOME, V39, P749, DOI 10.1139/g96-094; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Naylor E, 2000, J NEUROSCI, V20, P8138; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rosekind MR, 2005, SLEEP MED, V6, pS21, DOI 10.1016/S1389-9457(05)80005-X; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Wang JW, 2000, J NEUROSCI, V20, P5958, DOI 10.1523/JNEUROSCI.20-16-05958.2000; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277	37	212	220	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					372	376		10.1126/science.1155942	http://dx.doi.org/10.1126/science.1155942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635795	Green Accepted			2022-12-28	WOS:000257713900040
J	Farag, N; Reynolds, E				Farag, Nadine; Reynolds, Eileen			Update: A 35-year-old physician with opioid dependence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Knight JR, 2004, JAMA-J AM MED ASSOC, V292, P1351, DOI 10.1001/jama.292.11.1351	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					322	322		10.1001/jama.2008.61	http://dx.doi.org/10.1001/jama.2008.61			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325ZB	18632545				2022-12-28	WOS:000257626600024
J	Nader, PR; Bradley, RH; Houts, RM; McRitchie, SL; O'Brien, M				Nader, Philip R.; Bradley, Robert H.; Houts, Renate M.; McRitchie, Susan L.; O'Brien, Marion			Moderate-to-vigorous physical activity from ages 9 to 15 years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; CHILDREN; YOUTH; ADOLESCENTS; GIRLS; ACCELEROMETER; POPULATION; OVERWEIGHT; LESSONS	Context Decreased physical activity plays a critical role in the increase in childhood obesity. Although at least 60 minutes per day of moderate- to- vigorous physical activity ( MVPA) is recommended, few longitudinal studies have determined the recent patterns of physical activity of youth. Objective To determine the patterns and determinants of MVPA of youth followed from ages 9 to 15 years. Design, Setting, and Participants Longitudinal descriptive analyses of the 1032 participants in the 1991- 2007 National Institute of Child Health and Human Development Study of Early Child Care and Youth Development birth cohort from 10 study sites who had accelerometer- determined minutes of MVPA at ages 9 ( year 2000), 11 ( 2002), 12 ( 2003), and 15 ( 2006) years. Participants included boys ( 517 [ 50.1%]) and girls ( 515 [ 49.9%]); 76.6% white ( n= 791); and 24.5% ( n= 231) lived in low- income families. Main Outcome Measure Mean MVPA minutes per day, determined by 4 to 7 days of monitored activity. Results At age 9 years, children engaged in MVPA approximately 3 hours per day on both weekends and weekdays. Weekday MVPA decreased by 38 minutes per year, while weekend MVPA decreased by 41 minutes per year. By age 15 years, adolescents were only engaging in MVPA for 49 minutes per weekday and 35 minutes per weekend day. Boys were more active than girls, spending 18 and 13 more minutes per day in MVPA on the weekdays and weekends, respectively. The rate of decrease in MVPA was the same for boys and girls. The estimated age at which girls crossed below the recommended 60 minutes of MVPA per day was approximately 13.1 years for weekday activity compared with boys at 14.7 years, and for weekend activity, girls crossed below the recommended 60 minutes of MVPA at 12.6 years compared with boys at 13.4 years. Conclusion In this study cohort, measured physical activity decreased significantly between ages 9 and 15 years.	[Nader, Philip R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Bradley, Robert H.] Univ Arkansas, Ctr Appl Studies Educ, Little Rock, AR 72204 USA; [Houts, Renate M.; McRitchie, Susan L.] RTI Int, Stat & Epidemiol, Res Triangle Pk, NC USA; [O'Brien, Marion] Univ N Carolina, Dept Human Dev & Family Studies, Greensboro, NC 27412 USA	University of California System; University of California San Diego; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Research Triangle Institute; University of North Carolina; University of North Carolina Greensboro	Nader, PR (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pnader@ucsd.edu	Houts, Renate/AAC-5304-2019	Houts, Renate/0000-0002-1518-2631; Vandell, Deborah/0000-0003-2373-9783				AARON DJ, 1993, MED SCI SPORT EXER, V25, P847, DOI 10.1249/00005768-199307000-00014; Aiken L.S., 1991, MULTIPLE REGRESSION; Anderson PM, 2006, FUTURE CHILD, V16, P19, DOI 10.1353/foc.2006.0001; [Anonymous], 1998, PHYS ACTIVITY CHILDR; [Anonymous], BMI BOD MASS IND BMI; Appelbaum M, 1999, DEV PSYCHOL, V35, P1399; Cavill N, 2001, PEDIATR EXERC SCI, V13, P12, DOI 10.1123/pes.13.1.12; Citro C. F., 1995, MEASURING POVERTY NE; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; Frank GC, 2003, J SCHOOL HEALTH, V73, P51, DOI 10.1111/j.1746-1561.2003.tb03571.x; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Guinhouya CB, 2006, OBESITY, V14, P774, DOI 10.1038/oby.2006.89; KANN L, 1999, MMWR-MORBID MORTAL W, V49, P1; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Koplan J., 2005, PREVENTING CHILDHOOD; Krishnamoorthy J. S., 2006, Social Policy Report, V20, P3; Pate RR, 2002, ANN EPIDEMIOL, V12, P303, DOI 10.1016/S1047-2797(01)00263-0; Pate RR, 2006, ARCH PEDIAT ADOL MED, V160, P1262, DOI 10.1001/archpedi.160.12.1262; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P294; Safrit MJ, 1989, MEASUREMENT CONCEPTS; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Thomas P, 2003, FISH PHYSIOL BIOCHEM, V28, P3, DOI 10.1023/B:FISH.0000030461.35242.57; Treuth MS, 2005, OBES RES, V13, P1606, DOI 10.1038/oby.2005.197; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; United States Department of Agriculture (USDA), DIET GUID AM; *US BUR CENS, 1990 CENS; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2	32	832	845	1	65	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					295	305		10.1001/jama.300.3.295	http://dx.doi.org/10.1001/jama.300.3.295			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325ZB	18632544	Bronze			2022-12-28	WOS:000257626600021
J	Van Hoyweghen, I; Horstman, K				Van Hoyweghen, Ine; Horstman, Klasien			European practices of genetic information and insurance - Lessons for the Genetic Information Nondiscrimination Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISCRIMINATION; BILL		[Van Hoyweghen, Ine; Horstman, Klasien] Maastricht Univ, Dept Hlth Eth & Soc Caphri, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands	Maastricht University	Van Hoyweghen, I (corresponding author), Maastricht Univ, Dept Hlth Eth & Soc Caphri, Fac Hlth Med & Life Sci, POB 616, NL-6200 MD Maastricht, Netherlands.	i.vanhoyweghen@zw.unimaas.nl	Van Hoyweghen, Ine/ABC-8853-2020	Van Hoyweghen, Ine/0000-0002-9402-2918				Alper JS, 1998, SCI ENG ETHICS, V4, P141, DOI 10.1007/s11948-998-0044-8; Godard B, 2003, EUR J HUM GENET, V11, pS123, DOI 10.1038/sj.ejhg.5201117; Hampton T, 2008, JAMA-J AM MED ASSOC, V299, P2493, DOI 10.1001/jama.299.21.2493; Hudson KL, 2007, NEW ENGL J MED, V356, P2021, DOI 10.1056/NEJMp078033; Morrison PJ, 2005, LANCET, V366, P877, DOI 10.1016/S0140-6736(05)67298-4; *MUN RE GROUP, 2007, IS OB EP STOPP TREND; *SCOR GROUP, 2002, SCOR TECHNICAL NEWSL, V5, P1; *SWISS REINS CO, 2004, TOO BIG IGN IMP OB M; *SWISS REINS CO, 1994, SMOK ALC LIF INS MOR; Van Hoyweghen I., 2007, RISKS MAKING TRAVELS; Van Hoyweghen I, 2007, HEALTH CARE ANAL, V15, P179, DOI 10.1007/s10728-006-0041-5; Van Hoyweghen I, 2006, SOC SCI MED, V63, P1225, DOI 10.1016/j.socscimed.2006.03.029; Van Hoyweghen I, 2007, HEALTH TECHNOL SOC, P118; Wadman M, 2008, NATURE, V453, P9, DOI 10.1038/453009a	14	27	27	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					326	327		10.1001/jama.2008.62	http://dx.doi.org/10.1001/jama.2008.62			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	325ZB	18632546				2022-12-28	WOS:000257626600026
J	Gibbs, KA; Urbanowski, ML; Greenberg, EP				Gibbs, Karine A.; Urbanowski, Mark L.; Greenberg, E. Peter			Genetic determinants of self identity and social recognition in bacteria	SCIENCE			English	Article							PROTEUS-MIRABILIS; IDENTIFICATION	The bacterium Proteus mirabilis is capable of movement on solid surfaces by a type of motility called swarming. Boundaries form between swarming colonies of different P. mirabilis strains but not between colonies of a single strain. A fundamental requirement for boundary formation is the ability to discriminate between self and nonself. We have isolated mutants that form boundaries with their parent. The mutations map within a six- gene locus that we term ids for identification of self. Five of the genes in the ids locus are required for recognition of the parent strain as self. Three of the ids genes are interchangeable between strains, and two encode specific molecular identifiers.	[Gibbs, Karine A.; Greenberg, E. Peter] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Urbanowski, Mark L.] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa	Greenberg, EP (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	epgreen@u.washington.edu		Gibbs, Karine/0000-0002-1246-6401; Greenberg, Everett/0000-0001-9474-8041	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396] Funding Source: NIH RePORTER; NIAID NIH HHS [AI55396, T32 AI055396-04, T32 AI055396-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELAS R, 1991, J BACTERIOL, V173, P6289, DOI 10.1128/jb.173.19.6289-6293.1991; DIENES L, 1946, P SOC EXP BIOL MED, V63, P265; Munson EL, 2002, J CLIN MICROBIOL, V40, P4285, DOI 10.1128/JCM.40.11.4285-4288.2002; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Sabbuba NA, 2004, J UROLOGY, V171, P1925, DOI 10.1097/01.ju.0000123062.26461.f9; Sabbuba NA, 2003, J CLIN MICROBIOL, V41, P4961, DOI 10.1128/JCM.41.11.4961-4965.2003; SENIOR BW, 1983, J MED MICROBIOL, V16, P323, DOI 10.1099/00222615-16-3-323; SENIOR BW, 1977, J GEN MICROBIOL, V102, P235, DOI 10.1099/00221287-102-2-235; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004	11	143	149	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					256	259		10.1126/science.1160033	http://dx.doi.org/10.1126/science.1160033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621670	Green Accepted			2022-12-28	WOS:000257512900042
J	Reeves, S; Albert, M; Kuper, A; Hodges, BD				Reeves, Scott; Albert, Mathieu; Kuper, Ayelet; Hodges, Brian David			Qualitative research - Why use theories in qualitative research?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reeves, Scott] Univ Toronto, Dept Psychiat, Li Ka Shing Knowledge Inst, Ctr Fac Dev, Toronto, ON M5G 2C4, Canada; [Reeves, Scott; Albert, Mathieu; Kuper, Ayelet; Hodges, Brian David] Univ Toronto, Wilson Ctr Res Educ, Toronto, ON M5G 2C4, Canada; [Albert, Mathieu; Hodges, Brian David] Univ Toronto, Dept Psychiat, Toronto, ON M5G 2C4, Canada; [Kuper, Ayelet] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Reeves, S (corresponding author), Univ Toronto, Dept Psychiat, Li Ka Shing Knowledge Inst, Ctr Fac Dev, 200 Elizabeth St,Eaton S 1-565, Toronto, ON M5G 2C4, Canada.	scott.reeves@utoronto.ca	Albert, Mathieu/A-6685-2008	Albert, Mathieu/0000-0003-1008-7085; Reeves, Scott/0000-0002-0573-0622				Battiste M., 2005, TEACHING ACTIVISM EQ, P121; Blumer H., 1969, SYMB INTERACT; Calhoun C., 1995, CRITICAL SOCIAL THEO; Freidson E., 1988, PROFESSION MED STUDY; Goffman E., 1963, PRESENTATION SELF EV; HAUG M, 1993, SOCIOL REV MONOGR, V20, P195; KINCHLOE J., 2000, HDB QUALITATIVE RES; Lewin K., 1951, FIELD THEORY SOCIAL; Link B. G., 1999, HDB STUDY MENTAL HLT, P361; Merton R., 2006, SOCIAL THEORY SOCIAL; MITCHELL GJ, 1994, NURS SCI QUART, V7, P70, DOI 10.1177/089431849400700207; MUZZIN L, 2005, TEACHING ACTIVISM EQ, P149; Porter EJ, 2004, GERONTOLOGIST, V44, P750, DOI 10.1093/geront/44.6.750; Scheff T.J., 1999, BEING MENTALLY ILL S, V3rd; SCHUTZ A, 1967, PHENOMENEOLOGY SOCIA; SINCLAIR S., 1997, MAKING DOCTORS I APP; Smith DW, 2007, ROUTL PHILOS, P1; Strauss A., 1963, HOSP MODERN SOC, P147; Svensson R, 1996, SOCIOL HEALTH ILL, V18, P379, DOI 10.1111/1467-9566.ep10934735; Witz, 1992, PROFESSIONS PATRIARC	20	137	138	6	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2008	337	7670							a949	10.1136/bmj.a949	http://dx.doi.org/10.1136/bmj.a949			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	354DT	18687730				2022-12-28	WOS:000259619800042
J	Kinra, S; Sarma, KVR; Ghafoorunissa; Mendu, VVR; Ravikumar, R; Mohan, V; Wilkinson, IB; Cockcroft, JR; Smith, GD; Ben-Shlomo, Y				Kinra, Sanjay; Sarma, K. V. Rameshwar; Ghafoorunissa; Mendu, Vishnu Vardhana Rao; Ravikumar, Radhakrishnan; Mohan, Viswanthan; Wilkinson, Ian B.; Cockcroft, John R.; Smith, George Davey; Ben-Shlomo, Yoav			Effect of integration of supplemental nutrition with public health programmes in pregnancy and early childhood on cardiovascular risk in rural Indian adolescents: long term follow-up of Hyderabad nutrition trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FASTING PLASMA-GLUCOSE; BODY-MASS-INDEX; ARTERIAL STIFFNESS; INSULIN-RESISTANCE; HEART-DISEASE; BIRTH-WEIGHT; HYPERTENSION; INTERVENTIONS; EPIDEMIOLOGY; CHOLESTEROL	Objective To determine whether integration of nutritional supplementation with other public health programmes in early life reduces the risk of cardiovascular disease in undernourished populations. Design Approximately 15 years' follow-up of participants born within an earlier controlled, community trial of nutritional supplementation integrated with other public health programmes. Setting 29 villages (15 intervention, 14 control) near Hyderabad city, south India. Participants 1165 adolescents aged 13-18 years. Intervention Balanced protein-calorie supplementation (2.51 MJ, 20 g protein) offered daily to pregnant women and preschool children aged under 6 years, coupled with integrated delivery of vertical public health programmes. Main outcome measures Height, adiposity, blood pressures, lipids, insulin resistance (homoeostasis model assessment (HOMA) score), and arterial stiffness (augmentation index). Results The participants from the intervention villages were 14 mm (95% confidence interval 4 to 23; P=0.007) taller than controls but had similar body composition. The participants from the intervention villages had more favourable measures of insulin resistance and arterial stiffness: 20% (3% to 39%; P=0.02) lower HOMA score and 3.3% (1% to 5.7%; P=0.008) lower augmentation index. No strong evidence existed for differences in blood pressures and serum lipids. Conclusions In this undernourished population, integrated delivery of supplemental nutrition with other public health programmes in pregnancy and early childhood was associated with a more favourable profile of cardiovascular disease risk factors in adolescence. This pragmatic study provides the most robust evidence to date on this important hypothesis for which classic trials are unlikely. Improved maternal and child nutrition may have a role in reducing the burden of cardiovascular disease in low income and middle income countries.	[Kinra, Sanjay] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; [Sarma, K. V. Rameshwar; Ghafoorunissa; Mendu, Vishnu Vardhana Rao] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Ravikumar, Radhakrishnan; Mohan, Viswanthan] Madras Diabet Res Fdn, Madras 600086, Tamil Nadu, India; [Wilkinson, Ian B.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 2QQ, England; [Cockcroft, John R.] Welsh Heart Ctr, Cardiff CF14 4XN, Wales; [Smith, George Davey; Ben-Shlomo, Yoav] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; London School of Hygiene & Tropical Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Madras Diabetes Research Foundation; University of Cambridge; University of Bristol	Kinra, S (corresponding author), Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	sanjay.kinra@lshtm.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Davey Smith, George/A-7407-2013; Biguzzi, Felipe A/E-4724-2015	Ben-Shlomo, Yoav/0000-0001-6648-3007; Davey Smith, George/0000-0002-1407-8314; wilkinson, ian/0000-0001-6598-9399; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Indian Council of Medical Research; United States Assistance for International Development; Eden Fellowship in Paediatrics; Royal College of Physicians, UK; British Heart Foundation [FS/07/001/21990] Funding Source: researchfish; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); United States Assistance for International Development; Eden Fellowship in Paediatrics; Royal College of Physicians, UK; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The initial trial was funded jointly by the Indian Council of Medical Research and the United States Assistance for International Development. The follow-up study was funded by a personal fellowship to SK (Eden Fellowship in Paediatrics, granted by the Royal College of Physicians, UK). The study sponsor had no role in the study design; in the collection, analysis, and interpretation of data; in writing of the report: or in the decision to submit the paper for publication. The researchers were completely independent from the funding sources.	Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; ARNETT DK, 1994, AM J EPIDEMIOL, V140, P669, DOI 10.1093/oxfordjournals.aje.a117315; Barker DJP, 1998, MOTHERS BABIES HLTH; BASU AM, 1989, POP STUD-J DEMOG, V43, P193, DOI 10.1080/0032472031000144086; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Breithaupt-Grogler K, 1999, PATHOL BIOL, V47, P604; CLARK PMS, 1994, DIABETES METAB REV, V10, P79, DOI 10.1002/dmr.5610100203; Cockcroft JR, 2000, J HUM HYPERTENS, V14, P377, DOI 10.1038/sj.jhh.1001023; Conlisk AJ, 2004, J NUTR, V134, P890, DOI 10.1093/jn/134.4.890; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; *DIR, 1991, ANN REP 1990 91, P8; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33; Franklin SS, 2005, HYPERTENSION, V45, P349, DOI 10.1161/01.HYP.0000157819.31611.87; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GILLMAN MW, 1995, CIRCULATION, V92, P1049, DOI 10.1161/01.CIR.92.4.1049; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; International Institute for Population Sciences (IIPS) and ORC Macro, 2000, NAT FAM HLTH SURV NF; Kapil U, 1990, Indian J Public Health, V34, P41; Lawlor DA, 2006, ANN EPIDEMIOL, V16, P19, DOI 10.1016/j.annepidem.2005.04.006; LAWLOR DA, 2004, LIFE COURSE APPROACH, P41; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Murtaugh MA, 2003, DIABETES CARE, V26, P187, DOI 10.2337/diacare.26.1.187; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; ORourke MF, 1996, J HYPERTENS, V14, pS147; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Ruige JB, 1998, CIRCULATION, V97, P996; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Siri W., 1961, TECHNIQUES MEASURING, P223; Stanner S A, 2001, Twin Res, V4, P287, DOI 10.1375/1369052012498; TANDON BN, 1989, B WORLD HEALTH ORGAN, V67, P77; TANDON BN, 1981, LANCET, V1, P650; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; TOMPKINS A, 1989, 5 ACC SCN WHO; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Webb AL, 2005, INT J EPIDEMIOL, V34, P898, DOI 10.1093/ije/dyi097; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Westerbacka Jukka, 2002, Semin Vasc Med, V2, P157, DOI 10.1055/s-2002-32039; WINGARD DL, 1995, DIABETES CARE, V18, P1299, DOI 10.2337/diacare.18.9.1299	48	87	88	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2008	337	7667							a605	10.1136/bmj.a605	http://dx.doi.org/10.1136/bmj.a605			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346FD	18658189	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000259053100027
J	Tada, Y; Spoel, SH; Pajerowska-Mukhtar, K; Mou, ZL; Song, JQ; Wang, C; Zuo, JR; Dong, XN				Tada, Yasuomi; Spoel, Steven H.; Pajerowska-Mukhtar, Karolina; Mou, Zhonglin; Song, Junqi; Wang, Chun; Zuo, Jianru; Dong, Xinnian			Plant immunity requires conformational charges of NPR1 via S-nitrosylation and thioredoxins	SCIENCE			English	Article							NITRIC-OXIDE; DISEASE RESISTANCE; OXIDATIVE STRESS; ARABIDOPSIS; PROTEINS; NITROSOTHIOLS; EXPRESSION; DOMAIN; SIGNAL	Changes in redox status have been observed during immune responses in different organisms, but the associated signaling mechanisms are poorly understood. In plants, these redox changes regulate the conformation of NPR1, a master regulator of salicylic acid ( SA)- mediated defense genes. NPR1 is sequestered in the cytoplasm as an oligomer through intermolecular disulfide bonds. We report that S- nitrosylation of NPR1 by S- nitrosoglutathione ( GSNO) at cysteine- 156 facilitates its oligomerization, which maintains protein homeostasis upon SA induction. Conversely, the SA- induced NPR1 oligomer- to- monomer reaction is catalyzed by thioredoxins ( TRXs). Mutations in both NPR1 cysteine- 156 and TRX compromised NPR1- mediated disease resistance. Thus, the regulation of NPR1 is through the opposing action of GSNO and TRX. These findings suggest a link between pathogen- triggered redox changes and gene regulation in plant immunity.	[Tada, Yasuomi; Spoel, Steven H.; Pajerowska-Mukhtar, Karolina; Mou, Zhonglin; Song, Junqi; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Wang, Chun; Zuo, Jianru] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Duke University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Dong, XN (corresponding author), Duke Univ, Dept Biol, POB 90338, Durham, NC 27708 USA.	xdong@duke.edu	Tada, Yasuomi/M-5041-2014; Song, Junqi/N-9219-2019	Song, Junqi/0000-0002-2555-3408; Tada, Yasuomi/0000-0001-9900-069X; Spoel, Steven/0000-0003-4340-7591	NIGMS NIH HHS [R01 GM069594, 1R01-GM69594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Dietz KJ, 2003, INT REV CYTOL, V228, P141, DOI 10.1016/S0074-7696(03)28004-9; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Grun S, 2006, J EXP BOT, V57, P507, DOI 10.1093/jxb/erj053; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Li XM, 1999, CANCER RES, V59, P5275; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Reichheld JP, 2002, PLANT PHYSIOL BIOCH, V40, P685, DOI 10.1016/S0981-9428(02)01406-7; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103	23	741	780	15	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					952	956		10.1126/science.1156970	http://dx.doi.org/10.1126/science.1156970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18635760	Green Accepted			2022-12-28	WOS:000258436700036
J	Poulet, JFA; Petersen, CCH				Poulet, James F. A.; Petersen, Carl C. H.			Internal brain state regulates membrane potential synchrony in barrel cortex of behaving mice	NATURE			English	Article							CAT VISUAL-CORTEX; MOTOR CORTEX; SOMATOSENSORY CORTEX; RHYTHMIC WHISKING; IN-VIVO; NEURONS; RAT; OSCILLATIONS; RESPONSES; AWAKE	Internal brain states form key determinants for sensory perception, sensorimotor coordination and learning(1,2). A prominent reflection of different brain states in the mammalian central nervous system is the presence of distinct patterns of cortical synchrony, as revealed by extracellular recordings of the electroencephalogram, local field potential and action potentials. Such temporal correlations of cortical activity are thought to be fundamental mechanisms of neuronal computation(3-11). However, it is unknown how cortical synchrony is reflected in the intracellular membrane potential (V(m)) dynamics of behaving animals. Here we show, using dual whole-cell recordings from layer 2/3 primary somatosensory barrel cortex in behaving mice, that the Vm of nearby neurons is highly correlated during quiet wakefulness. However, when the mouse is whisking, an internally generated state change reduces the Vm correlation, resulting in a desynchronized local field potential and electroencephalogram. Action potential activity was sparse during both quiet wakefulness and active whisking. Single action potentials were driven by a large, brief and specific excitatory input that was not present in the Vm of neighbouring cells. Action potential initiation occurs with a higher signal-to-noise ratio during active whisking than during quiet periods. Therefore, we show that an internal brain state dynamically regulates cortical membrane potential synchrony during behaviour and defines different modes of cortical processing.	[Poulet, James F. A.; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Poulet, James/0000-0003-0296-5415				Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; DORFL J, 1985, J ANAT, V142, P173; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gao PH, 2003, SOMATOSENS MOT RES, V20, P191, DOI 10.1080/08990220310001622924; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Leiser SC, 2007, NEURON, V53, P117, DOI 10.1016/j.neuron.2006.10.036; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030	34	546	550	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2008	454	7206					881	U36		10.1038/nature07150	http://dx.doi.org/10.1038/nature07150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18633351				2022-12-28	WOS:000258398600035
J	Fahrenkamp-Uppenbrink, J; Szuromi, P; Yeston, J; Coontz, R				Fahrenkamp-Uppenbrink, Julia; Szuromi, Phil; Yeston, Jake; Coontz, Robert			Theoretical possibilities - Introduction	SCIENCE			English	Editorial Material																			0	7	7	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					783	783		10.1126/science.321.5890.783	http://dx.doi.org/10.1126/science.321.5890.783			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687948				2022-12-28	WOS:000258261000028
J	Ifa, DR; Manicke, NE; Dill, AL; Cooks, G				Ifa, Demian R.; Manicke, Nicholas E.; Dill, Allison L.; Cooks, Graham			Latent fingerprint chemical imaging by mass spectrometry	SCIENCE			English	Article							DESORPTION ELECTROSPRAY-IONIZATION; AMBIENT CONDITIONS		[Ifa, Demian R.; Manicke, Nicholas E.; Dill, Allison L.; Cooks, Graham] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Ifa, Demian R.; Manicke, Nicholas E.; Dill, Allison L.; Cooks, Graham] Purdue Univ, Ctr Analyt Instrumentat Dev, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cooks, G (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	cooks@purdue.edu	Cooks, R Graham/G-1051-2015; Ifa, Demian/D-3978-2012	Cooks, R Graham/0000-0002-9581-9603; 				Dorozhkin LM, 2004, SENSOR ACTUAT B-CHEM, V99, P568, DOI 10.1016/j.snb.2004.01.007; Ifa DR, 2007, INT J MASS SPECTROM, V259, P8, DOI 10.1016/j.ijms.2006.08.003; Leggett R, 2007, ANGEW CHEM INT EDIT, V46, P4100, DOI 10.1002/anie.200700217; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; Tahtouh M, 2007, J FORENSIC SCI, V52, P1089, DOI 10.1111/j.1556-4029.2007.00517.x; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404	6	293	304	7	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					805	805		10.1126/science.1157199	http://dx.doi.org/10.1126/science.1157199			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687956				2022-12-28	WOS:000258261000036
J	Quinton, PM				Quinton, Paul M.			Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis	LANCET			English	Article							INTRALUMINAL ORGANIZATION; AIRWAY; MUCINS; CELLS; ION; PH	For more than 20 years, the abnormally thick mucus (mucoviscidosis) in cystic fibrosis has been widely shown to be linked to a genetic defect in the cystic fibrosis transmembrane conductance regulator Cl- channel. The defect is widely thought to cause mucus to become dehydrated as a result of basic defects in Cl- dependent fluid transport. However, this widely held explanation is inconsistent with the known physiological properties and functions of organs affected by cystic fibrosis. During the process of releasing highly condensed mucins from intracellular granules, Ca2(+) and H+ cations must be removed to enable the mucins to expand by as much as 1000 times, forming extracellular mucus-gel networks. Over the past few years, that HCO3- transport is also defective in patients with cystic fibrosis has become apparent. I propose that HCO3- is crucial to normal mucin expansion because it forms complexes with these cations. Thus, because HCO3- secretion is defective in cystic fibrosis, mucins in organs affected by cystic fibrosis tend to remain aggregated, poorly solubilised, and less transportable. If the hypothesis is valid, pathogenesis in cystic fibrosis could be due as much to defective transport of HCO3- as to defective Cl- transport.	Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif Riverside, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California Riverside	Quinton, PM (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pquinton@ucsd.edu			NHLBI NIH HHS [R01-HL084042] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084042] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen A, 1998, INT J BIOCHEM CELL B, V30, P797, DOI 10.1016/S1357-2725(98)00028-4; Bodian M, 1953, FIBROCYSTIC DIS PANC; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Burgel PR, 2007, THORAX, V62, P153, DOI 10.1136/thx.2006.062190; Davies JR, 2002, NOVART FDN SYMP, V248, P76; DISCHE Z, 1959, ARCH BIOCHEM BIOPHYS, V84, P205, DOI 10.1016/0003-9861(59)90571-5; Espinosa M, 2002, HUM REPROD, V17, P1964, DOI 10.1093/humrep/17.8.1964; FREEDMAN SD, 1994, ANN NY ACAD SCI, V713, P199, DOI 10.1111/j.1749-6632.1994.tb44066.x; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Hays SR, 2006, AM J RESP CRIT CARE, V174, P1018, DOI 10.1164/rccm.200603-310OC; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Leir SH, 2005, AM J RESP CELL MOL, V32, P453, DOI 10.1165/rcmb.2004-0306OC; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; Perez-Vilar J, 2006, J BIOL CHEM, V281, P4844, DOI 10.1074/jbc.M510520200; Perez-Vilar J, 2005, J BIOL CHEM, V280, P16868, DOI 10.1074/jbc.M413289200; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; QUINTON PM, 2001, HCO3 CYSTIC FIBROSIS; Trout L, 1998, AM J PHYSIOL-LUNG C, V274, pL258, DOI 10.1152/ajplung.1998.274.2.L258; VERDUGO P, 1990, BIORHEOLOGY, V27, P465; VERDUGO P, 1987, J DENT RES, V66, P506, DOI 10.1177/00220345870660022001; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF	22	270	274	2	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					415	417		10.1016/S0140-6736(08)61162-9	http://dx.doi.org/10.1016/S0140-6736(08)61162-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18675692	Green Submitted			2022-12-28	WOS:000258196000033
J	Fluckiger, J				Flueckiger, Jacqueline			Climate change - Did you say "fast"?	SCIENCE			English	Editorial Material							HULU CAVE; RESOLUTION; CIRCULATION; RECORD		ETH, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Fluckiger, J (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Universitatstr 16, CH-8092 Zurich, Switzerland.	jacqueline.flueckiger@env.ethz.ch	Fluckiger, Jacqueline/G-3457-2011					Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Brauer A, 1999, QUATERNARY SCI REV, V18, P321, DOI 10.1016/S0277-3791(98)00084-5; Fluckiger J, 2008, CLIM DYNAM, V31, P633, DOI 10.1007/s00382-008-0373-y; GLUCKIGER J, 2004, GLOBAL BIOGEOCHEM CY, V18, P23513; Hendy IL, 2003, QUATERNARY SCI REV, V22, P673, DOI 10.1016/S0277-3791(02)00186-5; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; Treble PC, 2007, CHEM GEOL, V238, P197, DOI 10.1016/j.chemgeo.2006.11.009; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618	12	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					650	651		10.1126/science.1159821	http://dx.doi.org/10.1126/science.1159821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669851				2022-12-28	WOS:000258077700030
J	Carpenter, KE; Abrar, M; Aeby, G; Aronson, RB; Banks, S; Bruckner, A; Chiriboga, A; Cortes, J; Delbeek, JC; DeVantier, L; Edgar, GJ; Edwards, AJ; Fenner, D; Guzman, HM; Hoeksema, BW; Hodgson, G; Johan, O; Licuanan, WY; Livingstone, SR; Lovell, ER; Moore, JA; Obura, DO; Ochavillo, D; Polidoro, BA; Precht, WF; Quibilan, MC; Reboton, C; Richards, ZT; Rogers, AD; Sanciangco, J; Sheppard, A; Sheppard, C; Smith, J; Stuart, S; Turak, E; Veron, JEN; Wallace, C; Weil, E; Wood, E				Carpenter, Kent E.; Abrar, Muhammad; Aeby, Greta; Aronson, Richard B.; Banks, Stuart; Bruckner, Andrew; Chiriboga, Angel; Cortes, Jorge; Delbeek, J. Charles; DeVantier, Lyndon; Edgar, Graham J.; Edwards, Alasdair J.; Fenner, Douglas; Guzman, Hector M.; Hoeksema, Bert W.; Hodgson, Gregor; Johan, Ofri; Licuanan, Wilfredo Y.; Livingstone, Suzanne R.; Lovell, Edward R.; Moore, Jennifer A.; Obura, David O.; Ochavillo, Domingo; Polidoro, Beth A.; Precht, William F.; Quibilan, Miledel C.; Reboton, Clarissa; Richards, Zoe T.; Rogers, Alex D.; Sanciangco, Jonnell; Sheppard, Anne; Sheppard, Charles; Smith, Jennifer; Stuart, Simon; Turak, Emre; Veron, John E. N.; Wallace, Carden; Weil, Ernesto; Wood, Elizabeth			One-third of reef-building corals face elevated extinction risk from climate change and local impacts	SCIENCE			English	Article							DISEASE	The conservation status of 845 zooxanthellate reef- building coral species was assessed by using International Union for Conservation of Nature Red List Criteria. Of the 704 species that could be assigned conservation status, 32.8% are in categories with elevated risk of extinction. Declines in abundance are associated with bleaching and diseases driven by elevated sea surface temperatures, with extinction risk further exacerbated by local- scale anthropogenic disturbances. The proportion of corals threatened with extinction has increased dramatically in recent decades and exceeds that of most terrestrial groups. The Caribbean has the largest proportion of corals in high extinction risk categories, whereas the Coral Triangle ( western Pacific) has the highest proportion of species in all categories of elevated extinction risk. Our results emphasize the widespread plight of coral reefs and the urgent need to enact conservation measures.	[Carpenter, Kent E.; Livingstone, Suzanne R.; Polidoro, Beth A.; Sanciangco, Jonnell; Smith, Jennifer] Old Dominion Univ, IUCN Species Programme SSC & CI Global Marine Spe, Norfolk, VA 23529 USA; [Abrar, Muhammad] Indonesian Inst Sci, Res Ctr Oceanog, Jakarta, Indonesia; [Aeby, Greta] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Aronson, Richard B.] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Banks, Stuart] Charles Darwin Res Stn Puerto Ayora, Santa Cruz, Galapagos, Ecuador; [Bruckner, Andrew] NOAA Fisheries, Silver Spring, MD 20910 USA; [Bruckner, Andrew] NOAA Coral Reef Conservat Program, Silver Spring, MD 20910 USA; [Chiriboga, Angel] Brown Univ, Providence, RI 02912 USA; [Cortes, Jorge] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol CIMAR, San Jose, Costa Rica; [Delbeek, J. Charles] Univ Hawaii Manoa, Waikiki Aquarium, Honolulu, HI 96822 USA; [DeVantier, Lyndon; Turak, Emre; Veron, John E. N.] Coral Reef Res, Townsville, Qld 4811, Australia; [Edgar, Graham J.] CI, CABS, Arlington, VA 22202 USA; [Edgar, Graham J.] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas 7011, Australia; [Edwards, Alasdair J.] Univ Newcastle, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fenner, Douglas] Dept Marine & Wildlife Resources, Pago Pago, AS USA; [Guzman, Hector M.] Smithsonian Trop Res Inst, Balboa 084303092, Panama; [Hoeksema, Bert W.] Natl Museum Nat Hist Naturalis, NL-2333 AA Leiden, Netherlands; [Hodgson, Gregor] Reef Check Fdn, Pacific Palisades, CA 90272 USA; [Johan, Ofri] Res Ctr Aquaculture, Jakarta, Indonesia; [Licuanan, Wilfredo Y.] De La Salle Univ, Dept Biol, Manila, Philippines; [Licuanan, Wilfredo Y.] De La Salle Univ, Shields Marine Stn, Manila, Philippines; [Lovell, Edward R.] Univ S Pacific, Sch Marine Studies, Suva, Fiji; [Moore, Jennifer A.] NOAA, Fisheries Serv, Protected Resources Div, St Petersburg, FL 33701 USA; [Obura, David O.] CORDIO E Africa, Mombasa, Kenya; [Ochavillo, Domingo] Reef Check Philippines, Manila, Philippines; [Precht, William F.] NOAA, Florida Keys Natl Marine Sanctuary, Damage Assessment & Restorat Program, Key Largo, FL 33040 USA; [Quibilan, Miledel C.] CI Philippines, Sulu Sulawesi Seascape Program, Quezon City, Philippines; [Reboton, Clarissa] Silliman Univ, Inst Environm & Marine Sci, Dumaguete, Philippines; [Richards, Zoe T.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Rogers, Alex D.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Sheppard, Anne; Sheppard, Charles] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Stuart, Simon] Conservat Int, IUCN SSC, Norfolk, VA 23529 USA; [Stuart, Simon] Conservat Int, CI CABS Biodivers Assessment Unit, Norfolk, VA 23529 USA; [Wallace, Carden] Museum Trop Queensland, Townsville, Qld 4810, Australia; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Lajas, PR USA; [Wood, Elizabeth] Marine Conservat Soc, Ross On Wye, Herts, England	Old Dominion University; Indonesian Institute of Sciences; Dauphin Island Sea Lab; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Brown University; Universidad Costa Rica; University of Hawaii System; University of Hawaii Manoa; University of Tasmania; Newcastle University - UK; Smithsonian Institution; Smithsonian Tropical Research Institute; Naturalis Biodiversity Center; De La Salle University; De La Salle University; University of the South Pacific; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Silliman University; James Cook University; Zoological Society of London; University of Warwick; Conservation International; Conservation International; University of Puerto Rico; University of Puerto Rico Mayaguez	Carpenter, KE (corresponding author), Old Dominion Univ, IUCN Species Programme SSC & CI Global Marine Spe, Norfolk, VA 23529 USA.	kcarpent@odu.edu	Cortés, Jorge/AAC-9782-2020; Hoeksema, Bert W/B-2973-2010; Edwards, Alasdair J/C-9558-2009; Weil, Ernesto/AAI-3591-2020; Hoeksema, Bert W./U-8530-2019; Edgar, Graham/AAY-3797-2020; Edgar, Graham/C-8341-2013; Weil, Ernesto/ABF-1290-2020	Cortés, Jorge/0000-0001-7004-8649; Hoeksema, Bert W/0000-0001-8259-3783; Edwards, Alasdair J/0000-0002-2979-7389; Hoeksema, Bert W./0000-0001-8259-3783; Edgar, Graham/0000-0003-0833-9001; Edgar, Graham/0000-0003-0833-9001; Weil, Ernesto/0000-0001-5275-1584; Obura, David/0000-0003-2256-6649; sheppard, charles/0000-0002-2579-5124; Aronson, Richard/0000-0003-0383-3844; Guzman, Hector M./0000-0001-9928-8523; Licuanan, Wilfredo/0000-0001-7697-5902; Sheppard, Anne/0000-0003-4686-5256; Sanciangco, Jonnell Cueto/0000-0001-8268-3180; Abrar, Muhammad/0000-0002-9192-4043				Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; FRIEDLANDER A, 2005, STATE CORAL REEF ECO, P222; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Guzman HM, 2007, MAR BIOL, V151, P401, DOI 10.1007/s00227-006-0495-x; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoeksema Bert W., 2007, V29, P117; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kiessling W, 2004, PALAEOGEOGR PALAEOCL, V214, P195, DOI 10.1016/j.palaeo.2004.05.025; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 2008, REEF TIME GREAT BARR; WILKINSON C, 2004, STAT CORAL REEFS WOR; WILKINSON C, 2000, STAT CORAL REEFS WOR	24	885	920	20	819	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					560	563		10.1126/science.1159196	http://dx.doi.org/10.1126/science.1159196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653892				2022-12-28	WOS:000257888900047
J	Galli, SJ; Tsai, M; Piliponsky, AM				Galli, Stephen J.; Tsai, Mindy; Piliponsky, Adrian M.			The development of allergic inflammation	NATURE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; MAST-CELL ACTIVATION; REGULATORY T-CELLS; ATOPIC-DERMATITIS; HYGIENE HYPOTHESIS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; BRONCHIAL-ASTHMA; DENDRITIC CELLS; NERVOUS-SYSTEM	Allergic disorders, such as anaphylaxis, hay fever, eczema and asthma, now afflict roughly 25% of people in the developed world. In allergic subjects, persistent or repetitive exposure to allergens, which typically are intrinsically innocuous substances common in the environment, results in chronic allergic inflammation. This in turn produces long-term changes in the structure of the affected organs and substantial abnormalities in their function. It is therefore important to understand the characteristics and consequences of acute and chronic allergic inflammation, and in particular to explore how mast cells can contribute to several features of this maladaptive pattern of immunological reactivity.	[Galli, Stephen J.; Tsai, Mindy; Piliponsky, Adrian M.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.	sgalli@stanford.edu		Tsai, Mindy/0000-0002-8421-4721	NCI NIH HHS [R01 CA072074-15, R01 CA072074] Funding Source: Medline; NIAID NIH HHS [R01 AI023990-20, R01 AI070813-01, R01 AI070813, R01 AI023990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070813, R01AI023990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akdis CA, 2004, CURR OPIN IMMUNOL, V16, P717, DOI 10.1016/j.coi.2004.09.004; Akdis M, 2007, J ALLERGY CLIN IMMUN, V119, P780, DOI 10.1016/j.jaci.2007.01.022; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2006, TRENDS MOL MED, V12, P515, DOI 10.1016/j.molmed.2006.09.006; Bonness S, 2007, CURR OPIN ALLERGY CL, V7, P382, DOI 10.1097/ACI.0b013e3282a643c3; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Bradding P, 1996, ANN NY ACAD SCI, V796, P272, DOI 10.1111/j.1749-6632.1996.tb32589.x; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brown JM, 2008, CLIN EXP ALLERGY, V38, P4, DOI 10.1111/j.1365-2222.2007.02886.x; Burgel PR, 2001, J IMMUNOL, V167, P5948, DOI 10.4049/jimmunol.167.10.5948; Casale TB, 2001, JAMA-J AM MED ASSOC, V286, P2956, DOI 10.1001/jama.286.23.2956; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Cevikbas F, 2007, CURR OPIN ALLERGY CL, V7, P365, DOI 10.1097/ACI.0b013e3282a644d2; Chanez P, 1998, AM J RESP CRIT CARE, V158, P985, DOI 10.1164/ajrccm.158.3.9608104; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Dickey BF, 2007, NEW ENGL J MED, V357, P2082, DOI 10.1056/NEJMe0706634; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1986, RETICULOENDOTHELIAL, V9, P321; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gern JE, 2002, NAT REV IMMUNOL, V2, P132, DOI 10.1038/nri725; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hall IP, 2007, EUR RESPIR J, V29, P1239, DOI 10.1183/09031936.00088206; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Holgate ST, 2005, CLIN EXP ALLERGY, V35, P408, DOI 10.1111/j.1365-2222.2005.02191.x; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; Joos GF, 2003, ANN NY ACAD SCI, V992, P218, DOI 10.1111/j.1749-6632.2003.tb03152.x; Kasperska-Zajac A, 2007, INFLAMMATION, V30, P161, DOI 10.1007/s10753-007-9033-3; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kay AB, 2007, ALLERGY, V62, P495, DOI 10.1111/j.1398-9995.2007.01342.x; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Konig P, 1996, J ALLERGY CLIN IMMUN, V98, pS96; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lalloo UG, 1996, J ALLERGY CLIN IMMUN, V98, pS91, DOI 10.1016/S0091-6749(96)80134-5; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Lewis MJ, 2006, RESP MED, V100, P1688, DOI 10.1016/j.rmed.2006.01.019; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lucas SR, 2005, J ALLERGY CLIN IMMUN, V115, P928, DOI 10.1016/j.jaci.2005.01.033; MacGlashan Donald Jr, 2002, Curr Allergy Asthma Rep, V2, P126, DOI 10.1007/s11882-002-0007-0; Marone G, 2005, TRENDS IMMUNOL, V26, P25, DOI 10.1016/j.it.2004.10.010; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Min B, 2008, NAT IMMUNOL, V9, P223, DOI 10.1038/ni0308-223; OLLERENSHAW SL, 1991, EUR RESPIR J, V4, P673; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ownby DR, 2003, CURR OPIN ALLERGY CL, V3, P517, DOI 10.1097/01.all.0000104444.09202.ae; Pawankar R, 2004, IMMUNOL ALLERGY CLIN, V24, P75, DOI 10.1016/S0889-8561(03)00109-7; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Platts-Mills TAE, 2004, SPRINGER SEMIN IMMUN, V25, P271, DOI 10.1007/s00281-003-0149-8; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Romagnani S, 2007, J ALLERGY CLIN IMMUN, V119, P1511, DOI 10.1016/j.jaci.2007.04.005; Ryan JJ, 2007, CRIT REV IMMUNOL, V27, P15, DOI 10.1615/CritRevImmunol.v27.i1.20; Saito H, 2001, INT ARCH ALLERGY IMM, V125, P1, DOI 10.1159/000053790; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Sandilands A, 2007, J INVEST DERMATOL, V127, P1282, DOI 10.1038/sj.jid.5700876; Sarin S, 2006, J ALLERGY CLIN IMMUN, V118, P999, DOI 10.1016/j.jaci.2006.09.013; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Silverstein AM, 2000, NAT IMMUNOL, V1, P453, DOI 10.1038/82691; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Takano K, 2005, J HISTOCHEM CYTOCHEM, V53, P611, DOI 10.1369/jhc.4A6539.2005; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Von Pirquet C., 1906, MUNCHEN MED WOCHEN, V30, P1457; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Ying S, 2006, J ALLERGY CLIN IMMUN, V118, P1386, DOI 10.1016/j.jaci.2006.08.030; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219	100	1201	1270	5	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					445	454		10.1038/nature07204	http://dx.doi.org/10.1038/nature07204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650915	Green Accepted			2022-12-28	WOS:000257860300039
J	Ackert, RP; Becker, RA; Singer, BS; Kurz, MD; Caffee, MW; Mickelson, DM				Ackert, Robert P., Jr.; Becker, Richard A.; Singer, Brad S.; Kurz, Mark D.; Caffee, Marc W.; Mickelson, David M.			Patagonian glacier response during the late glacial-holocene transition	SCIENCE			English	Article							CLIMATE-CHANGE; SOUTHERN ANDES; LAGO-CARDIEL; ARGENTINA; HISTORY; RECORD; AGE; PLEISTOCENE; ICEFIELD; VALLEY	Whether cooling occurred in the Southern Hemisphere during the Younger Dryas (YD) is key to understanding mechanisms of millennial climate change. Although Southern Hemisphere records do not reveal a distinct climate reversal during the late glacial period, many mountain glaciers readvanced. We show that the Puerto Bandera moraine (50 degrees S), which records a readvance of the Southern Patagonian Icefield (SPI), formed at, or shortly after, the end of the YD. The exposure age (10.8 +/- 0.5 thousand years ago) is contemporaneous with the highest shoreline of Lago Cardiel (49 degrees S), which records peak precipitation east of the Andes since 13 thousand years ago. Absent similar moraines west of the Andes, these data indicate an SPI response to increased amounts of easterly-sourced precipitation-reflecting changes in the Southern Westerly circulation-rather than regional cooling.	[Ackert, Robert P., Jr.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Becker, Richard A.; Singer, Brad S.; Mickelson, David M.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Kurz, Mark D.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Caffee, Marc W.] Purdue Univ, Purdue Rare Isotope Measurement Lab, W Lafayette, IN 47907 USA	Harvard University; University of Wisconsin System; University of Wisconsin Madison; Woods Hole Oceanographic Institution; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ackert, RP (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	rackert@fas.harvard.edu	Singer, Bradley/F-4991-2012	Singer, Bradley/0000-0003-3595-5168; Kurz, Mark/0000-0003-1745-2356				Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Applegate PJ, 2008, SCIENCE, V320, DOI 10.1126/science.1152098; ASHWORTH AC, 1994, ANTHROPOLOGIE, V98, P3; Barrows TT, 2007, SCIENCE, V318, P86, DOI 10.1126/science.1145873; Bennett KD, 2000, SCIENCE, V290, P325, DOI 10.1126/science.290.5490.325; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; Douglass DC, 2006, QUAT GEOCHRONOL, V1, P43, DOI 10.1016/j.quageo.2006.06.001; Gilli A, 2001, TERRA NOVA, V13, P443, DOI 10.1046/j.1365-3121.2001.00377.x; Glasser NF, 2006, QUATERNARY RES, V65, P70, DOI 10.1016/j.yqres.2005.09.002; Heusser CJ, 2002, J S AM EARTH SCI, V15, P577, DOI 10.1016/S0895-9811(02)00076-7; Ivy-Ochs S, 1999, GEOGR ANN A, V81A, P313, DOI 10.1111/1468-0459.00060; Lamy F, 2004, SCIENCE, V304, P1959, DOI 10.1126/science.1097863; Markgraf V, 2003, HOLOCENE, V13, P581, DOI 10.1191/0959683603hl648rp; MERCER JH, 1976, QUATERNARY RES, V6, P125, DOI 10.1016/0033-5894(76)90047-8; MERCER JH, 1968, AM J SCI, V266, P91, DOI 10.2475/ajs.266.2.91; PETEET D, 1995, QUATERN INT, V28, P93, DOI 10.1016/1040-6182(95)00049-O; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Stenni B, 2004, EARTH PLANET SC LETT, V217, P183, DOI 10.1016/S0012-821X(03)00574-0; STINE S, 1990, NATURE, V345, P705, DOI 10.1038/345705a0; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Strelin JA, 2000, QUATERNARY RES, V54, P339, DOI 10.1006/qres.2000.2178; Sugden DE, 2005, GEOGR ANN A, V87A, P273, DOI 10.1111/j.0435-3676.2005.00259.x; Turner KJ, 2005, GEOGR ANN A, V87A, P363, DOI 10.1111/j.0435-3676.2005.00263.x; Wenzens G, 1999, QUATERNARY RES, V51, P238, DOI 10.1006/qres.1999.2043	25	58	58	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					392	395		10.1126/science.1157215	http://dx.doi.org/10.1126/science.1157215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635799				2022-12-28	WOS:000257713900046
J	Tu, L; Tai, WCS; Chen, L; Banfield, DK				Tu, Linna; Tai, William C. S.; Chen, Lu; Banfield, David K.			Signal-mediated dynamic retention of glycosyltransferases in the Golgi	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; KIN RECOGNITION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; HELA-CELLS; LOCALIZATION; TRANSMEMBRANE; APPARATUS; PROTEOMICS; SEQUENCES	Golgi-resident glycosyltransferases are a family of enzymes that sequentially modify glycoproteins in a subcompartment-specific manner. These type II integral membrane proteins are characterized by a short cytoplasmically exposed amino-terminal tail and a luminal enzymatic domain. The cytoplasmic tails play a role in the localization of glycosyltransferases, and coat protein complex I (COPI) vesicle-mediated retrograde transport is also involved in their Golgi localization. However, the tails of these enzymes lack known COPI-binding motifs. Here, we found that Vps74p bound to a pentameric motif present in the cytoplasmic tails of the majority of yeast Golgi-localized glycosyltransferases, as well as to COPI. We propose that Vps74p maintains the steady-state localization of Golgi glycosyltransferases dynamically, by promoting their incorporation into COPI-coated vesicles.	[Tu, Linna; Tai, William C. S.; Chen, Lu; Banfield, David K.] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Banfield, DK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	bodkb@ust.hk		Tu, Linna/0000-0003-0162-2162; Tai, William Chi-Shing/0000-0002-0771-7894				BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; BURKE J, 1992, J BIOL CHEM, V267, P24433; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; LUSSIER M, 1995, J CELL BIOL, V131, P913, DOI 10.1083/jcb.131.4.913; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nagano-Ito M, 2007, GENE, V400, P82, DOI 10.1016/j.gene.2007.06.007; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nilsson T, 1996, J CELL SCI, V109, P1975; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Opat AS, 2001, BIOCHIMIE, V83, P763, DOI 10.1016/S0300-9084(01)01312-8; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Romero PA, 1999, GLYCOBIOLOGY, V9, P1045, DOI 10.1093/glycob/9.10.1045; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x	26	170	173	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					404	407		10.1126/science.1159411	http://dx.doi.org/10.1126/science.1159411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635803				2022-12-28	WOS:000257713900050
J	Keitt, TH				Keitt, Timothy H.			Coherent ecological dynamics induced by large-scale disturbance	NATURE			English	Article							COMPENSATORY DYNAMICS; COMMUNITY DYNAMICS; CURRENT KNOWLEDGE; BIODIVERSITY; ACIDIFICATION; VARIABILITY; SYNCHRONY; STABILITY; WAVELETS	Aggregate community- level response to disturbance is a principle concern in ecology because post- disturbance dynamics are integral to the ability of ecosystems to maintain function in an uncertain world. Community- level responses to disturbance can be arrayed along a spectrum ranging from synchronous oscillations where all species rise and fall together, to compensatory dynamics where total biomass remains relatively constant despite fluctuations in the densities of individual species(1). An important recent insight is that patterns of synchrony and compensation can vary with the timescale of analysis(2) and that spectral time series methods can enable detection of coherent dynamics that would otherwise be obscured by opposing patterns occurring at different scales(3). Here I show that application of wavelet analysis to experimentally manipulated plankton communities reveals strong synchrony after disturbance. The result is paradoxical because it is well established that these communities contain both disturbance- sensitive and disturbance- tolerant species leading to compensation within functional groups(4,5). Theory predicts that compensatory substitution of functionally equivalent species should stabilize ecological communities(6-10), yet I found at the whole- community level a large increase in seasonal biomass variation. Resolution of the paradox hinges on patterns of seasonality among species. The compensatory shift in community composition after disturbance resulted in a loss of cold- season dominants, which before disturbance had served to stabilize biomass throughout the year. Species dominating the disturbed community peaked coherently during the warm season, explaining the observed synchrony and increase in seasonal biomass variation. These results suggest that theory relating compensatory dynamics to ecological stability needs to consider not only complementarity in species responses to environmental change, but also seasonal complementarity among disturbance- tolerant and disturbance- sensitive species.	Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Keitt, TH (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	tkeitt@mail.utexas.edu	Keitt, Timothy/AAF-9787-2021	Keitt, Timothy/0000-0002-4587-1083				Benjamini Y, 2001, ANN STAT, V29, P1165; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Daubechies I., 1992, 10 LECT WAVELETS, V61; DOWNING AL, IN PRESS ECOLOGY; Ernest SKM, 2001, ECOLOGY, V82, P2118, DOI 10.2307/2680220; Fischer JM, 2001, ECOL APPL, V11, P1060, DOI 10.1890/1051-0761(2001)011[1060:CDIZCR]2.0.CO;2; FORST TM, 2005, LONG TERM DYNAMICS L; Frost TM, 2006, ECOL APPL, V16, P353, DOI 10.1890/04-1800; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Keitt TH, 2006, ECOLOGY, V87, P2895, DOI 10.1890/0012-9658(2006)87[2895:DOSCDU]2.0.CO;2; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Micheli F, 1999, OIKOS, V85, P161, DOI 10.2307/3546802; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PERCIVAL DB, 2002, CAMBRIDGE SERIES STA; Rao J. S., 2001, TOPICS CIRCULAR STAT; Solow AR, 2007, ECOSYSTEMS, V10, P1034, DOI 10.1007/s10021-007-9076-1; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Vasseur DA, 2007, ECOL LETT, V10, P1066, DOI 10.1111/j.1461-0248.2007.01099.x; Vasseur DA, 2007, ECOLOGY, V88, P2058, DOI 10.1890/06-1899.1	29	81	82	5	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					331	U39		10.1038/nature06935	http://dx.doi.org/10.1038/nature06935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633416				2022-12-28	WOS:000257665300038
J	Grossman, CM				Grossman, Charles M.			The first use of penicillin in the United States	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Legacy Good Samaritan Hosp, Portland, OR 97210 USA		Grossman, CM (corresponding author), Legacy Good Samaritan Hosp, 1015 NW 22nd Ave, Portland, OR 97210 USA.							Abraham EP, 1941, LANCET, V2, P177; CURTIS J, 2000, FULTON PENICILLIN CH; Dohrmann G J, 1975, Surg Neurol, V3, P277; FULTON JF, 1942, DAIRY, V18, P9; GOODMAN LS, 1980, PHARMACOL BASIS THER, P1127; RICHARDS AN, 1964, NATURE, V201, P441, DOI 10.1038/201441a0; TAGER M, 1976, YALE J BIOL MED, V49, P391	7	31	33	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					135	136		10.7326/0003-4819-149-2-200807150-00009	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626052				2022-12-28	WOS:000257853700007
J	Stringer, JSA; Chi, BH				Stringer, Jeffrey S. A.; Chi, Benjamin H.			Extended nevirapine prophylaxis to prevent HIV transmission	LANCET			English	Editorial Material							CHILDREN		[Stringer, Jeffrey S. A.; Chi, Benjamin H.] Univ Alabama Birmingham, CIDRZ, Lusaka, Zambia		Stringer, JSA (corresponding author), Univ Alabama Birmingham, CIDRZ, Lusaka, Zambia.	stringer@cidrz.org	Stringer, Jeffrey S. A./AAU-2342-2021	Stringer, Jeffrey/0000-0002-9590-7216				Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; *CLINICALTRIALSGOV, 2008, EFF SAF INF PER PROP; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; Taha TE, 2003, LANCET, V362, P1171, DOI 10.1016/S0140-6736(03)14538-2; *WHO UNICEF UNAIDS, 2008, UN ACC SCAL PRIOR HI	9	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					267	269		10.1016/S0140-6736(08)61087-9	http://dx.doi.org/10.1016/S0140-6736(08)61087-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657690				2022-12-28	WOS:000258042800006
J	Reed, TE; Daunt, F; Hall, ME; Phillips, RA; Wanless, S; Cunningham, EJA				Reed, T. E.; Daunt, F.; Hall, M. E.; Phillips, R. A.; Wanless, S.; Cunningham, E. J. A.			Parasite treatment affects maternal investment in sons	SCIENCE			English	Article							SEX-RATIO	Parasitism can be a major constraint on host condition and an important selective force. Theoretical and empirical evidence shows that maternal condition affects relative investment in sons and daughters; however, the effect of parasitism on sex ratio in vertebrates is seldom considered. We demonstrate experimentally that parasitism constrains the ability of mothers to rear sons in a long- lived seabird, the European shag Phalacrocorax aristotelis. The effect contributes to the decline in offspring survival as the breeding season progresses and hence has important population- level consequences for this, and potentially other, seasonal breeders.	[Reed, T. E.; Cunningham, E. J. A.] Univ Edinburgh, Inst Evolut Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Reed, T. E.; Daunt, F.; Wanless, S.] NERC Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Hall, M. E.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Phillips, R. A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Edinburgh; UK Centre for Ecology & Hydrology (UKCEH); University of Glasgow; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Reed, TE (corresponding author), Univ Edinburgh, Inst Evolut Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	tomreed@u.washington.edu	Cunningham, Emma/I-9190-2012; Hall, Maggie/C-7906-2009; Reed, Thomas E/A-5788-2012; Daunt, Francis/K-6688-2012; Wanless, Sarah/K-2338-2012	Reed, Thomas E/0000-0002-2993-0477; Daunt, Francis/0000-0003-4638-3388; Wanless, Sarah/0000-0002-2788-4606	University of Edinburgh; Royal Society; NERC CASE; The Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council [CEH010021, bas010017] Funding Source: researchfish; NERC [bas010017] Funding Source: UKRI	University of Edinburgh; Royal Society(Royal Society of London); NERC CASE(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); The Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Harris, M. Frederiksen, L. Kruuk, S. Reece, S. West, P. Monaghan, and A. Young for helpful discussion and A. Kiploks and M. Newell for invaluable field assistance. Thanks also to M. Melo, S. Preuss, and J. Pemberton (University of Edinburgh) and K. Griffiths and A. Adams (University of Glasgow) for help with molecular sexing; B. Craig and A. Meredith for advice on parasitology; and H.-P. Fagerholm, D. Gibson, and M. Blaxter for nematode identification. Special thanks to Scottish Natural Heritage for permission to work on the island and the Isle of May Bird Observatory for help maintaining the marked population of shags. This work was supported by a Principal's Studentship to T. E. R. from the University of Edinburgh, a fellowship to E. J. A. C. from the Royal Society, and a NERC CASE studentship to M. E. H. The Association for the Study of Animal Behaviour (ASAB) funded the logger work.	CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; Moller AP, 1998, OIKOS, V83, P301, DOI 10.2307/3546841; Moreno J, 1998, OECOLOGIA, V115, P312, DOI 10.1007/s004420050522; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90	8	28	28	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1681	1682		10.1126/science.1159466	http://dx.doi.org/10.1126/science.1159466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18687923				2022-12-28	WOS:000259300400037
J	Stefansson, H; Rujescu, D; Cichon, S; Pietilainen, OPH; Ingason, A; Steinberg, S; Fossdal, R; Sigurdsson, E; Sigmundsson, T; Buizer-Voskamp, JE; Hansen, T; Jakobsen, KD; Muglia, P; Francks, C; Matthews, PM; Gylfason, A; Halldorsson, BV; Gudbjartsson, D; Thorgeirsson, TE; Sigurdsson, A; Jonasdottir, A; Jonasdottir, A; Bjornsson, A; Mattiasdottir, S; Blondal, T; Haraldsson, M; Magnusdottir, BB; Giegling, I; Moller, HJ; Hartmann, A; Shianna, KV; Ge, DL; Need, AC; Crombie, C; Fraser, G; Walker, N; Lonnqvist, J; Suvisaari, J; Tuulio-Henriksson, A; Paunio, T; Toulopoulou, T; Bramon, E; Di Forti, M; Murray, R; Ruggeri, M; Vassos, E; Tosato, S; Walshe, M; Li, T; Vasilescu, C; Muhleisen, TW; Wang, AG; Ullum, H; Djurovic, S; Melle, I; Olesen, J; Kiemeney, LA; Franke, B; Sabatti, C; Freimer, NB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Andreassen, OA; Ophoff, RA; Georgi, A; Rietschel, M; Werge, T; Petursson, H; Goldstein, DB; Nothen, MM; Peltonen, L; Collier, DA; St Clair, D; Stefansson, K				Stefansson, Hreinn; Rujescu, Dan; Cichon, Sven; Pietilainen, Olli P. H.; Ingason, Andres; Steinberg, Stacy; Fossdal, Ragnheidur; Sigurdsson, Engilbert; Sigmundsson, Thordur; Buizer-Voskamp, Jacobine E.; Hansen, Thomas; Jakobsen, Klaus D.; Muglia, Pierandrea; Francks, Clyde; Matthews, Paul M.; Gylfason, Arnaldur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel; Thorgeirsson, Thorgeir E.; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Bjornsson, Asgeir; Mattiasdottir, Sigurborg; Blondal, Thorarinn; Haraldsson, Magnus; Magnusdottir, Brynja B.; Giegling, Ina; Moeller, Hans-Juergen; Hartmann, Annette; Shianna, Kevin V.; Ge, Dongliang; Need, Anna C.; Crombie, Caroline; Fraser, Gillian; Walker, Nicholas; Lonnqvist, Jouko; Suvisaari, Jaana; Tuulio-Henriksson, Annamarie; Paunio, Tiina; Toulopoulou, Timi; Bramon, Elvira; Di Forti, Marta; Murray, Robin; Ruggeri, Mirella; Vassos, Evangelos; Tosato, Sarah; Walshe, Muriel; Li, Tao; Vasilescu, Catalina; Muehleisen, Thomas W.; Wang, August G.; Ullum, Henrik; Djurovic, Srdjan; Melle, Ingrid; Olesen, Jes; Kiemeney, Lambertus A.; Franke, Barbara; Sabatti, Chiara; Freimer, Nelson B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Andreassen, Ole A.; Ophoff, Roel A.; Georgi, Alexander; Rietschel, Marcella; Werge, Thomas; Petursson, Hannes; Goldstein, David B.; Noethen, Markus M.; Peltonen, Leena; Collier, David A.; St Clair, David; Stefansson, Kari		GROUP	Large recurrent microdeletions associated with schizophrenia	NATURE			English	Article							FRAGILE-X-SYNDROME; GENOMIC DISORDERS; LINKAGE ANALYSIS; DELETION; GENES; AMPLIFICATION; CHROMOSOMES; IMPAIRMENT; PHENOTYPE; DEFICIT	Reduced fecundity, associated with severe mental disorders(1), places negative selection pressure on risk alleles and may explain, in part, why common variants have not been found that confer risk of disorders such as autism(2), schizophrenia(3) and mental retardation(4). Thus, rare variants may account for a larger fraction of the overall genetic risk than previously assumed. In contrast to rare single nucleotide mutations, rare copy number variations ( CNVs) can be detected using genome- wide single nucleotide polymorphism arrays. This has led to the identification of CNVs associated with mental retardation(4,5) and autism(2). In a genome- wide search for CNVs associating with schizophrenia, we used a population-based sample to identify de novo CNVs by analysing 9,878 transmissions from parents to offspring. The 66 de novo CNVs identified were tested for association in a sample of 1,433 schizophrenia cases and 33,250 controls. Three deletions at 1q21.1, 15q11.2 and 15q13.3 showing nominal association with schizophrenia in the first sample ( phase I) were followed up in a second sample of 3,285 cases and 7,951 controls ( phase II). All three deletions significantly associate with schizophrenia and related psychoses in the combined sample. The identification of these rare, recurrent risk variants, having occurred independently in multiple founders and being subject to negative selection, is important in itself. CNV analysis may also point the way to the identification of additional and more prevalent risk variants in genes and pathways involved in schizophrenia.	[Crombie, Caroline; Fraser, Gillian; St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland; [Stefansson, Hreinn; Ingason, Andres; Steinberg, Stacy; Fossdal, Ragnheidur; Gylfason, Arnaldur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel; Thorgeirsson, Thorgeir E.; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Bjornsson, Asgeir; Mattiasdottir, Sigurborg; Blondal, Thorarinn; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, CNS Div, IS-101 Reykjavik, Iceland; [Rujescu, Dan; Giegling, Ina; Moeller, Hans-Juergen; Hartmann, Annette] Univ Munich, Div Mol & Clin Neurobiol, Dept Psychiat, Genet Res Ctr, D-80336 Munich, Germany; [Cichon, Sven; Vasilescu, Catalina; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-53127 Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Pietilainen, Olli P. H.; Paunio, Tiina; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Biomedicum, Helsinki 00290, Finland; [Sigurdsson, Engilbert; Sigmundsson, Thordur; Haraldsson, Magnus; Magnusdottir, Brynja B.; Petursson, Hannes] Natl Univ Hosp Reykjavik, Dept Psychiat, IS-101 Reykjavik, Iceland; [Buizer-Voskamp, Jacobine E.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Netherlands Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Buizer-Voskamp, Jacobine E.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Hansen, Thomas; Jakobsen, Klaus D.; Werge, Thomas] Univ Copenhagen Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, DK-4000 Roskilde, Denmark; [Hansen, Thomas; Jakobsen, Klaus D.] Univ Copenhagen, Ctr Pharmacogenom, DK-2200 Copenhagen N, Denmark; [Muglia, Pierandrea; Francks, Clyde] GlaxoSmithKline R&D, Med Genet, I-37135 Verona, Italy; [Matthews, Paul M.] Hammersmith Hosp, GlaxoSmithKline, Clin Imaging Ctr, London W12 0NN, England; [Shianna, Kevin V.; Ge, Dongliang; Need, Anna C.; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Ctr Populat Genom & Pharmacogenet, Durham, NC 27708 USA; [Walker, Nicholas] Ravenscraig Hosp, Greenock PA16 9HA, Scotland; [Lonnqvist, Jouko; Suvisaari, Jaana; Tuulio-Henriksson, Annamarie; Paunio, Tiina] Natl Publ Hlth Inst, Dept Mental Hlth & Addict, FIN-00300 Helsinki, Finland; [Toulopoulou, Timi; Bramon, Elvira; Di Forti, Marta; Murray, Robin; Vassos, Evangelos; Walshe, Muriel; Li, Tao; Collier, David A.] Kings Coll London, Div Psychol Med & Social, Genet & Dev Psychiat Ctr, Inst Psychiat, London SE5 8AF, England; [Ruggeri, Mirella; Tosato, Sarah] Univ Verona, Sect Psychiat & Clin Psychol, I-37134 Verona, Italy; [Li, Tao; Collier, David A.] Sichuan Univ, W China Hosp, Dept Psychiat, Psychiat Lab, Chengdu 610041, Peoples R China; [Wang, August G.] Copenhagen Univ Hosp, Dept Clin Immunol, DK-2200 Copenhagen N, Denmark; [Ullum, Henrik] Copenhagen Univ Hosp, Mental Hlth Ctr Amager, DK-2300 Copenhagen S, Denmark; [Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Psychiat, N-0318 Oslo, Norway; [Djurovic, Srdjan; Melle, Ingrid; Andreassen, Ole A.] Ullevaal Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Djurovic, Srdjan; Melle, Ingrid; Andreassen, Ole A.] Ullevaal Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Olesen, Jes] Glostrup Cty Hosp, Dept Neurol, DK-2600 Glostrup, Denmark; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat EPIB 133, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol URO 659, NL-6500 HB Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Sabatti, Chiara] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Sabatti, Chiara] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Freimer, Nelson B.; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Georgi, Alexander; Rietschel, Marcella] Heidelberg Univ, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Peltonen, Leena] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [St Clair, David; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland	University of Aberdeen; University of Munich; University of Bonn; University of Bonn; Finland National Institute for Health & Welfare; University of Helsinki; Landspitali National University Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Copenhagen; University of Copenhagen; GlaxoSmithKline; GlaxoSmithKline; Imperial College London; Duke University; Finland National Institute for Health & Welfare; University of London; King's College London; University of Verona; Sichuan University; University of Copenhagen; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; University of Copenhagen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iceland	St Clair, D (corresponding author), Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland.	d.stclair@abdn.ac.uk; kari.stefansson@decode.is	Giegling, Ina/ABA-3677-2021; Stefansson, Kari/AAE-7187-2019; Sigurdsson, Engilbert/D-2486-2014; Andreassen, Ole A./AAY-7531-2020; Francks, Clyde/E-1384-2012; Krabbendam, Lydia/F-9163-2010; Ingason, Andres/G-6817-2012; Walshe, Muriel/E-5214-2010; St Clair, David/AAN-2412-2021; Nöthen, Markus/B-2027-2009; Muglia, Pierandrea/ABD-9235-2020; Cichon, Sven/B-9618-2014; Cichon, Sven/H-8803-2013; van Os, Jim/I-9496-2012; Kiemeney, Lambertus A./D-3357-2009; Melle, Ingrid S/B-4858-2011; Francks, Clyde/AGU-8875-2022; Werge, Thomas/G-7263-2012; Magnusdottir, Brynja/AAH-3482-2019; Hartmann, Annette/AAS-6331-2021; Toulopoulou, Timothea/F-4458-2011; Goldstein, David/AAY-8125-2020; Tosato, Sarah/E-6045-2010; Ruggeri, Mirella/E-6091-2010; Hansen, Thomas Folkmann/O-5965-2014; Franke, Barbara/D-4836-2009; Collier, David A/D-1649-2011; Bramon, Elvira/HHC-3809-2022; van Os, Jim/C-2113-2014; Vassos, Evangelos/F-9825-2013; Rujescu, Dan/GRS-3875-2022; Bramon, Elvira/A-9463-2011; Myin-Germeys, Inez/L-5106-2014; Walshe, Margaret/M-9102-2016; murray, robin/F-8658-2012	Sigurdsson, Engilbert/0000-0001-9404-7982; Francks, Clyde/0000-0002-9098-890X; Krabbendam, Lydia/0000-0003-4074-5149; Walshe, Muriel/0000-0001-6829-1105; Nöthen, Markus/0000-0002-8770-2464; Muglia, Pierandrea/0000-0002-3973-8606; Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; van Os, Jim/0000-0002-7245-1586; Kiemeney, Lambertus A./0000-0002-2368-1326; Melle, Ingrid S/0000-0002-9783-548X; Magnusdottir, Brynja/0000-0002-6131-7269; Tosato, Sarah/0000-0002-9665-7538; Hansen, Thomas Folkmann/0000-0001-6703-7762; Franke, Barbara/0000-0003-4375-6572; Collier, David A/0000-0003-4087-1559; Bramon, Elvira/0000-0003-1369-5983; Vassos, Evangelos/0000-0001-6363-0438; Myin-Germeys, Inez/0000-0002-3731-4930; Ge, David/0000-0002-9732-8170; Wang, August G./0000-0003-4518-0466; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Andreassen, Ole A./0000-0002-4461-3568; Ullum, Henrik/0000-0001-7306-9058; Suvisaari, Jaana/0000-0001-7167-0990; Djurovic, Srdjan/0000-0002-8140-8061; Need, Anna/0000-0003-3955-8207; Stefansson, Hreinn/0000-0002-9331-6666; Georgi, Alexander/0000-0002-1499-8524; Gudbjartsson, Daniel/0000-0002-5222-9857; Walshe, Margaret/0000-0003-3924-8073; Halldorsson, Bjarni/0000-0003-0756-0767; Olesen, Jes/0000-0002-6712-2702; murray, robin/0000-0003-0829-0519; Kong, Augustine/0000-0001-8193-5438; Matthews, Paul M/0000-0002-1619-8328; Li, Tao/0000-0003-3831-901X; Bruggeman, Richard/0000-0002-3238-8471	EU grant [LSHM-CT-2006-037761 ( Project SGENE)]; Simons Foundation; NIMH [R01 MH078075]; Chinese National Natural Science Foundation; National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF); Alfried Krupp von Bohlen und Halbach-Stiftung;  [R01MH71425-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075, R01MH071425] Funding Source: NIH RePORTER; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish	EU grant(European Commission); Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfried Krupp von Bohlen und Halbach-Stiftung; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Health Research(National Institute for Health Research (NIHR))	We want to thank the subjects and their relatives and staff at the recruitment centres. This work was sponsored by EU grant LSHM-CT-2006-037761 ( Project SGENE), Simons Foundation and R01MH71425-01A1. Genotyping of the Dutch samples was sponsored by NIMH funding, R01 MH078075. This work was also supported by the Chinese National Natural Science Foundation and the National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF). M.M.N. received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. We are grateful to S. Schreiber and M. Krawczak for providing genotype data for PopGen controls, and to K.- H. Jockel and R. Erbel for providing control individuals from the Heinz Nixdorf Recall Study. We thank L. Priebe and M. Alblas for technical assistance and analysis of CNV data from Bonn.	Bieche I, 1998, INT J CANCER, V78, P661, DOI 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.3.CO;2-9; BORGHGRAEF M, 1990, CLIN GENET, V37, P341; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Dimitropoulos Anastasia, 2007, Curr Psychiatry Rep, V9, P159; Erdogan F, 2007, AM J MED GENET A, V143A, P172, DOI 10.1002/ajmg.a.31541; Fernandes C, 2006, GENES BRAIN BEHAV, V5, P433, DOI 10.1111/j.1601-183X.2005.00176.x; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hancock ML, 2008, J CELL BIOL, V181, P511, DOI 10.1083/jcb.200710037; Hastie TJ., 2017, GEN ADDITIVE MODELS; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Murthy SK, 2007, CYTOGENET GENOME RES, V116, P135, DOI 10.1159/000097433; Ni XQ, 2007, J MED GENET, V44, P532, DOI 10.1136/jmg.2006.047944; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; THOMPSON NM, 1994, AM J MED GENET, V54, P378, DOI 10.1002/ajmg.1320540418; VOGEL HP, 1979, ACTA PSYCHIAT SCAND, V60, P483, DOI 10.1111/j.1600-0447.1979.tb00558.x; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zheng YL, 2006, BIOCHEM BIOPH RES CO, V342, P1049, DOI 10.1016/j.bbrc.2006.02.041	30	1315	1373	3	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					232	U61		10.1038/nature07229	http://dx.doi.org/10.1038/nature07229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18668039	Green Accepted, Green Published			2022-12-28	WOS:000259090800049
J	Dimos, JT; Rodolfa, KT; Niakan, KK; Weisenthal, LM; Mitsumoto, H; Chung, W; Croft, GF; Saphier, G; Leibel, R; Goland, R; Wichterle, H; Henderson, CE; Eggan, K				Dimos, John T.; Rodolfa, Kit T.; Niakan, Kathy K.; Weisenthal, Laurin M.; Mitsumoto, Hiroshi; Chung, Wendy; Croft, Gist F.; Saphier, Genevieve; Leibel, Rudy; Goland, Robin; Wichterle, Hynek; Henderson, Christopher E.; Eggan, Kevin			Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons	SCIENCE			English	Article							DIRECTED DIFFERENTIATION; FIBROBLASTS; PROGRESSION; DEATH; LINES	The generation of pluripotent stem cells from an individual patient would enable the large- scale production of the cell types affected by that patient's disease. These cells could in turn be used for disease modeling, drug discovery, and eventually autologous cell replacement therapies. Although recent studies have demonstrated the reprogramming of human fibroblasts to a pluripotent state, it remains unclear whether these induced pluripotent stem (iPS) cells can be produced directly from elderly patients with chronic disease. We have generated iPS cells from an 82- year- old woman diagnosed with a familial form of amyotrophic lateral sclerosis (ALS). These patient- specific iPS cells possess properties of embryonic stem cells and were successfully directed to differentiate into motor neurons, the cell type destroyed in ALS.	[Dimos, John T.; Rodolfa, Kit T.; Niakan, Kathy K.; Weisenthal, Laurin M.; Saphier, Genevieve; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Stowers Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rodolfa, Kit T.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Mitsumoto, Hiroshi] Columbia Univ, Med Ctr, Inst Neurol, Eleanor & Lou Gehrig MDA ALS Res Ctr, New York, NY 10032 USA; [Mitsumoto, Hiroshi; Chung, Wendy; Croft, Gist F.; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Chung, Wendy; Leibel, Rudy] Columbia Univ, Coll Phys & Surg, Div Mol Genet, New York, NY 10032 USA; [Chung, Wendy; Leibel, Rudy] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Croft, Gist F.; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Croft, Gist F.; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Dept Neurol & Neurosci, New York, NY 10032 USA; [Goland, Robin] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Goland, Robin] Columbia Univ, Med Ctr, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Harvard University; Stowers Institute for Medical Research; Harvard University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Eggan, K (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Stowers Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018	Croft, Gist/0000-0002-9721-0148; Rodolfa, Kit/0000-0002-0829-1282; Wichterle, Hynek/0000-0002-7817-0080; Niakan, Kathy/0000-0003-1646-4734; Henderson, Christopher/0000-0002-9936-3279	Project ALS/Jenifer Estess Laboratory for Stem Cell Research; Harvard Stem Cell Institute; Project ALS; SMA Foundation; Claire and Leonard Tow Foundation; MDA Wings Over Wall Street; Spina and Bowen families; New York Stem Cell Foundation	Project ALS/Jenifer Estess Laboratory for Stem Cell Research; Harvard Stem Cell Institute; Project ALS; SMA Foundation; Claire and Leonard Tow Foundation; MDA Wings Over Wall Street(Muscular Dystrophy Association); Spina and Bowen families; New York Stem Cell Foundation	We thank D. Melton, D. Egli, A. McMahon, K. Osafune, K. Plath, S. Fielding, and K. Hochedlinger for helpful discussions; T. Kitamura, S. Yamanaka, and R. Weinberg for providing viral vectors through Addgene; L. Rubin for generously providing the small-molecule SHH agonist; the Developmental Studies Hybridoma Bank for monoclonal antibodies; and J. Montes and M. Lee for their support in obtaining institutional review board approval and culturing biopsies. This collaboration was supported and enabled by the Project ALS/Jenifer Estess Laboratory for Stem Cell Research, where much of the Columbia research was carried out. Supported by the Harvard Stem Cell Institute, Project ALS, the SMA Foundation, the Claire and Leonard Tow Foundation, MDA Wings Over Wall Street, the Spina and Bowen families, and the New York Stem Cell Foundation. K. T. R. is a National Science Foundation predoctoral fellow, G. F. C. is a Project ALS predoctoral fellow, and K. E. is a fellow of the John D. and Catherine T. MacArthur Foundation.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Cibelli J, 2007, SCIENCE, V318, P1879, DOI 10.1126/science.1153229; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Eggan K, 2007, CLONING STEM CELLS, V9, P21, DOI 10.1089/clo.2006.0013; Ferrera L, 2003, AMYOTROPH LATERAL SC, V4, P167, DOI 10.1080/aml.4.3.167.170; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	1467	1656	7	509	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1218	1221		10.1126/science.1158799	http://dx.doi.org/10.1126/science.1158799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18669821				2022-12-28	WOS:000258754400047
J	Pillow, JW; Shlens, J; Paninski, L; Sher, A; Litke, AM; Chichilnisky, EJ; Simoncelli, EP				Pillow, Jonathan W.; Shlens, Jonathon; Paninski, Liam; Sher, Alexander; Litke, Alan M.; Chichilnisky, E. J.; Simoncelli, Eero P.			Spatio-temporal correlations and visual signalling in a complete neuronal population	NATURE			English	Article							GANGLION-CELLS; INFORMATION; CONNECTIVITY; SPIKES; CODE	Statistical dependencies in the responses of sensory neurons govern both the amount of stimulus information conveyed and the means by which downstream neurons can extract it. Although a variety of measurements indicate the existence of such dependencies(1-3), their origin and importance for neural coding are poorly understood. Here we analyse the functional significance of correlated firing in a complete population of macaque parasol retinal ganglion cells using a model of multi-neuron spikeresponses(4,5). The model, with parameters fit directly to physiological data, simultaneously captures both the stimulus dependence and detailed spatio-temporal correlations in population responses, and provides two insights into the structure of the neural code. First, neural encoding at the population level is less noisy than one would expect from the variability of individual neurons: spike times are more precise, and can be predicted more accurately when the spiking of neighbouring neurons is taken into account. Second, correlations provide additional sensory information: optimal, model- based decoding that exploits the response correlation structure extracts 20% more information about the visual scene than decoding under the assumption of independence, and preserves 40% more visual information than optimal linear decoding(6). This model- based approach reveals the role of correlated activity in the retinal coding of visual stimuli, and provides a general framework for understanding the importance of correlated activity in populations of neurons.	[Pillow, Jonathan W.] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; [Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst, San Diego, CA 92037 USA; [Paninski, Liam] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, New York, NY 10027 USA; [Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY 10003 USA	University of London; University College London; Salk Institute; Columbia University; Columbia University; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; New York University; New York University	Pillow, JW (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	pillow@gatsby.ucl.ac.uk		Sher, Alexander/0000-0001-6655-6456; Pillow, Jonathan/0000-0002-3638-8831; Chichilnisky, E.J./0000-0002-5613-0248; Simoncelli, Eero/0000-0002-1206-527X	Royal Society USA/Canada Research Fellowship; NSF IGERT [DGE-03345]; NEI [EY018003]; Gatsby Foundation Pilot Grant; Burroughs Wellcome Fund Career Award at the Scientific Interface; US National Science Foundation [PHY-0417175]; McKnight Foundation; HHMI; NATIONAL EYE INSTITUTE [R01EY018003] Funding Source: NIH RePORTER	Royal Society USA/Canada Research Fellowship; NSF IGERT(National Science Foundation (NSF)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Gatsby Foundation Pilot Grant; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); US National Science Foundation(National Science Foundation (NSF)); McKnight Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Bethge, C. Brody, D. Butts, P. Latham, M. Lengyel, S. Nirenberg and R. Sussman for comments and discussions; G. Field, M. Greschner, J. Gauthier and C. Hulse for experimental assistance; M. I. Grivich, D. Petrusca, W. Dabrowski, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development; H. Fox, M. Taffe, E. Callaway and K. Osborn for providing access to retinas; and S. Barry for machining. Funding was provided a Royal Society USA/Canada Research Fellowship ( J. W. P.); NSF IGERT DGE-03345 ( J. S.); NEI grant EY018003 ( E. J. C., L. P. and E. P. S.); Gatsby Foundation Pilot Grant ( L. P.); Burroughs Wellcome Fund Career Award at the Scientific Interface ( A. S.); US National Science Foundation grant PHY-0417175 ( A. M. L.); McKnight Foundation ( A. M. L. and E. J. C.); and HHMI ( J. W. P., L. P. and E. P. S.).	Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Latham PE, 2005, J NEUROSCI, V25, P5195, DOI 10.1523/JNEUROSCI.5319-04.2005; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2004, J NEUROSCI, V24, P8551, DOI 10.1523/JNEUROSCI.0919-04.2004; Panzeri S, 2001, VIS COGN, V8, P531, DOI 10.1080/13506280143000106; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Pillow JW, 2008, ADV NEURAL INFORM PR, P1161; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Rigat F, 2006, BAYESIAN ANAL, V1, P733, DOI 10.1214/06-BA124; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schneidman E, 2003, J NEUROSCI, V23, P11539; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308	30	779	794	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					995	U37		10.1038/nature07140	http://dx.doi.org/10.1038/nature07140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18650810	Green Accepted			2022-12-28	WOS:000258591000039
J	Vaithianathan, R; Lewis, G				Vaithianathan, Rhema; Lewis, Geraint			Operational independence for the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Vaithianathan, Rhema] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Lewis, Geraint] NYU, New York, NY 10003 USA	Harvard University; New York University	Vaithianathan, R (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	vaithianathan@hcp.med.harvard.edu						Blinder AS, 2000, AM ECON REV, V90, P1421, DOI 10.1257/aer.90.5.1421; BRITNELL M, 2007, INSIDE KNOWLEDGE YOU; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; DEVLIN N, 2007, WRITTEN EVIDENCE HOU; DIXON A, 1980, GOVERNING NHS ALTERN; Edwards B, 2007, INDEPENDENT NHS REV; European Central Bank, OBJ MON POL; GLASBY E, 2007, THINGS CAN ONLY GET; *HEALTHC COMM, AB US; Kmietowicz Z, 2007, BRIT MED J, V334, P969, DOI 10.1136/bmj.39210.522188.4E; KYDLAND FE, 1977, J POLIT ECON, V85, P473, DOI 10.1086/260580; MEIKLE J, 2005, GUARDIAN        1109; PECK E, 2005, RECONFIGURING PCTS I; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; REVILL J, 2007, OBSERVER        0506; WADHWANI S, 2001, BANK ENGL Q B    AUT	16	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 16	2008	337	7666							a497	10.1136/bmj.a497	http://dx.doi.org/10.1136/bmj.a497			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	340TZ	18647775				2022-12-28	WOS:000258669200023
J	Merson, MH; O'Malley, J; Serwadda, D; Apisuk, C				Merson, Michael H.; O'Malley, Jeffrey; Serwadda, David; Apisuk, Chantawipa			HIV prevention 1 - The history and challenge of HIV prevention	LANCET			English	Article							IMMUNE-DEFICIENCY-SYNDROME; SOCIOECONOMIC-STATUS; MALE CIRCUMCISION; AIDS VACCINE; DIAGONAL APPROACH; CONTROLLED-TRIAL; PREGNANT-WOMEN; GLOBAL HEALTH; RISK-FACTORS; HIV/AIDS	The HIV/AIDS pandemic has become part of the contemporary global landscape. Few predicted its effect on mortality and morbidity or its devastating social and economic consequences, particularly in sub-Saharan Africa. Successful responses have addressed sensitive social factors surrounding HIV prevention, such as sexual behaviour, drug use, and gender equalities, countered stigma and discrimination, and mobilised affected communities; but such responses have been few and far between. Only in recent years has the international response to HIV prevention gathered momentum, mainly due to the availability of treatment with antiretroviral drugs, the recognition that the pandemic has both development and security implications, and a substantial increase in financial resources brought about by new funders and funding mechanisms. We now require an urgent and revitalised global movement for HIV prevention that supports a combination of behavioural, structural, and biomedical approaches and is based on scientifically derived evidence and the wisdom and ownership of communities.	[Merson, Michael H.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [O'Malley, Jeffrey] UN Dev Programme, New York, NY USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Apisuk, Chantawipa] EMPOWER, Bangkok, Thailand	Duke University; Makerere University	Merson, MH (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.							Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; Alnwick D., 2007, BRINGING HIV PREVENT; ALTMAN LK, 1981, NY TIMES        0703; [Anonymous], 2004, 2004 REP GLOB AIDS E; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baleta A, 2007, LANCET, V370, P17, DOI 10.1016/S0140-6736(07)61029-0; Barnett T, 2006, INT AFF, V82, P297, DOI 10.1111/j.1468-2346.2006.00532.x; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; *BAY AR PHYS HUM R, 1982, KAP SARC GAY MEN; Berkley SF, 2007, LANCET, V370, P94, DOI 10.1016/S0140-6736(07)61054-X; Berkman A, 2005, AM J PUBLIC HEALTH, V95, P1162, DOI 10.2105/AJPH.2004.054593; Berkowitz R., 2003, STAYIN ALIVE INVENTI; BERTOZZI SM, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60889-2; Bertozzi S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P331; Brodie M., 2004, COLUMBIA JOURNAL REV, V42, P8; CHAO A, 1994, INT J EPIDEMIOL, V23, P371, DOI 10.1093/ije/23.2.371; CLUMECK N, 1983, LANCET, V1, P642; Compston Alastair, LANCET, V372, P1502, DOI [DOI 10.1016/S0140-6736(08)60885-5, 10.1016/S0140-6736(08)61620-7, DOI 10.1016/S0140-6736(08)61620-7]; Crimp D., 1988, AIDS CULTURAL ANAL C; CURRAN JW, 1985, SCIENCE, V229, P1352, DOI 10.1126/science.2994217; DALLABETTA GA, 1993, J INFECT DIS, V167, P36, DOI 10.1093/infdis/167.1.36; DAVIS P, 1993, LEGACY J GATES; Department for International Development, 2004, TAK ACT UKS STRAT TA; DEWALQUE D, 2006, DOES IMPACT HIV AIDS; Feachem R, 2007, Glob Public Health, V2, P325, DOI 10.1080/17441690701494824; Fee E, 2008, J PUBLIC HEALTH POL, V29, P54, DOI 10.1057/palgrave.jphp.3200160; *GLOB FUND, MONTHL PROGR UPD 24; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2004, SOC SCI MED, V58, P2119, DOI 10.1016/j.socscimed.2003.09.001; GUPTA GR, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60887-9; Ho DD, 1998, SCIENCE, V280, P1866, DOI 10.1126/science.280.5371.1866; *INT AIDS VACC IN, 2006, IM WORLD AIDS HIST I; International HIV/AIDS Alliance, 2006, KEY IND FRONT PREV P; Kates J., 2007, FINANCING RESPONSE A; King E., 1993, SAFETY NUMBERS SAFER; LAY PD, 2008, BMJ RAPID RESPONSE; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; MAHLER H, 1987, INF BRIEF AIDS 42 SE; Mann J M, 1991, AIDS, V5 Suppl 2, pS221, DOI 10.1097/00002030-199101001-00031; MERSON M, 1995, SEXUAL BEHAV AIDS DE; Merson MH, 2006, NEW ENGL J MED, V354, P2414, DOI 10.1056/NEJMp068074; O'Malley Jeff, 1992, P774; OMALLEY J, CAN THIS MARRIAGE WO; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; PAMUK E, 1998, SOCIOECONOMIC STAT H; *POP COUNC, 2002, HOR REP HLTH PROM CO; Rau B, 2006, INT AFF, V82, P285, DOI 10.1111/j.1468-2346.2006.00531.x; Saba J, 2002, LANCET, V359, P1178; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shilts R, 1987, BAND PLAYED, P451; *SIST PERP IND, PLAY FAIR; SMITH R, 1995, BRIT MED J, V310, P543, DOI 10.1136/bmj.310.6979.543; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; The Denver Principles, 1983, DENVER PRINCIPLES; Tonks A, 2007, BMJ-BRIT MED J, V334, P1346, DOI 10.1136/bmj.39240.416968.AD; *UN GEN ASS, 2001, UN GEN ASS SPEC SESS; *UN SEC COUNC, 2000, SEC COUNC RES 1308 2; UNAIDS, 2001, HIV PREV NEEDS SUCC; *UNAIDS, 2007, MON DECL COMM HIV AI; *UNAIDS, IN PRESS UNAIDS CHRO; *UNAIDS, 2008, UNAIDS REP GLOB AIDS; UNAIDS, 2007, FIN RES REQ ACH UN A; *UNAIDS, 2006, 2006 REP GLOB HIV AI; *UNAIDS WHO, 2007, AIDS EP UPD DEC 2007; *US CDCP, 1999, HIV AIDS SURV REP, V11, P1; *US CDCP, 2006, HIV AIDS SURVEILLANC, V18, P1; *US CDCP, 2005, HIV AIDS SURVEILLANC, V17, P1; Wakabi W, 2007, LANCET, V370, P15, DOI 10.1016/S0140-6736(07)61028-9; Wannan GJ, 1997, INT J STD AIDS, V8, P317, DOI 10.1258/0956462971920163; *WHO, 1997, WHO GLOB PROGR AIDS; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; *WORLD BANK, HIV AIDS FUND COMM D; *WORLD SUMM MIN HL, 1988, LOND DECL AIDS PREV; *WORLD TRAD ORG, 2001, WTO MIN C; Yamada T, 2008, NEW ENGL J MED, V358, P1324, DOI 10.1056/NEJMp0801848; 2001, 5 YEAR EVALUATION UN; 1985, WHO ACTIVITIES PREVE; 2008, ACHIEVING UNIVERSAL; 1981, MMWR MORB MORTAL WKL, V30, P250; 1982, MMWR MORB MORTAL WKL, V31, P353; 2007, US PRES EM PLAN AIDS; 2000, MMWR MORB MORTAL WKL, V49, P4	86	181	184	0	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					475	488		10.1016/S0140-6736(08)60884-3	http://dx.doi.org/10.1016/S0140-6736(08)60884-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335OD	18687461				2022-12-28	WOS:000258299000031
J	Bassermann, F; Frescas, D; Guardavaccaro, D; Busino, L; Peschiaroli, A; Pagano, M				Bassermann, Florian; Frescas, David; Guardavaccaro, Daniele; Busino, Luca; Peschiaroli, Angelo; Pagano, Michele			The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint	CELL			English	Article							SCF-BETA-TRCP; ANAPHASE-PROMOTING COMPLEX; POLO-LIKE KINASE-1; CELL-CYCLE; MEDIATED DEGRADATION; CLASPIN; PHOSPHATASE; RECOVERY; PROLIFERATION; CENTROSOME	In response to DNA damage in G2, mammalian cells must avoid entry into mitosis and instead initiate DNA repair. Here, we show that, in response to genotoxic stress in G2, the phosphatase Cdc14B translocates from the nucleolus to the nucleoplasm and induces the activation of the ubiquitin ligase APC/C(Cdh1), with the consequent degradation of Plk1, a prominent mitotic kinase. This process induces the stabilization of Claspin, an activator of the DNA-damage checkpoint, and Wee1, an inhibitor of cell-cycle progression, and allows an efficient G2 checkpoint. As a by-product of APC/C(Cdh1) reactivation in DNA-damaged G2 cells, Claspin, which we show to be an APC/C(Cdh1) substrate in G1, is targeted for degradation. However, this process is counteracted by the deubiquitylating enzyme Usp28 to permit Claspin-mediated activation of Chk1 in response to DNA damage. These findings define a novel pathway that is crucial for the G2 DNA-damage-response checkpoint.	[Bassermann, Florian; Frescas, David; Guardavaccaro, Daniele; Busino, Luca; Peschiaroli, Angelo; Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Pagano, Michele] Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, Dept Pathol, 550 1st Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@nyumc.org	Holt, Janet E/B-2415-2013	Guardavaccaro, Daniele/0000-0002-4517-1765; PESCHIAROLI, ANGELO/0000-0001-6311-2382; pagano, michele/0000-0003-3210-2442	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R21 CA125173-01, R21 CA125173, R37 CA076584-09, R21 CA125173-02, R37 CA076584, R37 CA076584-10, R37 CA076584-11] Funding Source: Medline; NIGMS NIH HHS [R01 GM057587-10, R01 GM057587-09S1, R01 GM057587, R01 GM057587-09, R01 GM057587-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA076584, R21CA125173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kaiser BK, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-27; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Mitra J, 2006, CELL CYCLE, V5, P661; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tsimaratou K, 2007, J PATHOL, V211, P331, DOI 10.1002/path.2095; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	32	313	328	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					256	267		10.1016/j.cell.2008.05.043	http://dx.doi.org/10.1016/j.cell.2008.05.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662541	Green Accepted, Bronze			2022-12-28	WOS:000257891700015
J	Chen, CC; Carson, JJ; Feser, J; Tamburini, B; Zabaronick, S; Linger, J; Tyler, JK				Chen, Chin-Chuan; Carson, Joshua J.; Feser, Jason; Tamburini, Beth; Zabaronick, Susan; Linger, Jeffrey; Tyler, Jessica K.			Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair	CELL			English	Article							DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND BREAKS; S-PHASE; CHAPERONE ASF1; CELL-CYCLE; REPLICATION; RAD53; ADAPTATION; RECOVERY; H3	DNA damage causes checkpoint activation leading to cell cycle arrest and repair, during which the chromatin structure is disrupted. The mechanisms whereby chromatin structure and cell cycle progression are restored after DNA repair are largely unknown. We show that chromatin reassembly following double- strand break (DSB) repair requires the histone chaperone Asf1 and that absence of Asf1 causes cell death, as cells are unable to recover from the DNA damage checkpoint. We find that Asf1 contributes toward chromatin assembly after DSB repair by promoting acetylation of free histone H3 on lysine 56 (K56) via the histone acetyl transferase Rtt109. Mimicking acetylation of K56 bypasses the requirement for Asf1 for chromatin reassembly and checkpoint recovery, whereas mutations that prevent K56 acetylation block chromatin reassembly after repair. These results indicate that restoration of the chromatin following DSB repair is driven by acetylated H3 K56 and that this is a signal for the completion of repair.	[Chen, Chin-Chuan; Carson, Joshua J.; Feser, Jason; Tamburini, Beth; Zabaronick, Susan; Linger, Jeffrey; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jessica.tyler@uchsc.edu	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; Linger, Jeffrey/0000-0003-3935-751X; Tyler, Jessica/0000-0001-9765-1659	NCI NIH HHS [R01 CA095641-03, R01 CA095641-06, R01 CA095641-05A1, R01 CA095641-04, R01 CA095641, R01 CA095641-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lupardus PJ, 2004, CELL, V117, P555, DOI 10.1016/j.cell.2004.05.005; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Pasero P, 2003, CELL CYCLE, V2, P568, DOI 10.4161/cc.2.6.577; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; Qin J, 2003, RADIAT RES, V159, P139, DOI 10.1667/0033-7587(2003)159[0139:MAOTDD]2.0.CO;2; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, CELL CYCLE, V3, P1383, DOI 10.4161/cc.3.11.1248; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005	56	310	319	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					231	243		10.1016/j.cell.2008.06.035	http://dx.doi.org/10.1016/j.cell.2008.06.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662539	Bronze, Green Accepted			2022-12-28	WOS:000257891700013
J	Xu, H; DeLuca, SZ; O'Farrell, PH				Xu, Hong; DeLuca, Steven Z.; O'Farrell, Patrick H.			Manipulating the metazoan mitochondrial genome with targeted restriction enzymesu	SCIENCE			English	Article							DNA MUTATIONS; DISEASE; CELLS	High copy number and random segregation confound genetic analysis of the mitochondrial genome. We developed an efficient selection for heritable mitochondrial genome ( mtDNA) mutations in Drosophila, thereby enhancing a metazoan model for study of mitochondrial genetics and mutations causing human mitochondrial disease. Targeting a restriction enzyme to mitochondria in the germline compromised fertility, but escaper progeny carried homoplasmic mtDNA mutations lacking the cleavage site. Among mutations eliminating a site in the cytochrome c oxidase gene, mt:Col(A302T) was healthy, mt:CoI(R301L) was male sterile but otherwise healthy, and mt: CoI(R301S) exhibited a wide range of defects, including growth retardation, neurodegeneration, muscular atrophy, male sterility, and reduced life span. Thus, germline expression of mitochondrial restriction enzymes creates a powerful selection and has allowed direct isolation of mitochondrial mutants in a metazoan.	[Xu, Hong; DeLuca, Steven Z.; O'Farrell, Patrick H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	O'Farrell, PH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	ofarrell@cgl.ucsf.edu	Xu, Hong/H-9997-2016	Xu, Hong/0000-0003-1049-1184; DeLuca, Steven/0000-0003-0683-8413; O'Farrell, Patrick/0000-0003-0011-2734	NIAID NIH HHS [R01 AI060102, R01 AI060102-08] Funding Source: Medline; NIGMS NIH HHS [R01 GM086854, R01 GM037193-22, R01 GM037193, R01 GM086854-09A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086854, R01GM037193] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bayona-Bafaluy MP, 2002, MITOCHONDRION, V2, P3, DOI 10.1016/S1567-7249(02)00044-2; Bergstrom CT, 1998, GENETICS, V149, P2135; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006; Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719; Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	12	80	80	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					575	577		10.1126/science.1160226	http://dx.doi.org/10.1126/science.1160226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653897	Green Accepted			2022-12-28	WOS:000257888900052
J	Kuris, AM; Hechinger, RF; Shaw, JC; Whitney, KL; Aguirre-Macedo, L; Boch, CA; Dobson, AP; Dunham, EJ; Fredensborg, BL; Huspeni, TC; Lorda, J; Mababa, L; Mancini, FT; Mora, AB; Pickering, M; Talhouk, NL; Torchin, ME; Lafferty, KD				Kuris, Armand M.; Hechinger, Ryan F.; Shaw, Jenny C.; Whitney, Kathleen L.; Aguirre-Macedo, Leopoldina; Boch, Charlie A.; Dobson, Andrew P.; Dunham, Eleca J.; Fredensborg, Brian L.; Huspeni, Todd C.; Lorda, Julio; Mababa, Luzviminda; Mancini, Frank T.; Mora, Adrienne B.; Pickering, Maria; Talhouk, Nadia L.; Torchin, Mark E.; Lafferty, Kevin D.			Ecosystem energetic implications of parasite and free-living biomass in three estuaries	NATURE			English	Article							REPRODUCTIVE EFFORT	Parasites can have strong impacts but are thought to contribute little biomass to ecosystems(1-3). We quantified the biomass of free-living and parasitic species in three estuaries on the Pacific coast of California and Baja California. Here we show that parasites have substantial biomass in these ecosystems. We found that parasite biomass exceeded that of top predators. The biomass of trematodes was particularly high, being comparable to that of the abundant birds, fishes, burrowing shrimps and polychaetes. Trophically transmitted parasites and parasitic castrators subsumed more biomass than did other parasitic functional groups. The extended phenotype biomass controlled by parasitic castrators sometimes exceeded that of their uninfected hosts. The annual production of free-swimming trematode transmission stages was greater than the combined biomass of all quantified parasites and was also greater than bird biomass. This biomass and productivity of parasites implies a profound role for infectious processes in these estuaries.	[Kuris, Armand M.; Hechinger, Ryan F.; Shaw, Jenny C.; Whitney, Kathleen L.; Boch, Charlie A.; Lorda, Julio; Mababa, Luzviminda; Talhouk, Nadia L.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Aguirre-Macedo, Leopoldina] IPN, Ctr Invest & Estud Avanzados, Merida 97310, Mexico; [Dobson, Andrew P.] Princeton Univ, Princeton, NJ 08544 USA; [Dunham, Eleca J.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16802 USA; [Fredensborg, Brian L.] Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78539 USA; [Huspeni, Todd C.] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Mancini, Frank T.] NOAA, Natl Marine Fisheries Serv, Pacific Isl Fisheries Res Ctr, Honolulu, HI 96822 USA; [Mora, Adrienne B.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Pickering, Maria] Univ Connecticut, Unit 3043, Storrs, CT 06269 USA; [Torchin, Mark E.] Smithsonian Trop Res Inst, Balboa 03092, Panama; [Lafferty, Kevin D.] Univ Calif Santa Barbara, Western Ecol Res Ctr, US Geol Survey, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Instituto Politecnico Nacional - Mexico; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Rio Grande Valley; University of Wisconsin System; University of Wisconsin Stevens Point; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Riverside; University of Connecticut; Smithsonian Institution; Smithsonian Tropical Research Institute; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara	Kuris, AM (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	kuris@lifesci.ucsb.edu	Aguirre-Macedo, Ma. Leopoldina/P-7812-2019; Lorda, Julio/A-3951-2009; Fredensborg, Brian Lund/G-1548-2014; Fredensborg, Brian L/A-5632-2010; Hechinger, Ryan/F-6754-2010; Lafferty, Kevin D./B-3888-2009; Lorda, Julio/J-1464-2019; Fredensborg, Brian Lund/N-9008-2019; Aguirre-Macedo, Ma. L/A-2511-2008	Aguirre-Macedo, Ma. Leopoldina/0000-0002-3910-8305; Lorda, Julio/0000-0002-4293-7518; Fredensborg, Brian Lund/0000-0002-4837-5974; Lorda, Julio/0000-0002-4293-7518; Fredensborg, Brian Lund/0000-0002-4837-5974; Aguirre-Macedo, Ma. L/0000-0002-3910-8305; Shaw, Jenny/0000-0002-2113-3692; Hechinger, Ryan/0000-0002-6633-253X				ALLEN LG, 1982, FISH B-NOAA, V80, P769; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P43, DOI 10.3354/meps320043; BROWNE RA, 1978, OECOLOGIA, V37, P23, DOI 10.1007/BF00349988; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; CALOW P, 1983, PARASITOLOGY, V86, P197, DOI 10.1017/S0031182000050897; Dawkins R., 1982, pi; Erwin RM, 1996, ESTUARIES, V19, P213, DOI 10.2307/1352226; Fingerut JT, 2003, BIOL BULL-US, V205, P110, DOI 10.2307/1543232; Hechinger RF, 2009, EVOL ECOL, V23, P651, DOI 10.1007/s10682-008-9262-4; HUGHES RN, 1980, OECOLOGIA, V47, P130, DOI 10.1007/BF00541788; HUXHAM M, 1995, J ANIM ECOL, V64, P168, DOI 10.2307/5752; Kuris AM, 2000, DEV AN VET, V32, P9; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Lafferty KD, 1996, ECOLOGY, V77, P1390, DOI 10.2307/2265536; Lafferty Kevin D., 2006, P119; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loreau Michel, 2005, P13; McLusky D., 1989, ESTUARINE ECOSYSTEM, V2nd; OBRIEN J, 1985, CRUSTACEAN ISSUES 3, P191; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Poulin R, 1999, INT J PARASITOL, V29, P903, DOI 10.1016/S0020-7519(99)00045-4; RAMER B A, 1991, Western Birds, V22, P157; Rigby MC, 2002, TRENDS PARASITOL, V18, P116, DOI 10.1016/S1471-4922(01)02203-6; Spruzen FL, 2008, HYDROBIOLOGIA, V598, P325, DOI 10.1007/s10750-007-9166-2; Thompson RM, 2005, J ANIM ECOL, V74, P77, DOI 10.1111/j.1365-2656.2004.00899.x; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	30	416	432	2	201	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					515	518		10.1038/nature06970	http://dx.doi.org/10.1038/nature06970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650923				2022-12-28	WOS:000257860300051
J	Hawkes, N				Hawkes, Nigel			A discriminating judgment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a809	10.1136/bmj.a809	http://dx.doi.org/10.1136/bmj.a809			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SB	18625604	Green Published			2022-12-28	WOS:000257962000036
J	St George-Hyslop, PH; Morris, JC				St George-Hyslop, Peter H.; Morris, John C.			Will anti-amyloid therapies work for Alzheimer's disease?	LANCET			English	Editorial Material							MOUSE MODEL; TAU; IMMUNIZATION; PLAQUES		[St George-Hyslop, Peter H.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0XY, England; [St George-Hyslop, Peter H.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [St George-Hyslop, Peter H.] Univ Toronto, Toronto Western Hosp, Div Neurol, Dept Med, Toronto, ON M5T 2S8, Canada; [Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of Cambridge; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Washington University (WUSTL)	St George-Hyslop, PH (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0XY, England.	phs22@cam.ac.uk	Morris, John C/A-1686-2012	St George-Hyslop, Peter/0000-0003-0796-7209	Wellcome Trust [081864] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lippa CF, 1998, LANCET, V352, P1117, DOI 10.1016/S0140-6736(05)79757-9; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogaeva E, 2006, J ALZHEIMERS DIS, V9, P381; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schupf N, 2002, BRIT J PSYCHIAT, V180, P405, DOI 10.1192/bjp.180.5.405; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	13	61	73	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					180	182		10.1016/S0140-6736(08)61047-8	http://dx.doi.org/10.1016/S0140-6736(08)61047-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640437				2022-12-28	WOS:000257763900005
J	Vo, AA; Lukovsky, M; Toyoda, M; Wang, J; Reinsmoen, NL; Lai, C; Peng, A; Villicana, R; Jordan, SC				Vo, Ashley A.; Lukovsky, Marina; Toyoda, Mieko; Wang, Jennifer; Reinsmoen, Nancy L.; Lai, Chih-Hung; Peng, Alice; Villicana, Rafael; Jordan, Stanley C.			Rituximab and intravenous immune globulin for desensitization during renal transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-HLA ANTIBODIES; RHEUMATOID-ARTHRITIS; CROSS-MATCH; KIDNEY-TRANSPLANTATION; SENSITIZED PATIENTS; LIVING-DONOR; RECIPIENTS; THERAPY; DISEASE; CELL	Background: Few options for transplantation currently exist for patients highly sensitized to HLA. This exploratory, open-label, phase 1-2, single-center study examined whether intravenous immune globulin plus rituximab could reduce anti-HLA antibody levels and improve transplantation rates. Methods: Between September 2005 and May 2007, a total of 20 highly sensitized patients (with a mean [+/-SD] T-cell panel-reactive antibody level, determined by use of the complement-dependent cytotoxicity assay, of 77+/-19% or with donor-specific antibodies) were enrolled and received treatment with intravenous immune globulin and rituximab. We recorded rates of transplantation, panel-reactive antibody levels, cross-matching results at the time of transplantation, survival of patients and grafts, acute rejection episodes, serum creatinine values, adverse events and serious adverse events, and immunologic factors. Results: The mean panel-reactive antibody level was 44+/-30% after the second infusion of intravenous immune globulin (P<0.001 for the comparison with the pretreatment level). At study entry, the mean time on dialysis among recipients of a transplant from a deceased donor was 144+/-89 months (range, 60 to 324). However, the time to transplantation after desensitization was 5+/-6 months (range, 2 to 18). Sixteen of the 20 patients (80%) received a transplant. At 12 months, the mean serum creatinine level was 1.5+/-1.1 mg per deciliter (133+/-97 micromol per liter), and the mean survival rates of patients and grafts were 100% and 94%, respectively. There were no infusion-related adverse events or serious adverse events during the study. Long-term monitoring for infectious complications and neurologic problems revealed no unanticipated events. Conclusions: These findings suggest that the combination of intravenous immune globulin and rituximab may prove effective as a desensitization regimen for patients awaiting a transplant from either a living donor or a deceased donor. Larger and longer trials are needed to evaluate the clinical efficacy and safety of this approach. (ClinicalTrials.gov number, NCT00642655.).	[Vo, Ashley A.; Lukovsky, Marina; Toyoda, Mieko; Wang, Jennifer; Reinsmoen, Nancy L.; Lai, Chih-Hung; Peng, Alice; Villicana, Rafael; Jordan, Stanley C.] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Transplant Immunol Lab, Los Angeles, CA 90048 USA; [Vo, Ashley A.; Lukovsky, Marina; Toyoda, Mieko; Wang, Jennifer; Reinsmoen, Nancy L.; Lai, Chih-Hung; Peng, Alice; Villicana, Rafael; Jordan, Stanley C.] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, HLA Lab, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Vo, AA (corresponding author), Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Transplant Immunol Lab, 8635 W 3rd St,Suite 590W, Los Angeles, CA 90048 USA.	ashley.vo@cshs.org	Jordan, Stan/AAI-1250-2021	Jordan, Stan/0000-0002-0456-8635				Ahmed AR, 2006, NEW ENGL J MED, V355, P1772, DOI 10.1056/NEJMoa062930; BRAY RA, 1989, TRANSPLANTATION, V48, P834, DOI 10.1097/00007890-198911000-00022; Cho Y W, 2001, Clin Transpl, P237; *CTR DRUG EV RES, 2006, FDA PUBL HLTH ADV LI; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Faguer S, 2007, TRANSPLANTATION, V83, P1277, DOI 10.1097/01.tp.0000261113.30757.d1; Gebel HM, 2003, AM J TRANSPLANT, V3, P1488, DOI 10.1046/j.1600-6135.2003.00273.x; Gloor JM, 2003, AM J TRANSPLANT, V3, P1017, DOI 10.1034/j.1600-6143.2003.00180.x; Glotz D, 2004, TRANSPLANT INT, V17, P1, DOI 10.1007/s00147-003-0674-3; Jordan SC, 2005, PEDIATR TRANSPLANT, V9, P408, DOI 10.1111/j.1399-3046.2005.00363.x; Jordan SC, 2006, AM J TRANSPLANT, V6, P459, DOI 10.1111/j.1600-6143.2005.01214.x; Jordan SC, 2003, TRANSPLANTATION, V76, P631, DOI 10.1097/01.TP.0000080685.31697.FC; Jordan SC, 2004, J AM SOC NEPHROL, V15, P3256, DOI 10.1097/01.ASN.0000145878.92906.9F; Jordan SC, 2006, CLIN J AM SOC NEPHRO, V1, P421, DOI 10.2215/CJN.01651105; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; KERMAN R, 2002, AM J TRANSPLANT S3, V2, P258; Montgomery Robert A, 2003, Clin Transpl, P199; Organ Procurement and Transplant Network, SCI REG TRANSPL REC; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; REFF ME, 1994, BLOOD, V83, P435; RUSSELL JD, 1992, TRANSPLANTATION, V54, P656, DOI 10.1097/00007890-199210000-00018; Salama AD, 2006, NAT CLIN PRACT NEPHR, V2, P221, DOI 10.1038/ncpneph0133; Schuna AA, 2007, PHARMACOTHERAPY, V27, P1702, DOI 10.1592/phco.27.12.1702; Schweitzer EJ, 2000, TRANSPLANTATION, V70, P1531, DOI 10.1097/00007890-200011270-00023; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Toyoda M, 2005, TRANSPLANTATION, V80, P198, DOI 10.1097/01.TP.0000165110.78397.93; TYAN DB, 1994, TRANSPLANTATION, V57, P553; Vieira CA, 2004, TRANSPLANTATION, V77, P542, DOI 10.1097/01.TP.0000112934.12622.2B; Vo AA, 2008, AM J TRANSPLANT, V8, P144, DOI 10.1111/j.1600-6143.2007.02017.x	31	494	519	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					242	251		10.1056/NEJMoa0707894	http://dx.doi.org/10.1056/NEJMoa0707894			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KD	18635429				2022-12-28	WOS:000257656600004
J	Krab, LC; de Goede-Bolder, A; Aarsen, FK; Pluijm, SMF; Bouman, MJ; van der Geest, JN; Lequin, M; Catsman, CE; Arts, WFM; Kushner, SA; Silva, AJ; de Zeeuw, CI; Moll, HA; Elgersma, Y				Krab, Lianne C.; de Goede-Bolder, Arja; Aarsen, Femke K.; Pluijm, Saskia M. F.; Bouman, Marlies J.; van der Geest, Jos N.; Lequin, Maarten; Catsman, Coriene E.; Arts, Willem Frans M.; Kushner, Steven A.; Silva, Alcino J.; de Zeeuw, Chris I.; Moll, Henriette A.; Elgersma, Ype			Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1 - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOUSE MODEL; PRISM ADAPTATION; MRI; DEFICITS	Context Neurofibromatosis type 1 ( NF1) is among the most common genetic disorders that cause learning disabilities. Recently, it was shown that statin- mediated inhibition of 3- hydroxy- 3- methylglutaryl coenzyme A reductase restores the cognitive deficits in an NF1 mouse model. Objective To determine the effect of simvastatin on neuropsychological, neurophysiological, and neuroradiological outcome measures in children with NF1. Design, Setting, and Participants Sixty- two of 114 eligible children ( 54%) with NF1 participated in a randomized, double- blind, placebo- controlled trial conducted between January 20, 2006, and February 8, 2007, at an NF1 referral center at a Dutch university hospital. Intervention Simvastatin or placebo treatment once daily for 12 weeks. Main Outcome Measures Primary outcomes were scores on a Rey complex figure test ( delayed recall), cancellation test ( speed), prism adaptation, and the mean brain apparent diffusion coefficient based on magnetic resonance imaging. Secondary out-come measures were scores on the cancellation test ( standard deviation), Stroop color word test, block design, object assembly, Rey complex figure test ( copy), Beery developmental test of visual- motor integration, and judgment of line orientation. Scores were corrected for baseline performance, age, and sex. Results No significant differences were observed between the simvastatin and placebo groups on any primary outcome measure: Rey complex figure test (beta = 0.10; 95% confidence interval [ CI], - 0.36 to 0.56); cancellation test (beta = -0.19; 95% CI, - 0.67 to 0.29); prism adaptation ( odds ratio= 2.0; 95% CI, 0.55 to 7.37); and mean brain apparent diffusion coefficient (beta = 0.06; 95% CI, - 0.07 to 0.20). In the secondary outcome measures, we found a significant improvement in the simvastatin group in object assembly scores (beta = 0.54; 95% CI, 0.08 to 1.01), which was specifically observed in children with poor baseline performance (beta = 0.80; 95% CI, 0.29 to 1.30). Other secondary outcome measures revealed no significant effect of simvastatin treatment. Conclusion In this 12- week trial, simvastatin did not improve cognitive function in children with NF1. Trial Registration isrctn. org Identifier: ISRCTN14965707.	[Krab, Lianne C.; de Goede-Bolder, Arja; Moll, Henriette A.] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr, NF1 Core Cognit Res Team, Dept Gen Pediat, Rotterdam, Netherlands; [Krab, Lianne C.; van der Geest, Jos N.; de Zeeuw, Chris I.; Elgersma, Ype] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr, NF1 Core Cognit Res Team, Dept Neurosci, Rotterdam, Netherlands; [Aarsen, Femke K.; Bouman, Marlies J.; Catsman, Coriene E.; Arts, Willem Frans M.] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr, NF1 Core Cognit Res Team, Dept Pediat Neurol, Rotterdam, Netherlands; [Pluijm, Saskia M. F.] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr, NF1 Core Cognit Res Team, Dept Publ Hlth, Rotterdam, Netherlands; [Lequin, Maarten] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr, NF1 Core Cognit Res Team, Dept Pediat Radiol, Rotterdam, Netherlands; [Kushner, Steven A.] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr, NF1 Core Cognit Res Team, Dept Psychiat, Rotterdam, Netherlands; [Kushner, Steven A.; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Kushner, Steven A.; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90024 USA; [Kushner, Steven A.; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90024 USA; [de Zeeuw, Chris I.] Royal Acad Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Elgersma, Y (corresponding author), Erasmus MC, Dept Neurosci, Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	y.elgersma@erasmusmc.nl	Silva, Alcino/ABD-7684-2021; Elgersma, Ype/F-5164-2013	Silva, Alcino/0000-0002-1587-4558; Elgersma, Ype/0000-0002-3758-1297; Kushner, Steven/0000-0002-9777-3338; van der Geest, J/0000-0002-2870-4208; Krab, Lianne/0000-0002-2480-2011; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038480-06, R01 NS038480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; Billingsley RL, 2004, NEUROPSYCHOLOGIA, V42, P395, DOI 10.1016/j.neuropsychologia.2003.07.008; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; de Jongh S, 2002, CIRCULATION, V106, P2231, DOI 10.1161/01.CIR.0000035247.42888.82; Descheemaeker MJ, 2005, J INTELL DISABIL RES, V49, P33, DOI 10.1111/j.1365-2788.2005.00660.x; Feldmann R, 2003, NEUROLOGY, V61, P1725, DOI 10.1212/01.WNL.0000098881.95854.5F; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Guilding C, 2007, EUR J NEUROSCI, V25, P99, DOI 10.1111/j.1460-9568.2006.05238.x; GUTMANN DH, 1991, P NATL ACAD SCI USA, V88, P9658, DOI 10.1073/pnas.88.21.9658; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; KRAB LC, 2008, J CHILD NEUROL, V23; LEGIUS E, 1995, J NEUROL NEUROSUR PS, V59, P638, DOI 10.1136/jnnp.59.6.638; Levine Terry M, 2006, Semin Pediatr Neurol, V13, P8, DOI 10.1016/j.spen.2006.01.006; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; *MED EV BOARD, 2005, SUMM PROD CHAR ZCR T; NIH. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis, 1987, NEUROFIBROMATOSIS, V1, P172; NORTH K, 1994, NEUROLOGY, V44, P878, DOI 10.1212/WNL.44.5.878; North K, 2002, J CHILD NEUROL, V17, P605, DOI 10.1177/088307380201700811; Pisella L, 2005, NEUROLOGY, V65, P150, DOI 10.1212/01.wnl.0000167945.34177.5e; Rapport LJ, 1997, CLIN NEUROPSYCHOL, V11, P375, DOI 10.1080/13854049708400466; RUIJSEENAARS AJJ, 2004, MATH PROBLEMS DYSACA; STRUIKSMA AJM, 2004, DIAGNOSTICS TOOL TEC; Van der Geest JN, 2005, EXP BRAIN RES, V166, P200, DOI 10.1007/s00221-005-2355-1; van Engelen SJPM, 2008, AM J NEURORADIOL, V29, P816, DOI 10.3174/ajnr.A0921; Vandersteene G., 1986, NEDERLANDSTALIGE UIT	28	132	133	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					287	294		10.1001/jama.300.3.287	http://dx.doi.org/10.1001/jama.300.3.287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325ZB	18632543	Green Accepted, Bronze			2022-12-28	WOS:000257626600020
J	Das, P				Das, Pamela			Profile - Jorge Saavedra: committed campaigner on HIV/AIDS in Mexico	LANCET			English	Biographical-Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					283	283		10.1016/S0140-6736(08)61097-1	http://dx.doi.org/10.1016/S0140-6736(08)61097-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657696				2022-12-28	WOS:000258042800014
J	Hogg, R; Lima, V; Sterne, JAC; Grabar, S; Battegay, M; Bonarek, M; Monforte, AD; Esteve, A; Gill, MJ; Harris, R; Justice, A; Hayden, A; Lampe, F; Mocroft, A; Mugavero, MJ; Staszewski, S; Wasmuth, JC; van Sighem, A; Kitahata, M; Guest, J; Egger, M; May, M				Hogg, Robert; Lima, Viviane; Sterne, Jonathan A. C.; Grabar, Sophie; Battegay, Manuel; Bonarek, Mojgan; Monforte, Antonella D'Arminio; Esteve, Anna; Gill, M. John; Harris, Ross; Justice, Amy; Hayden, Anna; Lampe, Fiona; Mocroft, Amanda; Mugavero, Michael J.; Staszewski, Schlomo; Wasmuth, Jan-Christian; van Sighem, Ard; Kitahata, Mari; Guest, Jodie; Egger, Matthias; May, Margaret		Antiretroviral Therapy Cohort Coll	Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED INDIVIDUALS; HIV-1-INFECTED PATIENTS; DRUG USE; AIDS; MORTALITY; SURVIVAL; DEATH; IMPACT; LAMIVUDINE	Background Combination antiretroviral therapy has led to significant increases in survival and quality of life, but at a population-level the effect on life expectancy is not well understood. Our objective was to compare changes in mortality and life expectancy among HIV-positive individuals on combination antiretroviral therapy. Methods The Antiretroviral Therapy Cohort Collaboration is a multinational collaboration of HIV cohort studies in Europe and North America. Patients were included in this analysis if they were aged 16 years or over and antiretroviral-naive when initiating combination therapy. We constructed abridged life tables to estimate life expectancies for individuals on combination antiretroviral therapy in 1996-99, 2000-02, and 2003-05, and stratified by sex, baseline CD4 cell count, and history of injecting drug use. The average number of years remaining to be lived by those treated with combination antiretroviral therapy at 20 and 35 years of age was estimated. Potential years of life lost from 20 to 64 years of age and crude mortality rates were also calculated. Findings 18 587, 13 914, and 10 854 eligible patients initiated combination antiretroviral therapy in 1996-99, 2000-02, and 2003-05, respectively. 2056 (4.7%) deaths were observed during the study period, with crude mortality rates decreasing from 16.3 deaths per 1000 person-years in 1996-99 to 10 . 0 deaths per 1000 person-years in 2003-05. Potential years of life lost per 1000 person-years also decreased over the same time, from 366 to 189 years. Life expectancy at age 20 years increased from 36. 1 (S E 0 . 6) years to 49.4 (0.5) years. Women had higher life expectancies than did men. Patients with presumed transmission via injecting drug use had lower life expectancies than did those from other transmission groups (32.6 [1. 1] years vs 44.7 [0.3] years in 2003-05). Life expectancy was lower in patients with lower baseline CD4 cell counts than in those with higher baseline counts (32.4 [1. 1] years for CD4 cell counts below 100 cells per mu L vs 50.4 [0.4] years for counts of 200 cells per mu L or more). Interpretation life expectancy in HIV-infected patients treated with combination antiretroviral therapy increased between 1996 and 2005, although there is considerable variability between subgroups of patients. The average number of years remaining to be lived at age 20 years was about two-thirds of that in the general population in these countries. Funding UK Medical Research Council, GlaxoSmithKIine.	[Hogg, Robert; Lima, Viviane; Hayden, Anna] BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Hogg, Robert] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Sterne, Jonathan A. C.; Harris, Ross; May, Margaret] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Grabar, Sophie] INSERM, U 720, F-75013 Paris, France; [Grabar, Sophie] Univ Paris 05, Fac Med, Paris, France; [Grabar, Sophie] Hop Cochin, AP HP, F-75674 Paris, France; [Battegay, Manuel] Univ Basel, Div Infect Dis & Hosp Epidemiol, CH-4003 Basel, Switzerland; [Bonarek, Mojgan] Univ Victor Segalen, INSERM, U897, Bordeaux, France; [Monforte, Antonella D'Arminio] Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Milan, Italy; [Esteve, Anna] Ctr Epidemiol Studies Sexually Transmitted Infect, Badalona, Spain; [Gill, M. John] Univ Calgary, Div Infect Dis, Calgary, AB, Canada; [Justice, Amy] Yale Univ, Sch Med, New Haven, CT USA; [Lampe, Fiona; Mocroft, Amanda] UCL Royal Free & Univ Coll Med Sch, Res Dept Infect & Populat Hlth, Div Populat Hlth, London WC1E 6BT, England; [Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Staszewski, Schlomo] Goethe Univ Frankfurt, Zentrum Inneren Med, Frankfurt, Germany; [Wasmuth, Jan-Christian] Univ Bonn, Dept Internal Med, D-5300 Bonn, Germany; [van Sighem, Ard] HIV Monitoring Fdn, Amsterdam, Netherlands; [Kitahata, Mari] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Guest, Jodie] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Egger, Matthias] Univ Bern, Dept Social & Prevent Med, Bern, Switzerland	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of Bristol; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; San Paolo-Polo Universitaria Hospital; University of Milan; University of Calgary; Yale University; University of London; University College London; UCL Medical School; University of Alabama System; University of Alabama Birmingham; Goethe University Frankfurt; University of Bonn; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Bern	Hogg, R (corresponding author), BC Ctr Excellence HIV AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	bobhogg@cfenet.ubc.ca	Mocroft, Amanda/C-1527-2008; Lampe, Fiona/I-5826-2019; Sterne, Jonathan/Z-3106-2019; VALLET, Yannick/F-9979-2011; Grabar, Sophie/AAM-9857-2020; , Felipe/F-4242-2014; Hogg, Robert S/B-2783-2012; Dodsley, Maria/G-7083-2016; Mocroft, Amanda/G-8748-2011; Gill, Michael John/G-7083-2016	Lampe, Fiona/0000-0001-6851-5471; Sterne, Jonathan/0000-0001-8496-6053; , Felipe/0000-0001-7658-5832; Hogg, Robert S/0000-0003-3463-5488; Dodsley, Maria/0000-0001-7587-558X; Mocroft, Amanda/0000-0001-8316-1122; Gill, Michael John/0000-0002-8546-8790	Medical Research Council [G0700820] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA013566] Funding Source: NIH RePORTER; MRC [G0700820] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bonnet F, 2002, HIV Med, V3, P195, DOI 10.1046/j.1468-1293.2002.00117.x; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Chiasson MA, 1999, J ACQ IMMUN DEF SYND, V21, P59, DOI 10.1097/00126334-199905010-00008; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Lange JMA, 2003, JAIDS-J ACQ IMM DEF, V34, pS40, DOI 10.1097/00126334-200309011-00007; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Lloyd-Smith E, 2006, AIDS, V20, P445, DOI 10.1097/01.aids.0000206508.32030.92; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; McGuire AL, 2005, HIV MED, V6, P57, DOI 10.1111/j.1468-1293.2005.00266.x; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Selik RM, 1997, AIDS, V11, P1635, DOI 10.1097/00002030-199713000-00013; Staehelin C, 2004, AIDS PATIENT CARE ST, V18, P665, DOI 10.1089/apc.2004.18.665; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba; Valdez H, 2001, CLIN INFECT DIS, V32, P1487, DOI 10.1086/320164; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wong KH, 2004, CLIN INFECT DIS, V39, P853, DOI 10.1086/423183	41	1186	1204	2	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					293	299						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657708	Green Accepted, Bronze			2022-12-28	WOS:000258042800030
J	Sallee, NA; Rivera, GM; Dueber, JE; Vasilescu, D; Mullins, RD; Mayer, BJ; Lim, WA				Sallee, Nathan A.; Rivera, Gonzalo M.; Dueber, John E.; Vasilescu, Dan; Mullins, R. Dyche; Mayer, Bruce J.; Lim, Wendell A.			The pathogen protein EspF(U) hijacks actin polymerization using mimicry and multivalency	NATURE			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; N-WASP; WASP/SCAR PROTEINS; ACTIVATION; EFFECTOR; NUCLEATION; NCK; CYTOSKELETON; MECHANISMS	Enterohaemorrhagic Escherichia coli attaches to the intestine through actin pedestals that are formed when the bacterium injects its protein EspFU ( also known as TccP) into host cells(1). EspFU potently activates the host WASP ( Wiskott - Aldrich syndrome protein) family of actin- nucleating factors, which are normally activated by the GTPase CDC42, among other signalling molecules. Apart from its amino- terminal type III secretion signal, EspFU consists of five- and- a- half 47- amino- acid repeats. Here we show that a 17- residue motif within this EspFU repeat is sufficient for interaction with N- WASP ( also known as WASL). Unlike most pathogen proteins that interface with the cytoskeletal machinery, this motif does not mimic natural upstream activators: instead of mimicking an activated state of CDC42, EspFU mimics an auto-nhibitory element found within N- WASP. Thus, EspFU activates N- WASP by competitively disrupting the autoinhibited state. By mimicking an internal regulatory element and not the natural activator, EspFU selectively activates only a precise subset of CDC42- activated processes. Although one repeat is able to stimulate actin polymerization, we show that multiple- repeat fragments have notably increased potency. The activities of these EspFU fragments correlate with their ability to coordinate activation of at least two N- WASP proteins. Thus, this pathogen has used a simple autoinhibitory fragment as a component to build a highly effective actin polymerization machine.	[Sallee, Nathan A.; Dueber, John E.; Mullins, R. Dyche; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Sallee, Nathan A.; Dueber, John E.; Mullins, R. Dyche; Lim, Wendell A.] Univ Calif San Francisco, Cell Propuls Lab, NIH Nanomed Dev Ctr, San Francisco, CA 94158 USA; [Sallee, Nathan A.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Rivera, Gonzalo M.; Vasilescu, Dan; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Rivera, Gonzalo M.; Vasilescu, Dan; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, CCAM, Farmington, CT 06030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Connecticut; University of Connecticut	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu			NIH; NIGMS; Nanomedicine Development Centers; NIH Roadmap; NSF; Packard Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA082258] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062583, R01GM061010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nanomedicine Development Centers; NIH Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Akin for reagents and assistance with the bead motility experiments; J. C. Anderson, A. Chau, R. Howard, M. Lohse, A. Remenyi and L. Weaver for assistance; and members of the Lim laboratory for discussion. This work was supported by grants from the NIH (NIGMS and Nanomedicine Development Centers, NIH Roadmap), the NSF and the Packard Foundation. G. M. R. was supported by the American Heart Association.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Garmendia J, 2006, CELL MICROBIOL, V8, P1444, DOI 10.1111/j.1462-5822.2006.00723.x; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lommel S, 2004, CELL MICROBIOL, V6, P243, DOI 10.1111/j.1462-5822.2004.00364.x; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mattoo S, 2007, CURR OPIN IMMUNOL, V19, P392, DOI 10.1016/j.coi.2007.06.005; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Sallee NA, 2007, J AM CHEM SOC, V129, P4606, DOI 10.1021/ja0672728; Stebbins CE, 2004, CURR OPIN STRUC BIOL, V14, P731, DOI 10.1016/j.sbi.2004.09.011; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	35	81	84	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2008	454	7207					1005	U49		10.1038/nature07170	http://dx.doi.org/10.1038/nature07170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18650806	Green Accepted			2022-12-28	WOS:000258591000041
J	Moore, W				Moore, Wendy			Searching for Dr Condom	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2008	337	7665							a1166	10.1136/bmj.a1166	http://dx.doi.org/10.1136/bmj.a1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EO	18684754				2022-12-28	WOS:000258561100039
J	Bishop, JL; Dobrea, EZN; McKeown, NK; Parente, M; Ehlmann, BL; Michalski, JR; Milliken, RE; Poulet, F; Swayze, GA; Mustard, JF; Murchie, SL; Bibring, JP				Bishop, Janice L.; Dobrea, Eldar Z. Noe; McKeown, Nancy K.; Parente, Mario; Ehlmann, Bethany L.; Michalski, Joseph R.; Milliken, Ralph E.; Poulet, Francois; Swayze, Gregg A.; Mustard, John F.; Murchie, Scott L.; Bibring, Jean-Pierre			Phyllosilicate diversity and past aqueous activity revealed at Mawrth Vallis, Mars	SCIENCE			English	Article							HYDROTHERMAL ALTERATION; INFRARED-SPECTROSCOPY; SMECTITES; BACTERIA; MINERALS; ORIGIN	Observations by the Mars Reconnaissance Orbiter/Compact Reconnaissance Imaging Spectrometer for Mars in the Mawrth Vallis region show several phyllosilicate species, indicating a wide range of past aqueous activity. Iron/magnesium (Fe/Mg)-smectite is observed in light-toned outcrops that probably formed via aqueous alteration of basalt of the ancient cratered terrain. This unit is overlain by rocks rich in hydrated silica, montmorillonite, and kaolinite that may have formed via subsequent leaching of Fe and Mg through extended aqueous events or a change in aqueous chemistry. A spectral feature attributed to an Fe2+ phase is present in many locations in the Mawrth Vallis region at the transition from Fe/Mg-smectite to aluminum/silicon (Al/Si)-rich units. Fe2+-bearing materials in terrestrial sediments are typically associated with microorganisms or changes in pH or cations and could be explained here by hydrothermal activity. The stratigraphy of Fe/Mg-smectite overlain by a ferrous phase, hydrated silica, and then Al-phyllosilicates implies a complex aqueous history.	[Bishop, Janice L.] SETI Inst, Mountain View, CA 94043 USA; [Bishop, Janice L.] NASA, Ames Res Ctr, Mountain View, CA 94043 USA; [Dobrea, Eldar Z. Noe; Milliken, Ralph E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [McKeown, Nancy K.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Parente, Mario] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Ehlmann, Bethany L.; Mustard, John F.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Michalski, Joseph R.; Poulet, Francois; Bibring, Jean-Pierre] Inst Astrophys Spatiale, F-91405 Orsay, France; [Swayze, Gregg A.] US Geol Survey, Lakewood, CO 80225 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Santa Cruz; Stanford University; Brown University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; United States Department of the Interior; United States Geological Survey; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Bishop, JL (corresponding author), SETI Inst, Mountain View, CA 94043 USA.	jbishop@seti.org	Michalski, Joseph/AAU-5631-2020; Murchie, Scott L/E-8030-2015	Murchie, Scott L/0000-0002-1616-8751; Michalski, Joseph/0000-0002-4543-6452; Bishop, Janice/0000-0002-6681-9954	NASA [NNX13AK19A] Funding Source: Medline	NASA(National Aeronautics & Space Administration (NASA))		Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bishop J, 2002, CLAY MINER, V37, P607, DOI 10.1180/0009855023740063; Bishop J, 2002, CLAY MINER, V37, P617, DOI 10.1180/0009855023740064; Bishop JL, 2007, CLAY CLAY MINER, V55, P1, DOI 10.1346/CCMN.2007.0550101; BISHOP JL, 2005, LUN PLAN SCI C LUN P; BROCK TD, 1976, APPL ENVIRON MICROB, V32, P567, DOI 10.1128/AEM.32.4.567-571.1976; BROWNE PRL, 1978, ANNU REV EARTH PL SC, V6, P229, DOI 10.1146/annurev.ea.06.050178.001305; Chamley H., 1989, CLAY SEDIMENTOLOGY, DOI DOI 10.1007/978-3-642-85916-8; DOBREA EZ, 2008, LUN PLAN SCI C LUN P; JACKSON M. L., 1957, Proceedings. 6th nat. Conf. Clays & Clay Min., P133, DOI 10.1346/CCMN.1957.0060111; Loizeau D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002877; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Michalski JR, 2007, GEOLOGY, V35, P951, DOI 10.1130/G23854A.1; MICHALSKI JR, 2007, 7 INT MARS C PAS CA; MILLIKEN RE, IN PRESS GEOLOGY; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Nelson MJ, 2005, GEOCHIM COSMOCHIM AC, V69, P2701, DOI 10.1016/j.gca.2005.01.020; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; STUCKI JW, 1991, CLAY CLAY MINER, V39, P137, DOI 10.1346/CCMN.1991.0390204; Wray JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034385	23	294	294	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					830	833		10.1126/science.1159699	http://dx.doi.org/10.1126/science.1159699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687963	Green Accepted			2022-12-28	WOS:000258261000044
J	Yin, P; Hariadi, RF; Sahu, S; Choi, HMT; Park, SH; LaBean, TH; Reif, JH				Yin, Peng; Hariadi, Rizal F.; Sahu, Sudheer; Choi, Harry M. T.; Park, Sung Ha; LaBean, Thomas H.; Reif, John H.			Programming DNA tube circumferences	SCIENCE			English	Article							CONDUCTIVE NANOWIRES; NANOTUBES; DESIGN; NANOARCHITECTURES; NANOTECHNOLOGY; NANOSTRUCTURES; TEMPLATES; ASSEMBLE; CRYSTALS; 6-HELIX	Synthesizing molecular tubes with monodisperse, programmable circumferences is an important goal shared by nanotechnology, materials science, and supermolecular chemistry. We program molecular tube circumferences by specifying the complementarity relationships between modular domains in a 42-base single-stranded DNA motif. Single-step annealing results in the self-assembly of long tubes displaying monodisperse circumferences of 4, 5, 6, 7, 8, 10, or 20 DNA helices.	[Yin, Peng; Park, Sung Ha] CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA; [Yin, Peng; Choi, Harry M. T.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Yin, Peng] CALTECH, Ctr Biol Circuit Design, Pasadena, CA 91125 USA; [Hariadi, Rizal F.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Park, Sung Ha] CALTECH, Ctr Phys Informat, Pasadena, CA 91125 USA; [Sahu, Sudheer; LaBean, Thomas H.; Reif, John H.] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; [LaBean, Thomas H.] Duke Univ, Dept Chem, Durham, NC 27708 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; Duke University; Duke University	Yin, P (corresponding author), CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA.	py@caltech.edu	Reif, John H/C-2684-2008; LaBean, Thomas H/G-2859-2011	LaBean, Thomas H/0000-0002-6739-2059; Choi, Harry/0000-0002-1530-0773; Hariadi, Rizal/0000-0001-7840-859X	Direct For Computer & Info Scie & Enginr [0829798] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [0829797] Funding Source: National Science Foundation	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Barish RD, 2005, NANO LETT, V5, P2586, DOI 10.1021/nl052038l; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Feldkamp U, 2006, ANGEW CHEM INT EDIT, V45, P1856, DOI 10.1002/anie.200502358; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Ke YG, 2006, J AM CHEM SOC, V128, P4414, DOI 10.1021/ja058145z; Kuzuya A, 2007, NANO LETT, V7, P1757, DOI 10.1021/nl070828k; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h; Park SH, 2005, NANO LETT, V5, P693, DOI 10.1021/nl050108i; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Reishus D, 2005, J AM CHEM SOC, V127, P17590, DOI 10.1021/ja0557177; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Schulman R, 2007, P NATL ACAD SCI USA, V104, P15236, DOI 10.1073/pnas.0701467104; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Seeman NC, 1998, NANOTECHNOLOGY, V9, P257, DOI 10.1088/0957-4484/9/3/018; Sherman WB, 2006, BIOPHYS J, V90, P4546, DOI 10.1529/biophysj.105.080390; Wei B, 2005, BIOMACROMOLECULES, V6, P2528, DOI 10.1021/bm050230b; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451	25	358	387	3	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					824	826		10.1126/science.1157312	http://dx.doi.org/10.1126/science.1157312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687961				2022-12-28	WOS:000258261000042
J	Berry, DA				Berry, Donald A.			The science of doping	NATURE			English	Editorial Material									Univ Texas Houston, MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA; Univ Texas Houston, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; Univ Texas Houston, MD Anderson Canc Ctr, Frank T McGraw Mem Chair Canc Res, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Berry, DA (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Div Quantitat Sci, 1400 Pressler St, Houston, TX 77030 USA.	dberry@mdanderson.org						Berry D.A., 1996, STAT BAYESIAN PERSPE; Berry D. A., 2004, CHANCE, V17, P5; Berry DA, 1991, STAT SCI, V6, P175; BUCHANAN M, 2007, NY TIMES        0516	4	48	48	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					692	693		10.1038/454692a	http://dx.doi.org/10.1038/454692a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	334NH	18685682				2022-12-28	WOS:000258228000019
J	Chen, TH; Hollingsworth, H				Chen, Ting-hsu; Hollingsworth, Helen			Allergic bronchopulmonary aspergillosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Ting-hsu; Hollingsworth, Helen] Boston Univ, Boston, MA 02118 USA	Boston University	Chen, TH (corresponding author), Boston Univ, Med Campus, Boston, MA 02118 USA.	tchen@bu.edu		Hollingsworth, Helen/0000-0001-9007-9012; Chen, Ting-hsu/0000-0002-1231-4600					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					E7	E7		10.1056/NEJMicm055764	http://dx.doi.org/10.1056/NEJMicm055764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687635				2022-12-28	WOS:000258216700011
J	Pham, CB; Shaughnessy, AF				Pham, Cung B.; Shaughnessy, Allen F.			Uncertainties page - Should we treat subclinical hypothyroidism?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; L-THYROXINE; THYROID-DISORDERS; ASSOCIATION; RISK		[Pham, Cung B.; Shaughnessy, Allen F.] Tufts Univ, Sch Med, Dept Publ Hlth & Family Med, Cambridge Hlth Alliance,Tufts Univ Family Med Res, Malden, MA 02148 USA	Harvard University; Cambridge Health Alliance; Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Family Med, Cambridge Hlth Alliance,Tufts Univ Family Med Res, 195 Canal St, Malden, MA 02148 USA.	Allen.Shaughnessy@Tufts.edu						[Anonymous], 2006, UK GUIDELINES USE TH; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Danese ND, 2000, J CLIN ENDOCR METAB, V85, P2993, DOI 10.1210/jcem.85.9.6841; FABER J, 1994, EUR J ENDOCRINOL, V130, P350, DOI 10.1530/eje.0.1300350; Gammage MD, 2007, ARCH INTERN MED, V167, P928, DOI 10.1001/archinte.167.9.928; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Ineck BA, 2003, ANN PHARMACOTHER, V37, P725, DOI 10.1345/aph.1C376; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kong WM, 2002, AM J MED, V112, P348, DOI 10.1016/S0002-9343(02)01022-7; NYGAARD B, 2007, SUBCLINICAL HYPOTHYR; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Rodondi N, 2006, AM J MED, V119, P541, DOI 10.1016/j.amjmed.2005.09.028; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; *US PREV SERV TASK, 2004, REC STAT SCREEN THYR; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x	17	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a834	10.1136/bmj.a834	http://dx.doi.org/10.1136/bmj.a834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18632678				2022-12-28	WOS:000258561000032
J	Vaidya, B; Pearce, SHS				Vaidya, Bijay; Pearce, Simon H. S.			Management of hypothyroidism in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							THYROID-HORMONE; DOUBLE-BLIND; THYROXINE REPLACEMENT; DISEASE; TRIIODOTHYRONINE; LEVOTHYROXINE; METAANALYSIS; COMMUNITY; SYMPTOMS; THERAPY		[Vaidya, Bijay] Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England; [Vaidya, Bijay] Peninsula Med Sch, Exeter, Devon, England; [Pearce, Simon H. S.] Royal Victoria Infirm, Endocrine Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Pearce, Simon H. S.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Exeter; University of Exeter; Newcastle University - UK; Newcastle University - UK	Vaidya, B (corresponding author), Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England.	bijay.vaidya@pms.ac.uk	Pearce, Simon/AAB-3692-2019; Vaidya, Bijay/AAF-1947-2020	Pearce, Simon/0000-0001-8384-8063; 				ADRIAANSE R, 1992, ACTA ENDOCRINOL-COP, V126, P206, DOI 10.1530/acta.0.1260206; Arafah BM, 2001, NEW ENGL J MED, V344, P1743, DOI 10.1056/NEJM200106073442302; Berg AO, 2004, ANN INTERN MED, V140, P125, DOI 10.7326/0003-4819-140-2-200401200-00014; Bernstein R, 1995, THYROID, V5, P443, DOI 10.1089/thy.1995.5.443; Bolk N, 2007, CLIN ENDOCRINOL, V66, P43, DOI 10.1111/j.1365-2265.2006.02681.x; British Thyroid Association, UK GUID US THYR FUNC; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; CARR D, 1988, CLIN ENDOCRINOL, V28, P325, DOI 10.1111/j.1365-2265.1988.tb01219.x; Checchi S, 2008, J CLIN ENDOCR METAB, V93, P465, DOI 10.1210/jc.2007-1544; DEMERS LM, 2002, LAB MED PRACTICE GUI; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; Glinoer D, 2007, BRIT MED J, V335, P300, DOI 10.1136/bmj.39189.513935.BE; Grebe SKG, 1997, J CLIN ENDOCR METAB, V82, P870, DOI 10.1210/jc.82.3.870; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Harris KB, 2007, MOL GENET METAB, V91, P268, DOI 10.1016/j.ymgme.2007.03.012; *INF CTR HLTH SOC, 2006, PRESCR COST AN 2006; Ito M, 2007, J CLIN ENDOCR METAB, V92, P608, DOI 10.1210/jc.2006-1605; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; McDermott JH, 2005, THYROID, V15, P386, DOI 10.1089/thy.2005.15.386; Murray JS, 2001, BRIT MED J, V323, P332, DOI 10.1136/bmj.323.7308.332; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; PARLE JV, 1993, BRIT J GEN PRACT, V43, P107; Pollock MA, 2001, BRIT MED J, V323, P891, DOI 10.1136/bmj.323.7318.891; Raftopoulos Y, 2004, OBES SURG, V14, P509, DOI 10.1381/096089204323013514; RAZVI S, 2008, J CLIN ENDOCRINOL ME; Roos A, 2005, ARCH INTERN MED, V165, P1714, DOI 10.1001/archinte.165.15.1714; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SAWIN CT, 1983, AM J MED, V75, P206, DOI 10.1016/0002-9343(83)91192-0; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Villar HCCE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003419.pub2; Walsh JP, 2006, J CLIN ENDOCR METAB, V91, P2624, DOI 10.1210/jc.2006-0099	35	69	73	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a801	10.1136/bmj.a801	http://dx.doi.org/10.1136/bmj.a801			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18662921				2022-12-28	WOS:000258561000031
J	Gupta, GR; Parkhurst, JO; Ogden, JA; Aggleton, P; Mahal, A				Gupta, Geeta Rao; Parkhurst, Justin O.; Ogden, Jessica A.; Aggleton, Peter; Mahal, Ajay			HIV prevention 4 - Structural approaches to HIV prevention	LANCET			English	Article							INTIMATE-PARTNER VIOLENCE; FEMALE SEX WORKERS; RISK BEHAVIORS; SOUTH-AFRICA; HIV/AIDS; INFECTION; PREVALENCE; POVERTY; INTERVENTIONS; TRANSMISSION	Recognition that social, economic, political, and environmental factors directly affect HIV risk and vulnerability has stimulated interest in structural approaches to HIV prevention. Progress in the use of structural approaches has been limited for several reasons: absence of a clear definition; lack of operational guidance; and limited data on the effectiveness of structural approaches to the reduction of HIV incidence. In this paper we build on evidence and experience to address these gaps. We begin by defining structural factors and approaches. We describe the available evidence on their effectiveness and discuss methodological challenges to the assessment of these often complex efforts to reduce HIV risk and vulnerability. We identify core principles for implementing this kind of work. We also provide recommendations for ensuring the integration of structural approaches as part of combined prevention strategies.	[Gupta, Geeta Rao; Ogden, Jessica A.] ICRW, Washington, DC 20036 USA; [Parkhurst, Justin O.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Aggleton, Peter] Univ London, Inst Educ, London WC1N 1AZ, England; [Mahal, Ajay] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Institute of Education; Harvard University; Harvard T.H. Chan School of Public Health	Gupta, GR (corresponding author), ICRW, Washington, DC 20036 USA.	geeta@icrw.org	Parkhurst, Justin/AAP-3615-2021	Aggleton, Peter/0000-0001-5966-4969				Aidala A, 2005, AIDS BEHAV, V9, P251, DOI 10.1007/s10461-005-9000-7; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Barnett T, 2005, LANCET INFECT DIS, V5, P590, DOI 10.1016/S1473-3099(05)70219-X; Barnett T., 2002, AIDS 21 CENTURY DIS; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Bernard TE, 2008, J OCCUP ENVIRON HYG, V5, P1, DOI 10.1080/15459620701732355; Black N, 1996, BRIT MED J, V312, P1215; Bloom David E., 2004, ASIAS EC CHALLENGE A; Bonell C, 2001, BRIT MED BULL, V58, P155, DOI 10.1093/bmb/58.1.155; Campbell C, 1999, SOC SCI MED, V48, P1625, DOI 10.1016/S0277-9536(98)00449-3; Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7; Campbell C., 2003, LETTING THEM DIE WHY; CARSWELL JW, 1989, AIDS, V3, P759, DOI 10.1097/00002030-198911000-00013; Cohen J, 2004, SCIENCE, V304, P506, DOI 10.1126/science.304.5670.506; Cohen Jonathan, 2005, HIV AIDS Policy Law Rev, V10, P23; Des Jarlais DC, 2000, AIDS, V14, pS41, DOI 10.1097/00002030-200006001-00006; Drucker E, 1998, AIDS, V12 Suppl A, pS217; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Dutta M., 1999, RES SEX WORK, V2; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gould P, 1993, SLOW PLAGUE GEOGRAPH; Guy RJ, 2007, MED J AUSTRALIA, V187, P437, DOI 10.5694/j.1326-5377.2007.tb01353.x; Hall J, 2006, MICROFINANCE BRIEF T; HALLMAN K, 2005, IUSSP SEM POV HIV AI; Hallman K, 2006, HIV VULNERABILITY NO; Hallman Kelly, 2005, Afr J AIDS Res, V4, P37, DOI 10.2989/16085900509490340; HARGREAVES J, 2002, IMAGE STUDY EVALUATI, P1; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; Heald S, 2006, J BIOSOC SCI, V38, P29, DOI 10.1017/S0021932005000933; *HIV INF MYANM, MUS JEG END AIDS ROA; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jin L, 2008, J SEX MED, V5, P12; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; KANE F, 1993, AIDS, V7, P1261, DOI 10.1097/00002030-199309000-00017; KAWACHI I, 2002, HLTH NATIONS WHY INE; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2008, HEALTH EDUC RES, V23, P137, DOI 10.1093/her/cym011; Kippax S, 2003, SOC SCI MED, V57, P1, DOI 10.1016/S0277-9536(02)00303-9; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; MAMAN S, 2007, HIV STAT DISCLOSURE; MERSON MH, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60884-3; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Murphy EM, 2006, PLOS MED, V3, P1443, DOI 10.1371/journal.pmed.0030379; Okware S, 2001, B WORLD HEALTH ORGAN, V79, P1113; Over M, 1998, CONFRONTING AIDS EVI, P39; PARKHURST JO, IN PRESS AIDS ED PRE; Parkhurst Justin O., 2001, INT RELAT, V15, P69, DOI DOI 10.1177/004711701015006006; Pawson R., 1997, REALISTIC EVALUATION; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; PEREZSTABLE EJ, 1991, AM J PUBLIC HEALTH, V81, P563, DOI 10.2105/AJPH.81.5.563; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; PRONYK P, 2006, DEV FINANCE SOCIAL C; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2006, PROMOTING MORE GENDE; Ravi A, 2007, WOMEN HEALTH ISS, V17, P210, DOI 10.1016/j.whi.2007.02.009; Rwenge M., 2003, AFRICAN POPULATION S, V18, P91; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; SERWADDA D, 1992, AIDS, V6, P983, DOI 10.1097/00002030-199209000-00012; Singh S, 2003, A B C UGANDA ROLES A; Sumartojo E, 2000, AIDS, V14, pS1, DOI 10.1097/00002030-200006001-00001; Sweat M D, 1995, AIDS, V9 Suppl A, pS251; *UNAIDS, 2005, EV UNAIDS UNITAR AID; *UNAIDS, 2007, MON DECL COMM HIV AI; UNAIDS, 2000, EV 100 COND PROGR TH; UNAIDS, 2006, REP GLOB AIDS EP; UNAIDS, 1998, EXP GLOB RESP HIV AI; Watson C, 1988, Afr Rep, P32; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Whiteside A, 2002, THIRD WORLD Q, V23, P313, DOI 10.1080/01436590220126667; Wood K, 2004, HIV RELATED STIGMA D; WOOD K, PROMOTING YOUNG PEOP; Zablotska IB, 2008, SEX HEALTH, V5, P125, DOI 10.1071/SH07076	75	555	565	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2008	372	9640					764	775		10.1016/S0140-6736(08)60887-9	http://dx.doi.org/10.1016/S0140-6736(08)60887-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344YZ	18687460				2022-12-28	WOS:000258964500033
J	Viguera, AC; Emmerich, AD; Cohen, LS; Koukopoulos, AE; Harris, NL; Rosenbaum, JF; Rosenberg, ES				Viguera, Adele C.; Emmerich, Anne D.; Cohen, Lee S.; Koukopoulos, Alexia E.; Harris, Nancy Lee; Rosenbaum, Jerrold F.; Rosenberg, Eric S.			A woman with postpartum confusion, agitation, and delusions - Postpartum psychosis in a patient with bipolar disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; PUERPERAL PSYCHOSIS; PROPHYLACTIC LITHIUM; SUICIDAL-BEHAVIOR; MOOD DISORDERS; RISK-FACTORS; WOMEN; PREGNANCY; ILLNESS; ANTIDEPRESSANTS		Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Harvard Univ, Dept Psychiat, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Viguera, AC (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.		Viguera, Adele/AGP-7361-2022					ABOUSALEH MT, 1983, BRIT J PSYCHIAT, V142, P539, DOI 10.1192/bjp.142.5.539; Altshuler LL, 1996, AM J PSYCHIAT, V153, P592; Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; AUSTIN MPV, 1992, BRIT J PSYCHIAT, V161, P692, DOI 10.1192/bjp.161.5.692; Blackmore ER, 2006, BRIT J PSYCHIAT, V188, P32, DOI 10.1192/bjp.188.1.32; Bonari L, 2005, ARCH WOMEN MENT HLTH, V8, P214, DOI 10.1007/s00737-005-0094-8; Brockington IF., 1999, INFANT OBSERV, V2, P116, DOI [10.1080/13698039908400552, DOI 10.1080/13698039908400552]; Chaudron LH, 2003, J CLIN PSYCHIAT, V64, P1284, DOI 10.4088/JCP.v64n1102; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; COHEN LS, 1989, PSYCHOSOMATICS, V30, P25, DOI 10.1016/S0033-3182(89)72314-8; COHEN LS, 1995, AM J PSYCHIAT, V152, P1641; COHEN LS, 1994, JAMA-J AM MED ASSOC, V271, P146, DOI 10.1001/jama.271.2.146; COHEN LS, 1994, JAMA-J AM MED ASSOC, V271, P1485; CORYELL W, 1993, AM J PSYCHIAT, V150, P720; DEAN C, 1989, PSYCHOL MED, V19, P637, DOI 10.1017/S0033291700024235; Department of Health, 1998, WHY MOTH DIE REP CON; Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; Einarson TR, 2005, PHARMACOEPIDEM DR S, V14, P823, DOI 10.1002/pds.1084; Freeman MP, 2002, J CLIN PSYCHIAT, V63, P284, DOI 10.4088/JCP.v63n0403; GITLIN MJ, 1995, AM J PSYCHIAT, V152, P1635; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Greene MF, 2007, NEW ENGL J MED, V356, P2732, DOI 10.1056/NEJMe078079; Jones I, 2005, BRIT J PSYCHIAT, V186, P453, DOI 10.1192/bjp.186.6.453; Jones I, 2002, PSYCHIATR GENET, V12, P177, DOI 10.1097/00041444-200209000-00011; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; Jones I, 2007, AM J PSYCHIAT, V164, P1099, DOI 10.1176/appi.ajp.164.7.1099; Judd LL, 2005, ARCH GEN PSYCHIAT, V62, P1322, DOI 10.1001/archpsyc.62.12.1322; KENDELL RE, 1987, BRIT J PSYCHIAT, V151, P135; KENDELL RE, 1981, PSYCHOL MED, V11, P341, DOI 10.1017/S0033291700052156; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khong SY, 2007, OBSTET GYNECOL, V109, P515, DOI 10.1097/01.AOG.0000226856.21741.3f; KUMAR R, 1995, J AFFECT DISORDERS, V33, P11, DOI 10.1016/0165-0327(94)00067-J; Lanska DJ, 2000, STROKE, V31, P1274, DOI 10.1161/01.STR.31.6.1274; Leibenluft E, 1996, AM J PSYCHIAT, V153, P163; Leverich GS, 2006, AM J PSYCHIAT, V163, P232, DOI 10.1176/appi.ajp.163.2.232; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Mann JJ, 2005, AM J PSYCHIAT, V162, P1672, DOI 10.1176/appi.ajp.162.9.1672; Oates M, 2003, BRIT MED BULL, V67, P219, DOI 10.1093/bmb/ldg011; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Payne JL, 2008, BIPOLAR DISORD, V10, P38, DOI 10.1111/j.1399-5618.2008.00455.x; Post RM, 2003, J CLIN PSYCHIAT, V64, P680, DOI 10.4088/JCP.v64n0610; Robertson E, 2005, BRIT J PSYCHIAT, V186, P258, DOI 10.1192/bjp.186.3.258; Royal College of Obstetricians and Gynaecologists, 2004, WHY MOTH DIE 2000 20; Sachs GS, 2007, NEW ENGL J MED, V356, P1711, DOI 10.1056/NEJMoa064135; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Sharma V, 2003, BIPOLAR DISORD, V5, P98, DOI 10.1034/j.1399-5618.2003.00015.x; Sharma V, 2006, BIPOLAR DISORD, V8, P411, DOI 10.1111/j.1399-5618.2006.00336.x; Sit D, 2006, J WOMENS HEALTH, V15, P352, DOI 10.1089/jwh.2006.15.352; Spinelli MG, 2004, AM J PSYCHIAT, V161, P1548, DOI 10.1176/appi.ajp.161.9.1548; STEWART DE, 1991, BRIT J PSYCHIAT, V158, P393, DOI 10.1192/bjp.158.3.393; STEWART DE, 1988, J NERV MENT DIS, V176, P485, DOI 10.1097/00005053-198808000-00006; Stowe ZN, 2005, AM J OBSTET GYNECOL, V192, P522, DOI 10.1016/j.ajog.2004.07.054; Swanson JW, 2006, AM J PSYCHIAT, V163, P1943, DOI 10.1176/appi.ajp.163.11.1943; Tondo L, 2003, CNS DRUGS, V17, P491, DOI 10.2165/00023210-200317070-00003; VIDEBECH P, 1995, ACTA PSYCHIAT SCAND, V91, P167, DOI 10.1111/j.1600-0447.1995.tb09761.x; Viguera AC, 2002, AM J PSYCHIAT, V159, P2102, DOI 10.1176/appi.ajp.159.12.2102; Viguera AC, 2000, AM J PSYCHIAT, V157, P179, DOI 10.1176/appi.ajp.157.2.179; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; Viguera AC, 2007, AM J PSYCHIAT, V164, P342, DOI 10.1176/appi.ajp.164.2.342; Wisner KL, 2004, BIOL PSYCHIAT, V56, P592, DOI 10.1016/j.biopsych.2004.07.022; Yonkers KA, 2004, AM J PSYCHIAT, V161, P608, DOI 10.1176/appi.ajp.161.4.608; Zajiceck E., 1981, PREGNANCY PSYCHOL SO, P57	66	8	8	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					509	515		10.1056/NEJMcpc0804290	http://dx.doi.org/10.1056/NEJMcpc0804290			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669430				2022-12-28	WOS:000258039700010
J	Lee, TH; Emanuel, EJ				Lee, Thomas H.; Emanuel, Ezekiel J.			Tier 4 drugs and the fraying of the social compact	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BREAST-CANCER; COSTS		[Lee, Thomas H.] Partners Healthcare Syst, Boston, MA 02199 USA; [Emanuel, Ezekiel J.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	Partners Healthcare System; National Institutes of Health (NIH) - USA	Lee, TH (corresponding author), Partners Healthcare Syst, Boston, MA 02199 USA.							Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P947, DOI 10.1001/jama.299.8.947; KOLATA G, 2008, NY TIMES        0414; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Willey VJ, 2008, HEALTH AFFAIR, V27, P824, DOI 10.1377/hlthaff.27.3.824	5	53	53	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					333	335		10.1056/NEJMp0804261	http://dx.doi.org/10.1056/NEJMp0804261			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650510				2022-12-28	WOS:000257852100001
J	Cain, KP; Benoit, SR; Winston, CA; Mac Kenzie, WR				Cain, Kevin P.; Benoit, Stephen R.; Winston, Carla A.; Mac Kenzie, William R.			Tuberculosis among foreign-born persons in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS ANALYSIS; RISK; POPULATION; PREVENTION; IMMIGRANTS; INFECTION; HEALTH; AGE	Context Foreign-born persons accounted for 57% of all tuberculosis (TB) cases in the United States in 2006. Current TB control strategies have not sufficiently addressed the high levels of TB disease and latent TB infection in this population. Objective To determine the risk of TB disease and drug-resistant TB among foreign-born populations and the potential impact of adding TB culture to overseas screening procedures for foreign-born persons entering the United States. Design, Setting, and Participants Descriptive epidemiologic analysis of foreign-born persons in the United States diagnosed with TB from 2001 through 2006. Main Outcome Measures TB case rates, stratified by time since US entry, country of origin, and age at US entry; anti-TB drug-resistance patterns; and characteristics of TB cases diagnosed within 3 months of US entry. Results A total of 46 970 cases of TB disease were reported among foreign-born persons in the United States from 2001 through 2006, of which 12 928 (28%) were among recent entrants (within 2 years of US entry). Among the foreign-born population overall, TB case rates declined with increasing time since US entry, but remained higher than among US-born persons - even more than 20 years after arrival. In total, 53% of TB cases among foreign-born persons occurred among the 22% of the foreign-born population born in sub-Saharan Africa and Southeast Asia. Isoniazid resistance was as high as 20% among recent entrants from Vietnam and 18% for recent entrants from Peru. On average, 250 individuals per year were diagnosed with smear-negative, culture-positive TB disease within 3 months of US entry; 46% of these were from the Philippines or Vietnam. Conclusion The relative yield of finding and treating latent TB infection is particularly high among individuals from most countries of sub-Saharan Africa and Southeast Asia.	[Cain, Kevin P.; Benoit, Stephen R.; Winston, Carla A.; Mac Kenzie, William R.] Ctr Dis Control, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Cain, KP (corresponding author), Ctr Dis Control, Div TB Eliminat, 1600 Clifton Rd,MS-E-10, Atlanta, GA 30333 USA.	kcain@cdc.gov	Kenzie, William R Mac/F-1528-2013	Kenzie, William R Mac/0000-0001-7723-0339				[Anonymous], [No title captured]; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; Cain KP, 2008, CLIN INFECT DIS, V46, P107, DOI 10.1086/523732; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; *CDCP, 2007, REP TUB US 2006; *CDCP, 2007 TECHN INSTR TUB; *CDCP, 2007, CDC IMM REQ TECHN IN; Centers for Disease Control and Prevention, 1991, 1991 TECHN INSTR MED; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Dasgupta K, 2005, EUR RESPIR J, V25, P1107, DOI 10.1183/09031936.05.00074004; Deardorff K, EVALUATING COMPONENT; GEITER L, 2000, ENDING NEGLECT ELIMI; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Goldberg SV, 2004, INT J TUBERC LUNG D, V8, P76; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Moran-Mendoza O, 2007, INT J TUBERC LUNG D, V11, P1014; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Parsyan AE, 2007, J INFECTION, V54, P262, DOI 10.1016/j.jinf.2006.04.010; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; ROSE DN, 1988, AM J PREV MED, V4, P102, DOI 10.1016/S0749-3797(18)31204-2; ROSE DN, 1986, JAMA-J AM MED ASSOC, V256, P2709, DOI 10.1001/jama.256.19.2709; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; SCHECHTER CB, 1990, AM J PREV MED, V6, P167, DOI 10.1016/S0749-3797(18)31022-5; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; *US BUR CENS, US CENS BUR AM FACTF; *US DEP HOM SEC, 2006, YB IMM STAT 2006; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	34	171	176	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					405	412		10.1001/jama.300.4.405	http://dx.doi.org/10.1001/jama.300.4.405			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647983	Bronze			2022-12-28	WOS:000257831200018
J	McCurry, J				McCurry, Justin			G8 meeting disappoints on global health	LANCET			English	News Item																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					191	194		10.1016/S0140-6736(08)61054-5	http://dx.doi.org/10.1016/S0140-6736(08)61054-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	327YH	18646289				2022-12-28	WOS:000257763900012
J	Lowell, TV; Kelly, MA				Lowell, Thomas V.; Kelly, Meredith A.			Was the Younger Dryas global?	SCIENCE			English	Editorial Material							FRANZ-JOSEF-GLACIER; NEW-ZEALAND; ADVANCE; AGE		[Lowell, Thomas V.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Kelly, Meredith A.] Lamont Doherty Earth Observ, Geochem Div, Palisades, NY 10964 USA	University System of Ohio; University of Cincinnati; Columbia University	Lowell, TV (corresponding author), Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA.	thomas.lowell@uc.edu		Lowell, Thomas/0000-0001-7826-0636; Kelly, Meredith/0000-0001-8163-3907				Ackert RP, 2008, SCIENCE, V321, P392, DOI 10.1126/science.1157215; Barrows TT, 2007, SCIENCE, V318, P86, DOI 10.1126/science.1145873; Cheng H, 2006, GEOLOGY, V34, P217, DOI 10.1130/G22289.1; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Strelin JA, 2000, QUATERNARY RES, V54, P339, DOI 10.1006/qres.2000.2178; Turney CSM, 2007, QUATERNARY SCI REV, V26, P3037, DOI 10.1016/j.quascirev.2007.09.014	7	15	18	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					348	349		10.1126/science.1160148	http://dx.doi.org/10.1126/science.1160148			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635782				2022-12-28	WOS:000257713900027
J	Weissman, JS; Schneider, EC; Weingart, SN; Epstein, AM; David-Kasdan, J; Feibelmann, S; Annas, CL; Ridley, N; Kirle, L; Gatsonis, C				Weissman, Joel S.; Schneider, Eric C.; Weingart, Saul N.; Epstein, Arnold M.; David-Kasdan, JoAnn; Feibelmann, Sandra; Annas, Catherine L.; Ridley, Nancy; Kirle, Leslie; Gatsonis, Constantine			Comparing patient-reported hospital adverse events with medical record review: Do patients know something that hospitals do not?	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE UTILIZATION; QUALITY-OF-CARE; SELF-REPORT; PROVIDER RECORDS; AMBULATORY-CARE; DRUG EVENTS; CONCORDANCE; DISCHARGE; VALIDITY	Background: Hospitals routinely survey patients about the quality of care they receive, but little is known about whether patient interviews can detect adverse events that medical record reviews do not. Objective: To compare adverse events reported in postdischarge patient interviews with adverse events detected by medical record review. Design: Random sample survey. Setting: Massachusetts, 2003. Patients: Recently hospitalized adults. Measurements: By using parallel methods, physicians reviewed postdischarge interviews and medical records to classify hospital adverse events. Results: Among 998 study patients, 23% had at least 1 adverse event detected by an interview and 11 % had at least 1 adverse event identified by record review. The K statistic showed relatively poor agreement between interviews and medical records for occurrence of any type of adverse event (K = 0.20 [95% CI, 0.03 to 0.27]) and somewhat better agreement between interviews and medical records for life-threatening or serious events (K = 0.33 [CI, 0.20 to 0.451). Record review identified 11 serious, preventable events (1.1 % of patients). Interviews identified an additional 21 serious and preventable events that were not documented in the medical record, including 12 predischarge events and 9 postdischarge events, in which symptoms occurred after the patient left the hospital. Limitations: Patients had to be healthy enough to be interviewed. Delay in reaching patients (6 to 12 months after discharge) may have resulted in poor recall of events during the hospital stay. Conclusion: Patients report many events that are not documented in the medical record; some are serious and preventable. Hospitals should consider monitoring patient safety by adding questions about adverse events to postdischarge interviews.	Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Massachusetts Dept Publ Hlth, Boston, MA USA; Massachusetts Hosp Assoc, Burlington, MA USA; Brown Univ, Providence, RI 02912 USA	Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Massachusetts Department of Public Health; Brown University	Weissman, JS (corresponding author), Massachusetts Execut Off, Hlth & Human Serv, 1 Asburton Pl,Room 1109, Boston, MA 02108 USA.	joel.weissman@state.ma.us		Schneider, Eric/0000-0002-1132-5084	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011928] Funding Source: NIH RePORTER; AHRQ HHS [U18 HS11928] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Beckmann U, 2003, CRIT CARE MED, V31, P1006, DOI 10.1097/01.CCM.0000060016.21525.3C; Bolcic-Jankovic D, 2007, MED CARE, V45, P100, DOI 10.1097/01.mlr.0000241062.79855.35; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Castle NG, 2005, HEALTH SERV RES, V40, P1996, DOI 10.1111/j.1475-6773.2005.00475.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Forster AJ, 2005, J GEN INTERN MED, V20, P317, DOI 10.1111/j.1525-1497.2005.30390.x; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Fowles J B, 1998, J Ambul Care Manage, V21, P24; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Goldstein E, 2005, HEALTH SERV RES, V40, P1977, DOI 10.1111/j.1475-6773.2005.00477.x; Griffin FA., 2007, IHI INNOV SER WHITE; Groves RM., 2011, SURV METHODOL; Institute of Medicine, 2003, PAT SAF ACH NEW STAN; Kwon A, 2003, MED CARE, V41, P368, DOI 10.1097/00005650-200303000-00005; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; MARCHEV M, 2003, NATL ACAD STATE HLTH; Michel P, 2007, QUAL SAF HEALTH CARE, V16, P369, DOI 10.1136/qshc.2005.016964; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Rozario PA, 2004, MED CARE, V42, P952, DOI 10.1097/00005650-200410000-00003; SAFTAN DG, 2006, J GEN INTERN MED, V21, P13; Sofaer S, 2005, HEALTH SERV RES, V40, P2018, DOI 10.1111/j.1475-6773.2005.00473.x; Thomas E. J., 1997, JGIM, V12, P81; Thomas EJ, 2000, INT J QUAL HEALTH C, V12, P371, DOI 10.1093/intqhc/12.5.371; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Wallihan DB, 1999, MED CARE, V37, P662, DOI 10.1097/00005650-199907000-00006; Weingart SN, 2005, J GEN INTERN MED, V20, P830, DOI 10.1111/j.1525-1497.2005.0180.x; Weissman JS, 2007, MED CARE, V45, P448, DOI 10.1097/01.mlr.0000257231.86368.09; Weissman JS, 1996, AIDS, V10, P775, DOI 10.1097/00002030-199606001-00013; *WHO, 2006, NAT STUD HOSP REL AD; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	35	208	210	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					100	108		10.7326/0003-4819-149-2-200807150-00006	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	329GA	18626049				2022-12-28	WOS:000257853700004
J	Maheshwari, A; Ray, S; Thuluvath, PJ				Maheshwari, Anurag; Ray, Stuart; Thuluvath, Paul J.			Acute hepatitis C	LANCET			English	Review							INTERFERON-ALPHA THERAPY; RANDOMIZED CONTROLLED-TRIAL; POSITIVE HOMOSEXUAL-MEN; SINGLE-SOURCE OUTBREAK; T-CELL RESPONSES; NON-A-HEPATITIS; VIRUS-INFECTION; SEXUAL TRANSMISSION; LONG-TERM; NON-B	Symptomatic acute hepatitis C occurs in only about 15% of patients who are infected with hepatitis C virus (HCV). Acute hepatitis C is most often diagnosed in the setting of post-exposure surveillance, or seroconversion in high-risk individuals (eg, health-care professionals or injecting drug users) previously known to be seronegative. Although transmission via transfusion and injecting drug use has declined in developed countries, unsafe blood products and medical practices continue to increase transmission of HCV in many developing countries. Clinically, acute hepatitis C can increase concentrations of alanine aminotransferase to ten times the upper limit of normal but almost never causes fulminant hepatic failure. Diagnosis of HCV infection in the acute phase is difficult since production of antibodies against HCV can be delayed by up to 12 weeks, and about a third of infected individuals might not have detectable antibody at the onset of symptoms. Therefore, testing for HCV RNA by PCR is the only reliable test for the diagnosis of acute infection. Symptomatic patients with jaundice have a higher likelihood of spontaneous viral clearance than do asymptomatic patients, and thus should be monitored for at least 12 weeks before initiating antiviral therapy. By contrast, asymptomatic patients have a much lower chance of spontaneous clearance, and might benefit from early antiviral therapy. Antiviral therapy for 12 weeks is generally effective in treating patients who are HCV RNA negative after 4 weeks of treatment; lengthier courses could be needed for those who relapse or fail to show early virological clearance.	[Maheshwari, Anurag; Thuluvath, Paul J.] Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Ray, Stuart] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Thuluvath, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, 1830 E Monument St,Suite 430, Baltimore, MD 21205 USA.	pjthuluv@jhmi.edu	Ray, Stuart C./B-7527-2008	Ray, Stuart C./0000-0002-1051-7260	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024565] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alberti A, 2002, HEPATOLOGY, V36, pS195, DOI 10.1053/jhep.2002.36808; Alizadeh AHM, 2005, WORLD J GASTROENTERO, V11, P4085, DOI 10.3748/wjg.v11.i26.4085; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Alter HJ, 1997, HEPATOLOGY, V26, pS29, DOI 10.1002/hep.510260705; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bodsworth NJ, 1996, GENITOURIN MED, V72, P118; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Broers B, 2005, J HEPATOL, V42, P323, DOI 10.1016/j.jhep.2004.11.018; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; BUCHBINDER SP, 1994, J INFECTION, V29, P263, DOI 10.1016/S0163-4453(94)91128-2; Calleri G, 2004, J HEPATOL, V40, P139, DOI 10.1016/S0168-8278(04)90469-2; Calleri G, 1998, ITAL J GASTROENTEROL, V30, P181; Capa L, 2007, ANTIVIR THER, V12, P459; *CDCP, VIR HEP SLID SETS; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen M, 1999, GASTROENTEROLOGY, V116, P135, DOI 10.1016/S0016-5085(99)70237-4; Chowdhury A, 2003, HEPATOLOGY, V37, P802, DOI 10.1053/jhep.2003.50157; Chung H, 2003, J GASTROENTEROL, V38, P877, DOI 10.1007/s00535-003-1156-1; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; De Carli G, 2003, INFECTION, V31, P22, DOI 10.1007/s15010-003-8230-8; Delwaide J, 2004, ALIMENT PHARM THER, V20, P15, DOI 10.1111/j.1365-2036.2004.02023.x; Dienstag JL, 1997, HEPATOLOGY, V26, pS66, DOI 10.1002/hep.510260712; Dore Gregory J, 2003, Aust Fam Physician, V32, P796; Eckels DD, 2000, IMMUNOL REV, V174, P90, DOI 10.1034/j.1600-0528.2002.017403.x; Edlin BR, 2005, HEPATOLOGY, V42, p213A; El-Hazmi MM, 2004, SAUDI MED J, V25, P26; European Paediatric Hepatitis C Virus Network, 2001, BJOG, V108, P371; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; FARCI P, 1994, P NATL ACAD SCI USA, V91, P7792, DOI 10.1073/pnas.91.16.7792; Farci P, 1996, NEW ENGL J MED, V335, P631, DOI 10.1056/NEJM199608293350904; FARCI P, 1991, NEW ENGL J MED, V325, P98, DOI 10.1056/NEJM199107113250205; FERAY C, 1993, GASTROENTEROLOGY, V104, P549, DOI 10.1016/0016-5085(93)90425-C; Fletcher Shona, 2003, J Assoc Nurses AIDS Care, V14, p87S, DOI 10.1177/1055329003255815; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; Gibb DM, 2000, LANCET, V356, P904, DOI 10.1016/S0140-6736(00)02681-7; Gilleece YC, 2005, JAIDS-J ACQ IMM DEF, V40, P41, DOI 10.1097/01.qai.0000174930.64145.a9; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Gursoy M, 2001, J VIRAL HEPATITIS, V8, P70, DOI 10.1046/j.1365-2893.2001.00268.x; Hammer GP, 2003, SEX TRANSM DIS, V30, P919, DOI 10.1097/01.OLQ.0000091152.31366.E6; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; HWANG SJ, 1994, J HEPATOL, V21, P831, DOI 10.1016/S0168-8278(94)80246-7; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Kamal SM, 2006, HEPATOLOGY, V43, P923, DOI 10.1002/hep.21197; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Kamal SM, 2004, HEPATOLOGY, V39, P1721, DOI 10.1002/hep.20266; Kapoor D, 2000, Indian J Gastroenterol, V19, P64; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Khattak M F, 2002, J Pak Med Assoc, V52, P398; Koziel MJ, 2006, HEPATOLOGY, V43, P395, DOI 10.1002/hep.21127; LAMPERTICO P, 1994, HEPATOLOGY, V19, P19, DOI 10.1016/0270-9139(94)90047-7; Lauer GM, 2005, J VIROL, V79, P12979, DOI 10.1128/JVI.79.20.12979-12988.2005; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lehmann M, 2004, J MED VIROL, V73, P387, DOI 10.1002/jmv.20103; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Licata A, 2003, J HEPATOL, V39, P1056, DOI 10.1016/S0168-8278(03)00461-6; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Luby S, 2000, HEALTH POLICY PLANN, V15, P217, DOI 10.1093/heapol/15.2.217; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; Marcellin P, 1999, J HEPATOL, V31, P9, DOI 10.1016/S0168-8278(99)80368-7; Marx MA, 2003, CLIN INFECT DIS, V37, P514, DOI 10.1086/376639; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; MELBYE M, 1990, BRIT MED J, V301, P210, DOI 10.1136/bmj.301.6745.210; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Moore A, 2001, LANCET, V358, P657, DOI 10.1016/S0140-6736(01)05783-X; Moriya T, 1999, INTERVIROLOGY, V42, P153, DOI 10.1159/000024974; Netski DM, 2005, CLIN INFECT DIS, V41, P667, DOI 10.1086/432478; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nomura H, 2004, HEPATOLOGY, V39, P1213, DOI 10.1002/hep.20196; OMATA M, 1991, LANCET, V338, P914, DOI 10.1016/0140-6736(91)91774-O; Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112; Patel PR, 2006, JAMA-J AM MED ASSOC, V296, P2005, DOI 10.1001/jama.296.16.2005; Post JJ, 2004, J INFECT DIS, V189, P1846, DOI 10.1086/383279; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; QUIROGA JA, 1991, HEPATOLOGY, V14, P38, DOI 10.1002/hep.1840140107; Rahman F, 2004, HEPATOLOGY, V40, P87, DOI 10.1002/hep.20253; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Ray V L, 2000, Dev Biol (Basel), V102, P195; Roberts EA, 2002, HEPATOLOGY, V36, pS106, DOI 10.1053/jhep.2002.36792; Rocca P, 2003, GASTROEN CLIN BIOL, V27, P294; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Rosen HR, 2002, HEPATOLOGY, V35, P190, DOI 10.1053/jhep.2002.30293; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Santantonio T, 2005, J HEPATOL, V42, P329, DOI 10.1016/j.jhep.2004.11.021; Schackman BR, 2004, AIDS, V18, P1827, DOI 10.1097/00002030-200409030-00012; Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Singh S, 2000, SCAND J INFECT DIS, V32, P3, DOI 10.1080/00365540050164137; Stroffolini T, 2001, AM J GASTROENTEROL, V96, P3138, DOI 10.1111/j.1572-0241.2001.05267.x; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; TAKANO S, 1994, GASTROENTEROLOGY, V107, P805, DOI 10.1016/0016-5085(94)90130-9; TASSOPOULOS NC, 1993, GUT, V34, pS130, DOI 10.1136/gut.34.2_Suppl.S130; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; THOMAS DL, 1995, J INFECT DIS, V171, P768, DOI 10.1093/infdis/171.4.768; Tovo PA, 2005, J INFECT DIS, V192, P1872, DOI 10.1086/497695; Tsai SL, 1997, HEPATOLOGY, V25, P449; Tsai SL, 2003, J BIOMED SCI, V10, P120, DOI [10.1159/000068091, 10.1007/BF02256004]; Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; VILADOMIU L, 1992, HEPATOLOGY, V15, P767, DOI 10.1002/hep.1840150504; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Vogel M, 2005, J VIRAL HEPATITIS, V12, P207, DOI 10.1111/j.1365-2893.2005.00580.x; VOGEL W, 1996, DIG DIS SCI S, V41, P81; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wedemeyer H, 2006, HEPATOLOGY, V44, P1051, DOI 10.1002/hep.21348; Wedemeyer H, 2006, GASTROENTEROLOGY, V131, P682, DOI 10.1053/j.gastro.2006.06.043; WEINER A, 1995, P NATL ACAD SCI USA, V92, P2755, DOI 10.1073/pnas.92.7.2755; Wejstal R, 1999, J HEPATOL, V31, P92, DOI 10.1016/S0168-8278(99)80382-1; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Wiese M, 2000, HEPATOLOGY, V32, P91, DOI 10.1053/jhep.2000.8169; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; World Health Organization, 1999, WKLY EPIDEMIOL REC, V49, P421; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	140	168	177	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					321	332		10.1016/S0140-6736(08)61116-2	http://dx.doi.org/10.1016/S0140-6736(08)61116-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657711				2022-12-28	WOS:000258042800033
J	Pini, P; Kleinert, S				Pini, Pia; Kleinert, Sabine			SWEN - when authors disagree	LANCET			English	Editorial Material									[Pini, Pia; Kleinert, Sabine] The Lancet, London NW1 7BY, England		Pini, P (corresponding author), The Lancet, London NW1 7BY, England.							Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Phadke MA, 2008, LANCET, V372, P287, DOI 10.1016/S0140-6736(08)61100-9	2	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					269	270		10.1016/S0140-6736(08)61088-0	http://dx.doi.org/10.1016/S0140-6736(08)61088-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657691				2022-12-28	WOS:000258042800007
J	Saxena, S; Mitton, SG; Pollok, R				Saxena, Sonia; Mitton, Sally G.; Pollok, Richard			10-minute consultation - Chronic diarrhoea in a teenager	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN		[Saxena, Sonia] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England; [Mitton, Sally G.] Univ London St Georges Hosp, Dept Child Hlth, London SW17 0RE, England; [Pollok, Richard] St Georges Hosp Trust, Dept Gastroenterol, London SW17 0QT, England	Imperial College London; St Georges University London	Saxena, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England.	s.saxena@imperial.ac.uk	Saxena, Sonia K/G-4821-2013; Saxena, Sonia/ABD-7737-2021; Pollok, Richard C G/AAF-4713-2020	Saxena, Sonia K/0000-0003-3787-2083; Saxena, Sonia/0000-0003-3787-2083; Pollok, Richard C G/0000-0001-6452-6763				Christie D, 2005, BRIT MED J, V330, P301, DOI 10.1136/bmj.330.7486.301; Elliott EJ, 2007, BMJ-BRIT MED J, V334, P35, DOI 10.1136/bmj.39036.406169.80; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 27	2008	337	7672							a430	10.1136/bmj.39490.625197.BE	http://dx.doi.org/10.1136/bmj.39490.625197.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18625595				2022-12-28	WOS:000259797600046
J	Piot, P; Bartos, M; Larson, H; Zewdie, D; Mane, P				Piot, Peter; Bartos, Michael; Larson, Heidi; Zewdie, Debrework; Mane, Purnima			HIV prevention 6 - Coming to terms with complexity: a call to action for HIV prevention	LANCET			English	Article							SEXUAL-BEHAVIOR; HIV/AIDS; REDUCTION; HEALTH; IMPACT	A quarter of a century of AIDS responses has created a huge body of knowledge about HIV transmission and how to prevent it, yet every day, around the world, nearly 7000 people become infected with the virus. Although HIV prevention is complex, it ought not to be mystifying. Local and national achievements in curbing the epidemic have been myriad, and have created a body of evidence about what works, but these successful approaches have not yet been fully applied. Essential programmes and services have not had sufficient coverage; they have often lacked the funding to be applied with sufficient quality and intensity. Action and funding have not necessarily been directed to where the epidemic is or to what drives it. Few programmes address vulnerability to HIV and structural determinants of the epidemic. A prevention constituency has not been adequately mobilised to stimulate the demand for HIV prevention. Confident and unified leadership has not emerged to assert what is needed in HIV prevention and how to overcome the political, sociocultural, and logistic barriers in getting there. We discuss the combination of solutions which are needed to intensify HIV prevention, using the existing body of evidence and the lessons from our successes and failures in HIV prevention.	[Piot, Peter; Bartos, Michael] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland; [Larson, Heidi] Clark Univ, Dept Int Dev Community & Environm, Worcester, MA 01610 USA; [Larson, Heidi] Harvard Univ, Sch Publ Hlth, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Zewdie, Debrework] World Bank, Washington, DC 20433 USA; [Mane, Purnima] United Nations Populat Fund UNFPA, New York, NY USA	UNAIDS; Clark University; Harvard University; Harvard T.H. Chan School of Public Health; The World Bank; United Nations Population Fund	Bartos, M (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	bartosm@unaids.org	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				*AIDS2031 CONS, 2008, DEV AG FUT ANT 50 YE; ALEXANDER A, 2007, GLOB HLTH COUNC C WA; ANDERSON RM, 1996, AIDS WORLD, V2, P71; BAXTER D, 2006, HIV AUSTR, V5, P6; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; BERTOZZI SM, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60889-2; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Cohen J, 2004, SCIENCE, V304, P509, DOI 10.1126/science.304.5670.509; *COMM PREV HIV INF, 2006, PREV HIV INF INJ DRU; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Compston Alastair, LANCET, V372, P1502, DOI [DOI 10.1016/S0140-6736(08)60885-5, 10.1016/S0140-6736(08)61620-7, DOI 10.1016/S0140-6736(08)61620-7]; Crimp D., 1988, AIDS CULTURAL ANAL C; DEGENHARDT L, 2008, GLOBAL EPIDEMIOLOGY; DEWALQUE D, 2006, 3956 WORLD BANK; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; *FED DEM REP ETH, 2008, REP PROGR IMPL UN DE; *FED MIN HLTH, 2005, ACC ACC HIV AIDS PRE; Galvao J, 2005, AM J PUBLIC HEALTH, V95, P1110, DOI 10.2105/AJPH.2004.044313; Garnett GP, 2007, SEX TRANSM DIS, V34, P737, DOI 10.1097/OLQ.0b013e3181559c5c; *GOV SWED, 2006, C STOCKH SWED MAY; Grunseit A, 1997, J ADOLESCENT RES, V12, P421, DOI 10.1177/0743554897124002; GUPTA GR, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60887-9; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Hankins C, 2004, LANCET, V364, P1915, DOI 10.1016/S0140-6736(04)17488-6; HELGUERA G, 1990, INT C AIDS, V6, P294; *HLTH POL IN, 2006, INT CONS MAL SEX HLT; *INT TASK TEAM PRE, 2007, GUID GLOB SCAL UP PR; *IRIN AFR, 2007, W AFR IMP LOW RISK M; IZAZOLALICEA JA, 2002, FINANCING EXPENDITUR; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jitsuiki D, 2006, J HYPERTENS, V24, P68; LINGAPPA JR, 2008, REGIONAL DIFFERENCES; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; MERSON MH, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60884-3; Mesquita Fabio, 2007, Harm Reduct J, V4, P9, DOI 10.1186/1477-7517-4-9; *MIN PUBL HLTH THA, 2006, UN ACC 2010 THAIL NA; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Piot P, 2007, AM J PUBLIC HEALTH, V97, P1934, DOI 10.2105/AJPH.2007.121418; Piot P, 2006, LANCET, V368, P526, DOI 10.1016/S0140-6736(06)69161-7; *PMTCT GLOB PARTN, 2007, CONS STAT ACH UN ACC; *POP COUNC, 2008, ENG COMM SUPP HIV PR; PRIEUR A, 1990, AIDS EDUC PREV, V2, P101; Rogers EM., 2005, INNOVATION J PUBLIC, V10, P1, DOI DOI 10.1002/9781118785317.WE0M120209]; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; SAMUELS F, 2008, ENGAGING COMMUNITIES; SCHLEIFER R, 2006, RHETORIC RISK HUMAN; *SOUL CIT RES UN, 2007, HIV PREV MULT CONC S; Southern African Development Community (SADC), 2006, EXP THINK TANK M HIV; [State Council HIV/AIDS Working Committee UN Theme Group on HIV/AIDS in China], 2004, JOINT ASS HIV AIDS P; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; *TRAV RES CTR INDR, 2008, INT COORD INF SERV D; *TREATM ACT CAMP, 2006, MAK HIV PREV WORK; *UN GEN ASS, 2008, DECL COMM HIV AIDS P; *UNAIDS, 2004, 3 1S KEY PRINC; *UNAIDS, 2001, GLOB STRAT FRAM HIV; *UNAIDS, 2004, AIDS AFR 3 SCEN 2025; *UNAIDS, 2008, UNAIDS REP IN PRESS; UNAIDS, 2007, FIN RES REQ ACH UN A; *UNAIDS, 2007, INF DASHB; UNAIDS, 2005, INT HIV PREV UNAIDS; UNAIDS, 1998, EXP GLOB RESP HIV AI; *UNAIDS, 2007, PRACT GUID INT HIV P; *UNAIDS E EUR CENT, 2008, AIDS EP UPD REG SUMM; *UNAIDS E SO AFR R, 2007, REV HIV PREV RESP UN; *UNFPA, 2004, CULT MATT WORK COMM; *UNICEF UNAIDS WHO, 2008, CHILDR AIDS 2 STOCKT; *UNODC, 2007, 2007 WORLD DRUG REP; *US CDC, 2008, UPD COMP EV BAS INT; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868; VANGRIENSVEN F, 2007, 8 INT C AIDS AS PAC; Vernazza P, 2008, B MED SUISSES, V89, P165; WABRIREMANGEN F, 2006, RAPID ASSESSMENT TRE; WATNEY S, 1990, IDENTITY COMMUNITY C, P157; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Whiteside A., 2007, REV EMERGENCIES SWAZ; WHITSIDE A, 2008, HIV AIDS VERY SHORT; *WHO UNODC UNAIDS, 2008, DRAFT TECHN GUID COU; World Health Organization, 2008, UN ACC SCAL PRIOR HI	81	182	187	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					845	859		10.1016/S0140-6736(08)60888-0	http://dx.doi.org/10.1016/S0140-6736(08)60888-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	347FB	18687458				2022-12-28	WOS:000259124900027
J	Srinivasan, J; Kaplan, F; Ajredini, R; Zachariah, C; Alborn, HT; Teal, PEA; Malik, RU; Edison, AS; Sternberg, PW; Schroeder, FC				Srinivasan, Jagan; Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Alborn, Hans T.; Teal, Peter E. A.; Malik, Rabia U.; Edison, Arthur S.; Sternberg, Paul W.; Schroeder, Frank C.			A blend of small molecules regulates both mating and development in Caenorhabditis elegans	NATURE			English	Article							DAUER-INDUCING PHEROMONE; GENE; LONGEVITY; SEX	In many organisms, population- density sensing and sexual attraction rely on small- molecule- based signalling systems(1,2). In the nematode Caenorhabditis elegans, population density is monitored through specific glycosides of the dideoxysugar ascarylose ( the 'ascarosides') that promote entry into an alternative larval stage, the non- feeding and highly persistent dauer stage(3,4). In addition, adult C. elegans males are attracted to hermaphrodites by a previously unidentified small- molecule signal(5,6). Here we show, by means of combinatorial activity- guided fractionation of the C. elegans metabolome, that the mating signal consists of a synergistic blend of three dauer- inducing ascarosides, which we call ascr#2, ascr#3 and ascr#4. This blend of ascarosides acts as a potent male attractant at very low concentrations, whereas at the higher concentrations required for dauer formation the compounds no longer attract males and instead deter hermaphrodites. The ascarosides ascr#2 and ascr# 3 carry different, but overlapping, information, as ascr# 3 is more potent as a male attractant than ascr#2 , whereas ascr# 2 is slightly more potent than ascr# 3 in promoting dauer formation(7). We demonstrate that ascr# 2, ascr# 3 and ascr# 4 are strongly synergistic, and that two types of neuron, the amphid single- ciliated sensory neuron type K ( ASK) and the male- specific cephalic companion neuron ( CEM), are required for male attraction by ascr#3. On the basis of these results, male attraction and dauer formation in C. elegans appear as alternative behavioural responses to a common set of signalling molecules. The ascaroside signalling system thus connects reproductive and developmental pathways and represents a unique example of structure- and concentration-dependent differential activity of signalling molecules.	[Srinivasan, Jagan; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Srinivasan, Jagan; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Edison, Arthur S.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Edison, Arthur S.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; [Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Edison, Arthur S.] Univ Florida, Natl High Magnet Field Lab, Gainesville, FL 32610 USA; [Alborn, Hans T.; Teal, Peter E. A.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32604 USA; [Malik, Rabia U.; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	art@mbi.ufl.edu; pws@caltech.edu; fs31@cornell.edu	Srinivasan, Jagan/B-6215-2015; Kaplan, Fatma/AAJ-7666-2020; Schroeder, Frank/H-5026-2012	Kaplan, Fatma/0000-0002-9565-0211; Edison, Arthur/0000-0002-5686-2350; Srinivasan, Jagan/0000-0001-5449-7938; Sternberg, Paul/0000-0002-7699-0173; Schroeder, Frank/0000-0002-4420-0237	Human Frontiers Science Program; US National Institutes of Health [P41 GM079571]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079571] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Human Frontiers Science Program (A.S.E., P.W.S. and P.E.A.T.), a US National Institutes of Health grant (P41 GM079571) to F. C. S., and the Howard Hughes Medical Institute, of which J. S. is an associate and P. W. S. an investigator. NMR data were collected in the UF-AMRIS facility; we thank J. Rocca for assistance. We thank E. Peden and D. Xue for the ceh-30 strains, C. J. Cronin and A. Choe for advice on behavioural assays, L. R. Baugh for liquid-culture dauer formation assays, B. Fox for assistance with the synthesis of ascr#2, ascr#3 and ascr#4, and M. de Bono, A. Dossey and M. Stadler for discussions. E. Hallem, J. Bungert and D. Hutchinson provided comments on the manuscript.	Bae YK, 2006, DEVELOPMENT, V133, P3859, DOI 10.1242/dev.02555; Brey WW, 2006, J MAGN RESON, V179, P290, DOI 10.1016/j.jmr.2005.12.008; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; CARDE RT, 1984, FIELD TRAPPING ATTRA, P111; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Collet J, 1998, GENETICS, V148, P187; CRONIN CJ, 2005, BMC GENET, V6; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; GOLDEN JW, 1985, MOL GEN GENET, V198, P534, DOI 10.1007/BF00332953; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Tissenbaum HA, 1998, GENETICS, V148, P703; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Zwaal RR, 1997, GENETICS, V145, P715	23	257	276	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1115	U46		10.1038/nature07168	http://dx.doi.org/10.1038/nature07168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	341MW	18650807	Green Accepted			2022-12-28	WOS:000258719600037
J	Musters, C; McDonald, E; Jones, I				Musters, Charles; McDonald, Elizabeth; Jones, Ian			Management of postnatal depression	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POSTPARTUM DEPRESSION; WOMEN; RISK; PREVENTION; DISORDER		[Musters, Charles; McDonald, Elizabeth] City & Hackney Ctr Mental Hlth, E London NHS Fdn Trust, London E9 6SR, England; [Jones, Ian] Univ Wales Hosp, Dept Med Psychol, Cardiff CF14 4XN, Wales	Cardiff University	Musters, C (corresponding author), City & Hackney Ctr Mental Hlth, E London NHS Fdn Trust, London E9 6SR, England.	charles.musters@eastlondon.nhs.uk	Jones, Ian R/B-4925-2009	Jones, Ian R/0000-0001-5821-5889	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	CM was paid the attendance fee for a conference by Janssen-Cilag. EM was paid an honorarium for chairing an academic meeting and the attendance fee and travel expenses for a conference by Janssen-Cilag. 1) has received honorariums or consultancy fees from Lilly, GlaxoSmithKline, Lundbeck, Sanofi-Aventis, Janssen-Cilag, and AstraZeneca and has received research funding from GlaxoSmithKline.	Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Confidential Enquiry Into Maternal and Child Health, 2004, WHY MOTH 2000 2002 6; Cooper C, 2007, PSYCHOL MED, V37, P1273, DOI 10.1017/S0033291707000116; COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CL, 2005, BIRTH-ISS PERINAT C, V32, P187, DOI 10.1111/j.0730-7659.2005.00368.x; Eberhard-Gran M, 2002, ACTA PSYCHIAT SCAND, V106, P426, DOI 10.1034/j.1600-0447.2002.02408.x; Forty L, 2006, AM J PSYCHIAT, V163, P1549, DOI 10.1176/appi.ajp.163.9.1549; HARRIS B, 1994, BRIT MED J, V308, P949, DOI 10.1136/bmj.308.6934.949; Heron J, 2005, BIPOLAR DISORD, V7, P103, DOI 10.1111/j.1399-5618.2005.00185.x; Jones I, 2005, BRIT J PSYCHIAT, V186, P453, DOI 10.1192/bjp.186.6.453; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; National Institute for Health and Clinical Excellence, 2007, DEPR MAN DEPR PRIM S; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Weissman AM, 2004, AM J PSYCHIAT, V161, P1066, DOI 10.1176/appi.ajp.161.6.1066; WHO, 2019, INT STAT CLASS DIS R, V10th; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Wisner KL, 2004, AM J PSYCHIAT, V161, P1290, DOI 10.1176/appi.ajp.161.7.1290; Wisner KL, 2001, J CLIN PSYCHIAT, V62, P82, DOI 10.4088/JCP.v62n0202	24	19	19	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2008	337	7666							a736	10.1136/bmj.a736	http://dx.doi.org/10.1136/bmj.a736			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18689433	Green Accepted			2022-12-28	WOS:000258669200028
J	Padian, NS; Buve, A; Balkus, J; Serwadda, D; Cates, W				Padian, Nancy S.; Buve, Anne; Balkus, Jennifer; Serwadda, David; Cates, Ward, Jr.			HIV prevention 2 - Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; RANDOMIZED CONTROLLED-TRIAL; SUB-SAHARAN AFRICA; TO-CHILD TRANSMISSION; HERPES-SIMPLEX-VIRUS; REDUCING HETEROSEXUAL TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; MATERNAL-INFANT TRANSMISSION; SINGLE-DOSE NEVIRAPINE	intensive research efforts for more than two decades have not yet resulted in an HIV vaccine of even moderate effectiveness. However, some progress has been made with other biomedical interventions, albeit on the basis of inconsistent levels of evidence. The male condom, if used correctly and consistently, has been proven in observational studies to be very effective in blocking HIV transmission during sexual intercourse; and, in three randomised trials, male circumcision was protective against HIV acquisition among men. Treatment of sexually transmitted infections, a public health intervention in its own right, has had mixed results, depending in part on the epidemic context in which the approach was assessed. Finally, oral and topical antiretroviral compounds are being assessed for their role in reduction of HIV transmission during sexual intercourse. Research on biomedical interventions poses formidable challenges. Difficulties with product adherence and the possibility of sexual disinhibition are important concerns. Biomedical interventions will need to be part of an integrative package that includes biomedical, behavioural, and structural interventions. Assessment of such multicomponent approaches with moderate effects is difficult. Issues to be considered include the nature of control groups and the effect of adherence on the true effectiveness of the intervention.	[Padian, Nancy S.; Balkus, Jennifer] RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA; [Buve, Anne] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Cates, Ward, Jr.] Family Hlth Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute; Institute of Tropical Medicine (ITM); Makerere University	Padian, NS (corresponding author), RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA.	npadian@rti.org			Bill Melinda Gates	Bill Melinda Gates(Bill & Melinda Gates Foundation)	We thank Cate Hankins (UNAIDS), Mores Loolpapit (FH1), and Agnes Binagwaho (Executive Secretary of Rwanda's National Commission to Fight AIDS) for input in the section on male circumcision and Matthew Warner-Smith and Michael Bartos (both from UNAIDS) for their insights and guidance on the UNGASS indicators. Part of the research for this article (NSP) was supported by the Bill & Melinda Gates	*6 WEEK EXT DOS NE, IN PRESS LANCET; Abdool Q, 2001, J Am Med Womens Assoc (1972), V56, P193; Ahmed A, 1999, ANN TROP PAEDIATR, V19, P113, DOI 10.1080/02724939992743; Ali MM, 2005, SOC SCI MED, V60, P1175, DOI 10.1016/j.socscimed.2004.07.002; *ALL MICR DEV, 2008, MICR CAND ANC DEV DE; Alliance for Microbicide Development, 2008, MICR CAND ONG CLIN T; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2005, J INFECT DIS, V191, P546, DOI 10.1086/427656; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BARNHART K, 2006, MICR C CAP TOWN S AF; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; BECKER MH, 1988, AM J PUBLIC HEALTH, V78, P394, DOI 10.2105/AJPH.78.4.394; BERTOZZI SM, 2008, LANCET          0806; BONGAARTS J, 1989, AIDS, V3, P373, DOI 10.1097/00002030-198906000-00006; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Buck J, 2005, AIDS BEHAV, V9, P415, DOI 10.1007/s10461-005-9013-2; CALLEN M, 1983, HAVE SEX EPIDEMIC 1; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; CAREY RF, 1992, SEX TRANSM DIS, V19, P230, DOI 10.1097/00007435-199207000-00009; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; CATES W, 1990, AM J EPIDEMIOL, V131, P749, DOI 10.1093/oxfordjournals.aje.a115564; CATES W, 1992, NEW ENGL J MED, V327, P492, DOI 10.1056/NEJM199208133270711; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P101; Chaisilwattana P, 2002, CLIN INFECT DIS, V35, P1405, DOI 10.1086/344274; CHYS P, 1997, AIDS, V11, pF85; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; COATES TJ, 2008, LANCET          0806; Coffey PS, 2006, CONTRACEPTION, V73, P588, DOI 10.1016/j.contraception.2005.10.017; Cohen J, 2005, SCIENCE, V309, P1002, DOI 10.1126/science.309.5737.1002; Cohen J, 2008, SCIENCE, V319, P888, DOI 10.1126/science.319.5865.888; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; CONANT M, 1986, JAMA-J AM MED ASSOC, V255, P1706, DOI 10.1001/jama.1986.03370130062013; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Craib KJP, 1997, J INFECT DIS, V176, P798, DOI 10.1086/517305; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; Dabis F, 2005, AIDS, V19, P309; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Day M, 2007, BRIT MED J, V334, P1133, DOI 10.1136/bmj.39227.629803.DB; dCruzGrote D, 1996, LANCET, V348, P1071, DOI 10.1016/S0140-6736(95)11031-3; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; DESROSIERS R, 2008, 15 C RETR OPP INF BO; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; DREW WL, 1990, SEX TRANSM DIS, V17, P110, DOI 10.1097/00007435-199004000-00014; Duerr A, 2005, LANCET, V366, P261, DOI 10.1016/S0140-6736(05)66917-6; Eron JJ, 1996, JAMA-J AM MED ASSOC, V275, P36, DOI 10.1001/jama.275.1.36; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Feldblum PJ, 2001, AIDS, V15, P1037, DOI 10.1097/00002030-200105250-00012; *FEM HLTH CO, WHAT IS FC2 FEM COND; Fergusson DM, 2006, PEDIATRICS, V118, P1971, DOI 10.1542/peds.2006-1175; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Fiore JR, 1997, AIDS, V11, P1089, DOI 10.1097/00002030-199709000-00002; Fiore JR, 2003, AIDS, V17, P2169, DOI 10.1097/00002030-200310170-00004; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fontanet AL, 1998, AIDS, V12, P1851, DOI 10.1097/00002030-199814000-00017; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; FRANCIS DP, 1985, NEW ENGL J MED, V313, P1586, DOI 10.1056/NEJM198512193132506; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; French PP, 2003, SEX TRANSM DIS, V30, P433, DOI 10.1097/00007435-200305000-00010; Galvao LW, 2005, CONTRACEPTION, V71, P130, DOI 10.1016/j.contraception.2004.08.008; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; HALPERN V, 2007, 4 IAS C HIV PATH TRE; Hanenberg R, 1996, Aidscaptions, V3, P24; Hardy E, 2007, CONTRACEPTION, V76, P126, DOI 10.1016/j.contraception.2007.04.013; HEISE LL, 1995, SOC SCI MED, V40, P931, DOI 10.1016/0277-9536(94)00165-P; *HIV PREV TRIALS N, HPTN 052; *HIV VACC MICR RES, BUILD COMPR RESP FUN; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Howell AL, 1997, J VIROL, V71, P3498, DOI 10.1128/JVI.71.5.3498-3506.1997; Institute of Medicine, 2008, METH CHALL BIOM HIV; JAFFE HW, 1983, ANN INTERN MED, V99, P145, DOI 10.7326/0003-4819-99-2-145; JEFFERYS R, SCANNING SCI HORIZON; Jespers V, 2007, AIDS REV, V9, P61; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; KRESGE KJ, ADDITIONAL DATA RELE; KRIESS JK, 1993, J INFECT DIS, V168, P1404, DOI 10.1093/infdis/168.6.1404; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lagarde E, 2001, AIDS, V15, pS71, DOI 10.1097/00002030-200108004-00008; Lau JTF, 2007, SEX TRANSM DIS, V34, P908, DOI 10.1097/OLQ.0b013e3180e904b4; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; Lefrere JJ, 1998, J INFECT DIS, V177, P1541, DOI 10.1086/515308; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Liu AY, 2006, JAMA-J AM MED ASSOC, V296, P863, DOI 10.1001/jama.296.7.863; Lytle CD, 1997, SEX TRANSM DIS, V24, P161, DOI 10.1097/00007435-199703000-00007; Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; Mayatula V, 1997, Curationis, V20, P16; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; MCKUSICK L, 1985, PUBLIC HEALTH REP, V100, P622; MCNEIL DG, 2007, NY TIMES        1113; MELO M, 2006, 16 INT AIDS C TOR ON; *MERCK, VACC ENR DISC PHAS 2; *MICR DEV PROGR, MICR DEV PROGR MDP U; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nasio JM, 1996, INT J STD AIDS, V7, P410, DOI 10.1258/0956462961918374; National Institute of Allergy and Infectious Diseases (NIAID), 2001, WORKSH SUMM SCI EV C; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; NETO LFP, 2003, REV SOC BRAS MED TRO, V36, P689; O'Farrell N, 2006, JAIDS-J ACQ IMM DEF, V43, P69, DOI 10.1097/01.qai.0000225014.61192.98; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; *PEPFAR, PREV POS; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; *PETRA STUD TEAM, 2008, LANCET, V359, P1178; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; *POP COUNC, PROJECT NONCL LAB ST; *POP COUNC, TRIAL SHOWS ANT MICR; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; Ramjee Gita, 2006, AIDS Res Ther, V3, P25, DOI 10.1186/1742-6405-3-25; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; STOVER J, ISSUE BRIEF ADDING F; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Templeton D. J., 2007, 4 IAS C HIV PATH TRE, P22; THOMAS T, 2008, 15 C RETR OPP INF BO; Thomsen SC, 2006, SEX TRANSM INFECT, V82, P397, DOI 10.1136/sti.2006.019992; Tovanabutra S, 2002, J ACQ IMMUN DEF SYND, V29, P275, DOI 10.1097/00126334-200203010-00008; *UN GEN ASS, 2008, DECL COMM HIV AIDS P; UNAIDS, 2007, MAL CIRC GLOB TRENDS; *UNAIDS, 2007, AIDS EP UPD; UNAIDS, 2006, REP GLOB AIDS EP; *UNAIDS, ANT THER SEX TRANSM; *UNAIDS WHO, 2007, NEW DAT MAL CIRC HIV; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2007, 4 IAS C HIV PATH TRE; van de Wijgert JHHM, 2007, AIDS, V21, P2369, DOI 10.1097/QAD.0b013e3282ef83fd; VANDEPERRE P, 1987, AIDS, V1, P49; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; WAWER M, 2008, 15 C RETR OPP INF BO; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; WEISS HA, IN PRESS EMERG THEME; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; White RG, 2008, JAIDS-J ACQ IMM DEF, V47, P346, DOI 10.1097/QAI.0b013e318160d56a; WHO, 2004, MED EL CRIT CONTR US, V3; WHO, 2006, ANT DRUGS TREAT PREG; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization, 2002, PREV HIV INF YOUNG C; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	185	175	188	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2008	372	9638					585	599		10.1016/S0140-6736(08)60885-5	http://dx.doi.org/10.1016/S0140-6736(08)60885-5			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339MS	18687456				2022-12-28	WOS:000258582300032
J	Kyewski, B				Kyewski, Bruno			A breath of Aire for the periphery	SCIENCE			English	Editorial Material							AUTOIMMUNE REGULATOR AIRE; T-CELL TOLERANCE; LYMPHOID ORGANS; SELF; EXPRESSION; NODES; GENE		German Canc Res Ctr, Div Dev Immunol, Tumor Immunol Program, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Kyewski, B (corresponding author), German Canc Res Ctr, Div Dev Immunol, Tumor Immunol Program, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	b.kyewski@dkfz.de						Alferink J, 1999, IMMUNOL REV, V169, P255, DOI 10.1111/j.1600-065X.1999.tb01320.x; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; FRANKE WW, 1987, DIFFERENTIATION, V36, P145, DOI 10.1111/j.1432-0436.1987.tb00189.x; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Halonen M, 2001, J HISTOCHEM CYTOCHEM, V49, P197, DOI 10.1177/002215540104900207; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Saltis M, 2008, IMMUNOGENETICS, V60, P105, DOI 10.1007/s00251-007-0268-9	12	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					776	777		10.1126/science.1162966	http://dx.doi.org/10.1126/science.1162966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687943				2022-12-28	WOS:000258261000023
J	Savee, JD; Mozhayskiy, VA; Mann, JE; Krylov, AI; Continetti, RE				Savee, John D.; Mozhayskiy, Vadim A.; Mann, Jennifer E.; Krylov, Anna I.; Continetti, Robert E.			The role of excited-state topology in three-body dissociation of sym-triazine	SCIENCE			English	Article							EXCITATION-ENERGIES; CHARGE-TRANSFER; AB-INITIO; PHOTODISSOCIATION; 1,3,5-TRIAZINE; COLLISIONS	Molecular fragmentation into three products poses an analytical challenge to theory and experiment alike. We used translational spectroscopy and high-level ab initio calculations to explore the highly debated three-body dissociation of sym-triazine to three hydrogen cyanide molecules. Dissociation was induced by charge exchange between the sym-triazine radical cation and cesium. Calculated state energies and electronic couplings suggest that reduction initially produces a population of sym-triazine partitioned between the 3s Rydberg and pi* <- n electronically excited manifolds. Analysis of the topology of these manifolds, along with momentum correlation in the dissociation products, suggests that a conical intersection of two potential energy surfaces in the 3s Rydberg manifold leads to stepwise dissociation, whereas a four-fold glancing intersection in the pi* <- n manifold leads to a symmetric concerted reaction.	[Mozhayskiy, Vadim A.; Krylov, Anna I.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Savee, John D.; Mann, Jennifer E.; Continetti, Robert E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Southern California; University of California System; University of California San Diego	Krylov, AI (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	krylov@usc.edu; rcontinetti@ucsd.edu	Continetti, Robert E/L-4235-2013	Krylov, Anna/0000-0001-6788-5016; Continetti, Robert/0000-0002-0685-4459				Cave RJ, 1996, CHEM PHYS LETT, V249, P15, DOI 10.1016/0009-2614(95)01310-5; Continetti RE, 2001, ANNU REV PHYS CHEM, V52, P165, DOI 10.1146/annurev.physchem.52.1.165; DALITZ RH, 1953, PHILOS MAG, V44, P1068; DEMKOV YN, 1964, SOV PHYS JETP-USSR, V18, P138; Dillon JJ, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710255; Dyakov YA, 2007, J PHYS CHEM A, V111, P9591, DOI 10.1021/jp0740649; FRIDH C, 1972, INT J MASS SPECTROM, V8, P85; Galster U, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062506; Gejo T, 1996, J PHYS CHEM-US, V100, P13941, DOI 10.1021/jp9609592; Guenther J, 2000, CHEM PHYS LETT, V324, P31, DOI 10.1016/S0009-2614(00)00550-9; INNES KK, 1988, J MOL SPECTROSC, V132, P492, DOI 10.1016/0022-2852(88)90343-8; KATO H, 1982, J MOL STRUCT, V88, P265; KOCH H, 1995, CHEM PHYS LETT, V244, P75, DOI 10.1016/0009-2614(95)00914-P; KOLAITIS L, 1986, ANAL CHEM, V58, P1993, DOI 10.1021/ac00122a017; Krylov AI, 2008, ANNU REV PHYS CHEM, V59, P433, DOI 10.1146/annurev.physchem.59.032607.093602; Laperle CM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.153202; Lee J, 2004, PHYS CHEM CHEM PHYS, V6, P945, DOI 10.1039/b314730d; Maul C, 1997, INT REV PHYS CHEM, V16, P1, DOI 10.1080/014423597230307; Mozhayskiy VA, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2204602; ONDREY GS, 1984, J CHEM PHYS, V81, P4517, DOI 10.1063/1.447421; OSAMURA Y, 1981, J CHEM PHYS, V75, P5828, DOI 10.1063/1.442031; OSAMURA Y, 1987, J AM CHEM SOC, V109, P1370, DOI 10.1021/ja00239a014; Pai SV, 1996, J PHYS CHEM-US, V100, P5681, DOI 10.1021/jp9532778; Parusel ABJ, 1999, J PHYS CHEM A, V103, P4056, DOI 10.1021/jp984346w; SALOP A, 1971, J CHEM PHYS, V54, P1187, DOI 10.1063/1.1674954; Schinke R., 1993, PHOTODISSOCIATION DY, P109; SIDIS V, 1989, J PHYS CHEM-US, V93, P8128, DOI 10.1021/j100362a003; STANTON JF, 1993, J CHEM PHYS, V98, P7029, DOI 10.1063/1.464746	28	36	36	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					826	830		10.1126/science.1157617	http://dx.doi.org/10.1126/science.1157617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687962				2022-12-28	WOS:000258261000043
J	Stone, AJ				Stone, Anthony J.			Intermolecular potentials	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; 1ST PRINCIPLES; FREE-ENERGY; MOLECULES; MODEL; WATER; POLARIZATION; COEFFICIENTS; PREDICTION; DYNAMICS		[Stone, Anthony J.] Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England	University of Cambridge	Stone, AJ (corresponding author), Univ Cambridge, Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	ajs1@cam.ac.uk	Stone, Anthony/M-8040-2015	Stone, Anthony/0000-0002-3846-245X				BUCKINGHAM AD, 1985, CAN J CHEM, V63, P2018, DOI 10.1139/v85-334; Bukowski R, 2007, SCIENCE, V315, P1249, DOI 10.1126/science.1136371; Clary DC, 2008, SCIENCE, V321, P789, DOI 10.1126/science.1157718; Day GM, 2005, CRYST GROWTH DES, V5, P1023, DOI 10.1021/cg049651n; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Geerke DP, 2007, J PHYS CHEM B, V111, P6425, DOI 10.1021/jp0706477; Joubert L, 2002, MOL PHYS, V100, P3357, DOI 10.1080/00268970210152773; LESLIE M, IN PRESS MOL PHYS; Misquitta AJ, 2008, CHEM PHYS LETT, V456, P105, DOI 10.1016/j.cplett.2008.02.113; Murdachaew G, 2001, FARADAY DISCUSS, V118, P121, DOI 10.1039/b009748i; Neumann MA, 2005, J PHYS CHEM B, V109, P15531, DOI 10.1021/jp050121r; Rasmussen TD, 2007, INT J QUANTUM CHEM, V107, P1390, DOI 10.1002/qua.21278; Schwabe T, 2007, PHYS CHEM CHEM PHYS, V9, P3397, DOI 10.1039/b704725h; Scribano Y, 2006, J PHYS CHEM A, V110, P5411, DOI 10.1021/jp056759k; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Stone AJ, 2007, INT REV PHYS CHEM, V26, P193, DOI 10.1080/01442350601081931; Stone AJ, 2005, J CHEM THEORY COMPUT, V1, P1128, DOI 10.1021/ct050190+; TANG KT, 1984, J CHEM PHYS, V80, P3726, DOI 10.1063/1.447150; Wales D. J., 2003, ENERGY LANDSCAPES; Wheatley RJ, 2007, INT REV PHYS CHEM, V26, P449, DOI 10.1080/01442350701371539	20	106	108	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					787	789		10.1126/science.1158006	http://dx.doi.org/10.1126/science.1158006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687950				2022-12-28	WOS:000258261000030
J	Raghavan, S; Manzanillo, P; Chan, K; Dovey, C; Cox, JS				Raghavan, Sridharan; Manzanillo, Paolo; Chan, Kaman; Dovey, Cole; Cox, Jeffery S.			Secreted transcription factor controls Mycobacterium tuberculosis virulence	NATURE			English	Article							BACILLUS-CALMETTE-GUERIN; PSEUDOMONAS-AERUGINOSA; ESAT-6 SECRETION; GENE-EXPRESSION; SYSTEM; INFECTION; ANTIGEN; PROTEIN; MACROPHAGES; VACCINATION	Bacterial pathogens trigger specialized virulence factor secretion systems on encountering host cells. The ESX-1 protein secretion system of Mycobacterium tuberculosis - the causative agent of the human disease tuberculosis - delivers bacterial proteins into host cells during infection and is critical for virulence, but how it is regulated is unknown. Here we show that EspR (also known as Rv3849) is a key regulator of ESX-1 that is required for secretion and virulence in mice. EspR activates transcription of an operon that includes three ESX-1 components, Rv3616c-Rv3614c, whose expression in turn promotes secretion of ESX-1 substrates. EspR directly binds to and activates the Rv3616c-Rv3614c promoter and, unexpectedly, is itself secreted from the bacterial cell by the ESX-1 system that it regulates. Efflux of the DNA-binding regulator results in reduced Rv3616c-Rv3614c transcription, and thus reduced ESX-1 secretion. Our results reveal a direct negative feedback loop that regulates the activity of a secretion system essential for virulence. As the virulence factors secreted by the ESX-1 system are highly antigenic, fine control of secretion may be critical to successful infection.	[Raghavan, Sridharan; Manzanillo, Paolo; Chan, Kaman; Dovey, Cole; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, 600 16th St,Campus Box 2200, San Francisco, CA 94143 USA.	Jeffery.Cox@ucsf.edu			NIAID NIH HHS [P01 AI063302, R01 AI051667-06, P01 AI063302-040001, P01 AI063302-020001, P01 AI063302-050001, P01 AI063302-010001, AI63302, R01 AI051667-08, R01 AI051667-07, P01 AI063302-030001, R01 AI051667, AI51667] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051667, P01AI063302] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Colangeli R, 2000, INFECT IMMUN, V68, P990, DOI 10.1128/IAI.68.2.990-993.2000; Coler RN, 2001, J IMMUNOL, V166, P6227, DOI 10.4049/jimmunol.166.10.6227; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lewis RJ, 1996, FEBS LETT, V378, P98, DOI 10.1016/0014-5793(95)01432-2; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Maizel A, 2002, DEVELOPMENT, V129, P3545; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh B, 2003, CLIN EXP IMMUNOL, V134, P70, DOI 10.1046/j.1365-2249.2003.02258.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367	40	146	169	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					717	U49		10.1038/nature07219	http://dx.doi.org/10.1038/nature07219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685700	Green Accepted			2022-12-28	WOS:000258228000035
J	Rawstron, AC; Bennett, FL; O'Connor, SJM; Kwok, M; Fenton, JAL; Plummer, M; de Tute, R; Owen, RG; Richards, SJ; Jack, AS; Hillmen, P				Rawstron, Andy C.; Bennett, Fiona L.; O'Connor, Sheila J. M.; Kwok, Marwan; Fenton, James A. L.; Plummer, Marieth; de Tute, Ruth; Owen, Roger G.; Richards, Stephen J.; Jack, Andrew S.; Hillmen, Peter			Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE MUTATION STATUS; EXPRESSION; PROGRESSION; EXPANSIONS; GUIDELINES; DIAGNOSIS; FREQUENT; BLOOD	Background: A diagnosis of chronic lymphocytic leukemia (CLL) requires a count of over 5000 circulating CLL-phenotype cells per cubic millimeter. Asymptomatic persons with fewer CLL-phenotype cells have monoclonal B-cell lymphocytosis (MBL). The goal of this study was to investigate the relation between MBL and CLL. Methods: We investigated 1520 subjects who were 62 to 80 years of age with a normal blood count and 2228 subjects with lymphocytosis (>4000 lymphocytes per cubic millimeter) for the presence of MBL, using flow cytometry. Monoclonal B cells were further characterized by means of cytogenetic and molecular analyses. A representative cohort of 185 subjects with CLL-phenotype MBL and lymphocytosis were monitored for a median of 6.7 years (range, 0.2 to 11.8). Results: Monoclonal CLL-phenotype B cells were detected in 5.1% of subjects (78 of 1520) with a normal blood count and 13.9% (309 of 2228) with lymphocytosis. CLL-phenotype MBL had a frequency of 13q14 deletion and trisomy 12 similar to that of CLL and showed a skewed repertoire of the immunoglobulin heavy variable group (IGHV) genes. Among 185 subjects presenting with lymphocytosis, progressive lymphocytosis occurred in 51 (28%), progressive CLL developed in 28 (15%), and chemotherapy was required in 13 (7%). The absolute B-cell count was the only independent prognostic factor associated with progressive lymphocytosis. During follow-up over a median of 6.7 years, 34% of subjects (62 of 185) died, but only 4 of these deaths were due to CLL. Age above 68 years and hemoglobin level below 12.5 g per deciliter were the only independent prognostic factors for death. Conclusions: The CLL-phenotype cells found in the general population and in subjects with lymphocytosis have features in common with CLL cells. CLL requiring treatment develops in subjects with CLL-phenotype MBL and with lymphocytosis at the rate of 1.1% per year.	[Rawstron, Andy C.] St James Inst Oncol, HMDS, Dept Haematol, Leeds LS9 7TF, W Yorkshire, England; Leeds Teaching Hosp, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Rawstron, AC (corresponding author), St James Inst Oncol, HMDS, Dept Haematol, Bexley Wing,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	andy.rawstron@hmds.org.uk	Kwok, Marwan/AAG-7558-2019	Kwok, Marwan/0000-0002-3985-5079; Richards, Stephen/0000-0002-8421-5353; Rawstron, Andy/0000-0003-0798-9790				Bennett FL, 2004, BRIT J HAEMATOL, V125, P6; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fung SS, 2007, LEUKEMIA LYMPHOMA, V48, P1087, DOI 10.1080/10428190701321277; Ghia P, 2004, BLOOD, V103, P2337, DOI 10.1182/blood-2003-09-3277; *HAEM MAL RES NETW, ANN EST INC MON B CE; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin BJ, 2000, BLOOD, V95, P2455, DOI 10.1182/blood.V95.7.2455.007a43c_2455_2457; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Marti GE, 2003, CYTOM PART B-CLIN CY, V52B, P1, DOI 10.1002/cyto.b.10013; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; McCarthy B, 2006, J INVEST MED, V54, pS386; (NCI) NCI, SURV EP END RES SEER; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Rawstron AC, 2002, BLOOD, V100, P635, DOI 10.1182/blood.V100.2.635; Rawstron AC, 2002, BLOOD, V100, P2289, DOI 10.1182/blood-2002-03-0892; Rawstron AC, 2001, BLOOD, V98, P29, DOI 10.1182/blood.V98.1.29; Shanafelt TD, 2008, LEUKEMIA RES, V32, P1458, DOI 10.1016/j.leukres.2007.11.030; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948	24	391	409	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					575	583		10.1056/NEJMoa075290	http://dx.doi.org/10.1056/NEJMoa075290			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687638	Bronze			2022-12-28	WOS:000258216700005
J	Sokol, DK				Sokol, Daniel K.			Clarifying best interests - What should doctors consider when determining what's best for their patients?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, St Georges, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, St Georges, London WC1E 7HU, England.	daniel.sokol@talk21.com							0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a994	10.1136/bmj.a994	http://dx.doi.org/10.1136/bmj.a994			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18667474				2022-12-28	WOS:000258561000025
J	Jansen, JFA; Gearhart, JD; Bulte, JWM				Jansen, Jacobus F. A.; Gearhart, John D.; Bulte, Jeff W. M.			Comment on "magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain"	SCIENCE			English	Editorial Material									[Jansen, Jacobus F. A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Jansen, Jacobus F. A.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Jansen, Jacobus F. A.] Maastricht Univ Hosp, Dept Radiol, NL-6202 AZ Maastricht, Netherlands; [Gearhart, John D.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD 21205 USA; [Gearhart, John D.; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Cellular Imaging Sect, Inst Cell Engn, Baltimore, MD 21205 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Maastricht University; Maastricht University Medical Centre (MUMC); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Jansen, JFA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med Phys, 1275 York Ave, New York, NY 10021 USA.	jansenjfa@gmail.com	Bulte, Jeff W.M./A-3240-2008; Jansen, Jacobus F.A./C-4098-2009	Bulte, Jeff W.M./0000-0003-1202-1610; Jansen, Jacobus F.A./0000-0002-5271-8060				BARKHUIJSEN H, 1985, MAGNET RESON MED, V2, P86, DOI 10.1002/mrm.1910020111; Bartha R, 2007, NMR BIOMED, V20, P512, DOI 10.1002/nbm.1122; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Jansen JFA, 2006, MAGN RESON MED, V56, P666, DOI 10.1002/mrm.20968; Kassem MNE, 2003, MAGNET RESON MED, V49, P918, DOI 10.1002/mrm.10443; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; McIntyre DJO, 2007, J MAGN RESON IMAGING, V26, P1596, DOI 10.1002/jmri.21198	7	19	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					640	640		10.1126/science.1153997	http://dx.doi.org/10.1126/science.1153997			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669846				2022-12-28	WOS:000258077700023
J	Brown, RH; Soderblom, LA; Soderblom, JM; Clark, RN; Jaumann, R; Barnes, JW; Sotin, C; Buratti, B; Baines, KH; Nicholson, PD				Brown, R. H.; Soderblom, L. A.; Soderblom, J. M.; Clark, R. N.; Jaumann, R.; Barnes, J. W.; Sotin, C.; Buratti, B.; Baines, K. H.; Nicholson, P. D.			The identification of liquid ethane in Titan's Ontario Lacus	NATURE			English	Article							SURFACE; ICE; SATURN; OCEAN; LAKES; SEAS	Titan was once thought to have global oceans of light hydrocarbons on its surface(1-5), but after 40 close flybys of Titan by the Cassini spacecraft, it has become clear that no such oceans exist(6). There are, however, features similar to terrestrial lakes and seas(7), and widespread evidence for fluvial erosion(8,9), presumably driven by precipitation of liquid methane from Titan's dense, nitrogen-dominated atmosphere(10). Here we report infrared spectroscopic data, obtained by the Visual and Infrared Mapping Spectrometer(11) ( VIMS) on board the Cassini spacecraft, that strongly indicate that ethane, probably in liquid solution with methane, nitrogen and other low- molecular- mass hydrocarbons, is contained within Titan's Ontario Lacus.	[Brown, R. H.; Soderblom, J. M.] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Soderblom, L. A.] US Geol Survey, Flagstaff, AZ 86001 USA; [Clark, R. N.] US Geol Survey, Lakewood, CO 80225 USA; [Jaumann, R.] Deutsch Zentrum Luft & Raumfahrt, D-12489 Berlin, Germany; [Barnes, J. W.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Sotin, C.; Buratti, B.; Baines, K. H.] CALTECH, Jet Prop Lab, Pasadena, CA 91107 USA; [Nicholson, P. D.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	University of Arizona; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University	Brown, RH (corresponding author), Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA.	rhb@lpl.arizona.edu	Barnes, Jason W/B-1284-2009; Jaumann, Ralf/N-1001-2018	Barnes, Jason W/0000-0002-7755-3530; Jaumann, Ralf/0000-0002-9759-6597; Soderblom, Jason/0000-0003-3715-6407				Barnes JW, 2007, ICARUS, V186, P242, DOI 10.1016/j.icarus.2006.08.021; Barnes JW, 2005, SCIENCE, V310, P92, DOI 10.1126/science.1117075; Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; BROWN RH, 1988, ICARUS, V74, P262, DOI 10.1016/0019-1035(88)90041-3; Brown RH, 1997, ANNU REV EARTH PL SC, V25, P243, DOI 10.1146/annurev.earth.25.1.243; CLARK RN, 1984, J GEOPHYS RES, V89, P6341, DOI 10.1029/JB089iB07p06341; CLARK RN, 1980, ICARUS, V41, P323, DOI 10.1016/0019-1035(80)90217-1; CLARK RN, IN PRESS ICARUS; CLARK RN, UNPUB J GEOPHYS RES; DERMOTT SF, 1995, NATURE, V374, P238, DOI 10.1038/374238a0; Elachi C, 2006, NATURE, V441, P709, DOI 10.1038/nature04786; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; Grundy WM, 2002, ICARUS, V155, P486, DOI 10.1006/icar.2001.6726; LEWIS JS, 1973, ANNU REV PHYS CHEM, V24, P339, DOI 10.1146/annurev.pc.24.100173.002011; Lopes R. M. C., 2007, EOS, V88, P569, DOI [DOI 10.1029/2007EO510001, 10.1029/2007EO510001]; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; LUNINE JI, 1994, AM SCI, V82, P134; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; Mitri G, 2007, ICARUS, V186, P385, DOI 10.1016/j.icarus.2006.09.004; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; PRINN RG, 1981, ASTROPHYS J, V249, P308, DOI 10.1086/159289; SAGAN C, 1982, NATURE, V300, P731, DOI 10.1038/300731a0; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2025, DOI 10.1016/j.pss.2007.04.014; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126	29	191	192	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					607	610		10.1038/nature07100	http://dx.doi.org/10.1038/nature07100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668101				2022-12-28	WOS:000258026500039
J	Walter, MJ; Bulanova, GP; Armstrong, LS; Keshav, S; Blundy, JD; Gudfinnsson, G; Lord, OT; Lennie, AR; Clark, SM; Smith, CB; Gobbo, L				Walter, M. J.; Bulanova, G. P.; Armstrong, L. S.; Keshav, S.; Blundy, J. D.; Gudfinnsson, G.; Lord, O. T.; Lennie, A. R.; Clark, S. M.; Smith, C. B.; Gobbo, L.			Primary carbonatite melt from deeply subducted oceanic crust	NATURE			English	Article							EARTHS LOWER MANTLE; HIGH-PRESSURE; TRANSITION ZONE; PHASE-RELATIONS; MATO-GROSSO; JUINA AREA; DIAMONDS; FLUIDS; METASOMATISM; SUBSOLIDUS	Partial melting in the Earth's mantle plays an important part in generating the geochemical and isotopic diversity observed in volcanic rocks at the surface(1). Identifying the composition of these primary melts in the mantle is crucial for establishing links between mantle geochemical 'reservoirs' and fundamental geodynamic processes(2). Mineral inclusions in natural diamonds have provided a unique window into such deep mantle processes(3-8). Here we provide experimental and geochemical evidence that silicate mineral inclusions in diamonds from Juina, Brazil, crystallized from primary and evolved carbonatite melts in the mantle transition zone and deep upper mantle. The incompatible trace element abundances calculated for a melt coexisting with a calcium-titanium- silicate perovskite inclusion indicate deep melting of carbonated oceanic crust, probably at transition- zone depths. Further to perovskite, calcic- majorite garnet inclusions record crystallization in the deep upper mantle from an evolved melt that closely resembles estimates of primitive carbonatite on the basis of volcanic rocks. Small- degree melts of subducted crust can be viewed as agents of chemical mass- transfer in the upper mantle and transition zone, leaving a chemical imprint of ocean crust that can possibly endure for billions of years.	[Walter, M. J.; Bulanova, G. P.; Armstrong, L. S.; Blundy, J. D.; Lord, O. T.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Keshav, S.; Gudfinnsson, G.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; [Lennie, A. R.] SERC, Daresbury Lab, Warrington WA4 4AD, Cheshire, England; [Clark, S. M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [Smith, C. B.] Rio Tinto Min & Explorat Ltd, London W2 6LG, England; [Gobbo, L.] Rio Tinto Desinvolvimentos Min Ltda, BR-71200020 Brasilia, DF, Brazil	University of Bristol; University of Bayreuth; STFC Daresbury Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rio Tinto	Walter, MJ (corresponding author), Univ Bristol, Dept Earth Sci, Queens Rd, Bristol BS8 1RJ, Avon, England.	m.j.walter@bris.ac.uk	Facility, Edinburgh Ion Microprobe/AAD-8512-2020; Lord, Oliver T/D-4663-2014; Clark, Simon/B-2041-2013; Armstrong, Lora/D-3310-2013	Facility, Edinburgh Ion Microprobe/0000-0001-6248-6657; Lord, Oliver T/0000-0003-0563-1293; Clark, Simon/0000-0002-7488-3438; Gudfinnsson, Gudmundur/0000-0003-3275-9866; Armstrong, Lora/0000-0003-0198-5692; Keshav, Satish/0000-0003-0508-8665	NERC [NE/E010466/1] Funding Source: UKRI; Natural Environment Research Council [NE/E010466/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Arima M, 2002, GEOLOGY, V30, P691, DOI 10.1130/0091-7613(2002)030<0691:DNAGBR>2.0.CO;2; BRENAN JM, 1995, GEOCHIM COSMOCHIM AC, V59, P3331, DOI 10.1016/0016-7037(95)00215-L; Brenker FE, 2005, EARTH PLANET SC LETT, V236, P579, DOI 10.1016/j.epsl.2005.05.021; Brenker FE, 2007, EARTH PLANET SC LETT, V260, P1, DOI 10.1016/j.epsl.2007.02.038; BULANOVA GP, 1995, J GEOCHEM EXPLOR, V53, P1, DOI 10.1016/0375-6742(94)00016-5; Coltorti M, 1999, J PETROL, V40, P133, DOI 10.1093/petrology/40.1.133; Corgne A, 2002, GEOPHYS RES LETT, V29, DOI [10.1029/2001GL014398, 10.1029/2001GL614398]; Dasgupta R, 2004, EARTH PLANET SC LETT, V227, P73, DOI 10.1016/j.epsl.2004.08.004; Haggerty S.E., 1999, GEOCHEM SOC SPEC PUB, V6, P105; Harmer RE, 1998, J PETROL, V39, P1895, DOI 10.1093/petrology/39.11.1895; Harte B, 1999, MANTLE PETROLOGY FIE, P125, DOI [10.1007/978-81-322-1170-9_15, DOI 10.1007/978-81-322-1170-9_15]; Harte B., 1994, MINERAL MAG A, V58A, P384, DOI DOI 10.1180/MINMAG.1994.58A.1.201; HAURI EH, 1993, NATURE, V365, P221, DOI 10.1038/365221a0; Hayman PC, 2005, CONTRIB MINERAL PETR, V149, P430, DOI 10.1007/s00410-005-0657-8; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; Hirose K, 2004, PHYS EARTH PLANET IN, V146, P249, DOI 10.1016/j.pepi.2002.11.001; Hirose K, 2002, GEOCHIM COSMOCHIM AC, V66, P2099, DOI 10.1016/S0016-7037(02)00847-5; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Ionov D, 1998, J PETROL, V39, P1931, DOI 10.1093/petroj/39.11-12.1931; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; Kaminsky FV, 2001, CONTRIB MINERAL PETR, V140, P734, DOI 10.1007/s004100000221; KESHAV S, 2006, P 11 INT C EMPG; Kessel R, 2005, NATURE, V437, P724, DOI 10.1038/nature03971; Kogarko L. N., 1993, S AFR J GEOL, V96, P119; Kubo A, 1997, PHYS CHEM MINER, V24, P488, DOI 10.1007/s002690050063; Manning CE, 2004, EARTH PLANET SC LETT, V223, P1, DOI 10.1016/j.epsl.2004.04.030; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Safonov OG, 2007, EARTH PLANET SC LETT, V253, P112, DOI 10.1016/j.epsl.2006.10.020; Stachel T, 2001, EUR J MINERAL, V13, P883, DOI 10.1127/0935-1221/2001/0013/0883; Stachel T, 2000, CONTRIB MINERAL PETR, V140, P16, DOI 10.1007/s004100000174; Stachel T, 2000, CONTRIB MINERAL PETR, V140, P1, DOI 10.1007/s004100000173; Tappert R, 2005, GEOLOGY, V33, P565, DOI 10.1130/G21637.1; Walter MJ, 2006, EARTH PLANET SC LETT, V248, P77, DOI 10.1016/j.epsl.2006.05.017; Walter MJ, 2004, PHYS EARTH PLANET IN, V143, P541, DOI 10.1016/j.pepi.2003.09.019; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	35	198	217	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					622	U30		10.1038/nature07132	http://dx.doi.org/10.1038/nature07132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668105	Green Submitted			2022-12-28	WOS:000258026500043
J	Light, D				Light, Donald			Will the NHS strategic plan benefit patients?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-SERVICE; CARE; QUALITY		[Light, Donald] Univ Med & Dent New Jersey, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Light, D (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	dlight@princeton.edu						Audit Commission, 2008, IS TREATM WORK PROGR; Boyd J., 2007, 2006 INPATIENTS IMPO; Darzi A., 2008, HIGH QUALITY CARE AL; Delamothe T, 2008, BRIT MED J, V336, P1410, DOI 10.1136/bmj.a292; Dixon M, 2008, BRIT MED J, V336, P1164, DOI 10.1136/bmj.a130; Ham C, 2003, LANCET, V361, P1978, DOI 10.1016/S0140-6736(03)13593-3; Ham C., 2007, COMMISSIONING ENGLIS; Ham C, 2008, BRIT MED J, V336, P805, DOI 10.1136/bmj.39532.445197.AD; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Klein R., 2006, NEW POLITICS NHS CRE, V5st edition; Leatherman S., 2008, QUEST QUALITY NHS; Light D, 2004, BRIT MED J, V328, P763, DOI 10.1136/bmj.328.7442.763; Light DW, 1998, BRIT MED J, V316, P217; Liker J. K., 2004, TOYOTA WAY 14 MANAGE; *NHS ALL, 2008, SICKN HLTH ACH INT N; Perlin JB, 2004, AM J MANAG CARE, V10, P828; Pollock A., 2008, NHS PLC PRIVATISATIO; Schneider EC, 2005, AM J MED, V118, P1392, DOI 10.1016/j.amjmed.2005.05.032; Smith J, 2001, BRIT MED J, V323, P1262, DOI 10.1136/bmj.323.7324.1262	19	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2008	337	7663							a824	10.1136/bmj.a824	http://dx.doi.org/10.1136/bmj.a824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335EG	18640955				2022-12-28	WOS:000258273000036
J	Fillingham, J; Greenblatt, JF				Fillingham, Jeffrey; Greenblatt, Jack F.			A histone code for chromatin assembly	CELL			English	Editorial Material							REPLICATION; COMPLEX	In this issue, two papers implicate histone H3 lysine 56 acetylation in histone deposition in chromatin. Li et al. ( 2008) show that acetylation of H3K56 promotes S phase chromatin assembly that is mediated by the histone chaperones CAF-1 and Rtt106. Chen et al. ( 2008) establish that the acetylation mark promotes chromatin reassembly following DNA double-strand break repair.	[Fillingham, Jeffrey; Greenblatt, Jack F.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto	Greenblatt, JF (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	jack.greenblatt@utoronto.ca						Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147	6	20	21	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					206	208		10.1016/j.cell.2008.07.007	http://dx.doi.org/10.1016/j.cell.2008.07.007			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662534	Bronze			2022-12-28	WOS:000257891700008
J	Tang, WQ; Kim, TW; Oses-Prieto, JA; Sun, Y; Deng, ZP; Zhu, SW; Wang, RJ; Burlingame, AL; Wang, ZY				Tang, Wenqiang; Kim, Tae-Wuk; Oses-Prieto, Juan A.; Sun, Yu; Deng, Zhiping; Zhu, Shengwei; Wang, Ruiju; Burlingame, Alma L.; Wang, Zhi-Yong			BSKs mediate signal transduction from the receptor kinase BRI1 in Arabidopsis	SCIENCE			English	Article							PLASMA-MEMBRANE; BAK1; GROWTH; MECHANISMS; PROTEOMICS; REGULATOR; PLANTS; BZR1	Brassinosteroids ( BRs) bind to the extracellular domain of the receptor kinase BRI1 to activate a signal transduction cascade that regulates nuclear gene expression and plant development. Many components of the BR signaling pathway have been identified and studied in detail. However, the substrate of BRI1 kinase that transduces the signal to downstream components remains unknown. Proteomic studies of plasma membrane proteins lead to the identification of three homologous BR- signaling kinases ( BSK1, BSK2, and BSK3). The BSKs are phosphorylated by BRI1 in vitro and interact with BRI1 in vivo. Genetic and transgenic studies demonstrate that the BSKs represent a small family of kinases that activate BR signaling downstream of BRI1. These results demonstrate that BSKs are the substrates of BRI1 kinase that activate downstream BR signal transduction.	[Tang, Wenqiang; Kim, Tae-Wuk; Sun, Yu; Deng, Zhiping; Zhu, Shengwei; Wang, Ruiju; Wang, Zhi-Yong] Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; [Oses-Prieto, Juan A.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Zhu, Shengwei] Chinese Acad Sci, Key Lab Photosynth & Environm Mol Biol, Inst Bot, Beijing 100093, Peoples R China; [Wang, Ruiju] Nankai Univ, Inst Mol Biol, Coll Life Sci, Tianjin 300071, Peoples R China	Carnegie Institution for Science; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Botany, CAS; Nankai University	Wang, ZY (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Oses-Prieto, Juan/0000-0003-4759-2341; Tang, Wenqiang/0000-0002-2972-5748; Deng, zhiping/0000-0001-9663-3088	NCRR NIH HHS [RR01614, RR019934, RR012961] Funding Source: Medline; NIGMS NIH HHS [R01 GM066258-07, R01 GM066258, R01GM066258] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012961, S10RR019934, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Deng ZP, 2007, MOL CELL PROTEOMICS, V6, P2058, DOI 10.1074/mcp.M700123-MCP200; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Johnson KL, 2005, CURR OPIN PLANT BIOL, V8, P648, DOI 10.1016/j.pbi.2005.09.007; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044	24	444	487	11	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					557	560		10.1126/science.1156973	http://dx.doi.org/10.1126/science.1156973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653891	Green Accepted			2022-12-28	WOS:000257888900046
J	Dienstag, JL				Dienstag, Jules L.			Relevance and rigor in premedical education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dienstag, JL (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Dienstag, Jules/0000-0001-7024-0980					0	48	49	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					221	224		10.1056/NEJMp0803098	http://dx.doi.org/10.1056/NEJMp0803098			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326KD	18635426				2022-12-28	WOS:000257656600001
J	Redondo, P; Del Olmo, J				Redondo, Pedro; Del Olmo, Julio			Vitiligo and cutaneous melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Redondo, Pedro; Del Olmo, Julio] Univ Navarra Clin, E-31080 Pamplona, Spain	University of Navarra	Redondo, P (corresponding author), Univ Navarra Clin, E-31080 Pamplona, Spain.	predondo@unav.es	REDONDO, PEDRO/H-7989-2017	REDONDO, PEDRO/0000-0001-7899-2511					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					E3	E3		10.1056/NEJMicm053764	http://dx.doi.org/10.1056/NEJMicm053764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326KD	18635425				2022-12-28	WOS:000257656600010
J	Gonzalez, R; Zamora, J; Gomez-Camarero, J; Molinero, LM; Banares, R; Albillos, A				Gonzalez, Rosario; Zamora, Javier; Gomez-Camarero, Judith; Molinero, Luis-Migu; Banares, Rafael; Albillos, Agustin			Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis	ANNALS OF INTERNAL MEDICINE			English	Review							LIGATION PLUS NADOLOL; ESOPHAGEAL-VARICES; PORTAL-HYPERTENSION; GASTROESOPHAGEAL VARICES; INJECTION SCLEROTHERAPY; PRESSURE-GRADIENT; PROPRANOLOL; MULTICENTER; OBLITERATION; PROPHYLAXIS	Background: Combining endoscopic therapy and beta-blockers may improve outcomes in patients with cirrhosis and bleeding esophageal varices. Purpose: To assess whether a combination of endoscopic and drug therapy prevents overall and variceal rebleeding and improves survival better than either therapy alone. Data Sources: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and conference proceedings through 30 December 2007. Study Selection: Randomized trials comparing encloscopic plus p-blocker therapy with either therapy alone, without language restrictions. Data Extraction: Two reviewers independently extracted data on interventions and the primary study outcomes of overall rebleeding and mortality. Metaregression and stratified analysis were used to explore heterogeneity. Data Synthesis: 23 trials (1860 patients) met inclusion criteria. Combination therapy reduced overall rebleeding more than endoscopic therapy alone (pooled relative risk, 0.68 [95% CI, 0.52 to 0.89]; I-2 = 0 %) or beta-blocker therapy alone (pooled relative risk, 0.71 [CI, 0.59 to 0.861; 12 = 0%). Combination therapy also reduced variceal rebleeding and variceal recurrence. Reduction in mortality from combination therapy did not statistically significantly differ from that from endoscopic (Peto odds ratio, 0.78 [CI, 0.58 to 1.07) or drug therapy (Peto odds ratio, 0.70 [CI, 0.46 to 1.06]). Effects were independent of the encloscopic procedure (injection sclerotherapy or banding). No trial-level variable associated with the effect was identified through metaregression or stratified analysis. Limitation: Statistically significant heterogeneity in trial quality and evidence for selective reporting and publication bias were found. Conclusion: A combination of encloscopic and drug therapy reduces overall and variceal rebleeding in cirrhosis more than either therapy alone.	[Gonzalez, Rosario; Zamora, Javier; Gomez-Camarero, Judith; Molinero, Luis-Migu; Banares, Rafael; Albillos, Agustin] Univ Alcala de Henares, Univ Complutense,Hosp Univ Ramon Y Cajal, Hosp Gen Univ Gregorio Maranon, CSIC,Ciberehd,Ciberesp,Unidad I D Asociada, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBERESP; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); General University Gregorio Maranon Hospital; Hospital Universitario Ramon y Cajal; Universidad de Alcala	Albillos, A (corresponding author), Hosp Univ Ramon Y Cajal, Serv Gastroenterol, Carretera Colmenar Km 9-100, Madrid 28034, Spain.	aalbillosm@meditex.es	Zamora, Javier/AEO-0608-2022; Molinero, Luis Miguel/AAY-9337-2020; Banares, Rafael/J-1460-2012; Zamora, Javier/B-1722-2009	Zamora, Javier/0000-0003-4901-588X; Molinero, Luis Miguel/0000-0002-8036-9523; Banares, Rafael/0000-0002-7860-0861; Zamora, Javier/0000-0003-4901-588X; Banares, Rafael/0000-0002-0412-8437				ACHARYA SK, 1993, J HEPATOL, V19, P291, DOI 10.1016/S0168-8278(05)80585-9; Albillos A, 2007, AM J GASTROENTEROL, V102, P1116, DOI 10.1111/j.1572-0241.2007.01191.x; AVGERINOS A, 1993, J HEPATOL, V19, P301, DOI 10.1016/S0168-8278(05)80586-0; Banares R, 2002, HEPATOLOGY, V35, P609, DOI 10.1053/jhep.2002.31354; Benedeto-Stojanov D, 2000, J HEPATOL, V32, P72, DOI 10.1016/S0168-8278(00)80611-X; BERTONI G, 1990, J CLIN GASTROENTEROL, V12, P364; Bosch J, 2003, LANCET, V361, P952, DOI 10.1016/S0140-6736(03)12778-X; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; D'Amico G, 1999, SEMIN LIVER DIS, V19, P475, DOI 10.1055/s-2007-1007133; D'Amico G, 2004, PORTAL HYPERTENSION IN THE 21ST CENTURY, P147; D'Amico G, 2003, HEPATOLOGY, V38, P599, DOI 10.1053/jhep.2003.50385; D'Amico G, 2006, GASTROENTEROLOGY, V131, P1611, DOI 10.1053/j.gastro.2006.09.013; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; de la Pena J, 2005, HEPATOLOGY, V41, P572, DOI 10.1002/hep.20584; Dowidar N., 2005, Journal of the Egyptian Society of Parasitology, V35, P773; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elsayed SS, 1996, GUT, V38, P770, DOI 10.1136/gut.38.5.770; Garcia-Pagan JC, 2006, J HEPATOL, V44, pS11, DOI 10.1016/S0168-8278(06)80024-3; Garcia-Tsao G, 2007, AM J GASTROENTEROL, V102, P2086, DOI 10.1111/j.1572-0241.2007.01481.x; GERUNDA GE, 1990, HEPATOLOGY, V12, P988; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; INK O, 1992, HEPATOLOGY, V16, P912, DOI 10.1002/hep.1840160410; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; JENSEN LS, 1990, SCAND J GASTROENTERO, V25, P352, DOI 10.3109/00365529009095498; JENSEN LS, 1989, SCAND J GASTROENTERO, V24, P339, DOI 10.3109/00365528909093057; Jha SK, 2007, HEPATOLOGY, V46, p250A; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kanazawa H, 1991, Nihon Shokakibyo Gakkai Zasshi, V88, P1341; LAINE L, 1995, ANN INTERN MED, V123, P280, DOI 10.7326/0003-4819-123-4-199508150-00007; LIGHT RJ, 1984, SUMMING SCI; Lo GH, 2000, HEPATOLOGY, V32, P461, DOI 10.1053/jhep.2000.16236; LO GH, 1993, J GASTROEN HEPATOL, V8, P358, DOI 10.1111/j.1440-1746.1993.tb01528.x; LO GH, 2005, GUT S7, V54, pA78; LUNDELL L, 1990, ACTA CHIR SCAND, V156, P711; OCONNOR KW, 1989, GASTROENTEROLOGY, V96, P899; Sharara AI, 2001, NEW ENGL J MED, V345, P669, DOI 10.1056/NEJMra003007; Signorelli S., 1996, Journal of Hepatology, V25, P92; Sollano JD, 2001, GASTROINTEST ENDOSC, V53, pAB143; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; VICKERS C, 1994, J HEPATOL, V21, P81, DOI 10.1016/S0168-8278(94)80141-X; VILLANUEVA C, 1994, REV ESP ENFERM DIG, V86, P499; VINEL JP, 1992, GASTROENTEROLOGY, V102, P1760, DOI 10.1016/0016-5085(92)91740-U; WESTABY D, 1986, HEPATOLOGY, V6, P673, DOI 10.1002/hep.1840060422	45	114	131	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					109	122		10.7326/0003-4819-149-2-200807150-00007	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626050				2022-12-28	WOS:000257853700005
J	Goodge, JW; Vervoort, JD; Fanning, CM; Brecke, DM; Farmer, GL; Williams, IS; Myrow, PM; DePaolo, DJ				Goodge, J. W.; Vervoort, J. D.; Fanning, C. M.; Brecke, D. M.; Farmer, G. L.; Williams, I. S.; Myrow, P. M.; DePaolo, D. J.			A positive test of east Antarctica-Laurentia juxtaposition within the Rodinia supercontinent	SCIENCE			English	Article							U-PB GEOCHRONOLOGY; A-TYPE GRANITES; UNITED-STATES; TRANSANTARCTIC MOUNTAINS; ISOTOPIC EVIDENCE; AUSTRALIA; ND; CONSTRAINTS; PROVENANCE; HISTORY	The positions of Laurentia and other landmasses in the Precambrian supercontinent of Rodinia are controversial. Although geological and isotopic data support an East Antarctic fit with western Laurentia, alternative reconstructions favor the juxtaposition of Australia, Siberia, or South China. New geologic, age, and isotopic data provide a positive test of the juxtaposition with East Antarctica: Neodymium isotopes of Neoproterozoic rift- margin strata are similar; hafnium isotopes of similar to 1.4- billion- year- old Antarctic- margin detrital zircons match those in Laurentian granites of similar age; and a glacial clast of A- type granite has a uraniun- lead zircon age of similar to 1440 million years, an epsilon- hafnium initial value of +7, and an epsilon- neodymium initial value of +4. These tracers indicate the presence of granites in East Antarctica having the same age, geochemical properties, and isotopic signatures as the distinctive granites in Laurentia.	[Goodge, J. W.] Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA; [Vervoort, J. D.] Washington State Univ, Sch Earth & Environm Sci, Pullman, WA 99164 USA; [Fanning, C. M.; Williams, I. S.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Brecke, D. M.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA; [Farmer, G. L.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Farmer, G. L.] Univ Colorado, CIRES, Boulder, CO 80309 USA; [Myrow, P. M.] Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA; [DePaolo, D. J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of Minnesota System; University of Minnesota Duluth; Washington State University; Australian National University; University of Minnesota System; University of Minnesota Duluth; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Colorado College; University of California System; University of California Berkeley	Goodge, JW (corresponding author), Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA.	jgoodge@d.umn.edu	Fanning, C. Mark/I-6449-2016; Vervoort, Jeff/AAJ-6234-2020; Goodge, John/GQI-3878-2022; SHRIMP, ANU/F-5312-2011; Williams, Ian S/F-4302-2012	Fanning, C. Mark/0000-0003-3331-3145; Williams, Ian S/0000-0003-4465-6493; Vervoort, Jeff/0000-0002-1138-4527; Goodge, John/0000-0003-2578-3147				Anderson J., 1999, ROCKY MOUNTAIN GEOLO, V34, P149, DOI DOI 10.2113/34.2.149; Anderson JL, 2005, LITHOS, V80, P45, DOI 10.1016/j.lithos.2004.05.008; BAROVICH KM, 1992, CONTRIB MINERAL PETR, V109, P386, DOI 10.1007/BF00283326; BENNETT VC, 1987, GEOL SOC AM BULL, V99, P674, DOI 10.1130/0016-7606(1987)99<674:PCHOTW>2.0.CO;2; BOND GC, 1997, GEOLOGICAL SOC AM AB, V29, P280; BORG SG, 1990, J GEOPHYS RES-SOLID, V95, P6647, DOI 10.1029/JB095iB05p06647; Collins AS, 2005, EARTH-SCI REV, V71, P229, DOI 10.1016/j.earscirev.2005.02.004; Daly S.J., 1998, AGSO J AUSTR GEOLOGY, V17, P145; DALZIEL IWD, 1991, GEOLOGY, V19, P598, DOI 10.1130/0091-7613(1991)019<0598:PMOLAE>2.3.CO;2; Dalziel IWD, 1997, GEOL SOC AM BULL, V109, P16, DOI 10.1130/0016-7606(1997)109<0016:ONPGAT>2.3.CO;2; Fanning C.M., 2003, GEOL SOC AM ABSTR, V35, P465; Fanning CM, 2004, GEOLOGY, V32, P881, DOI 10.1130/G20609.1; Farmer GL, 1997, GEOL SOC AM BULL, V109, P1193; FROST CD, 1987, J GEOL, V95, P309, DOI 10.1086/629132; GLEASON JD, 1994, CONTRIB MINERAL PETR, V118, P182, DOI 10.1007/BF01052868; Goodge JW, 2006, EARTH PLANET SC LETT, V243, P711, DOI 10.1016/j.epsl.2006.01.040; Goodge JW, 2004, GEOL SOC AM BULL, V116, P1253, DOI 10.1130/B25347.1; Goodge JW, 2002, J GEOL, V110, P393, DOI 10.1086/340629; Goodge JW, 2001, PRECAMBRIAN RES, V112, P261, DOI 10.1016/S0301-9268(01)00193-0; Goodge JW, 1999, GEOLOGY, V27, P1007, DOI 10.1130/0091-7613(1999)027<1007:BYOPEH>2.3.CO;2; Hoffman P.F., 1989, GEOLOGY N AM OVERVIE, VA, P447, DOI DOI 10.1130/DNAG-GNA-A.447; HOFFMAN PF, 1991, SCIENCE, V252, P1409, DOI 10.1126/science.252.5011.1409; IDNURM M, 1995, GEOLOGY, V23, P149, DOI 10.1130/0091-7613(1995)023<0149:PNNAAL>2.3.CO;2; Kendall B, 2006, GEOLOGY, V34, P729, DOI 10.1130/G22775.1; Li ZX, 2008, PRECAMBRIAN RES, V160, P179, DOI 10.1016/j.precamres.2007.04.021; Lund K, 2003, GEOL SOC AM BULL, V115, P349, DOI 10.1130/0016-7606(2003)115<0349:SUPGON>2.0.CO;2; Meert JG, 2003, TECTONOPHYSICS, V362, P1, DOI 10.1016/S0040-1951(02)00629-7; MOORES EM, 1991, GEOLOGY, V19, P425, DOI 10.1130/0091-7613(1991)019<0425:SUSEAS>2.3.CO;2; Myrow PM, 2002, GEOL SOC AM BULL, V114, P1070; NELSON BK, 1985, GEOL SOC AM BULL, V96, P746, DOI 10.1130/0016-7606(1985)96<746:RPOCCT>2.0.CO;2; Peucat JJ, 1999, PRECAMBRIAN RES, V94, P205, DOI 10.1016/S0301-9268(98)00119-3; POWELL CM, 1993, GEOLOGY, V21, P889, DOI 10.1130/0091-7613(1993)021<0889:PCOTOT>2.3.CO;2; Preiss WV, 2000, PRECAMBRIAN RES, V100, P21, DOI 10.1016/S0301-9268(99)00068-6; ROSS GM, 1992, EARTH PLANET SC LETT, V113, P57, DOI 10.1016/0012-821X(92)90211-D; Torsvik TH, 2003, SCIENCE, V300, P1379, DOI 10.1126/science.1083469; VANSCHMUS WR, 1993, PRECAMBRIAN CONTERMI, P171; Weil AB, 1998, EARTH PLANET SC LETT, V154, P13, DOI 10.1016/S0012-821X(97)00127-1; WHALEN JB, 1987, CONTRIB MINERAL PETR, V95, P407, DOI 10.1007/BF00402202; Wingate MTD, 2002, TERRA NOVA, V14, P121, DOI 10.1046/j.1365-3121.2002.00401.x; WOODEN JL, 1990, J GEOPHYS RES-SOLID, V95, P20133, DOI 10.1029/JB095iB12p20133	40	147	150	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					235	240		10.1126/science.1159189	http://dx.doi.org/10.1126/science.1159189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621666				2022-12-28	WOS:000257512900036
